Citrus Sinensis ID: 041043
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S9M5 | 730 | Wall-associated receptor | yes | no | 0.946 | 0.879 | 0.452 | 1e-156 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.914 | 0.782 | 0.443 | 1e-154 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.898 | 0.791 | 0.451 | 1e-154 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.942 | 0.854 | 0.427 | 1e-150 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.949 | 0.857 | 0.428 | 1e-150 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.915 | 0.812 | 0.423 | 1e-148 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.948 | 0.844 | 0.424 | 1e-145 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.923 | 0.869 | 0.439 | 1e-144 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.911 | 0.784 | 0.425 | 1e-143 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.918 | 0.852 | 0.423 | 1e-142 |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 554 bits (1427), Expect = e-156, Method: Compositional matrix adjust.
Identities = 322/712 (45%), Positives = 440/712 (61%), Gaps = 70/712 (9%)
Query: 3 LQLLLQVIILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIG-ENCYFDKL 61
Q ++ ++ LL+ S A PPPP + +C +CG ++IPFPFGIG ++CY +
Sbjct: 8 FQFIVASVLTLLIN--DSSAATPPPPISNSSTSCNKTCGG-ISIPFPFGIGGKDCYLNGW 64
Query: 62 YAIDCKSSK-------PILRSINLEVLEFLLEKST-----MRVNQSVIS-SCQDKTTEAS 108
Y + C ++ P+L IN EV+ L S +++ V S C T+E
Sbjct: 65 YEVICNTTTSDSNTTVPLLSMINREVVNISLPDSNEPYGLVQIKGPVTSLGCSSNTSEGP 124
Query: 109 FVNLEKLPF------YFSYYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKTEDD 162
+L L YF +N +GC A M+ + + + GC S C+ R E+
Sbjct: 125 QNSLPVLNVTGKGSPYFLTDENRLVAVGCGIKALMTDTESEIL--GCESSCEHRKSGEEV 182
Query: 163 S---CNGIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNF 219
+ C G CC+A +P I++N SS E CK AF+ +K + SN
Sbjct: 183 TNLICTGYRCCQARLPVGRPQ----AITVNIENSSGG----EETCKVAFLTDKRYSPSNV 234
Query: 220 KSARRVQNWNQVPVILDWRIP--NSSFGEL------ERDESSKFTSTSHCESD--EGGLF 269
+ N V + L W NS F L R S CE D G +
Sbjct: 235 TEPEQFHNNGYVVLELGWYFATSNSRFKSLLGCTNMSRKGSGFSDDNCSCEYDYFSGMSY 294
Query: 270 R-CSCKEKYHGNPYFLHGCQDLRCENYEGGYRC-----------------VNPK--RPKV 309
R C C Y GNPY GC D ++ EG + C NPK +P
Sbjct: 295 RNCYCDYGYTGNPYLRGGCVDT--DSCEGNHNCGEDAHCVNMPGPMSMCRPNPKITKPTK 352
Query: 310 YTIILGIGTGLGGLLLSIGALWLCIII--RRRIKQKEENFKKNGGLLLEQQLNSLDGSID 367
++ GI GL GL+ +G WL +I RR I + ++ FK+NGGLLL+QQL + DG+++
Sbjct: 353 PPVLQGILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVE 412
Query: 368 RCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFIN 427
KIF+SKEL KATD+F+++R+LGQGGQGTVYKGML DG I+AVK+SKVVDE K+EEFIN
Sbjct: 413 MSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFIN 472
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
E+V+LSQI+HRN+VKLLG CLE EVP+LVYE+IPNG LF+ LHD S++ ++TWE+RLRIA
Sbjct: 473 EIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIA 532
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
E+A AL Y+HS+A PI+HRDIK+TNILLDEKYRAK++DFGTSRS+ +DQTH++T V G
Sbjct: 533 IEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAG 592
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607
TFGY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP+S + + EGR LAT+F+E ++EN
Sbjct: 593 TFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKEN 652
Query: 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
+ DI+D +++ K E++M V+ +A++CLN G++RP MKEV+ ELERIR+
Sbjct: 653 RVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRS 704
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 547 bits (1409), Expect = e-154, Method: Compositional matrix adjust.
Identities = 322/726 (44%), Positives = 435/726 (59%), Gaps = 106/726 (14%)
Query: 36 CPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKSSK-----PILRSINLEVLEFLL--EKS 88
C CG + IP+PFG+G+ CY +K Y I C +S P L IN EV+ L E
Sbjct: 31 CQPDCGG-IKIPYPFGMGKGCYLEKWYEITCNTSTSGKLVPYLSVINKEVVGISLPTEGR 89
Query: 89 TMRVN---QSV-----ISS--CQDKTTE-ASFVNLEKLPFYFSYYDNIFSGIGCNNLASM 137
R N QSV I+S C E S +NL PFY S ++ + + +GCNN AS+
Sbjct: 90 GSRYNNPYQSVNIKNPIASKECSSNGEELGSLLNLTGTPFYVSQHNELVA-VGCNNTASL 148
Query: 138 SSADHDFILGGCFSICDPRNKT--------------------------------EDDSCN 165
++ + C S C + T ++ SCN
Sbjct: 149 TNVKPSIV--QCTSSCSTKPHTHIKDYLAVLNCQNYNGYEKNCNEDSSMDESIMDETSCN 206
Query: 166 GIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRV 225
GI CC A + SI I T ++ ++ CK AF+ K + SN +++
Sbjct: 207 GIGCCNAYMRGG------SIQQIVGVTIENTITR---GCKVAFLTNKAEYLSNKSDPQKL 257
Query: 226 QNWNQVPVILDWRI--PNSSFGE------LERDESSKFTST------SHCESDEGGLF-- 269
V L W I N SF + ++ + ++TST + C D+
Sbjct: 258 HARGYSTVELGWFIHTTNHSFIKSLGCYSVKEYNNERYTSTQRRINITSCICDDNAYLSY 317
Query: 270 -RCSCKEKYHGNPYFLHGCQDL---------------RCENYEGGYRCV-NPKRPKVYTI 312
RCSC + GNPY L GC+D+ +C N +G ++CV N RP +
Sbjct: 318 ARCSCTRGFQGNPYRLGGCKDINECKEEEGMTYCGTNKCVNLQGHFKCVYNNHRP----L 373
Query: 313 ILGIGTGLGGLLLSIGALWLCIIIR--RRIKQKEENFKKNGGLLLEQQLNSLDGSIDRCK 370
+G+G G L+ +G L I+ R++ QK++ FK+NGGLLL+QQL S G +++
Sbjct: 374 AIGLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTI 433
Query: 371 IFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVV 430
+F+S+EL+KAT++F+ NRILGQGGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEVV
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493
Query: 431 ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATE 489
ILSQI+HRN+VKLLG CLE +VP+LVYEFIPNG LF++LHD E + TW +RLRIA +
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAID 553
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+A AL+YLHSSA PIYHRD+KSTNI+LDEKYRAK++DFGTSR++ +D TH++T V GT
Sbjct: 554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTV 613
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609
GY+DPEYF SSQFTDKSDVYSFGVVLVEL+TG+K IS++ + E R LATYF+ ++EN L
Sbjct: 614 GYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKL 673
Query: 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNI 669
FDI+D ++R ++ + VA++CLN GR RP+M+EV+MEL+ IR + D +
Sbjct: 674 FDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR---MPCGDMQL 730
Query: 670 QKCYEE 675
Q+C E
Sbjct: 731 QECVSE 736
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 545 bits (1405), Expect = e-154, Method: Compositional matrix adjust.
Identities = 316/700 (45%), Positives = 430/700 (61%), Gaps = 91/700 (13%)
Query: 35 NCPYSCGNNVTIPFPFGIGENCYFDKLYAIDC-KSSKPILRSINLEVLE----------F 83
+CP +CG + IP+PFGIG CY +K Y I C +S P L IN EV+ F
Sbjct: 26 SCPKTCGG-IDIPYPFGIGTGCYLEKWYEIICVNNSVPFLSIINREVVSISFSDMYRRFF 84
Query: 84 LLEKSTMRVNQSVIS-SCQDKTTE-ASFVNLEKLPFYFSYYDNIFSGIGCNNLASMSSAD 141
+ ++R+ + S C E S +N+ PFY +N+ +GCNN AS+++ +
Sbjct: 85 NVGYGSIRIRNPIASKGCSSGGQEFGSLLNMTGYPFYLGD-NNMLIAVGCNNTASLTNVE 143
Query: 142 HDFILGGCFSICD-----PRNK----------------------TEDDSCNGIECCKAGV 174
+ GC S C P N D SCNGI CCKA +
Sbjct: 144 PSIV--GCESTCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCCKASL 201
Query: 175 PWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVI 234
P + I + I++ S+ E CK AF+ ++E+F SN R+ V
Sbjct: 202 PARYQ--QIIGVEIDD------SNTESKGCKVAFITDEEYFLSNGSDPERLHANGYDTVD 253
Query: 235 LDWRI--PNSSF-GELE----------RDESSKFTSTSHCE--SDEGGLFRCSCKEKYHG 279
L W I N SF G L R ++ ++ C+ S G CSC + G
Sbjct: 254 LRWFIHTANHSFIGSLGCKSIDEYTILRRDNREYGIGCLCDYNSTTTGYATCSCASGFEG 313
Query: 280 NPYFLHGCQDL----------------RCENYEGGYRC-VNPKRPKVYTIILGIGTGLGG 322
NPY C+D+ +C N GGY C RP +++G+ T
Sbjct: 314 NPYIPGECKDINECVRGIDGNPVCTAGKCVNLLGGYTCEYTNHRP----LVIGLSTSFST 369
Query: 323 LLLSIGALWLCIIIRR--RIKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKA 380
L+ G WL IRR R+ QK++ FK+NGGLLL+QQL + +G++D ++FNS+EL+KA
Sbjct: 370 LVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKA 429
Query: 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
T++F++ RILG+GGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEVVILSQI+HRN+
Sbjct: 430 TENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNI 489
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLT-WEMRLRIATEVAEALAYLHS 499
VKLLG CLE +VP+LVYEFIPNG LF++LHD S++ ++T WE+RLRIA ++A AL+YLHS
Sbjct: 490 VKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHS 549
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+A PIYHRDIKSTNI+LDEK+RAK++DFGTSR++ +D TH++T V GT GY+DPEYF S
Sbjct: 550 AASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQS 609
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619
SQFTDKSDVYSFGVVL EL+TG+K +S++ + E R LATYF ++EN L DI+D ++R
Sbjct: 610 SQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRD 669
Query: 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
K ++ + +A++CLN GR RP+M++V+MELE+IR+
Sbjct: 670 GCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1368), Expect = e-150, Method: Compositional matrix adjust.
Identities = 301/704 (42%), Positives = 426/704 (60%), Gaps = 65/704 (9%)
Query: 2 NLQLLLQVIILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIG-ENCYFDK 60
N Q + I +L L+ I V+ A PP C CG ++IPFPFGIG ++CY +
Sbjct: 7 NRQCIPLAISVLSLF-INGVSSARQPPD-----RCNRVCGE-ISIPFPFGIGGKDCYLNP 59
Query: 61 LYAIDCKS--SKPILRSINLEVLEFLLEKSTMRVNQSVISS-CQDKTTEASFVNLEKLPF 117
Y + C S S P L IN E++ L + + V SS C T++ L P
Sbjct: 60 WYEVVCNSTNSVPFLSRINRELVNISL-NGVVHIKAPVTSSGCSTGTSQP----LTPPPL 114
Query: 118 --------YFSYYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKTEDDS----CN 165
YF N+ +GC A M+ + C S C+ RN + + CN
Sbjct: 115 NVAGQGSPYFLTDKNLLVAVGCKFKAVMAGITSQ--ITSCESSCNERNSSSQEGRNKICN 172
Query: 166 GIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRV 225
G +CC+ +P +IS++ +++ EG C+ AF+ ++ N +
Sbjct: 173 GYKCCQTRIPEG----QPQVISVDIEIPQGNNTTGEGGCRVAFLTSDKYSSLNVTEPEKF 228
Query: 226 QNWNQVPVILDWRIPNSSFGELE------RDESSKFTSTSHCESDEGGL----FR-CSCK 274
V L W S + + +++ +TS + C G +R C C
Sbjct: 229 HGHGYAAVELGWFFDTSDSRDTQPISCKNASDTTPYTSDTRCSCSYGYFSGFSYRDCYCN 288
Query: 275 EK-YHGNPYFLHGC---------------QDLRCENYEGGYRCVNPKRP-KVYTIILGIG 317
Y GNP+ GC +D C N G + C PK+P ++ +I G+
Sbjct: 289 SPGYKGNPFLPGGCVDVDECKLDIGRNQCKDQSCVNLPGWFDC-QPKKPEQLKRVIQGVL 347
Query: 318 TGLGGLLLSIG--ALWLCIIIRRRIKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSK 375
G LL + G L+ + RR++ + + F++NGG+LL+QQL +G+++ +IF+S
Sbjct: 348 IGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSH 407
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
EL+KATD+FN NR+LGQGGQGTVYKGML DGRI+AVK+SK VDE ++EEFINEVV+L+QI
Sbjct: 408 ELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQI 467
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+HRN+VKLLG CLE EVP+LVYEF+PNG L + LHD S++ ++TWE+RL IA E+A AL+
Sbjct: 468 NHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALS 527
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
YLHS+A PIYHRDIK+TNILLDE+ RAK++DFGTSRS+ IDQTH++T+V GTFGY+DPE
Sbjct: 528 YLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPE 587
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615
YF SS+FT+KSDVYSFGVVLVELLTG+KP S + + E R LA +FVE V+EN + DI+DD
Sbjct: 588 YFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDD 647
Query: 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
+++ +++M V+++A+RCLN G+ RP M+EV++ELE IR+
Sbjct: 648 RIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRS 691
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1367), Expect = e-150, Method: Compositional matrix adjust.
Identities = 301/702 (42%), Positives = 428/702 (60%), Gaps = 58/702 (8%)
Query: 3 LQLLLQVIILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIGE-NCYFDKL 61
+LL ++ L + P+ + A++PP + +C CG + IPFPFGIG +C+ +
Sbjct: 8 FSVLLSILTLFINGPLITTAQSPPS----SSTSCNRICGG-IEIPFPFGIGRRDCFLNDW 62
Query: 62 YAIDC------KSSKPILRSINLEVLEFLLEKS------TMRVNQSVISS-CQDKTTEAS 108
Y + C KS P L IN E++ L S + + V SS C + +
Sbjct: 63 YEVVCNSTTSGKSLAPFLYKINRELVSITLRSSIDSSYGVVHIKSPVTSSGCSQRPVKPL 122
Query: 109 FVNL--EKLPFYFSYYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKTEDDSCNG 166
+NL + PF+ + + + S +GC+N A ++ D + + GC S CD D C G
Sbjct: 123 PLNLTGKGSPFFITDSNRLVS-VGCDNRALIT--DIESQITGCESSCDGDKSRLDKICGG 179
Query: 167 IECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQ 226
CC+A +P + +I ++ +S +++Q G CK AF+ + + +N +
Sbjct: 180 YTCCQAKIP----ADRPQVIGVDLESSGGNTTQG-GNCKVAFLTNETYSPANVTEPEQFY 234
Query: 227 NWNQVPVILDWRIPNSS------FGELERDESSKFTSTSHCESDEG-----GLFRCSCKE 275
+ L W S G + E+ +TS C + G G C C +
Sbjct: 235 TNGFTVIELGWYFDTSDSRLTNPVGCVNLTETGIYTSAPSCVCEYGNFSGFGYSNCYCNQ 294
Query: 276 -KYHGNPYFLHGCQD---------------LRCENYEGGYRCVNPKRPKVYTIILGIGTG 319
Y GNPY GC D L C N G +RC K+ + G+ G
Sbjct: 295 IGYRGNPYLPGGCIDIDECEEGKGLSSCGELTCVNVPGSWRCELNGVGKIKPLFPGLVLG 354
Query: 320 LGGLLLSIGALWLCIIIRRRIKQKEEN--FKKNGGLLLEQQLNSLDGSIDRCKIFNSKEL 377
L L +G L +++R K + FK+NGGLLL+QQL + G++ KIF+SKEL
Sbjct: 355 FPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKEL 414
Query: 378 DKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISH 437
+KATD+FN+NR+LGQGGQGTVYKGML DGRI+AVK+SKV+DE K+EEFINEV +LSQI+H
Sbjct: 415 EKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINH 474
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
RN+VKL+G CLE EVP+LVYE IPNG LF+ LH S++ ++TW++RLRI+ E+A ALAYL
Sbjct: 475 RNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYL 534
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS+A P+YHRD+K+TNILLDEKYRAK++DFGTSRSI +DQTH++T V GTFGYLDPEYF
Sbjct: 535 HSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYF 594
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617
+SQFTDKSDVYSFGVVLVEL+TG+KP S + E R L ++F E +++N + DI+D ++
Sbjct: 595 QTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRI 654
Query: 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
++ E+++ V+ +A+RCL+ G+ RP M+EV++ELERIR+
Sbjct: 655 KEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 527 bits (1357), Expect = e-148, Method: Compositional matrix adjust.
Identities = 310/732 (42%), Positives = 432/732 (59%), Gaps = 111/732 (15%)
Query: 29 PPLTKPNCPYSCGNNVTIPFPFGIGE-NCYFDKLYAIDCKSSK------PILRSINLEVL 81
P L +C + CG+ + IPFPFGIGE CY D+ Y ++C+ S P L IN+EV+
Sbjct: 19 PILHFSSCTHKCGD-IQIPFPFGIGEIGCYLDEWYQVECRPSATSGKVFPFLPKINMEVV 77
Query: 82 EFLLEK------------STMRVNQSVIS-SCQDKTTEASF-VNLEKLPFYFSYYDNIFS 127
L S++RV V S C ++ +N + PF+F +N+ +
Sbjct: 78 NISLPGTNDDIFYTYPSFSSIRVKSPVASMGCSTDGNDSGLTLNFTETPFFFGDQNNLVA 137
Query: 128 GIGCNNLASMSSADHDFILGGCFSICD----------------------------PRN-- 157
+GCNN AS+++ + + GC S C P+N
Sbjct: 138 -VGCNNKASLTNVEPTMV--GCESTCTTSNNSRSIPFFNKVGCSGSVDSVTRDLLPKNYI 194
Query: 158 ------KTEDDS--CNGIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKCKYAFM 209
K +DD+ CNG CC+A P + +I + S++ + + G CK AF+
Sbjct: 195 PVCSTTKIQDDTLICNGEGCCQAKAPVGSQQ----LIGVTITNSTNGNLTKGGGCKVAFL 250
Query: 210 VEKEWFESNFKSARRVQNWNQVPVILDWRI--PNSSF---------GELERDESSKFTST 258
++ + SN + + V V L W I N SF GEL D+ K T
Sbjct: 251 TDEVYTLSNATDPEQFFS-KGVTVSLGWFIQTKNHSFLQSLDCQNRGEL--DKGKKRTRQ 307
Query: 259 SHCESDEG---GLFRCSCKEKYHGNPYFLHGCQDLR-------------------CENYE 296
C++ G C+C Y GNPY CQD+ C N
Sbjct: 308 CTCDNHIASGMGYASCACASGYKGNPYVSDDCQDINECTEYKNPCGDTRILYRNTCINTS 367
Query: 297 GGYRCVNPKRPKVYTIILGIGTGLGGLLLSIGALWLCIIIRRR--IKQKEENFKKNGGLL 354
GG+RC++ P+V +LG+G G L++ G W ++R+R +K + FK+NGGLL
Sbjct: 368 GGHRCIDYHIPEV---MLGLGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLL 424
Query: 355 LEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKS 414
L+QQLN+ G +++ K+F+S+EL+KATD+FN NR++GQGGQGTVYKGML DGR +AVKKS
Sbjct: 425 LQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKS 484
Query: 415 KVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE 474
VVDE KL+EFINEV+ILSQI+HR+VVKLLG CLE EVP+LVYEFIPNG LFQ+LH+ +
Sbjct: 485 NVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFD 544
Query: 475 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534
+ + W +R+RIA +++ A +YLH++A PIYHRDIKSTNILLDEKYRAK++DFGTSRS+
Sbjct: 545 DYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSV 604
Query: 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP-ISYIWANEG 593
+ID TH +T + GT GY+DPEY+ SS FT+KSDVYSFGVVLVEL+TG+KP I+ E
Sbjct: 605 SIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEI 664
Query: 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653
LA YF + EN LF+I+D ++R K E+++ V+++A RCL G++RP M+EV+
Sbjct: 665 TGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTA 724
Query: 654 LERIRACNLQDD 665
LERI C+ +D
Sbjct: 725 LERI--CSAPED 734
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-145, Method: Compositional matrix adjust.
Identities = 308/726 (42%), Positives = 419/726 (57%), Gaps = 83/726 (11%)
Query: 2 NLQLLLQVIILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIG-ENCYFDK 60
NLQ + VI +L L+ + S K PP L C CG ++IPFPFGIG + CY +
Sbjct: 7 NLQCIPLVISVLSLFGVSSARK----PPYL----CNRVCGG-ISIPFPFGIGGKECYLNP 57
Query: 61 LYAIDCKS--SKPILRSINLEVLEFLLEKSTMRVNQSVI--------SSCQDKTTEASFV 110
Y + C + S P L IN E++ L T + V+ S C T++
Sbjct: 58 WYEVVCNTTTSVPFLSRINRELVNIYLPDPTEYYSNGVVHIKGPVTSSGCSTGTSQP--- 114
Query: 111 NLEKLPF--------YFSYYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKT--- 159
L P YF N+ +GCN A M I GC S CD RN +
Sbjct: 115 -LTPQPLNVAGQGSPYFLTDKNLLMAVGCNVKAVMMDVKSQII--GCESSCDERNSSSQV 171
Query: 160 -EDDSCNGIECCKAGVPWA---LKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWF 215
+ C+G +CC+ +P + NI I N T EG CK AF+ ++
Sbjct: 172 VRNKICSGNKCCQTRIPEGQPQVIGVNIEIPENKNTT--------EGGCKVAFLTSNKYS 223
Query: 216 ESNFKSARRVQNWNQVPVILDWRIPNSS------FGELERDESSK---FTSTSHCESDEG 266
N + V L W S G + ++S+ + S + C G
Sbjct: 224 SLNVTEPEEFHSDGYAVVELGWYFDTSDSRVLSPIGCMNVSDASQDGGYGSETICVCSYG 283
Query: 267 GL----FR-CSCKE-KYHGNPYFLHGCQDL---------------RCENYEGGYRCVNPK 305
+R C C Y GNP+ GC D+ C N G + C PK
Sbjct: 284 YFSGFSYRSCYCNSMGYAGNPFLPGGCVDIDECKLEIGRKRCKDQSCVNKPGWFTC-EPK 342
Query: 306 RP-KVYTIILGIGTGLGGLLLSIGALWLCIIIR--RRIKQKEENFKKNGGLLLEQQLNSL 362
+P ++ + G+ G LL + G L I+ RR + F++NGG+LL+QQL
Sbjct: 343 KPGQIKPVFQGVLIGSALLLFAFGIFGLYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARK 402
Query: 363 DGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL 422
+G+++ KIF+S EL+KATD+FN NR+LGQGGQGTVYKGML DGRI+AVK+SK +DE K+
Sbjct: 403 EGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKV 462
Query: 423 EEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEM 482
EEFINEVV+L+QI+HRN+VKLLG CLE EVP+LVYEF+PNG L + L D ++ +TWE+
Sbjct: 463 EEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEV 522
Query: 483 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542
RL IA E+A AL+YLHS+A PIYHRDIK+TNILLDEKY+ K++DFGTSRS+ IDQTH++
Sbjct: 523 RLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLT 582
Query: 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE 602
T+V GTFGY+DPEYF SS+FTDKSDVYSFGVVLVEL+TG+ P S + + E R A +FV
Sbjct: 583 TQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVA 642
Query: 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662
V+EN DI+D++++ +++M V+ +AKRCLN G+ RP M+EV++ELERIR+ +
Sbjct: 643 AVKENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSY 702
Query: 663 QDDDDN 668
+ + N
Sbjct: 703 KSEIHN 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1316), Expect = e-144, Method: Compositional matrix adjust.
Identities = 301/685 (43%), Positives = 420/685 (61%), Gaps = 59/685 (8%)
Query: 8 QVIILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCK 67
+ ++++LL I A A P L NC CGN V++P+PFGIG+ CY +K + I CK
Sbjct: 7 RFLVVMLLLRICEYAAASTFP--LALRNCSDHCGN-VSVPYPFGIGKGCYKNKWFEIVCK 63
Query: 68 SS---KPIL--RSINLEVLEFLLEK--STMRVNQSVI------SSCQDKTT-EASFVNLE 113
SS +PIL I V F L S N+ I S C ++ +S +NL+
Sbjct: 64 SSSDQQPILLLPRIRRAVTSFNLGDPFSISVYNKFYIQSPLKHSGCPNRDGYSSSSLNLK 123
Query: 114 KLPFYFSYYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPR---NKTEDDSCNGIECC 170
PF+ S +N F+ +GCNN A M+ + GC + C K + SC G +CC
Sbjct: 124 GSPFFISE-NNKFTAVGCNNKAFMNVTGLQIV--GCETTCGNEIRSYKGANTSCVGYKCC 180
Query: 171 KAGVPWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQ 230
+ +P L+ + + +AT ++G C+ AF+ + S F ++
Sbjct: 181 QMTIPPLLQ------LQVFDATVEKLEPNKQG-CQVAFLTQFTLSGSLFTPPELMEYSEY 233
Query: 231 VPVILDWRIPNSSFGELERDESSKFTSTSHCESDEGGLFRCSCKEKYHGNPYFLHGCQDL 290
+ L+WR+ +L S + + ++ ++CSC Y GNPY GCQD+
Sbjct: 234 TTIELEWRL------DLSYMTSKRVLCKGNTFFEDS--YQCSCHNGYEGNPYIPGGCQDI 285
Query: 291 --------------RCENYEGGYRCVNPKRPKVYTIILGIGTGLGGLLLSIGALWLCIII 336
+C N G YRC K + IL G LLL G LC
Sbjct: 286 DECRDPHLNKCGKRKCVNVLGSYRC-----EKTWPAILSGTLSSGLLLLIFGMWLLCKAN 340
Query: 337 RRR--IKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGG 394
R+R KQK + F++NGGLLL+QQ + L GS++R K+F+S +L+ ATD FN +RILGQGG
Sbjct: 341 RKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGG 400
Query: 395 QGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454
QGTVYKGML DG I+AVKKSK + E LEEFINE+++LSQI+HRNVVK+LG CLE EVP+
Sbjct: 401 QGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPI 460
Query: 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514
LVYEFIPN LF +LH+PSE+ ++WE+RL IA EVA+AL+YLHS+ +PIYHRD+KSTN
Sbjct: 461 LVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTN 520
Query: 515 ILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVV 574
ILLDEK+RAK++DFG SRS+AID TH++T VQGT GY+DPEY S+ FT KSDVYSFGV+
Sbjct: 521 ILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVL 580
Query: 575 LVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAK 634
L+ELLTG+KP+S + E R L YF+E + + L +ILD ++++ EE++ V+ +A+
Sbjct: 581 LIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLAR 640
Query: 635 RCLNSNGRSRPTMKEVAMELERIRA 659
RCL+ N RPTM++V +EL+R+++
Sbjct: 641 RCLSLNSEHRPTMRDVFIELDRMQS 665
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 303/712 (42%), Positives = 424/712 (59%), Gaps = 94/712 (13%)
Query: 40 CGNNVTIPFPFGIGENCYFDKLYAIDCKSSK-PILRSINLEVLEFLL----------EKS 88
CGN + IP+PFGI + CY ++ Y I+CK++ P L + + V+ L
Sbjct: 38 CGN-INIPYPFGIEKGCYLNEWYKIECKNATYPFLFKMGMAVVNISLPGDDGYNNPVSYG 96
Query: 89 TMRVNQSV--ISSCQDKTTEASFVNLEKLPFYFSYYDNIFSGIGCNNLASMSSADHD--- 143
++RV + I +D S +N PFYF +++ + +GCN+ AS+++ +
Sbjct: 97 SIRVKIPITSIGCSRDGKESGSVLNFTDSPFYFGIGNSLVA-VGCNSKASLTNINPSKVG 155
Query: 144 -------------------FILGGCF--------SICDPRNKTEDDSCNGIECCKAGVPW 176
F GC S+C N ++ SC+G CC AG+
Sbjct: 156 CELNCTASKETLPSKSIPFFDKTGCSNNKLPYYSSLCTKNNGEDERSCDGNGCCIAGL-- 213
Query: 177 ALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVILD 236
L S +I IN + +S + +C+ AF+ + SN +R+ V L
Sbjct: 214 -LDSEAPQVIGINIESFDHGNSTKL-ECRVAFLTDDVSPFSNASEPKRLFAKRYATVSLG 271
Query: 237 WRI--PNSSF-------GELERDESS---KFTSTSHCES---DEGGLFRCSCKEKYHGNP 281
W I N SF E D S+ K ++ C + C C + Y GNP
Sbjct: 272 WVIQTKNLSFVNSLSCKNTKEYDNSTYNIKLVTSCICNNVTISGTDYANCGCSQGYEGNP 331
Query: 282 YFLHGCQDLR------------------CENYEGGYRCVNPKRPKVYTIILGIGTGLGGL 323
Y GC+D+ C N G + C+ K ++G+G+ G L
Sbjct: 332 YLPGGCKDINECLRNSYGQRQNCRESDTCVNLPGTFNCIGNK---TRVTMIGVGSAFGIL 388
Query: 324 LLSIGALWLCIIIRRRIKQKEEN--FKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKAT 381
+L +G WL +++R K + FK+NGGLLL+QQLN+ G++++ +IF+S+EL+KAT
Sbjct: 389 VLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKAT 448
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
D+F+ +RILGQGGQGTVYKGML DGR +AVKKSKVVDE KLEEFINEVVILSQI+HR+VV
Sbjct: 449 DNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVV 508
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
KLLG CLE EVP LVYEFIPNG LFQ++H+ S++ + TW MRLRIA ++A AL+YLHS+A
Sbjct: 509 KLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAA 568
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
PIYHRDIKSTNILLDEKYR K++DFGTSRS+ ID TH +T + GT GY+DPEY+ SSQ
Sbjct: 569 SSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQ 628
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIW-ANEGRNLATYFVECVEENCLFDILDDQVRKS 620
+TDKSDVYSFGVVLVEL+TG+KP+ + + E R LA +F ++EN F+I+D ++R
Sbjct: 629 YTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDG 688
Query: 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA------CNLQDDD 666
K E++M V+++A+RCLNS G+ RP M++V +LE+I A N+++DD
Sbjct: 689 CKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVNIENDD 740
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 295/697 (42%), Positives = 417/697 (59%), Gaps = 74/697 (10%)
Query: 35 NCPYSCGNNVTIPFPFGIG-ENCYFDKLYAIDCKSSK--------PILRSINLEVLEFLL 85
+C +CG ++IPFPFGIG ++CY + Y + C ++ P L IN EV+ L
Sbjct: 41 SCNRTCGG-ISIPFPFGIGGKDCYLNGWYEVVCNATTSGSSGTTVPFLSRINREVVNISL 99
Query: 86 ------EKSTMRVNQSVIS-SCQDKTTEASFVNLEKLPF------YFSYYDNIFSGIGCN 132
+ + + V S C T++ +L L YF +N +GC
Sbjct: 100 PEGNNEQYGVVHIKGPVTSLGCSSNTSQVPQKSLPDLNVTGKGSPYFITDENRLVAVGCG 159
Query: 133 NLASMSSADHDFILGGCFSICDPRNKTEDDS---CNGIECCKAGVPWALKSFNISIISIN 189
A M+ + + + GC S C +++ + C+G +CC+A +P +
Sbjct: 160 TKALMTDIESEIL--GCESSCKDSKSSQEVTNLLCDGYKCCQARIP----------VERP 207
Query: 190 NATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIPNSS------ 243
A + S CK AF+ K + SN + V V L W +
Sbjct: 208 QAVGVNIESSGGDGCKVAFLSSKRYSPSNVTIPEQFHAGGYVVVELGWYFATTDSRFRNP 267
Query: 244 FGELERDESSKFTSTSHCESDEG-----GLFRCSCKEKYHGNPYFLHGCQD--------- 289
G + S + S C + G C C + GNPY GC D
Sbjct: 268 LGCINLTYSGSYLSGDSCLCEYGYFSEMSYRNCYCSLGFTGNPYLRGGCIDNDDCKGPNI 327
Query: 290 ---LRCENYEGGYRC------VNPKRPKVYTIILGIGTGLGGLLLSIGALWLCIIIRRRI 340
C N GGYRC + P +P V +L GL L++ L + I RRRI
Sbjct: 328 CEEGTCVNVPGGYRCDPKPKIIKPAKPLVLQGVLLGLMGLLFLVVGTLGLIIFIKKRRRI 387
Query: 341 KQKEENFKKNGGLLLEQQLNSL-DGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVY 399
+ FK+NGGLLL+QQL + DG++D ++F+S+EL KATD+F+V R+LG+G QGTVY
Sbjct: 388 ISSRKFFKRNGGLLLKQQLTTTNDGNVDMSRLFSSEELKKATDNFSVKRVLGKGSQGTVY 447
Query: 400 KGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459
KGM+ DG+IIAVK+SKVVDE KLE+FINE+++LSQI+HRN+VKL+G CLE EVP+LVYE+
Sbjct: 448 KGMMVDGKIIAVKRSKVVDEDKLEKFINEIILLSQINHRNIVKLIGCCLETEVPILVYEY 507
Query: 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE 519
IPNG +F+ LHD S++ ++TWE+RLRIA E+A AL Y+HS+A PIYHRDIK+TNILLDE
Sbjct: 508 IPNGDMFKRLHDESDDYAMTWEVRLRIAIEIAGALTYMHSAASFPIYHRDIKTTNILLDE 567
Query: 520 KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELL 579
KY AK++DFGTSRS+ IDQTH++T V GTFGY+DPEYF SSQ+TDKSDVYSFGVVLVEL+
Sbjct: 568 KYGAKVSDFGTSRSVTIDQTHLTTMVAGTFGYMDPEYFLSSQYTDKSDVYSFGVVLVELI 627
Query: 580 TGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNS 639
TG+KP+S I + EGR LAT+F+E ++EN + DI+D ++++ K +++M V+ +A++CL+
Sbjct: 628 TGEKPLSRIRSEEGRGLATHFLEAMKENRVIDIIDIRIKEESKLDQLMAVAKLARKCLSR 687
Query: 640 NGRSRPTMKEVAMELERIRA------CNLQDDDDNIQ 670
G RP M+E ++ELERIR+ ++++DD+ Q
Sbjct: 688 KGIKRPNMREASLELERIRSSPEDLEAHIENDDEEDQ 724
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | ||||||
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.961 | 0.877 | 0.506 | 0.0 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.939 | 0.774 | 0.496 | 1e-179 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.949 | 0.891 | 0.505 | 1e-176 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.883 | 0.690 | 0.525 | 1e-176 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.889 | 0.888 | 0.516 | 1e-176 | |
| 224103351 | 685 | predicted protein [Populus trichocarpa] | 0.902 | 0.893 | 0.523 | 1e-176 | |
| 224053050 | 741 | predicted protein [Populus trichocarpa] | 0.935 | 0.855 | 0.513 | 1e-172 | |
| 224053068 | 721 | predicted protein [Populus trichocarpa] | 0.938 | 0.882 | 0.498 | 1e-171 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.920 | 0.899 | 0.510 | 1e-171 | |
| 224118592 | 642 | predicted protein [Populus trichocarpa] | 0.870 | 0.919 | 0.512 | 1e-169 |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/718 (50%), Positives = 464/718 (64%), Gaps = 66/718 (9%)
Query: 1 MNLQLLLQVIILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIGENCYFDK 60
M +QL+L I++ W I S A + KP C CGN VTIP+PFGIGE CY D
Sbjct: 1 MAVQLVLLFRIIIFPWLINSSMAAAS----VAKPGCSDRCGN-VTIPYPFGIGEGCYMDS 55
Query: 61 LYAIDCKSS----KPILRSINLEVLEFLLEKSTMRVNQSVISS-CQDKTTEASFVNLEKL 115
+A+ C + +P L SINLE+L LE + +RVN V++S CQD+ +
Sbjct: 56 GFAVTCNKTSLPYRPYLTSINLELLRVSLESTLVRVNNPVLNSNCQDRPPVSDLSFSGSP 115
Query: 116 PFYFSYYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKTEDDSCNGIECCKAGVP 175
+ +N F+ +GCNNLA + D ++GGC SIC+ + SC GI CC+ +P
Sbjct: 116 FSFSD--NNRFTALGCNNLALIYR--QDMVIGGCLSICNV--TVTESSCYGINCCQTSIP 169
Query: 176 WALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFK-SARRVQNWNQVPVI 234
LK N S+ SI+ + +C+ AFMV++EWF SN + + QVP +
Sbjct: 170 PYLKFINASLRSIDPV--------PDEQCRVAFMVDREWFSSNASDNISALLGAKQVPAV 221
Query: 235 LDWRIPNSSFGELERDESSK--FTSTSHCESDEGGLFRCSCKEKYHGNPYFLHGCQDLR- 291
L+W I N + + E+S S + C G ++CSC + Y GNPY CQD+
Sbjct: 222 LEWGISNGTCADSPGAENSTDICGSNASCSVKVGINYQCSCNQGYEGNPYL--SCQDINE 279
Query: 292 ------------CENYEGGYRCVNPK-------------------RPKVYTIILGIGTGL 320
C N G Y+C P RP V I+L G G+
Sbjct: 280 CEDSQKNKCSMICVNTPGSYKCSCPDGYISMGNNCYLTDGYTERFRP-VIAIVLSAGLGI 338
Query: 321 GGLLLSIGALWLCIIIRRR--IKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELD 378
LL IG WL + +RR K ++ FK+NGGLLL+QQL+S + SI++ +F +KEL+
Sbjct: 339 PFLL--IGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSIEKTNMFTAKELE 396
Query: 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR 438
KATDH+N NRILGQGGQGTVYKGML DG+++A+KKSK+ DESK E+FINEVVILSQI+HR
Sbjct: 397 KATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFINEVVILSQINHR 456
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
NVVKLLG CLE EVPLLVYEFIPNGTL+Q+LHDPSEE +TWEMRLRIA E AL+YLH
Sbjct: 457 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIAIETGSALSYLH 516
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
S+A +PIYHRDIKSTNILLD+KYRAK++DFGTS+SIA+DQTHV+T+VQGTFGYLDPEYF
Sbjct: 517 SAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLDPEYFQ 576
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
SSQFT+KSDVYSFGVVLVELLTGQKPIS A E R+LA YF+ +E+N LF+ILD +V
Sbjct: 577 SSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNRLFEILDARVL 636
Query: 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQKCYEEL 676
K G EEI+ V+ +A+RCLN NG+ RPTM+ V E+ERIRA N + Y+EL
Sbjct: 637 KEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRASQQGTCFTNGENDYQEL 694
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 343/691 (49%), Positives = 460/691 (66%), Gaps = 54/691 (7%)
Query: 11 ILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIGE-NCYFDKLYAIDCKSS 69
I LLLW + +A K C +CG+ V IP+PFGIG CYFD+ + + C +S
Sbjct: 134 ISLLLWLSRGLAATQ------GKSGCLETCGD-VDIPYPFGIGSAGCYFDEWFEVTCNNS 186
Query: 70 ------KPILRSINLEVLEFLLEKSTMRVNQSVIS--SCQDKTTEASFVNLEKLPFYFSY 121
KP L+ +NLEVL L +ST+RVN V+ +C K + + + E PF FS
Sbjct: 187 IHPHIPKPFLKILNLEVLNVSLNRSTIRVNNPVLGYMNCSGKPSNDA-QSWEGGPFSFSD 245
Query: 122 YDNIFSGIGCNNLASMSSADHDFILGGCFSICDP-RNKTEDDSCNGIECCKAGVPWALKS 180
F+ +GC+ LA ++ +D ++GGC S C ++ SC G++CC+ P L+
Sbjct: 246 TYTRFTAVGCSTLAYITQ--NDSVIGGCMSYCKQGTTAAKNGSCYGLKCCQTQFPPGLQY 303
Query: 181 FNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIP 240
F + S+S ++ +CKYAFMV++EWF S + +V++ P +LDWRI
Sbjct: 304 FTTMLGDF------PSNSDDQDECKYAFMVDQEWFISMEQDPDKVKDVGHAPAVLDWRIY 357
Query: 241 NSSFGELERDESSKFT-------STSHCESD-EGGLFRCSCKEKYHGNPYFLHGCQDLRC 292
N++ + + +S + + C +D + C C Y GNPY GC+
Sbjct: 358 NATCKSVGWNNTSTSNTSTSFCGANAICSADTQTPSLTCRCPRGYEGNPYLTEGCEGTNY 417
Query: 293 ENYEGGYRCVN------------------PKRPKVYTIILGIGTGLGGLLLSIGALWLCI 334
+ YE G C+N P+R + I +GI G+G LLL I A WL
Sbjct: 418 KLYENGTVCINRNANFSCYPVDKLIVDPRPRRMVLPGICVGILAGVGTLLLVICAWWLYK 477
Query: 335 IIRRR--IKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQ 392
+++RR IK KE+ FK+NGGLLLEQQL+S +G++D+ K+F SKEL+KATD +N NR++GQ
Sbjct: 478 VLKRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEKATDRYNENRVIGQ 537
Query: 393 GGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452
GGQGTVYKGML DGRI+AVKK K+V + K+E+FINEVVILSQI+HRNVVKLLG CLE V
Sbjct: 538 GGQGTVYKGMLMDGRIVAVKKLKIVGDGKVEQFINEVVILSQINHRNVVKLLGCCLETAV 597
Query: 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512
PLLVYEFIPNGTL +++HD +EE +TWEMRLRIA EVA AL+YLHS+A +PIYHRDIKS
Sbjct: 598 PLLVYEFIPNGTLSEHIHDQNEEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRDIKS 657
Query: 513 TNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFG 572
TNILLD+KYRAK+ADFGTS+S+AIDQTH++T+VQGTFGYLDPEYF SSQFT+KSDVYSFG
Sbjct: 658 TNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFG 717
Query: 573 VVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDV 632
+VL+ELLTG+KPI + EG++LA+YF+ + E+ L D+LD QV K GK EEI ++ +
Sbjct: 718 IVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKEGKKEEINAIAFL 777
Query: 633 AKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663
A+RC+N NG+ RPTM EVAMELE ++ +Q
Sbjct: 778 ARRCINLNGKKRPTMMEVAMELEILKTKKMQ 808
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1614), Expect = e-176, Method: Compositional matrix adjust.
Identities = 351/694 (50%), Positives = 460/694 (66%), Gaps = 50/694 (7%)
Query: 10 IILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKS- 68
+I LL+ + +A + +PNC +CGN +TIPFPFGIG CY + +++ C
Sbjct: 8 LIFFLLFLVPEIATVSALI--MARPNCTETCGN-ITIPFPFGIGTGCYMNDWFSVHCNET 64
Query: 69 -----SKPILRSINLEVLEFLLEKSTMRVNQSVISS-CQDKTTEASFVNLEKLPFYFSYY 122
S+ L IN+EV + LE S +RVN +ISS C + + +N+ PF FS
Sbjct: 65 TADSPSRAFLSRINMEVFKISLESSVVRVNSPIISSGCSGRGANLA-INMTGSPFSFSS- 122
Query: 123 DNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKTEDDS-CNGIECCKAGVPWALKSF 181
NIF+ +GCNN A ++ + + + GC S C + +++S C+G CC+ +P +L+
Sbjct: 123 SNIFTAMGCNNRALLNGIEPEIV--GCTSTCGASTEGKENSYCSGNNCCQTTIPSSLQVV 180
Query: 182 NISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIPN 241
N S+ + + + +Q CK AF+V+++WF +N S VQ+ VPVILDW +
Sbjct: 181 NASLGTPEHPINDQGRNQ----CKVAFIVQEKWFRNNISSPEVVQDMQYVPVILDWN-SD 235
Query: 242 SSFGE----LERDESSKFTSTSHCESDEGGLFRCSCKEKYHGNPYFLHGCQDL------- 290
+ + + L S T T + S CSC Y GNPY GC D+
Sbjct: 236 AMYCDPPMNLTSGRSGLRTVTLYSNST-----ICSCNWGYDGNPYLPDGCTDIDECKIPR 290
Query: 291 --------RCENYEGGYRCVNPKRPKVYTIILGIGTGLGGLLLSIGALWLCIIIRRRIKQ 342
+C N GG++C + K L TGL LL+ I L+ + R+ I+
Sbjct: 291 GNSCSGMTKCVNVPGGFKC---ELDKAKITFLSAATGLLLLLVGIWRLYKLVKKRKNIEL 347
Query: 343 KEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGM 402
K++ FK+NGGLLL+QQL+S DGSI + KIF SKEL+KATD FN NRILGQGGQGTVYKGM
Sbjct: 348 KKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGM 407
Query: 403 LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462
ADG I+AVKKS +VDE KLEEFINEVVILSQ++HRNVVKLLG CLE EVPLLVYEFIPN
Sbjct: 408 QADGMIVAVKKSILVDEEKLEEFINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPN 467
Query: 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522
G LF+Y+HD EE +WEMRLRIATEVA AL+YLHS+A +P+YHRDIKSTNI+LDEK+R
Sbjct: 468 GNLFEYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFR 527
Query: 523 AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
AK++DFGTSRSIAIDQTH++T VQGTFGYLDPEYF SSQFT KSDVYSFGVVL ELL+GQ
Sbjct: 528 AKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQ 587
Query: 583 KPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGR 642
KPISY + E +LAT+F+ VEEN +FDILD+++ + EE++ V+++A+RCLN GR
Sbjct: 588 KPISYERSEERGSLATHFILLVEENKIFDILDERLMGQDREEEVIAVANLARRCLNLIGR 647
Query: 643 SRPTMKEVAMELERIRACNLQDDDDNIQKCYEEL 676
RPTM+EVA+ELE+IR L + Q+C +EL
Sbjct: 648 KRPTMREVAIELEQIR---LSKGALHPQQCSKEL 678
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1611), Expect = e-176, Method: Compositional matrix adjust.
Identities = 339/645 (52%), Positives = 437/645 (67%), Gaps = 46/645 (7%)
Query: 33 KPNCPYSCGNNVTIPFPFGIGE-NCYFDKLYAIDCKSS----KPILRSINLEVLEFLLEK 87
KP C CG+ V IP+PFGIG CYFD+ + + C +S KP L+ +NLEVL L+
Sbjct: 34 KPGCQERCGD-VDIPYPFGIGSAGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVLNVSLD- 91
Query: 88 STMRVNQSVISS--CQDKTTEASFVNLEKLPFYFSYYDNIFSGIGCNNLASMSSADHDFI 145
T+RVN V+ S C K + + E PF FS F+ +GC+ L + D +
Sbjct: 92 GTIRVNNPVLLSQNCSGKPSNDTQW-WEGGPFSFSNTYTRFTAVGCSALVYI--MQDDTV 148
Query: 146 LGGCFSICDPRNKTEDD-SCNGIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKC 204
+GGC + C SC G+ECC+ VP L SF + N T S S+ E+ +C
Sbjct: 149 IGGCMTFCKKDATAAKKASCYGLECCQTQVPPGLLSF-----TANLGTFSDGSADEQEQC 203
Query: 205 KYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIPNSSFGELERDESSKFTSTSHCESD 264
K+AFMV++EWF SN V++ VP +LDWRI N++ S+ TSTS C +
Sbjct: 204 KFAFMVDQEWFISNVPDPHTVKDMEYVPAVLDWRIYNATCAA---STSNLNTSTSFCGEN 260
Query: 265 -------EGGLFRCSCKEKYHGNPYFLHGCQDLRCENYEGGYRCVNPKRPKVYTIILGIG 317
+ CSC Y GNPY GCQ G + + ++ IG
Sbjct: 261 TLCSTDTQTSSLICSCFPVYEGNPYLPQGCQ---------GTQSIED------CAVITIG 305
Query: 318 TGLGGLLLSIGALWLCIIIRRR--IKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSK 375
LG LLL + A WL I+++RR IK KE+ F +NGGLLLEQQL+S +G+ID+ K+F SK
Sbjct: 306 -ALGTLLLVLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGNIDKTKLFTSK 364
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
EL+KATD +N NR++GQGG+GTVYKGML DGRI+AVKK K++ +SKLE+FINEVVIL QI
Sbjct: 365 ELEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQI 424
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+HRNVVKLLG CLE EVPLLVYEFIPNGTL +++H +EE +TWE+RLRIATEVA AL+
Sbjct: 425 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGALS 484
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
YLHS+A +PIYHRDIKSTNILLD+KYRAK+ADFG S+ +AIDQTH++T+VQGTFGYLDPE
Sbjct: 485 YLHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPE 544
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615
YF SSQFT+KSDVYSFG+VL+ELLTG+KPI + EG++LA+YF+ + E+ L D+LD
Sbjct: 545 YFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDA 604
Query: 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660
QV K + EEI ++ +A+RC+N NG+ RPTM EVAMELERIR C
Sbjct: 605 QVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKC 649
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1608), Expect = e-176, Method: Compositional matrix adjust.
Identities = 342/662 (51%), Positives = 441/662 (66%), Gaps = 59/662 (8%)
Query: 33 KPNCPYSCGNNVTIPFPFGIGEN-CYFDKLYAIDCKSS----KPILRSINLEVLEFLLEK 87
KP C CG+ V IP+PFGIG + CYFD+ + + C +S KP L+ +NLEVL L
Sbjct: 27 KPGCQEWCGD-VDIPYPFGIGSSGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVLNVSLH- 84
Query: 88 STMRVNQSVISS--CQDKTTEASFVNLEKLPFYFSYYDNIFSGIGCNNLASMSSADHDFI 145
T+RVN V+ S C K + + E PF FS F+ +GC+ +A D +
Sbjct: 85 GTVRVNNPVLLSQNCSGKPSNDTQW-WEGGPFSFSNTYTRFTAVGCSAMAYF--MQDDTV 141
Query: 146 LGGCFSIC--DPRNKTEDDSCNGIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGK 203
+GGC ++C D ++ SC G+ECC+ VP L SF + N T S+ E+
Sbjct: 142 IGGCMTLCKKDVATAAKNASCYGLECCQTQVPPGLLSF-----TANLDTFPEGSADEQEP 196
Query: 204 CKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIPNSSFGELERDESSKFTSTSHCES 263
CKYAFMV++EWF SN V++ VP +LDWRI N++ + S+ TSTS C
Sbjct: 197 CKYAFMVDQEWFISNVPDPHTVKDMEYVPAVLDWRIYNAT---CDASTSNLNTSTSFCGE 253
Query: 264 D-------EGGLFRCSCKEKYHGNPYFLHGCQDLRCENYEGGYRCVNPKRPKVYTIILGI 316
+ + CSC Y GNPY GCQ ++ I
Sbjct: 254 NTFCSTDTQTSSLTCSCPLLYEGNPYLPQGCQ------------------------VITI 289
Query: 317 GTGLGGLLLSIGALWLCIIIRRR--IKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNS 374
G+ LG LLL + A WL I ++RR IK KE+ F +NGGLLLEQQL+S +G+ID+ K+F S
Sbjct: 290 GS-LGTLLLVLCAWWLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGNIDKTKLFTS 348
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ 434
KEL+KATD +N NR++GQG QGT YKGML DGRI+AVKK K++ +SKLE+FINEVVIL Q
Sbjct: 349 KELEKATDRYNENRVIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQ 408
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
I+HRNVVKLLG CLE EVPLLVYEFIPNGTL +++H +EE +TWEMRLRIATEV AL
Sbjct: 409 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEMRLRIATEVXGAL 468
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
+YLHS A +PIYHRDIKSTNILLB+KYRAK+ADFG S+ +AIDQTH++T+VQGTFGYLDP
Sbjct: 469 SYLHSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDP 528
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614
EYF SSQFT+KSDVYSFG+VL+ELLTG+KPI I + EG++LA+YF+ + E+ L D+LD
Sbjct: 529 EYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIASEEGKSLASYFILSMNEDRLSDLLD 588
Query: 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQKCYE 674
QV K + EEI ++ +A+RC+N NG+ RPTM EVAMELERIR C D Q+ +E
Sbjct: 589 AQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQ---GDFRAQENFE 645
Query: 675 EL 676
E+
Sbjct: 646 EI 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103351|ref|XP_002334062.1| predicted protein [Populus trichocarpa] gi|222869636|gb|EEF06767.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 623 bits (1607), Expect = e-176, Method: Compositional matrix adjust.
Identities = 341/651 (52%), Positives = 437/651 (67%), Gaps = 39/651 (5%)
Query: 31 LTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKS------SKPILRSINLEVLEFL 84
+ +PNC +CGN ++IPFPFGIG CY + +++ C S+ L SIN+EVLE
Sbjct: 1 MARPNCKDTCGN-ISIPFPFGIGTGCYLNYWFSVHCNKTTADSRSRAFLSSINMEVLEIS 59
Query: 85 LEKSTMRVNQSVISS-CQDKTTEASFVNLEKLPFYFSYYDNIFSGIGCNNLASMSSADHD 143
L +S +RVN +ISS C + S +++ PF FS NIF +GCNN A +S + +
Sbjct: 60 LRRSVVRVNSPIISSGCSGRGANIS-IDMTGSPFAFSS-SNIFIAMGCNNRALLSRIEPE 117
Query: 144 FILGGCFSICDPRNKTEDDSCNGIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGK 203
+ GC + E+ C+G CC+ +P L+ FN S+ T + Q +
Sbjct: 118 IV--GCTTTGSSTEGKENSYCSGNNCCQTTIPSNLQVFNASL----GTTEHPINDQGRNQ 171
Query: 204 CKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIPNSSFGELERDESSKFTSTSHCES 263
CK AF+VE+EWF +N S VQ+ VPVIL W + + ++ + ST S
Sbjct: 172 CKVAFIVEEEWFRNNISSPEVVQDMQYVPVILRWLMYYGT--DIPEGVTLWGLSTVTLYS 229
Query: 264 DEGGLFRCSCKEKYHGNPYFLHGCQDL---------------RCENYEGGYRCVNPKRPK 308
+ C C Y G+PY GC D+ +C N G Y+C + K
Sbjct: 230 NS---ITCWCSPGYDGHPYLPDGCTDIDQCKIPGVNWCSGMTKCVNVPGWYKC---ELDK 283
Query: 309 VYTIILGIGTGLGGLLLSIGALWLCIIIRRRIKQKEENFKKNGGLLLEQQLNSLDGSIDR 368
L TGL LL+ I L+ + R+ I+ K++ FK+NGGLLL+QQL+S DGSI +
Sbjct: 284 AKITFLSAATGLLLLLVGIWRLYKLVKKRKNIELKKKFFKRNGGLLLQQQLSSSDGSIQK 343
Query: 369 CKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINE 428
KIF SKEL+KATD FN NRILGQGGQGTVYKGM ADG I+AVKKS +VDE KLEEFINE
Sbjct: 344 TKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEEFINE 403
Query: 429 VVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488
VVILSQ++HRNVVKLLG CLE EVPLLVYEFIPNG LF+Y+HD EE +WEMRLRIAT
Sbjct: 404 VVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIAT 463
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
EVA AL+YLHS+A +P+YHRDIKSTNI+LDEK+RAK++DFGTSRSIAIDQTH++T VQGT
Sbjct: 464 EVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGT 523
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608
FGYLDPEYF SSQFT KSDVYSFGVVL ELL+GQKPISY + R+LAT+F+ +EEN
Sbjct: 524 FGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERPEDRRSLATHFILLMEENK 583
Query: 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
+FDILD+++ + EE++ V+++A+RCLN NGR RPTM+EVA+ELE+IR
Sbjct: 584 IFDILDERLMGQDREEEVIAVANLARRCLNLNGRKRPTMREVAIELEQIRV 634
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053050|ref|XP_002297682.1| predicted protein [Populus trichocarpa] gi|222844940|gb|EEE82487.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 354/690 (51%), Positives = 456/690 (66%), Gaps = 56/690 (8%)
Query: 10 IILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKS- 68
+I LL+ + +A P +TKPNC +CGN ++I FPFGIG C + +++DC
Sbjct: 8 LIFFLLFLVPEIA---PVSALMTKPNCTETCGN-ISISFPFGIGTGCSMNDWFSVDCNKT 63
Query: 69 -----SKPILRSINLEVLEFLLEKSTM---RVNQSVISSCQDKTTEASFVNLEKLPFYFS 120
S+ L IN+EVLE L ST+ RVN +ISS + +N+ PF FS
Sbjct: 64 TADSPSRAFLSRINMEVLEISLGYSTIPLVRVNSPIISSGCAGSGANLAINMTGSPFAFS 123
Query: 121 YYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKT-------EDDSCNGIECCKAG 173
NIF +GCNN A +S + + + GC S C N T E+ C+G CC+
Sbjct: 124 S-SNIFIAMGCNNRALLSRIEPEIV--GCTSTCGANNLTSSSAEGKENSYCSGNNCCQTT 180
Query: 174 VPWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPV 233
+P +L+ F+ S+ + + + +Q CK AF+VE+EWF +N S V++ VPV
Sbjct: 181 IPSSLQVFDASLGTPEHPINDQGRNQ----CKTAFIVEEEWFRNNISSPEVVRDMQYVPV 236
Query: 234 ILDWR----------IPNSSFGELERDESSKFTSTSHCESDEGGLFRCSCKEKYHGNPYF 283
ILDW + NS R + T S+ CSC Y GNPY
Sbjct: 237 ILDWEMYYGTDIPEDVTNSDAKNCWRGLTMWGLRTVTLYSNST---TCSCNPGYDGNPYL 293
Query: 284 LHGCQDL---------------RCENYEGGYRCVNPKRPKVYTIILGIGTGLGGLLLSIG 328
GC D+ +C N G Y+C + K+ +ILG TGL LL+ I
Sbjct: 294 PDGCTDIDECKIPGENSCSGMTKCVNRPGRYKC-ELDKAKITFLILGAATGLLLLLVGIW 352
Query: 329 ALWLCIIIRRRIKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNR 388
L+ + ++ I+ K++ FK+NGGLLL+QQL+S DGSI + KIF SKEL+KATD FN NR
Sbjct: 353 RLYKLVKKKKNIELKKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNR 412
Query: 389 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
ILGQGGQGTVYKGMLADG I+AVKKSK+VDE KLEEFINEVVILSQ++HRNVVKLLG CL
Sbjct: 413 ILGQGGQGTVYKGMLADGMIVAVKKSKIVDEEKLEEFINEVVILSQLNHRNVVKLLGCCL 472
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
E EVPLLVYEFIPNG LF+Y+HD EE +WEMRLRIATEVA AL+YLHS+A +P+YHR
Sbjct: 473 ETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHR 532
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKSTNI+LDEK+RAK++DFGTSRSIAIDQTH++T VQGTFGYLDPEYF SSQFT KSDV
Sbjct: 533 DIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDV 592
Query: 569 YSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIME 628
YSFGVVL ELL+GQKPISY + R+LAT+F+ +EEN +FDILD+++ + + EE++
Sbjct: 593 YSFGVVLAELLSGQKPISYERPEDRRSLATHFILLMEENKIFDILDERLMEQDREEEVIA 652
Query: 629 VSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
V+++A+RCLN NGR RPT++EVA+ELE+IR
Sbjct: 653 VANLARRCLNLNGRKRPTIREVAIELEQIR 682
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053068|ref|XP_002297691.1| predicted protein [Populus trichocarpa] gi|222844949|gb|EEE82496.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1568), Expect = e-171, Method: Compositional matrix adjust.
Identities = 346/694 (49%), Positives = 449/694 (64%), Gaps = 58/694 (8%)
Query: 31 LTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKS------SKPILRSINLEVLEFL 84
+ KPNC +CGN ++IPFPFGIG CY + +++DC S+ L IN+E L
Sbjct: 1 MAKPNCIDTCGN-ISIPFPFGIGTGCYMNDWFSVDCNKTTADSPSRAFLSRINMEFLGIS 59
Query: 85 LEKSTMRVNQSVISS-CQDKTTEASFVNLEKLPFYFSYYDNIFSGIGCNNLASMSSADHD 143
LE +RVN +ISS C + + +N+ + PF FS N F+ +GCNN A ++ +
Sbjct: 60 LEDRVVRVNSPIISSGCAGRGANLA-INMTRSPFAFSS-SNRFAAMGCNNHALLTQIQPE 117
Query: 144 FILGGCFSICDPRNKT-------EDDSCNGIECCKAGVPWALKSFNISIISINNATSSSS 196
I+G S C N T E+ C+G CC+ +P L+ FN S+ +
Sbjct: 118 -IVGCTTSTCSANNLTSFSTEGKENCYCSGNNCCQTSIPSNLQVFNASL-----GPTEDP 171
Query: 197 SSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIPNSSFGELERDESSKFT 256
+ Q +CK AF+V+ EW N KS + VQ VPVILDW + +E ++ +
Sbjct: 172 NDQGRNQCKLAFIVDGEWSLDNIKSPKAVQYMQHVPVILDWFVYGDDI-PVENSDAKYCS 230
Query: 257 STSHCESDEGGL---------FRCSCKEKYHGNPYFLHGCQDL---------------RC 292
S GL C C + Y GNPY GC D+ +C
Sbjct: 231 PPVKLVSGRWGLRTVTLYSNSITCRCNQGYDGNPYLPDGCTDIDECKIPKGNWCSGMTKC 290
Query: 293 ENYEGGYRC-VNPKRPKVYTIILGIG-----TGLGGLLLSIGALWLCIIIRRRIKQKEEN 346
N G ++C ++ + + L + TGL LL+ I L+ R+ I+ K++
Sbjct: 291 VNVPGWHKCELDKAKITFLSKFLSLNSFFLPTGLLLLLVGIWRLYKLEKKRKNIELKKKF 350
Query: 347 FKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADG 406
FK+NGGLLL+QQL+S DGSI + KIF SKEL+KATD FN NRILGQGGQGTVYKGMLADG
Sbjct: 351 FKQNGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMLADG 410
Query: 407 RIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF 466
I+AVKKSK++DE K EEFINEVVILSQ++HRNVVKLLG CLE EVPLLVYEFIPNG LF
Sbjct: 411 SIVAVKKSKMMDEEKWEEFINEVVILSQLNHRNVVKLLGCCLETEVPLLVYEFIPNGNLF 470
Query: 467 QYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526
+Y+HD EE +WEMRLRIATEVA AL+YLHS+A +P+YHRDIKSTNILLDEK++AK++
Sbjct: 471 EYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNILLDEKFKAKVS 530
Query: 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPIS 586
DFGTSRSIAIDQTH++T VQGTFGYLDPEYF SSQFT KSDVYSFGVVL ELL+GQKPIS
Sbjct: 531 DFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPIS 590
Query: 587 YIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT 646
Y E R+LAT+F+ +EEN +FDILD+++ + EE++ V+++A+RCLN NGR RPT
Sbjct: 591 YERPEERRSLATHFILLMEENKIFDILDERLMGQDREEEVIAVANLARRCLNLNGRKRPT 650
Query: 647 MKEVAMELERIR----ACNLQDDDDNIQKCYEEL 676
M+EVA+ELE+IR A + Q ++ +EE+
Sbjct: 651 MREVAIELEQIRLSKGALHAQQSSKELENIWEEV 684
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 355/696 (51%), Positives = 457/696 (65%), Gaps = 72/696 (10%)
Query: 5 LLLQVIILLLLWPIKSVAKAPPPPPPLTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAI 64
+L+++ + L+LW ++ + P C CGN V I FPFGIG+ CY D+ + +
Sbjct: 11 VLIKLQLFLILWLAQARSVEP----------CESYCGN-VPIEFPFGIGKGCYMDESFEV 59
Query: 65 DCKSS----KPILRSINLEVLEFLLEKSTMRVNQSVI-SSCQDKTTEASFVNLEKLPFYF 119
C SS KP L SIN+E+LE +L + ++VN VI S+C KT+ AS V+L PF F
Sbjct: 60 TCNSSSEPPKPFLTSINMELLE-VLSPNQVQVNNPVIYSNCSHKTSTASRVSLSGTPFTF 118
Query: 120 SYYDNIFSGIGCNNLASMSSADHDFILGGCFSICDPRNKTEDDSCNGIECCKAGVPWALK 179
S N F+ GCNN A + D + GGC SIC R++ C GI C + +P +K
Sbjct: 119 SNASNRFTAKGCNNYAILMQDIGDTV-GGCLSIC--RDEANSSGCYGINCWQTTIPPYMK 175
Query: 180 SFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWN---QVPVILD 236
SF A ++ S CK AFMV++ WF S+R + + N VP +LD
Sbjct: 176 SFE--------ANMTNPFSDNTNNCKSAFMVDQSWFAFQSSSSRSLDDLNYKDHVPAVLD 227
Query: 237 WRIPNSSFGELERDESSKFTSTSHC--ESDEGGLFRCSCKEKYHGNPYFLHGCQD----- 289
W E + T +S+C E + + C C++ + C D
Sbjct: 228 WANYQGYCDISEYYNITCTTDSSYCWKELNRSQVCICQCEDP--------NKCPDQSSNY 279
Query: 290 ---LRCENYEGGYRCVNPK---------------------RPKVYTIILGIGTGLGGLLL 325
L C GGY C P+ R K +II+G G+G+G LLL
Sbjct: 280 NCRLFCMYRPGGYNCPCPRGHGKYENSNRCYPNSVFWGKSRTKTKSIIIGCGSGIGFLLL 339
Query: 326 SIGALWLCIIIRRR--IKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDH 383
IG L II+RR +K K+ FK+NGGLLLEQQL+S + +++ K+F SKEL+KATD
Sbjct: 340 LIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEKATDD 399
Query: 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
++ NRILGQGGQGTVYKGML DGR++A+KKSKVVDE KL++FINEVVILSQI+HRNVVKL
Sbjct: 400 YHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRNVVKL 459
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
+G CLE EVPLLVYEFIPNGTL+QY+H+P+EE +TWEMRLRIATEVA ALAYLH++A +
Sbjct: 460 IGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHAAASM 519
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
PIYHRDIKS+NILLDEKYRAK+ADFGTS+SI+IDQTHV+T+VQGTFGYLDPEYF SSQFT
Sbjct: 520 PIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFT 579
Query: 564 DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623
+KSDVYSFGVVLVELLTGQKPIS + E R+LATYF+ +EE+ LF+ILD +V K G
Sbjct: 580 EKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGGR 639
Query: 624 EEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
EEI+ ++ +A++CLN NG+ RP MK VA+ELE IR+
Sbjct: 640 EEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRS 675
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118592|ref|XP_002331400.1| predicted protein [Populus trichocarpa] gi|222873614|gb|EEF10745.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1554), Expect = e-169, Method: Compositional matrix adjust.
Identities = 331/646 (51%), Positives = 429/646 (66%), Gaps = 56/646 (8%)
Query: 31 LTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKSS----KPILRSINLEVLEFLLE 86
+T P C CG+ ++IP+PFG+ E CY D+ + I C SS K + +LEV ++
Sbjct: 1 MTLPGCESYCGD-ISIPYPFGMKEGCYLDERFKILCNSSSGVPKLTVNGTDLEVNNISVD 59
Query: 87 KSTMRVNQSVI-SSCQDKTTEASFVNLEKLPFYFSYYDNIFSGIGCNNLASMSSADHDFI 145
ST+ V ++ ++C K + V+LE PF FS +N F GC NLA M+ +
Sbjct: 60 DSTIAVMFPIVFANCSGKDGN-TVVDLEGSPFVFSS-ENYFIARGCGNLALMNQ--NQSA 115
Query: 146 LGGCFSICDPRNKTEDDSCNGIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKCK 205
+GGC S+CD + SC+GI+CC+ +P LK FN+++ + + S+ E +C+
Sbjct: 116 IGGCVSLCDKNRDSMMASCSGIDCCQTRIPSFLKVFNVTMKGLEDG----KGSRGENECR 171
Query: 206 YAFMVEKEW-----------FESNFKSARRVQNWNQVPVILDWRIPNSSFGELERDES-- 252
YAF++++ W F NF + + VPV+LDW I F L ++ S
Sbjct: 172 YAFLIDERWTNYGGYYYDYYFGGNFDFYYDKRERDHVPVVLDWGIDRRVFESLVKNGSFY 231
Query: 253 -SKFTSTSHCESDEGGLFRCSCKEKYHGNPYFLHGCQD--LRCENYEGGYRCVNPKRPKV 309
S +TST + GNPY CQ L + + +N K
Sbjct: 232 NSSYTSTC-----------------FEGNPYLSGICQGKLLIVVSQFSSFPSMNNAFLKK 274
Query: 310 YTIILGIGTGLGGLLLSIGALWLCIIIRRRI--KQKEENFKKNGGLLLEQQLNSLDGSID 367
G G L L IG WL + +R+ K K++ FK+NGGLLL++QL+S + +++
Sbjct: 275 CV------GGFGALFLLIGLWWLYKVFKRKRSEKLKKKYFKRNGGLLLQEQLSSGEVNVE 328
Query: 368 RCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFIN 427
+ K+F SKELDKATDH+NVNR LGQGGQGTVYKGMLADG+I+AVKKSK +DE L +FIN
Sbjct: 329 KIKMFPSKELDKATDHYNVNRTLGQGGQGTVYKGMLADGKIVAVKKSKEIDEGNLRQFIN 388
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
EVV+LSQI+HRNVVKLLG CLE E+PLL+YEFIPNGTLFQ+LHDP+EE LTWEMRLRIA
Sbjct: 389 EVVLLSQINHRNVVKLLGCCLETELPLLIYEFIPNGTLFQFLHDPNEEFPLTWEMRLRIA 448
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
EVA AL YLHS+A LPI+HRDIKSTNILLDE+YRAK+ADFGTSRS++IDQTHV+T+VQG
Sbjct: 449 AEVAGALFYLHSAASLPIFHRDIKSTNILLDEEYRAKVADFGTSRSVSIDQTHVTTRVQG 508
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE-GRNLATYFVECVEE 606
TFGYLDPEYF SSQFTDKSDVYSFGVVLVELLTGQKPIS+ + E GR+LATYF+ +E
Sbjct: 509 TFGYLDPEYFQSSQFTDKSDVYSFGVVLVELLTGQKPISFTRSEEQGRSLATYFIMAMES 568
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652
NCLFDILD QV K G+ E+++ V+ +A+ CL NG+ RPTMK V M
Sbjct: 569 NCLFDILDPQVVKQGEREDVLMVASLARSCLRLNGKERPTMKGVTM 614
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | ||||||
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.576 | 0.508 | 0.545 | 8e-146 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.589 | 0.505 | 0.551 | 7.2e-139 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.497 | 0.448 | 0.604 | 6.6e-136 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.480 | 0.413 | 0.627 | 7.2e-133 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.461 | 0.428 | 0.661 | 1.6e-132 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.570 | 0.517 | 0.539 | 4.2e-132 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.547 | 0.485 | 0.549 | 6.4e-132 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.905 | 0.852 | 0.425 | 3.2e-129 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.591 | 0.510 | 0.529 | 8.9e-128 | |
| TAIR|locus:2200527 | 642 | WAKL6 "wall associated kinase- | 0.466 | 0.492 | 0.597 | 2.8e-123 |
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1150 (409.9 bits), Expect = 8.0e-146, Sum P(3) = 8.0e-146
Identities = 224/411 (54%), Positives = 294/411 (71%)
Query: 267 GLFRCSCKEKYHGNPYFLHGCQDL----------------RCENYEGGYRC-VNPKRPKV 309
G CSC + GNPY C+D+ +C N GGY C RP V
Sbjct: 301 GYATCSCASGFEGNPYIPGECKDINECVRGIDGNPVCTAGKCVNLLGGYTCEYTNHRPLV 360
Query: 310 YTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKQKEENFKKNGGLLLEQQLNSLDGSIDRC 369
QK++ FK+NGGLLL+QQL + +G++D
Sbjct: 361 I--GLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDST 418
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 429
++FNS+EL+KAT++F++ RILG+GGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEV
Sbjct: 419 RVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 478
Query: 430 VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLT-WEMRLRIAT 488
VILSQI+HRN+VKLLG CLE +VP+LVYEFIPNG LF++LHD S++ ++T WE+RLRIA
Sbjct: 479 VILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAV 538
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
++A AL+YLHS+A PIYHRDIKSTNI+LDEK+RAK++DFGTSR++ +D TH++T V GT
Sbjct: 539 DIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGT 598
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608
GY+DPEYF SSQFTDKSDVYSFGVVL EL+TG+K +S++ + E R LATYF ++EN
Sbjct: 599 VGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENR 658
Query: 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
L DI+D ++R K ++ + +A++CLN GR RP+M++V+MELE+IR+
Sbjct: 659 LSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1169 (416.6 bits), Expect = 7.2e-139, Sum P(3) = 7.2e-139
Identities = 234/424 (55%), Positives = 300/424 (70%)
Query: 270 RCSCKEKYHGNPYFLHGCQDL---------------RCENYEGGYRCV-NPKRPKVYTXX 313
RCSC + GNPY L GC+D+ +C N +G ++CV N RP
Sbjct: 319 RCSCTRGFQGNPYRLGGCKDINECKEEEGMTYCGTNKCVNLQGHFKCVYNNHRP--LAIG 376
Query: 314 XXXXXXXXXXXXXXXXXXXXXXXXXXXKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFN 373
QK++ FK+NGGLLL+QQL S G +++ +F+
Sbjct: 377 LGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFS 436
Query: 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILS 433
S+EL+KAT++F+ NRILGQGGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEVVILS
Sbjct: 437 SRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILS 496
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEE-LSLTWEMRLRIATEVAE 492
QI+HRN+VKLLG CLE +VP+LVYEFIPNG LF++LHD +E + TW +RLRIA ++A
Sbjct: 497 QINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAG 556
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
AL+YLHSSA PIYHRD+KSTNI+LDEKYRAK++DFGTSR++ +D TH++T V GT GY+
Sbjct: 557 ALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYM 616
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612
DPEYF SSQFTDKSDVYSFGVVLVEL+TG+K IS++ + E R LATYF+ ++EN LFDI
Sbjct: 617 DPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDI 676
Query: 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA-CNLQDDDDNIQK 671
+D ++R ++ + VA++CLN GR RP+M+EV+MEL+ IR C D +Q+
Sbjct: 677 IDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCG----DMQLQE 732
Query: 672 CYEE 675
C E
Sbjct: 733 CVSE 736
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1115 (397.6 bits), Expect = 6.6e-136, Sum P(2) = 6.6e-136
Identities = 206/341 (60%), Positives = 279/341 (81%)
Query: 342 QKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKG 401
+K FK+NGGLLL+QQL + G++ KIF+SKEL+KATD+FN+NR+LGQGGQGTVYKG
Sbjct: 379 RKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKG 438
Query: 402 MLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461
ML DGRI+AVK+SKV+DE K+EEFINEV +LSQI+HRN+VKL+G CLE EVP+LVYE IP
Sbjct: 439 MLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIP 498
Query: 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521
NG LF+ LH S++ ++TW++RLRI+ E+A ALAYLHS+A P+YHRD+K+TNILLDEKY
Sbjct: 499 NGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKY 558
Query: 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTG 581
RAK++DFGTSRSI +DQTH++T V GTFGYLDPEYF +SQFTDKSDVYSFGVVLVEL+TG
Sbjct: 559 RAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITG 618
Query: 582 QKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNG 641
+KP S + E R L ++F E +++N + DI+D ++++ E+++ V+ +A+RCL+ G
Sbjct: 619 EKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKG 678
Query: 642 RSRPTMKEVAMELERIRAC----NLQDDDDNIQKCYEELSM 678
+ RP M+EV++ELERIR+ L ++++ ++C E++M
Sbjct: 679 KKRPNMREVSVELERIRSSPEDLELHIEEEDEEECAMEINM 719
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 7.2e-133, Sum P(3) = 7.2e-133
Identities = 209/333 (62%), Positives = 272/333 (81%)
Query: 341 KQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYK 400
K+K + FK+NGGLLL+QQLN+ G++++ +IF+S+EL+KATD+F+ +RILGQGGQGTVYK
Sbjct: 408 KRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYK 467
Query: 401 GMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460
GML DGR +AVKKSKVVDE KLEEFINEVVILSQI+HR+VVKLLG CLE EVP LVYEFI
Sbjct: 468 GMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFI 527
Query: 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK 520
PNG LFQ++H+ S++ + TW MRLRIA ++A AL+YLHS+A PIYHRDIKSTNILLDEK
Sbjct: 528 PNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEK 587
Query: 521 YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580
YR K++DFGTSRS+ ID TH +T + GT GY+DPEY+ SSQ+TDKSDVYSFGVVLVEL+T
Sbjct: 588 YRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELIT 647
Query: 581 GQKPISYIW-ANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNS 639
G+KP+ + + E R LA +F ++EN F+I+D ++R K E++M V+++A+RCLNS
Sbjct: 648 GEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNS 707
Query: 640 NGRSRPTMKEVAMELERIRAC------NLQDDD 666
G+ RP M++V +LE+I A N+++DD
Sbjct: 708 KGKKRPCMRKVFTDLEKILASQEDSLVNIENDD 740
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 1.6e-132, Sum P(2) = 1.6e-132
Identities = 207/313 (66%), Positives = 271/313 (86%)
Query: 347 FKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADG 406
FK+NGGLLL+QQL + DG+++ KIF+SKEL KATD+F+++R+LGQGGQGTVYKGML DG
Sbjct: 392 FKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDG 451
Query: 407 RIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF 466
I+AVK+SKVVDE K+EEFINE+V+LSQI+HRN+VKLLG CLE EVP+LVYE+IPNG LF
Sbjct: 452 SIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLF 511
Query: 467 QYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526
+ LHD S++ ++TWE+RLRIA E+A AL Y+HS+A PI+HRDIK+TNILLDEKYRAK++
Sbjct: 512 KRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVS 571
Query: 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPIS 586
DFGTSRS+ +DQTH++T V GTFGY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP+S
Sbjct: 572 DFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLS 631
Query: 587 YIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT 646
+ + EGR LAT+F+E ++EN + DI+D +++ K E++M V+ +A++CLN G++RP
Sbjct: 632 RVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPN 691
Query: 647 MKEVAMELERIRA 659
MKEV+ ELERIR+
Sbjct: 692 MKEVSNELERIRS 704
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 4.2e-132, Sum P(2) = 4.2e-132
Identities = 214/397 (53%), Positives = 291/397 (73%)
Query: 287 CQDLRCENYEGGYRCVNPKRPKVYTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKQ---K 343
C+D C N G + C PK+P+ ++
Sbjct: 317 CKDQSCVNLPGWFDC-QPKKPEQLKRVIQGVLIGSALLLFAFGIFGLYKFVQKRRKLIRM 375
Query: 344 EENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGML 403
+ F++NGG+LL+QQL +G+++ +IF+S EL+KATD+FN NR+LGQGGQGTVYKGML
Sbjct: 376 RKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGML 435
Query: 404 ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463
DGRI+AVK+SK VDE ++EEFINEVV+L+QI+HRN+VKLLG CLE EVP+LVYEF+PNG
Sbjct: 436 VDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNG 495
Query: 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523
L + LHD S++ ++TWE+RL IA E+A AL+YLHS+A PIYHRDIK+TNILLDE+ RA
Sbjct: 496 DLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRA 555
Query: 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQK 583
K++DFGTSRS+ IDQTH++T+V GTFGY+DPEYF SS+FT+KSDVYSFGVVLVELLTG+K
Sbjct: 556 KVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEK 615
Query: 584 PISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS 643
P S + + E R LA +FVE V+EN + DI+DD+++ +++M V+++A+RCLN G+
Sbjct: 616 PSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKK 675
Query: 644 RPTMKEVAMELERIRACN------LQDDDDNIQKCYE 674
RP M+EV++ELE IR+ + ++DDD+ + E
Sbjct: 676 RPNMREVSIELEMIRSSHYDSGIHIEDDDEEDDQAME 712
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 6.4e-132, Sum P(3) = 6.4e-132
Identities = 206/375 (54%), Positives = 273/375 (72%)
Query: 292 CENYEGGYRCVNPKRPKVYTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKQKEENFKKNG 351
C N GG+RC++ P+V + K + FK+NG
Sbjct: 363 CINTSGGHRCIDYHIPEVMLGLGAGFFVLIVGGGIWWWRKLLRKRRMTNR-KRKFFKRNG 421
Query: 352 GLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAV 411
GLLL+QQLN+ G +++ K+F+S+EL+KATD+FN NR++GQGGQGTVYKGML DGR +AV
Sbjct: 422 GLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAV 481
Query: 412 KKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD 471
KKS VVDE KL+EFINEV+ILSQI+HR+VVKLLG CLE EVP+LVYEFIPNG LFQ+LH+
Sbjct: 482 KKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHE 541
Query: 472 PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531
++ + W +R+RIA +++ A +YLH++A PIYHRDIKSTNILLDEKYRAK++DFGTS
Sbjct: 542 EFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTS 601
Query: 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP-ISYIWA 590
RS++ID TH +T + GT GY+DPEY+ SS FT+KSDVYSFGVVLVEL+TG+KP I+
Sbjct: 602 RSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSET 661
Query: 591 NEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
E LA YF + EN LF+I+D ++R K E+++ V+++A RCL G++RP M+EV
Sbjct: 662 QEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREV 721
Query: 651 AMELERIRACNLQDD 665
+ LERI C+ +D
Sbjct: 722 STALERI--CSAPED 734
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1268 (451.4 bits), Expect = 3.2e-129, P = 3.2e-129
Identities = 284/667 (42%), Positives = 400/667 (59%)
Query: 24 AXXXXXXLTKPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKSS---KPILR--SINL 78
A L NC CGN V++P+PFGIG+ CY +K + I CKSS +PIL I
Sbjct: 21 AAASTFPLALRNCSDHCGN-VSVPYPFGIGKGCYKNKWFEIVCKSSSDQQPILLLPRIRR 79
Query: 79 EVLEFLL-EKSTMRV-NQSVISS------CQDKTT-EASFVNLEKLPFYFSYYDNIFSGI 129
V F L + ++ V N+ I S C ++ +S +NL+ PF+ S +N F+ +
Sbjct: 80 AVTSFNLGDPFSISVYNKFYIQSPLKHSGCPNRDGYSSSSLNLKGSPFFISE-NNKFTAV 138
Query: 130 GCNNLASMSSADHDFILGGCFSIC--DPRN-KTEDDSCNGIECCKAGVPWALKXXXXXXX 186
GCNN A M+ + GC + C + R+ K + SC G +CC+ +P L+
Sbjct: 139 GCNNKAFMNVTGLQIV--GCETTCGNEIRSYKGANTSCVGYKCCQMTIPPLLQLQVFDAT 196
Query: 187 XXXXXXXXXXXXQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRIPNSSFGE 246
++G C+ AF+ + S F ++ + L+WR+ +
Sbjct: 197 VEKLEP------NKQG-CQVAFLTQFTLSGSLFTPPELMEYSEYTTIELEWRL------D 243
Query: 247 LERDESSKFTSTSHCESDEGGLFRCSCKEKYHGNPYFLHGCQDL--------------RC 292
L S + + ++ ++CSC Y GNPY GCQD+ +C
Sbjct: 244 LSYMTSKRVLCKGNTFFEDS--YQCSCHNGYEGNPYIPGGCQDIDECRDPHLNKCGKRKC 301
Query: 293 ENYEGGYRCVNPKRPKVYTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKQKEENFKKNGG 352
N G YRC P + + KQK + F++NGG
Sbjct: 302 VNVLGSYRC-EKTWPAILSGTLSSGLLLLIFGMWLLCKANRKRKVA--KQKRKFFQRNGG 358
Query: 353 LLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVK 412
LLL+QQ + L GS++R K+F+S +L+ ATD FN +RILGQGGQGTVYKGML DG I+AVK
Sbjct: 359 LLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVK 418
Query: 413 KSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP 472
KSK + E LEEFINE+++LSQI+HRNVVK+LG CLE EVP+LVYEFIPN LF +LH+P
Sbjct: 419 KSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNP 478
Query: 473 SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532
SE+ ++WE+RL IA EVA+AL+YLHS+ +PIYHRD+KSTNILLDEK+RAK++DFG SR
Sbjct: 479 SEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISR 538
Query: 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592
S+AID TH++T VQGT GY+DPEY S+ FT KSDVYSFGV+L+ELLTG+KP+S + E
Sbjct: 539 SVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQE 598
Query: 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652
R L YF+E + + L +ILD ++++ EE++ V+ +A+RCL+ N RPTM++V +
Sbjct: 599 VRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFI 658
Query: 653 ELERIRA 659
EL+R+++
Sbjct: 659 ELDRMQS 665
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 8.9e-128, Sum P(2) = 8.9e-128
Identities = 223/421 (52%), Positives = 291/421 (69%)
Query: 271 CSCKEKYHGNPYFLHGCQDL--------------RCENYEGGYRCVNPKRPKVYTXXXXX 316
C C Y GNPY GC+D+ C N+EGGYRCV K K
Sbjct: 318 CECNLGYKGNPYDSDGCRDIDECKENPKYCKETDTCVNFEGGYRCVGDKT-KAIMIGAGT 376
Query: 317 XXXXXXXXXXXXXXXXXXXXXXXXKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKE 376
K+K++ FK+NGGLLL+Q+LN+ G +++ +IF SKE
Sbjct: 377 GFGVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKE 436
Query: 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS 436
L+KAT++F+ NR+LG GGQGTVYKGML DGR +AVKKSKV+DE KL+EFINEVVILSQI+
Sbjct: 437 LEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQIN 496
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALA 495
HR+VVKLLG CLE EVP+LVYEFI NG LF+++H+ +++ ++ W MRLRIA ++A AL+
Sbjct: 497 HRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALS 556
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
YLHS+A PIYHRDIKSTNILLDEKYRAK+ADFGTSRS+ IDQTH +T + GT GY+DPE
Sbjct: 557 YLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPE 616
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIW-ANEGRNLATYFVECVEENCLFDILD 614
Y+ SSQ+T+KSDVYSFGV+L EL+TG KP+ + E LA +F ++E L DI+D
Sbjct: 617 YYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMD 676
Query: 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQKCYE 674
++R K E++M V+++A +CL+S GR+RP M+EV ELERI C +D +Q +
Sbjct: 677 ARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI--CT-SPEDSQVQNRID 733
Query: 675 E 675
E
Sbjct: 734 E 734
|
|
| TAIR|locus:2200527 WAKL6 "wall associated kinase-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-123, Sum P(3) = 2.8e-123
Identities = 199/333 (59%), Positives = 246/333 (73%)
Query: 271 CSCKEKYHGNPYFLHGCQDL-RCENYE--GGYRCVN-PK----RPKVYTXXXXXXXXXXX 322
C C Y GNPY HGC D+ CE + G CVN P PK+
Sbjct: 304 CYCNYGYTGNPYLRHGCIDIDECEGHHNCGEGTCVNMPGTHSCEPKITKPEKASVLQGVL 363
Query: 323 XXXXXXXXXXXXXXXXXXKQKE------ENF-KKNGGLLLEQQLNSLDGSIDRCKIFNSK 375
+K +NF K+NGGLLL+QQL + +G++D +IF+SK
Sbjct: 364 ISLGVLLFVLGILGLYKFIKKRTRIIRNKNFFKRNGGLLLKQQLITKNGNVDMSRIFSSK 423
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
EL KATD+F++NR+LGQGGQGTVYKGMLA+GRI+AVK+SKVV E K+EEFINEVV+LSQI
Sbjct: 424 ELKKATDNFSMNRVLGQGGQGTVYKGMLAEGRIVAVKRSKVVGEGKMEEFINEVVLLSQI 483
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE--ELSLTWEMRLRIATEVAEA 493
+HRN+VKLLG CLE EVP+LVYE+IPNG LF+ LH+ SE + ++TWE+RLRIA E+A A
Sbjct: 484 NHRNIVKLLGCCLETEVPVLVYEYIPNGDLFKRLHEKSESNDYTMTWEVRLRIAIEIAGA 543
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
L+Y+HS+A +PIYHRDIK+TNILLDEKYRAK++DFGTSRSI I QTH++T V GTFGY+D
Sbjct: 544 LSYMHSAASIPIYHRDIKTTNILLDEKYRAKVSDFGTSRSITIAQTHLTTLVAGTFGYMD 603
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPIS 586
PEYF SSQ+TDKSDVYSFGVVLVEL+TG+KP+S
Sbjct: 604 PEYFLSSQYTDKSDVYSFGVVLVELITGEKPLS 636
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S9M5 | WAKLA_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4522 | 0.9469 | 0.8794 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00005799001 | SubName- Full=Chromosome chr3 scaffold_158, whole genome shotgun sequence; (970 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 678 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-31 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-29 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-26 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 6e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-06 | |
| pfam08488 | 103 | pfam08488, WAK, Wall-associated kinase | 6e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 7e-51
Identities = 84/279 (30%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 387 NRILGQGGQGTVYKGML----ADGRI-IAVKKSKV-VDESKLEEFINEVVILSQISHRNV 440
+ LG+G G VYKG L + +AVK K E ++EEF+ E I+ ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
VKLLG C E E ++V E++P G L YL + L+ L A ++A + YL S
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLES- 121
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
HRD+ + N L+ E KI+DFG SR + D + + ++ PE
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 561 QFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR- 618
+FT KSDV+SFGV+L E+ T G++P Y + + +V
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP--YP----------------------GMSNAEVLE 215
Query: 619 --KSGKTEEIM-----EVSDVAKRCLNSNGRSRPTMKEV 650
K G E+ + +C + RPT E+
Sbjct: 216 YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 8e-51
Identities = 87/279 (31%), Positives = 128/279 (45%), Gaps = 44/279 (15%)
Query: 387 NRILGQGGQGTVYKGML-----ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNV 440
+ LG+G G VYKG L +AVK K E ++EEF+ E I+ ++ H NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
VKLLG C E E +V E++ G L YL +LSL L A ++A + YL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSL--SDLLSFALQIARGMEYLES- 120
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
HRD+ + N L+ E KI+DFG SR + D + + ++ PE
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 561 QFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR- 618
+FT KSDV+SFGV+L E+ T G++P Y + +++V
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP--Y----------------------PGMSNEEVLE 214
Query: 619 --KSGKTEEIM-----EVSDVAKRCLNSNGRSRPTMKEV 650
K+G E+ D+ +C + RPT E+
Sbjct: 215 YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 9e-51
Identities = 72/193 (37%), Positives = 104/193 (53%), Gaps = 10/193 (5%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447
LG+GG GTVY G+ +A+K K S LEE + E+ IL +++H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
+ LV E+ G+L L + +LS + LRI ++ E L YLHS I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLS--EDEILRILLQILEGLEYLHS---NGIIH 115
Query: 508 RDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ-FTDK 565
RD+K NILLD + K+ADFG S+ + + + GT Y+ PE +++K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 566 SDVYSFGVVLVEL 578
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 92/275 (33%), Positives = 133/275 (48%), Gaps = 29/275 (10%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNV 440
+ + R LG G GTVYK G+I+AVK K K + E+ IL ++SH N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
V+L+ + + + LV E+ G LF YL S L+ + +IA ++ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS- 116
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHS 559
I HRD+K NILLDE KIADFG ++ + + ++T V GT Y+ PE
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRN--LATYFVECVEENCLFDILDDQV 617
+ + K DV+S GV+L ELLTG+ P ++ E L IL +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRR----------ILGPPL 219
Query: 618 RKSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
E D+ K+CLN + RPT +E+
Sbjct: 220 EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 5e-49
Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 23/269 (8%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQISHRNVV 441
+ + LG+G G VY G+++A+K K + E + E+ IL ++ H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+L + + LV E+ G LF L + L+ + ++ AL YLHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
I HRD+K NILLDE K+ADFG +R +D T GT Y+ PE
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR--QLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
+ D++S GV+L ELLTG+ P + + L F + + F + +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP----FPGDD-QLLELFKKIGKPKPPFPPPEWDISPEA 227
Query: 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
K D+ ++ L + R T +E
Sbjct: 228 K--------DLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 86/278 (30%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 387 NRILGQGGQGTVYKGML-----ADGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNV 440
+ LG+G G VYKG L +AVK K E + EEF+ E I+ ++SH N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
V+LLG C + E +V E++P G L +L E+L+L L++A ++A+ + YL S
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESK 121
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG---YLDPEYF 557
++ HRD+ + N L+ E KI+DFG SR I D + G ++ PE
Sbjct: 122 NFV---HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176
Query: 558 HSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616
+FT KSDV+SFGV+L E+ T G++P + E +E +E+ +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRLPRPE-- 227
Query: 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654
+E+ ++ +C + RPT E+ +L
Sbjct: 228 ----NCPDELY---ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 5e-47
Identities = 86/281 (30%), Positives = 140/281 (49%), Gaps = 46/281 (16%)
Query: 388 RILGQGGQGTVYKGMLAD-GRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLL 444
+LG+G G+VY + D G ++AVK ++ E +LE E+ ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 445 GSCLEVEVP-LLVY-EFIPNGTLFQYLHD---PSEELSLTWEMRLRIATEVAEALAYLHS 499
GS + E L ++ E++ G+L L E + +R + ++ E LAYLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV-----IR-KYTRQILEGLAYLHS 119
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFH 558
+ + HRDIK NIL+D K+ADFG ++ + I+ + V+GT ++ PE
Sbjct: 120 NGIV---HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
++ +D++S G ++E+ TG+ P W+ G +A L+ I
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP----WSELGNPMAA----------LYKIG----- 217
Query: 619 KSGKTEEIME-VSDVAK----RCLNSNGRSRPTMKEVAMEL 654
SG+ EI E +S+ AK +CL + + RPT A EL
Sbjct: 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT----ADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 87/291 (29%), Positives = 128/291 (43%), Gaps = 52/291 (17%)
Query: 388 RILGQGGQGTVYKGMLADG----RIIAVKKSK-VVDESKLEEFINEVVILSQISHRNVVK 442
+ LG+G G VYKG L +AVK K E + ++F+ E ++ ++ H NVV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYL------HDPSEELSLTWEMRLRIATEVAEALAY 496
LLG C E E LV E++ G L YL E+ +L+ + L A ++A+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDP 554
L S HRD+ + N L+ E KI+DFG SR + D + G ++ P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAP 176
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWANEGRNLATYFVECV 604
E FT KSDV+SFGV+L E+ T G P + Y+ +G L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL--RKGYRLPKP----- 229
Query: 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
E C ++ E+M C + RPT E+ LE
Sbjct: 230 -EYCPDEL-----------YELM------LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+G+GG G VYK G+ +A+K K+ + K E+ INE+ IL + H N+VK GS L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT---EVAEALAYLHSSAYLPI 505
+ + +V EF G+L L ++ L+ + IA E+ + L YLHS I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS---NGI 119
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDK 565
HRDIK+ NILL K+ DFG S ++ T + GT ++ PE + + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 566 SDVYSFGVVLVELLTGQKPISY 587
+D++S G+ +EL G+ P S
Sbjct: 178 ADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (326), Expect = 1e-32
Identities = 76/280 (27%), Positives = 120/280 (42%), Gaps = 22/280 (7%)
Query: 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH-R 438
+ + R LG+G G VY D +++A+K K ++E F+ E+ IL+ ++H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
N+VKL + LV E++ G+L L + L+ L I ++ AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 499 SSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQTHVS-----TKVQGTFGYL 552
S I HRDIK NILLD K+ DFG ++ + + S + GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 553 DPEYFHSSQF---TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609
PE + SD++S G+ L ELLTG P + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELP 231
Query: 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649
L + S SD+ K+ L + ++R +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 85/290 (29%), Positives = 131/290 (45%), Gaps = 43/290 (14%)
Query: 388 RILGQGGQGTVYKGMLA------DGRIIAVKKSK-VVDESKLEEFINEVVILSQISHRNV 440
R LG+G G V+ G D ++AVK K ++F E +L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDP---------SEELSLTWEMRLRIATE 489
VK G C E + P++V+E++ +G L ++L H P S LT L+IA +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT- 548
+A + YL S ++ HRD+ + N L+ KI DFG SR + T +V G
Sbjct: 131 IASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVGGHT 184
Query: 549 ---FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605
++ PE +FT +SDV+SFGVVL E+ T K Y +NE +EC+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------EVIECIT 238
Query: 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
+ L R EV D+ C + + R +K++ L+
Sbjct: 239 QGRLLQ------RPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 4e-32
Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 24/267 (8%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLL 444
+ +G+G G VY +DG++ +K+ + + E + E+ +NEV IL +++H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEE-LSLTWEMRLRIATEVAEALAYLHSSAYL 503
S E +V E+ G L Q + +E E L ++ AL YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
I HRDIK NI L K+ DFG S+ ++ T V GT YL PE + +
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 564 DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623
KSD++S G VL EL T + P EG NL ++ ++ + + Q
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPF------EGENLLELALKILKGQ--YPPIPSQYSS---- 229
Query: 624 EEIMEVSDVAKRCLNSNGRSRPTMKEV 650
E+ ++ L + RP++ ++
Sbjct: 230 ----ELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRN 439
++ + ++G+G G VYKG+ L G +A+K+ + + E L+ + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDP-SEELSLTWEMRLRIATEVAEALAY 496
+VK +GS + ++ E+ NG+L Q + P E L + +V + LAY
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY------VYQVLQGLAY 114
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
LH + HRDIK+ NIL + K+ADFG + + D + V GT ++ PE
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEV 170
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKP 584
S + SD++S G ++ELLTG P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 34/296 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKV-VDESKLEEFINEVVILSQI 435
H + LG+G G V G +AVK +E +F E+ IL +
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 436 SHRNVVKLLGSCLEV--EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
H N+VK G C + L+ E++P+G+L YL ++++L L ++++ +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKG 121
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---TFG 550
+ YL S Y+ HRD+ + NIL++ + KI+DFG ++ + D+ + K G F
Sbjct: 122 MDYLGSQRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLT--------GQKPISYIWANEGRNLATYFVE 602
Y PE +S+F+ SDV+SFGV L EL T + + I +G+ + T +E
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
++E R EV D+ K C + + RP+ ++ + ++R+R
Sbjct: 238 LLKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 6/202 (2%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
F + R LG G G V++G+ + +A+K K D K ++F EV L ++ H++++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
C E ++ E + G+L +L P E L + +A +VAE +AYL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSI 126
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
HRD+ + NIL+ E K+ADFG +R I + ++S+ + + + PE F+
Sbjct: 127 ---HRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 564 DKSDVYSFGVVLVELLT-GQKP 584
KSDV+SFG++L E+ T GQ P
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 76/269 (28%), Positives = 131/269 (48%), Gaps = 25/269 (9%)
Query: 390 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
LG G G VY+G+ +AVK K D ++EEF+ E ++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 449 EVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
E P ++ EF+ G L YL + + + + + L +AT+++ A+ YL ++ H
Sbjct: 73 R-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSD 567
RD+ + N L+ E + K+ADFG SR + D + + PE ++F+ KSD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 568 VYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEI 626
V++FGV+L E+ T G P ++ + ++++L+ R
Sbjct: 188 VWAFGVLLWEIATYGMSPYP----------------GIDLSQVYELLEKGYRMERPEGCP 231
Query: 627 MEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
+V ++ + C N RP+ E+ E
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 42/294 (14%)
Query: 384 FNVNRILGQGGQGTVYKGMLA--DGRI--IAVKKSKV--VDESKLEEFINEVVILSQISH 437
+ +ILG+G G+V +G L+ DG +AVK K+ S++EEF++E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 438 RNVVKLLGSCLEVE------VPLLVYEFIPNGTLFQYL-HDPSEELS--LTWEMRLRIAT 488
NV+KL+G C E P+++ F+ +G L +L + L L + L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID----QTHVSTK 544
++A + YL + ++ HRD+ + N +L E +ADFG S+ I Q ++
Sbjct: 121 DIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-- 175
Query: 545 VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVEC 603
+ ++ E +T KSDV++FGV + E+ T GQ P
Sbjct: 176 -KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP----------------G 218
Query: 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
VE + ++D L R + + E+ D+ C ++ + RPT ++ LE I
Sbjct: 219 VENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVKLLG 445
LG+G G V G++ A+K K K++ ++E + E ILS+I+H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 446 SCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
+ E L LV E+ P G LF +L S+E + E A E+ AL YLHS L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLHS---LG 113
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
I +RD+K NILLD K+ DFG ++ ++ + + +T GT YL PE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 565 KSDVYSFGVVLVELLTGQKP 584
D +S GV+L E+LTG+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 64/196 (32%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447
LG G G V+ G +A+K + + E ++FI E ++ ++SH N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
+ +V E++ NG L YL + +L E L + ++V EA+ YL S+ ++ H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSD 567
RD+ + N L+ E K++DFG +R + DQ S + + PE F S+F+ KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 568 VYSFGVVLVELLTGQK 583
V+SFGV++ E+ + K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 71/203 (34%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGS 446
R LG G G V+ G +AVK K S E F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
C E E +V E++ G+L +L E L + +A ++AE +AYL S Y+
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYI--- 125
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGYLDPEYFHSSQF 562
HRD+ + NIL+ E KIADFG +R I D+ K ++ T PE + +F
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRF 181
Query: 563 TDKSDVYSFGVVLVELLT-GQKP 584
T KSDV+SFG++L E++T G+ P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 40/232 (17%)
Query: 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS- 436
D F +I+G+G TV + A+K K +++ E K++ E +L++++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 437 HRNVVKLLG-----SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
H ++KL L V E+ PNG L QY+ SL + A E+
Sbjct: 61 HPGIIKLYYTFQDEENL-----YFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEIL 112
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ----- 546
AL YLHS I HRD+K NILLD+ KI DFGT++ + + + S K
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 547 --------------GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
GT Y+ PE + SD+++ G ++ ++LTG+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 53/314 (16%)
Query: 378 DKATDHFNVNRILGQGGQGTVY----------------KGMLADG-RIIAVKKSKV-VDE 419
+ N LG+G G V+ + AD ++AVK + +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 420 SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH--------D 471
+ E+F+ EV ILS++S N+ +LLG C ++ E++ NG L Q+L
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 472 PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531
SL++ L +AT++A + YL S ++ HRD+ + N L+ + Y KIADFG S
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNCLVGKNYTIKIADFGMS 177
Query: 532 RSIAIDQTHVSTKVQGT----FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT--GQKPI 585
R++ + +VQG ++ E +FT KSDV++FGV L E+LT ++P
Sbjct: 178 RNL---YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 586 SYI---WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGR 642
++ E N +F + + L + K ++ ++ C +
Sbjct: 235 EHLTDQQVIE--NAGHFFRDDGRQIYL-----PRPPNCPK-----DIYELMLECWRRDEE 282
Query: 643 SRPTMKEVAMELER 656
RPT +E+ + L+R
Sbjct: 283 DRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 25/226 (11%)
Query: 389 ILGQGGQGTVYKGMLADGRIIAVKK------SKVVDESKLEEFINEVVILSQISHRNVVK 442
+LG+G GTVY G+ G++IAVK+ + + E + E+ EV +L + H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLH--DPSEELSLTWEMRLRIATEVAEALAYLHSS 500
LG+CL+ + EF+P G++ L+ P E + ++ + +AYLH++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-----KYTKQILDGVAYLHNN 121
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-----TKVQGTFGYLDPE 555
+ HRDIK N++L K+ DFG +R +A H + + GT ++ PE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601
+ S + KSD++S G + E+ TG+ P A+ R A +++
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPP----LASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 22/271 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFI-NEVVILSQISHRN 439
++LGQG G VYK G+I A+KK V + + + + E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYLH 498
VVK G+ + +V E++ G+L L ++ E L IA ++ + L YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIP---EPVLAYIARQILKGLDYLH 116
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
+ I HRDIK +N+L++ K KIADFG S+ + +T V GT Y+ PE
Sbjct: 117 TK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
++ +D++S G+ L+E G+ P ++ + F E ++ C +
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP--FLPPGQPS-----FFELMQAICDGPPPS--LP 224
Query: 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649
+ E D CL + + RP+ E
Sbjct: 225 AEEFSPEF---RDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 8/205 (3%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ + +G+G G VYK A G+ +A+KK ++ ++K E INE++I+ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPN 76
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+V S L + +V E++ G+L + + + + + EV + L YLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS 134
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+ HRDIKS NILL + K+ADFG + + +++ ++ V GT ++ PE
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
+ K D++S G++ +E+ G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 71/202 (35%), Positives = 115/202 (56%), Gaps = 14/202 (6%)
Query: 388 RILGQGGQGTVYKGML--ADGRII--AVKK-SKVVDESKLEEFINEVVILSQISHRNVVK 442
R++G+G G VY G L +DG+ I AVK +++ D ++E+F+ E +I+ SH NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 443 LLGSCLEVE-VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
LLG CL E PL+V ++ +G L ++ + + T + + +VA+ + YL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI---AIDQTHVSTKVQGTFGYLDPEYFH 558
++ HRD+ + N +LDE + K+ADFG +R I H T + ++ E
Sbjct: 119 FV---HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 559 SSQFTDKSDVYSFGVVLVELLT 580
+ +FT KSDV+SFGV+L EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 67/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449
+G G G V+ G + R +A+K + S+ E+FI E ++ ++SH +V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509
LV+EF+ +G L YL ++ + E L + +V E +AYL SS + HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSNVI---HRD 125
Query: 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVY 569
+ + N L+ E K++DFG +R + DQ ST + + PE F S+++ KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 570 SFGVVLVELLT-GQKP 584
SFGV++ E+ + G+ P
Sbjct: 186 SFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 83/290 (28%), Positives = 132/290 (45%), Gaps = 42/290 (14%)
Query: 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK-LEEFINEVVI 431
NSKEL +G+G G V G G+ +AVK K D+S + F+ E +
Sbjct: 4 NSKELKLGA-------TIGKGEFGDVMLGDYR-GQKVAVKCLK--DDSTAAQAFLAEASV 53
Query: 432 LSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
++ + H N+V+LLG L+ +V E++ G+L YL + +T +L A +V
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVC 112
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
E + YL HRD+ + N+L+ E AK++DFG ++ + Q V+ T
Sbjct: 113 EGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--- 166
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611
PE +F+ KSDV+SFG++L E+ S+ GR Y +++
Sbjct: 167 -APEALREKKFSTKSDVWSFGILLWEIY------SF-----GR--VPYPRIPLKD----- 207
Query: 612 ILDDQVRKSGKTEEIM----EVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+ V K + E EV V K C + RPT K++ +L I
Sbjct: 208 -VVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 78/273 (28%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGS 446
+G G G VY + L G ++AVK+ ++ D ++E +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT-EVAEALAYLHSSAYLPI 505
+ E + E+ GTL + L E +R+ T ++ E LAYLHS I
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILD----EHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG---YLDPEYFHSSQF 562
HRDIK NI LD K+ DFG + + + T + +VQ G Y+ PE +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 563 TDK---SDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619
+D++S G V++E+ TG++P W+ F Q+
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP----WSELDNEFQIMFHVGAGHKPPIPD-SLQLSP 235
Query: 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652
GK D RCL S+ + RPT E+
Sbjct: 236 EGK--------DFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 44/275 (16%)
Query: 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLE--EFINEVVILSQISHRNV 440
F + +G+G G V+K + AD R+ A+K+ + ++ E E I+E +L+++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
++ S L+ +V E+ NG L + L L + R ++ LA+LHS
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSK 120
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
I HRDIKS N+ LD KI D G ++ ++ D T+ + + GT YL PE
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDK 176
Query: 561 QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ---V 617
+ +KSDV++ GVVL E TG+ P FD ++Q +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHP-------------------------FDA-NNQGALI 210
Query: 618 RK--SGKTEEI-----MEVSDVAKRCLNSNGRSRP 645
K G + +++ + +CL + R RP
Sbjct: 211 LKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 390 LGQGGQGTVYKG--MLADGRII--AVKKSKVVDESKLE-EFINEVVILSQISHRNVVKLL 444
LG G G+V KG ++ G+ + AVK K + + EF+ E +++Q+ H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSE--ELSLTWEMRLRIATEVAEALAYLHSSAY 502
G C E +LV E P G L +YL E L +A +VA +AYL S +
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESKHF 116
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFHSS 560
+ HRD+ + N+LL +++AKI+DFG SR++ + G + + PE +
Sbjct: 117 V---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 561 QFTDKSDVYSFGVVLVELLT-GQKP 584
+F+ KSDV+S+GV L E + G KP
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL-EEFINEVVILSQISHRNVVKLLGS 446
+G+G G VYKG+L +AVK + L +F+ E IL Q H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
C++ + +V E +P G+L +L L++ +++ + + A + YL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESKNCI--- 115
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFGYLDPEYFHSSQFTDK 565
HRD+ + N L+ E KI+DFG SR VS + Q + PE + ++T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 566 SDVYSFGVVLVELLTG 581
SDV+S+G++L E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 80/305 (26%), Positives = 141/305 (46%), Gaps = 57/305 (18%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKS-KVVDESK----LE 423
+I EL+K ++LG G GTVYKG+ + +G + + + KV+ E +
Sbjct: 2 RILKETELEKI-------KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK 54
Query: 424 EFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS----LT 479
E ++E +++ + H +VV+LLG CL +V L+ + +P G L Y+ + + + L
Sbjct: 55 EILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLN 113
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
W ++A+ ++YL + HRD+ + N+L+ KI DFG ++ + +D+
Sbjct: 114 W------CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164
Query: 540 HVSTKVQG---TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRN 595
+G ++ E +T KSDV+S+GV + EL+T G KP I A E
Sbjct: 165 EY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--- 219
Query: 596 LATYFVECVEENCLFDILDDQVRKSGKTEE----IMEVSDVAKRCLNSNGRSRPTMKEVA 651
+ D + K + + ++V V +C + SRPT KE+
Sbjct: 220 -----------------IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262
Query: 652 MELER 656
E +
Sbjct: 263 NEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 87/294 (29%), Positives = 140/294 (47%), Gaps = 32/294 (10%)
Query: 383 HFNVNRILGQGGQGTVYK---GMLAD--GRIIAVKKSKVVDESKLEEFINEVVILSQISH 437
H + LG+G G+V L D G ++AVKK + L +F E+ IL + H
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64
Query: 438 RNVVKLLGSCLEVEVP--LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
N+VK G C LV E++P G+L YL E L L A+++ + +
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR--KLLLYASQICKGME 122
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---TFGYL 552
YL S Y+ HRD+ + NIL++ + R KI DFG ++ + D+ + + G F Y
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC---- 608
PE S+F+ SDV+SFGVVL EL T ++++ + F+ + +
Sbjct: 180 -PESLTESKFSVASDVWSFGVVLYELFT--------YSDKSCSPPAEFMRMMGNDKQGQM 230
Query: 609 ----LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
L ++L + R E+ + K C N++ RP+ E+A+++E IR
Sbjct: 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 6/198 (3%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447
R LG G G V++G+ + +AVK K ++F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
E +V E + G+L +YL +L + +A +VA +AYL + Y+ H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSD 567
RD+ + N+L+ E K+ADFG +R I D + + PE ++F+ KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 568 VYSFGVVLVELLT-GQKP 584
V+SFG++L E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 68/205 (33%), Positives = 107/205 (52%), Gaps = 14/205 (6%)
Query: 387 NRILGQGGQGTVYKGM---LADGRI-IAVKKSKV-VDESKLEEFINEVVILSQISHRNVV 441
R +G+G G VY+G+ + +I +AVK K S E+F+ E I+ Q H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 442 KLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
KL+G E P+ +V E P G L YL L L + + +++ ALAYL S
Sbjct: 71 KLIGVI--TENPVWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYLESK 126
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
++ HRDI + N+L+ K+ DFG SR + + + ++K + ++ PE +
Sbjct: 127 RFV---HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 561 QFTDKSDVYSFGVVLVELLT-GQKP 584
+FT SDV+ FGV + E+L G KP
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 9e-27
Identities = 73/236 (30%), Positives = 116/236 (49%), Gaps = 28/236 (11%)
Query: 390 LGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
LG+G G V+ D ++AVK K ES ++F E +L+ + H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEEL----------SLTWEMRLRIATEVA 491
G C E L+V+E++ +G L ++L H P ++ LT L IA+++A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFG 550
+ YL A L HRD+ + N L+ + KI DFG SR I + D V +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
++ PE +FT +SD++SFGVVL E+ T K Y +N T +EC+ +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 72/222 (32%), Positives = 105/222 (47%), Gaps = 31/222 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK----LEEFINEVVILSQIS 436
D + + ++G G VY + L + +A+K+ +D K ++E EV +SQ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCN 57
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTL-----FQYLHDPSEELSLTWEMRLRIAT--- 488
H NVVK S + + LV ++ G+L Y +E IAT
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI--------IATVLK 109
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA---IDQTHVSTKV 545
EV + L YLHS+ + HRDIK+ NILL E KIADFG S S+A V
Sbjct: 110 EVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 546 QGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPIS 586
GT ++ PE + K+D++SFG+ +EL TG P S
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 82/292 (28%), Positives = 145/292 (49%), Gaps = 35/292 (11%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKKS-KVVDESKLE----EFINEVVILSQISHRNVV 441
++LG G GTVYKG+ + +G + + + K+++E+ EF++E +I++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+LLG CL + LV + +P+G L Y+H+ + + ++ L ++A+ + YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGS--QLLLNWCVQIAKGMMYLEERR 129
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-VQGTFGYLDPEYFHSS 560
+ HRD+ + N+L+ KI DFG +R + D+ + + ++ E H
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 561 QFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619
+FT +SDV+S+GV + EL+T G KP I E + D+L+ R
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----------------IPDLLEKGERL 230
Query: 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI-----RACNLQDDD 666
++V V +C + SRP KE+A E R+ R +Q DD
Sbjct: 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDD 282
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 58/211 (27%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 386 VNRILGQGGQGTVYKGMLA----DGRIIAVK--KSKVVDESKLEEFINEVVILSQISHRN 439
+ +++G G G V +G L +A+K K+ D+ +L+ F+ E I+ Q H N
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPN 66
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+++L G + +++ E++ NG+L ++L + + T + + +A + YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSE 124
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-----VQGTFGYLDP 554
Y+ HRD+ + NIL++ K++DFG SR + + +TK ++ T P
Sbjct: 125 MNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----AP 177
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
E +FT SDV+SFG+V+ E+++ G++P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 79/302 (26%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 386 VNRILGQGGQGTVYKGM------LADGRIIAVKKSKV-VDESKLEEFINEVVILSQISHR 438
+ + LG+G G V K A +AVK K S+L + ++E +L Q++H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH---------------------DPSEELS 477
+V+KL G+C + LL+ E+ G+L +L D +E +
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 478 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537
LT + A +++ + YL A + + HRD+ + N+L+ E + KI+DFG SR + +
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 538 QTHVS-TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRN 595
++V +K + ++ E +T +SDV+SFGV+L E++T G P I
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI------- 233
Query: 596 LATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
E LF++L R E+ ++ C RPT +++ ELE
Sbjct: 234 --------APER-LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
Query: 656 RI 657
++
Sbjct: 285 KM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 5e-26
Identities = 80/268 (29%), Positives = 127/268 (47%), Gaps = 23/268 (8%)
Query: 389 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVVKLLGSC 447
+LG+G G V+KG L D +AVK K +L+ +F++E IL Q H N+VKL+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
+ + +V E +P G +L +EL + ++ A + A +AYL S + H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI---H 116
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSD 567
RD+ + N L+ E KI+DFG SR S Q + PE + +++ +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 568 VYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEI 626
V+S+G++L E + G P + + R E VE+ R S +
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKG---------YRMSCPQKCP 220
Query: 627 MEVSDVAKRCLNSNGRSRPTMKEVAMEL 654
+V V +RC + +RP E+ EL
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-26
Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 9/108 (8%)
Query: 33 KPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKSS----KPILRSINLEVLEFLLEKS 88
P CP CGN V+IP+PFGIG C D + + C ++ + +L + N EVL L
Sbjct: 1 LPGCPDRCGN-VSIPYPFGIGPGCARDPGFELTCNNTTSPPRLLLGNGNYEVLSISLANG 59
Query: 89 TMRVNQSVISSCQD---KTTEASFVNLEKLPFYFSYYDNIFSGIGCNN 133
T+RV + S+C + K T+ ++L PF+FS N F +GCN
Sbjct: 60 TVRVLDPISSNCYNSSGKRTDNGSLSLG-GPFFFSSSRNKFVVVGCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 44/276 (15%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK-----LEEFINEVVILSQISHRNVV 441
+LG G G+VY+G+ L DG AVK+ + D+ + +++ E+ +LS++ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 442 KLLGSCLEVEVPLLVY-EFIPNGTLFQYLHDPSEELSLTWEMRLRIATE-VAEALAYLHS 499
+ LG+ E E L ++ E +P G+L + L S E +R+ T + L YLH
Sbjct: 66 QYLGTERE-EDNLYIFLELVPGGSLAKLLKKYG---SFP-EPVIRLYTRQILLGLEYLHD 120
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
HRDIK NIL+D K+ADFG ++ + S K G+ ++ PE
Sbjct: 121 RN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIAQ 175
Query: 560 S-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
+ +D++S G ++E+ TG+ P S + +F I
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWS---------------QLEGVAAVFKIG----- 215
Query: 619 KSGKTEEIME-VSDVAK----RCLNSNGRSRPTMKE 649
+S + I + +SD AK +CL + RPT E
Sbjct: 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVK 442
+G+G G VYK G ++A+KK ++ +E E F I E+ +L ++ H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 443 LLGSCLEVEVP--LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
L +V+E++ + L L P + + + +++ ++ E L YLHS+
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-QIK-CYMKQLLEGLQYLHSN 119
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHS 559
L HRDIK +NIL++ K+ADFG +R + T T Y PE +
Sbjct: 120 GIL---HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPI 585
+++ + D++S G +L EL G KPI
Sbjct: 177 TRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 389 ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVKL 443
LG+G G VYK G I+A+KK ++ +E E + E+ +L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
L LV+E+ L +YL LS + I ++ LAY HS L
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYCHSHRIL 120
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
HRD+K NIL++ K+ADFG +R+ I + +V T Y PE S+
Sbjct: 121 ---HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 564 DKS-DVYSFGVVLVELLTGQKPI 585
+ D++S G + E++TG KP+
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 384 FNVNRILGQGGQGTVYK-GMLADGRIIAVKKSKVVDESKLE--EFINEVVILSQISHRNV 440
F V + LG+G G+VYK L+D + A+K+ + S+ E + +NE+ IL+ ++H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSL-TWEMRLRIATEVAEALAYLHS 499
+ + L+ +V E+ P G L + + ++ L + RI ++ L LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
I HRD+KS NILL KI D G S+ + + T++ GT Y+ PE +
Sbjct: 122 ---QKILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMAPEVWKG 175
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
++ KSD++S G +L E+ T P
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 390 LGQGGQGTVYKGML------ADGRIIAVKKSKVVDESKL-EEFINEVVILSQISHRNVVK 442
LG+G G VYKG L +A+K K E K+ +EF E ++S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEELSLTWEMR-----------LRIATE 489
LLG C + + +++E++ +G L ++L + P ++ L IA +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 548
+A + YL S ++ HRD+ + N L+ E KI+DFG SR I + D V +K
Sbjct: 133 IAAGMEYLSSHHFV---HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
++ PE +FT +SD++SFGVVL E+ + G +P
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+GQG GTVY + +A G+ +A+K+ + + K E INE++++ + H N+V L S L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
+ +V E++ G+ L D E + + E +AL +LHS+ + HR
Sbjct: 87 VGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 139
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKS NILL K+ DFG I +Q+ ST V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 569 YSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601
+S G++ +E++ G+ P + NE A Y +
Sbjct: 199 WSLGIMAIEMVEGEPP----YLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 390 LGQGGQGTVYKG--MLADGRII--AVK--KSKVVDESKLEEFINEVVILSQISHRNVVKL 443
LG G G V +G + G++I AVK KS + + +++F+ E I+ + H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEE---LSLTWEMRLRIATEVAEALAYLHSS 500
G L + ++V E P G+L L + +S + A ++A + YL S
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY----AVQIANGMRYLESK 116
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT--FGYLDPEYFH 558
++ HRD+ + NILL + KI DFG R++ ++ H + F + PE
Sbjct: 117 RFI---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 559 SSQFTDKSDVYSFGVVLVELLT-GQKP 584
+ F+ SDV+ FGV L E+ T G++P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 21/211 (9%)
Query: 389 ILGQGGQGTVYKGMLA-DGRIIAVK---------KSKVVDESKLEEFINEVVILSQISHR 438
++G G G+VY GM A G ++AVK SK S L+ E+ +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
N+V+ LGS L+ + + E++P G++ L++ + + ++ + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH 123
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-----VQGTFGYLD 553
+ I HRDIK NIL+D K KI+DFG S+ + + T +QG+ ++
Sbjct: 124 NRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE + +T K+D++S G ++VE+LTG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 63/200 (31%), Positives = 110/200 (55%), Gaps = 11/200 (5%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL--EEFINEVVILSQISHRNVVKLLG 445
+ LG G G V+ G +A+K ++E + E+FI E ++ ++SH +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
C + + +V EF+ NG L YL +LS +M L + +V E + YL ++++
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK--DMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDK 565
HRD+ + N L+ K++DFG +R + D+ S+ + + PE F+ S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 566 SDVYSFGVVLVELLT-GQKP 584
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 388 RILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDESKLE--EFINEVVILSQISHRN 439
R LGQG G VY+G+ +A+K + + S E EF+NE ++ + + +
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIK-TVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEEL-----SLTWEMRLRIATEVAE 492
VV+LLG + L+V E + G L YL P E T + +++A E+A+
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGY 551
+AYL + ++ HRD+ + N ++ E KI DFG +R I D K +
Sbjct: 131 GMAYLAAKKFV---HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+ PE FT KSDV+SFGVVL E+ T ++P
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 31/217 (14%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVK 442
F++ LG+G G+VYK + G+++A+K V E L+E I E+ IL Q +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 443 LLGSCLEVEVPLLVYEF-----------IPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
GS + +V E+ I N TL EE++ I +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAA-------ILYQTL 109
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
+ L YLHS+ HRDIK+ NILL+E+ +AK+ADFG S D V GT +
Sbjct: 110 KGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFW 165
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYI 588
+ PE + +K+D++S G+ +E+ G+ P S I
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 26/267 (9%)
Query: 388 RILGQG--GQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKL 443
R+LG+G G+ T+Y+ D ++ K+ + + E + + +NE+VILS + H N++
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
++ L+ E+ GTL+ + +L EM L ++ A++Y+H +
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
I HRDIK+ NI L + K+ DFG S+ + + + T V GT Y+ PE ++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 564 DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623
KSD+++ G VL ELLT ++ + N V+ V+ N S +
Sbjct: 180 FKSDIWALGCVLYELLTLKR------TFDATNPLNLVVKIVQGNY-------TPVVSVYS 226
Query: 624 EEIMEVSDVAKRCLNSNGRSRPTMKEV 650
E++ + L + RPT EV
Sbjct: 227 SELIS---LVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 7/196 (3%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449
LG G G V G +A+K K S+ +EFI E ++ ++SH +V+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509
+V E++ NG L YL + + + L + +V E +AYL S ++ HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYLESKQFI---HRD 125
Query: 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVY 569
+ + N L+D++ K++DFG SR + D+ S + + PE S+F+ KSDV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 570 SFGVVLVELLT-GQKP 584
+FGV++ E+ + G+ P
Sbjct: 186 AFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/283 (27%), Positives = 140/283 (49%), Gaps = 45/283 (15%)
Query: 389 ILGQGGQGTVYKGMLAD-GRIIAVKKSKVV------DESKLEEFI----NEVVILSQISH 437
++G+G G VY + G ++AVK+ ++ +S+ ++ + +E+ L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 438 RNVVKLLGSCLEVEVPLLVY-EFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAEAL 494
N+V+ LG E L ++ E++P G++ L + EE ++ +V E L
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGL 121
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR-SIAIDQTHVSTKVQGTFGYLD 553
AYLHS I HRD+K+ N+L+D KI+DFG S+ S I + +QG+ ++
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 554 PEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611
PE HS ++ K D++S G V++E+ G++P W++E E + +F
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP----WSDE---------EAIA--AMFK 223
Query: 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNS----NGRSRPTMKEV 650
+ + + + M +S VA LN+ N +RPT +E+
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 72/239 (30%), Positives = 118/239 (49%), Gaps = 28/239 (11%)
Query: 386 VNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ R LG+G G V+ D ++AVK K ++ ++F E +L+ + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEEL--------SLTWEMRLRIATE 489
+VK G C+E + ++V+E++ +G L ++L H P L LT L IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 548
+A + YL S ++ HRD+ + N L+ E KI DFG SR + + D V
Sbjct: 129 IAAGMVYLASQHFV---HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606
++ PE +FT +SDV+S GVVL E+ T G++P + NE +EC+ +
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECITQ 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 383 HFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISHR 438
HF + R++G+G G V D ++ A+K K K V++ + +NE IL +++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYL 497
+V L S + E LV + + G L +L S+++ + E +++ E+ AL YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFS-EEQVKFWICEIVLALEYL 116
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS I HRDIK NILLDE+ I DF + + D ++T GT GY+ PE
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVL 171
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ D +S GV E L G++P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN-----EVVILSQISHRNVVKL 443
LG+G VYK GRI+A+KK K+ + + ++ IN E+ +L ++ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 444 L-----GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEEL------SLTWEMRLRIATEVAE 492
L S + LV+EF+ L + + D S L S M LR
Sbjct: 68 LDVFGHKSNIN-----LVFEFME-TDLEKVIKDKSIVLTPADIKSYML-MTLR------- 113
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
L YLHS+ L HRD+K N+L+ K+ADFG +RS ++ +V T Y
Sbjct: 114 GLEYLHSNWIL---HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169
Query: 553 DPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE F + + D++S G + ELL + P
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 78/272 (28%), Positives = 137/272 (50%), Gaps = 29/272 (10%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447
+ +G+G G V ML D R V + +++ + F+ E +++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 448 LEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+E + L +V E++ G+L YL + L + L+ + +V EA+ YL ++ ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV--- 124
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKS 566
HRD+ + N+L+ E AK++DFG ++ + Q V+ T PE +F+ KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 180
Query: 567 DVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625
DV+SFG++L E+ + G+ P I + V VE+ D D G
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPD------GCPP- 226
Query: 626 IMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
V DV K+C + + +RP+ ++ +LE I
Sbjct: 227 --VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 33/277 (11%)
Query: 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVK 442
+ I+G+G G V +G G+ +AVK K + + F+ E +++++ H+N+V+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVR 63
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
LLG L + +V E + G L +L L ++ L+ + +VAE + YL S
Sbjct: 64 LLGVILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKKL 121
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
+ HRD+ + NIL+ E AK++DFG +R S+ +D + + K + PE
Sbjct: 122 V---HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHK 172
Query: 561 QFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619
+F+ KSDV+S+GV+L E+ + G+ P + E ECVE+ R
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKG---------YRM 216
Query: 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656
+V + C + + RP+ ++ +LE+
Sbjct: 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 389 ILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLG 445
+G+G GTV K +DG+I+ K+ + E + ++ ++EV IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 446 SCL--EVEVPLLVYEFIPNGTLFQYL-HDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
+ + +V E+ G L Q + E + E RI T++ AL H+ +
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 503 LP--IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
+ HRD+K NI LD K+ DFG ++ + D + T V GT Y+ PE +
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185
Query: 561 QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620
+ +KSD++S G ++ EL P RN L ++ K
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPF------TARN--------------QLQLASKI-KE 224
Query: 621 GKTEEI-----MEVSDVAKRCLNSNGRSRPTMKE 649
GK I E+++V K LN + RP+ +E
Sbjct: 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 75/268 (27%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449
LG G G V+ G +A+K K S E F+ E ++ Q+ H +V+L + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLY-AVVT 71
Query: 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509
E ++ E++ NG+L +L P E + LT + +A ++AE +A++ Y+ HRD
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYI---HRD 127
Query: 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVY 569
+++ NIL+ E KIADFG +R I ++ + + PE + FT KSDV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 570 SFGVVLVELLT-GQKPISYIWANEG-RNLATYFVECVEENCLFDILDDQVRKSGKTEEIM 627
SFG++L E++T G+ P + E +NL + +NC
Sbjct: 188 SFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNC-----------------PE 230
Query: 628 EVSDVAKRCLNSNGRSRPTMKEVAMELE 655
E+ ++ + C RPT + + LE
Sbjct: 231 ELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 32/280 (11%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV---VDESKLEEFINEVVILSQIS 436
+F + + +G+G VYK + L DGR++A+KK ++ +D ++ + E+ +L Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALA 495
H NV+K L S +E +V E G L + + ++ L E + + ++ AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
++HS I HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF----- 610
H + + KSD++S G +L E+ Q P + + NL + + E C +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKI--EKCDYPPLPA 230
Query: 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
D +++R D+ RC+N + RP + V
Sbjct: 231 DHYSEELR------------DLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 83/279 (29%), Positives = 128/279 (45%), Gaps = 34/279 (12%)
Query: 388 RILGQGGQGTV--YKGMLAD---GRIIAVKKSKVVDESKLEE-FINEVVILSQISHRNVV 441
R+LG+G G V Y A+ G ++AVK K + + E+ IL + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 442 KLLGSCLEV--EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
K G C E + L+ E++P G+L YL P +L+L L A ++ E +AYLHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLA--QLLLFAQQICEGMAYLHS 125
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---TFGYLDPEY 556
Y+ HRD+ + N+LLD KI DFG ++++ + + G F Y E
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC-------L 609
++F+ SDV+SFGV L ELLT ++ F E + L
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS--------KQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648
++L+ +R EV + K C + + RPT +
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 65/213 (30%), Positives = 115/213 (53%), Gaps = 19/213 (8%)
Query: 383 HFNVNRILGQGGQGTVYKGML-ADGR---IIAVKKSKV-VDESKLEEFINEVVILSQISH 437
H +++G G G V++G+L GR +A+K K E + ++F++E I+ Q SH
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS---LTWEMRLRIATEVAEAL 494
N+++L G + + +++ E++ NG L +YL D E S L +R +A +
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGM 120
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID--QTHVSTKVQGTFGYL 552
YL Y+ HRD+ + NIL++ K++DFG SR + D T+ ++ + +
Sbjct: 121 KYLSDMNYV---HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE +FT SDV+SFG+V+ E+++ G++P
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 66/281 (23%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK------LEEFINEVVILSQI 435
+ + LG G + Y+ + G ++AVK+ V + +E E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD--PSEELSLTWEMRLRIATEVAEA 493
+H +++++LG+ E L E++ G++ L +E + + ++
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVIINYTEQLLRG 115
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQT---HVSTKVQGTF 549
L+YLH + I HRD+K N+L+D R +IADFG + +A T ++ GT
Sbjct: 116 LSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609
++ PE Q+ DV+S G V++E+ T + P W E + + +
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP----WNAE--KHSNHLA------LI 220
Query: 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
F I S + DV RCL RP +E+
Sbjct: 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 10/214 (4%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQ 434
E + D +LG+G G VY L+ IA+K+ D ++ E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+ HRN+V+ LGS E + E +P G+L L L + + ++ E L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
YLH I HRDIK N+L++ Y KI+DFGTS+ +A T GT Y+
Sbjct: 122 KYLHD---NQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYM 176
Query: 553 DPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKP 584
PE + +D++S G +VE+ TG+ P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 72/225 (32%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 389 ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVVKLLGS 446
ILG G GTVYK L RI+AVK + +L+ + ++E+ IL + ++ G+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ EF+ G+L Y P L RIA V + L YL S L I
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKIL 117
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSI--AIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
HRD+K +N+L++ + + K+ DFG S + +I +T+V GT Y+ PE Q+
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGI 172
Query: 565 KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC-VEENC 608
SDV+S G+ +EL G+ P I N+G + ++C V+E+
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP 217
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 83/305 (27%), Positives = 140/305 (45%), Gaps = 63/305 (20%)
Query: 388 RILGQGGQGTVYK----GMLA--DGRIIAVKKSKVVDESKLE---EFINEVVILSQISHR 438
R +GQG G V++ G+L ++AVK K +E+ + +F E ++++ H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDHP 68
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPS-------------------EELSLT 479
N+VKLLG C + L++E++ G L ++L S L L+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQ 538
+L IA +VA +AYL ++ HRD+ + N L+ E KIADFG SR+I + D
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLA 597
S ++ PE +++T +SDV+++GVVL E+ + G +P Y A+E
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY-YGMAHEE---V 241
Query: 598 TYFVE------CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVA 651
Y+V C +NC +E+ ++ + C + RP+ +
Sbjct: 242 IYYVRDGNVLSC-PDNC-----------------PLELYNLMRLCWSKLPSDRPSFASIN 283
Query: 652 MELER 656
L+R
Sbjct: 284 RILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-22
Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 31/273 (11%)
Query: 390 LGQGGQGTVYKG---MLADGRIIAVK--KSKVVDESKLEEFINEVVILSQISHRNVVKLL 444
LG G GTV KG M + +AVK K+ D + +E + E ++ Q+ + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
G C E E +LV E G L ++L + +T + + +V+ + YL + ++
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETNFV- 117
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFHSSQF 562
HRD+ + N+LL ++ AKI+DFG S+++ D+ + K G + + PE + +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 563 TDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
+ KSDV+SFGV++ E + GQKP + NE T +E E R
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQMIESGE------------RMEC 219
Query: 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654
E+ D+ K C RP V + L
Sbjct: 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD----GRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
D F + LG G G V ML G+ A+K K+K+V ++E +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL---HDPSEELSLTWEMRLRIATEVA 491
I H +V L GS + LV E++P G LF +L E ++ + A +V
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY------AAQVV 111
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
AL YLHS L I +RD+K N+LLD KI DFG ++ + +T+ + GT Y
Sbjct: 112 LALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYT---LCGTPEY 164
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
L PE S + D ++ G+++ E+L G P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 75/288 (26%), Positives = 135/288 (46%), Gaps = 35/288 (12%)
Query: 386 VNRILGQGGQGTVYKGMLADGRII---AVKKSKVV--DESKLEEFINEVVILSQISHRNV 440
+ + LG+G G+V +G L I AVK K+ S++E+F++E V + + H NV
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 441 VKLLGSCLE------VEVPLLVYEFIPNGTLFQYL---HDPSEELSLTWEMRLRIATEVA 491
++L+G CL+ P+++ F+ +G L +L L +M ++ T++A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFG 550
+ YL S +++ HRD+ + N +L+E +ADFG S+ I + ++ +
Sbjct: 123 SGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCL 609
++ E +T KSDV+SFGV + E+ T GQ P VE + +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP----------------GVENSEI 223
Query: 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+D L R + + + + C N + RP+ + + ELE+
Sbjct: 224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 44/288 (15%)
Query: 386 VNRILGQGGQGTVYKGM------LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ R LG+G G V+ D ++AVK K + ++F E +L+ + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSE-------------ELSLTWEMRL 484
+VK G C + + ++V+E++ +G L ++L H P EL L+ L
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QML 126
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVST 543
IA+++A + YL S ++ HRD+ + N L+ KI DFG SR + + D V
Sbjct: 127 HIASQIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVE 602
++ PE +FT +SDV+SFGV+L E+ T G++P W +E
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQLSNTEV---IE 236
Query: 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
C+ + + ++ R K EV D+ C + R +KE+
Sbjct: 237 CITQGRVL----ERPRVCPK-----EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKG-MLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
+ + + + +G G G VYK +A G ++A+K K+ E E+ +L + H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTL---FQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
V GS L + +V E+ G+L +Q P EL + + + E + LAYL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRETLKGLAYL 117
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ---GTFGYLDP 554
H + + HRDIK NILL E K+ADFG S + T K + GT ++ P
Sbjct: 118 HETGKI---HRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAP 170
Query: 555 EYF---HSSQFTDKSDVYSFGVVLVELLTGQKPIS 586
E + K D+++ G+ +EL Q P+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 16/213 (7%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF--INEVVILSQISHRNVVKLL 444
R++G+G G V+ AD +++ +K+ V +K E NE +L +SH N+++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
+ LE + ++V E+ P GTL +Y+ L L + L ++ AL ++H+
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTKL--- 121
Query: 505 IYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
I HRD+K+ NILLD+ K KI DFG S+ I ++ T V GT Y+ PE +
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYISPELCEGKPYN 179
Query: 564 DKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596
KSD+++ G VL EL + ++ A E NL
Sbjct: 180 QKSDIWALGCVLYELASLKR------AFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 78/219 (35%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 388 RILGQGGQGTVYKGMLAD------GRI-IAVK--KSKVVDESKLEEFINEVVILSQISHR 438
LG G G VY+G D G I +AVK + D+ K +EF+ E ++S +H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD------PSEELSLTWEMRLRIATEVAE 492
N+VKLLG CL E ++ E + G L YL D L+L E+ L I +VA+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLK-EL-LDICLDVAK 117
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEK-YRA----KIADFGTSRSI-AIDQTHVSTKVQ 546
YL ++ HRD+ + N L+ EK Y A KI DFG +R I D +
Sbjct: 118 GCVYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
++ PE +FT +SDV+SFGV++ E+LT GQ+P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 69/208 (33%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVK---KSKVVDESKLEE----FINEVVILSQISHRNV 440
R LG G G VY+G+ AV+ K + ES E+ F+ E +I+S+ +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD----PSEELSLTWEMRLRIATEVAEALAY 496
V+L+G E ++ E + G L +L + P SLT + L A +VA+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 497 LHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYL 552
L + ++ HRDI + N LL K AKIADFG +R I + ++
Sbjct: 132 LEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT 580
PE F FT K+DV+SFGV+L E+ +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 388 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESK-----LEEFINEVVILSQISHRNVV 441
++LGQG G VY D GR +AVK+ +S + E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 442 KLLGSCLEVEVPLLVY-EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
+ G CL + L ++ E++P G++ L +LT + + ++ E + YLHS+
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN 123
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGYLDPEYF 557
I HRDIK NIL D K+ DFG S+ +I T + + V GT ++ PE
Sbjct: 124 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVI 179
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWAN 591
+ K+DV+S G +VE+LT + P WA
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP----WAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 35/282 (12%)
Query: 382 DHFNVNRILGQGGQGTVYK----GMLADGRII--AVKKSK-VVDESKLEEFINEVVILSQ 434
++ + + LG G G V + G+ ++ AVK K S+ E ++E+ I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 435 I-SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
+ +H N+V LLG+C L++ E+ G L +L E ++ L + +VA+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKG 153
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT----F 549
+A+L S + HRD+ + N+LL KI DFG +R I D +V V+G
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENC 608
++ PE + +T +SDV+S+G++L E+ + G P + +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--------------- 252
Query: 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ ++ + R + E+ D+ K C +++ RPT K++
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 80/266 (30%), Positives = 129/266 (48%), Gaps = 32/266 (12%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVD----ESKLEEFINEVVILSQISHRNVVKLLG 445
+G+G G VYKG+ D R V K++D E ++E+ E+ +LSQ + + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLH-DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
S L+ ++ E++ G+ L P EE + +R E+ + L YLHS +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHSERKI- 123
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
HRDIK+ N+LL E+ K+ADFG + + Q +T V GT ++ PE S +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 565 KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTE 624
K+D++S G+ +EL G+ P S + + F+ + +N L+ Q K K
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDL-----HPMRVLFL--IPKNSP-PTLEGQYSKPFK-- 230
Query: 625 EIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ + CLN + R RPT KE+
Sbjct: 231 ------EFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+GQG GTVY + +A G+ +A+K+ + + K E INE++++ + + N+V L S L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
+ +V E++ G+L D E + + E +AL +LHS+ + HR
Sbjct: 87 VGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHR 139
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKS NILL K+ DFG I +Q+ ST V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 569 YSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601
+S G++ +E++ G+ P + NE A Y +
Sbjct: 199 WSLGIMAIEMVEGEPP----YLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 74/254 (29%), Positives = 123/254 (48%), Gaps = 27/254 (10%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+GQG GTVY M +A G+ +A+++ + + K E INE++++ + + N+V L S L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
+ +V E++ G+L D E + + E +AL +LHS+ + HR
Sbjct: 88 VGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKS NILL K+ DFG I +Q+ ST V GT ++ PE + K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 569 YSFGVVLVELLTGQKPISYIWANEGRNLATYFV--------------ECVEENCLFDILD 614
+S G++ +E++ G+ P + NE A Y + + + L LD
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 615 DQVRKSGKTEEIME 628
V K G +E+++
Sbjct: 256 MDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 60/202 (29%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 390 LGQGGQGTVYKGM--LADGRI-IAVKKSKVVDESKL-EEFINEVVILSQISHRNVVKLLG 445
LG G G V KG+ + +I +A+K K +E + +E + E I+ Q+ + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
C E E +LV E G L ++L +E+ T + + +V+ + YL ++
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEI--TVSNVVELMHQVSMGMKYLEGKNFV-- 117
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFHSSQFT 563
HRD+ + N+LL ++ AKI+DFG S+++ D ++ + G + + PE + +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 564 DKSDVYSFGVVLVELLT-GQKP 584
+SDV+S+G+ + E + GQKP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVD----ESKLEEFINEVVILSQISHRNVVKLLG 445
+G+G G V+KG+ D R V K++D E ++E+ E+ +LSQ V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLH-DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
S L+ ++ E++ G+ L P +E + ++ E+ + L YLHS +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSEKKI- 123
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
HRDIK+ N+LL E+ K+ADFG + + Q +T V GT ++ PE S +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 565 KSDVYSFGVVLVELLTGQKPIS 586
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 49/277 (17%)
Query: 390 LGQGGQGTVYKGML--ADGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGS 446
LG G G V K +L G+I+AVK ++ ++E+ ++ + E+ IL + + +V G+
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 447 CL-EVEVPLLVYEFIPNGTLFQYL---HDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
++ + + E++ G+L + L E L +IA V + L YLH
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK-- 119
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSR----SIAIDQTHVSTKVQGTFGYLDPEYFH 558
I HRD+K +NIL++ + + K+ DFG S S+A +T V GT Y+ PE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFV-----GTSSYMAPERIQ 172
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
+ ++ KSD++S G+ L+EL TG+ P + E +F++L V
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFP----YPPENDPPDG----------IFELLQYIVN 218
Query: 619 K------SGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649
+ SGK + D CL + R RP+ KE
Sbjct: 219 EPPPRLPSGKFSP--DFQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKL--EEFINEVVILSQISHRNVVKLLGS 446
+G+G G V K A G I+A+KK K ++ + + + EV +L Q+ H N+V L +
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLH------DPSEELSLTWEMRLRIATEVAEALAYLHSS 500
LV+E++ TL + L P S W++ +A+AY HS
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHS- 118
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
I HRDIK NIL+ E K+ DFG +R++ T T Y PE
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 561 QFTDKS-DVYSFGVVLVELLTGQ 582
K DV++ G ++ ELL G+
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-22
Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 13/213 (6%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+GQG GTV+ + +A G+ +A+K+ + + K E INE++++ ++ + N+V L S L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
+ +V E++ G+L D E + + E +AL +LH++ + HR
Sbjct: 87 VGDELFVVMEYLAGGSL----TDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHR 139
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKS N+LL K+ DFG I +Q+ ST V GT ++ PE + K D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 569 YSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601
+S G++ +E++ G+ P + NE A Y +
Sbjct: 199 WSLGIMAIEMVEGEPP----YLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 8e-22
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 390 LGQGGQGTVYKGMLA----DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLG 445
+G+G G V +A GR +AVK + + + E NEVVI+ H+NVV++
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
S L E ++ EF+ G L D + L E + V +AL YLHS +
Sbjct: 86 SYLVGEELWVLMEFLQGGA----LTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDK 565
HRDIKS +ILL R K++DFG I+ D + V GT ++ PE + + +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTE 197
Query: 566 SDVYSFGVVLVELLTGQKP 584
D++S G++++E++ G+ P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKS-KVVDESKL----E 423
+I EL K ++LG G GTVYKG+ DG + + + KV+ E+ +
Sbjct: 2 RILKETELKKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54
Query: 424 EFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS----LT 479
E ++E +++ + V +LLG CL V L V + +P G L Y+ + + + L
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLN 113
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
W ++A+ ++YL + + HRD+ + N+L+ KI DFG +R + ID+T
Sbjct: 114 W------CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
Query: 540 HVST---KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRN 595
KV ++ E +FT +SDV+S+GV + EL+T G KP I A E
Sbjct: 165 EYHADGGKV--PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--- 219
Query: 596 LATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
+ D+L+ R ++V + +C + RP +E+ E
Sbjct: 220 -------------IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266
Query: 656 RI 657
R+
Sbjct: 267 RM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 74/292 (25%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 384 FNVNRILGQGGQGTVYKGML----ADGRIIAVK--KSKVVDESKLEEFINEVVILSQISH 437
F + R+LG+G G+V + L + +AVK K+ + S +EEF+ E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 438 RNVVKLLGSCLE------VEVPLLVYEFIPNGTLFQYL---HDPSEELSLTWEMRLRIAT 488
NV+KL+G L + +P+++ F+ +G L +L E +L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQG 547
++A + YL S ++ HRD+ + N +L+E +ADFG S+ I + D +
Sbjct: 121 DIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606
+L E + +T SDV++FGV + E++T GQ P + VE
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA----------------GVEN 221
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
+ +++ L R + + +V ++ +C + + RP+ + + +LE I
Sbjct: 222 SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 380 ATDHFNVNRILGQGGQGTVYKGMLAD---GRIIAVKKSKVVDES----KLEEFINEVVIL 432
+ + + R LGQG G VY+G D G K V+ES + EF+NE ++
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 433 SQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL-------HDPSEELSLTWEMRLR 485
+ +VV+LLG + + L+V E + +G L YL + T + ++
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 486 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTK 544
+A E+A+ +AYL++ ++ HRD+ + N ++ + KI DFG +R I D K
Sbjct: 124 MAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 545 VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580
++ PE FT SD++SFGVVL E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 390 LGQGGQGTVYKGMLADG--RIIAVK----------KSKVVDESKLEEFINEVVIL-SQIS 436
LG G G VYK + ++A+K K K + + + ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFI---PNGTLFQYLHDPSEELSLTWEMRL-RIATEVAE 492
H N+V+ + LE + +V + I P G F L + + + E R+ I ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
AL YLH I HRD+ NI+L E + I DFG ++ + T V GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYS 180
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612
PE + + +K+DV++FG +L ++ T Q P ++ +LAT VE V E +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVA 651
+ V DV CL + +RP + +V+
Sbjct: 238 YSEDVT------------DVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+G+G G V + GR +AVKK + + + E NEVVI+ H N+V++ S L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
+ +V EF+ G L D + E + V +AL++LH+ + HR
Sbjct: 87 VGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHR 139
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKS +ILL R K++DFG ++ + + V GT ++ PE + + D+
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDI 198
Query: 569 YSFGVVLVELLTGQKP 584
+S G++++E++ G+ P
Sbjct: 199 WSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449
LG G G V+ G +AVK K S E F+ E I+ ++ H +V+L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509
E +V E++ G+L +L D E +L + +A +VA +AY+ Y+ HRD
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIERMNYI---HRD 127
Query: 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVY 569
++S NIL+ + KIADFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 570 SFGVVLVELLT-GQKP 584
SFG++L EL+T G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 67/218 (30%), Positives = 115/218 (52%), Gaps = 22/218 (10%)
Query: 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV----VDES----KLEEFINEVVI 431
A + ++R LGQG G VY+G +A G + +++V V+E+ + EF+NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 432 LSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH--------DPSEELSLTWEMR 483
+ + + +VV+LLG + + L++ E + G L YL +P + +M
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM- 121
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVS 542
+++A E+A+ +AYL+++ ++ HRD+ + N ++ E + KI DFG +R I D
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580
K ++ PE FT SDV+SFGVVL E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 59/180 (32%), Positives = 99/180 (55%), Gaps = 10/180 (5%)
Query: 406 GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLVYEFIPN 462
G +AVK K + + + E+ IL + H N+VK G C E L+ EF+P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522
G+L +YL P + + + +L+ A ++ + + YL S Y+ HRD+ + N+L++ +++
Sbjct: 93 GSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 147
Query: 523 AKIADFGTSRSIAIDQTHVSTK--VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580
KI DFG +++I D+ + + K + + PE S+F SDV+SFGV L ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 389 ILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVILSQISH---RNVVKL 443
++G+G G VY+G + GR++A+K + + + + EV +LSQ+ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLH-DPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
GS L+ ++ E+ G++ + P E ++ +R EV AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
+ HRDIK+ NIL+ K+ DFG + + + + ST V GT ++ PE ++
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 563 TD-KSDVYSFGVVLVELLTGQKPIS 586
D K+D++S G+ + E+ TG P S
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 6e-21
Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 387 NRILGQGGQGTVYKG-MLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLG 445
++ +G +G YKG + +G VK+ V+ S I + + ++ H N+VKL+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIAD---MGKLQHPNIVKLIG 750
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
C + L++E+I L + L +L+WE R +IA +A+AL +LH +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDK 565
++ I++D K + + D + Y+ PE + T+K
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEK 858
Query: 566 SDVYSFGVVLVELLTGQKPISYIWANEGR--NLATYFVECVEENCLFDI-LDDQVRK--S 620
SD+Y FG++L+ELLTG+ P + G A Y +C D+ +D +R S
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY----CYSDCHLDMWIDPSIRGDVS 914
Query: 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
EI+EV ++A C ++ +RP +V LE
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 69/296 (23%), Positives = 126/296 (42%), Gaps = 62/296 (20%)
Query: 389 ILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFINEVVILSQISHRNVV 441
LG+G G V+ ++ VK K DE+ EF E+ + ++SH+NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYL------HDPSEELSLTWEMRLRIATEVAEALA 495
+LLG C E E ++ E+ G L Q+L + + L+ + ++ + T++A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
+L ++ ++ HRD+ + N L+ + K++ S+ + + + +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILD 614
F+ KSDV+SFGV++ E+ T G+ P + D
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY------------------------GLSD 224
Query: 615 DQV---RKSGKTE------------EIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
++V ++GK E ++M RC N + RP+ E+ L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMT------RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447
+ LG G G V+ G + +AVK K S ++ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
+ E ++ E++ G+L +L E + + + ++AE +AY+ Y+ H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSD 567
RD+++ N+L+ E KIADFG +R I ++ + + PE + FT KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 568 VYSFGVVLVELLT-GQKP 584
V+SFG++L E++T G+ P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVD----ESKLEEFINEVVILSQISHRNVVKLLG 445
+G+G G V+KG+ D R V K++D E ++E+ E+ +LSQ V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLH-DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
S L+ ++ E++ G+ L P +E + +R E+ + L YLHS +
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSEKKI- 123
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
HRDIK+ N+LL E K+ADFG + + Q +T V GT ++ PE S +
Sbjct: 124 --HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 180
Query: 565 KSDVYSFGVVLVELLTGQKPIS 586
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 48/307 (15%)
Query: 380 ATDHFNVNRILGQG--GQGTVYKGMLAD----GRI--IAVKKSKV-VDESKLEEFINEVV 430
D + + LG+G GQ + + + D R+ +AVK K E L + I+E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 431 ILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL---------------HDPSE 474
++ I H+N++ LLG+C + ++ E+ G L +YL P E
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 475 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534
+LS + + A +VA + YL S + HRD+ + N+L+ E KIADFG +R I
Sbjct: 136 QLSF--KDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 535 -AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592
ID +T + ++ PE +T +SDV+SFGV+L E+ T G P
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------- 242
Query: 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652
Y VEE LF +L + R + E+ + + C ++ RPT K++
Sbjct: 243 ------YPGVPVEE--LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
Query: 653 ELERIRA 659
+L+RI A
Sbjct: 295 DLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQISHRNVVKLLGS 446
+G+G G VYK G I+A+KK K+ ES+ E+ +L +++H N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEEL------SLTWEMRLRIATEVAEALAYLHSS 500
LV+EF+ + L++ + D L S +++ + LA+ HS
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL--------LQGLAFCHSH 117
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ---TH-VSTKVQGTFGYLDPE- 555
I HRD+K N+L++ + K+ADFG +RS TH V T+ Y PE
Sbjct: 118 G---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
++ D++S G + ELL+ +
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 86/304 (28%), Positives = 134/304 (44%), Gaps = 52/304 (17%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-----GRI-IAVKKSKV-VDESKLEEFINEVVILSQ 434
D + + LG+G G V K +AVK K E L + ++E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 435 I-SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD---PSEELS----------LTW 480
I H+N++ LLG C + +V E+ +G L +L P E S LT
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 481 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQT 539
+ + A +VA + +L S HRD+ + N+L+ E + KIADFG +R I ID
Sbjct: 132 KDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLAT 598
+T + ++ PE +T +SDV+SFGV+L E+ T G P I
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---------- 238
Query: 599 YFVECVEENCLFDILDDQVRKSGKTEE-----IMEVSDVAKRCLNSNGRSRPTMKEVAME 653
VEE LF +L K G E E+ + + C + RPT K++ +
Sbjct: 239 ----PVEE--LFKLL-----KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287
Query: 654 LERI 657
L+R+
Sbjct: 288 LDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 27/270 (10%)
Query: 390 LGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVVKLLGSC 447
+G+G G V+ G L AD +AVK + L+ +F+ E IL Q SH N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
+ + +V E + G +L +E L + +++ A + YL S + H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYLDPEYFHSSQFTDK 565
RD+ + N L+ EK KI+DFG SR D + ST Q + PE + +++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 566 SDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTE 624
SDV+SFG++L E + G P + + + R E +E+ VR
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQG---------VRLPCPEL 220
Query: 625 EIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654
V + +RC + RP+ V EL
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-20
Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 25/217 (11%)
Query: 390 LGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESK-LEEFINEVVILSQISHRNVVKL 443
LG+ G +YKG L +++A+K K ++ + EF E +++++ H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYL--------------HDPSEELSLTWEMRLRIATE 489
LG + + +++E++ G L ++L D + + SL L IA +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 548
+A + YL S ++ H+D+ + NIL+ E+ KI+D G SR I + D V K
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
++ PE +F+ SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 390 LGQGGQGTVYK-GMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHRNVVKLL-- 444
+G+G G V+K G +A+KK + ++ + + E+ L H VVKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 445 ---GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
GS +LV E++P L + L D L +++ + + +AY+H++
Sbjct: 68 FPHGSGF-----VLVMEYMP-SDLSEVLRDEERPLPEA-QVK-SYMRMLLKGVAYMHANG 119
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
I HRD+K N+L+ KIADFG +R + ++ + + T Y PE + ++
Sbjct: 120 ---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 562 FTDKS-DVYSFGVVLVELLTGQ 582
D D+++ G + ELL G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449
LGQG G V+ G +A+K K S E F+ E ++ ++ H +V+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509
E +V E++ G+L +L + L + +A ++A +AY+ Y+ HRD
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 127
Query: 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVY 569
+++ NIL+ E K+ADFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 570 SFGVVLVELLT-GQKP 584
SFG++L EL T G+ P
Sbjct: 188 SFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 76/208 (36%), Positives = 115/208 (55%), Gaps = 23/208 (11%)
Query: 388 RILGQGGQGTVY---KGMLAD-GRIIAVK---KS--KVVDESKLEEFINEVVILSQISHR 438
++LGQG G V+ K D G++ A+K K+ KV D + + E IL++++H
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHP 58
Query: 439 NVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWE-MRLRIATEVAEALAY 496
+VKL + E L L+ +F+ G LF L S+E+ T E ++ +A E+A AL +
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLA-ELALALDH 113
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
LHS L I +RD+K NILLDE+ K+ DFG S+ +ID + GT Y+ PE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEV 169
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ T +D +SFGV++ E+LTG P
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 48/292 (16%)
Query: 389 ILGQGGQGTVYK------GMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVV 441
++G+G G V K G+ D I +K+ D+ + +F E+ +L ++ H N++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNII 71
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLH-------DPSEEL------SLTWEMRLRIAT 488
LLG+C L E+ P+G L +L DP+ + +L+ + L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQ 546
+VA + YL ++ HRD+ + NIL+ E Y AKIADFG SR + + +T V+
Sbjct: 132 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE 605
++ E + S +T SDV+S+GV+L E+++ G P + C E
Sbjct: 189 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------------TCAE 231
Query: 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
L++ L R EV D+ ++C RP+ ++ + L R+
Sbjct: 232 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 390 LGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+G+G G V + + G+++AVKK + + + E NEVVI+ H NVV++ S L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
+ +V EF+ G L D + E + V +AL+ LH+ + HR
Sbjct: 88 VGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHR 140
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKS +ILL R K++DFG ++ + + V GT ++ PE + + D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDI 199
Query: 569 YSFGVVLVELLTGQKP 584
+S G++++E++ G+ P
Sbjct: 200 WSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 44/290 (15%)
Query: 389 ILGQGGQGTVYKGMLA-DGRII--AVKKSK-VVDESKLEEFINEVVILSQISHR-NVVKL 443
++G+G G V + M+ DG + A+K K E+ +F E+ +L ++ H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLH-------DPS------EELSLTWEMRLRIATEV 490
LG+C + E+ P G L +L DP+ +LT + L+ A++V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQGT 548
A + YL ++ HRD+ + N+L+ E +KIADFG SR + + +T V+
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR-- 183
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607
++ E + S +T KSDV+SFGV+L E+++ G P + C E
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-------------TCAE-- 226
Query: 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
L++ L R EV ++ ++C RP +++++L R+
Sbjct: 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 71/296 (23%), Positives = 138/296 (46%), Gaps = 37/296 (12%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKS-KVVDE----SKLE 423
+I EL K ++LG G GTV+KG+ + +G I + + K + + +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 424 EFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMR 483
E + ++ + + H +V+LLG C + L V + P G+L ++ + SL +
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRD--SLDPQRL 111
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVS 542
L ++A+ + YL + HR++ + NILL +IADFG + + D+ +
Sbjct: 112 LNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY 168
Query: 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFV 601
++ + ++ E ++T +SDV+S+GV + E+++ G +P + + +E
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------- 219
Query: 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+ D+L+ R + ++V V +C + RPT KE+A E R+
Sbjct: 220 -------VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 73/284 (25%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADG---RI-IAVKKSKVVDESKL-EEFINEVVILSQISH 437
F ++LG G GTVYKG+ + +G +I +A+K+ + K +E ++E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+V +LLG CL V L + + +P G L Y+ + + + + L ++A+ + YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST---KVQGTFGYLDP 554
+ HRD+ + N+L+ KI DFG ++ + D+ KV ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMAL 180
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
E +T +SDV+S+GV + EL+T G KP I A+E + IL
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSIL 224
Query: 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+ R ++V + +C + SRP +E+ +E ++
Sbjct: 225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 390 LGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVK 442
+ +G G V+ LA G I A+K K+ ++ ++++++ + E ILSQ VVK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
L S + LV E++P G L L + SL ++ E+ AL YLHS
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEIVLALEYLHS--- 111
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-------STKVQGTFGYLDPE 555
I HRD+K NIL+D K+ DFG S+ + + ++ GT Y+ PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ D +S G +L E L G P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQI-SHRN 439
+ V + LG G G+VY G ++A+KK K S EE +N EV L ++ H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPN 59
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLR-IATEVAEALAYLH 498
+VKL E + V+E++ G L+Q + D + E +R I ++ + LA++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH---VSTKVQGTFGYLDPE 555
+ +HRD+K N+L+ KIADFG +R I + VST+ Y PE
Sbjct: 117 KHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPE 168
Query: 556 YF-HSSQFTDKSDVYSFGVVLVELLTGQKPI 585
S+ ++ D+++ G ++ EL T +P+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 44/301 (14%)
Query: 382 DHFNVNRILGQGGQGTVY--------KGMLADGRIIAVKKSK-VVDESKLEEFINEVVIL 432
D + + LG+G G V K + +AVK K E L + ++E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 433 SQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH---DPSEELS----------L 478
I H+N++ LLG+C + ++ E+ G L +YL P E S +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AID 537
T++ + +VA + YL S + HRD+ + N+L+ E KIADFG +R + ID
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNL 596
+T + ++ PE +T +SDV+SFGV++ E+ T G P I
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 243
Query: 597 ATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656
VEE LF +L + R E+ + + C ++ RPT K++ +L+R
Sbjct: 244 ------PVEE--LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295
Query: 657 I 657
I
Sbjct: 296 I 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449
LGQG G V+ G +A+K K E F+ E I+ ++ H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509
E +V EF+ G+L +L + + L + +A ++A+ +AY+ Y+ HRD
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIERMNYI---HRD 127
Query: 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVY 569
+++ NIL+ + KIADFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 570 SFGVVLVELLT-GQKP 584
SFG++L EL+T G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 389 ILGQGGQGTVYKGMLA-DGRII--AVKKSK-VVDESKLEEFINEVVILSQISHR-NVVKL 443
++G+G G V K + DG + A+K+ K + +F E+ +L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLH-------DPS------EELSLTWEMRLRIATEV 490
LG+C L E+ P+G L +L DP+ +L+ + L A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQGT 548
A + YL ++ HRD+ + NIL+ E Y AKIADFG SR + + +T V+
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607
++ E + S +T SDV+S+GV+L E+++ G P + C E
Sbjct: 177 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------------TCAE-- 219
Query: 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
L++ L R EV D+ ++C RP+ ++ + L R+
Sbjct: 220 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 7e-19
Identities = 68/237 (28%), Positives = 114/237 (48%), Gaps = 42/237 (17%)
Query: 364 GSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGR--IIAVKKSKVVDESK 421
G + C++ N ++L FNV + GR ++AVK + D +K
Sbjct: 19 GEVHLCEVVNPQDLPTLQFPFNVRK-----------------GRPLLVAVKILRP-DANK 60
Query: 422 --LEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH-----DPSE 474
+F+ EV ILS++ N+++LLG C++ + ++ E++ NG L Q+L D E
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 475 E-----------LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523
++++ L +A ++A + YL S L HRD+ + N L+ E
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTI 177
Query: 524 KIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELL 579
KIADFG SR++ A D + + ++ E +FT SDV++FGV L E+L
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 381 TDHFNVNRILGQGGQGTVYK------GMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ 434
D + + LG G G VYK G+ A +II ++ E +LE+F+ E+ ILS+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSE 58
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS--LTWEMRLR-IATEVA 491
H N+V L + ++ EF G L EL LT E ++R + ++
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGA----LDSIMLELERGLT-EPQIRYVCRQML 113
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
EAL +LHS + HRD+K+ NILL K+ADFG S T + GT +
Sbjct: 114 EALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYW 169
Query: 552 LDPEYFHSSQFTD-----KSDVYSFGVVLVELLTGQKP 584
+ PE F D K+D++S G+ L+EL + P
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 377 LDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQI 435
L T F + ++G+G G VYK G+++A+K ++++ + EE E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 436 S-HRNVVKLLG-------SCLEVEVPLLVYEFIPNGT---LFQYLHDPSEELSLTWEMRL 484
S H N+ G + ++ LV E G+ L + L + L E
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIA 116
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 544
I E LAYLH + + HRDIK NILL + K+ DFG S + +T
Sbjct: 117 YILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 545 VQGTFGYLDPEYFHSSQFTD-----KSDVYSFGVVLVELLTGQKPIS 586
+ GT ++ PE + D +SDV+S G+ +EL G+ P+
Sbjct: 174 I-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 24/220 (10%)
Query: 383 HFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-----KLEEFINEVVILSQIS 436
++ + ++LGQG G VY AD GR +AVK+ + ES ++ E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 437 HRNVVKLLGSCLE--VEVPLLVY-EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
H +V+ G CL +E L ++ E +P G++ L +LT + + ++ E
Sbjct: 63 HERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEG 118
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFG 550
++YLHS+ I HRDIK NIL D K+ DFG S+ +I + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWA 590
++ PE + K+D++S G +VE+LT + P WA
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP----WA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 71/219 (32%), Positives = 108/219 (49%), Gaps = 45/219 (20%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVKKSKVV----DESKLEEFINEVVILSQISHRNV 440
VNRI G G GTVYK + GR+ A+K V+ +++ + E+ IL ++H NV
Sbjct: 79 VNRI-GSGAGGTVYKVIHRPTGRLYALK---VIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 441 VKLLGSCLEV-----EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLR-IATEVAEAL 494
VK C ++ E+ +L+ EF+ G+L E + E L +A ++ +
Sbjct: 135 VK----CHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQFLADVARQILSGI 181
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
AYLH I HRDIK +N+L++ KIADFG SR +A ++ V GT Y+ P
Sbjct: 182 AYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSP 237
Query: 555 EYFHSSQFTD---------KSDVYSFGVVLVELLTGQKP 584
E + TD D++S GV ++E G+ P
Sbjct: 238 ERIN----TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVD----ESKLEEFINEVVILSQISHRNVVKLL 444
+G+G G VYK + +++A+K V+D E ++E+ E+ LSQ + K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLH-DPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
GS L+ ++ E+ G+ L +E + + +R EV L YLH +
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVLLGLEYLHEEGKI 120
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
HRDIK+ NILL E+ K+ADFG S + + +T V GT ++ PE S +
Sbjct: 121 ---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 564 DKSDVYSFGVVLVELLTGQKPIS 586
+K+D++S G+ +EL G+ P+S
Sbjct: 177 EKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 82/290 (28%), Positives = 137/290 (47%), Gaps = 44/290 (15%)
Query: 409 IAVK--KSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVY-EFIPNGT 464
+AVK K D+ L + ++E+ ++ I H+N++ LLG+C + + PL V E+ G
Sbjct: 47 VAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVLVEYASKGN 104
Query: 465 LFQYLHD---------------PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509
L +YL P E+L T++ + A +VA + YL S + HRD
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQL--TFKDLVSCAYQVARGMEYLASQKCI---HRD 159
Query: 510 IKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
+ + N+L+ E KIADFG +R + ID +T + ++ PE +T +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 569 YSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIM 627
+SFGV+L E+ T G P I VEE LF +L + R
Sbjct: 220 WSFGVLLWEIFTLGGSPYPGI--------------PVEE--LFKLLKEGHRMDKPANCTH 263
Query: 628 EVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQKCYEELS 677
E+ + + C ++ RPT K++ +L+R+ D+ ++ +E+ S
Sbjct: 264 ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYS 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 390 LGQGGQGTVYKGMLA-DGRIIAVK--KSKVVDESKLEEFI-NEVVILSQISHRNVVKLLG 445
LG GG G V + R A+K K + + E+ +E I +E IL + +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
+ + + ++ E+ G L+ L D L + R IA V A YLH+ I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIAC-VVLAFEYLHN---RGI 114
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ-THVSTKVQGTFGYLDPEYFHSSQFTD 564
+RD+K N+LLD K+ DFG ++ + Q T T GT Y+ PE + +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYDF 171
Query: 565 KSDVYSFGVVLVELLTGQKPIS 586
D +S G++L ELLTG+ P
Sbjct: 172 SVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQISH 437
D + +G G G V+ A+K +V+ + + NE +L ++SH
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+++L + + ++ E++P G LF YL + + L A+E+ AL YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYL 117
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS I +RD+K NILLD++ K+ DFG ++ + D+T + GT YL PE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVI 170
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKP 584
S D ++ G+++ E+L G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 22/282 (7%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV---VDESKLEEFINEVVILSQISHR 438
+F + + +G+G VY+ L DG +A+KK ++ +D + I E+ +L Q++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYL 497
NV+K S +E +V E G L + + ++ L E + + ++ AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS + HRDIK N+ + K+ D G R + +T + + GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617
H + + KSD++S G +L E+ Q P G + Y + E C + L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLCKKIEQCDYPPLP--- 229
Query: 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
+EE+ ++ ++ C+N + RP + V +R+ A
Sbjct: 230 -SDHYSEELRQLVNM---CINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 30/271 (11%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSC 447
LG G G+V K + KK + S ++ + E+ I+ + +V G+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
L + EF+ G+L + + + E+ +IA V E L YL++ I H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMH 127
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSI--AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDK 565
RDIK +NIL++ + + K+ DFG S + +I T V GT Y+ PE ++T K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVK 182
Query: 566 SDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK------ 619
SDV+S G+ ++EL G+ P + + + + + D+L V++
Sbjct: 183 SDVWSLGISIIELALGKFPFA---FSNIDDDGQ-----DDPMGILDLLQQIVQEPPPRLP 234
Query: 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
S E + D CL + RPT +++
Sbjct: 235 SSDFPEDLR--DFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 388 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-----KLEEFINEVVILSQISHRNVV 441
++LGQG G VY D GR +A K+ + ES ++ E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 442 KLLGSCLE--VEVPLLVY-EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
+ G CL E L ++ E++P G++ L +LT + + ++ E ++YLH
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH 123
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGYLDPE 555
S+ I HRDIK NIL D K+ DFG S+ +I + T + + V GT ++ PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPE 179
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWA 590
+ K+DV+S G +VE+LT + P WA
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP----WA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+G+G G V G+ +AVKK + + + E NEVVI+ H NVV + S L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508
+ +V EF+ G L D + E + V AL+YLH+ + HR
Sbjct: 90 VGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHR 142
Query: 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDV 568
DIKS +ILL R K++DFG ++ + + V GT ++ PE + + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDI 201
Query: 569 YSFGVVLVELLTGQKP 584
+S G++++E++ G+ P
Sbjct: 202 WSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 384 FNVNRILGQG--GQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
+NV R++G+G G+ + + + +D + + S +E+ E V+L+++ H N+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 442 KLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
S E + L +V E+ G L Q + +L + L+ ++ + ++H
Sbjct: 62 AFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEK 119
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
L HRDIKS NI L + + K+ DFG++R + + T V GT Y+ PE + +
Sbjct: 120 RVL---HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 561 QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596
+ +KSD++S G +L EL T + P AN +NL
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQ---ANSWKNL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 72/223 (32%), Positives = 110/223 (49%), Gaps = 31/223 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEF----INEVVILSQIS 436
D F++ +G+G G VYK D G ++A+KK ++ +E E F I E+ IL Q++
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 437 HRNVVKLLGSCLEVEVPL----------LVYEFIPN---GTLFQYLHDPSEELSLTWEMR 483
HRN+V L + + L LV+E++ + G L L SE+ +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS---- 120
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543
++ E L Y H +L HRDIK +NILL+ K + K+ADFG +R +++ T
Sbjct: 121 --FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 544 KVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPI 585
T Y PE + + DV+S G +L EL T +KPI
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 390 LGQGGQGTVYK------GMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
LG G G VYK G LA ++I K E +LE+++ E+ IL+ +H +VKL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLR-IATEVAEALAYLHSSAY 502
LG+ ++ EF P G + + + L+ E +++ I ++ EAL YLHS
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS--- 128
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTS-RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
+ I HRD+K+ N+LL K+ADFG S +++ Q S GT ++ PE
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCET 186
Query: 562 FTD-----KSDVYSFGVVLVELLTGQKP 584
D K+D++S G+ L+E+ + P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
+ + LG G G V+ +AVK K S +E F+ E ++ + H +VKL
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL 66
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYLHSSAY 502
+ + E ++ EF+ G+L +L S+E S +L + ++AE +A++ Y
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
+ HRD+++ NIL+ KIADFG +R I ++ + + PE + F
Sbjct: 124 I---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 563 TDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
T KSDV+SFG++L+E++T G+ P + E + L+ R
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------------VIRALERGYRMPR 224
Query: 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
E+ ++ RC + RPT + + L+
Sbjct: 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 55/184 (29%), Positives = 96/184 (52%), Gaps = 14/184 (7%)
Query: 408 IIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF 466
++AVK + V ++ +F+ E+ I+S++ + N+++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 467 QYLHDPSEELSLT---------WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 517
Q+L E + T L +A ++A + YL S L HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLV 162
Query: 518 DEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLV 576
Y KIADFG SR++ + D + + ++ E +FT SDV++FGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 577 ELLT 580
E+ T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 9/206 (4%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRN 439
F + + +G+G VY+ L D + +A+KK ++ +D ++ + E+ +L Q++H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYLH 498
V+K L S +E +V E G L Q + ++ L E + + ++ A+ ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
S + HRDIK N+ + K+ D G R + T + V GT Y+ PE H
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKP 584
+ + KSD++S G +L E+ Q P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFI--------NEVVILSQI 435
+ + + +G+G G +Y LA + + + V+ E L + EV++L+++
Sbjct: 2 YEIIKKIGEGSFGKIY---LAKAKSDS--EHCVIKEIDLTKMPVKEKEASKKEVILLAKM 56
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP-----SEELSLTWEMRLRIATEV 490
H N+V S E +V E+ G L + ++ SE+ L+W ++
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQI 110
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-AKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ L ++H I HRDIKS NI L + AK+ DFG +R + D ++ GT
Sbjct: 111 SLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTP 166
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596
YL PE + + +K+D++S G VL EL T + P EG NL
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF------EGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 40/270 (14%)
Query: 409 IAVK--KSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLV-YEFIPNGT 464
+AVK K D+ L + I+E+ ++ I H+N++ LLG C + E PL V E+ G
Sbjct: 47 VAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104
Query: 465 LFQYLH---DPSEELS----------LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 511
L ++L P + + L+++ + A +VA + YL S + HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161
Query: 512 STNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYS 570
+ N+L+ E KIADFG +R + ID ++ + ++ PE +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 571 FGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEV 629
FG+++ E+ T G P Y VEE LF +L + R + E+
Sbjct: 222 FGILMWEIFTLGGSP--------------YPGIPVEE--LFKLLREGHRMDKPSNCTHEL 265
Query: 630 SDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
+ + C ++ RPT K++ L+++ A
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 386 VNRILGQGGQGTVYKGMLA-DGR---IIAVKKSKV-VDESKLEEFINEVVILSQISHRNV 440
+ +++G G G V G L G+ +A+K K E + +F++E I+ Q H N+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPS-EELSLTWEMRLRIATEVAEALAYL 497
+ L G + + ++V E++ NG+L +L HD + L +R +A + YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL 122
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG--YLDPE 555
Y+ HRD+ + NIL++ K++DFG SR + D T G + PE
Sbjct: 123 SDMGYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 384 FNVNRILGQGGQGTVY----KGMLADGRIIAVK---KSKVVDESK-LEEFINEVVILSQI 435
F + R+LG G G V+ G G++ A+K K+ +V ++K E E +L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 436 SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+ L + + L L+ +++ G LF +L+ E + + E+R+ IA E+ AL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTES-EVRVYIA-EIVLAL 118
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
+LH L I +RDIK NILLD + + DFG S+ ++ + GT Y+ P
Sbjct: 119 DHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 555 EYFH--SSQFTDKSDVYSFGVVLVELLTGQKP 584
E S D +S GV+ ELLTG P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 380 ATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQ 434
+ + LG+G G VYK + GR++A+KK + +E + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 435 ISHRNVVKLLGSCLE-----VEVPLLVYEFIP--NGTLFQYLHDPSEELSLTWEMRLRIA 487
+ H NVV L+ +E VY P + L L +PS +L+ + +++
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES-QIKC-YM 121
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI----------AID 537
++ E + YLH + L HRDIK+ NIL+D + KIADFG +R
Sbjct: 122 LQLLEGINYLHENHIL---HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 538 QTHVSTKVQGTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
T T + T Y PE ++T D++ G V E+ T +PI
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 55/183 (30%), Positives = 102/183 (55%), Gaps = 13/183 (7%)
Query: 408 IIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF 466
++AVK + +++ +F+ E+ I+S++ N+++LL C+ + ++ E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 467 QYL--HDPSEEL------SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 518
Q+L H+P E ++++ + +AT++A + YL S L HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVG 164
Query: 519 EKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVE 577
+ Y KIADFG SR++ + D + + ++ E +FT SDV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 578 LLT 580
+LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 30/233 (12%)
Query: 366 IDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLAD---GRIIAVKKSKVVDESKL 422
I R ++ +L + +G G ++ G+L D G+ V V D +
Sbjct: 3 ISRDRV-TLSDLLQ------------EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE 49
Query: 423 EE---FINEVVILSQISHRNVVKLLGSCLEV-EVPLLVYEFIPNGTLFQYLHDPSE---- 474
+ + E +L +SH+N++ +L C+E E P ++Y ++ G L +L
Sbjct: 50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN 109
Query: 475 -ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533
+L+ + + +A ++A ++YLH + H+DI + N ++DE+ + KI D SR
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRD 166
Query: 534 IAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+ H + ++ E + +++ SDV+SFGV+L EL+T GQ P
Sbjct: 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 387 NRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDE------SKLEEFINEVVILSQISHRN 439
NRI G+G G VY+ G I+A+KK ++ +E S L E + +L + H N
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPN 67
Query: 440 VVKLL----GSCLEVEVPLLVYEFIPN--GTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
+V+L G L + LV E+ +L + P E + + ++
Sbjct: 68 IVELKEVVVGKHL--DSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-----LMLQLLRG 120
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
L YLH + I HRD+K +N+LL +K KIADFG +R+ + ++ KV T Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176
Query: 554 PE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE + +T D+++ G +L ELL KP+
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-17
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 18/183 (9%)
Query: 411 VKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL--VYEFIPNGTLFQY 468
++ +E + F E + +++ H N+V LL S E LL V+E++P TL +
Sbjct: 11 LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG-EAPPGLLFAVFEYVPGRTLREV 69
Query: 469 LHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKI 525
L + + +L R+ +V +ALA H+ I HRD+K NI++ + AK+
Sbjct: 70 L---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKV 123
Query: 526 ADFGTS------RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELL 579
DFG R + +T+V GT Y PE T SD+Y++G++ +E L
Sbjct: 124 LDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECL 183
Query: 580 TGQ 582
TGQ
Sbjct: 184 TGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 24/220 (10%)
Query: 383 HFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKV-VDESKLEEFIN----EVVILSQIS 436
++ + ++LG+G G VY AD GR +AVK+ D + + +N E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 437 HRNVVKLLGSCLE--VEVPLLVY-EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
H +V+ G CL E L ++ E++P G++ L +LT + R ++ +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQG 118
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFG 550
++YLHS+ I HRDIK NIL D K+ DFG S+ +I + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPY 174
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWA 590
++ PE + K+DV+S +VE+LT + P WA
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP----WA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 386 VNRILGQGGQGTVYKGML-ADGR---IIAVKKSKV-VDESKLEEFINEVVILSQISHRNV 440
+ ++G G G V +G L G+ +A+K K E + +F++E I+ Q H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
+ L G + +++ EF+ NG L +L + ++ + + +A + YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLSEM 125
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI---AIDQTHVST---KVQGTFGYLDP 554
Y+ HRD+ + NIL++ K++DFG SR + D T+ S+ K+ + P
Sbjct: 126 NYV---HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI--PIRWTAP 180
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
E +FT SDV+S+G+V+ E+++ G++P
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 75/270 (27%), Positives = 114/270 (42%), Gaps = 28/270 (10%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL--EEFINEVVILSQISHRNVVKLLG 445
LG+G G+V K L + +I K+ D + ++ + E+ I +VK G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 446 SCLEVEVPLL--VYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYLHSSAY 502
+ L+ + E+ G+L + E L +IA V + L+YLHS
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK- 125
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
I HRDIK +NILL K + K+ DFG S + T GT Y+ PE +
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPY 180
Query: 563 TDKSDVYSFGVVLVELLTGQKPISYIWANEGR------NLATYFVECVEENCLFDILDDQ 616
+ SDV+S G+ L+E+ + P EG L +Y V + L D +
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFP----PEGEPPLGPIELLSYIVN-MPNPELKDEPGNG 235
Query: 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPT 646
++ S E D K+CL + RPT
Sbjct: 236 IKWS------EEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 39/242 (16%)
Query: 388 RILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
++LG+G G V +LA+ + + +KK ++ + +E + E +L+
Sbjct: 1 KVLGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 441 VKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLH 498
+ L SC + + L V E++ G L ++ E R R A E+ L +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR-SIAIDQTHVSTKVQGTFGYLDPEYF 557
I +RD+K N+LLD + KIADFG + I T ++ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD-ILDDQ 616
+ D ++ GV+L E+L GQ P E +E+ LF IL+D+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPF----------------EGDDEDELFQSILEDE 212
Query: 617 VR 618
VR
Sbjct: 213 VR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 70/200 (35%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 394 GQGTVYKGMLA----DGRIIAVK--KSKVVDESKLEEFI--NEVVILSQISHRNVVKLLG 445
G+G+ K +LA DG+ AVK + K+V K ++ I V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHY 63
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLHSSAYLP 504
S E V +F+ G LF +L E S E R R A E+A AL YLHS +
Sbjct: 64 SFQTTEKLYFVLDFVNGGELFFHLQ---RERSFP-EPRARFYAAEIASALGYLHS---IN 116
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
I +RD+K NILLD + + DFG + I Q+ +T GT YL PE + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 565 KSDVYSFGVVLVELLTGQKP 584
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 395 QGTVYKGMLADGRIIA--VKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452
G ++GM + R++ ++ S DE L F+ EV +++H NV++ LG C+E
Sbjct: 13 LGEAHRGM-SKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL--RIATEVAEALAYLHSSAYLPIYHRDI 510
LLV EF P G L YL ++ + + R+A EVA L +LH + ++ H D+
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDL 126
Query: 511 KSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG--YLDPEYFHSSQ------- 561
N L KI D+G + + + TK +L PE
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185
Query: 562 FTDKSDVYSFGVVLVELLT-GQKPIS 586
T KS+++S GV + EL T +P
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYP 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGS 446
+G+G G VYKG G+I+A+KK ++ +E I E+ +L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 447 CLEVEVPLLVYEF-----------IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
++ L++EF +P G QY+ D S +++ + +
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKG---QYM-DAELVKSYLYQI--------LQGIL 115
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
+ HS L HRD+K N+L+D K K+ADFG +R+ I V T T Y PE
Sbjct: 116 FCHSRRVL---HRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPE 171
Query: 556 YFHSSQ-FTDKSDVYSFGVVLVELLTGQKPI 585
S ++ D++S G + E+ T +KP+
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 383 HFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISHR 438
F + +GQGG G V+ D G I+A+K KS + +++ + E IL+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNG---TLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+VKLL + + E L E++P G TL L SE+ R +A E+ EA+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMA-EMFEAVD 115
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
LH Y+ HRD+K N L+D K+ DFG S+ I + + V G+ Y+ PE
Sbjct: 116 ALHELGYI---HRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPE 168
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592
+ D +S G +L E L G P S NE
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RNVV 441
F + ++G G G VYKG + G++ A+K V + + EE E+ +L + SH RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 442 KLLGSCLEVEVP------LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
G+ ++ P LV EF G++ + + ++ +L E I E+ L+
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLS 125
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGY 551
+LH + HRDIK N+LL E K+ DFG S R++ T + GT +
Sbjct: 126 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYW 177
Query: 552 LDPEYFHSSQFTD-----KSDVYSFGVVLVELLTGQKPI 585
+ PE + D KSD++S G+ +E+ G P+
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 33/211 (15%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEF-INEVVILSQI---SHRN 439
+ I G+G GTVYK L GR +A+KK +V + E + + E+ +L Q+ H N
Sbjct: 4 LAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 440 VVKLLGSCLEVEVP-----LLVYEFIPNGTLFQYL-HDPSEELS------LTWEMRLRIA 487
+V+LL C LV+E + + L YL P L L ++ LR
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL-LR-- 118
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
+ +LHS I HRD+K NIL+ + KIADFG +R + + S V
Sbjct: 119 -----GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-- 168
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVEL 578
T Y PE S + D++S G + EL
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 27/208 (12%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLL-- 444
+G+G G VYK G I+A+KK ++ DE I E+ +L +++H N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 445 ---GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+ L LV+EF+ + L +Y+ D S L + ++ + +AY HS
Sbjct: 67 VHSENKL-----YLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI---DQTHVSTKVQGTFGYLDPE-YF 557
+ HRD+K N+L+D + K+ADFG +R+ + TH T Y PE
Sbjct: 120 ---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILL 172
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPI 585
S Q++ D++S G + E++ ++P+
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 392 QGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVIL-SQISHRNVVKL 443
+G G+VY LA R I +KKS ++ ++++ E I+ Q V KL
Sbjct: 6 KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 444 LGSCLEVEVPLLVYEFIPNG---TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
S + LV E++ G +L + L E+ + + EV + LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQR 116
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
I HRDIK N+L+D+ K+ DFG SR+ + K GT YL PE
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGV 168
Query: 561 QFTDKSDVYSFGVVLVELLTGQKP 584
SD +S G V+ E L G P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGS 446
LG G G VYK + ++A +KV+D E +LE+++ E+ IL+ H N+VKLL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA-TEVAEALAYLHSSAYLPI 505
++ EF G + + + L+ E ++R+ + EAL YLH + I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHENK---I 124
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
HRD+K+ NIL K+ADFG S R+I + + GT ++ PE
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCET 179
Query: 562 FTD-----KSDVYSFGVVLVELLTGQKP 584
D K+DV+S G+ L+E+ + P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 26/204 (12%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSC 447
LG+G TVYKG G I+A+K+ + +E I E+ ++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 448 LEVEVPL-LVYEFIPNGTLFQYLH--------DPSEELSLTWEMRLRIATEVAEALAYLH 498
+ E L LV+E++ + L +Y+ DP+ S T+++ + +A+ H
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--------LKGIAFCH 117
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
+ L HRD+K N+L++++ K+ADFG +R+ I S +V T Y P+
Sbjct: 118 ENRVL---HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 559 SSQ-FTDKSDVYSFGVVLVELLTG 581
S+ ++ D++S G ++ E++TG
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 390 LGQGGQGTVYKGMLA-DGRIIAVKK----SKVVDESKLEEFINEVVILSQISHRNVVKLL 444
+G G G VY + ++AVKK K +E K ++ I EV L Q+ H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 445 GSCLEVEVPLLVYEFIPNGT--LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
G L+ LV E+ L + P +E+ + I + LAYLHS
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHSHNM 142
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY---FHS 559
+ HRDIK+ NILL E + K+ADFG++ + + V GT ++ PE
Sbjct: 143 I---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDE 194
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPI 585
Q+ K DV+S G+ +EL + P+
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQISHRNVVKL 443
R +G G G VY + ++A+KK S K ++ I EV L Q+ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 444 LGSCLEVEVPLLVYEFIPNGT--LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
G L LV E+ + + P +E+ + I + LAYLHS
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-----AICHGALQGLAYLHS-- 133
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY---FH 558
HRDIK+ NILL E K+ADFG++ ++ + V GT ++ PE
Sbjct: 134 -HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPI 585
Q+ K DV+S G+ +EL + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
D F V +++G+G G V+ L G++ A+K KS ++ +++ E IL+
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEM-RLRIATEVAEA 493
+VKL S + E LV E++P G L L + E R IA E+ A
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIA-ELVLA 113
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA------------------ 535
L +H ++ HRDIK NIL+D K+ADFG + +
Sbjct: 114 LDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 536 -IDQTHVSTKVQ---------GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
Q GT Y+ PE + + + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 586 S 586
Sbjct: 231 Y 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RNVV 441
F + ++G G G VYKG + G++ A+K V ++ + EE E+ +L + SH RN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 442 KLLGSCLEVEVP------LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
G+ ++ P LV EF G++ + + ++ +L + I E+ LA
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGLA 135
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGY 551
+LH+ + HRDIK N+LL E K+ DFG S R++ T + GT +
Sbjct: 136 HLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYW 187
Query: 552 LDPEYFHSSQFTD-----KSDVYSFGVVLVELLTGQKPI 585
+ PE + D +SD++S G+ +E+ G P+
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 388 RILGQGGQGTVYKGMLADGR---IIAVKK---SKVVDESKLEEFINEVVILSQISHRNVV 441
R +G G G VY D R ++A+KK S K ++ I EV L +I H N +
Sbjct: 31 REIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 442 KLLGSCLEVEVPLLVYEFIPNGT--LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+ G L LV E+ L + P +E+ + I + LAYLHS
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHS 143
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY--- 556
+ HRDIK+ NILL E + K+ADFG++ + + V GT ++ PE
Sbjct: 144 HNMI---HRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILA 195
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
Q+ K DV+S G+ +EL + P+
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL 448
+G G G VYK L G + AVK K+ E+ ++ + H N+V GS L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 449 EVEVPLLVYEFIPNGTLFQYLH--DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
E + E+ G+L H P EL + + R E + LAYLHS +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKM--- 128
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ---FT 563
HRDIK NILL + K+ADFG + I + + GT ++ PE + +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 564 DKSDVYSFGVVLVELLTGQKPI 585
D+++ G+ +EL Q P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINE-VVILSQISHRNVVK 442
+++G+G G V ADG+ AVK K ++ + + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLHSSA 501
L S + V +++ G LF +L E S E R R A E+A AL YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFP-EPRARFYAAEIASALGYLHS-- 114
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
L I +RD+K NILLD + + DFG + I+ + ++ GT YL PE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 562 FTDKSDVYSFGVVLVELLTGQKP 584
+ D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 52/221 (23%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQ----------- 434
+G G G VYK G ++AVK ++ +E+K +VV+ S
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 435 -ISHRNV---VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
I+ +V ++L+ +CL+ ++ + IP L ++ +
Sbjct: 83 FITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILG------------------KMTVAI 123
Query: 491 AEALAYL---HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
+AL YL H + HRD+K +NILLD K+ DFG S + + T+ G
Sbjct: 124 VKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAG 176
Query: 548 TFGYLDPEYFHSSQFTDK----SDVYSFGVVLVELLTGQKP 584
Y+ PE K +DV+S G+ LVEL TGQ P
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 63/276 (22%), Positives = 121/276 (43%), Gaps = 40/276 (14%)
Query: 392 QGGQGTVYKGMLADGRII--AVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449
+ Q ++YKG+ + +I KK + ++ NE+ L +I N++K+ G ++
Sbjct: 30 ENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89
Query: 450 VEVPL----LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
+ L L+ E+ G L + L +E L+++ +L +A + + L L+ P
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS--SQFT 563
++++ S + L+ E Y+ KI G + ++ K Y + + S++T
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYT 200
Query: 564 DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK- 622
K D+YS GVVL E+ TG+ P NL T +I D + K+
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPF--------ENLTTK-----------EIYDLIINKNNSL 241
Query: 623 ---TEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
+ +E+ + + C + + RP +KE+ L
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFI--NEVVILSQISHRNVVK 442
+++G+G G V A+ + AVK + K + + K E+ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLHSSA 501
L S + V ++I G LF +L E L E R R A E+A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ--RERCFL--EPRARFYAAEIASALGYLHS-- 114
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
L I +RD+K NILLD + + DFG + I+ ++ GT YL PE H
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 562 FTDKSDVYSFGVVLVELLTGQKP 584
+ D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 394 GQGTVYKGMLA----DGRIIAVKKSKVVDESKLE--EFINEVVILSQISHRNVVKLLGSC 447
G+G+ K +L DG+ +K+ + S E E EV +LS + H N+V+ S
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDP-----SEELSLTWEMRLRIATEVAEALAYLHSSAY 502
E +V ++ G L++ ++ E+ L W +++ +A L ++H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK- 121
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
I HRDIKS NI L + K+ DFG +R + ++ GT YL PE + +
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRPY 178
Query: 563 TDKSDVYSFGVVLVELLT 580
+KSD+++ G VL E+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK--LEEFINEVVILSQISHRNVVKLLGS 446
+G+G G VYK G ++A+KK ++ E++ I E+ +L +++H N+VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL-D 66
Query: 447 CLEVEVPL-LVYEFIPNGTLFQYLH-DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
+ E L LV+EF+ + L +++ P + L + ++ + LA+ HS L
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLP--LIKSYLFQLLQGLAFCHSHRVL- 122
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF-T 563
HRD+K N+L++ + K+ADFG +R+ + + +V T Y PE ++ +
Sbjct: 123 --HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYS 179
Query: 564 DKSDVYSFGVVLVELLT 580
D++S G + E++T
Sbjct: 180 TAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 390 LGQGGQGTVYKGMLAD-GRIIAVKK-SKVVDESKLEEFINEV-VILSQISHRNVVKLLGS 446
+G+G GTV K + G I+AVK+ VDE + + + ++ V++ +VK G+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 447 CLEVEVPLLVYEF--IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
+ E I ++Y+++ + + E+ +IA +AL YL L
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--LK 128
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
I HRD+K +NILLD K+ DFG S SIA T+ G Y+ PE S
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA------KTRDAGCRPYMAPERIDPS 182
Query: 561 Q---FTDKSDVYSFGVVLVELLTGQKP 584
+ +SDV+S G+ L E+ TG+ P
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQISHRN 439
F R+LG+GG G V + A G++ A KK K + + K E +NE IL +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTL-FQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
VV L + + LV + G L F H E + A E+ L LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
I +RD+K NILLD+ +I+D G + + QT + +V GT GY+ PE
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVK 174
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKP 584
+ ++T D ++ G +L E++ GQ P
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 79/271 (29%), Positives = 118/271 (43%), Gaps = 43/271 (15%)
Query: 388 RILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNV 440
R+LG+G G V MLA GR+ AVK K ++ + +E + E ILS +
Sbjct: 1 RVLGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 441 VKLLGSCLEV-EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLH 498
+ L C + + V EF+ G L ++ S E R R A E+ AL +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFD---EARARFYAAEITSALMFLH 113
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
I +RD+K N+LLD + K+ADFG + + ST GT Y+ PE
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQ 169
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD-ILDDQV 617
+ D ++ GV+L E+L G P E E+ LF+ IL+D+V
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPF----------------EAENEDDLFEAILNDEV 213
Query: 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648
+ + D+ K + N PTM+
Sbjct: 214 VYPTWLSQ--DAVDILKAFMTKN----PTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 389 ILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFI--NEVVILSQISHRNVVKLLG 445
++G+G G V K + G+I+A+KK ++ K+ + I E+ +L Q+ H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
+ LV+EF+ + L P+ L + ++ + + HS I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF-HSSQFTD 564
HRDIK NIL+ + K+ DFG +R++A V T T Y PE +++
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 565 KSDVYSFGVVLVELLTGQ 582
D+++ G ++ E+LTG+
Sbjct: 181 AVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 382 DHFNVNRILGQGGQGTVY----KGMLADGRIIA---VKKSKVVDESKLEEFINEVVILSQ 434
F+V ++G+G G V K A G I A +KKS ++ + + F E ILS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH---DPSEELSLTWEMRLRIATEVA 491
+ + +L + + + LV E+ P G L L+ D +E +M E+
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE-----DMAQFYLAELV 112
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
A+ +H Y+ HRDIK N+L+D K+ADFG++ + ++ S GT Y
Sbjct: 113 LAIHSVHQMGYV---HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 552 LDPEYFHSSQFTDKS------DVYSFGVVLVELLTGQKPISYIWANEGRNLATY 599
+ PE + K D +S GV+ E++ G+ P EG + TY
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-----EGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
+ F + + +G G G VYK + G + A+K K+ E++++ H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLH--DPSEELSLTWEMRLRIATEVAEALAYLH 498
V GS L + + EF G+L H P E + + ++ E + L YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-----VSRETLQGLYYLH 123
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
S + HRDIK NILL + K+ADFG S I + + GT ++ PE
Sbjct: 124 SKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAA 179
Query: 559 SSQ---FTDKSDVYSFGVVLVELLTGQKPI 585
+ + D+++ G+ +EL Q P+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 383 HFNVNRILGQGGQGTVY---------KGMLADGRIIAVKKSKVVDESKLEEFI-NEVVIL 432
+F + ++LG G G V+ G L +++ KK+ +V ++K E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVL--KKATIVQKAKTTEHTRTERQVL 58
Query: 433 SQISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
I + L + + L L+ ++I G LF +L E E+++ E+
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFKEQEVQIYSG-EIV 115
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
AL +LH L I +RDIK NILLD + DFG S+ D+ + GT Y
Sbjct: 116 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 552 LDPEYFHSSQFT-DKS-DVYSFGVVLVELLTGQKPIS 586
+ P+ DK+ D +S GV++ ELLTG P +
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 25/217 (11%)
Query: 390 LGQGGQGTVYKGML---ADG---RIIAVKKSKVVDESKL-EEFINEVVILSQISHRNVVK 442
LG+ G VYKG L A G + +A+K K E L EEF +E ++ S++ H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEELSLTWEMR-----------LRIATE 489
LLG + + +++ + + L ++L P ++ T + + + I T+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 548
+A + +L S + H+D+ + N+L+ +K KI+D G R + A D +
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 33/215 (15%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNV 440
+NRI +G G VY+ G I+A+KK K+ E + E F + E+ IL ++ H N+
Sbjct: 10 LNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQHPNI 66
Query: 441 VKL----LGSCLEVEVPLLVYEFIPNG--TLFQYLHDP---SEELSLTWEMRLRIATEVA 491
V + +GS L+ ++ +V E++ + +L + + P SE L M ++
Sbjct: 67 VTVKEVVVGSNLD-KI-YMVMEYVEHDLKSLMETMKQPFLQSEVKCL---ML-----QLL 116
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
+A+LH + L HRD+K++N+LL+ + KI DFG +R T++ T Y
Sbjct: 117 SGVAHLHDNWIL---HRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWY 172
Query: 552 LDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE + +++ D++S G + ELLT +KP+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQISHRNVVKL 443
R +G G G VY + + ++A+KK S K ++ I EV L ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 444 LGSCLEVEVPLLVYEFIPNGT--LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
G L LV E+ L + P +E+ + + + LAYLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYLHSHN 135
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY---FH 558
+ HRD+K+ NILL E K+ DFG++ +A V GT ++ PE
Sbjct: 136 MI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMD 187
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPI 585
Q+ K DV+S G+ +EL + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447
LG G G V K +I +K + + + I E+ +L + + +V G+
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507
+ E + G+L Q L E + E+ +++ V LAYL I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMH 127
Query: 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSD 567
RD+K +NIL++ + K+ DFG S + ID ++ GT Y+ PE + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 568 VYSFGVVLVELLTGQKPI 585
++S G+ LVEL G+ PI
Sbjct: 185 IWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSC 447
LG+G G+VYK + G +A+K+ ++ +DESK + I E+ IL + +V G+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYLHSSAYLPIY 506
+ E++ G+L L+ E L RI V + L +L I
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSI--AIDQTHVSTKVQGTFGYLDPEYFHS----- 559
HRD+K TN+L++ + K+ DFG S ++ ++ +T++ G Y+ PE S
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQ 180
Query: 560 -SQFTDKSDVYSFGVVLVELLTGQKP 584
+T +SDV+S G+ ++E+ G+ P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-14
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKL--EEFINEVVILSQISHR 438
+++ R++G+GG G VY R +A+KK + + E+ L + F+ E I + + H
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMR--------LRIATEV 490
+V + C + + +I TL L ++ SL+ E+ L I ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH---------- 540
+ Y+HS L HRD+K NILL I D+G + +++
Sbjct: 123 CATIEYVHSKGVL---HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 541 -------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580
+ K+ GT Y+ PE ++ +D+Y+ GV+L ++LT
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 66/200 (33%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 394 GQGTVYKGMLA----DGRIIAVK--KSKVVDESKLEEFI--NEVVILSQISHRNVVKLLG 445
G+G+ K +LA DG AVK + K + + K + I V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLHSSAYLP 504
S E V +++ G LF H E L E R R A EVA A+ YLHS L
Sbjct: 64 SFQTAEKLYFVLDYVNGGELF--FHLQRERCFL--EPRARFYAAEVASAIGYLHS---LN 116
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
I +RD+K NILLD + + DFG + ++ ++ GT YL PE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 565 KSDVYSFGVVLVELLTGQKP 584
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 47/137 (34%), Positives = 66/137 (48%), Gaps = 17/137 (12%)
Query: 455 LVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512
+V E++P G L + +D E+ W R A EV AL +HS ++ HRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEK----WA-RFYTA-EVVLALDAIHSMGFI---HRDVKP 170
Query: 513 TNILLDEKYRAKIADFGTS-RSIAIDQTHVSTKVQGTFGYLDPEYF----HSSQFTDKSD 567
N+LLD+ K+ADFGT + A T V GT Y+ PE + + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 568 VYSFGVVLVELLTGQKP 584
+S GV L E+L G P
Sbjct: 230 WWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 380 ATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEE-----FINEVVILS 433
AT + N+ + LG+G TVYKG+ +G+++A+K V K EE I E +L
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALK----VISMKTEEGVPFTAIREASLLK 58
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
+ H N+V L E V+E++ + L QY+ L + +RL ++
Sbjct: 59 GLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRG 115
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI-DQTHVSTKVQGTFGYL 552
LAY+H I HRD+K N+L+ K+ADFG +R+ +I QT+ S V T Y
Sbjct: 116 LAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYR 170
Query: 553 DPE-YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
P+ ++ ++ D++ G + +E+L GQ
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 22/263 (8%)
Query: 388 RILGQGGQGTVYKGMLAD-GRIIA---VKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
R++G+G V L RI A VKK V D+ ++ E + Q S+ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 444 LGSCLEVEVPLL-VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
L SC + E L V E++ G L ++ + L E + E++ AL YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG- 116
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
I +RD+K N+LLD + K+ D+G + + ++ GT Y+ PE +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 563 TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD-ILDDQVRKSG 621
D ++ GV++ E++ G+ P + +++ + T E+ LF IL+ Q+R
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-------EDYLFQVILEKQIRIPR 226
Query: 622 KTEEIMEVSDVAKRCLNSNGRSR 644
++ + V K LN + + R
Sbjct: 227 SLS--VKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 13/215 (6%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGR---IIAVKKSKV-VDESKLEEFINEVV 430
ELD + + RILG G G + +G L + +A+ + + + F+ E +
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 431 ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
L Q H N+V+L G ++V E++ NG L +L +L M + +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM--LPGL 116
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
A + YL Y+ H+ + + +L++ KI+ F + + + + +
Sbjct: 117 ASGMKYLSEMGYV---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+ PE F+ SDV+SFG+V+ E+++ G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 12/224 (5%)
Query: 388 RILGQGGQGTVYKGMLADGRII----AVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
R++G+G V L I VKK V D+ ++ E + Q S +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 444 LGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
L SC + L LV E++ G L ++ + L E A E+ AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG- 116
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
I +RD+K N+LLD K+ D+G + + ++ GT Y+ PE ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 563 TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
D ++ GV++ E++ G+ P I N N Y + + E
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 388 RILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLE-EFINEVVILSQISHRN 439
++LG+G G V MLA+ + I A+KK V+++ +E + V+ H
Sbjct: 1 KVLGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLH 498
+ L + E V E++ G L ++ S E R R A E+ L +LH
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFD---EARARFYAAEIICGLQFLH 113
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
I +RD+K N+LLD+ KIADFG + + ST GT Y+ PE
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILK 169
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPIS 586
++ + D +SFGV+L E+L GQ P
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 390 LGQGGQGTVYKG--MLADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVVKLLGS 446
LG+G TVYKG L D ++A+K+ ++ E I EV +L + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ LV+E++ + L QYL D +++ ++L + ++ L Y H L
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFL-FQLLRGLNYCHRRKVL--- 126
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHSSQFTDK 565
HRD+K N+L++E+ K+ADFG +R+ +I S +V T Y P+ S+ ++ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 566 SDVYSFGVVLVELLTGQ 582
D++ G + E+ TG+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 38/244 (15%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVKKSKVV----DESKLEEFIN----------EVV 430
LG+G G V K G+I+A+KK K++ D +K + + E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 431 ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
I+++I H N++ L+ +E + LV + I L + + ++ LT I ++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDR---KIRLTESQVKCILLQI 128
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG--- 547
L LH ++ HRD+ NI ++ K KIADFG +R +
Sbjct: 129 LNGLNVLHKWYFM---HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 548 ----------TFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596
T Y PE + ++ D++S G + ELLTG KP+ + NE L
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL-FPGENEIDQL 243
Query: 597 ATYF 600
F
Sbjct: 244 GRIF 247
|
Length = 335 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 68/264 (25%), Positives = 110/264 (41%), Gaps = 46/264 (17%)
Query: 388 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL--- 443
R LG G G V+ + +D + +AVKK + D ++ + E+ I+ ++ H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 444 -----------LGSCLEVEVPLLVYEF--------IPNGTLFQYLHDPSEELSLTWEMRL 484
+GS E+ +V E+ + G L E L L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL------SEEHARLFMYQLL 124
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVST 543
R L Y+HS+ L HRD+K N+ ++ E KI DFG +R + +H
Sbjct: 125 R-------GLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 544 KVQG--TFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600
+G T Y P + +T D+++ G + E+LTG+ + E L
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 601 VECVEE---NCLFDILDDQVRKSG 621
V V E N L +++ VR G
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDG 258
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQIS 436
FN +LG+G G V MLA+ + I +KK ++ + +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG 58
Query: 437 HRNVVKLLGSCLEVEVPL-LVYEFIPNGTLF---QYLHDPSEELSLTWEMRLRIATEVAE 492
+ L SC + L V E++ G L Q + E ++ + A E+A
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAI 112
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
L +LHS I +RD+K N++LD + KIADFG + T GT Y+
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYI 168
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE + D ++FGV+L E+L GQ P
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 389 ILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVKLL 444
I+G+GG G VY AD G++ A+K K ++ + +NE ++LS +S + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 445 GSCLEVEVP---LLVYEFIPNGTLFQYLHDP---SEELSLTWEMRLRIATEVAEALAYLH 498
P + + + G L +L SE+ EMR ATE+ L ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK-----EMRF-YATEIILGLEHMH 114
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
+ + +RD+K NILLDE +I+D G + + + H S GT GY+ PE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168
Query: 559 SSQFTDKS-DVYSFGVVLVELLTGQKP 584
D S D +S G +L +LL G P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVIL---S 433
F +LG+G G V +LA+ + I A+KK ++ ++E + E I +
Sbjct: 1 FRCLAVLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 434 QISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
H +V L +C + E + V E+ G L ++H + S E R A V
Sbjct: 58 SERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFS---EPRAVFYAACVV 111
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS-IAIDQTHVSTKVQGTFG 550
L YLH + I +RD+K N+LLD + KIADFG + + ST GT
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST-FCGTPE 166
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+L PE + +T D + GV++ E+L G+ P
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 388 RILGQGGQGTVYKGMLADGR-----IIAVKKSKVVDESKLEEFINEVVILSQISHRNVVK 442
++LG+G G V L G+ + A+KK V+ + +E + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 443 LLGSCLEVEVPLL-VYEFIPNGTLFQYLHDPS--EELSLTWEMRLRIATEVAEALAYLHS 499
L + + L V EF+ G L ++ D + T+ A E+ L +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
I +RD+K N++LD KIADFG + ST GT Y+ PE
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
++T D +SFGV+L E+L GQ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGS 446
+G+G G VYK IA+KK ++ DE I E+ +L ++ H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ LV+E++ + L +++ D S + + + ++ +AY HS L
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL--- 124
Query: 507 HRDIKSTNILLDEKYRA-KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHSSQFTD 564
HRD+K N+L+D + A K+ADFG +R+ I + +V T Y PE S ++
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYST 183
Query: 565 KSDVYSFGVVLVELLTGQKPI 585
D++S G + E++ QKP+
Sbjct: 184 PVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 5/101 (4%)
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 544
+I+ V L YL I HRD+K +NIL++ + K+ DFG S + ID ++
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANS 157
Query: 545 VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
GT Y+ PE + +T +SD++S G+ LVE+ G+ PI
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF-INEVV-------ILSQISHRNVV 441
LG+G GTVY ++ D + +A ++ KV+ E + E NE V +LS++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTL---FQYLHDPSEELS----LTWEMRLRIATEVAEAL 494
K S LE + ++ E+ L + L + LS W ++L +
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH----- 120
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
Y+H I HRD+K+ NI L + KI DFG SR + + ++T GT Y+ P
Sbjct: 121 -YMHQRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSR-LLMGSCDLATTFTGTPYYMSP 174
Query: 555 EYFHSSQFTDKSDVYSFGVVLVEL 578
E + KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 390 LGQGGQGTVYKGMLADGRII----AVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLG 445
+G+G G V + D + I ++K+ +V S++ + E +L+Q++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
S E LV FI G LF +L E R A E+ AL LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ--REGRFDLSRARFYTA-ELLCALENLHK---FNV 114
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDK 565
+RD+K NILLD + + DFG + + + + GT YL PE +T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 566 SDVYSFGVVLVELLTGQKP 584
D ++ GV+L E+LTG P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 77/286 (26%), Positives = 120/286 (41%), Gaps = 45/286 (15%)
Query: 382 DHFNVNRILGQGGQGTVYKGML--ADGRIIAVKKSKV-VDESKLEEFINEVVILSQISH- 437
D V LG+G G V K M G I+AVK+ + V+ + + + ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 438 RNVVKLLGS---------CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488
V G+ C+EV L +F L P + L +IA
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSL-DKFYKKVYDKG-LTIPEDILG-------KIAV 110
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
+ +AL YLHS L + HRD+K +N+L++ + K+ DFG S + +D T G
Sbjct: 111 SIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSV-AKTIDAGC 166
Query: 549 FGYLDPEYF----HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604
Y+ PE + + KSDV+S G+ ++EL TG+ P W + L + V
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-WKTPFQQLK----QVV 221
Query: 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
EE Q+ + E D +CL N + RP E+
Sbjct: 222 EEP------SPQLPAEKFSPEFQ---DFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 388 RILGQGGQGTV-YKGMLADGRIIAVKKSKVVDESKLEEFI--NEVVILSQISHRNVVKLL 444
R++G+G G V DG+ +KK + + S+ E E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 445 GSCLEVEVPLL--VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
S E E LL V F G L+ L + +L L + ++A AL YLH
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
I HRD+K+ N+ L K+ D G +R + +Q +++ + GT Y+ PE F + +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 563 TDKSDVYSFGVVLVELLT 580
KSDV++ G + E+ T
Sbjct: 180 NYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 390 LGQGGQGTVYKG--MLADGRIIAVKKSKV--VDESKLEEFINEVVILSQIS---HRNVVK 442
+G+G G V+K + GR +A+K+ +V +E I EV +L + H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 443 LLGSCL----EVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
L C + E L LV+E + + L YL D E + E + ++ L +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS + HRD+K NIL+ + K+ADFG +R + T V T Y PE
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVL 181
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPI 585
S + D++S G + E+ +KP+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 69/236 (29%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQIS 436
FN +LG+G G V MLA+ + I +KK V+ + +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 437 HRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+ L SC + L V E++ G L + + A E+A L
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLF 115
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFGYLDP 554
+LHS I +RD+K N++LD + KIADFG + D V+TK GT Y+ P
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAP 170
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
E + D ++FGV+L E+L GQ P EG + F +E N +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF------EGEDEDELFQSIMEHNVAY 220
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 388 RILGQGGQGTVYKGMLADG----RIIAVK---KSKVVDESKLEEFIN-EVVILSQISHRN 439
++LG+GG G V++ G +I A+K K+ +V K E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+V L+ + L+ E++ G LF +L + T L +E++ AL +LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL---SEISLALEHLHQ 118
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
I +RD+K NILLD + K+ DFG + +I + V+ GT Y+ PE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPIS 586
S D +S G ++ ++LTG P +
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 390 LGQGGQGTVYKG--MLADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVVKLLGS 446
LG+G TV+KG L + ++A+K+ ++ E I EV +L + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ LV+E++ + L QY+ D +S+ +++ + ++ LAY H L
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFL-YQILRGLAYCHRRKVL--- 126
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHSSQFTDK 565
HRD+K N+L++E+ K+ADFG +R+ ++ S +V T Y P+ SS+++ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 566 SDVYSFGVVLVELLTGQ 582
D++ G + E+ +G+
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 411 VKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH 470
+KK +++ +++ E IL ++SH +V ++ S + + EF+ G LF +L
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 471 D----PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526
P++ E+ A YLHS I +RD+K N+LLD K K+
Sbjct: 111 KAGRFPNDVAKF-------YHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVT 160
Query: 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
DFG ++ + D+T + GT YL PE S D ++ GV+L E + G P
Sbjct: 161 DFGFAKKVP-DRTFT---LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQISHRN 439
F R+LG+GG G V + A G++ A KK K + + K E +NE IL +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
VV L + + LV + G L ++++ E + A E+ L LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLHR 120
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
I +RD+K NILLD+ +I+D G + I +T + +V GT GY+ PE +
Sbjct: 121 ER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKN 175
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
++T D + G ++ E++ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRI--IAVK---KSKVVDESKLEEFINEVVILSQIS 436
+ FN R LG G G V + +A+K KSK++ + +++ +E IL+ I+
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H V L GS + LV EF+ G F +L ++ A ++ Y
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEY 146
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
L S L I +RD+K N+LLD+ K+ DFG ++ + T T + GT Y+ PE
Sbjct: 147 LQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEI 199
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592
+ +D ++ G+ + E+L G P +ANE
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP---FYANE 232
|
Length = 340 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 10/205 (4%)
Query: 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQISHRN 439
F R+LG+GG G V + A G++ A K+ K + + K E +NE IL +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
VV L + + LV + G L ++++ E L A E+ L LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHR 120
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+RD+K NILLD+ +I+D G + + I + GT GY+ PE ++
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
++T D + G ++ E++ GQ P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 384 FNVNRILGQGGQGTVY---------KGMLADGRIIAVKKSKVVDESKLEEFI-NEVVILS 433
F + ++LG G G V+ G L +++ +K+ +V ++K E E +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVL--QKAALVQKAKTVEHTRTERNVLE 59
Query: 434 QISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
+ + L + E L L+ +++ G +F +L+ + S E +R + E+
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFS---EDEVRFYSGEII 115
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
AL +LH L I +RDIK NILLD + + DFG S+ ++ + GT Y
Sbjct: 116 LALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 552 LDPEYFHSSQFTDKS-DVYSFGVVLVELLTGQKPIS 586
+ PE K+ D +S G+++ ELLTG P +
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 389 ILGQGGQGTVYKGM-LADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRN-VVKLL 444
+G+G G VYK G+++A+KK+++ +E + E+ +L +S +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 445 GSCLE-VEVPL------LVYEFIPNGTLFQYL-------HDPSEELSLTWEMRLRIATEV 490
+E VE LV+E++ + L +++ P ++ ++
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK-----SFMYQL 119
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ +A+ H + HRD+K N+L+D +K KIAD G R+ +I + ++ T
Sbjct: 120 LKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TL 175
Query: 550 GYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
Y PE S+ ++ D++S G + E+ Q
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 388 RILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
++LG+G G V MLA+ + I +KK ++ + ++ + E IL+ +
Sbjct: 1 KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 441 VKLLGSCLEVEVPLL-VYEFIPNGTL-FQYLHDPSEELSLTWEMRLRI-ATEVAEALAYL 497
+ L C + + L V E++ G L FQ + E R R A EV AL +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFL 112
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
H + +RD+K NILLD + K+ADFG + I +T GT Y+ PE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEIL 168
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ D ++ GV++ E++ GQ P
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQIS 436
FN +LG+G G V MLA+ + I +KK V+ + +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 437 HRNVVKLLGSCLE-VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+ L SC + V+ V E++ G L ++ + + A E++ L
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLF 115
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
+LH I +RD+K N++LD + KIADFG + +D T GT Y+ PE
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYIAPE 171
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ D +++GV+L E+L GQ P
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLE-EFINEVVIL---SQISHRNVVKL 443
+G G GTVYK G +A+K +V +E L + EV +L H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 444 LGSCL------EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+ C E +V L V+E + + L YL D L E + + L +L
Sbjct: 68 MDVCATSRTDRETKVTL-VFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-TKVQGTFGYLDPEY 556
H++ I HRD+K NIL+ + K+ADFG +R I ++ T V T Y PE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPEV 178
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
S + D++S G + E+ +KP+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 41/225 (18%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQISHRN 439
+ + + +G G G V + GR +A+KK V + ++ + E+ +L + H N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 440 VVKLLGSCLEVEVPL---------LVYEFIPNGT-LFQYLHDPSEELS------LTWEMR 483
++ LL ++ P +V E + T L + + P + L+ +++
Sbjct: 61 IIGLL----DILRPPSPEDFNDVYIVTELME--TDLHKVIKSP-QPLTDDHIQYFLYQI- 112
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543
LR L YLHS+ + HRD+K +NIL++ KI DFG +R + D+
Sbjct: 113 LR-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 544 KVQG--TFGYLDPEYFHSSQFTDKS-DVYSFGVVLVELLTGQKPI 585
+ T Y PE SS K+ D++S G + ELLT KP+
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 394 GQGTVYKGML----ADGRIIA---VKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGS 446
G+GT K +L A G+ A +KK ++ + ++ + E +L H + L S
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ V E++ G LF +L S E + + E+ AL YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSGK---IV 117
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKS 566
+RD+K N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 567 DVYSFGVVLVELLTGQKP 584
D + GVV+ E++ G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSC 447
LG+G TV+KG ++A+K+ ++ +E I EV +L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL-HDI 71
Query: 448 LEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT-EVAEALAYLHSSAYLPI 505
+ E L LV+E++ + L QYL + +S+ ++I ++ L+Y H I
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSM---HNVKIFMFQLLRGLSYCHKRK---I 124
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHSSQFTD 564
HRD+K N+L++EK K+ADFG +R+ ++ S +V T Y P+ S++++
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 565 KSDVYSFGVVLVELLTGQ 582
D++ G +L E+ TG+
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 43/226 (19%)
Query: 389 ILGQGGQGT---VYKGML---ADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHR 438
I G G+GT VYK DG+ A+KK K D+ + E+ +L ++ H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSACREIALLRELKHE 62
Query: 439 NVVKLLGSCLEVEVPL--LVYEFIPNGTLFQYLHDPSEEL----------SLTWEMRLRI 486
NVV L+ LE L++++ + L+Q + + SL W
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLW------ 115
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSI--AIDQTH 540
++ + YLHS+ + HRD+K NIL+ E+ KI D G +R +
Sbjct: 116 --QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 541 VSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPI 585
V T Y PE ++ +T D+++ G + ELLT +PI
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 390 LGQGGQGTVYKGMLAD-GRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGS 446
+G+G GTV+K + I+A+K+ ++ DE + E+ +L ++ H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLH------DPSEELSLTWEMRLRIATEVAEALAYLHSS 500
+ LV+E+ + L +Y DP S +++ L+ LA+ HS
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL-LK-------GLAFCHSH 118
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
L HRD+K N+L+++ K+ADFG +R+ I S +V T Y P+ +
Sbjct: 119 NVL---HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 174
Query: 561 QFTDKS-DVYSFGVVLVELLTGQKPI 585
+ S D++S G + EL +P+
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 390 LGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVVKLLGSC 447
LG+G TVYKG +G+++A+K ++ +E I E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 448 LEVEVPLLVYEFIPNGTLFQY-------LHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
E LV+E++ + L QY LH + +L L +R L+Y+H
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR---------GLSYIHQR 122
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHS 559
I HRD+K N+L+ + K+ADFG +R+ ++ S +V T Y P+ S
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGS 178
Query: 560 SQFTDKSDVYSFGVVLVELLTG 581
++++ D++ G + VE++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 39/215 (18%)
Query: 389 ILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVKLL 444
I+G+GG G VY AD G++ A+K K ++ + +NE ++LS +S
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-------T 53
Query: 445 GSCLEVEVPLLV---YEF-----------IPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
G C P +V Y F + NG Y H + EMR A E+
Sbjct: 54 GDC-----PFIVCMSYAFHTPDKLSFILDLMNGGDLHY-HLSQHGVFSEAEMRF-YAAEI 106
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
L ++H+ + +RD+K NILLDE +I+D G + + + H S GT G
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHG 160
Query: 551 YLDPEYFHSSQFTDKS-DVYSFGVVLVELLTGQKP 584
Y+ PE D S D +S G +L +LL G P
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 20/237 (8%)
Query: 388 RILGQGGQGTVYKGML-ADGRIIA---VKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
R++G+G V L RI A +KK V D+ ++ E + S+ +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 444 LGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
L SC + E L V EF+ G L ++ + L E + E++ AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
I +RD+K N+LLD + K+ D+G + I ++ GT Y+ PE +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 563 TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD-ILDDQVR 618
D ++ GV++ E++ G+ P + ++ + T E+ LF IL+ Q+R
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT-------EDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 80/255 (31%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 360 NSLDGSIDR-CKIFNSK-ELDKATDH-----FNVNRILGQGGQGTV-YKGMLADGRIIAV 411
S D I R C+ F D+AT + ++R+LG G GTV ++DG AV
Sbjct: 3 ASGDAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAV 62
Query: 412 KKSKVVD-ESKLEEFIN----EVVILSQISHRNVVKLLGSCLE------------VEVPL 454
K VVD E E N EV L ++VK C E V +
Sbjct: 63 K---VVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK----CHEDFAKKDPRNPENVLMIA 115
Query: 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYLHSSAYLPIYHRDIKST 513
LV ++ G L Q + ++ E + +V A+ ++HS + HRDIKS
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMI---HRDIKSA 172
Query: 514 NILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG----YLDPEYFHSSQFTDKSDVY 569
NILL K+ DFG S+ A VS V TF Y+ PE + ++ K+D++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYA---ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 570 SFGVVLVELLTGQKP 584
S GV+L ELLT ++P
Sbjct: 230 SLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 46/235 (19%)
Query: 372 FNSKELDKAT----DHFNVNRILGQGGQGTVYKGMLADGRI-IAVKKSKVVDESKLEEF- 425
F +EL+K D + +G G G V +A+KK +S
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHA 58
Query: 426 ---INEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL--FQ--YLHDPSEELSL 478
E+ +L + H NV+ LL +V F P +L FQ YL L
Sbjct: 59 KRTYRELRLLKHMDHENVIGLL------DV------FTPASSLEDFQDVYLVTHLMGADL 106
Query: 479 TWEMRLR---------IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529
++ + + ++ L Y+HS+ I HRD+K +NI ++E KI DFG
Sbjct: 107 NNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163
Query: 530 TSRSIAIDQT-HVSTKVQGTFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
+R + T +V+T+ Y PE + + D++S G ++ ELLTG+
Sbjct: 164 LARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 10/205 (4%)
Query: 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQISHRN 439
F R+LG+GG G V + A G++ A KK K + + K E +NE IL +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
VV L + + LV + G L ++++ + + A E+ L L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQR 120
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
I +RD+K NILLD++ +I+D G + I +T V +V GT GY+ PE ++
Sbjct: 121 ER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
++T D + G ++ E++ GQ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP--NGTLFQYLHDPSEELSLTWEMRLR 485
E ++L ++H +V+++ + + + +V +P + L+ YL S L + + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPI--DQALI 161
Query: 486 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 545
I ++ E L YLH+ I HRD+K+ NI +++ + I D G ++ + + +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELL 579
GT PE ++ K+D++S G+VL E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 394 GQGTVYKGML----ADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVKLLGS 446
G+GT K +L A G+ A+K K ++ + ++ + E +L H + L S
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLHSSAYLPI 505
+ V E+ G LF +L S E + E R R E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHL---SRERVFS-EDRARFYGAEIVSALGYLHSCD---V 116
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDK 565
+RD+K N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 566 SDVYSFGVVLVELLTGQKP 584
D + GVV+ E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 39/300 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHRN 439
D F LG G G V+K +I +K + + + I E+ +L + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+V G+ + E + G+L Q L + ++ +++ V + L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 121
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
I HRD+K +NIL++ + K+ DFG S + ID ++ GT Y+ PE
Sbjct: 122 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPERLQG 176
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPISYIWANE-------------------------GR 594
+ ++ +SD++S G+ LVE+ G+ PI A E GR
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236
Query: 595 NLATYFVECVEENCLFDILDDQVRK-SGKTEEIM---EVSDVAKRCLNSNGRSRPTMKEV 650
L++Y + +F++LD V + K + E D +CL N R +K++
Sbjct: 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL 296
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 394 GQGTVYKGML----ADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVKLLGS 446
G+GT K +L A GR A+K K ++ + ++ + E +L H + L +
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ V E+ G LF +L S E T E E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VV 117
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKS 566
+RDIK N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 567 DVYSFGVVLVELLTGQKP 584
D + GVV+ E++ G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 58/232 (25%)
Query: 384 FNVNRILGQGGQGTVYKGMLAD---GRIIAVKKSKVVDESKLEEFIN---------EVVI 431
+ + + LG+G G V+K + D ++A+KK + D F N E++
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKK--IFDA-----FRNATDAQRTFREIMF 59
Query: 432 LSQIS-HRNVVKLLGSCLEVEVPL---LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
L ++ H N+VKLL + ++ E LV+E++ E L +R I
Sbjct: 60 LQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM--------------ETDLHAVIRANIL 104
Query: 488 TEV---------AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA--- 535
+V +AL Y+HS + HRD+K +NILL+ R K+ADFG +RS++
Sbjct: 105 EDVHKRYIMYQLLKALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 536 -IDQTHVSTKVQGTFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ V T T Y PE S+++T D++S G +L E+L G KP+
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 31/226 (13%)
Query: 375 KELDKATDHFNVNRILGQGGQGTV----YKGMLADGRIIAVK---KSKVVDESKLEEFIN 427
++L + ++V +++G+G G V +K + ++ A+K K +++ S F
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEELSLTWEMRLR 485
E I++ + VV+L + + + +V E++P G L + +D E+ + +
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY----- 147
Query: 486 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT---HVS 542
EV AL +HS + + HRD+K N+LLD+ K+ADFGT + +D+T
Sbjct: 148 -TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCD 201
Query: 543 TKVQGTFGYLDPEYFHSS----QFTDKSDVYSFGVVLVELLTGQKP 584
T V GT Y+ PE S + + D +S GV L E+L G P
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546
A E+ L +LHS I +RD+K NILLD KIADFG + + T
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FC 157
Query: 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
GT Y+ PE ++ D +SFGV+L E+L GQ P
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 390 LGQGGQGTVYKGM---LADGRIIAVKKS--KVVDESK---LEEFINEVVILSQISHRNVV 441
LGQG ++KG+ + D + + KV+D+S E F ++SQ+SH+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
G C+ + ++V E++ G+L YL ++++W +L +A ++A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD------PE 555
+ H ++ + N+LL R + G I + +S V L+ PE
Sbjct: 121 ---LTHGNVCAKNVLL---IREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 556 YFHSSQ-FTDKSDVYSFGVVLVELLTG-QKPIS 586
+ Q + +D +SFG L E+ +G KP+S
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 390 LGQGGQGTVYK-GMLADGRIIAVKK--SKVVDESKLEEF-INEVVILSQISHRNVVKLLG 445
LG+GG G V + A G++ A KK K + + K E+ +NE IL ++S R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLHSSAYLP 504
E + L + + NG +Y H + E R A ++ L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKY-HIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RR 115
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD 564
I +RD+K N+LLD+ +I+D G + + + + GT GY+ PE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRA-GTPGYMAPEVLQGEVYDF 173
Query: 565 KSDVYSFGVVLVELLTGQKP 584
D ++ G L E++ G+ P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 389 ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVKL 443
+GQG G V+K +I+A+KK + +E E F + E+ IL + H NVV L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 76
Query: 444 LGSCLEVEVP--------LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+ C P LV+EF + L L + + + +L+ E++ ++ + L
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS-EIK-KVMKMLLNGLY 133
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI---DQTHVSTKVQGTFGYL 552
Y+H + I HRD+K+ NIL+ + K+ADFG +R+ ++ + + T T Y
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 553 DPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE + D++ G ++ E+ T + PI
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 390 LGQGGQGTVYKGMLADGRIIA--VKKSKVVDESKLEE--FINEVVILSQISHRNVVKLLG 445
+G G G V G + G A V K V S E+ F+ E + H N+++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL--RIATEVAEALAYLHSSAYL 503
C EV LLV EF P G L YL + +T + R+A E+A L +LH + ++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRS-------IAIDQTHVSTKVQGTFGYLDPEY 556
H D+ N LL KI D+G S + + DQ V + ++ PE
Sbjct: 123 ---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR------WIAPEL 173
Query: 557 F---HSSQF----TDKSDVYSFGVVLVELLT-GQKP 584
H + T +S+V+S GV + EL G +P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 53/188 (28%), Positives = 95/188 (50%), Gaps = 26/188 (13%)
Query: 474 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533
+EL+L E L + +VA+ +++L S + HRD+ + NILL KI DFG +R
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARD 263
Query: 534 IAIDQTHVSTKVQGT----FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYI 588
I D +V V+G ++ PE + +T +SDV+S+G++L E+ + G P
Sbjct: 264 IRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-- 318
Query: 589 WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648
G + + F + ++E + +L + S E+ D+ K C +++ RPT K
Sbjct: 319 ----GMPVDSKFYKMIKEG--YRMLSPECAPS-------EMYDIMKSCWDADPLKRPTFK 365
Query: 649 EVAMELER 656
++ +E+
Sbjct: 366 QIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 390 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFIN-----EVVILSQISHRNVVKL 443
+G+G G V+K + G+I+A+KK ES+ + I E+ +L Q+ H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK---FVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 444 LGSCLEVEV------PLLVYEFIPN---GTLFQYLHDPSEEL--SLTWEMRLRIATEVAE 492
+ EV LV+E+ + L + E L + W+ +
Sbjct: 66 I------EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQ 111
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
A+ + H + HRD+K NIL+ ++ + K+ DFG +R I T T Y
Sbjct: 112 AVNFCHKHNCI---HRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYR 167
Query: 553 DPEYF-HSSQFTDKSDVYSFGVVLVELLTGQ 582
PE +Q+ DV++ G V ELLTGQ
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 17/234 (7%)
Query: 361 SLDGSIDRCK--IFNSKELDKATDHFNVNRILGQGGQGTV----YKGMLADGRIIAVKKS 414
++D ++R K I ++L + + V +++G+G G V +K + + K
Sbjct: 20 NIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 79
Query: 415 KVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE 474
+++ S F E I++ + VV+L + + +V E++P G L + +
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--Y 137
Query: 475 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534
++ W R A EV AL +HS ++ HRD+K N+LLD+ K+ADFGT +
Sbjct: 138 DVPEKWA-RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 535 AIDQTHVSTKVQGTFGYLDPEYFHSS----QFTDKSDVYSFGVVLVELLTGQKP 584
+ GT Y+ PE S + + D +S GV L E+L G P
Sbjct: 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 42/214 (19%)
Query: 388 RILGQGGQGT---VYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-------S 436
+ILG+ G+GT V K G+ A+K K +S + +V L +I
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-----LEQVNNLREIQALRRLSP 56
Query: 437 HRNVVKLLGSCLEVEVPL--------LVYEFIPNGTLFQYLHDPSEELSLTWEMRLR-IA 487
H N+++L +EV LV+E + + L++ + L E R++
Sbjct: 57 HPNILRL------IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP---EKRVKSYM 106
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
++ ++L ++H + I+HRDIK NIL+ K+ADFG+ R I + T+
Sbjct: 107 YQLLKSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPY--TEYIS 160
Query: 548 TFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLT 580
T Y PE + + K D+++ G V E+L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 394 GQGTVYKGML----ADGRIIA---VKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGS 446
G+GT K +L A GR A +KK +V + ++ + E +L H + L S
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ V E+ G LF +L S E + + E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEK--NVV 118
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKS 566
+RD+K N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 177
Query: 567 DVYSFGVVLVELLTGQKP 584
D + GVV+ E++ G+ P
Sbjct: 178 DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEE-------FINEVVILSQISHRNVV 441
LG+G TVYKG G+++A+K E +LE I E +L + H N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK------EIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT-EVAEALAYLHSS 500
L + LV+E++ + L QY+ D LS+ +R+ ++ LAY H
Sbjct: 67 TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH---NVRLFLFQLLRGLAYCHQR 122
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHS 559
L HRD+K N+L+ E+ K+ADFG +R+ ++ S +V T Y P+ S
Sbjct: 123 RVL---HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGS 178
Query: 560 SQFTDKSDVYSFGVVLVELLTGQ 582
++++ D++ G + E+ TG+
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 67/242 (27%), Positives = 99/242 (40%), Gaps = 50/242 (20%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
HF ++LG+G G V+ L G++ A+K K +++ +K++ + E IL+ + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH-DPSEELSLTWEMRLRI-ATEVAEALA 495
+ L S LV ++ P G LF+ L P + LS E R A EV AL
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS---EEVARFYAAEVLLALE 117
Query: 496 YLHSSAYLPIYHRDIKSTNILLDE-------------------KYRAKIADFGTSRSIAI 536
YLH +Y RD+K NILL E +K G+ RS
Sbjct: 118 YLHLLGI--VY-RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 537 DQTHVSTKVQ----------GTFGYLDPE----YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
T + GT Y+ PE H S D ++ G++L E+L G
Sbjct: 175 SIPS-ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGT 229
Query: 583 KP 584
P
Sbjct: 230 TP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 28/192 (14%)
Query: 410 AVKKSKVV-------DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462
+ K KVV DE + +E+ L+ H +VK + LL+ E+
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 463 GTLFQYL------HDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 516
G L + + H P +E +E+ L + ++ AL +HS + HRD+KS NI
Sbjct: 150 GDLNKQIKQRLKEHLPFQE----YEVGL-LFYQIVLALDEVHSRKMM---HRDLKSANIF 201
Query: 517 LDEKYRAKIADFGTSR----SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFG 572
L K+ DFG S+ S+++D V++ GT YL PE + +++ K+D++S G
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 573 VVLVELLTGQKP 584
V+L ELLT +P
Sbjct: 259 VILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 31/223 (13%)
Query: 390 LGQGGQGTVYKGML---ADGRIIA-VKKSKVV------DESKLEEFINEVVILSQISHRN 439
LGQG +YKG+L +D I+ ++ VV D F ++SQ+SH++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+VKL G C+ E ++V E++ G L +LH +SL W +L +A ++A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 500 SAYLPIYHRDIKSTNILL-----DEKYR--AKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
+ H ++ NIL+ +E Y K++D G ++ + V ++
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 553 DPEYFH--SSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592
PE + T +D +SFG L+E+ + G++P+S + ++E
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 428 EVVILSQISHRNVVKLL-----GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEM 482
E+ IL ISHR ++ L+ S + + +P + LF Y+ D S L L E
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD------LFTYV-DRSGPLPL--EQ 186
Query: 483 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542
+ I + EALAYLH I HRD+K+ NI LDE A + DFG + +D +
Sbjct: 187 AITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPDT 241
Query: 543 TKVQGTFGYLD---PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ G G L+ PE + K+D++S G+VL E+ +
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 66/256 (25%), Positives = 108/256 (42%), Gaps = 62/256 (24%)
Query: 382 DHFNVNRILGQGGQGTV-YKGMLADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ F+ +++G+G G V G+I A+K KS++ + +L E +L++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDP-SEELSLTWEMRLRIATEVAEAL 494
VV L S + + L+ EF+P G L L +D SE+++ R +A E A+
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT-----RFYMA-ECVLAI 114
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----------------------- 531
+H ++ HRDIK NIL+D K++DFG S
Sbjct: 115 EAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 532 -----RSIAIDQTH--VSTKVQ----------------GTFGYLDPEYFHSSQFTDKSDV 568
S+A+D + +S+K Q GT Y+ PE F + + D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 569 YSFGVVLVELLTGQKP 584
+S G ++ E L G P
Sbjct: 232 WSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLR-IATEVAEALA 495
+ N +KL S ++ +L+ ++I +G LF L +E L+ E ++ I ++ EAL
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLS-EAEVKKIIRQLVEALN 123
Query: 496 YLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
LH + H DIK N+L D K R + D+G + I + GT Y P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 555 EYFHSSQFTDKS-DVYSFGVVLVELLTGQKP 584
E D S D ++ GV+ ELLTG+ P
Sbjct: 176 EKI-KGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 81/338 (23%), Positives = 118/338 (34%), Gaps = 86/338 (25%)
Query: 382 DHFNVNRILGQGGQGTV--------YKGMLADGRIIAVKKSKV-VDESKLEEFINEVVIL 432
D + ++LG G G V K + +AVK K S+ + ++E+ IL
Sbjct: 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCN--TVAVKMLKEGATASEHKALMSELKIL 64
Query: 433 SQI-SHRNVVKLLGSCLEVEVPLLV-YEFIPNGTLFQYLH------DPSEELSLTWEMRL 484
I +H NVV LLG+C + PL+V EF G L +L P E S R
Sbjct: 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRF 124
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKST------------------------------- 513
R E + + + ++ R ST
Sbjct: 125 RAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVA 184
Query: 514 -------------------NILLDEKYRAKIADFGTSRSIAIDQTHVST-KVQGTFGYLD 553
NILL E KI DFG +R I D +V + ++
Sbjct: 185 RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612
PE +T +SDV+SFGV+L E+ + G P + N EE C
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------------EEFC--QR 289
Query: 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
L D R E+ + C + + RPT +
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 44/189 (23%), Positives = 84/189 (44%), Gaps = 24/189 (12%)
Query: 473 SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532
+E +L++ + + +VA + +L S + HRD+ + N+L+ E KI DFG +R
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLAR 287
Query: 533 SIAIDQTHVSTKVQGTF---GYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYI 588
I D ++S TF ++ PE ++ +T SDV+SFG++L E+ T G P +
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
Query: 589 WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648
NE ++ + R + E+ ++ ++C RP
Sbjct: 346 PMNE---------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS 390
Query: 649 EVAMELERI 657
++ + +
Sbjct: 391 QLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKS--KVVDESKLEEFINEVVILSQISHRNVVKLLG 445
+ + K ++AVKK + L+ E++ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYL--HDPS--EELSLTWEMRLRIATEVAEALAYLHSSA 501
S + +V + G+ L H P EL++ + ++ +V AL Y+HS
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKG 121
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI---------AIDQTHVSTKVQGTFGYL 552
++ HR +K+++ILL + ++ S S+ D S K +L
Sbjct: 122 FI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WL 175
Query: 553 DPEYFHSS--QFTDKSDVYSFGVVLVELLTGQKPIS 586
PE + + +KSD+YS G+ EL G P
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKL-EEFINEVVILSQISHRN 439
+ +G+G G V G +A+KK + + + E+ IL + H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 440 VVKLL-----GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS------LTWEMRLRIAT 488
++ +L S +V E + L++ + ++ LS +++ LR
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQI-LR--- 117
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS--TKVQ 546
L Y+HS+ L HRD+K +N+LL+ KI DFG +R + H T+
Sbjct: 118 ----GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 547 GTFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
T Y PE +S +T D++S G +L E+L+ +P+
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 64/250 (25%), Positives = 103/250 (41%), Gaps = 59/250 (23%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
D F +++G+G G V D G I A+K KS+++++ ++ E IL++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE------VA 491
VVKL S + L+ E++P G + L M+ TE +A
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL------------MKKDTFTEEETRFYIA 108
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG---------------------T 530
E + + S L HRDIK N+LLD K K++DFG
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 531 SRSIAIDQTHVSTKVQ----------------GTFGYLDPEYFHSSQFTDKSDVYSFGVV 574
S + +S+K + GT Y+ PE F + + + D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 575 LVELLTGQKP 584
+ E+L G P
Sbjct: 229 MYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 66/251 (26%), Positives = 122/251 (48%), Gaps = 25/251 (9%)
Query: 346 NFKKNGGLLLEQQL---NSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGM 402
F+ N L E++ N+ D K+ ++ + + I+G G G VY+ +
Sbjct: 27 KFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAI 86
Query: 403 LAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL----LGSCL---EVEVPL 454
D +A+KK V+ + + + E++I+ ++H N++ L C E + L
Sbjct: 87 CIDTSEKVAIKK--VLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142
Query: 455 -LVYEFIPNGTLFQYL-HDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512
+V EFIP T+ +Y+ H +L + + ++ ALAY+HS I HRD+K
Sbjct: 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKP 198
Query: 513 TNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHSSQFTDKSDVYS 570
N+L+D + K+ DFG+++++ Q VS + F Y PE ++ +T D++S
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWS 256
Query: 571 FGVVLVELLTG 581
G ++ E++ G
Sbjct: 257 LGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HR 438
+D + + +G+G G V+K + +G AVK + + EE E IL +S H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 439 NVVKLLGSCLEVEVP-----LLVYEFIPNGTL------FQYLHDPSEELSLTWEMRLRIA 487
NVVK G + +V LV E G++ F + EE + + I
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----IL 130
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
E L +LH + + HRD+K NILL + K+ DFG S + + +T V G
Sbjct: 131 HEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 186
Query: 548 TFGYLDPEYFHSSQFTDKS-----DVYSFGVVLVELLTGQKPIS 586
T ++ PE Q D + DV+S G+ +EL G P++
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYK-GMLADGRIIAVKKSKVVDESKLEEFINEVVILS 433
+ L TD + + +G+G G VYK DG + AVK + + EE E IL
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQ 73
Query: 434 QIS-HRNVVKLLGSCLEVEVPL-----LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
+ H NVVK G + + + LV E G++ + + + L
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----------KGLLICG 122
Query: 488 TEVAEAL-AYLHSSAYL--------PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538
+ EA+ +Y+ A L I HRD+K NILL + K+ DFG S + +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 539 THVSTKVQGTFGYLDPEYFHSSQFTDKS-----DVYSFGVVLVELLTGQKPI 585
+T V GT ++ PE Q D S DV+S G+ +EL G P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 52/188 (27%), Positives = 81/188 (43%), Gaps = 22/188 (11%)
Query: 471 DPSE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528
+ E + LT E + + +VA + +L S + HRD+ + NILL E KI DF
Sbjct: 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDF 217
Query: 529 GTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPIS 586
G +R I D +V + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 218 GLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
Query: 587 YIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT 646
+ + EE C L + R E+ + C ++N RPT
Sbjct: 278 GVQID-------------EEFC--RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322
Query: 647 MKEVAMEL 654
E+ L
Sbjct: 323 FSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 44/241 (18%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
D F +++G+G G V D G I A+K K+ ++++ ++ E IL +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
VVK+ S + L+ EF+P G + L +L+ E E A+ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAI 117
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFG---------------------------- 529
H ++ HRDIK N+LLD K K++DFG
Sbjct: 118 HQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 530 ------TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQK 583
+ + ++ ++ GT Y+ PE F + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 584 P 584
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 26/178 (14%)
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543
LR +++VA+ + +L S + HRD+ + N+LL + AKI DFG +R I D +V
Sbjct: 215 LRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-- 269
Query: 544 KVQGT----FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLAT 598
V+G ++ PE +T +SDV+S+G++L E+ + G+ P I N
Sbjct: 270 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------- 321
Query: 599 YFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656
+ + ++ + S E+ + K C N RPT +++ ++R
Sbjct: 322 --------SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHRNVVKLL 444
+ +G G QG V G +AVKK +++ + E+V+L ++H+N++ LL
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 445 G------SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
S E + LV E + + L Q +H + L E + ++ + +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH 140
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
S+ I HRD+K +NI++ KI DFG +R+ + + T T Y PE
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVIL 195
Query: 559 SSQFTDKSDVYSFGVVLVELLTG 581
+ + D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 516
Y+ + + L D E LT L +VA + +L S + HRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSE-GLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVL 269
Query: 517 LDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF---GYLDPEYFHSSQFTDKSDVYSFGV 573
L + KI DFG +R I D +VS TF ++ PE + +T SDV+S+G+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 574 VLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDV 632
+L E+ + G P + + ++ ++ + R + EV D+
Sbjct: 328 LLWEIFSLGGTP---------------YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 633 AKRCLNSNGRSRPTMKEVAMELERI 657
+C NS RP+ ++ +E +
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+AE + +HS L HRDIK N+LLD ++ADFG+ + D T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 550 GYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKP 584
Y+ PE + ++ + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (144), Expect = 4e-09
Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 419 ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLVYEFIPNGTLFQYLHDPSEEL 476
E + + + EV ++ ++ H+N+V+ + L + ++ EF G L + + +
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 477 SLTWEMRL-RIATEVAEALAYLHSSAYLP----IYHRDIKSTNILLDEKYR--------- 522
E + I ++ ALAY H+ P + HRD+K NI L R
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 523 --------AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF--HSSQFTDKSDVYSFG 572
AKI DFG S++I I+ ++ GT Y PE + + DKSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 573 VVLVELLTGQKP 584
++ EL +G+ P
Sbjct: 231 CIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 390 LGQGGQGTVYK-GMLADGRIIAVKK--SKVVDESK-LEEFINEVVILSQISHRNVVKLLG 445
LG+GG G V M A G++ A KK K + + K E + E IL+++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 446 SCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMR-LRIATEVAEALAYLHSSAYL 503
+ + L LV + G L ++++ EE E R ++ L +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-VQGTFGYLDPEYFHSSQF 562
I +RD+K N+LLD +I+D G + + Q+ TK GT G++ PE ++
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEY 174
Query: 563 TDKSDVYSFGVVLVELLTGQKP 584
D ++ GV L E++ + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 390 LGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVKLLG 445
+G+G G VY+ D RI A+K K ++V + ++ I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 446 SCLEVEVP---LLVYEFIPNGTLFQYL-HDPSEELSLTWEMRLRI-ATEVAEALAYLHSS 500
+ LV +++ G LF +L + E R + E+ AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-----EDRAKFYIAELVLALEHLHKY 115
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHS 559
I +RD+K NILLD + DFG S++ D +T GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDE 171
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
+T D +S GV++ E+ G P
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 40/118 (33%), Positives = 61/118 (51%), Gaps = 8/118 (6%)
Query: 472 PSEELS---LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528
E+L LT E + + +VA+ + +L S + HRD+ + NILL E KI DF
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDF 223
Query: 529 GTSRSIAIDQTHVST-KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
G +R I D +V + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 224 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 382 DHFNVNRILGQG--GQGTVYKGMLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
D F + +++G+G G+ V K M G++ A+K K +++ ++ F E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
R + L + + LV ++ G L L + L +M E+ A+
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE--DMARFYLAEMVLAIDS 117
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
+H Y+ HRDIK N+LLD+ ++ADFG+ + D T S GT Y+ PE
Sbjct: 118 VHQLGYV---HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 557 FHS-----SQFTDKSDVYSFGVVLVELLTGQKP 584
+ ++ + D +S GV + E+L G+ P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKL-EEFINEVVILSQISHRNVVKLL 444
+G G G V + G+ +A+KK D L + + E+ IL H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 445 GSCLEVEVPL-----LVYEFIPNGTLFQYLHDPSEELSLTWEMR------LRIATEVAEA 493
L +V + + + L +H + L+ +R LR
Sbjct: 71 -DILRPPGADFKDVYVVMDLMES-DLHHIIHS-DQPLTEE-HIRYFLYQLLR-------G 119
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA---IDQTHVSTKVQGTFG 550
L Y+HS+ + HRD+K +N+L++E +I DFG +R ++ + + T+ T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 551 YLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
Y PE ++T D++S G + E+L G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 67/287 (23%), Positives = 126/287 (43%), Gaps = 50/287 (17%)
Query: 390 LGQGGQGTVYKGMLA-----DGRIIAVKKS-----KVVDESKLE---EFINEVVILSQIS 436
LG+G + +Y G+L + + +K KV+D S + F ++ Q+S
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H+++V L G C+ ++V EF+ G L ++H S+ L+ W + ++A ++A AL+Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 497 LHSSAYLPIYHRDIKSTNILL-----DEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTF 549
L + H ++ + NILL D + K++D G ++ Q V
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RI 172
Query: 550 GYLDPEYFHSSQ-FTDKSDVYSFGVVLVEL-LTGQKPISYIWANEGRNLATYFVECVEEN 607
++ PE S+ + +D +SFG L E+ G+ P+ + + LA E E
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL------KDKTLAEK--ERFYEG 224
Query: 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654
+ T E++D+ C+N + RP + + ++
Sbjct: 225 QCMLV----------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---TF 549
L Y+HS+ L HRD+K N+L++ KI DFG +R + + + + T
Sbjct: 117 GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 550 GYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPI 585
Y PE S Q +T DV+S G +L ELL G+KP+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 390 LGQGGQGTVYKGMLADGRIIA---VKKSKVVDESK-LEEFINEVVILSQISHRNVVKLLG 445
+G G G V + +A VK+ K SK EF+ + + H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAEALAYLHSSAYLP 504
C+E LLV+E+ G L YL + + L R+A E+A + ++H +L
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL- 121
Query: 505 IYHRDIKSTNILLDEKYRAKIADFGTSRS-IAIDQTHVSTKVQGTFGYLDPEY---FH-- 558
H D+ N L K+ D+G S D +L PE FH
Sbjct: 122 --HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 559 --SSQFTDKSDVYSFGVVLVELL 579
+++ T S+V++ GV L EL
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 44/241 (18%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ F +++G+G G V D G + A+K K+ ++++ ++ E IL +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
VVK+ S + L+ EF+P G + L +LT E E A+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSI 117
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFG----------------TSRSIAIDQT-- 539
H ++ HRDIK N+LLD K K++DFG + S+ D T
Sbjct: 118 HQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 540 ----------------HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQK 583
++ GT Y+ PE F + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 584 P 584
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR-IIAVKKSKVVDESK--LEEFINEVVILSQISHR 438
+ F V ++G+G G V K + + I+A+KK K +E++ E + E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 439 NVVKLLGSCLEVEVPLLVYEFI-----------PNGTLFQYLHDPSEELSLTWEMRLRIA 487
N+V+L + LV+E++ PNG P + S +++
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP------PEKVRSYIYQL----- 109
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
+A+ + H + I HRDIK N+L+ K+ DFG +R+++ T+
Sbjct: 110 ---IKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA 163
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
T Y PE + + D++S G +L EL GQ
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADG-RIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ F + +++G+G G V L + ++ A+K K +++ ++ F E +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+ + L + + LV ++ G L L + L +M E+ A+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP--EDMARFYLAEMVIAIDSV 118
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
H Y+ HRDIK NIL+D ++ADFG+ + D T S+ GT Y+ PE
Sbjct: 119 HQLHYV---HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 558 HS-----SQFTDKSDVYSFGVVLVELLTGQKP 584
+ ++ + D +S GV + E+L G+ P
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
L YLHS+ I HRDIK N+L++ KI DFG +R D++ T+ T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 554 PEYFHSSQ-FTDKSDVYSFGVVLVELLTGQ 582
PE S+ +T D++S G + ELL +
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 39/160 (24%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 427 NEVVILSQISHRNVVKL---LGSCLEVEVPLLVYEFIPNGTLFQYLHDPS---EELSLTW 480
NE++ L +++H N++K+ L S + Y+F L+ +++D + ++ L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267
Query: 481 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540
+ R I ++ A+ Y+H + HRDIK NI L+ + + DFGT+ ++
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580
GT PE + + +D++S G++L+++L+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKL--EEFINEVVILSQISHRNVVKLLGS 446
+G G G+V + G +A+KK +S++ + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 447 CLEVEVPLLVYEFIPNGTLFQ--YLHDPSEELSLTWEMRLRIATEVAE--------ALAY 496
+V +G FQ YL P + L M ++ + + L Y
Sbjct: 81 --DVFTSA------VSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPE 555
+HS+ I HRD+K N+ ++E KI DFG +R + T +V T+ Y PE
Sbjct: 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184
Query: 556 YFHS-SQFTDKSDVYSFGVVLVELLTGQ 582
+ + D++S G ++ E+LTG+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
++ L Y+HS+ + HRD+K +NIL++E KI DFG +R Q T T
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVST 168
Query: 549 FGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPI 585
Y PE + Q + + D++S G + E+L G KP+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 61/251 (24%), Positives = 96/251 (38%), Gaps = 58/251 (23%)
Query: 383 HFNVNRILGQGGQGTVYKGMLADGRII-AVK---KSKVVDESKLEEFINEVVILSQISHR 438
F + +G G G V D + A+K K+ V+ ++ E IL++ +
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPS---EELSLTWEMRLRIATEVAEALA 495
VVKL S + + V ++IP G + L E+L+ R IA E+ A+
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-----RFYIA-ELTCAIE 115
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG-------------------------- 529
+H ++ HRDIK NIL+D K+ DFG
Sbjct: 116 SVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 530 ---------TSRSIAIDQTHV--STKVQ-----GTFGYLDPEYFHSSQFTDKSDVYSFGV 573
R +++ + GT Y+ PE + +T D +S GV
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232
Query: 574 VLVELLTGQKP 584
+L E+L GQ P
Sbjct: 233 ILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS---TKVQGTF 549
AL Y+H++ ++HRD+K NIL + + KI DFG +R +A + T + T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATR 170
Query: 550 GYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPI 585
Y PE S S++T D++S G + E+LTG KP+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 47/218 (21%)
Query: 390 LGQGGQGTVYKGMLADGRI---IAVKKSKVVDESKL--EEFINEVVILSQISHRNVVKLL 444
+G G GTV + D R +A+KK +S+L + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 445 GSCLEVEVP----------LLVYEFIPN--GTLFQYLHDPSEELSLTWEMRLR-IATEVA 491
+V P LV F+ G L ++ E+LS E R++ + ++
Sbjct: 81 ----DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----EKLS---EDRIQFLVYQML 128
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---T 548
+ L Y+H++ I HRD+K N+ ++E KI DFG +R +++ G T
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVT 178
Query: 549 FGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPI 585
Y PE + +T D++S G ++ E+LTG KP+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 390 LGQGGQGTV---YKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHRNVVKLL 444
+G G QG V Y +L R +A+KK +++ + E+V++ ++H+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSE----ELSLTWEMRLRIATEVAEALAYLHSS 500
V P E + L L D + ++ L E + ++ + +LHS+
Sbjct: 83 ----NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
I HRD+K +NI++ KI DFG +R+ + + T T Y PE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGM 193
Query: 561 QFTDKSDVYSFGVVLVELL 579
+ + D++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 32/229 (13%)
Query: 371 IFNSKELDKAT----DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKL--E 423
F +EL+K + + +G G G+V G +AVKK +S + +
Sbjct: 2 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 61
Query: 424 EFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL-----HDPSEELSL 478
E+ +L + H NV+ LL +V P E + L +L ++ + L
Sbjct: 62 RTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538
T + + ++ L Y+HS+ I HRD+K +N+ ++E KI DFG +R +
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 174
Query: 539 T-HVSTKVQGTFGYLDPE----YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
T +V+T+ Y PE + H +Q D++S G ++ ELLTG+
Sbjct: 175 TGYVATR-----WYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
L Y+HS+ L HRD+K +N+LL+ KI DFG +R+ + ++ V T Y
Sbjct: 121 LKYIHSANVL---HRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176
Query: 554 PE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE + S++T DV+S G + ELL G+KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 390 LGQGGQGTV---YKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHRNVVKLL 444
+G G QG V Y +L R +A+KK +++ + E+V++ ++H+N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 445 G------SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
S E + +V E + + L Q + ++ L E + ++ + +LH
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
S+ I HRD+K +NI++ KI DFG +R+ + + T T Y PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 198
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQ 582
+ + D++S G ++ E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 13/160 (8%)
Query: 426 INEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP--NGTLFQYLHDPSEELSLTWEMR 483
E IL I+H ++++L G+ + L+ +P L+ YL + + ++
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYL---AAKRNIAICDI 184
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS-RSIAIDQTHVS 542
L I V A+ YLH + I HRDIK+ NI ++ + DFG + + I+
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
GT PE + D++S G+VL E+ T
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 14/145 (9%)
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
N+V L + + LV + G L+ ++ S+ L++ E R A E+ AL LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI---SKFLNIPEECVKRWAAEMVVALDALH 102
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA--IDQTHVSTKVQGTFGYLDPEY 556
I RD+ NILLD++ ++ F + D V Y PE
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTG 581
S+ T+ D +S G +L ELLTG
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 390 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVV------ILSQISHRNVVK 442
LG+GG G V + + G++ A KK +D+ +L++ E + IL +++ +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
L E + L + + NG +Y E L E + + ++ + +LHS
Sbjct: 58 L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562
+ I +RD+K N+LLD++ +++D G + + + T+ GT GY+ PE +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 563 TDKSDVYSFGVVLVELLTGQKP 584
+ D ++ G + E++ G+ P
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVV---KLLG 445
+G+G G VYK DG+ K ++ + + E+ +L ++ H NV+ K+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYL--HDPSEE----LSLTWEMRLRIATEVAEALAYLHS 499
S + +V LL +++ + L+ + H S+ + L M + ++ + + YLH+
Sbjct: 69 SHSDRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 500 SAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVST--KVQGTFGYLD 553
+ L HRD+K NIL+ E+ R KIAD G +R ++ V TF Y
Sbjct: 127 NWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 554 PEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPI 585
PE ++ +T D+++ G + ELLT + PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRN 439
F + + + +G G VY G + ++ AVK K+ +++++ + + E L+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH-----DPSEELSLTWEMRLRIATEVAEAL 494
+V L S LV E++ G + LH D EM ++ +EVA AL
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKYISEVALAL 117
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532
YLH I HRD+K N+L+ + K+ DFG S+
Sbjct: 118 DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINEVVILSQISHRNVV---KLLG 445
+G+G G VYK DG+ K ++ + + E+ +L ++ H NV+ K+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYL--HDPSEE----LSLTWEMRLRIATEVAEALAYLHS 499
S + +V LL +++ + L+ + H S+ + L M + ++ + + YLH+
Sbjct: 69 SHADRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 500 SAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVST--KVQGTFGYLD 553
+ L HRD+K NIL+ E+ R KIAD G +R ++ V TF Y
Sbjct: 127 NWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 554 PEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPI 585
PE ++ +T D+++ G + ELLT + PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 58/223 (26%)
Query: 411 VKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH 470
++K V++ +++ E IL++ + VVKL S + + V ++IP G + L
Sbjct: 34 LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93
Query: 471 DPS---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527
E L+ + L +A E + ++H RDIK NIL+D K+ D
Sbjct: 94 RMEVFPEVLARFYIAELTLAIESVHKMGFIH---------RDIKPDNILIDLDGHIKLTD 144
Query: 528 FG----------------------------------------------TSRSIAIDQTHV 541
FG R+ Q +
Sbjct: 145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCL 204
Query: 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ + GT Y+ PE +T D +S GV+L E+L GQ P
Sbjct: 205 AHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 66/299 (22%), Positives = 118/299 (39%), Gaps = 62/299 (20%)
Query: 390 LGQGGQGTVYKGML-----------------------ADGRIIAVKKSKVVDESKLE--- 423
LGQG + +Y G L +GR + V KV+D S +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVV-LKVLDPSHRDIAL 61
Query: 424 EFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMR 483
F ++SQ+SH ++ + G C+ ++V EF+ +G L L + + W++
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI- 120
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543
+A ++A AL+YL + H ++ + NILL R +A+ GTS I + VS
Sbjct: 121 -TVAQQLASALSYLEDKN---LVHGNVCAKNILLA---RLGLAE-GTSPFIKLSDPGVSF 172
Query: 544 KVQG------TFGYLDPEYFHS-SQFTDKSDVYSFGVVLVEL-LTGQKPISYIWANEGRN 595
++ PE + + +D +SFG L+E+ G+ P+ +E
Sbjct: 173 TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
Query: 596 LATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654
E +C E++ + +CL RP+ + + +L
Sbjct: 233 FYEKKHRLPEPSC------------------KELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 36/116 (31%), Positives = 49/116 (42%), Gaps = 18/116 (15%)
Query: 483 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---------- 532
R+ A E AL YLH+ I HRD+K N+L+ K+ DFG S+
Sbjct: 104 RMYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 533 ---SIAIDQTHVSTK-VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
I D K V GT Y+ PE + D ++ G++L E L G P
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|219861 pfam08488, WAK, Wall-associated kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-06
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 7/86 (8%)
Query: 161 DDSCNGIECCKAGVPWALKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFK 220
+ SCNG CC+A +P +I +N +S +++ + G CK AF+ ++ + SN
Sbjct: 1 NTSCNGYGCCQARLP----VERPQVIGVNIESSDGNTTTKGG-CKVAFLTDETYSLSNVT 55
Query: 221 SARRVQNWNQVPVILDWRI--PNSSF 244
+ V L W NSSF
Sbjct: 56 EPEQFHAKGYATVELGWYFDTSNSSF 81
|
This domain is found together with the eukaryotic protein kinase domain pfam00069 in plant wall-associated kinases (WAKs) and related proteins. WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion. Length = 103 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 15/147 (10%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV--KLLG 445
++L G VY D + +K + K + EV IL ++ + + K+L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYV-LKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
S L+ E+I TL + + E+ IA ++AE LA LH L +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVL 110
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSR 532
H D+ NIL+D+ I D+ +
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 58/253 (22%), Positives = 94/253 (37%), Gaps = 68/253 (26%)
Query: 388 RILGQGGQGTVYKGMLADGRII----AVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
+ LG G G V D + + ++K V+ +++ E IL++ + VV+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE------VAEALAYL 497
S + + V ++IP G + L +R+ I E +AE +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL------------IRMGIFPEDLARFYIAELTCAV 114
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS------------------RSIAID-- 537
S + HRDIK NIL+D K+ DFG R ++D
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 538 --------------------------QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSF 571
Q ++ + GT Y+ PE + +T D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 572 GVVLVELLTGQKP 584
GV+L E+L GQ P
Sbjct: 235 GVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 50/197 (25%), Positives = 79/197 (40%), Gaps = 30/197 (15%)
Query: 406 GRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKL-----LGSCLEVEVPLLVYE 458
G ++ V+ + + E L+ NEVV+ H N++ GS L V P + Y
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY- 83
Query: 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 518
G+ L E ++ + I L YLH + Y+ HR+IK+++IL+
Sbjct: 84 ----GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILIS 135
Query: 519 EKYRAKIADF---------GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS--SQFTDKSD 567
++ G + D ST V +L PE + KSD
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGYNVKSD 192
Query: 568 VYSFGVVLVELLTGQKP 584
+YS G+ EL TG+ P
Sbjct: 193 IYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 388 RILGQGGQGTV---YKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHRNVVK 442
+ +G G QG V Y + G+ +A+KK + + + E+V++ ++H+N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 443 LLGSCLEVEVPLLVYEFIPNGTL--FQYLHDPSE----ELSLTWEMRL---RIATEVAEA 493
LL F P +L FQ ++ E L +M L R++ + +
Sbjct: 80 LLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQM 127
Query: 494 LA---YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
L +LHS+ I HRD+K +NI++ KI DFG +R A ++ V T
Sbjct: 128 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVV-TRY 182
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
Y PE + + D++S G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 372 FNSKELDKAT----DHFNVNRILGQGGQGTVYKGMLADGR-IIAVKKSKVVDESKLE--E 424
F +EL+K + + +G G G+V R +AVKK +S +
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR 60
Query: 425 FINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE-----FIPNGTLFQYLHDPSEELSLT 479
E+ +L + H NV+ LL +V P E ++ + L++ + L+
Sbjct: 61 TYRELRLLKHMKHENVIGLL----DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLS 116
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
E + ++ L Y+HS+ I HRD+K +N+ ++E +I DFG +R + T
Sbjct: 117 DEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT 173
Query: 540 -HVSTKVQGTFGYLDPE----YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
+V+T+ Y PE + H +Q D++S G ++ ELL G+
Sbjct: 174 GYVATR-----WYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 57/254 (22%), Positives = 90/254 (35%), Gaps = 70/254 (27%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDESKLEEFINEVVILSQIS 436
D F + + LG+G G VYK L + +KK+ + +E ++NE V + +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT--EYGAVEIWMNERV---RRA 186
Query: 437 HRN-VVKLLGSCLEV-----EVPL-LVYEFIPNGTLFQYLHD---------------PSE 474
N + LE E LV+ + TL +
Sbjct: 187 CPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL 246
Query: 475 ELSLTWEMRL--RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA-KIADFGTS 531
L E ++ I ++ AL LHS+ I HRD+K NI+ E + KI D G
Sbjct: 247 PKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG-- 301
Query: 532 RSIAIDQTHVSTKVQGTFGYLDP------EYFHSSQ---------------------FTD 564
A V LDP +Y S+Q D
Sbjct: 302 ---AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358
Query: 565 KSDVYSFGVVLVEL 578
+ D+YS G++ +++
Sbjct: 359 RFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 386 VNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL-- 443
+++++G GG G VY+ A I + ++ + E + E ++ + I + + L
Sbjct: 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK 75
Query: 444 -------LG-----SCLEVEVPLLVYEFIPNGTLFQYLHDPSEEL---SLTWEMRL--RI 486
LG C + + Y FI L + L + ++E+ +L I
Sbjct: 76 NIHNIDHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-TKV 545
++ L Y+H I H DIK NI++D R I D+G + I H+ +K
Sbjct: 132 MKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 546 Q-----GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVE 577
Q GT Y + + + T + D+ S G +++
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 22/114 (19%)
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD----------------EKYRAKIADF 528
+I + AL Y H+ +L H D+K NIL++ + R +I D
Sbjct: 235 QIIFQTGVALDYFHTELHL--MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
G D+ H T + T Y PE + +D++S G ++ EL TG+
Sbjct: 293 GG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 36/113 (31%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 382 DHFNVNRILGQGGQGTVYK------GMLADGRIIAVKKSKV-VDESKLEEFINEVVILSQ 434
D + + LG+G G V + A R +AVK K S+ + + E+ IL
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIH 66
Query: 435 ISHR-NVVKLLGSCLEVEVPLLV-YEFIPNGTLFQYLHDPSEELSLTWEMRLR 485
I H NVV LLG+C + PL+V E+ G L YL E S R
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTR 119
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 26/202 (12%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443
F ++R L G +G V++ D + VV ++E +L ++SH V+ L
Sbjct: 171 FAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGWYASSVHEARLLRRLSHPAVLAL 225
Query: 444 LGSCLEVEVPLLVYEFIP--NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
L + + LV +P L+ YL L L +A ++ A+ Y+H
Sbjct: 226 LDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLA--QVTAVARQLLSAIDYIHGEG 280
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGT------SRSIAIDQTHVSTKVQGTFGYLDPE 555
I HRDIK+ N+L++ + DFG S S T + GT PE
Sbjct: 281 ---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-----TPFHYGIAGTVDTNAPE 332
Query: 556 YFHSSQFTDKSDVYSFGVVLVE 577
+T D++S G+V+ E
Sbjct: 333 VLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 35/104 (33%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKG------MLADGRIIAVKKSKV-VDESKLEEFINEVVILSQ 434
D + + LG+G G V + A R +AVK K S+ ++E+ IL
Sbjct: 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 66
Query: 435 ISHR-NVVKLLGSCLEVEVPLLV-YEFIPNGTLFQYLHDPSEEL 476
I H NVV LLG+C + PL+V EF G L YL E
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.74 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.96 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.88 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.71 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.47 | |
| PLN02236 | 344 | choline kinase | 96.39 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.17 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.38 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.27 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 95.14 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.95 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.77 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.27 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 94.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.01 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.86 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.86 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.75 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.66 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.57 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=446.39 Aligned_cols=292 Identities=46% Similarity=0.735 Sum_probs=258.2
Q ss_pred cccccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEE
Q 041043 368 RCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447 (678)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 447 (678)
..+.|++++++.+|++|...++||+|+||.||+|.+++|+.||||++.........+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred eeCC-cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEe
Q 041043 448 LEVE-VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526 (678)
Q Consensus 448 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 526 (678)
.+.+ ..+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||....++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999986544 79999999999999999999999988899999999999999999999999
Q ss_pred eccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 527 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
|||+++..............||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....+..|+.....+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999765431222111117999999999999999999999999999999999999998765545556699999999999
Q ss_pred ccchhhcchhhh-cCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 607 NCLFDILDDQVR-KSGKT-EEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 607 ~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+.+.+++|+.+. ..... +....+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999987 55554 6888899999999999999999999999999776654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=395.47 Aligned_cols=263 Identities=32% Similarity=0.497 Sum_probs=228.2
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+...+.+.+.+.||+|.||+||.|.++....||+|.++... ...+.|.+|+++|++|+|+|||+++|+|...+..+|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 33344556778999999999999999888899999988653 33478999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
|||+.|+|.+||+.. ....+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+||||++....+
T Consensus 281 E~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999873 3457899999999999999999999999 999999999999999999999999999966666
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+... ...+ +.+.++..
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m------sn~e----------v~~~le~G 420 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM------SNEE----------VLELLERG 420 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC------CHHH----------HHHHHhcc
Confidence 5555565667889999999999999999999999999999999 88887532 2222 33445556
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.+...+..+++++.+|+..||+.+|++|||++.+...|+.+...+
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 666678888999999999999999999999999999999987643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=386.43 Aligned_cols=261 Identities=37% Similarity=0.560 Sum_probs=216.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-cceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLEVE-VPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 458 (678)
..+...+.||+|+||+||+|.+.....||||++...+. ...++|.+|+.+|.+++|||||+++|++.+.. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34455667999999999999998555599999875432 22569999999999999999999999999887 7899999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccccCC
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAID 537 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~~~~ 537 (678)
|+++|+|.++|+.. .+..+++..++.|+.|||+||.|||+.+. ||||||||+||||+.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999875 35579999999999999999999999983 99999999999999997 9999999999876543
Q ss_pred cceeeeccccccCccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 538 QTHVSTKVQGTFGYLDPEYFH--SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
. ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||.... ..+...... ..
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~------~~~~~~~v~---------~~ 261 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA------PVQVASAVV---------VG 261 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHH---------hc
Confidence 2 2233367999999999999 5689999999999999999999999995322 122222222 22
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
..+...+....+.+..|+.+||..||++||++.+++..|+.+...-
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2333334446778999999999999999999999999999998643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=361.07 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=211.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc-ceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV-PLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~ 459 (678)
+++..+.||+|..|+|||+.++ +++.+|+|.+.. .+....+++.+|+++++..+||+||+++|.|..... ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445678999999999999976 578999998843 456667899999999999999999999999999985 9999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++|+|.+++... +.+++..+.+|+.++++||.|||+ .+ |+||||||+||||+..|.+||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999854 469999999999999999999996 55 999999999999999999999999999877654
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
......||..|||||.+.+..|+.++||||||+.++|+.+|+.||.... .......+.+.. +++....
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~---------Iv~~ppP 300 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCA---------IVDEPPP 300 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHH---------HhcCCCC
Confidence 4456679999999999999999999999999999999999999986430 111222322222 2222221
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......++++++++..||++||.+|||++|++++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11122478899999999999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=396.64 Aligned_cols=267 Identities=30% Similarity=0.459 Sum_probs=227.5
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
+....+....+.||+|+||+||+|+.. +...||||.++..... ..++|.+|++++..++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 334556677889999999999999943 3578999999876665 788999999999999999999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSE-----------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE 519 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 519 (678)
+..++|+|||..|+|.+||...+. +.+|+..+.+.||.|||.|++||.++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 999999999999999999975321 234889999999999999999999998 999999999999999
Q ss_pred CCcEEEeeccCcccccCCcceeee-ccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChH
Q 041043 520 KYRAKIADFGTSRSIAIDQTHVST-KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLA 597 (678)
Q Consensus 520 ~~~~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~ 597 (678)
+..|||+|||+++.....+.+... ...-+.+||+||.+..++||.+||||||||+|||+++ |+.|+.+...++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 999999999999998766655443 5567889999999999999999999999999999999 999986443322
Q ss_pred HHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCC
Q 041043 598 TYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663 (678)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~ 663 (678)
+ +..+-+.++ ...+...+.++++|+..||+.+|++||+++||-..|+++.+....
T Consensus 714 --V--------Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 714 --V--------IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred --H--------HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 2 222222333 445677888999999999999999999999999999999865443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=375.78 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=216.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.+|...+.||+|+|..+|.++. ..|+.||+|.+.. ......+.+.+||++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 7899999998754 34566788999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
|+|++++|..++++ ...+++.+++.+.+||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999984 346999999999999999999999999 999999999999999999999999999988755
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ......|||.|+|||++.....+..+||||+||+||-|++|++||+ .+.+.+....+...+..
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe------tk~vkety~~Ik~~~Y~-------- 236 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE------TKTVKETYNKIKLNEYS-------- 236 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc------cchHHHHHHHHHhcCcc--------
Confidence 33 3455789999999999999999999999999999999999999994 44444444444333221
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+...+.+..+||.++|+.||.+|||+++|+..
T Consensus 237 ---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 ---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 134556678999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=354.78 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=200.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
..+|.+.+.||+|+|++||+|+++ ++..||||.+... .....+....|+++|+.++|||||.+++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888889999999999999965 5899999987654 6667778899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC------CcEEEeeccCc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK------YRAKIADFGTS 531 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~Dfgl~ 531 (678)
|||.+|+|.+||+... .+++..+..++.|||.||++||+++ ||||||||+||||+.. ..+||+|||++
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998654 6999999999999999999999999 9999999999999864 56899999999
Q ss_pred ccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
+.+.. ........|++-|||||++...+|+.|+|+||+|+|||++++|+.||. .....+.+...........
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~------a~t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD------AETPKELLLYIKKGNEIVP 234 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc------ccCHHHHHHHHhccccccC
Confidence 98763 334456789999999999999999999999999999999999999995 3334444443332222221
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 649 (678)
.+ +...+..+.+|+...++.+|.+|-+..+
T Consensus 235 ~~--------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 235 VL--------PAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred ch--------hhhccCchhhhhhHHHhcCccccCchHH
Confidence 11 2222233445666666666666654443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=359.42 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=205.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC-------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-------ESKLEEFINEVVILSQISHRNVVKLLGSCLEVE 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 451 (678)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++... ......+.+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788899999999999999995 579999999875421 112233579999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC---CcEEEeec
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADF 528 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Df 528 (678)
..|+|+||+++|+|.+++-.+. .+.+..-..+++|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999998643 5778888899999999999999999 9999999999999765 78999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ---FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
|+|+... ....+....||+.|.|||++.+.. +..+.|+||+||+||-+++|.+||+.... ...+.+ +
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~e---Q--- 393 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKE---Q--- 393 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHH---H---
Confidence 9999765 445677789999999999997754 33478999999999999999999962211 111111 1
Q ss_pred hccchhhcchhhh--cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 ENCLFDILDDQVR--KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+...... .....+.+++..+||.+||..||++|||+.|+++.
T Consensus 394 ------I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ------ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111111 11235667889999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=341.59 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=210.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeE-EeeC-CcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGS-CLEV-EVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~-~~~~-~~~~lv 456 (678)
.+|++.++||+|.||+|||+. ..+|..+|.|.++. .+....+....|+.+|++|+|||||+.++. +.++ +..++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457888999999999999999 56899999998764 466677889999999999999999999983 4343 458999
Q ss_pred EEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 457 YEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAY-LPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
||++..|+|...++..+ +...++++.+|+++.|++.||.++|+.-. -.|.||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999997533 34578999999999999999999999320 12999999999999999999999999999987
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
..... .....+|||.||+||.+.+..|+.||||||+||++|||..-+.||. ++++.+.-.+ ++.+...
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~------g~n~~~L~~K-I~qgd~~---- 246 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY------GDNLLSLCKK-IEQGDYP---- 246 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc------cccHHHHHHH-HHcCCCC----
Confidence 65433 3455779999999999999999999999999999999999999995 3444443332 2222111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.-...-++..+.+||..|+..||+.||+...++..+.
T Consensus 247 ----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 247 ----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1112567789999999999999999998655555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=384.90 Aligned_cols=258 Identities=23% Similarity=0.419 Sum_probs=224.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
....+.++||.|.||+|++|.++- ...||||.++.. .+.+..+|+.|+.||.++.||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 445678999999999999999752 468999999875 455678999999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
.|||++|+|+.||+.+. +.+++.++..++++||.|++||.+.+ +|||||.++||||+.+..+|++|||+++.+..
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999999765 45999999999999999999999999 99999999999999999999999999998765
Q ss_pred Ccceeeec--cccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 537 DQTHVSTK--VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 537 ~~~~~~~~--~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
+.....+. ..-+.+|.|||.+...+++.+|||||||++|||.++ |.+||=.+ ...++...+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm----------------SNQdVIkaI 847 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----------------SNQDVIKAI 847 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc----------------chHHHHHHH
Confidence 54332222 234679999999999999999999999999999988 99997311 122344556
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+...+...+.+.+..|.+|+..||++|-.+||.+.|++..|++|..+
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 66777778899999999999999999999999999999999998744
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=340.81 Aligned_cols=242 Identities=30% Similarity=0.434 Sum_probs=205.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.++||+|+||+|+.++.+ .++.+|+|.++. ....+.+..++|..+|.+++||.||+++-.+.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 568999999999999999999965 588999997754 3455678899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||+.||.|..+|++ +..+++..+..++.+|+.||.|||+.+ |+||||||+|||||++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999984 446999999999999999999999999 99999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. .......||+.|||||++....|+..+|.||||+++|||++|.+||. +.+...+...+....
T Consensus 178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~------~~~~~~~~~~I~~~k--------- 241 (357)
T KOG0598|consen 178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY------AEDVKKMYDKILKGK--------- 241 (357)
T ss_pred CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc------CccHHHHHHHHhcCc---------
Confidence 32 23445789999999999999999999999999999999999999994 333333333333322
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCC
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP 645 (678)
....+.-.+.+.++++.++|..||++|.
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1112233566889999999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=385.32 Aligned_cols=272 Identities=29% Similarity=0.495 Sum_probs=226.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC--Cc----EEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD--GR----IIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~----~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
..+.++.+.||+|+||.||.|...+ +. .||||.++. .+.++..+|.+|..+|+.++|||||+++|++.+...+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778899999999999999653 33 489998765 4677788999999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 454 LLVYEFIPNGTLFQYLHDPS----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
++++|||++|+|..||++.+ ....|+..+++.++.+||+|+.||++++ .|||||..+|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998752 1356899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeec-cccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhc
Q 041043 530 TSRSIAIDQTHVSTK-VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 530 l~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
+++.+...+...... ..-+..|||||.+..+.++.|+|||||||+|||++| |..||.... -.+....+.+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~------n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS------NFEVLLDVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc------hHHHHHHHHhCC
Confidence 999766544443332 245679999999999999999999999999999999 889986322 222222222222
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCchHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQK 671 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~ 671 (678)
+.+.+..+++.+.+|+.+||+.+|++||+++.+++.++.+.+.....+.-...+
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a 975 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPA 975 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccccc
Confidence 455577888899999999999999999999999999999997766655444433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.32 Aligned_cols=263 Identities=28% Similarity=0.439 Sum_probs=207.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCC
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVE 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 451 (678)
..++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456899999999999999999974 234689999886532 34456799999999999 8999999999887644
Q ss_pred -cceEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSE-------------------------------------------------------- 474 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 474 (678)
..+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999975321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccC
Q 041043 475 ---ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFG 550 (678)
Q Consensus 475 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~ 550 (678)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999998 999999999999999999999999999765432222 1223345678
Q ss_pred ccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHH
Q 041043 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEV 629 (678)
Q Consensus 551 y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (678)
|+|||++.+..++.++||||||++||||++ |..||..... ...+......+.. ...+...++.+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------NEEFCQRLKDGTR---------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHhcCCC---------CCCCCCCCHHH
Confidence 999999998899999999999999999997 9999853211 1111111111111 11123345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 630 SDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 630 ~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=322.81 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=204.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
+.|+...++|+|+||.|||++.+ .|+.||||++...+. .-.+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677789999999999999976 599999999865433 334557899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++. ++.+-|.+... .++...+.+++.|++.|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+.. .
T Consensus 82 ~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 9987 45555554433 4889999999999999999999999 99999999999999999999999999998774 3
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccC--------CChHHHHHHHHhhcc-
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG--------RNLATYFVECVEENC- 608 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~- 608 (678)
....+..+.|.+|.|||.+.+ .+|+...||||+||++.||++|.+-|++...-+. .++......+...+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 344566779999999999887 7899999999999999999999988763221110 011111111111111
Q ss_pred chhhcchhhh-----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 LFDILDDQVR-----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+.-+.+. ...-+..+..+.+|+..||+.||.+|++-+|++..
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 11113344578999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.45 Aligned_cols=264 Identities=24% Similarity=0.380 Sum_probs=212.3
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
...+.|++...||.|..++||+|. ...++.||||++.... ....+.+.+|+..|+.++||||++.+..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 345789999999999999999999 4568999999986533 33368899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|+||.+|++.+.++..-.. .+++..+..|++++++||.|||.+| .+|||||+.||||+.+|.+||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999875443 3999999999999999999999999 89999999999999999999999998766554
Q ss_pred Ccce---eeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 537 DQTH---VSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 537 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
.... ......||+.|||||++.. ..|+.|+||||||++..||.+|..||..+.+ .+.+....... ...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~-pp~ 251 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQND-PPT 251 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCC-CCC
Confidence 3322 1155689999999999543 4689999999999999999999999964332 22222222111 111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+........+.+++..||++||++|||++++++.
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111222233445589999999999999999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=354.58 Aligned_cols=268 Identities=30% Similarity=0.463 Sum_probs=220.8
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEcC--C--cE-EEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEE
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLAD--G--RI-IAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSC 447 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 447 (678)
.|+..-++..+.++||+|+||.||+|.++. + .. ||||..+. .......+|++|+++|++++|||||+++|+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345555667778999999999999999653 2 23 89998874 5577889999999999999999999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEee
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 527 (678)
......++|||++.+|+|.+||++... .++..+++.++.+.|.||+|||+.+ ++||||.++|+|++.++.+||+|
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999999999987543 6999999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhh
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
||+++.-. ..........-+..|+|||.+....|+.++|||||||++||+++ |..||.+. ...+....+.
T Consensus 306 FGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~------~~~~v~~kI~-- 376 (474)
T KOG0194|consen 306 FGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM------KNYEVKAKIV-- 376 (474)
T ss_pred cccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC------CHHHHHHHHH--
Confidence 99987543 11111112246789999999999999999999999999999999 88898533 2222222221
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCC
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQD 664 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 664 (678)
....+...+...+.++..++.+|+..+|++||||.++.+.|+.+.......
T Consensus 377 -------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 377 -------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred -------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 222333344566678899999999999999999999999999999765543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=348.46 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=214.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
..|...++||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.+...+..|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456777899999999999999 4568899999998877777788999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.+.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999999999643 4999999999999999999999999 99999999999999999999999999987765544
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....+|||.|||||+.....|+.|.||||||++++||+-|.+||-. ...+....+ +... ......
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-----E~PlrAlyL-Ia~n--------g~P~lk 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-----ENPLRALYL-IATN--------GTPKLK 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-----CChHHHHHH-Hhhc--------CCCCcC
Confidence 34456799999999999999999999999999999999999999851 222222111 1111 111233
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+...+..+.+++.+||+.|+++||+++|+|+.
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 356677899999999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=339.25 Aligned_cols=256 Identities=30% Similarity=0.459 Sum_probs=207.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC--cceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE--VPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 458 (678)
.++...+.||+|+||+||++...+ |...|||.....+....+.+.+|+.+|++++|||||+.+|...... .+.++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999999754 8999999887655444778899999999999999999999865554 5899999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeeccCcccccC-
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAI- 536 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~~~~~- 536 (678)
|+++|+|.+++.+... .+++..+..+.+||++||+|||+++ ++|+||||+||||+. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999987543 6999999999999999999999999 999999999999999 79999999999987653
Q ss_pred -CcceeeeccccccCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 537 -DQTHVSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 537 -~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
..........||+.|||||++..+. ...++|||||||++.||+||+.||... .....+......+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------- 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------- 239 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-------
Confidence 2222334567999999999999643 334999999999999999999998532 11112122111111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.....+...+.+..+++++|+..||++|||++++++..--
T Consensus 240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1113344566789999999999999999999999988533
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=341.44 Aligned_cols=263 Identities=29% Similarity=0.389 Sum_probs=209.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 456 (678)
+.|+..++||+|.||.||+|+ ..+|+.||+|++.... +....-..+||.+|++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 446667899999999999999 4679999999987654 44556778999999999999999999999877 689999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+|||+. +|.-++... ...+++.++..++.||+.||+|+|+.+ |+|||||.+|||||.+|.+||+||||++++..
T Consensus 197 FeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999987 888888642 346999999999999999999999999 99999999999999999999999999998887
Q ss_pred CcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH--Hhhccch---
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC--VEENCLF--- 610 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~--- 610 (678)
......+..+-|.+|.|||++.+ ..|+.+.|+||.||||.||+.|++.|.+....+ ++...+..+ ..+..+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HHHHHHHHhCCCChhcccccc
Confidence 77766777789999999999887 479999999999999999999999986433222 222222211 1111111
Q ss_pred ----hhcchh------hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 611 ----DILDDQ------VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 611 ----~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+.+. ++.. -...+....+|+..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 011000 0000 11223467899999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.22 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=218.2
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhh-HHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK-LEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.......+.++||+|.||.|.++....+.+||||+++...... ..+|.+|+++|.+++||||+.++|+|..++..++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3445677889999999999999999888999999998755444 589999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
|||++|+|..||.++.... +.-....+|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||+++.+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998764332 456677789999999999999999 999999999999999999999999999977665
Q ss_pred cce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 538 QTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT--GQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 538 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
..+ .....+-+.+|||+|.+..++++.+||||+||++|||+++ ...||+.+..+. ..+........ ..
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~------~~ 761 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRD------QG 761 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCC------CC
Confidence 554 3445567889999999999999999999999999999876 778885332211 11111111111 11
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.+.....+.-.+..+.+++.+||+.|-++||+++++...|+..
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1222333566778899999999999999999999999888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.88 Aligned_cols=252 Identities=30% Similarity=0.426 Sum_probs=210.9
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc---CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcc
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 453 (678)
+..++|.+++.||+|+|++|++|+. ..++.+|||++.. ..+...+-+..|=+.|.+| .||.|++|+-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3456899999999999999999995 4689999998753 2233345577888999999 799999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
|+|+||.++|+|.++|++. +.+++...+.++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||.++.
T Consensus 150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999865 46999999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCcce----------ee--eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 041043 534 IAIDQTH----------VS--TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 534 ~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~ 601 (678)
+...... .. ...+||..|.+||++..+..+..+|+|+||||||+|+.|++||. +.+-...|.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr------a~NeyliFq 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR------AANEYLIFQ 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc------cccHHHHHH
Confidence 7543221 11 34689999999999999999999999999999999999999994 233333333
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+++.-. ...+...++.+.+|+++.|..||.+|+|.+|+-+.
T Consensus 298 kI~~l~-----------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 KIQALD-----------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHhc-----------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 333211 22344555788999999999999999999887665
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=345.38 Aligned_cols=266 Identities=29% Similarity=0.490 Sum_probs=234.2
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
.++|+....+..+.++||-|.||.||.|+|+. .-.||||.++. +.-..++|+.|+.+|+.++|||+|+|+|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35666666778889999999999999999875 56899999876 44567999999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.|+|+|||.+|+|.+||++-. +..++.-.++.++.||+.|++||..++ +|||||.++|.|+.++..+||+||||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999998754 345778889999999999999999999 8999999999999999999999999999
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
++..+.........-+..|.|||.+..+.++.|+|||+|||+|||+.| |-.||.+. ++. .+.+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlS----------qVY~ 477 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLS----------QVYG 477 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHH----------HHHH
Confidence 988766655554556788999999999999999999999999999999 88898643 222 2456
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+++...+.+.+..+++.+.+|+++||+++|++||+++|+-+.+|.|-..
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 7777788888899999999999999999999999999999999988754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=311.04 Aligned_cols=263 Identities=25% Similarity=0.306 Sum_probs=207.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChh--hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDES--KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|...++||+|.||.||+|.. +.|+.||||+++..+.. ......+||+.|+.++|+||+.+++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677789999999999999994 57999999998765432 24567899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++. +|+..++.. ...++..++..++.++++||+|+|++. |+||||||.|+|++.+|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 899999864 457899999999999999999999999 9999999999999999999999999999887655
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH--Hhhcc------c
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC--VEENC------L 609 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~------~ 609 (678)
..... .+.|..|.|||.+.+ ..|+...|+||.|||+.||+-|.+-|.+.. +-+++...|... ..++. +
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccCcccccc
Confidence 44332 367899999999876 569999999999999999999998775321 212222222211 01111 1
Q ss_pred hhhcchh-----hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 FDILDDQ-----VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 ~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+..+-+ .....-...+....+|+..|+.+||.+|+|++|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111 0011123445677999999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=340.42 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=206.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChh-hHHHHHHHHHHHhcCC-CCceeeEEeEEeeCC-cceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDES-KLEEFINEVVILSQIS-HRNVVKLLGSCLEVE-VPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-~~~l 455 (678)
.-++|.+.++||.|.||.||+|+. .++..||||+++..-.. +.-.-++|++.|++|+ |||||++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346789999999999999999994 56899999988653222 1223468999999999 999999999999988 9999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|||||+ .+|++.++++ +..+++.++..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 5999999876 567999999999999999999999999 9999999999999999999999999999765
Q ss_pred CCcceeeeccccccCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc------
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFH-SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC------ 608 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 608 (678)
. ....+..+.|.+|+|||++. .+-|+.+.|+|++|||++|+.+-++-|++..+.+ ++.. +.++.....
T Consensus 162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~K-Ic~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYK-ICEVLGTPDKDSWPE 236 (538)
T ss_pred c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHH-HHHHhCCCccccchh
Confidence 3 33456677899999999875 5679999999999999999999999886432211 1111 111111110
Q ss_pred ---chhhcch--------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 ---LFDILDD--------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ---~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+...+.- .+..- -...+.+..+|+.+|+.+||.+|||++|.+++
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L-~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDL-LPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHh-CcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111 11111 12356788999999999999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.46 Aligned_cols=266 Identities=27% Similarity=0.406 Sum_probs=202.4
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhc--CCCCceeeEEeEEeeCC----cceEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ--ISHRNVVKLLGSCLEVE----VPLLV 456 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~~~lv 456 (678)
..++.++||+|+||.||||++. ++.||||++.. .+.+.|.+|-+|.+. ++|+||+++++.-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4566789999999999999996 59999999864 455678888777765 57999999999876655 78999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY------LPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~------~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
++|.++|+|.+||+.+ .++|....+|+..+++||+|||+... ++|+|||||++||||..|+++.|+|||+
T Consensus 287 t~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999754 59999999999999999999998643 6899999999999999999999999999
Q ss_pred cccccCCccee-eeccccccCccCccccccCC-CC-----cccchhhHHHHHHHHHhCCCCCCcc--------ccc---c
Q 041043 531 SRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQ-FT-----DKSDVYSFGVVLVELLTGQKPISYI--------WAN---E 592 (678)
Q Consensus 531 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwslGvll~elltg~~p~~~~--------~~~---~ 592 (678)
+..+....... ....+||.+|||||++.+.- +. .+.||||+|.+||||+++-..+... ... .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98887554432 22357999999999997742 22 2689999999999999976554310 000 0
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
...+.++....+.+.....+. ...+. -..+..+.+.+..||..||+.|.|+.=|.+++..+...
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p-~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIP-DAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhccCCCCh-hhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111122111111111111111 11111 13456789999999999999999999999998888754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=343.56 Aligned_cols=255 Identities=27% Similarity=0.476 Sum_probs=215.8
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
+.|+...+.....+-||.|+.|.||+|+++ ++.||||+++...+ .+|+.|++|+|+||+.+.|+|...-.++
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeE
Confidence 344555556666789999999999999986 78899998874332 5788899999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+..|-|...|+. ...+.......|..+||.|+.|||.+. |||||||+-||||+.+..+||+|||-++..
T Consensus 189 IiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred EeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999985 346889999999999999999999999 999999999999999999999999999866
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
....+ .-...||..|||||++.+...++|.|||||||+||||+||..||..... ...+..+-.
T Consensus 263 ~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---------------sAIIwGVGs 325 (904)
T KOG4721|consen 263 SDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---------------SAIIWGVGS 325 (904)
T ss_pred hhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch---------------heeEEeccC
Confidence 54322 2335799999999999999999999999999999999999999853221 122344444
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..+....+...++.+.-|+++||+-.|.+||++++++..|+-..+.
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 5555566778888999999999999999999999999999755543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=339.82 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=212.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.. ..+.+.+.+.+|+++++.++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788889999999999999965 578999998754 345567789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+.+ +|..+|.. ...++++.+..++.+++.||.|||+.+ |.|||+||+||||+.++.+|++|||+++.... .
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9976 99999974 456999999999999999999999998 99999999999999999999999999997654 5
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
+...+.+.|||.|||||+..+..|+..+|.||+|||+||+++|++||. .....+....+..+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~v---------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDPV---------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCCC----------
Confidence 556777889999999999999999999999999999999999999994 2233333333322221
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+...+..+..++...|.+||.+|.|..+++..
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1134667789999999999999999999998764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=332.50 Aligned_cols=261 Identities=22% Similarity=0.383 Sum_probs=207.3
Q ss_pred cccccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhh---HHHHHHHHHHHhcCCCCceeeEE
Q 041043 368 RCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK---LEEFINEVVILSQISHRNVVKLL 444 (678)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~ 444 (678)
.++.++.++++. .....|++|+++.||+|.+ +|+.||||.++...... .+.+.+|+.+|++++||||++++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 344455555532 2235799999999999998 58999999987543322 57788999999999999999999
Q ss_pred eEEee----CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECC
Q 041043 445 GSCLE----VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDE 519 (678)
Q Consensus 445 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~ 519 (678)
+++.+ ....++||||+++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+|||+++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECC
Confidence 99877 34678999999999999999753 3589999999999999999999985 6 779999999999999
Q ss_pred CCcEEEeeccCcccccCCcceeeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChH
Q 041043 520 KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLA 597 (678)
Q Consensus 520 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~ 597 (678)
++.+||+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||... ...
T Consensus 159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~------~~~ 228 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL------TTK 228 (283)
T ss_pred CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC------CHH
Confidence 9999999999987653321 22357889999999976 67999999999999999999999999522 122
Q ss_pred HHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 598 TYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
.........+ .+...+...++.+.+|+.+||+.||++|||++|+++.|+.++.
T Consensus 229 ~~~~~i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 229 EIYDLIINKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 2222221111 1111223456689999999999999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=339.89 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=211.2
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC----Ch-hhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCC
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV----DE-SKLEEFINEVVILSQIS-HRNVVKLLGSCLEVE 451 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 451 (678)
...++|.+.+.||+|.||+|++|.. .++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999985 46899999965442 11 23456778999999999 999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeeccC
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGT 530 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl 530 (678)
..++||||+.+|+|.+++.+ ...+.+.++..+++|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999986 346899999999999999999999999 9999999999999999 9999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ-FT-DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
+.... ..........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. .+....+..+....
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~ki~~~~- 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRKIRKGE- 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHHHhcCC-
Confidence 98764 2333455678999999999999877 75 689999999999999999999952 34444443322211
Q ss_pred chhhcchhhhcCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 609 LFDILDDQVRKSGKTEE-IMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
. ..+... +.++..|+++||..||.+|+|+.|++ .-.-++.
T Consensus 240 --------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 240 --------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred --------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 112222 67899999999999999999999999 5444443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.84 Aligned_cols=268 Identities=27% Similarity=0.476 Sum_probs=214.8
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
+.++|+...+.+.+...||+|.||+||+|.|.. .||||.++.. ..+..+.|++|+..+++-||.||+-+.|++...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 346778888889999999999999999999863 4899988654 455788999999999999999999999999988
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
.. .+|+.++++.+|+.+||... ..++..+.+.|+.||++|+.|||.++ |+|||||+.||||.++++|||+||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 77 99999999999999999754 46889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCC-cceeeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 531 SRSIAID-QTHVSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 531 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
+.....- .........|...|||||+++. ..|+..|||||||+++|||++|..||. ... .++ ..-.+..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~-~dq-----IifmVGr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQN-RDQ-----IIFMVGR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCC-hhh-----eEEEecc
Confidence 8543221 1111223346778999999864 469999999999999999999999996 111 111 1111111
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+.+. +.+ ........++|.+|+..||.+++++||++.+|+..|+.+...
T Consensus 608 G~l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 608 GYLM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1100 000 011234566899999999999999999999999998888763
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=309.05 Aligned_cols=267 Identities=24% Similarity=0.375 Sum_probs=218.7
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC----
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE---- 451 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 451 (678)
+....++|.+.+.||+|||+-||+++ ..++..+|+|++.....++.+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34456789999999999999999999 5678999999998888888899999999999999999999999876543
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEEL-SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
..|++++|...|+|.+.+...+.++ .+++.+.+.|+.+|.+||++||+.. +|++||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 4899999999999999998755443 7999999999999999999999998 579999999999999999999999999
Q ss_pred CcccccCCcceee--------eccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 041043 530 TSRSIAIDQTHVS--------TKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLAT 598 (678)
Q Consensus 530 l~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~ 598 (678)
.+........... ..-.-|..|.|||.+.- ...+++.|||||||+||+|+.|..||..... .+.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~Gg---- 249 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGG---- 249 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCC----
Confidence 9876542211110 11124778999999853 4578899999999999999999999964333 111
Q ss_pred HHHHHHhhccchh-hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 599 YFVECVEENCLFD-ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 599 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
.+.- +...++........++.+.+|+.+||+.||.+||++.+++..++.+.
T Consensus 250 ---------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 ---------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 22223333334458889999999999999999999999999998874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.89 Aligned_cols=272 Identities=28% Similarity=0.473 Sum_probs=232.2
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcC---C--cEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLAD---G--RIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
++...+...+.++||+|.||.||+|++.+ | -.||||..+. .+.+..+.|+.|..+|++++||||++++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 44445566778899999999999999532 3 3588998776 456667899999999999999999999999975
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
...|+|||.++-|.|..||+.++. .|+......++.||..||+|||+.. .|||||..+|||+....-+||+|||+
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred cceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 578999999999999999997543 6889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
++.+..+.....+...-+..|||||.+...+++.+||||.|||.+||++. |.+||.+.... ++
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DV 601 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DV 601 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ce
Confidence 99988777766666667889999999999999999999999999999998 99999754332 24
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCchHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQ 670 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~ 670 (678)
...++..-+...++.+++.|..|+.+||.++|.+||.+.|+...|+.+...+-....++.+
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r 662 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLR 662 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHH
Confidence 4455566666778889999999999999999999999999999999998765444444433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.71 Aligned_cols=270 Identities=25% Similarity=0.363 Sum_probs=209.1
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhc--CCCCceeeEEeEEeeCC---
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ--ISHRNVVKLLGSCLEVE--- 451 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~--- 451 (678)
.+.+.+...+.+.||+|.||+||+|.++ |+.||||++...++ +.+.+|.++.+. |||+||+.+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3456678899999999999999999997 89999999876544 578889999877 49999999998776543
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeecCCCCceEECCCCcEEE
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-----SAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
.+|||++|.+.|+|.|||.+ .+++....++++..+|.||++||. ++.|.|.|||||++||||.+++.+.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 57999999999999999975 469999999999999999999996 34588999999999999999999999
Q ss_pred eeccCcccccCCcce---eeeccccccCccCccccccCC------CCcccchhhHHHHHHHHHhC----------CCCCC
Q 041043 526 ADFGTSRSIAIDQTH---VSTKVQGTFGYLDPEYFHSSQ------FTDKSDVYSFGVVLVELLTG----------QKPIS 586 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwslGvll~elltg----------~~p~~ 586 (678)
+|+||+.....+... ..+..+||.+|||||++...- --..+||||||+++||+.-+ +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999766544322 245567999999999986532 12368999999999999853 35654
Q ss_pred ccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 587 YIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
...+.+.. .. ...+.+-.+++...+..+ -.+.+....|.+|++.||..+|..|.|+--+-+.|.++.+
T Consensus 438 d~Vp~DPs-~e-eMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPS-FE-EMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCC-HH-HHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 33332221 11 111111111111111111 1245677889999999999999999999999999988875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=377.88 Aligned_cols=265 Identities=27% Similarity=0.467 Sum_probs=212.7
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.....+...++||+|+||.||+|+. .++..||||+++...... .+|++.+++++||||+++++++.+.+..++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3345677888999999999999997 578999999886543222 34688999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.++++ .++|.++.+++.|+++||+|||....++|+||||||+||+++.++..++. |+........
T Consensus 763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999999999996 28999999999999999999996644559999999999999999888875 6654432211
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
....+++.|+|||++.+..++.++|||||||++|||+||+.||.... ........|.............+++.+
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccc
Confidence 12357899999999999999999999999999999999999985322 223445556554444444444555544
Q ss_pred hc--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 618 RK--SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 618 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.. ....+...++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 32 23456667889999999999999999999999999999764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=345.71 Aligned_cols=263 Identities=28% Similarity=0.453 Sum_probs=207.4
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEe
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCL 448 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 448 (678)
++...++|++.+.||+|+||.||+|++ .++..||||+++.. .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 334456799999999999999999973 23568999988643 234456789999999999 8999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCC------------------------------------------------------
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSE------------------------------------------------------ 474 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 474 (678)
+.+..++||||+++|+|.++++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999965321
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 475 ------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 475 ------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788999999999999999999998 99999999999999999999999999976543
Q ss_pred Ccce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 537 DQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 537 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...+......+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~------~~~~~~~~~~~------- 333 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV------DSKFYKMIKEG------- 333 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc------hHHHHHHHHhC-------
Confidence 3222 1222335667999999999999999999999999999998 8888853211 11111111111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.+...+...+.++.+|+.+||+.||++|||++||++.|++.
T Consensus 334 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 --YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=327.41 Aligned_cols=256 Identities=21% Similarity=0.366 Sum_probs=206.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... ....+.+.+|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999853 35689999887643 3445678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999997542 36899999999999999999999998 9999999999999999999999999876533
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
...........++..|+|||.+....++.++||||||+++||+++ |+.||.... ..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~------~~~~~-~~~~~~------- 224 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS------GQDVI-KAVEDG------- 224 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC------HHHHH-HHHHCC-------
Confidence 222111122334678999999999999999999999999999875 999985321 11111 111111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.....+...+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11112334556799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.95 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=203.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC-----------------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceee
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD-----------------GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~ 442 (678)
.++|.+.++||+|+||.||++.+++ +..||+|.+... ......+|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578889999999999999998542 336999987654 3445568999999999999999999
Q ss_pred EEeEEeeCCcceEEEEeccCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 041043 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPS----------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506 (678)
Q Consensus 443 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 506 (678)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986421 1134788999999999999999999999 99
Q ss_pred eecCCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh--CCC
Q 041043 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT--GQK 583 (678)
Q Consensus 507 H~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt--g~~ 583 (678)
||||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999765433222 2223345788999999988889999999999999999997 455
Q ss_pred CCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 584 PISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 584 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
||..... ............... .......+...+..+.+|+.+||+.||++|||+.||.+.|+
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6642211 111111111111100 00011112234567999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=325.74 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=209.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45788999999999999999998888899999876533 34578999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.++++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999997542 345889999999999999999999988 999999999999999999999999999865443322
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......++..|+|||++....++.++||||||+++|+|++ |+.||.... .......... . ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~-~---------~~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS------NSDVMSALQR-G---------YRM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC------HHHHHHHHHc-C---------CCC
Confidence 2223345678999999988889999999999999999998 999985321 1111111111 1 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
......+.++.+++.+||..+|++||+++++++.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223446789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=343.49 Aligned_cols=262 Identities=29% Similarity=0.472 Sum_probs=207.1
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeC
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEV 450 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 450 (678)
...++|++.+.||+|+||.||++... ++..||+|+++.. .....+.+.+|+++++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34567899999999999999998842 2357999998653 344456789999999999 899999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSE-------------------------------------------------------- 474 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 474 (678)
+..++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999864211
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce-ee
Q 041043 475 -----------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VS 542 (678)
Q Consensus 475 -----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~ 542 (678)
...+++.++++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 124788999999999999999999998 999999999999999999999999999765433222 12
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (678)
....++..|+|||++....++.++||||||+++|||++ |+.||....... .+....... .....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~---------~~~~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRG---------YQMSR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcc---------cCccC
Confidence 22335678999999998899999999999999999997 999985321110 111111111 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 622 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
+...+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1223467999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.88 Aligned_cols=236 Identities=30% Similarity=0.404 Sum_probs=202.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|+..+.||.|+||.|.+++.+ +|..+|+|.+.. ....+.+...+|-.+|+.+.||.++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999965 588999998764 34556677889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||.++|.|..+|++. +.++++.++.++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.++.+...
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999864 36999999999999999999999999 999999999999999999999999999876532
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.-...|||.|+|||.+....+..++|.|||||++|||+.|.+||... +....+.++.+.. +
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~------~~~~iY~KI~~~~---------v 258 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD------NPIQIYEKILEGK---------V 258 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC------ChHHHHHHHHhCc---------c
Confidence 45678999999999999999999999999999999999999999622 2233333333222 1
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCC
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSR 644 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~R 644 (678)
..+.-.+.++.+|+...|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1244556688999999999999999
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.78 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=209.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456789999999999999999998778899999886543 3356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997643 346899999999999999999999998 99999999999999999999999999987653222
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
........+..|+|||++.+..++.++||||||+++|||++ |+.||... ............ ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------~~~~~~~~~~~~----------~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM------TNAEVLQQVDQG----------YR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHcC----------CC
Confidence 21122223457999999998899999999999999999999 99998522 111111111111 11
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
...+...+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 112233456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=330.08 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=212.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..|+..+.||+|.||.||+|.. ..++.||+|.+... ...+.+++.+|+.+|.+++++||.+.++.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999995 46889999998653 455678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+.+|++.+.|+.. ..+++..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999743 34588888899999999999999999 99999999999999999999999999987765544
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
.. ....||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.. +.-++-+....
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPP 229 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCC
Confidence 44 66789999999999998899999999999999999999999986443311 11122222222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......++.+.+++..||.+||+.||++.++++.
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3334677789999999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.15 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=208.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+|.+.+.||+|+||.||+|..+ .++.+|+|..+.. ....+++.+|++++++++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345788899999999999999965 4789999988653 33457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999997543 345899999999999999999999998 99999999999999999999999999976654332
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
........+..|+|||.+.+..++.++||||||+++|||++ |..||... .....+..... ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------~~~~~~~~~~~----------~~~ 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK----------GYR 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHC----------CCC
Confidence 22222334668999999998899999999999999999998 88898522 22222211111 111
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
...+...+.++.+++.+||+.+|++|||+.|++++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 122333456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.98 Aligned_cols=258 Identities=29% Similarity=0.477 Sum_probs=214.4
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
....+|++.++||+|+||.||+|...++..+++|.+........+++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44567889999999999999999988899999999887766667789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.++++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999998643 346899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. .....++..|+|||.+....++.++||||||+++|+|++ |+.||.... ....+..... ..
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~----------~~ 221 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN------NHEVYDQITA----------GY 221 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHHh----------CC
Confidence 21 223345678999999988889999999999999999998 889985321 1112221111 11
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
+...+...++.+.+++.+||+.+|++|||++++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1122334556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=342.47 Aligned_cols=252 Identities=31% Similarity=0.514 Sum_probs=216.1
Q ss_pred cCCeeeeeCCcEEEEEEE-cCC----cEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 386 VNRILGQGGQGTVYKGML-ADG----RIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 386 ~~~~Lg~G~~g~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..++||+|+||+||+|.+ .+| -+||||.+.. ...+..+++++|+.+|.+|+|||+++|+|+|..+. +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 357999999999999995 334 4788887654 44556789999999999999999999999998877 8899999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
++.|+|.+|++.++. .+-.+..+.|..|||+||.|||.+. +|||||.++||||..-.++||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998654 5888999999999999999999988 99999999999999999999999999999887766
Q ss_pred eeeec-cccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 540 HVSTK-VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 540 ~~~~~-~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
..... ..-.+.|||-|.+....|+.+||||||||++||++| |..|+.+....+ +.+++....
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~ge 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGE 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccc
Confidence 54433 334678999999999999999999999999999999 999986543332 344444555
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
+...++..+.++..++.+||..|+..||+++++..++.++..
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 566677888899999999999999999999999999987763
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=326.65 Aligned_cols=249 Identities=35% Similarity=0.572 Sum_probs=196.4
Q ss_pred cCCeeeeeCCcEEEEEEEc-----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 386 VNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 386 ~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 2578999998653 344578999999999999999999999999988889999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.++|+.. ....+++..++.|+.||++||+|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999875 2346899999999999999999999998 99999999999999999999999999987632222
Q ss_pred -eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 540 -HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 540 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
...........|+|||.+....++.++||||||+++|||++ |+.||... ..........+.. .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~~~-~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQGQ-R-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHTTE-E--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccc-c--------
Confidence 22333457788999999999889999999999999999999 67887422 2222222221111 1
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
...+...+..+.+++.+||..+|++|||++++++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111233456789999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=324.58 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=207.0
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC--------------hhhHHHHHHHHHHHhcCCC
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--------------ESKLEEFINEVVILSQISH 437 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~Ei~~l~~l~h 437 (678)
...+-.+..++|++.+.||+|.||.|-+|.. .+++.||||++.... ....+...+||.+|++++|
T Consensus 88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 3334445567899999999999999999995 468999999765321 1224688999999999999
Q ss_pred CceeeEEeEEee--CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 438 RNVVKLLGSCLE--VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 438 ~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
||||+|+.+..+ .+..|||+||+..|.+.+.=- ....+++.++++++++++.||+|||.++ |+||||||+|+
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNL 241 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNL 241 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhhe
Confidence 999999999975 467899999999987754332 2223899999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeeccCcccccCCcc----eeeeccccccCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCc
Q 041043 516 LLDEKYRAKIADFGTSRSIAIDQT----HVSTKVQGTFGYLDPEYFHSSQ----FTDKSDVYSFGVVLVELLTGQKPISY 587 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwslGvll~elltg~~p~~~ 587 (678)
||+++|++||+|||.+..+..... .......|||.|+|||...++. -+.+.||||+||+||.|+.|+.||.
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~- 320 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF- 320 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-
Confidence 999999999999999976632211 1223367999999999987743 3457899999999999999999994
Q ss_pred cccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 588 IWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
+....+.+.++++ ..+.....++..+.+.+||++||++||.+|.++.+|....-
T Consensus 321 -----~~~~~~l~~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 321 -----DDFELELFDKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -----cchHHHHHHHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 3333444443333 33333333466778999999999999999999999876653
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.68 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=204.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
++|++.+.||+|+||.||++.++++..+|+|.++... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577889999999999999999888899999876432 334678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999997543 35899999999999999999999998 9999999999999999999999999987654333222
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....++..|+|||.+....++.++||||||+++|||++ |+.||... .....+........ ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~------~~~~~~~~i~~~~~----------~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK------SNYEVVEMISRGFR----------LY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHCCCC----------CC
Confidence 223335668999999988889999999999999999999 88898421 22222222221111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
.+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1222345789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.02 Aligned_cols=269 Identities=25% Similarity=0.358 Sum_probs=224.1
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCC-cEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeE-EeeC-----
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADG-RIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGS-CLEV----- 450 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~~----- 450 (678)
....++++.+.|.+|||+.||++....+ ..+|+|++-..++...+.+++||++|++|+ |+|||.+++. ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456778899999999999999997766 999999988889999999999999999997 9999999993 3221
Q ss_pred -CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 451 -EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 451 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
-+.+|.||||++|.|.+++..+.... |++.++++|+.++++|+++||... +||||||||-+||||+.+++.||+|||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 24689999999999999998654443 999999999999999999999998 779999999999999999999999999
Q ss_pred CcccccCCc-ce-e------eeccccccCccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 041043 530 TSRSIAIDQ-TH-V------STKVQGTFGYLDPEYF---HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLAT 598 (678)
Q Consensus 530 l~~~~~~~~-~~-~------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~ 598 (678)
.+.-..... .. . .-...-|+.|+|||.+ .+...++|+|||+|||+||-|.....||+.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~----------- 260 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE----------- 260 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc-----------
Confidence 985432221 11 0 1112358899999986 466789999999999999999999999952
Q ss_pred HHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCch
Q 041043 599 YFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDN 668 (678)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~ 668 (678)
.-...|+...........++..|.+||+.||+.||.+||++-||++.+-+|.....+-.+.+
T Consensus 261 --------sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 261 --------SGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred --------CcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 11234566666555567899999999999999999999999999999999997776655544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.92 Aligned_cols=257 Identities=30% Similarity=0.452 Sum_probs=207.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
++|++.+.||+|+||.||+|.... ...|++|.++... ....+++.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998643 2579999886433 344567999999999999999999999999989999
Q ss_pred EEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC
Q 041043 455 LVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 521 (678)
+++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975321 145889999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 041043 522 RAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATY 599 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~ 599 (678)
.+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||..... .+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------~~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------QEV 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 999999999876543222 12233346788999999988889999999999999999998 9999853211 111
Q ss_pred HHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 600 FVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
. ..+... .....+...+.++.+|+.+||+.||.+||+++||++.|+++
T Consensus 236 ~-~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 I-EMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H-HHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 111111 11122345567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.16 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=210.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
-|.+++-||.|+.|.|-+|++ ..|+.+|||++... .......+-+||.+|+.+.|||++++++++.+...+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 477889999999999999995 57999999987543 33445668899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|.|.++|.++ +.+++.++.++++||+.|+.|+|..+ |+||||||+|+|||+..++||+|||+|..-..+
T Consensus 93 yv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred ecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 99999999999754 46999999999999999999999999 999999999999999999999999999764432
Q ss_pred ceeeeccccccCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.......|.|+|.+||++.+..|. .++||||.|||||.|+||+.||+ ++++...+.++.... .
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlKV~~G~-f-------- 229 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLKVQRGV-F-------- 229 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHHHHcCc-c--------
Confidence 234456799999999999998874 58999999999999999999994 455555554443321 1
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
+.+...+.+.++|+++||..||++|.|++||++.-
T Consensus 230 --~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 --EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 12345566889999999999999999999999873
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=323.94 Aligned_cols=261 Identities=27% Similarity=0.453 Sum_probs=212.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.+|.+.+.||+|+||.||+++.. ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999842 345789999887666667789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc
Q 041043 456 VYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 522 (678)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975321 235899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 041043 523 AKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 523 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 600 (678)
+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVI 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence 99999999876543222 12233446788999999998899999999999999999999 9999853221 1111
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.....+... ..+...+..+.+++.+||+.+|++|||+++|+++|+++.+..
T Consensus 236 -~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 236 -ECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred -HHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 111111111 112234567999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=324.03 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=211.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
.++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356888999999999999999842 34568999987766667788999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEE
Q 041043 455 LVYEFIPNGTLFQYLHDPS----------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 524 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 524 (678)
+++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997432 1235899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 041043 525 IADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 602 (678)
|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .......
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~------~~~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEVIEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence 9999998765432221 1223335778999999998889999999999999999998 888885221 1111111
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
. ..+... ..+...+.++.+|+.+||+.+|.+|||++|+++.|+++.+.
T Consensus 235 i-~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 I-TQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred H-HcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 111111 11122345799999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.14 Aligned_cols=256 Identities=23% Similarity=0.433 Sum_probs=207.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.++|++.+.||+|+||.||+|.+.. ...||||.++.. ......+|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568899999999999999999742 457999987653 34455689999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
+|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999997643 36899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... ......++..|+|||.+....++.++||||||+++|||++ |..||.... ... ........
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~------~~~-~~~~~~~~------ 224 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS------NQD-VIKAVEDG------ 224 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC------HHH-HHHHHHcC------
Confidence 22222 2222335678999999998899999999999999999998 999984221 111 11111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.....+...++.+.+++.+||+.+|++||+++||++.|+++
T Consensus 225 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ---YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111233456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=326.37 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=201.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 6889999987542 2234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999998765432
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||.. ..............
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~------~~~~~~~~~i~~~~---------- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD------DNPFGIYEKILAGK---------- 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCC----------
Confidence 1234589999999999988899999999999999999999999852 12222222221111
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
...+......+.+|+.+||+.||.+||+ ++|+++.
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1112233557899999999999999995 7777755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=316.69 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=209.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
...+|++.+.||+|.||+|-++.. ..|+.||||.++. .++++.-.+++||+||+.|+||||+.++.+|...+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346788899999999999999995 6799999997653 456667789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||..+|.|++|+.+. +.|++.++..+++||++|+.|+|.++ ++|||||.+|||||+++++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999754 46999999999999999999999999 9999999999999999999999999998665
Q ss_pred CCcceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
. ....+...|++-|.+||++.+..| ....|-|||||+||-|+.|..||++.+ -..++.++..
T Consensus 205 ~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~--------- 267 (668)
T KOG0611|consen 205 D--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISR--------- 267 (668)
T ss_pred c--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhc---------
Confidence 3 334566789999999999999887 458999999999999999999996432 2222222211
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
...+ .++.+....-||++||..||++|.|+.+|...-
T Consensus 268 GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 268 GAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111 122334567899999999999999999998763
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=338.19 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=209.8
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCC-CCceeeEEeEEe
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQIS-HRNVVKLLGSCL 448 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~ 448 (678)
++...++|.+.++||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+++++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445678899999999999999999853 1347999998643 3344568999999999996 999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCC------------------------------------------------------
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSE------------------------------------------------------ 474 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 474 (678)
+.+..++||||+++|+|.++|+....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999864210
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 475 ---------------------------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 475 ---------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
...+++..++.++.|++.||+|||+.+ |+|+||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 124788899999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccC
Q 041043 516 LLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEG 593 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~ 593 (678)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--- 345 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--- 345 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch---
Confidence 9999999999999999765433222 1222346778999999998889999999999999999997 8899853211
Q ss_pred CChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
...+......+ .+...+...+..+.+++.+||+.||++|||+.+|+++|+++.+
T Consensus 346 ---~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 346 ---DSTFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---hHHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111111111 1111223445689999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=318.40 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=204.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
++|.+.+.||+|+||+||+|..+++..+|+|.++... ...+++.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777789999877433 234679999999999999999999999998889999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|+|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999975432 5899999999999999999999998 9999999999999999999999999987654433222
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....++..|++||.+....++.++||||||+++|||++ |+.||..... ......... ... ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~-~~~---------~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQ-GLR---------LY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhc-CCC---------CC
Confidence 222345678999999988889999999999999999999 9999852211 111111111 110 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11223568899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.49 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=200.9
Q ss_pred CCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999996 478999999875422 22335678999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999998886432 235899999999999999999999998 9999999999999999999999999997653222
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ............ ...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~----------~~~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER---VKREEVDRRVKE----------DQE 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHHhhc----------ccc
Confidence 223446899999999999999999999999999999999999999632111 011111111000 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
..+...+..+.+|+.+||+.||++||+ ++++++.
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 123345568899999999999999997 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=322.45 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=205.6
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE 451 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 451 (678)
..+++|++.+.||+|+||.||+|... .+..||||++... ......++.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999853 2467999987543 2344567899999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEE
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSE-------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 524 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 524 (678)
..++|+||+++|+|.++++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999975322 234678899999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 041043 525 IADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 602 (678)
|+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||... .......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~------~~~~~~~- 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM------SNEQVLR- 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHH-
Confidence 99999987654332221 122345778999999998889999999999999999999 68887522 1111111
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
........ ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 1122344578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.18 Aligned_cols=257 Identities=25% Similarity=0.478 Sum_probs=205.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.+|++.+.||+|+||.||+|++. +++ .||+|.++.. .....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 333 4899988653 345567899999999999999999999998764 5789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
++||+++|+|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999998643 35889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcceee-eccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTHVS-TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
....... .....+..|+|||.+....++.++||||||+++|||++ |+.||... ..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~------~~~~~-~~~~~~~------ 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEI-SSILEKG------ 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------CHHHH-HHHHhCC------
Confidence 4333221 22234678999999999899999999999999999998 99998522 11111 1111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+......+.+++.+||..+|.+||++.+++..|.++...
T Consensus 228 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11111223345788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.67 Aligned_cols=265 Identities=22% Similarity=0.238 Sum_probs=201.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.+.||+|+||.||++..+ +++.+|+|+++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999975 5789999987643 23345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++++.+..+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9998777655432 235899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHHHHHhhccc
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---------RNLATYFVECVEENCL 609 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~ 609 (678)
........+++.|+|||++.+..++.++||||||+++|||++|+.||......+. ................
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 3233345689999999999988899999999999999999999999963221110 0000000000000000
Q ss_pred hhhcchhhh------cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 610 FDILDDQVR------KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 610 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.....+... .......+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0001123467999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=322.40 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=207.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3468888999999999999998643 478999998765444 457899999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc
Q 041043 454 LLVYEFIPNGTLFQYLHDPS-----------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 522 (678)
+++|||+++++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 2245789999999999999999999998 999999999999999999
Q ss_pred EEEeeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 041043 523 AKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 523 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 600 (678)
+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~------~~~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN------EEVI 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHH
Confidence 99999999876533222 12223345788999999999999999999999999999998 9999853211 1111
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.. ...+.. ...+...+..+.+++++||+.||++||++.||++.|++
T Consensus 235 ~~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 EC-ITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH-HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 111111 11122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.31 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=197.9
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.||+|+||.||++... +|+.+|+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 6899999987642 3344567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeee
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~ 543 (678)
+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 999999753 36899999999999999999999999 9999999999999999999999999987532221 1223
Q ss_pred ccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCH
Q 041043 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623 (678)
Q Consensus 544 ~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (678)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||... +............ ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~~~~~~~~~~-----------~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMEE-----------IRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC------CHHHHHHHHHcCC-----------CCCCC
Confidence 356899999999999989999999999999999999999998521 1111111111110 11123
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 624 EEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 624 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
..+.++.+|+.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 4456789999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=322.41 Aligned_cols=264 Identities=31% Similarity=0.488 Sum_probs=205.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-----CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Ccce
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPL 454 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 454 (678)
++|++.+.||+|+||.||++..+ +++.||+|+++.......+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999843 5789999998877777778899999999999999999999987543 4678
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+|+||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999997532 35899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc----
Q 041043 535 AIDQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC---- 608 (678)
Q Consensus 535 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 608 (678)
....... .....++..|+|||.+.+..++.++||||||+++|||++|..++..... .+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--------EFMRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--------hhhhhccccccccc
Confidence 4433221 1122234569999999888899999999999999999998776532110 0000000000
Q ss_pred ----chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 609 ----LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 609 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
+.+.+............+.++.+|+.+||..+|++|||++||++.|+.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00111111111122334567999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.53 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=205.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 5889999987642 2334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999743 35899999999999999999999999 99999999999999999999999999975543
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
......|++.|+|||++.+..++.++||||||+++|||++|+.||... +..+.+....... ..+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~---~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS------TPNETWENLKYWK---ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC------CHHHHHHHHHhcc---ccccCCC
Confidence 223456899999999999989999999999999999999999999532 2222222111111 0011110
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+.++.+++.+||..+|.+||+++|+++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 111112345688999999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.64 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=205.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457888999999999999999988888899998865433 3467999999999999999999999875 45678999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.++++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999997542 235899999999999999999999998 999999999999999999999999999765433222
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......++..|+|||.+....++.++||||||+++|||++ |..||... ........... ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~------~~~~~~~~~~~----------~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------NNREVLEQVER----------GYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHc----------CCCC
Confidence 2222335668999999988889999999999999999999 88888522 11111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
..+...+..+.+|+.+||..+|++|||++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1233445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.42 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=202.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
.+|++.+.||+|+||.||++.++++..+|+|.+..... ...++.+|++++++++|+||+++++++...+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35788899999999999999988778899998754322 34578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999997543 26899999999999999999999999 9999999999999999999999999987654322222
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ... ....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~-~~~---------~~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN------SEVVESV-SAG---------YRLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHH-HcC---------CcCC
Confidence 222234567999999998889999999999999999999 7888853211 1111111 111 1111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
.+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2233566899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.96 Aligned_cols=263 Identities=29% Similarity=0.450 Sum_probs=210.6
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEe
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCL 448 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 448 (678)
++...++|++.+.||+|+||.||++...+ ...+|+|..... ......++.+|+++++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34455678899999999999999998642 368999987653 334556789999999999 7999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDP-------------SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
..+..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999999643 12356899999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccC
Q 041043 516 LLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEG 593 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~ 593 (678)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----- 238 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI----- 238 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC-----
Confidence 9999999999999999865443222 1222335678999999988889999999999999999998 88887422
Q ss_pred CChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
...+.+.... . ......+......+.+|+.+||..+|++|||++|+++.|+++.
T Consensus 239 -~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 -PVEELFKLLK-E---------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -CHHHHHHHHH-c---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2222121111 1 1111223344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.36 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=204.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467899999999999999999975 5788999987653 33445779999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999999753 35899999999999999999999853 2999999999999999999999999998755322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---h---------
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---E--------- 606 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~--------- 606 (678)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+ +...+..... .
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1233468999999999999899999999999999999999999995321110 1000000000 0
Q ss_pred ------------------ccchhhcch----hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 ------------------NCLFDILDD----QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ------------------~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+..+. ..........+.++.+|+.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 00011112345689999999999999999999999886
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.71 Aligned_cols=263 Identities=30% Similarity=0.454 Sum_probs=207.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeC-
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-SHRNVVKLLGSCLEV- 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~- 450 (678)
..++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+++++++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3467999999999999999999742 24789999886432 33456788999999999 799999999988654
Q ss_pred CcceEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSE-------------------------------------------------------- 474 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 474 (678)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999999864321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee-eeccccccCc
Q 041043 475 --ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGY 551 (678)
Q Consensus 475 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y 551 (678)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 126899999999999999999999998 9999999999999999999999999998764332221 2233456789
Q ss_pred cCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHH
Q 041043 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVS 630 (678)
Q Consensus 552 ~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (678)
+|||++.+..++.++|||||||++|||++ |..||..... .+.+....... .+...+....+++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------DEEFCRRLKEG---------TRMRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc------cHHHHHHHhcc---------CCCCCCccCCHHHH
Confidence 99999999999999999999999999998 9999853211 11111111111 11111233456799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 631 DVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 631 ~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+++.+||+.+|++||++.|+++.|+++...
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.29 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=204.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-----cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
+.|++.+.||+|+||.||+|.. .++..+++|.++.. ......++.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999984 24678999988743 34445788999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC
Q 041043 456 VYEFIPNGTLFQYLHDPS--------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 521 (678)
+|||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985322 1235889999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 041043 522 RAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATY 599 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~ 599 (678)
.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .. .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~------~~-~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS------NQ-E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HH-H
Confidence 9999999999765433221 2223335678999999988889999999999999999998 888885221 11 1
Q ss_pred HHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 600 FVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.......... ...+...+..+.+++.+||+.+|++||++.+++++|++
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111 11122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.26 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=206.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-C-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-D-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..|.+.+.||+|+||.||++... + ++.||+|+....+......+.+|+++++.++||||+++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34888999999999999999854 3 578888987666666667788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++|+|.++|+.. .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988643 22346899999999999999999999998 9999999999999999999999999998654332
Q ss_pred c-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 539 T-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 539 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ............. .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~------~~~~~~~~~~~~~-~-------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP------SQREIMQQVLYGK-Y-------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC-C--------
Confidence 2 1233456899999999999989999999999999999999999998521 1122221111110 0
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+.++.+++.+||+.+|++||++++++..
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01122345679999999999999999999998753
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.87 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=211.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC-----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEee-CCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLE-VEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~ 452 (678)
..++|.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999999765 688999987643 44556778999999999999999999998876 467
Q ss_pred ceEEEEeccCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEee
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEE-----LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 527 (678)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999754322 46899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHh
Q 041043 528 FGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 528 fgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
||+++.+....... .....++..|+|||.+....++.++||||||+++||+++ |+.||... ....+......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~~~~~~~~~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI------DPFEMAAYLKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC------CHHHHHHHHHc
Confidence 99998654433222 222345678999999988889999999999999999999 99998532 11111111111
Q ss_pred hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.. ........++++.+++.+||..+|++|||+.|+++.|+.+.+.
T Consensus 235 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 GY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11 1111223346789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.27 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=206.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+.|++.++||+|+||.||+|..++++.+|+|.+..... ..+++.+|++++++++|+||+++++++ ..+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 4567889999999999999999988899999998865433 346889999999999999999999986 45678999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999987543 346899999999999999999999998 99999999999999999999999999876553322
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.......++..|+|||.+....++.++||||||+++|||++ |+.||.... ........ ... ..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~-~~~---------~~ 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT------NPEVIQNL-ERG---------YR 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHH-HcC---------CC
Confidence 22223345678999999998889999999999999999999 999985221 11111111 111 11
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
...+...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122344579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.22 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=207.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~ 454 (678)
.-++|.+.++||+|.||+|+++..+ +++.+|||.++. ...++.+..+.|-.++...+ ||.++.++.++...++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999976 578999998875 34667788899999988875 999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||..||++..+.+. ..+++..+..++..|+.||+|||+++ |||||||.+|||||.+|++||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999996655542 35999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.... ..+....|||.|||||++.+..|+.+.|.|||||+||||+.|..||.+ .+-.+.+..+..++.
T Consensus 519 m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g------ddEee~FdsI~~d~~------ 585 (694)
T KOG0694|consen 519 MGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG------DDEEEVFDSIVNDEV------ 585 (694)
T ss_pred CCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC------CCHHHHHHHHhcCCC------
Confidence 4322 256678999999999999999999999999999999999999999963 333334444443332
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
.++...+.+...+++++|..+|++|.-+
T Consensus 586 -----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 -----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2355667788999999999999999876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.35 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=201.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 5889999987642 2334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999753 35889999999999999999999999 999999999999999999999999999765432
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
. ....|++.|+|||.+.+..++.++||||||+++|||++|+.||... ........... + ..
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~i~~-~--------~~ 232 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD------TPFRIYEKILA-G--------RL 232 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC------CHHHHHHHHhc-C--------Cc
Confidence 2 2346899999999999988999999999999999999999998521 11221211111 1 11
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
..+......+.+|+.+||+.||.+||+ ++|++..
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112223457889999999999999997 6777644
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.73 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=205.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|++.++||+|+||.||+|...+...||+|+++.... ..+++.+|++++++++|+||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 457899999999999999999987777899998875332 3467899999999999999999999874 45679999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.+++.+.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999997542 235799999999999999999999998 999999999999999999999999999765433322
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......++..|+|||.+....++.++||||||+++|||++ |+.||..... ....... .. ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------~~~~~~~-~~---------~~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQV-ER---------GYRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------HHHHHHH-hc---------CCCC
Confidence 2223346678999999988889999999999999999999 7888752211 1111111 11 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
....+.+..+.+++.+|++.+|++||+++++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 12334566889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.89 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=204.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|++.+.||+|+||.||+++.+ .|+.+|+|+++.. ...+.+.++.|=.+|....+|.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999965 5899999998764 35567788899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||++||++..+|.. ...|++..+..++.+++.|+..||+.| ++||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999985 457999999999999999999999999 9999999999999999999999999984321
Q ss_pred C----------------------C-cc----ee-------------------eeccccccCccCccccccCCCCcccchh
Q 041043 536 I----------------------D-QT----HV-------------------STKVQGTFGYLDPEYFHSSQFTDKSDVY 569 (678)
Q Consensus 536 ~----------------------~-~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVw 569 (678)
. + .. .. ....+|||.|||||++.+..|+...|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0 00 00 1123599999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC---
Q 041043 570 SFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT--- 646 (678)
Q Consensus 570 slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt--- 646 (678)
|||||+||||.|.+||.. ....+.+..++.-. ..+........+.+..+||.++|. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s------~tp~~T~rkI~nwr-------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCS------ETPQETYRKIVNWR-------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCC------CCHHHHHHHHHHHh-------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999963 33333333332211 011111223334788999999999 9999965
Q ss_pred HHHHHH
Q 041043 647 MKEVAM 652 (678)
Q Consensus 647 ~~evl~ 652 (678)
++||-+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 555543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=294.62 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=208.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++++.||+|.||.||.|..+ ++-.||+|++... ......++.+|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357899999999999999999964 5789999987542 223346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||.++|+|...|++.. ...+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++..||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999998543 346889999999999999999999999 9999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
........||..|.+||...+..++.+.|+|++|++.||++.|.+||... .-.+...++.+.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~------~~~etYkrI~k~---------- 237 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ------SHSETYKRIRKV---------- 237 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh------hhHHHHHHHHHc----------
Confidence 22334567999999999999999999999999999999999999999521 122222222221
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+...+...+++|.+|+..+|.+|.+..|+++.
T Consensus 238 -~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 -DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 122235566789999999999999999999999865
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.60 Aligned_cols=259 Identities=27% Similarity=0.483 Sum_probs=205.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-C--cEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-G--RIIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 456 (678)
++|++.+.||+|+||.||+|..++ + ..+++|.++. ......+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478899999999999999999753 3 3478888764 3344567899999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 457 YEFIPNGTLFQYLHDPS-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
+||+++++|.++++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999997532 1135889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 041043 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 602 (678)
||+|||++...... ........+..|+|||.+....++.++||||||+++|||++ |..||... ........
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~------~~~~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM------TCAELYEK 230 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHH
Confidence 99999998643211 11111223557999999988889999999999999999998 99998522 12222211
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
... ......+...+..+.+|+.+||+.+|.+|||++++++.|+.+....
T Consensus 231 ~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred Hhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 1111122334567899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.54 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=198.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.++||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999965 68899999876432 23345678999999999999999999999998999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
++ |+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 48999886532 35789999999999999999999999 99999999999999999999999999875433221
Q ss_pred eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH------------hh
Q 041043 540 HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV------------EE 606 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~~ 606 (678)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ........ ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccc
Confidence 1223457899999998865 5689999999999999999999999953221110 00000000 00
Q ss_pred ccchhhcchhhhcC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 607 NCLFDILDDQVRKS----GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 607 ~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........+..+.. .......++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011110100000 01123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=325.40 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=216.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc-ceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV-PLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 457 (678)
++|...+++|+|+||.++....+ +++.+++|++... .....+...+|+.++++++|||||...+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998864 5789999987653 34445578899999999999999999999999888 89999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
+|++||+|.+.|.+.+ ...++++++..++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+++.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 457899999999999999999999887 999999999999999999999999999988766
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ......||+.||.||.+.+..|..|+|||||||++|||++-+++|. +.++.....++....
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~------a~~m~~Li~ki~~~~---------- 222 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK------ASNMSELILKINRGL---------- 222 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC------ccchHHHHHHHhhcc----------
Confidence 53 3445679999999999999999999999999999999999999994 444554444443321
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+..++.++..|+..||+.+|..||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123356677899999999999999999999999987
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=317.97 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=206.7
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
+|++.+.||+|+||.||+|... ....+++|.+... .....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 2357888887643 33456789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCc
Q 041043 456 VYEFIPNGTLFQYLHDPS---------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 514 (678)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1235889999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccccc
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~ 592 (678)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---- 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI---- 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC----
Confidence 999999999999999987654332211 222345678999999988889999999999999999998 99998522
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+ ..... ......+...+.++.+++.+||+.+|++||+++|+++.|+++...
T Consensus 234 --~~~~~~-~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 234 --APERLF-NLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --CHHHHH-HHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111111 11111 111122334456899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=312.31 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=209.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||+|... +++.||||.++. .+......+.+|++++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999964 689999997653 33445567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 458 EFIPNGTLFQYLHDPSE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864322 345889999999999999999999998 99999999999999999999999999876543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.. +..+........ ....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~----~~~~~~~~~~~~-~~~~-------- 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLFSLCQKI-EQCD-------- 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc----ccccHHHHHHHH-hcCC--------
Confidence 221 12234578899999999888899999999999999999999999852 111222222111 1110
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
.........+..+.+++.+||..+|++||++.+|++.|+.++
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111112344567999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.99 Aligned_cols=239 Identities=27% Similarity=0.331 Sum_probs=195.2
Q ss_pred eeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
||+|+||.||++... +++.||+|.++. ........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 578999998753 2344556788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeecc
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 545 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 545 (678)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 9999753 35899999999999999999999999 9999999999999999999999999987543222 223345
Q ss_pred ccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHH
Q 041043 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625 (678)
Q Consensus 546 ~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (678)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||.. .+....+....... ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~------~~~~~~~~~~~~~~-----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD------ENVNEMYRKILQEP-----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC------CCHHHHHHHHHcCC-----------CCCCCcC
Confidence 689999999999998999999999999999999999999852 22222222222111 1122344
Q ss_pred HHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 041043 626 IMEVSDVAKRCLNSNGRSRPT---MKEVAM 652 (678)
Q Consensus 626 ~~~l~~li~~cl~~dP~~RPt---~~evl~ 652 (678)
.+++.+++.+||+.||++||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 567899999999999999985 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=324.48 Aligned_cols=242 Identities=26% Similarity=0.320 Sum_probs=197.2
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.||+|+||.||++... +|+.||+|.++.. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999964 6899999987642 3344567888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeee
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~ 543 (678)
+|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 999998743 35899999999999999999999999 99999999999999999999999999875332221 223
Q ss_pred ccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCH
Q 041043 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623 (678)
Q Consensus 544 ~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (678)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||... +............ ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~------~~~~~~~~~~~~~-----------~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEE-----------IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHhcCC-----------CCCCC
Confidence 356899999999999989999999999999999999999998521 1111111111110 01123
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 624 EEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 624 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
..++++.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 3456789999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.17 Aligned_cols=263 Identities=29% Similarity=0.440 Sum_probs=210.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEee
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCLE 449 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 449 (678)
..++|.+.+.||+|+||.||++... +...+|+|.++.. .....+++.+|+++++++ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467999999999999999999852 2357999988753 344556788999999999 79999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceE
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 516 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 516 (678)
.+..++|+||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 9999999999999999999976432 235899999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCC
Q 041043 517 LDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGR 594 (678)
Q Consensus 517 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~ 594 (678)
+++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.. .
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~------~ 246 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG------V 246 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc------C
Confidence 999999999999998765432211 1122234568999999998889999999999999999998 8888742 2
Q ss_pred ChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.....+..... . .....+...+.++.+|+.+||..+|.+|||+.||++.|+++.+..
T Consensus 247 ~~~~~~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 247 PVEELFKLLKE-G---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CHHHHHHHHHc-C---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 22222221111 1 111223344568899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.69 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=198.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+|++.+.||+|+||.||++... .++.||+|... .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 457999999999999999999964 68899999653 24577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+. ++|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 6898888643 35899999999999999999999998 99999999999999999999999999875433222
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCC-ChHHHHHHHHhh-c----------
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGR-NLATYFVECVEE-N---------- 607 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~-~---------- 607 (678)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......++. .....+...... +
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2333456999999999999889999999999999999999999887432211111 000011111000 0
Q ss_pred --cchhhc----chhhh--cCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 608 --CLFDIL----DDQVR--KSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 608 --~~~~~~----~~~~~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+.... ..... ... ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000 000 01335578999999999999999999999863
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=317.25 Aligned_cols=267 Identities=28% Similarity=0.400 Sum_probs=203.5
Q ss_pred CCcCCeeeeeCCcEEEEEEE-----cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceE
Q 041043 384 FNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLL 455 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 455 (678)
|...+.||+|+||+||++.. .+++.||+|..+... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 357889999886543 33457788999999999999999999988754 35789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
+|||+++++|.+++... .+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++....
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999643 4899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... ......++..|+|||.+....++.++||||||+++|||++|..|+....... ...............+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 32221 1122235667999999988889999999999999999999999975322110 00000000000000111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
+.......+...+.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111112223344568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=313.70 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=202.9
Q ss_pred CCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc-----
Q 041043 384 FNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV----- 452 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 452 (678)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+++.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999999642 367999987643 34456789999999999999999999998876554
Q ss_pred -ceEEEEeccCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 453 -PLLVYEFIPNGTLFQYLHDPS---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 453 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
.++++||+++|+|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 2346899999999999999999999998 999999999999999999999999
Q ss_pred cCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhh
Q 041043 529 GTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 529 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
|+++......... ......+..|+|||.+....++.++||||||+++|||++ |..||.... ..........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~------~~~~~~~~~~- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE------NHEIYDYLRH- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-
Confidence 9998664433221 112234678999999988889999999999999999999 888885321 1111111111
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
+. ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112234556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=320.57 Aligned_cols=265 Identities=27% Similarity=0.431 Sum_probs=211.9
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEe
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCL 448 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 448 (678)
...++|.+.+.||+|+||.||++... ++..||+|..... .....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999741 2457999987643 344567899999999999 8999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
.....+++|||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999975321 235788999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccC
Q 041043 516 LLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEG 593 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~ 593 (678)
|+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~------ 242 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------ 242 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc------
Confidence 99999999999999998664332221 222345678999999988889999999999999999998 7788742
Q ss_pred CChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
......+....... ....+...+..+.+|+.+||+.+|++|||+.|+++.|+++.....
T Consensus 243 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 243 IPVEELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred CCHHHHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 22222222222111 111123445679999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.46 Aligned_cols=280 Identities=26% Similarity=0.419 Sum_probs=217.5
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcC--------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLAD--------GRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSC 447 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 447 (678)
+....+|.+.+.||+|+||.||++.... +..+|+|..+.. .....+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3344578999999999999999997421 236899987643 344567899999999999 799999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCc
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPS-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 514 (678)
...+..++++||+++|+|.+++.+.. ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999999997532 2245889999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccccc
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~ 592 (678)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~----- 239 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG----- 239 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-----
Confidence 99999999999999998765432211 1122234567999999998889999999999999999998 8888742
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCchHHHH
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQKC 672 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~ 672 (678)
......+...... .....+...+.++.+++.+||+.+|.+|||+.|+++.|+++........-+...-+
T Consensus 240 -~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~~~~~~~~~~ 308 (334)
T cd05100 240 -IPVEELFKLLKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVP 308 (334)
T ss_pred -CCHHHHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCCCCeeeeeee
Confidence 2222222222111 11111233455789999999999999999999999999999976655444444444
Q ss_pred Hhhh
Q 041043 673 YEEL 676 (678)
Q Consensus 673 ~~~~ 676 (678)
++|+
T Consensus 309 ~~~~ 312 (334)
T cd05100 309 FEQY 312 (334)
T ss_pred eeec
Confidence 4444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.71 Aligned_cols=257 Identities=29% Similarity=0.450 Sum_probs=209.1
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
...++|.+.++||+|+||.||++..++++.+|||.+.... ...+++.+|++++++++|+||+++++++......++++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3457899999999999999999998888899999887533 334679999999999999999999999998889999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999997643 246899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.........+..|+|||.+.+..++.++||||||+++|||++ |+.||... ............ .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~------~~~~~~~~~~~~----------~ 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM------TNREVLEQVERG----------Y 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcC----------C
Confidence 222222234568999999998889999999999999999999 99998522 111111111111 1
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
....+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111122335679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.46 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=201.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC--CcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD--GRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.++|++.+.||+|+||.||+|..++ +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4568899999999999999998643 368999987532 33445678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999753 35899999999999999999999999 9999999999999999999999999997653
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +...........
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~------~~~~~~~~i~~~--------- 243 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN------EPLLIYQKILEG--------- 243 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC------CHHHHHHHHhcC---------
Confidence 22 12346899999999999888999999999999999999999999521 111111111111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
.. ..+......+.+++++||+.||++|+ +++|+++.
T Consensus 244 ~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 II--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 11223345688999999999999995 88888765
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=320.48 Aligned_cols=263 Identities=28% Similarity=0.460 Sum_probs=206.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCc--EEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGR--IIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 456 (678)
++|++.+.||+|+||.||+|.++ ++. .+++|+.+.. .....+++.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999965 343 4677776543 344567889999999999 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 457 YEFIPNGTLFQYLHDPS-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
+||+++++|.++++... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999997532 1235889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 041043 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 602 (678)
||+|||++...... ........+..|+|||.+....++.++||||||+++|||+| |..||.... ..+.+..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK 235 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC------hHHHHHH
Confidence 99999998632211 11111224667999999988889999999999999999998 999985221 1111111
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCC
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDD 665 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~ 665 (678)
... ......+...+..+.+|+.+||+.+|++||+++++++.|+++........
T Consensus 236 ~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~ 288 (303)
T cd05088 236 LPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288 (303)
T ss_pred Hhc----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence 111 01111122344578999999999999999999999999999886654333
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.28 Aligned_cols=265 Identities=25% Similarity=0.427 Sum_probs=210.0
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCC-CCceeeEEeEE
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQIS-HRNVVKLLGSC 447 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~ 447 (678)
+++...++|.+.++||+|+||.||+|.+. .++.||+|+++... ....+.+.+|++++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 45556678889999999999999999864 24689999987542 333567899999999997 99999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCCC-----------------------------------------------------
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPSE----------------------------------------------------- 474 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 474 (678)
...+..++|+||+++|+|.+++++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 041043 475 ------------------------------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512 (678)
Q Consensus 475 ------------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 512 (678)
...+++..++.++.|++.||+|||+.+ ++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 124678889999999999999999988 99999999
Q ss_pred CceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 041043 513 TNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWA 590 (678)
Q Consensus 513 ~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~ 590 (678)
+|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~- 346 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP- 346 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-
Confidence 9999999999999999999764322211 1222346788999999998889999999999999999998 888885221
Q ss_pred ccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 591 NEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
........... ..+...+...+.++.+|+.+||..+|.+||+++||++.|+++.
T Consensus 347 -----~~~~~~~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 -----MNEQFYNAIKR---------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----chHHHHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111111 1111122334568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=311.61 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=204.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|.+.+.||+|++|.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998877789999876433 23467889999999999999999999875 45688999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.++++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999997542 335899999999999999999999998 999999999999999999999999999765433222
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... .......... . ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~~-~---------~~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV------NREVLEQVER-G---------YRM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-C---------CCC
Confidence 2222345678999999988889999999999999999999 888985321 1111111111 1 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
..+...+..+.+++.+||..+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223455689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=314.49 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=202.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|++.+.||+|+||+||+|.+. +++ .+++|...... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45777899999999999999964 344 47788775432 334567888999999999999999999875 455789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999997533 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... .. ..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~-~~~~~~~~~~---- 229 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP------HE-VPDLLEKGER---- 229 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HH-HHHHHHCCCc----
Confidence 33222 2233456778999999998889999999999999999998 9999853211 11 1111111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
...+......+.+++.+||..+|++|||+.|+++.|+.+...
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 -----LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 111112234678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.70 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=206.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.+|.+.++||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999742 356899999887777777899999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 456 VYEFIPNGTLFQYLHDPSE------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975432 135889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 041043 524 KIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 601 (678)
||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------HHHHH
Confidence 99999998755432221 1222335678999999998889999999999999999998 8888842211 11111
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.... . .....+...+..+.+|+.+||+.||.+||+++||++.|++
T Consensus 236 ~~~~-~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQ-G---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHc-C---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111 1 0111122344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.28 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=207.7
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
+...++|++.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3456789999999999999999997542 4589999876433 33445688999999999999999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSE-------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 234577889999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 041043 524 KIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 601 (678)
||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~------~~~~~~ 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS------NEQVLK 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHH
Confidence 99999998765432221 1222235678999999998889999999999999999999 788875321 111111
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....... ...+...+..+.+++.+||+.+|++|||+.|+++.|++....
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 233 FVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1111110 011223346899999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=323.40 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=197.6
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.||+|+||.||++... +++.+|+|.+... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 6899999987642 3345567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeee
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~ 543 (678)
+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 999998753 35899999999999999999999999 9999999999999999999999999987533221 1223
Q ss_pred ccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCH
Q 041043 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623 (678)
Q Consensus 544 ~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (678)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||... ............. ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~------~~~~~~~~~~~~~-----------~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMED-----------IKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC------CHHHHHHHhccCC-----------ccCCC
Confidence 456899999999999889999999999999999999999998521 1111111111100 11123
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 624 EEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 624 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
..+.++.+|+.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3456789999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.07 Aligned_cols=257 Identities=29% Similarity=0.407 Sum_probs=203.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
.+++|.+.+.||+|++|.||+|.+.+ +..|++|...... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999999753 5688999876433 3445679999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC---cEEE
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSE----ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKI 525 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl 525 (678)
.++|+||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 235899999999999999999999998 99999999999998654 6999
Q ss_pred eeccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHH
Q 041043 526 ADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
+|||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |+.||..... .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------~~~~~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------QEVMEFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Confidence 9999998653222111 112233568999999998889999999999999999997 9999853211 1111111
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
... .....+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 235 ~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111 111122334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.66 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=199.9
Q ss_pred CCcCCeeeeeCCcEEEEEEEcCC-c--EEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC------Cc
Q 041043 384 FNVNRILGQGGQGTVYKGMLADG-R--IIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV------EV 452 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~ 452 (678)
|.+.++||+|+||.||+|++.+. . .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999997543 2 6899987643 455567899999999999999999999987532 24
Q ss_pred ceEEEEeccCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 453 PLLVYEFIPNGTLFQYLHDP---SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
.++++||+++|+|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12345899999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhc
Q 041043 530 TSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 530 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
+++......... .....+++.|++||.+....++.++||||||+++|||++ |+.||.... ........ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~-~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE------NSEIYDYL-RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHH-HcC
Confidence 998664332221 122345678999999999899999999999999999999 788885321 11111111 111
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.. ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 231 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 011223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.87 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=207.7
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
...++|.+.++||+|+||.||++...++..+++|.++.. ....+.+.+|++++++++|+||+++++.+.+ ...++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345789999999999999999999877888999987653 3345788999999999999999999999887 77899999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999997643 345889999999999999999999988 9999999999999999999999999987654332
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
........++..|+|||++....++.++|+||||+++|++++ |+.||... ...... ...... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~------~~~~~~-~~~~~~---------~ 220 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVI-RALERG---------Y 220 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC------CHHHHH-HHHhCC---------C
Confidence 222223345678999999988889999999999999999999 89898522 111111 111111 1
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
........+.++.+++.+|++.+|++||++.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1111233456799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=319.19 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=198.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.+.||+|+||.||+|... +++.+|||.++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999975 688999998864332 233467889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 68888886532 35889999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---hc---cch-
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---EN---CLF- 610 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~- 610 (678)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.... +.......... .. .+.
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK-----DIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc-----cHHHHHHHHHHHhCCCChhhccc
Confidence 12233457899999999865 457889999999999999999999996321 11111111110 00 000
Q ss_pred -----hhcchhhhcCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 611 -----DILDDQVRKSG---------KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 611 -----~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........... .......+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000 0012346889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.48 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=211.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||+|... +++.+|+|.++. .+....+.+.+|++++++++|+|++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 789999997753 33444678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 458 EFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
||+++++|.+++.... ....+++.+++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2346899999999999999999999998 99999999999999999999999999876543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||... ..+......... .+..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~-~~~~------- 225 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCKKIE-KCDY------- 225 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC----CccHHHHHhhhh-cCCC-------
Confidence 2221 22345788999999998888999999999999999999999998521 122222111111 1100
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
...........+.+++.+||..+|++|||+.+|+++|+.+.
T Consensus 226 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 -PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01111245568899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.78 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=197.5
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
+.||+|+||.||+|... +++.+|+|..... ..+....+.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999964 6889999987543 344557799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee-eec
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-STK 544 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~-~~~ 544 (678)
.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99997532 35899999999999999999999998 9999999999999999999999999987543221111 111
Q ss_pred cccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCH
Q 041043 545 VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623 (678)
Q Consensus 545 ~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (678)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... . ...... .......+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~-~~~~~~---------~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------Q-TREAIE---------QGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------H-HHHHHH---------cCCCCCCcc
Confidence 123457999999998889999999999999999998 88887422111 0 111111 111112233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 624 EEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 624 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
..+..+.+++.+||+.+|++|||+.|++++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 44568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.17 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=202.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.++||+|+||.||++... ++..+|+|.+... .....+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999976 5788999987653 34445779999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+|+||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999753 3588999999999999999999975 5 999999999999999999999999998754322
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh-----------
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE----------- 606 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 606 (678)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .+...+......
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK---ELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh---HHHHHhcCcccCCccccccCccc
Confidence 122345889999999999888999999999999999999999998632211 000000000000
Q ss_pred -----------------ccchhhcchhhhc----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 -----------------NCLFDILDDQVRK----SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 -----------------~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....+.+..... ........++.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000000 0011234678999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=310.49 Aligned_cols=276 Identities=22% Similarity=0.292 Sum_probs=211.2
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcc--cCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSK--VVDESKLEEFINEVVILSQISHRNVVKLLGSCLE---- 449 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~---- 449 (678)
...+...|...+.||+|+||.|..+... +|+.||||++. ..+....++..+|+++|+.++|+||+.+.+++..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3445566777899999999999999964 68999999987 5667778899999999999999999999998875
Q ss_pred -CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 450 -VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 450 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
-+..|+|+|+| ..+|...|+.. ..|+......++.|+++||+|+|+.+ |+||||||.|+|++.+...||+||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence 34679999999 45899988743 34999999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCC-cceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh--------HH
Q 041043 529 GTSRSIAID-QTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL--------AT 598 (678)
Q Consensus 529 gl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~--------~~ 598 (678)
|+|+..... .....+..+.|..|.|||++.. ..|+.+.||||.||||.||++|++-|.+...-+.-.+ ..
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999977543 1223466778999999998755 6799999999999999999999999864332211100 00
Q ss_pred HHHHHHhhccchhhcchhhhc-CCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 599 YFVECVEENCLFDILDDQVRK-SGK-----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
.....+........+...... ..+ +...+...+|+.+||..||.+|+|++|.++. |+....
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 111111111111111111000 000 1333578899999999999999999999987 566553
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=339.29 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=207.7
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE- 451 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~- 451 (678)
+.+...++|.+.+.||+|+||+||++.. .+++.||||.+.. .+......+.+|+..+..++|+|+++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3444567999999999999999999985 4689999998754 34555677889999999999999999988775432
Q ss_pred -------cceEEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 452 -------VPLLVYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 452 -------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
..++||||+++|+|.++++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 2579999999999999997532 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 041043 524 KIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 602 (678)
||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.. ......+..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~------~~~~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG------ENMEEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------CCHHHHHHH
Confidence 9999999976543222 223345689999999999999999999999999999999999999852 222222222
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..... ....+...++++.+++.+||+.||++||++.++++.
T Consensus 257 ~~~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGR----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 011223445689999999999999999999999864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.10 Aligned_cols=247 Identities=31% Similarity=0.451 Sum_probs=200.0
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChh
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF 466 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 466 (678)
++||+|+||.||+|...+++.+|+|...... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4789999999999998888999999876543 334457899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccc
Q 041043 467 QYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546 (678)
Q Consensus 467 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 546 (678)
+++.... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++...............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9997543 35889999999999999999999998 999999999999999999999999998754332222222233
Q ss_pred cccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHH
Q 041043 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625 (678)
Q Consensus 547 gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (678)
++..|+|||++....++.++||||||+++||+++ |..||.... ...... ..... .+...+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~------~~~~~~-~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT------NQQARE-QVEKG---------YRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHH-HHHcC---------CCCCCCCCC
Confidence 4677999999998889999999999999999998 999985321 111111 11111 111122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 626 IMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 626 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
+..+.+++.+|+..+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=329.69 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=203.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567899999999999999999965 5889999987532 23344567889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999999643 4788999999999999999999998 9999999999999999999999999997654
Q ss_pred CCcceeeeccccccCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSS----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
...........||+.|+|||++... .++.++||||||+++|||++|+.||.. .+....+........
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~------~~~~~~~~~i~~~~~--- 264 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMDHKN--- 264 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC------CCHHHHHHHHHcCCC---
Confidence 3332223345689999999998653 478899999999999999999999952 222222222221110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS--RPTMKEVAME 653 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 653 (678)
.+........+.++.+|+.+||+.+|++ |||+.|+++.
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111111234568899999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=316.19 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=194.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc--CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcC---CCCceeeEEeEEee-----
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA--DGRIIAVKKSKVVD--ESKLEEFINEVVILSQI---SHRNVVKLLGSCLE----- 449 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~----- 449 (678)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46889999876432 22334566777777765 69999999998853
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
....++|+||++ ++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 68999997543 235899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc--
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN-- 607 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 607 (678)
++...... .......+++.|+|||.+....++.++||||||+++|||++|+.||..... .+.........
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~------~~~~~~i~~~~~~ 227 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGKILDVIGL 227 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH------HHHHHHHHHHhCC
Confidence 99765432 223345689999999999888899999999999999999999999853211 11111111100
Q ss_pred ----cchh---hcchhhh--c-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 608 ----CLFD---ILDDQVR--K-----SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 608 ----~~~~---~~~~~~~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+.. ....... . .......+.+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000 0 001123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.45 Aligned_cols=245 Identities=29% Similarity=0.428 Sum_probs=196.9
Q ss_pred eeeeeCCcEEEEEEEc---CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 389 ILGQGGQGTVYKGMLA---DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
.||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++|+||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 57889999876432 345678999999999999999999999875 45678999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee-
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS- 542 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~- 542 (678)
+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999999743 35899999999999999999999999 99999999999999999999999999987654333211
Q ss_pred -eccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 543 -TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 543 -~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
....++..|+|||.+....++.++||||||+++|||++ |+.||.... ...... ....+ ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~-~i~~~---------~~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK------GNEVTQ-MIESG---------ERME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHH-HHHCC---------CCCC
Confidence 12234578999999988889999999999999999998 999985321 111111 11111 1112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.+...+.++.++|.+||+.||++||++++|.+.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 233455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.43 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=208.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.++|.+.++||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999999643 2468999876544 5566789999999999999999999998865 55789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999997542 35899999999999999999999998 9999999999999999999999999987665
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
...........++..|+|||.+....++.++||||||+++||+++ |+.||..... ...........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~------- 225 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN------NDVIGRIENGE------- 225 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcCC-------
Confidence 443322333345568999999988889999999999999999996 9999853211 11111111111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
+...+...+..+.+++.+|+..+|++|||+.++++.|++++..+
T Consensus 226 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 226 ---RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 11112344568999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=321.09 Aligned_cols=278 Identities=26% Similarity=0.427 Sum_probs=213.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEee
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCLE 449 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 449 (678)
..++|.+.+.||+|+||.||++... ....+|+|.++.. ......++.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3457888999999999999999742 2457899987643 344567789999999999 69999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceE
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPS-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 516 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 516 (678)
.+..++++||+++|+|.+++.... ....+++.++..++.|++.||.|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 889999999999999999997532 1245899999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCC
Q 041043 517 LDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGR 594 (678)
Q Consensus 517 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~ 594 (678)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~------ 240 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI------ 240 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC------
Confidence 999999999999999765432211 1112234567999999988889999999999999999999 88887422
Q ss_pred ChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCchHHHHHh
Q 041043 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQKCYE 674 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~~~~~ 674 (678)
.....+.... ... ....+...+.++.+++.+||..+|++|||+.|+++.|+++.... ..+.-.....++
T Consensus 241 ~~~~~~~~~~-~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~-~~~~~~~~~~~~ 309 (314)
T cd05099 241 PVEELFKLLR-EGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV-SEEYLDLSMPFE 309 (314)
T ss_pred CHHHHHHHHH-cCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh-cCCceeeEEehh
Confidence 2222222111 111 11112334457889999999999999999999999999987532 222223333444
Q ss_pred hhc
Q 041043 675 ELS 677 (678)
Q Consensus 675 ~~~ 677 (678)
+|+
T Consensus 310 ~~~ 312 (314)
T cd05099 310 QYS 312 (314)
T ss_pred hcC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=323.04 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=199.8
Q ss_pred CCCcCCeeeeeCCcEEEEEEE----cCCcEEEEEEcccC----ChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcc
Q 041043 383 HFNVNRILGQGGQGTVYKGML----ADGRIIAVKKSKVV----DESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~ 453 (678)
+|++.+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|++++++++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999885 35789999987532 2234467888999999995 99999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999999753 35899999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.............||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... .............
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~------ 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER--NTQSEVSRRILKC------ 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC--CCHHHHHHHHhcC------
Confidence 544333333345689999999998765 4788999999999999999999998532111 1111111111110
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
....+...+..+.+++.+||+.||++|| +++|+++.
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 -----DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111233456789999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.35 Aligned_cols=256 Identities=25% Similarity=0.459 Sum_probs=206.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CC---cEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DG---RIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.++|+..+.||+|+||.||+|..+ ++ ..+++|+.+.. .....+++..|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456788899999999999999975 23 37999988654 34456789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999997532 46899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCcceee--eccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 536 IDQTHVS--TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 536 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
....... .....+..|+|||++....++.++||||||+++|||++ |+.||.... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~------~~~~~~~i~~~------ 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS------NHEVMKAINDG------ 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC------HHHHHHHHhcC------
Confidence 3222211 11223457999999988889999999999999999998 999984221 11111111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.........+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111223456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.70 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=208.5
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCCceeeEEeEEee
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-SHRNVVKLLGSCLE 449 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 449 (678)
....++|.+.+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+++++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 334567999999999999999999742 34579999876543 44457799999999999 79999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
.+..++++||+++|+|.++++.... ..+++.+++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999975432 34899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhc
Q 041043 530 TSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 530 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
++......... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... ...+.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------~~~~~~~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------DSKFYKLIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc------hHHHHHHHHcC
Confidence 99765433221 1222345678999999998889999999999999999998 9999853211 11111111111
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.....+...+.++.+++.+||..+|++|||+.|+++.|+++
T Consensus 261 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111223346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.07 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=204.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhh--HHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK--LEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 456 (678)
++|+..+.|++|.||.||+|+.+ +++.||+|+++...+.. .-.-.+||.+|.+.+|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35677789999999999999964 68999999987644221 23457999999999999999999988754 568999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||++. +|...+...+ .++...++.-+..|+++|++|||++. |+|||||++|+|+.+.|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 8999998765 46889999999999999999999999 99999999999999999999999999998765
Q ss_pred CcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH--Hhhccchhhc
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC--VEENCLFDIL 613 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 613 (678)
... ..+..+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+... -.++...|... ..+..+..+.
T Consensus 230 p~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 PLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred Ccc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCccccCCCcc
Confidence 533 3455678999999999877 4699999999999999999999998864322 22222222211 1111111111
Q ss_pred --------------chhhhcCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 --------------DDQVRKSGKTE-EIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 --------------~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...++..+... .++.-.+|+..+|.+||++|.|+.|.++.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11112211111 34667899999999999999999998864
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=312.07 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=209.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||++.. .+++.++||.+.. .+....+++.+|+.+++.++|+||+++++++.+.+..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 4789999997654 23344568899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 458 EFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987422 2346899999999999999999999999 99999999999999999999999999876543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.... ............ ..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~---------~~ 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQ---------CD 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc----chHHHHhhhhhc---------CC
Confidence 222 1223457889999999988889999999999999999999999985211 111111111110 00
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
.........++.+.+++.+||..+|.+|||+.+|++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011112345668999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.70 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=206.5
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|++.+.||.|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888999999999999999875 78999999876544 5678999999999999999999999999989999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999975432 36899999999999999999999999 99999999999999999999999999976532211
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
....+..|+|||.+....++.++||||||+++|||++ |..||... .... ........ .+.
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~-~~~~~~~~---------~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKD-VVPHVEKG---------YRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC------CHHH-HHHHHhcC---------CCC
Confidence 2334667999999988889999999999999999997 99998522 1111 11111111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
..+...++.+.+++.+||..+|++|||++|++++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11223456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.97 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=204.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|.+.+.||+|+||+||++... +++.+|+|.++.. .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 6889999987643 2334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997642 36899999999999999999999999 999999999999999999999999999876544
Q ss_pred cceeeeccccccCccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFH------SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
.........+|+.|+|||++. ...++.++||||||+++|||++|+.||... .....+..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~------~~~~~~~~i~~~~~~~- 228 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG------TSAKTYNNIMNFQRFL- 228 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC------CHHHHHHHHHcCCCcc-
Confidence 433334456899999999986 456788999999999999999999999521 2222222222211100
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+..+.+|+.+||+ +|++|||+++++..
T Consensus 229 ------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 ------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111112345678999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.25 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=196.7
Q ss_pred eeeeeCCcEEEEEEEc---CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCC
Q 041043 389 ILGQGGQGTVYKGMLA---DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGT 464 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 464 (678)
.||+|+||.||+|.+. ++..||+|...... ....+++.+|+.++++++|+||+++++++. .+..++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35579999886543 334567999999999999999999999875 457799999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee--
Q 041043 465 LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-- 542 (678)
Q Consensus 465 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~-- 542 (678)
|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99999753 236899999999999999999999998 99999999999999999999999999976543332211
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (678)
....++..|+|||.+....++.++||||||+++||+++ |+.||..... .... .....+ .+...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~-~~~~~~---------~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVM-SFIEQG---------KRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHH-HHHHCC---------CCCCC
Confidence 11223578999999988889999999999999999996 9999853211 1111 111111 11122
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 622 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
+...++++.+++.+||..+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 334457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.20 Aligned_cols=242 Identities=27% Similarity=0.370 Sum_probs=195.7
Q ss_pred CeeeeeCCcEEEEEEE----cCCcEEEEEEcccC----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 388 RILGQGGQGTVYKGML----ADGRIIAVKKSKVV----DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+.||+|+||.||++.. .+++.||+|.++.. +......+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 35789999987642 223345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999999753 35788999999999999999999999 99999999999999999999999999875432222
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||... +........... . .
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~------~~~~~~~~~~~~---------~--~ 217 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE------NRKKTIDKILKG---------K--L 217 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC------CHHHHHHHHHcC---------C--C
Confidence 223356899999999999888999999999999999999999999521 111111111111 0 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
..+...+..+.+++.+||+.+|++|| ++.++++.
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11233456789999999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.53 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=205.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|.+.+.||+|+||+||++... +++.||||+++.. .....+.+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 6899999987642 2244567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999754 46899999999999999999999998 999999999999999999999999999765443
Q ss_pred c----------------------------ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 041043 538 Q----------------------------THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIW 589 (678)
Q Consensus 538 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~ 589 (678)
. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112233468999999999999999999999999999999999999995321
Q ss_pred cccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 041043 590 ANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-MKEVAME 653 (678)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 653 (678)
............ ...........++++.+|+.+||. ||.+||+ ++|+++.
T Consensus 235 ------~~~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 ------LQETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111121111100 011111111246688999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=316.33 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDE-SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
+|.+.+.||+|+||.||+|...+ ++.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46778899999999999998632 47899999875433 334678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc
Q 041043 456 VYEFIPNGTLFQYLHDPS-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 522 (678)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235888999999999999999999998 999999999999999999
Q ss_pred EEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 041043 523 AKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 523 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 600 (678)
+||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |..||... ......
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~------~~~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY------SNQDVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------CHHHHH
Confidence 999999998765432221 2233345778999999988889999999999999999998 77887522 112222
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
..... ... ...+...+..+.+|+.+||+.+|++||++++|+..|+.
T Consensus 237 ~~i~~-~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRN-RQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHc-CCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22111 111 11123455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.74 Aligned_cols=269 Identities=23% Similarity=0.334 Sum_probs=199.2
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----cce
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE-----VPL 454 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 454 (678)
+|++.++||+|+||.||+|... +++.||||++... ......++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999964 6899999987642 2334467889999999999999999999886432 479
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6899988643 35899999999999999999999999 999999999999999999999999999764
Q ss_pred cCCcce--eeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcccccc---------CCChHHHHH
Q 041043 535 AIDQTH--VSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYIWANE---------GRNLATYFV 601 (678)
Q Consensus 535 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~~~~~---------~~~~~~~~~ 601 (678)
...... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... +........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322211 1234568999999999875 678999999999999999999999985321100 000000000
Q ss_pred HHHhhccchhhcchh---hhcC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 602 ECVEENCLFDILDDQ---VRKS---GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~---~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
.... ......+... .... ........+.+++.+||+.||++|||++|+++. ++.+..
T Consensus 234 ~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 234 RVRN-EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred Hhhh-hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 0000000000 0000 001223568899999999999999999999976 544443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.53 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=206.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
..++|.+.+.||+|+||.||+|...+ +..+|+|...... .....++.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34678889999999999999998642 3689999976543 3445678999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSE-------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
.++|+||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 9999999999999999975322 234789999999999999999999998 999999999999999999999
Q ss_pred eeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHH
Q 041043 526 ADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
+|||+++........ ......++..|+|||.+....++.++||||||+++||+++ |+.||... .........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~------~~~~~~~~~ 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL------SNEEVLKFV 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC------CHHHHHHHH
Confidence 999998765433221 2233346788999999988889999999999999999998 88888421 112111111
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
. .... ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 I-DGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred h-cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 1111 11122335689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.48 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=205.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.+|++.+.||+|+||.||+|... .+..+|+|.++.. .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999863 2347999987643 234467899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997543 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccceeee--ccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 537 DQTHVST--KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 537 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
....... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ........ +.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~------~~~~~~~~-~~------ 225 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN------QDVIKAIE-EG------ 225 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH------HHHHHHHh-CC------
Confidence 3322221 1223568999999998889999999999999999887 9999853211 11111111 11
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.+...+...+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ---YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=327.85 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=201.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||++... +++.||||++... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 5899999988642 2344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999998654321
Q ss_pred cce-------------------------------------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh
Q 041043 538 QTH-------------------------------------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580 (678)
Q Consensus 538 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt 580 (678)
... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0012358999999999999899999999999999999999
Q ss_pred CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 041043 581 GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT---MKEVAME 653 (678)
Q Consensus 581 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 653 (678)
|..||... +............. .+........++++.+|+.+|+. +|.+|++ ++|+++.
T Consensus 235 G~~Pf~~~------~~~~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSD------NPQETYRKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCC------CHHHHHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999522 12222222211110 00111111235678899999996 9999997 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.90 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=202.8
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
...++|++.+.||+|+||.||++... +++.+|+|.+.. ......+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34568999999999999999999975 578999998753 22334456889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999999643 4889999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcceeeeccccccCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSS----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
............||+.|+|||++... .++.++||||||+++|||++|+.||.. .+....+.........
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~------~~~~~~~~~i~~~~~~- 265 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA------DSLVGTYSKIMDHKNS- 265 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC------CCHHHHHHHHHhCCcc-
Confidence 43332233445699999999998754 378899999999999999999999952 2222222222221110
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS--RPTMKEVAME 653 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 653 (678)
+........+..+.+++.+||..++.+ ||++.|+++.
T Consensus 266 ------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 ------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111112234567889999999865544 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=325.89 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=195.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|+..++||+|+||.||++... +++.||||.+... .....+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999965 6899999987543 334456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986533 3567888899999999999999999 99999999999999999999999999976543221
Q ss_pred eeeeccccccCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 540 HVSTKVQGTFGYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
......|+..|+|||.+.. ...+.++||||||+++|||++|+.||.... .............
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~---~~~~~~~~~~~~~--------- 290 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR---QGDWASLMCAICM--------- 290 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CccHHHHHHHHhc---------
Confidence 1233468999999998753 223568999999999999999999986211 1111111111100
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
............++.+|+.+||+.||++|||+.|+++.
T Consensus 291 -~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 -SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223445679999999999999999999999986
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.66 Aligned_cols=258 Identities=28% Similarity=0.488 Sum_probs=204.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
.++|+..++||+|+||+||+|.+. +++ .||+|.++.. .....+++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356788899999999999999853 444 4899987643 34456788999999999999999999999875 4568
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+++||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999997542 35899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 535 AIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 535 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~----- 227 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIP----DLLEKG----- 227 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCC-----
Confidence 5332221 122235678999999988889999999999999999998 8888852211 0111 111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+...+..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 228 ----ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11111233456789999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.24 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=194.4
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHH---hcCCCCceeeEEeEEeeCCcceEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVIL---SQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
|++.+.||+|+||.||++... +++.||||.++.. .....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 5899999988642 233445666776655 567899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|..+++. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999998864 35899999999999999999999999 99999999999999999999999999865332
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||... .............
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~------~~~~~~~~i~~~~--------- 217 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD------DEEEVFDSIVNDE--------- 217 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC---------
Confidence 22 1223456899999999999989999999999999999999999998522 2222222211111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAM 652 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 652 (678)
...+...+..+.+++.+||+.||++||+ +.++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112234567889999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.76 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=202.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC---------------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD---------------GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLL 444 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~ 444 (678)
.++|++.+.||+|+||.||++...+ ...||+|..+.. .....+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 235899987653 344556799999999999999999999
Q ss_pred eEEeeCCcceEEEEeccCCChhhhhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSE---------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 445 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999965321 124788999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcccccc
Q 041043 516 LLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT--GQKPISYIWANE 592 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt--g~~p~~~~~~~~ 592 (678)
++++++.+||+|||++......... ......++..|+|||.+....++.++||||||+++|||++ +..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 9999999999999998765433221 1222345678999999988889999999999999999998 5566642211
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
......... .............+...+..+.+|+++||+.+|++|||+.+|++.|+
T Consensus 239 ----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 ----EQVIENTGE---FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ----HHHHHHHHH---hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111100 00000011111112234468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.92 Aligned_cols=250 Identities=29% Similarity=0.493 Sum_probs=197.8
Q ss_pred CeeeeeCCcEEEEEEEcC-Cc--EEEEEEccc-CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLAD-GR--IIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||+|..++ +. .+++|..+. ......+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 33 568888764 3345567899999999999 799999999999999999999999999
Q ss_pred CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 463 GTLFQYLHDPS-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 463 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
|+|.++++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 1235789999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||... .....+......
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~------~~~~~~~~~~~~-- 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEKLPQG-- 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc------CHHHHHHHHhCC--
Confidence 985322111 1111223567999999988889999999999999999997 99998421 111222211111
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
.....+.....++.+|+.+||..+|.+|||+.|++..|++|.
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111112234457899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=321.39 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=196.3
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.||+|+||.||++... +++.||+|.++.. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 6889999987642 3344567788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
+|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 999998743 358999999999999999999997 67 99999999999999999999999999875432222 22
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....||+.|+|||++.+..++.++||||||+++|||++|+.||... ............ . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~------~~~~~~~~i~~~---------~--~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILME---------E--IRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC------CHHHHHHHHhcC---------C--CCCC
Confidence 3346899999999999989999999999999999999999998521 111111111111 0 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
.....++.+|+.+||+.||++|+ +++++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23456789999999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.24 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=202.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-----hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-----ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|.+.+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999964 68999999865422 2234678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
++||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999999753 35889999999999999999999999 9999999999999999999999999987554
Q ss_pred CCcceee--eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTHVS--TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||... ..... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~-~~~~~~-------- 221 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF-----EAMAA-IFKIAT-------- 221 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc-----chHHH-HHHHhc--------
Confidence 3221111 2345778999999999988999999999999999999999998521 11111 111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......+......+.+++.+||..+|.+|||+.|+++.
T Consensus 222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 -QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111112233455678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.71 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=197.2
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|+||.||++... +++.||+|.++.. .....+.+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999965 5889999988642 234456688999999988 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 9999998643 35999999999999999999999999 9999999999999999999999999986432211 122
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccccc--CCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE--GRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......+......... . .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--C
Confidence 34568999999999999899999999999999999999999996432221 1112222222221111 1 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPT------MKEVAM 652 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~ 652 (678)
.+...+.++.+++.+||+.||.+||+ ++|+++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12234557899999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.44 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=197.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||++... +++.+|+|+++.. .....+.+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 5889999988642 2334467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999753 36899999999999999999999999 999999999999999999999999998754321
Q ss_pred cc----------------------------------eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 041043 538 QT----------------------------------HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQK 583 (678)
Q Consensus 538 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~ 583 (678)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123468999999999999899999999999999999999999
Q ss_pred CCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 041043 584 PISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLN--SNGRSRPTMKEVAME 653 (678)
Q Consensus 584 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 653 (678)
||... ............. ..+........++++.+++.+++. .++..||+++|+++.
T Consensus 235 Pf~~~------~~~~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSE------TPQETYKKVMNWK-------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCC------CHHHHHHHHHcCc-------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99522 2222222222110 000011111234567788888664 233356899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.07 Aligned_cols=255 Identities=24% Similarity=0.440 Sum_probs=203.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-C---cEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-G---RIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..|++.+.||+|+||.||+|.... + ..||||.++.. +....++|..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347788999999999999999653 3 36999988654 455567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999997542 35899999999999999999999998 99999999999999999999999999876543
Q ss_pred Cccee--eeccc--cccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 537 DQTHV--STKVQ--GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 537 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
..... ..... .+..|+|||.+....++.++||||||+++||+++ |..||... ......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~------~~~~~~~~i-~~~---- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------SNQDVINAI-EQD---- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC------CHHHHHHHH-HcC----
Confidence 22211 11111 2457999999998899999999999999999886 99998422 111111111 110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.....+.+.+..+.+++.+||+.+|.+||++++++..|+++
T Consensus 228 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.27 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=202.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
++|++.+.||+|+||.||+|+. .+++.+|+|+...........+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4689999999999999999996 468899999887655555667889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.++++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999999743 35899999999999999999999998 99999999999999999999999999976542221
Q ss_pred eeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 541 VSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
......++..|+|||.+. ...++.++||||||+++|||++|+.||......+. .... ... ......
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~~~-~~~---~~~~~~- 230 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLM-SKS---NFQPPK- 230 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------heee-ecC---CCCCCC-
Confidence 122345788999999884 34578899999999999999999999842211110 0000 000 000000
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
.......+..+.+++.+||..+|++|||++++++.|
T Consensus 231 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 -LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011123456899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=311.07 Aligned_cols=263 Identities=29% Similarity=0.418 Sum_probs=205.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC-----------------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceee
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD-----------------GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~ 442 (678)
.++|++.+.||+|+||.||++...+ +..||+|.+... .....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988643 246899987653 3445678999999999999999999
Q ss_pred EEeEEeeCCcceEEEEeccCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCc
Q 041043 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE--------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 443 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 514 (678)
+++++...+..++++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976431 235899999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCccccc
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT--GQKPISYIWAN 591 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt--g~~p~~~~~~~ 591 (678)
|+++.++.++|+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ +..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 99999999999999998765433222 2233446778999999988889999999999999999998 666764221
Q ss_pred cCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
....+...... ............+...+.++.+++.+||+.||++|||+.||++.|+
T Consensus 239 ----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 ----DQQVIENAGHF---FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----hHHHHHHHHhc---cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111110 0000011111112234468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.99 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=197.8
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.|+..+.||+|+||+||+|... +++.+|||++... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 5789999988642 34456778999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999999753 35899999999999999999999998 9999999999999999999999999975431100
Q ss_pred c----------------------------------------------eeeeccccccCccCccccccCCCCcccchhhHH
Q 041043 539 T----------------------------------------------HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFG 572 (678)
Q Consensus 539 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslG 572 (678)
. .......||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234689999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhc--ccCCCCCCCHHHH
Q 041043 573 VVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCL--NSNGRSRPTMKEV 650 (678)
Q Consensus 573 vll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~RPt~~ev 650 (678)
|++|||++|+.||..... ........... ...........+.++.+|+.+|+ ..+|..||+++|+
T Consensus 236 ~il~elltG~~Pf~~~~~------~~~~~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP------TETQLKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCH------HHHHHHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999953211 11111111100 00111111234567888998854 5566669999999
Q ss_pred HHH
Q 041043 651 AME 653 (678)
Q Consensus 651 l~~ 653 (678)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=305.14 Aligned_cols=269 Identities=24% Similarity=0.324 Sum_probs=204.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCc-eeeEEeEEeeCC------
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRN-VVKLLGSCLEVE------ 451 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~------ 451 (678)
..|...++||+|+||+||+|+. .+|+.||+|+++...+ .......+|+.+|++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455667899999999999995 4689999999876433 24456789999999999999 999999998877
Q ss_pred cceEEEEeccCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEE-LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++|+||++. +|..++...... ..++...+..+..||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999965 999999875432 35777899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH--hhc
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV--EEN 607 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 607 (678)
++....+... .+..++|..|.|||++.+. .|+...||||+|||++||++++.-|.+... ..++...+.-.- .+.
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCcc
Confidence 9976644333 3445689999999999876 799999999999999999999988864322 111222121110 111
Q ss_pred cchhhc---chh--hhcCC-C-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 041043 608 CLFDIL---DDQ--VRKSG-K-------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERI 657 (678)
Q Consensus 608 ~~~~~~---~~~--~~~~~-~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l 657 (678)
.+..+. +.. ..... + ........+++.+||+++|.+|.|++.++++ +..+
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 121111 100 00000 1 1111467899999999999999999999987 5544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.43 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=214.9
Q ss_pred CCcCCeeeeeCCcEEEEEEEcC--C--cEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLAD--G--RIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
..+.++||+|.||.|++|.|.. | ..||||.++..... ...+|++|+.+|-+|+|+|+++|+|++.+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 4456799999999999999853 4 36899999876555 67899999999999999999999999998 78899999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
.++.|+|.+.|++ .....+....+-.++.|||.||+||.+++ +|||||..+|+||-....+||+||||.+.+...+
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999998 34567888899999999999999999999 9999999999999999999999999999887544
Q ss_pred cee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 539 THV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 539 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
... .....-...|+|||.+....++.+||||+|||+||||+| |..||.+.. -.+ +.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~------g~q----------IL~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR------GIQ----------ILKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC------HHH----------HHHhccc
Confidence 332 223345778999999999999999999999999999999 888985332 121 2233444
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
.-+...+..++++++++++.||..+|++|||+.++.+.+-..++
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 45556678889999999999999999999999999876644443
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.46 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=192.2
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhc-CCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQ-ISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||+|... +++.||+|.++.. .....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999965 5789999987642 23344556667777765 4899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 9999999753 35899999999999999999999998 9999999999999999999999999997543322 223
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||... +....+....... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~-----------~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE------DEDELFDSILNDR-----------PHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCC-----------CCCC
Confidence 3456899999999999888999999999999999999999998532 1122222211110 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMK-EVAM 652 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 652 (678)
...+.++.+++.+||+.||++||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 33455788999999999999999876 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.79 Aligned_cols=236 Identities=27% Similarity=0.378 Sum_probs=191.9
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|+||+||++..+ +++.||+|.++.. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 5789999987632 234456778888888876 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 9999999753 35899999999999999999999999 9999999999999999999999999987543221 122
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||... +............ ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~------~~~~~~~~i~~~~-----------~~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE------NEDDLFEAILNDE-----------VVYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC------CHHHHHHHHhcCC-----------CCCC
Confidence 3456899999999999888999999999999999999999999522 2222222221111 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
...+.++.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2345678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.68 Aligned_cols=248 Identities=31% Similarity=0.471 Sum_probs=197.8
Q ss_pred CeeeeeCCcEEEEEEEcC----CcEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLAD----GRIIAVKKSKVVDE-SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|+||.||+|.+.. +..+|+|....... ...+++.+|+++++++.|+||+++++++. .+..++|+||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899998765433 35568999999999999999999999875 4567999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.+++.... .+++..++.++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997543 5899999999999999999999998 99999999999999999999999999986644332221
Q ss_pred e--ccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 543 T--KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 543 ~--~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
. ...++..|+|||.+....++.++||||||+++|||++ |..||... ...+... ...... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~------~~~~~~~-~~~~~~---------~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM------KGAEVIA-MLESGE---------RL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC------CHHHHHH-HHHcCC---------cC
Confidence 1 1123467999999998889999999999999999998 99998522 1111111 111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
..+...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 122334567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.63 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=199.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----cce
Q 041043 383 HFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE-----VPL 454 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 454 (678)
+|++.+.||+|+||.||++.. .+++.||||++... +....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999996 46899999987642 3344567899999999999999999999998766 789
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 578888764 336899999999999999999999999 999999999999999999999999999765
Q ss_pred cCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc-----
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC----- 608 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 608 (678)
............+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+ .............
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHH
Confidence 44333333344578899999998764 47899999999999999999999996332111 0000000000000
Q ss_pred ------chhhcchhhh-------cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 ------LFDILDDQVR-------KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ------~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...... ........+++.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00112235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.47 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=205.0
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|++|.||++..+ +++.+++|.+.. ......+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 688999998753 3455667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.++++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998642 346899999999999999999999998 99999999999999999999999999876543322
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
. .....+++.|+|||++.+..++.++||||||+++|||++|+.||.... ......... .+ ...
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~---------~~~ 219 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN------QGALILKII-RG---------VFP 219 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH-cC---------CCC
Confidence 2 233457889999999999889999999999999999999999985321 111111111 11 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122455689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.96 Aligned_cols=263 Identities=30% Similarity=0.434 Sum_probs=204.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeC-
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEV- 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~- 450 (678)
..++|++.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|++++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346799999999999999999973 34678999998653 234456788999999999 689999999988654
Q ss_pred CcceEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSE-------------------------------------------------------- 474 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 474 (678)
...++++||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999999864321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce-eeecc
Q 041043 475 --------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKV 545 (678)
Q Consensus 475 --------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~ 545 (678)
...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124688899999999999999999998 999999999999999999999999998765332211 11223
Q ss_pred ccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHH
Q 041043 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTE 624 (678)
Q Consensus 546 ~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (678)
.++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...+......+. ....+..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~---------~~~~~~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEEFCRRLKEGT---------RMRAPDY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc------cHHHHHHHhccC---------CCCCCCC
Confidence 35678999999988889999999999999999997 8888853211 111111111111 1111112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 625 EIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 625 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..+++.+++.+||+.+|++|||+.||++.|+.+.+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 335789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=316.64 Aligned_cols=241 Identities=25% Similarity=0.335 Sum_probs=194.7
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCC-ceeeEEeEEeeCCcceEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHR-NVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 457 (678)
+|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 4689999987642 334556788999999999765 5888999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999999753 35899999999999999999999998 999999999999999999999999998653222
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||... .............
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~------~~~~~~~~i~~~~---------- 217 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE------DEDELFQSIMEHN---------- 217 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCC----------
Confidence 21 223456899999999999988999999999999999999999999522 1122222111110
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
...+...+.++.+++.+||+.||++|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122345678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.09 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=205.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
++|+..+.||+|+||.||+|..+ +.+.+++|........ ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999964 2467899987654443 5678999999999999999999999999989999
Q ss_pred EEEEeccCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 455 LVYEFIPNGTLFQYLHDPSEE------LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
+|+||+++|+|.++++..... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 25899999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhc
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.... ....... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~------~~~~~~~-~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS------DEEVLNR-LQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc------hHHHHHH-HHcC
Confidence 9987544333222333446778999999988888999999999999999999 778874221 1111111 1111
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.. ........+..+.+++.+||+.+|++|||+.|+++.|.+
T Consensus 235 ~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11 111122344679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.75 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=195.4
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|+||.||+|+.. +++.||+|.++.. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 4789999987642 234456678899999866 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 9999998743 35899999999999999999999999 99999999999999999999999999875432222 22
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....|++.|+|||++.+..++.++||||||+++|||++|+.||... +............. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~------~~~~~~~~i~~~~~-----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD------NEDDLFESILHDDV-----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC------CHHHHHHHHHcCCC-----------CCC
Confidence 3446899999999999889999999999999999999999999532 22222222221110 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRP-------TMKEVAME 653 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 653 (678)
...+.++.+++.+||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 22345788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.50 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=204.9
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
.+++...++|++.+.||+|+||.||++... +++.+|+|.+.. ......+.+.+|+++++.++||||+++++.+.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999975 578999998753 2233445678999999999999999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999999643 4788999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSS----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
+...............||+.|+|||++... .++.++||||||+++|||++|+.||.. .+....+......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC------CCHHHHHHHHHcC
Confidence 986654333333445699999999998754 378899999999999999999999952 2222233332221
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS--RPTMKEVAME 653 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 653 (678)
.... ........+..+.+++.+||..++.+ ||+++|+++.
T Consensus 263 ~~~~-------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSL-------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcc-------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 11112245567889999999844433 7889888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.53 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=203.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-----------------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceee
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-----------------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~ 442 (678)
.++|++.+.||+|+||.||++... ++..+|+|.++.. .....+++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998632 2346899988753 3445678999999999999999999
Q ss_pred EEeEEeeCCcceEEEEeccCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCc
Q 041043 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE--------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 443 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 514 (678)
+++++...+..++++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999975321 134788899999999999999999999 9999999999
Q ss_pred eEECCCCcEEEeeccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCccccc
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT--GQKPISYIWAN 591 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt--g~~p~~~~~~~ 591 (678)
||+++++.+||+|||++..+....... .....++..|++||....+.++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987654332211 122334678999999888889999999999999999998 66777422111
Q ss_pred cCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
+ ............ ........+...+..+.+|+.+||+.||++||++.||++.|++
T Consensus 241 ~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 010000000000 0000111122344689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.98 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=204.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++|++.+.||+|+||.||++... ++..+|+|.+... .....+++.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457889999999999999999863 4678999988653 334456799999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCc
Q 041043 454 LLVYEFIPNGTLFQYLHDPS-------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 514 (678)
++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999997432 1235788999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccccc
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~ 592 (678)
||+++++.+||+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---- 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---- 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 99999999999999998754332211 1122234667999999988889999999999999999998 87887422
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
...+..... ...... ..+...+.++.+|+.+||+.+|++|||+.|+++.|++
T Consensus 237 --~~~~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 --AHEEVIYYV-RDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --CHHHHHHHH-hcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111211111 111111 1122345679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=305.37 Aligned_cols=249 Identities=28% Similarity=0.468 Sum_probs=201.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEe-eCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL-EVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 460 (678)
++|.+.+.||+|+||.||++... +..+++|..+... ..+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999875 7889999876432 3467899999999999999999999765 445789999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999997643 235899999999999999999999998 9999999999999999999999999987543222
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
.....+..|+|||++....++.++||||||+++|||++ |+.||.. ............ + ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~------~~~~~~~~~~~~-~---------~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR------IPLKDVVPRVEK-G---------YKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC------CCHHHHHHHHhc-C---------CCC
Confidence 12234568999999998889999999999999999998 9998842 122222221111 1 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
......+..+.+++.+||+.+|++|||+.++++.|++|
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.91 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=193.2
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||++... +++.+|+|.++.. +....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999987642 334456678899988776 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 9999988643 35899999999999999999999999 99999999999999999999999999875332211 22
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC--CChHHHHHHHHhhccchhhcchhhhcC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG--RNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....+......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence 345689999999999999999999999999999999999999963322111 111222222211111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
.+...+..+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.53 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=202.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
.+|++.+.||+|+||.||++.+.++..+|+|.+..... ...++.+|++++++++|||++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999987788999998764332 34578999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999999997533 35889999999999999999999998 9999999999999999999999999987554322221
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.. .............. +..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~------~~~~~~~~~~~~~~----------~~~ 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN------RSNSEVVETINAGF----------RLY 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc------CCHHHHHHHHhCCC----------CCC
Confidence 222235678999999998889999999999999999998 8999842 11111121111110 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
.+...++.+.+|+.+||+.+|++|||+.|++++|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1122346799999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.28 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=201.0
Q ss_pred CeeeeeCCcEEEEEEEcC--C--cEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLAD--G--RIIAVKKSKVVDE-SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|++|.||+|.+.+ + ..+|||.+..... ...+++.+|++++++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3689999876555 567789999999999999999999999988 888999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee-
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV- 541 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~- 541 (678)
++|.+++.+... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999986532 46899999999999999999999998 9999999999999999999999999998765432221
Q ss_pred -eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 542 -STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 542 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
.....++..|+|||.+....++.++||||||+++|||++ |+.||... ...+......... ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------~~~~~~~~~~~~~---------~~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL------SGSQILKKIDKEG---------ERL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhcC---------CcC
Confidence 122346788999999998889999999999999999999 99998422 1111111111110 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=306.78 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=200.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.++||+|+||.||+|.. .+++.+|+|..... .....+++.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999985 46889999987543 344456799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999997653 3788899999999999999999998 9999999999999999999999999987653321
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCC-hHHHHHHHHhhccchhhcchhhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRN-LATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......+... ........... ...
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~ 218 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---------DPP 218 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc---------CCC
Confidence 223468899999999998889999999999999999999999986432222111 11111111110 000
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......+.++.+++.+||+.+|++||+++|+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01112244578999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=304.98 Aligned_cols=249 Identities=32% Similarity=0.496 Sum_probs=204.4
Q ss_pred CeeeeeCCcEEEEEEEcC----CcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLAD----GRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||++.... +..+++|.++..... ..+.+.+|++.++.++|+|++++++++......++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999754 788999988765443 367899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 463 GTLFQYLHDPSE------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 463 g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
++|.+++..... ...+++.+++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999986521 256999999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 537 DQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 537 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
... .......++..|+|||.+....++.++||||||+++|||++ |..||... ...........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~--------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL------SNEEVLEYLRK--------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHc---------
Confidence 321 12233457889999999988889999999999999999999 68998533 11222221111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
......+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.60 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=198.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|.+.++||+|+||+||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 6889999987542 2344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999753 35889999999999999999999999 999999999999999999999999998633210
Q ss_pred cce----------------------------------------------eeeccccccCccCccccccCCCCcccchhhH
Q 041043 538 QTH----------------------------------------------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSF 571 (678)
Q Consensus 538 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwsl 571 (678)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012358999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 041043 572 GVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR---PTMK 648 (678)
Q Consensus 572 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ 648 (678)
||++|||++|..||... .....+........ .+........+.++.+|+.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~------~~~~~~~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSE------NSHETYRKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCC------CHHHHHHHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999999522 11222222211100 00001111234678899999997 67665 5999
Q ss_pred HHHHH
Q 041043 649 EVAME 653 (678)
Q Consensus 649 evl~~ 653 (678)
|++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.50 Aligned_cols=238 Identities=28% Similarity=0.327 Sum_probs=193.2
Q ss_pred CeeeeeCCcEEEEEEE----cCCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 388 RILGQGGQGTVYKGML----ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
+.||+|+||.||++.. .+|+.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999876422 2234567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 99999999643 35899999999999999999999999 99999999999999999999999999876543322 2
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (678)
.....|++.|+|||.+....++.++||||||+++|||++|+.||... ............. ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~------~~~~~~~~i~~~~-----------~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK------DRKETMTMILKAK-----------LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC------CHHHHHHHHHcCC-----------CCC
Confidence 23456899999999999888999999999999999999999998522 1111111111110 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041043 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKE 649 (678)
Q Consensus 622 ~~~~~~~l~~li~~cl~~dP~~RPt~~e 649 (678)
+...+..+.+|+.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2234567889999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.97 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=195.4
Q ss_pred eeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
||+|+||+||++... +++.+|+|++.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999964 68899999875422 22346678899999999999999999999999999999999999999
Q ss_pred hhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeec
Q 041043 466 FQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 544 (678)
Q Consensus 466 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 544 (678)
.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 98885432 2346899999999999999999999998 99999999999999999999999999876543322 2233
Q ss_pred cccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHH
Q 041043 545 VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTE 624 (678)
Q Consensus 545 ~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (678)
..+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... .+.... ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~---------~~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQ---------RILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHH---------hhcccC--CCCccc
Confidence 468999999999999999999999999999999999999985321110 0011000 011111 112234
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 625 EIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 625 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
.+..+.+++.+||+.||++|| +++++++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 566889999999999999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=302.18 Aligned_cols=247 Identities=30% Similarity=0.471 Sum_probs=199.7
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChh
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF 466 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 466 (678)
++||+|+||.||++...+++.|++|........ ..+++.+|++++++++|+||+++++++.+.+..++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999987654433 5678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee-ecc
Q 041043 467 QYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-TKV 545 (678)
Q Consensus 467 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~ 545 (678)
+++.... ..+++..++.++.+++.||+|||+.+ ++||||+|+|||++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9997532 35889999999999999999999998 99999999999999999999999999875542221111 112
Q ss_pred ccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHH
Q 041043 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTE 624 (678)
Q Consensus 546 ~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (678)
..+..|+|||.+.+..++.++||||||+++|||++ |..||..... .... ..... ......+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~~~~-~~~~~---------~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------QQTR-ERIES---------GYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------HHHH-HHHhc---------CCCCCCCcc
Confidence 34567999999988889999999999999999999 7888753211 1111 11111 111112234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 625 EIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 625 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.00 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=201.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.|++.++||+|+||+||++... +++.||+|++.... ......+.+|++++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999964 68899999876432 2223457889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999999886532 245899999999999999999999998 9999999999999999999999999987653222
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...... ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~---~~~~~~~~~~~~~----------~~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE---KVKREEVERRVKE----------DQ 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch---hhHHHHHHHHhhh----------cc
Confidence 1 2234588999999999988899999999999999999999999963211 0011111111100 01
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
...+...+..+.+|+.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122334566789999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.47 Aligned_cols=262 Identities=29% Similarity=0.437 Sum_probs=204.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-----cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Ccc
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVP 453 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 453 (678)
+.|.+.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 347889999986543 44457899999999999999999999998775 567
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999996532 35899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccc--------ccCCChHHHHHHH
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWA--------NEGRNLATYFVEC 603 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~--------~~~~~~~~~~~~~ 603 (678)
....... ......++..|+|||.+.+..++.++||||||+++|||+++..|...... ..+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 12234467789999999888899999999999999999998766421100 0011111111111
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.... .....+...+..+.+|+.+||+.+|++|||++++++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 11111233556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=289.51 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=205.6
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCC-CCceeeEEeEE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--------ESKLEEFINEVVILSQIS-HRNVVKLLGSC 447 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~ 447 (678)
+...+.|...+.||.|..++|-+...+ .|...|+|++.... ..-.++-.+|+++|+++. ||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334567788899999999999888854 67888888765321 122355678999999985 99999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEee
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 527 (678)
......++|+|.|+.|.|.|+|.+ ..++++++..+|.+|+..|+.|||..+ ||||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 999999999999999999999974 457999999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCcceeeeccccccCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~ 601 (678)
||++..+.... ......|||+|+|||.+.. ..|+...|+|+.|||||.|+.|.+||-.. ++ ..+++
T Consensus 167 FGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-----kQ-mlMLR 238 (411)
T KOG0599|consen 167 FGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-----KQ-MLMLR 238 (411)
T ss_pred cceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----HH-HHHHH
Confidence 99998776543 3466789999999998853 35788999999999999999999998311 11 11111
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+-+++. +.......+.+....+||.+||+.||.+|.|++|+++.
T Consensus 239 -~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 -MIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -HHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111111 11223345667789999999999999999999999875
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=305.62 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=204.1
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++.+++.+.....||+|+||.||+|... ++..|++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556667777789999999999999954 578899998877666677889999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeeccCcccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSI 534 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~~~ 534 (678)
++||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999975432222378889999999999999999998 999999999999986 679999999998755
Q ss_pred cCCcceeeeccccccCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
..... ......+++.|+|||++.... ++.++||||||+++|+|++|+.||....... ..... ..
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~-~~-------- 225 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFK-VG-------- 225 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhh-hh--------
Confidence 33222 122335788999999986643 7889999999999999999999985221100 00000 00
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+....+++.+++.+||+.+|.+|||+.|+++.
T Consensus 226 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 -MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000111233445678999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=315.52 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=194.7
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+|++.+.||+|+||.||+|... +++.+|+|.++.. .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 5789999987642 233445677788888877 5899999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999999753 35899999999999999999999998 999999999999999999999999998754322
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ......||+.|+|||++....++.++||||||+++|||++|+.||... +............
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~------~~~~~~~~i~~~~---------- 217 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHN---------- 217 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC----------
Confidence 21 223456899999999999999999999999999999999999999522 2222222221111
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
...+...+.++.+++.+||+.+|.+|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11123345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.50 Aligned_cols=263 Identities=29% Similarity=0.448 Sum_probs=207.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-----CCcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLE--VEVP 453 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 453 (678)
+.|++.+.||+|+||.||++.+. +++.+|||.++..... ..++|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 3678999988765443 56789999999999999999999999877 5578
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++++||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999997643 25899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCC--------ChHHHHHHH
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGR--------NLATYFVEC 603 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 603 (678)
....... ......++..|++||.+....++.++||||||+++|||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6533221 111234566799999998888999999999999999999999987532211100 001111111
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
. ....+...+...+.++.+|+.+||+.+|++|||++||+++|++|.
T Consensus 239 ~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 239 L---------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred H---------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1 111111222334467999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=309.76 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=205.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+|++.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788899999999999999995 46889999988766666667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.++++. ..+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999964 24789999999999999999999999 99999999999999999999999999876443221
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........... ....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~~~~~~~~~~--------~~~~ 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNG--------TPEL 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH------HHhHHHHhcCC--------CCCC
Confidence 12234588899999999988899999999999999999999999852211 11111111100 0011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+......+.+++.+||..+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1123445678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=303.81 Aligned_cols=251 Identities=31% Similarity=0.472 Sum_probs=195.6
Q ss_pred CeeeeeCCcEEEEEEEc----CCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEe-eCCcceEEEEecc
Q 041043 388 RILGQGGQGTVYKGMLA----DGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCL-EVEVPLLVYEFIP 461 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 461 (678)
+.||+|+||.||+|.+. +...+|+|+... ......+.+.+|+.+++.++||||+++++++. ..+..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799998754 34455678999999999999999999999776 4556789999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999997542 34678888999999999999999998 9999999999999999999999999987654322111
Q ss_pred ---eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 542 ---STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTG-QKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 542 ---~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.....++..|+|||.+....++.++||||||+++|||++| ..||.. ..............
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~------~~~~~~~~~~~~~~---------- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD------VDSFDITVYLLQGR---------- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC------CCHHHHHHHHhcCC----------
Confidence 1123456789999999888899999999999999999995 455532 11111111111110
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
....+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 011112234578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.68 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=200.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||++... +++.||+|.+.. ......+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999965 588999998753 23334566889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999753 235899999999999999999999999 999999999999999999999999998765443
Q ss_pred cceeeeccccccCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.........||+.|+|||++.. ..++.++||||||+++|||++|+.||.. .+..+.............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~------~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC------CCHHHHHHHHHcCCCcccC
Confidence 3333333468999999999863 4578899999999999999999999852 2222222222221111110
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGR--SRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~ 653 (678)
.......++.+.+++.+||..+++ .||+++++++.
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011122456788999998865443 37899998877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=315.03 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=195.9
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||+||++... +++.+|+|.++.. .....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 4789999987642 234456778899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 9999998753 35899999999999999999999999 99999999999999999999999999865322221 22
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....+++.|+|||++.+..++.++|||||||++|||++|+.||... +............ ...+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~------~~~~~~~~i~~~~-----------~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD------DEDELFQSILEDE-----------VRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC------CHHHHHHHHHcCC-----------CCCC
Confidence 3345899999999999999999999999999999999999998522 1122222111111 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTM-----KEVAME 653 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 653 (678)
...+..+.+|+.+||+.||++||++ .++++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2345678999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.86 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=196.8
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
+|+..++||+|+||+||+|... +++.+|+|++... .....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 5789999987643 23445678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999999753 35889999999999999999999999 9999999999999999999999999975321100
Q ss_pred ----------------------------------------------ceeeeccccccCccCccccccCCCCcccchhhHH
Q 041043 539 ----------------------------------------------THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFG 572 (678)
Q Consensus 539 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslG 572 (678)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001124589999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 041043 573 VVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT---MKE 649 (678)
Q Consensus 573 vll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~e 649 (678)
|++|||++|+.||.... ............ ...........++++.+++.+++ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~------~~~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQT------PLETQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCC------HHHHHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 99999999999995321 111111111100 01111112234567788888876 59999987 777
Q ss_pred HHHH
Q 041043 650 VAME 653 (678)
Q Consensus 650 vl~~ 653 (678)
+++.
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=315.16 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=195.3
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|+||+||++... +++.+|+|.++.. +....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999988642 234456788999999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 9999988643 35999999999999999999999999 9999999999999999999999999987532211 122
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....................... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCC
Confidence 345689999999999999999999999999999999999999964433222222222222221111 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMK 648 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~ 648 (678)
...+..+.+++.+||+.||++|+++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23445788999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=339.49 Aligned_cols=264 Identities=23% Similarity=0.361 Sum_probs=207.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.++||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999965 5899999987642 2334567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 458 EFIPNGTLFQYLHDPSE--------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 134567888999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcc-----------------eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 041043 530 TSRSIAIDQT-----------------HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592 (678)
Q Consensus 530 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~ 592 (678)
+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9976521110 011224689999999999999999999999999999999999999853111
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhccC
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-TMKEVAMELERIRACNL 662 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~l~~~~~ 662 (678)
.... . .... .++. ......+.+..+.+++.+||+.||++|| +++++++.|+.+.+...
T Consensus 237 -~ki~--~-----~~~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 237 -RKIS--Y-----RDVI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred -hhhh--h-----hhhc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 0000 0 0000 0000 0001123456788999999999999995 77888888988876544
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=312.87 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=192.4
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhc-CCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQ-ISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||+|... +++.||||.++.. .....+.+..|..+++. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 4789999987642 22334566778888876 4899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 9999999743 35889999999999999999999998 99999999999999999999999999875322221 22
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....||+.|+|||++.+..++.++||||||+++|||++|+.||... +....+....... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~------~~~~~~~~i~~~~-----------~~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH------DEEELFQSIRMDN-----------PCYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC-----------CCCC
Confidence 3446899999999999888999999999999999999999998532 1122221111110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMK-EVAM 652 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 652 (678)
.....++.+++.+||+.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 23445788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=309.03 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=198.9
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|++|.||+|... +++.||+|+++.. +....+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 6889999987643 233346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
++ ++|.+++........+++..++.++.|++.||+|||+.+ ++|+||+|+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689999876554467999999999999999999999998 99999999999999999999999999875543221
Q ss_pred eeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh--hc------cch
Q 041043 540 HVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE--EN------CLF 610 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~------~~~ 610 (678)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+ .....+..... +. ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 12233468899999988654 57889999999999999999999985321100 00000000000 00 000
Q ss_pred -------hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 611 -------DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 611 -------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........ ......++++.+++.+||+.||++|||+++|++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 001124567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.18 Aligned_cols=237 Identities=26% Similarity=0.375 Sum_probs=189.9
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHH-HHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVV-ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||+||+|... +++.||+|.+... .....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 6899999987542 2223344555554 56889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 9999999753 35899999999999999999999999 9999999999999999999999999987533222 223
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||.. .+........... .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~------~~~~~~~~~i~~~---------~~--~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS------RDTAEMYDNILNK---------PL--RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC------CCHHHHHHHHHcC---------CC--CCC
Confidence 345689999999999998999999999999999999999999852 2222222222111 11 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMK 648 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~ 648 (678)
...+..+.+++.+||+.||++||+++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 23356789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.24 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=212.6
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCC---hhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcc
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD---ESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~ 453 (678)
.....|++.+.||+|.||.||+++.+. |+.+|+|.+.... ....+.+.+|+.+|+++. ||||+.+.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678999999999999999999765 9999999875432 234578999999999998 99999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC----CCcEEEeecc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE----KYRAKIADFG 529 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Dfg 529 (678)
++|||++.+|.|.+.|... .+++.++..++.|++.+++|||+.+ |+||||||+|+|+.. ++.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999865 3999999999999999999999999 999999999999963 3579999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
++..... ........||+.|+|||++....|+...||||+|+++|.|++|..||.... -...+..+.... +
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~------~~~~~~~i~~~~-~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET------EFEIFLAILRGD-F 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC------hhHHHHHHHcCC-C
Confidence 9987765 445667789999999999999999999999999999999999999995221 111122121111 1
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..........+..+.++++.+|..||.+|+|+.++++.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12233345667889999999999999999999999995
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.40 Aligned_cols=240 Identities=25% Similarity=0.405 Sum_probs=190.3
Q ss_pred CeeeeeCCcEEEEEEEcC-------------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 388 RILGQGGQGTVYKGMLAD-------------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358889877665666678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc-------EEEee
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-------AKIAD 527 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl~D 527 (678)
+++||+++|+|..++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999987532 35899999999999999999999998 999999999999987664 89999
Q ss_pred ccCcccccCCcceeeeccccccCccCccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCccccccCCChHHHHHHHHh
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH-SSQFTDKSDVYSFGVVLVELL-TGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwslGvll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|..|+.... .... .....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~-~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT------LAEK-ERFYE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc------hhHH-HHHHh
Confidence 9998654322 2234678899999886 466899999999999999998 4888874211 1110 00000
Q ss_pred hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
. ... ......+++.+|+.+||+.||.+||+++++++.|+
T Consensus 224 ~---------~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 G---------QCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred c---------Ccc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 000 01122457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=307.15 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=194.3
Q ss_pred eeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
||+|+||.||++..+ +|+.+|+|.+.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999964 58999999875321 22234566799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeecc
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 545 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 545 (678)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99886543 235889999999999999999999998 9999999999999999999999999987654322 22334
Q ss_pred ccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHH
Q 041043 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625 (678)
Q Consensus 546 ~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (678)
.++..|+|||++.+..++.++||||||+++|||++|+.||...... .......... ....... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~---------~~~~~~~-~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRT---------LEDEVKF-EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHh---------hcccccc-ccccC
Confidence 6899999999999888999999999999999999999998532111 0111111111 1111100 01234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 626 IMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 626 ~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
+.++.+|+.+||+.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 56789999999999999999998876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.30 Aligned_cols=242 Identities=27% Similarity=0.389 Sum_probs=191.9
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHH-HHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVV-ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||+||++... +|+.+|+|.+... +.....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999964 6899999987542 2233445556654 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 9999998643 36899999999999999999999999 9999999999999999999999999987532221 122
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||.. .+....+....... . ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~------~~~~~~~~~~~~~~---------~--~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC------RDVAEMYDNILHKP---------L--VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC------CCHHHHHHHHHcCC---------c--cCC
Confidence 345689999999999999999999999999999999999999852 22222222222111 0 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+..+.+++.+||+.+|.+||++++.++.
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 2344578899999999999999998744333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.04 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=205.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-Cc----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-GR----IIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.+|++.+.||+|+||.||+|..++ ++ .+|+|...... .....++.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999999643 32 58999876543 4456789999999999999999999999887 78899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999997643 34899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcceee-eccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTHVS-TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
....... ....++..|+|||.+....++.++||||||+++||+++ |+.||... ....... ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~~~~~~~-~~~~~~----- 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI------PAVEIPD-LLEKGE----- 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC------CHHHHHH-HHhCCC-----
Confidence 3332221 11223568999999988889999999999999999998 99998532 1111111 111110
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....+......+.+++.+||..+|.+||++.++++.|+++.+.
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 ----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1111222345688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.88 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=200.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----cceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE-----VPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~l 455 (678)
-.|...+++|.|+||.||+|... +++.||||+.-...+ --.+|+++|+.+.|||||+|+-++.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35677899999999999999965 469999998754332 1237999999999999999999887533 2358
Q ss_pred EEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeeccCccc
Q 041043 456 VYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRS 533 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl~~~ 533 (678)
|||||+. +|.++++.. ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 899888742 12345788888889999999999999998 9999999999999966 8999999999998
Q ss_pred ccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch--
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF-- 610 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 610 (678)
+...+.. ....-+..|+|||.+.+ .+|+.+.||||.||++.||+-|++-|.+... .+......++.......
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---VDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---HHHHHHHHHHhCCCCHHHH
Confidence 7655443 33456888999999877 5799999999999999999999999864222 11111122221111000
Q ss_pred --------hhcchhhhcC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhcc
Q 041043 611 --------DILDDQVRKS-----GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRACN 661 (678)
Q Consensus 611 --------~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~~~ 661 (678)
+...+++... ......++..+|+.++|+++|.+|.++.|++.. ++.++..+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 1111111111 223455688999999999999999999999865 67777543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.91 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=197.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
+|++.+.||+|+||.||++... +++.+|||.+... .....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999964 5889999987542 22345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999999753 35889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ------------------------------------------ceeeeccccccCccCccccccCCCCcccchhhHHHHHH
Q 041043 539 ------------------------------------------THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLV 576 (678)
Q Consensus 539 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ 576 (678)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011246899999999999989999999999999999
Q ss_pred HHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 041043 577 ELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP---TMKEVAME 653 (678)
Q Consensus 577 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 653 (678)
||++|+.||.... ............ ...........+.++.+++.+|+ .+|.+|+ ++.|++..
T Consensus 236 ell~G~~Pf~~~~------~~~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADT------PAETQLKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCC------HHHHHHHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999995321 111111111100 00111111234456788888876 5999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=307.27 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=199.3
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeC------
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEV------ 450 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~------ 450 (678)
.+.+.|++.+.||+|+||.||+|... +++.+|+|...... ....++..|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677889999999999999999965 57889999886543 3346788999999998 699999999998753
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
...++++||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 35789999999999999997642 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
+........ ......++..|+|||++. ...++.++||||||+++|||++|+.||..... ...... ...
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~~~~~~-~~~ 230 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRALFL-IPR 230 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----HHHHHH-Hhc
Confidence 876533221 223456889999999986 33578899999999999999999999852211 111110 000
Q ss_pred hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
. ..........+.++.+|+.+||..+|.+|||+.|+++
T Consensus 231 -~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -N--------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -C--------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0011112234457899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.08 Aligned_cols=240 Identities=26% Similarity=0.346 Sum_probs=192.1
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||++..+ +++.||+|.++.. .....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 5789999987642 123445677788888754 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 9999999753 35899999999999999999999999 9999999999999999999999999986432211 123
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....|++.|+|||++.+..++.++||||||+++|||++|+.||... +....+....... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~------~~~~~~~~~~~~~-----------~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD------DEDELFESIRVDT-----------PHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC-----------CCCC
Confidence 3456899999999999999999999999999999999999999522 1122221111110 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMK-EVA 651 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl 651 (678)
.....++.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22445788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.00 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=203.6
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
+|++.+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.++++++|+||+++++.+...+..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 688999998754 33445678889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999999986532 335789999999999999999999999 99999999999999999999999999876543222
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.. .+.......... +.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~------~~~~~~~~~~~~-~~~---------~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA------NSWKNLILKVCQ-GSY---------KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC------CCHHHHHHHHhc-CCC---------CC
Confidence 22334588899999999988899999999999999999999999852 121111111111 111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+...+..+.+|+.+||+.||++|||+.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 123345578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.35 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=203.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.+.|++.++||+|+||.||+|... +++.+++|.+...+....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356888999999999999999975 4889999998877777788899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|..++.+.. ..+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 99999998886432 35899999999999999999999998 9999999999999999999999999886543221
Q ss_pred eeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 540 HVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.......+++.|+|||++. ...++.++||||||+++|||++|+.||... +............. .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~~-~---- 233 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEP-P---- 233 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc------cHHHHHHHHhcCCC-c----
Confidence 1123345788999999985 344678999999999999999999998421 11111111111100 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+...+.++.+++.+||+.+|++||++.|+++.
T Consensus 234 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 ---TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011123345578999999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.74 Aligned_cols=244 Identities=29% Similarity=0.410 Sum_probs=201.7
Q ss_pred CCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
|.-.+.||.|+||.||.+.. .+.+.||||++... ..+.++++..|+..|++++|||+|...|++......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55567899999999999995 46889999998754 345577899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
|- |+-.|.|.-++ .++.+.++..|..+.+.||+|||+.+ .||||||+.||||++.|.|||+|||.+....+
T Consensus 108 Cl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred Hh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 95 56677765433 36889999999999999999999999 99999999999999999999999999876543
Q ss_pred eeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 540 HVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.+..+|||.|||||++. .+.|+.|.||||||++..||.-.++|+..+. ..+. +..+....
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---AMSA------------LYHIAQNe 241 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSA------------LYHIAQNE 241 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---HHHH------------HHHHHhcC
Confidence 34457999999999864 5789999999999999999999999975221 1111 11122221
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..-....+++..+..++..||++-|.+|||.+++++.
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1222257889999999999999999999999998764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=304.32 Aligned_cols=252 Identities=35% Similarity=0.540 Sum_probs=200.0
Q ss_pred CCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHH--HHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 384 FNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLE--EFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
|++.+.||+|+||+||++.... ++.+|+|.+......... ...+|+.++++++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999764 568999998776544433 3456999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++. ....+++..++.++.|+++||++||+.+ ++|+||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence 9999999997 2346899999999999999999999998 9999999999999999999999999987542 2223
Q ss_pred eeeccccccCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFH-SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......++..|+|||.+. ...++.++||||||+++|+|++|..||..... .+............ .... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~-----~~~~--~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKRP-----LPSS--S 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHTH-----HHHH--T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhccccc-----cccc--c
Confidence 344556899999999998 78899999999999999999999999863200 01111111111100 0000 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.........+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111268999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=311.44 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=201.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||+|+||.||++... ++..+|+|.++.. .....+++.+|++++++++||||+++++++.+.+..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999965 5788899987643 334456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.++++.. ..+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999754 3589999999999999999999984 6 9999999999999999999999999986543221
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc-----------
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN----------- 607 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 607 (678)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.......
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccC
Confidence 23345788999999998888999999999999999999999998532111 1111000000000
Q ss_pred ---------cchhhcchhh----hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 608 ---------CLFDILDDQV----RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 608 ---------~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+..+... ..........++.+++.+||..+|++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 000011245579999999999999999999999887
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=326.52 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=195.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--------
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEV-------- 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------- 450 (678)
..++|.+.++||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3567999999999999999999964 57899999875422 2345799999999999999999887532
Q ss_pred CcceEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeec
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADF 528 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Df 528 (678)
...++||||+++ +|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 677766432 23346899999999999999999999999 99999999999999665 7999999
Q ss_pred cCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh--
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE-- 605 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 605 (678)
|+++.+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|..||..... ...+.....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~------~~~~~~i~~~~ 287 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS------VDQLVRIIQVL 287 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHh
Confidence 99986543222 223457999999999865 4689999999999999999999999953211 111111111
Q ss_pred -hcc---------------chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 606 -ENC---------------LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 606 -~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
... ...+....+....+...+.++.+|+.+||+.||.+|||+.|+++. ++.+..
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 000000111111122334678999999999999999999999865 566553
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.66 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=198.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|.+.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 57889999876433 23345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 8888886532 35889999999999999999999998 99999999999999999999999999875433222
Q ss_pred eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---ccchhh---
Q 041043 540 HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---NCLFDI--- 612 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 612 (678)
. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........... ..+..+
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhhcch
Confidence 1 223457889999998865 468899999999999999999999996322111 11111100000 000000
Q ss_pred ---cchhhhc-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 ---LDDQVRK-------SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ---~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+..... ......+.++.+|+.+||+.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 0011234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=314.10 Aligned_cols=242 Identities=27% Similarity=0.364 Sum_probs=190.6
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHH-HHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEV-VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||++... +++.+|+|.+.... .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999975 56889999875421 22233444444 457889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 9999999753 35788899999999999999999999 9999999999999999999999999987543222 123
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....|++.|+|||++.+..++.++||||||+++|||++|+.||.. ......+...... . ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~------~~~~~~~~~i~~~---------~--~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS------RNTAEMYDNILNK---------P--LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC------CCHHHHHHHHHhC---------C--cCCC
Confidence 345689999999999998999999999999999999999999952 1222222222111 0 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 2345678999999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.59 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=203.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999765 78999998865433 678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999996532 46899999999999999999999998 99999999999999999999999999876554322
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . ...... . ......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~-~~~~~~-~-------~~~~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----A-IFMIPN-K-------PPPTLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----h-hhhhcc-C-------CCCCCC
Confidence 2233447889999999998889999999999999999999999985321111 0 000000 0 000111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+......+.+++.+||+.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12334567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.23 Aligned_cols=250 Identities=27% Similarity=0.413 Sum_probs=205.6
Q ss_pred CCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|+..+.||+|+||.||.+.. .+++.+++|.+... +....+++.+|++++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999999999885 45889999986543 455567889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997643 346899999999999999999999998 99999999999999999999999999876544332
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+++.|+|||.+.+..++.++||||||+++|||++|..||.. ............. .. .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~------~~~~~~~~~~~~~-~~---------~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA------TNPLNLVVKIVQG-NY---------T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC------CCHHHHHHHHHcC-CC---------C
Confidence 22344588999999999888889999999999999999999999852 2222222222211 11 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......+.++.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1123345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.11 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=200.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.++||+|+||.||++..+ .++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999975 4678999987532 2333456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999753 235899999999999999999999999 999999999999999999999999998765443
Q ss_pred cceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||.. .+................
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~------~~~~~~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC------CCHHHHHHHHhCCCcccc-
Confidence 333333456899999999986 34578899999999999999999999952 222222322222111000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS--RPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 653 (678)
........+.++.+|+++|+..++.+ |++++|+++.
T Consensus 229 -----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00111234567889999998665544 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.15 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=205.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 468999999887655556678899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|..++.. ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999999864 24899999999999999999999999 999999999999999999999999998765433221
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ............ . ....
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~------~~~~~~~~~~~~-~-------~~~~ 236 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRALYLIATNG-T-------PELQ 236 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcC-C-------cccC
Confidence 223457889999999998889999999999999999999999985221 111111111100 0 0011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+...+..+.++|.+||..||.+|||+.+++..
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 123345678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.55 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=201.3
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCC------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD------ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
+|...+.||+|+||+||+|...+++.+|+|.++... ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999875422 22345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999753 35889999999999999999999998 99999999999999999999999999875432
Q ss_pred Cc-----ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 537 DQ-----THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 537 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
.. ........++..|+|||++.+..++.++||||||+++|+|++|+.||.... ...... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~-~~~~~~---- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-----RLAAMF-YIGAHR---- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-----hHHHHH-Hhhhcc----
Confidence 11 111223457889999999998889999999999999999999999985221 111111 010000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......+.....++.+++++||+.+|.+||++.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 ----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011122345567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.12 Aligned_cols=250 Identities=30% Similarity=0.468 Sum_probs=198.1
Q ss_pred CeeeeeCCcEEEEEEEcC-------CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 388 RILGQGGQGTVYKGMLAD-------GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+.||+|+||.||+|+..+ ++.++||.+.... .....++.+|+++++.++||||+++++++...+..++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999999643 2578999775432 34567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-----cEEEeeccC
Q 041043 460 IPNGTLFQYLHDPS----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-----RAKIADFGT 530 (678)
Q Consensus 460 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~Dfgl 530 (678)
+++++|.++++... ....+++.+++.++.|++.||+|||+.+ ++|+||+|+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 2234789999999999999999999988 99999999999999877 899999999
Q ss_pred cccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 531 SRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 531 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
+......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~------~~~~~~~~-~~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN------NQEVLQHV-TAG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC------HHHHHHHH-hcC-
Confidence 8765432211 1222345678999999999899999999999999999998 999985221 11111111 111
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.....+...+..+.+++.+||+.+|.+||+++++++.|++
T Consensus 230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111223445688999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.53 Aligned_cols=268 Identities=26% Similarity=0.406 Sum_probs=208.8
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566678999999999999864 5788999987643 3445678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999999864 35899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ... ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~-~~~---------~~~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLF-LIP---------KNSPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHh-hhh---------cCCCCC
Confidence 122235788999999999888999999999999999999999998522111 0010 000 011111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhccCCCCCchHHHHHhhh
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRACNLQDDDDNIQKCYEEL 676 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~~~~~~~~~~~~~~~~~~ 676 (678)
.....+..+.+++.+||+.+|++||++.|+++. +.+... -..--++..+.|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~--~~~~~~~~~~~~~~~ 276 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK--KTSFLTELIDRYKRW 276 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh--hHHHHHHHHHHhhcc
Confidence 123345678999999999999999999999985 333221 122224555555544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=302.67 Aligned_cols=250 Identities=28% Similarity=0.374 Sum_probs=200.8
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999975 4778899988776667778899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
++|..++.+. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 9999988643 236899999999999999999999998 9999999999999999999999999987543221 122
Q ss_pred eccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 543 TKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
....++..|+|||++. ...++.++||||||+++|||++|+.||... .............. .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------~~~~~~~~~~~~~~-~------- 226 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEP-P------- 226 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc------CHHHHHHHHhhcCC-C-------
Confidence 3345888999999984 345778999999999999999999998521 11111111111100 0
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122345678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.90 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=205.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788999999999999999996 47899999998766656667889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999964 24889999999999999999999998 99999999999999999999999999876543322
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ + .. .. .......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~---~~-~~--------~~~~~~~ 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L---YL-IA--------TNGTPEL 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--e---ee-ec--------cCCCCCC
Confidence 12234578899999999988899999999999999999999999852211000 0 00 00 0000011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+......+.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223445678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.50 Aligned_cols=251 Identities=32% Similarity=0.502 Sum_probs=203.5
Q ss_pred CCcCCeeeeeCCcEEEEEEEcC-----CcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+++.+.||+|+||.||++...+ +..+|+|.+...... ..+.+.+|++.+++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999754 388999998755433 6678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999975432 12899999999999999999999998 999999999999999999999999999776544
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.........+++.|+|||.+....++.++||||||+++++|++ |..||.. ..............
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~------~~~~~~~~~~~~~~--------- 221 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG------MSNEEVLEYLKKGY--------- 221 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC------CCHHHHHHHHhcCC---------
Confidence 2222222336789999999988889999999999999999998 7788742 22222222221111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
....+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111223556799999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.08 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=197.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE----- 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 451 (678)
..++|++.+.||+|+||.||++... +++.||+|++.. .+....+++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999964 588999998753 23445677889999999999999999999986543
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 57666642 3788999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHH
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---------RNLATYFV 601 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---------~~~~~~~~ 601 (678)
++..... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+. .....+..
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 9754322 122334689999999999998999999999999999999999999963321100 00000000
Q ss_pred -------HHHhhcc-ch-----hhcchhh---hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 602 -------ECVEENC-LF-----DILDDQV---RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 602 -------~~~~~~~-~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....... .. +...... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 00 0000000 000011224578999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.26 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=205.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999964 57889999987766667788999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999987542 35899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeccccccCccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 541 VSTKVQGTFGYLDPEYFHSS---QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
......++..|+|||.+... .++.++||||||+++|||++|+.||..... ........... . . ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~------~~~~~~~~~~~-~----~-~~ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP------MRALFLISKSN-F----P-PP 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcc-C----C-Cc
Confidence 22334578899999998776 788999999999999999999999852211 11111111110 0 0 00
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........+.++.+++.+||..+|.+|||+.+|+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11123345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.25 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=194.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 457 (678)
+|+..+.||+|+||+||++... +++.||+|.+... .....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999965 6889999987642 2334567888999998886 577888999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999999753 35899999999999999999999998 999999999999999999999999998754322
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||... .............
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~------~~~~~~~~i~~~~---------- 217 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE------DEDELFQSIMEHN---------- 217 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC----------
Confidence 21 223345899999999999888999999999999999999999998532 1122222211111
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
...+...+.++.+++.+||+.+|.+|++.
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11122345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=297.75 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=192.1
Q ss_pred CeeeeeCCcEEEEEEEcC---CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 388 RILGQGGQGTVYKGMLAD---GRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998653 3578999876543 334457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 464 TLFQYLHDPSE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 464 ~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|.++++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 235677888899999999999999998 9999999999999999999999999987543322221
Q ss_pred -eeccccccCccCccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 542 -STKVQGTFGYLDPEYFHSS-------QFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 542 -~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+ ....... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------VLTYTVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHhh-cccCCC
Confidence 2234567889999998642 35789999999999999996 999985322111 1111111 111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.++.+ .....+.+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123446888999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.99 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=203.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||.|++|.||+|... +++.+++|...... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999965 58899999876543 44556788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999999753 6899999999999999999999998 99999999999999999999999999977654322
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ........ ..... .
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~------~~~~~~~~-~~~~~---------~ 216 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH------PMRVLFLI-PKNNP---------P 216 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc------hHHHHHHh-hhcCC---------C
Confidence 2233457889999999998889999999999999999999999985221 11111111 11100 0
Q ss_pred CCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTE-EIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..... .+..+.+++.+||..+|++|||++++++.
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111 45678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.42 Aligned_cols=253 Identities=28% Similarity=0.390 Sum_probs=205.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.++|++.+.||+|++|.||++... ++..+|+|..........+.+.+|++++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999974 6889999998877777778899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999987532 35899999999999999999999999 99999999999999999999999998865433222
Q ss_pred eeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 540 HVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||... ............. .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~-~----- 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL------NPMRVLLKILKSE-P----- 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC------CHHHHHHHHhcCC-C-----
Confidence 223345888999999975 344677999999999999999999998522 1111111111110 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011123345678999999999999999999999775
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.93 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=200.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.. ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 578899998753 22334456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997532 35899999999999999999999999 999999999999999999999999999766544
Q ss_pred cceeeeccccccCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.........|++.|+|||++.. ..++.++||||||+++|||++|+.||.. .+................
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~------~~~~~~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC------CCHHHHHHHHHcCCCccc-
Confidence 3333334568999999999875 4678899999999999999999999852 222222222221110000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS--RPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 653 (678)
. .......++++.+++.+||..++++ |++++++++.
T Consensus 229 ----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0111234567889999999876554 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=310.58 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=198.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|.+.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999965 57899999876432 33345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 58999887542 35889999999999999999999998 99999999999999999999999999875433222
Q ss_pred eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---hccchhhcch
Q 041043 540 HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---ENCLFDILDD 615 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 615 (678)
. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .......... ...+..+++.
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhcc
Confidence 1 223346889999998865 457889999999999999999999996332111 1111111100 0001111000
Q ss_pred ---------hhhc----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 ---------QVRK----SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ---------~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.... ......+..+.+||.+||+.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0011234578899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.95 Aligned_cols=239 Identities=23% Similarity=0.369 Sum_probs=188.3
Q ss_pred eeeeeCCcEEEEEEEcC-------------------------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeE
Q 041043 389 ILGQGGQGTVYKGMLAD-------------------------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL 443 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l 443 (678)
+||+|+||.||+|.+.. ...|++|.+........+++.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 13588898876555556789999999999999999999
Q ss_pred EeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC--
Q 041043 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-- 521 (678)
Q Consensus 444 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-- 521 (678)
++++.+....++||||+++|+|..++.+. ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999999753 236899999999999999999999998 99999999999997643
Q ss_pred -----cEEEeeccCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCccccccCC
Q 041043 522 -----RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELL-TGQKPISYIWANEGR 594 (678)
Q Consensus 522 -----~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~ell-tg~~p~~~~~~~~~~ 594 (678)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999987543221 12346788999998865 56899999999999999995 6888885321111
Q ss_pred ChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
... ... .... .+......+.+++.+||+.+|++|||++++++.|.
T Consensus 230 -~~~----~~~---------~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KER----FYE---------KKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHH----HHH---------hccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011 000 0000 11112346899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.16 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=212.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
+-|.+..+||+|+||.||++.++ .|+.+|||+... ..+.+++..|+.+|++.+.|++|+.+|.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34677889999999999999965 699999999875 345789999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
..|++.+.++.. +.+|++.++..+++..++||+|||... -+|||||+.||||+.+|.+||+|||.+-.+.... .
T Consensus 111 GAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 111 GAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 999999999864 357999999999999999999999987 8999999999999999999999999997765432 2
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc-hhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD-DQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 619 (678)
..+.+.||+-|||||++..-.|..++||||||+...||.-|++||....+... ++-+-. +....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------IFMIPT~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------IFMIPTKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------eEeccCCCCCCC
Confidence 34556799999999999998899999999999999999999999964333221 111111 11223
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+..++.++.++++.||.+.|++|.|+.++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 3467888999999999999999999999998765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=288.76 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=205.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcc--cCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSK--VVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..+.|++-+.||+|.|+.|++... ..|+.+|+|.+. .......+++.+|+.+-+.|+||||++|.+.+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999885 468888888653 23344678899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC---CCCcEEEeeccCccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRS 533 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgl~~~ 533 (678)
+|+|++++|..-|-.. ...++..+-..++||+.+|.|.|.++ |||||+||+|+||- ..--+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999998766432 35788888899999999999999999 99999999999994 344699999999988
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
+. .........|||+|||||++....|+..+|||+-||+||-|+.|.+||.. .+....+.+++... .
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~------~~~~rlye~I~~g~-----y 229 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD------EDQHRLYEQIKAGA-----Y 229 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC------ccHHHHHHHHhccc-----c
Confidence 77 33344556799999999999999999999999999999999999999952 12222232222211 1
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
| .........+++..+|+++||..||++|.|+.|.+..
T Consensus 230 d--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 D--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred C--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1 1122234566789999999999999999999998754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.73 Aligned_cols=251 Identities=26% Similarity=0.331 Sum_probs=199.6
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999965 68899999875422 22335678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999986532 235899999999999999999999998 99999999999999999999999999875433221
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .......... ....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~----------~~~~ 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVK----------EVQE 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhh----------hhhh
Confidence 123468999999999998899999999999999999999999996321110 0000110000 0011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
..+.....++.+|+.+||+.||++||| ++|+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 112334557899999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.31 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=192.4
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcC---CCCceeeEEeEEeeC-----C
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQI---SHRNVVKLLGSCLEV-----E 451 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~-----~ 451 (678)
+|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 58899999876422 22234566777777665 699999999988643 3
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++++||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 4789999997 48989887543 235899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---cc
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---NC 608 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 608 (678)
....... ......++..|+|||++.+..++.++||||||+++|||++|++||...... ..+.. ....... ..
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~-~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGK-IFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHH-HHHHhCCCChhh
Confidence 7654221 123345788999999999888999999999999999999999998532111 00111 1110000 00
Q ss_pred chh-------hcchhh---hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 609 LFD-------ILDDQV---RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 609 ~~~-------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
+.. ...... ......+..+.+.+|+.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000 00001234457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.44 Aligned_cols=237 Identities=26% Similarity=0.370 Sum_probs=188.7
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHH-HHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVV-ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|+||.||+++.. +++.+|+|.+... ......++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 5789999987532 2223344555554 67889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 9999988643 35889999999999999999999998 9999999999999999999999999987532222 122
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||.. .+........... . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~------~~~~~~~~~i~~~---------~--~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS------RDVSQMYDNILHK---------P--LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC------CCHHHHHHHHhcC---------C--CCCC
Confidence 345689999999999988899999999999999999999999852 2222222222111 1 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMK 648 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~ 648 (678)
......+.+++.+||+.||++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 33456789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=303.36 Aligned_cols=240 Identities=23% Similarity=0.408 Sum_probs=190.8
Q ss_pred CeeeeeCCcEEEEEEEcC--------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 388 RILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+.||+|+||.||+|.... ...+++|..........+++.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999998642 234888887665556667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc--------EEEeeccCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--------AKIADFGTS 531 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~Dfgl~ 531 (678)
+++|+|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999997643 25899999999999999999999998 999999999999987765 699999988
Q ss_pred ccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCC-CCCCccccccCCChHHHHHHHHhhccc
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQ-KPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.... ..... .....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~------~~~~~-~~~~~--- 220 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD------SQKKL-QFYED--- 220 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc------HHHHH-HHHHc---
Confidence 654321 22357788999999986 45789999999999999999985 5543111 11100 00000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
....+.....++.+|+.+||+.+|++|||++++++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01112223357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.59 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=201.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|+..+.||+|+||.||+|.+. ++. .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999864 343 57888876533 33345789999999999999999999988754 4679
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999997542 35889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ... .......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~------~~~-~~~~~~~~~----- 228 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP------TRE-IPDLLEKGE----- 228 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHH-HHHHHHCCC-----
Confidence 332221 122335678999999998889999999999999999997 889985321 111 111111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....+...+..+.+++.+||..+|++||+++++++.|+++...
T Consensus 229 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 ----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111122345789999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.08 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=200.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
++|.+.+.||+|+||.||+|... +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778889999999999999964 58899999887665566677889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 999999998743 35899999999999999999999999 9999999999999999999999999987554221 1
Q ss_pred eeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 541 VSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
......++..|+|||.+. ...++.++||||||+++|+|++|+.||...... ...+ ......... ...
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----~~~~-~~~~~~~~~----~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RALF-LMTKSNFQP----PKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----hhHH-hhhccCCCC----Ccc
Confidence 223346889999999974 455888999999999999999999998522111 1101 000000000 000
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......+..+.+++.+||+.+|++||+++++++
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 001123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.17 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=202.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||+|+||.||++... ++..+|+|.++.. +....+++.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999975 6899999987643 444567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|..++........+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999997643344689999999999999999999974 6 9999999999999999999999999987553221
Q ss_pred ceeeeccccccCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQ------FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.... .......... +
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~---------~ 222 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET---YANIFAQLSA---------I 222 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc---hhhHHHHHHH---------H
Confidence 22335788999999985543 4789999999999999999999985211 1111111111 1
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
... .....+.....++.+++.+||+.+|++||++++++..
T Consensus 223 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 110 1112234466789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.32 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=203.4
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677789999999999999975 58899999876433 455678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999999864 25889999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .... .........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~----------~~~~~~~~~ 220 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLF----------LIPKNNPPT 220 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhh----------hhhcCCCCC
Confidence 223345788899999998888999999999999999999999998532111 0000 001111122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....+..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 234566789999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.54 Aligned_cols=252 Identities=27% Similarity=0.341 Sum_probs=207.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+.|++.+.||.|.-|+||++.+++ +..+|+|++... ......+...|-+||+.+.||.+..|++.+..++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356677899999999999999875 589999987643 3444556778999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC-
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI- 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~- 536 (678)
|||+||+|...++++. ...+++..+..++.+++-||+|||..| ||+|||||+||||-++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999988764 457999999999999999999999999 99999999999999999999999988643211
Q ss_pred --------------------------------Ccc----------------------eeeeccccccCccCccccccCCC
Q 041043 537 --------------------------------DQT----------------------HVSTKVQGTFGYLDPEYFHSSQF 562 (678)
Q Consensus 537 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 562 (678)
... ......+||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01222468999999999999999
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCC
Q 041043 563 TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGR 642 (678)
Q Consensus 563 s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 642 (678)
+.+.|.|+||++||||+.|.-||.+. +-.+. +..++.+.+......+.+..+++||++.|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~------~~~~T---------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGS------NNKET---------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCC------Cchhh---------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999632 22222 3334444444444456778899999999999999
Q ss_pred CCCC----HHHHHH
Q 041043 643 SRPT----MKEVAM 652 (678)
Q Consensus 643 ~RPt----~~evl~ 652 (678)
+|.. +.||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9987 666644
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=297.53 Aligned_cols=238 Identities=24% Similarity=0.426 Sum_probs=189.4
Q ss_pred CeeeeeCCcEEEEEEEcCCc-----------EEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 388 RILGQGGQGTVYKGMLADGR-----------IIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
+.||+|+||.||+|...+.. .+++|........ ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47899999999999976433 5777876554333 6789999999999999999999999988 778999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-------cEEEeecc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-------RAKIADFG 529 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~Dfg 529 (678)
+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999986432 6899999999999999999999998 99999999999999887 79999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhh
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS--QFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+..... ..+.......
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~------~~~~~~~~~~ 222 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS------SEKERFYQDQ 222 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc------hhHHHHHhcC
Confidence 9876543 1223466789999999876 78999999999999999999 5667643211 1111111000
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
. .. +......+.+++.+||..+|.+|||+.|+++.|+
T Consensus 223 ~---------~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H---------RL---PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C---------CC---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0111267899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.79 Aligned_cols=264 Identities=20% Similarity=0.269 Sum_probs=198.0
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC----
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE---- 451 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 451 (678)
...++|++.+.||+|+||.||++... .++.+|||++... +....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 5889999988642 3444567889999999999999999999886432
Q ss_pred --cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 452 --VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 452 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999965 67777642 4789999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC---------CChHHH-
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---------RNLATY- 599 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---------~~~~~~- 599 (678)
+++..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||......+. ......
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99754322 222334689999999999988899999999999999999999999963221100 000000
Q ss_pred ------HHHHHhhcc-chhhcchhh-----h---cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 600 ------FVECVEENC-LFDILDDQV-----R---KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 600 ------~~~~~~~~~-~~~~~~~~~-----~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......... ......... . ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 000000000 0 00111234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.10 Aligned_cols=247 Identities=29% Similarity=0.513 Sum_probs=199.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
++|++.+.||+|+||.||++.. .++.+|+|..+... ..+.+.+|+.++++++|||++++++++... ..++++||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 57889999886532 346789999999999999999999998654 5799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999997643 335899999999999999999999998 999999999999999999999999998754321
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.... ..... .....+ .+..
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~-~~~~~~---------~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS------LKEVK-ECVEKG---------YRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC------HHHHH-HHHhCC---------CCCC
Confidence 112234567999999988889999999999999999998 899985321 11111 111111 1111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 223445678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=300.88 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=198.3
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+...+..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999964 68899999875432 22345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999999887542 235999999999999999999999998 9999999999999999999999999987543221
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ............ ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~----------~~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLET----------EE 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhcc----------cc
Confidence 1233468999999999998889999999999999999999999995321100 000000000000 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
......+..+.+|+.+||+.||++||+ +.+++..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 112334557889999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=299.23 Aligned_cols=248 Identities=29% Similarity=0.513 Sum_probs=199.6
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh---------hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE---------SKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999964 578999997754321 123568899999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++++||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999753 35889999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCcce-----eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc
Q 041043 533 SIAIDQTH-----VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 533 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||... ..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~-~~~~~~-- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC-----TQLQA-IFKIGE-- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc-----cHHHH-HHHHhc--
Confidence 66522111 112234788999999999888999999999999999999999998522 11111 111000
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......+...+..+.+++.+||+.||.+||++.|+++
T Consensus 227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111122345568899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=318.80 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=198.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|+|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 478899996432 3457899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+. ++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 78999886532 36999999999999999999999999 99999999999999999999999999976543222
Q ss_pred e-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccc-cCCChHHHHHHHHhhccc-----hhh
Q 041043 540 H-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWAN-EGRNLATYFVECVEENCL-----FDI 612 (678)
Q Consensus 540 ~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~ 612 (678)
. ......||..|+|||++.+..++.++|||||||+||||++|..|+...... ........+...+..... ...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 222356899999999999999999999999999999999988765432211 111111112222211110 000
Q ss_pred cc----hhh--------hcCC-C------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LD----DQV--------RKSG-K------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~----~~~--------~~~~-~------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. ... .... . ......+.+|+.+||+.||++|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000 0000 0 0123468899999999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.20 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=198.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc---CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
..+|.+.+.||+|+||.||++... .+..|++|.+... ....+|++++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999853 3578999987542 23468999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
|++. ++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 688888843 346899999999999999999999999 999999999999999999999999999765433
Q ss_pred cce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch------
Q 041043 538 QTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF------ 610 (678)
Q Consensus 538 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 610 (678)
... ......||+.|+|||++....++.++|||||||++|||++|+.||.........................
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 222 2234568999999999999899999999999999999999999986433221111011111110000000
Q ss_pred -hh------cchhhhcCC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 611 -DI------LDDQVRKSG-------KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 611 -~~------~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+ .....+... ......++.++|.+||..||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000 01223578899999999999999999999876
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.94 Aligned_cols=257 Identities=18% Similarity=0.279 Sum_probs=194.3
Q ss_pred cCCeeeee--CCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 386 VNRILGQG--GQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 386 ~~~~Lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
+.++||+| +|++||++.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999986 46899999988653 2344566788999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999965422 34899999999999999999999999 999999999999999999999999865433211110
Q ss_pred ------eeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 541 ------VSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 541 ------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
......++..|+|||++.. ..++.++||||||+++|||++|+.||...... ........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~-~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT------QMLLEKLN-GTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh------HHHHHHhc-CCcccc
Confidence 0112246678999999876 45889999999999999999999999532110 00000000 000000
Q ss_pred cc------------------------h------------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LD------------------------D------------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~------------------------~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+ . ...........+.+.+|+.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 0 00001122345689999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.47 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=197.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|+..+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 5889999987642 2344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999998654321
Q ss_pred cc----------------------------------eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 041043 538 QT----------------------------------HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQK 583 (678)
Q Consensus 538 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~ 583 (678)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00112468999999999999999999999999999999999999
Q ss_pred CCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 041043 584 PISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT---MKEVAME 653 (678)
Q Consensus 584 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 653 (678)
||... ............. ..+........++++.+|+.+++. +|++|++ +.|+++.
T Consensus 235 Pf~~~------~~~~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSE------TPQETYRKVMNWK-------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCC------CHHHHHHHHHcCC-------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99532 2222222221110 000000111234578889988774 9999985 5666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=297.83 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=201.2
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-----hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-----ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78999999875433 33567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999753 35889999999999999999999998 99999999999999999999999999876543
Q ss_pred CcceeeeccccccCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.... .............
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~------- 219 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRSKE------- 219 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHHHhccc-------
Confidence 32 223445788999999987766 8999999999999999999999985221 1111111111000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
....+....+.+.+++++||+.+|.+||++.+++.
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11112334567899999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.59 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=197.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC------
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV------ 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 450 (678)
..++|.+.+.||+|+||.||++... .++.||||++... +....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999964 5789999988642 344456788999999999999999999987543
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346899999965 77777742 3788999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-----
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE----- 605 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 605 (678)
++...... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... ..+.....
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~ 244 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLGTP 244 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCC
Confidence 97653221 223346899999999999999999999999999999999999999633211 11111110
Q ss_pred -----------------hccc-h-----hhcchhh---hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 -----------------ENCL-F-----DILDDQV---RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 -----------------~~~~-~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.... . ....... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0 0000000 000011123578899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=300.79 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=201.3
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcC--CcEEEEEEcccC----------ChhhHHHHHHHHHHHhc-CCCCceeeEEeEEee
Q 041043 383 HFNVNRILGQGGQGTVYKGMLAD--GRIIAVKKSKVV----------DESKLEEFINEVVILSQ-ISHRNVVKLLGSCLE 449 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~ 449 (678)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 688999976432 23345667889988865 799999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCCcEEEee
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIAD 527 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~D 527 (678)
.+..++++||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 223468999999999999999999996 55 99999999999999999999999
Q ss_pred ccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
||++....... ......++..|++||.+.+..++.++||||||+++|||++|+.||.. ............ .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~------~~~~~~~~~~~~-~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS------TNMLSLATKIVE-A 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc------cCHHHHHHHHhh-c
Confidence 99997654332 23344588899999999988899999999999999999999999842 111111111111 1
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.. ........+..+.+++.+||+.||++||++.|+.++++
T Consensus 229 ~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 11111134567999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=296.98 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=205.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999964 67899999876432 33567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.++++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976443356899999999999999999999998 99999999999999999999999999876654332
Q ss_pred e---eeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 540 H---VSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 540 ~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
. ......++..|+|||.+... .++.++|+||||+++|||++|+.||..... ...+.+..... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP------MKVLMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh------hhhHHHHhcCC------CC
Confidence 2 22334578899999998776 789999999999999999999999852211 11111111110 00
Q ss_pred hhhcC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKS-GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..... .....+..+.+++.+||+.||++||+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01100 01244567899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=299.19 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=199.8
Q ss_pred CCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC------
Q 041043 384 FNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE------ 451 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 451 (678)
|.+.+.||+|+||.||+|.+. .++.+|||.++.. +....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3688999987643 3455678999999999999999999999886542
Q ss_pred cceEEEEeccCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPS---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
..++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 2235789999999999999999999998 999999999999999999999999
Q ss_pred cCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhh
Q 041043 529 GTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 529 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||.... ...........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE------NSEIYNYLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC------HHHHHHHHHcC
Confidence 998865433221 1222335678999999998889999999999999999999 888875221 11111111111
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.. ...+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 232 ~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 011223446899999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=296.62 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=201.8
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-CcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV-EVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 458 (678)
+|++.+.||+|++|.||++..+ +++.+|+|++... .....+.+.+|++++++++|+|++++++.+... ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 5788999987543 344556789999999999999999999987643 45789999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++.... ...+++.+++.++.+++.||++||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999997532 335899999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
. ......+++.|+|||.+.+..++.++||||||+++++|++|+.||.. .+.......... +..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~------~~~~~~~~~~~~-~~~--------- 219 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA------KDMNSLVYRIIE-GKL--------- 219 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC------CCHHHHHHHHHh-cCC---------
Confidence 2 22334578899999999998899999999999999999999999852 122222211111 111
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+..+.+++.+|++.+|++|||+.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223455689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=335.71 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=199.8
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Cc
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EV 452 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~ 452 (678)
+...++|.+.+.||+|+||+||++... .+..+|+|.+.. ........+..|+.++++++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 334568999999999999999999965 467889998754 3444567899999999999999999999988654 46
Q ss_pred ceEEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeecCCCCceEECC--------
Q 041043 453 PLLVYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAY----LPIYHRDIKSTNILLDE-------- 519 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlk~~NILl~~-------- 519 (678)
.++||||+++|+|.++|.... ....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997532 22469999999999999999999998541 23999999999999964
Q ss_pred ---------CCcEEEeeccCcccccCCcceeeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 041043 520 ---------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYI 588 (678)
Q Consensus 520 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~ 588 (678)
.+.+||+|||++..+.... ......+|+.|+|||++.. ..++.++|||||||+||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~- 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK- 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc-
Confidence 2358999999997654322 2234468999999999854 4588999999999999999999999952
Q ss_pred ccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 589 WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.......+..... .. .+ .....+.++.+||.+||+.+|.+||++.|++.
T Consensus 246 ----~~~~~qli~~lk~-~p-------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ----ANNFSQLISELKR-GP-------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ----CCcHHHHHHHHhc-CC-------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2222222221111 10 00 01223467899999999999999999999984
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.10 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=190.6
Q ss_pred CeeeeeCCcEEEEEEEcC---CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 388 RILGQGGQGTVYKGMLAD---GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.||+|+||.||+|...+ ...+++|.+... .......+.+|+++++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999998543 357888876543 3344567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 464 TLFQYLHDPSE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 464 ~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|.+++..... ....++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 233567888999999999999999998 9999999999999999999999999986543322211
Q ss_pred -eeccccccCccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 542 -STKVQGTFGYLDPEYFHS-------SQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 542 -~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ........... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhhcc-CccC
Confidence 222345678999998743 356789999999999999999 7778752211 11111111111 1111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
..+. .....+..+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 12234456778888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.59 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=205.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||+|+||+||++... +++.+|+|...... ....+.+.+|+++++.++||||+++++.+......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999965 58899999865433 34457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999998753 358999999999999999999997 46 9999999999999999999999999986543221
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC-----CChHHHHHHHHhhccchhhc
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG-----RNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 613 (678)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||......+. ......+.....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 227 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-------- 227 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh--------
Confidence 1234688999999999888899999999999999999999999964322111 011111111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
...........+.++.+|+.+||+.||++|||+.|++++..-++
T Consensus 228 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 228 -EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 11111111224567999999999999999999999998754444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.44 Aligned_cols=195 Identities=27% Similarity=0.404 Sum_probs=159.9
Q ss_pred CCeeeeeCCcEEEEEEEc---CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcceEEEEecc
Q 041043 387 NRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE--VEVPLLVYEFIP 461 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 461 (678)
.++||+|+||+||+|... +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999964 45789999886432 23457889999999999999999998864 345789999986
Q ss_pred CCChhhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE----CCCCcEEEeeccCc
Q 041043 462 NGTLFQYLHDPS------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTS 531 (678)
Q Consensus 462 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgl~ 531 (678)
++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 1235899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccccCCcce--eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 041043 532 RSIAIDQTH--VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISY 587 (678)
Q Consensus 532 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~ 587 (678)
+........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 865433221 2234568999999999876 4588999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=297.55 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=195.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Ccc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVP 453 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 453 (678)
.+|+..+.||+|+||.||++... +++.+++|++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 5889999987532 223456788999999999999999999988753 567
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++++||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999999753 34889999999999999999999988 99999999999999999999999999876
Q ss_pred ccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||... . ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~-----~-~~~~~~~~~~~----- 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-----E-AMAAIFKIATQ----- 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc-----c-hHHHHHHHhcC-----
Confidence 5321111 112245788999999999888999999999999999999999998521 1 11111111110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......+....+.+.+++ +||..+|++||+++||++
T Consensus 225 ----~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 ----PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011122233445677777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.72 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=203.7
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|+||.+|++... +++.+|+|.+... .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999964 6889999987542 344556899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999997532 235789999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.. .............. ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~------~~~~~~~~~~~~~~----------~~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA------GNMKNLVLKIIRGS----------YP 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC------CCHHHHHHHHhcCC----------CC
Confidence 12234578899999999988899999999999999999999999852 12222222221111 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+.....++.+++.+||+.+|++||+++||++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1123445679999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.23 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=197.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Ccc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVP 453 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 453 (678)
++|++.++||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999965 5889999986532 123456788999999999999999999988764 457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++++||+++++|.+++... ..+++...+.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999999743 34788999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCcc--eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 534 IAIDQT--HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 534 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||... ..... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-----~~~~~-~~~~~~------ 223 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-----EAMAA-IFKIAT------ 223 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-----chHHH-HHHHhc------
Confidence 532111 1122345788999999998888999999999999999999999998521 11111 111110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.......+......+.+++.+|+. +|++||+++|+++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 ---QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011122234556678899999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=311.16 Aligned_cols=191 Identities=24% Similarity=0.419 Sum_probs=164.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++......++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 357999999999999999999975 4678999975432 335689999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+. ++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 139 ~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 139 YS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 95 6898888653 246899999999999999999999999 999999999999999999999999998743221
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~ 585 (678)
.......||+.|+|||++.+..++.++||||||+++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223345899999999999989999999999999999999966554
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.11 Aligned_cols=264 Identities=25% Similarity=0.340 Sum_probs=205.1
Q ss_pred ccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEe
Q 041043 371 IFNSKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCL 448 (678)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 448 (678)
++...++..+.++|.+.+.||+|+||.||++... +++.+|+|...... ...+++.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3455667777899999999999999999999964 68899999876532 2345678899999998 7999999999987
Q ss_pred eC-----CcceEEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc
Q 041043 449 EV-----EVPLLVYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522 (678)
Q Consensus 449 ~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 522 (678)
.. +..++|+||+++++|.++++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 54 35799999999999999986422 2346899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCcccccCCcceeeeccccccCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChH
Q 041043 523 AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLA 597 (678)
Q Consensus 523 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~ 597 (678)
+||+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.||..... .
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~ 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------V 239 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------H
Confidence 999999998765432211 2234578899999998653 368899999999999999999999853211 1
Q ss_pred HHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 598 TYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........ ..... ...+......+.+++.+||+.+|++||++.|+++.
T Consensus 240 ~~~~~~~~-~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 KTLFKIPR-NPPPT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHhc-CCCCC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111 10110 11122344579999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=308.75 Aligned_cols=259 Identities=21% Similarity=0.264 Sum_probs=196.2
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC---
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--- 450 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--- 450 (678)
.....++|.+.+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 334568899999999999999999996 46789999987643 223446688999999999999999999987543
Q ss_pred ---CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEee
Q 041043 451 ---EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527 (678)
Q Consensus 451 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 527 (678)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3468899987 7799888753 35899999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
||++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.... ....+......
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~ 231 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND------YIDQLKRIMEV 231 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHHH
Confidence 9999765432 223458999999999876 568899999999999999999999985321 11111111000
Q ss_pred --ccchhhc----c-------hhhhcCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 --NCLFDIL----D-------DQVRKSGK-------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 --~~~~~~~----~-------~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+.. . ..+..... ....+.+.+|+.+||+.||.+|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0 00000000 0122457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.63 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=200.3
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEE---EEcc-cCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc--ceEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAV---KKSK-VVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV--PLLV 456 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vav---K~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lv 456 (678)
.....+||+|+|-+||+|... +|..||= |.-. ..+....++|..|+++|+.|+||||++++..+.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345678999999999999964 4655652 2211 1345567899999999999999999999999987665 6789
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~~~~ 535 (678)
+|.+..|+|..|+++.+ .++.+.+..|++||++||.|||++. |||+|||||=+||+|+. -|.|||+|+|||....
T Consensus 122 TEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999998765 4889999999999999999999988 78999999999999985 5799999999998765
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.... ..+.|||.|||||.+. ..|.+..||||||+.|+||+|+..||. +=.+.++.+.+.....+.. .+.
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~SGiKP~-sl~- 266 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTSGIKPA-ALS- 266 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHcCCCHH-Hhh-
Confidence 4332 2368999999999998 689999999999999999999999995 5555666555544332211 111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.-..++++++|.+||.. .+.|||+.|+|..
T Consensus 267 -------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 -------KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 01124688999999999 9999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.08 Aligned_cols=262 Identities=22% Similarity=0.277 Sum_probs=201.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 68999999876543 34457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+ +++|.+++.... ..+++.+++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987543 46899999999999999999999998 99999999999999999999999999887654332
Q ss_pred eeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc-----------
Q 041043 540 HVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN----------- 607 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 607 (678)
.......++..|+|||.+.+. .++.++||||||++++||++|.+||...... .............
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCc
Confidence 223334588899999998654 4688999999999999999998777422110 0011111100000
Q ss_pred -cchhhcchhh----hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 608 -CLFDILDDQV----RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 608 -~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+..... ......+....+.+++.+||+.+|.+|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 000011234789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=298.19 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=204.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|+..+.||+|++|.||++..+ +++.+++|.+.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999976 58899999876543 44557799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997643 468999999999999999999999 88 9999999999999999999999999986553322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ................ .
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~----------~ 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVNEP----------P 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhcCC----------C
Confidence 21 15578899999999988999999999999999999999999853221 1111222221111110 0
Q ss_pred cCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKT-EEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+. ..+.++.++|.+||..+|++|||+.|++..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 256679999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.87 Aligned_cols=251 Identities=29% Similarity=0.448 Sum_probs=201.9
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|+..+.||+|+||.||+|... +++.+++|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999964 688999998765444 3678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999999753 34789999999999999999999999 99999999999999999999999999877654333
Q ss_pred eee---eccccccCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 540 HVS---TKVQGTFGYLDPEYFHSSQ---FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 540 ~~~---~~~~gt~~y~aPE~~~~~~---~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
... ....++..|+|||.+.... .+.++||||||+++||+++|+.||.... ........... .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-----~~~~~~~~~~~-~------ 222 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-----NEFQIMFHVGA-G------ 222 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-----chHHHHHHHhc-C------
Confidence 221 1345788999999998766 8889999999999999999999985221 11111111110 0
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..............+.+++.+||+.+|.+|||+.|++.
T Consensus 223 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111223567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=321.15 Aligned_cols=267 Identities=19% Similarity=0.239 Sum_probs=193.1
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCC------CceeeEEeEE
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISH------RNVVKLLGSC 447 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h------~niv~l~~~~ 447 (678)
++++..+++|++.++||+|+||+||+|... .++.||||+++... ...+++..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 445556788999999999999999999964 57889999986432 223455667777777654 4588898888
Q ss_pred eeC-CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCC----
Q 041043 448 LEV-EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKY---- 521 (678)
Q Consensus 448 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~---- 521 (678)
... ...++|+|++ +++|.+++.+. ..+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 754 4678899988 67899988753 3589999999999999999999984 7 99999999999998765
Q ss_pred ------------cEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 041043 522 ------------RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIW 589 (678)
Q Consensus 522 ------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~ 589 (678)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998754221 2234568999999999999999999999999999999999999996432
Q ss_pred cccCC---------ChHHHHHHH--------Hhh-ccchhhcchh-h---hc---CCCHHHHHHHHHHHHHhcccCCCCC
Q 041043 590 ANEGR---------NLATYFVEC--------VEE-NCLFDILDDQ-V---RK---SGKTEEIMEVSDVAKRCLNSNGRSR 644 (678)
Q Consensus 590 ~~~~~---------~~~~~~~~~--------~~~-~~~~~~~~~~-~---~~---~~~~~~~~~l~~li~~cl~~dP~~R 644 (678)
..+.. ....|.... ... ..+....+.. + .. .........+.+||.+||++||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 11100 000010000 000 0000000000 0 00 0001123567899999999999999
Q ss_pred CCHHHHHHH
Q 041043 645 PTMKEVAME 653 (678)
Q Consensus 645 Pt~~evl~~ 653 (678)
||++|+++.
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999974
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.83 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=201.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.+.||+|++|.||+|..+ +++.|++|+++.. +....+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 5789999987643 33445788999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++++.+..++.. ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777666543 234899999999999999999999998 9999999999999999999999999988765544
Q ss_pred ceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH------------h
Q 041043 539 THVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV------------E 605 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~ 605 (678)
........++..|+|||++... .++.++||||||+++|+|++|+.||......+ .+. ...... .
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLY-LIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHHHhCCCCHHHhhhccc
Confidence 3233345578899999999887 78999999999999999999999985321110 000 000000 0
Q ss_pred hcc-----chhhcchh-hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 606 ENC-----LFDILDDQ-VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 606 ~~~-----~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
... .....+.. .....+...+.++.+||++||..+|++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 00000000 000112223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=305.59 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=201.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh---hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE---SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|+..+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999975 489999998764332 35567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999997542 346899999999999999999999998 999999999999999999999999998654322
Q ss_pred cce----------------------------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 041043 538 QTH----------------------------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIW 589 (678)
Q Consensus 538 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~ 589 (678)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1112357889999999998889999999999999999999999985221
Q ss_pred cccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 041043 590 ANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT----MKEVAM 652 (678)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 652 (678)
. ...+.... ............+..+.+++.+||..+|++||| ++|++.
T Consensus 237 ~------~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R------DETFSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h------HHHHHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111111 111111112225678999999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=294.63 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=189.9
Q ss_pred CeeeeeCCcEEEEEEEcCC---cEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 388 RILGQGGQGTVYKGMLADG---RIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.||+|+||.||+|...++ ..+++|..+... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985443 356677655433 345678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc-cee
Q 041043 464 TLFQYLHDPSE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ-THV 541 (678)
Q Consensus 464 ~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~-~~~ 541 (678)
+|.+++++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 234677788899999999999999998 9999999999999999999999999975432211 112
Q ss_pred eeccccccCccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 542 STKVQGTFGYLDPEYFHS-------SQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||... ...........+. .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~------~~~~~~~~~~~~~-~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL------SDREVLNHVIKDQ-QVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhhc-ccccC
Confidence 233457889999998753 245779999999999999997 56677421 1122222222211 11122
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
++.+. ....+.+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22221 224457888999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.10 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=198.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|+..+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58999999875432 2234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++++.|..++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999888877542 35899999999999999999999988 9999999999999999999999999998664432
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-----------h
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE-----------E 606 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 606 (678)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +.. ...... .
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYL-IRKTLGDLIPRHQQIFST 230 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCChHHhhhccc
Confidence 2 1223347788999999876 4578899999999999999999999863221110 000 000000 0
Q ss_pred ccch-hhcchhhhcCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 607 NCLF-DILDDQVRKSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 607 ~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.... ....+...... ....+..+.+|+.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 00000000000 0123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.77 Aligned_cols=197 Identities=28% Similarity=0.401 Sum_probs=170.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-C-----CceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS-H-----RNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~~~~ 453 (678)
.-+|.+.+.||+|.||.|.++... +++.||||++++.. .-..+-..|+.+|..|+ | -|+|++++++...++.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 348999999999999999999954 58999999998743 34466778999999997 4 4999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC--CcEEEeeccCc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTS 531 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgl~ 531 (678)
+||+|.++ .+|.++|+.+.- ..++...++.|+.||+.||.+||..+ |||.||||+||||.+- ..+||+|||.+
T Consensus 264 ciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999995 599999998654 45999999999999999999999998 9999999999999754 37999999999
Q ss_pred ccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISY 587 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~ 587 (678)
......- . ....+..|+|||++.+..|+.+.||||||||++||++|.+-|.+
T Consensus 339 c~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 339 CFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 8643221 1 34567889999999999999999999999999999999877753
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=300.24 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=201.4
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEee--
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLE-- 449 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-- 449 (678)
.+.+..+.++|++.+.||+|+||.||++... +++.+|+|....... ...++.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3555667889999999999999999999964 578999998764322 235678899999999 69999999998853
Q ss_pred ---CCcceEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 450 ---VEVPLLVYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 450 ---~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
.+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 34679999999999999988642 12346889999999999999999999998 999999999999999999999
Q ss_pred eeccCcccccCCcceeeeccccccCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 041043 526 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~ 600 (678)
+|||++........ ......+++.|+|||++.. ..++.++||||||+++|||++|+.||..... ... .
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-----~~~-~ 238 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-----MRA-L 238 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-----hHH-H
Confidence 99999876543221 2223458899999999853 3478899999999999999999999853211 111 1
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..... .... ....+......+.+|+.+||+.+|++|||+.|+++.
T Consensus 239 ~~~~~-~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 FKIPR-NPPP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hhccc-cCCC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000 0000 000111234578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=301.58 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=200.2
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999964 5889999998766666677899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
++|.+++.. ..+++.+++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ..
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 999998853 24889999999999999999999998 99999999999999999999999999875433222 12
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....++..|+|||.+.+..++.++||||||+++|||++|+.||... .....+..... ....... ..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------~~~~~~~~~~~------~~~~~~~--~~ 241 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE------PPLQAMRRIRD------NLPPRVK--DS 241 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHh------cCCCccc--cc
Confidence 2345788999999998888999999999999999999999998521 11111111110 0111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......+.+++.+||..||++|||++|+++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2344578899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.35 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=202.0
Q ss_pred CCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcceEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLE--VEVPLLVY 457 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 457 (678)
+|++.+.||.|+||.||++.. .+++.+|+|.+.. ......+++.+|++++++++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 4678999998753 344556778999999999999999999998764 34578999
Q ss_pred EeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 458 EFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLH-----SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH-----~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
||+++++|.+++.... ....+++..++.++.|++.||+||| +.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997532 2356899999999999999999999 666 999999999999999999999999999
Q ss_pred ccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
......... .....+++.|+|||.+....++.++||||||+++|+|++|+.||... ...... ......
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~-~~~~~~---- 225 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR------NQLQLA-SKIKEG---- 225 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc------CHHHHH-HHHhcC----
Confidence 876543321 23345889999999999888999999999999999999999998522 111111 111111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....+...+..+.+++.+||+.+|++||+++||++.
T Consensus 226 -----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 -----KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112233455789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=301.32 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=198.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.++||+|+||.||++..+ +++.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999976 58899999865422 2235678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|..+.... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998877542 24899999999999999999999998 9999999999999999999999999987654433
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-hccc----hhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE-ENCL----FDI 612 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~ 612 (678)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ... ...... ...+ ...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-----IDQ-LYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-----HHH-HHHHHHHhCCCchhhHHH
Confidence 22233457889999999865 4478899999999999999999998852211 111 111000 0000 000
Q ss_pred cc----------hhhh-----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 LD----------DQVR-----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ~~----------~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+ .... .......+..+.+|+.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 0000 0001233567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.58 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=200.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999965 47899999876533 334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999653 35899999999999999999999998 999999999999999999999999988642111
Q ss_pred cc--------------eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 041043 538 QT--------------HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 538 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
.. .......++..|+|||.+....++.++||||||+++|||++|..||... ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~------~~~~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD------TPEELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH
Confidence 00 0111234678899999998888999999999999999999999998521 222222221
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.... .. ........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~-~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDD-IE-------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhcc-cC-------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111 00 000111345678999999999999999997666666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.95 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=200.9
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
-|+..+.||+|+||.||+|... +++.+|+|...... ....+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999864 67899999875432 344567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999999864 25899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ....... .... ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~-~~~~---------~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH------PMKVLFL-IPKN---------NPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc------hHHHHHH-HhcC---------CCCC
Confidence 1223457889999999988888999999999999999999999985211 1111111 1111 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....+.++.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223345678999999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=298.06 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=201.2
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCC-----
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVE----- 451 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----- 451 (678)
..+++|++.+.||+|++|.||+|..+ +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999975 578899998765443 346789999999999 6999999999997654
Q ss_pred -cceEEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
..++|+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3799999999999999987532 2346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.... . ........
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~-~~~~~~~~ 231 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-----P-MRALFKIP 231 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-----h-HHHHHHhh
Confidence 9875443222 2233457889999998753 346789999999999999999999985211 1 11111111
Q ss_pred hhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
. ... .....+...++.+.+|+.+||..||++|||+.|+++
T Consensus 232 ~-~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 R-NPP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-cCC-------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 000 011112335678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.24 Aligned_cols=195 Identities=26% Similarity=0.409 Sum_probs=159.3
Q ss_pred CCeeeeeCCcEEEEEEEcC---CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcceEEEEecc
Q 041043 387 NRILGQGGQGTVYKGMLAD---GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE--VEVPLLVYEFIP 461 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 461 (678)
..+||+|+||+||+|...+ +..+|+|.+.... ....+.+|++++++++||||+++++++.. ....++++||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999653 4789999876432 23467899999999999999999998864 456789999986
Q ss_pred CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE----CCCCcEEEeeccCc
Q 041043 462 NGTLFQYLHDP------SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTS 531 (678)
Q Consensus 462 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgl~ 531 (678)
+ +|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 787777532 12235889999999999999999999998 9999999999999 56679999999999
Q ss_pred ccccCCcce--eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 041043 532 RSIAIDQTH--VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISY 587 (678)
Q Consensus 532 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~ 587 (678)
+........ ......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 866433221 1233467899999999876 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=300.97 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=196.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|+||.||+|... +|+.+|+|.++.. .......+.+|++++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 6889999987643 222345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5788887643 235899999999999999999999999 99999999999999999999999999876543222
Q ss_pred eeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---c---c---c
Q 041043 540 HVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---N---C---L 609 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~---~ 609 (678)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+... .+....+...... . . .
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-----NDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC-----CCHHHHHHHHHHHhCCCChHHhHHh
Confidence 1 2233568899999998764 4788999999999999999999886421 1111111111100 0 0 0
Q ss_pred hhhcchhh----h-----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 610 FDILDDQV----R-----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 610 ~~~~~~~~----~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
....+... . .......++++.+++.+||+.||.+|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 0 0011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.33 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=207.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||+|++|.||+++.. +++.+++|++..... ...+.+.+|++.+++++|+|++++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 489999998766543 4567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 468999999999999999999999 88 9999999999999999999999999987664333
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.. .....++..|+|||.+....++.++||||||+++|+|++|+.||..... .............. .
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~----------~ 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ---PSFFELMQAICDGP----------P 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc---cCHHHHHHHHhcCC----------C
Confidence 22 2234578899999999988899999999999999999999999853321 11122121111110 0
Q ss_pred cCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTE-EIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+.. .+..+.+++.+||..+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 55789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.81 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=199.0
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC----------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD----------ESKLEEFINEVVILSQISHRNVVKLLGSCLEVE 451 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 451 (678)
+|.+.+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999854 68899999765311 112356888999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999754 36899999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcce-eeeccccccCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 532 RSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 532 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
......... ......++..|+|||.+.... ++.++|+||||+++||+++|..||.. ........ ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-----~~~~~~~~-~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD-----EEAIAAMF-KLGNKR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC-----cchHHHHH-Hhhccc-
Confidence 764432211 123345788999999987654 78899999999999999999999842 11111111 111110
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
... ..........+..+.+++.+||..+|.+|||++||++.
T Consensus 229 ~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAP----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCC----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 00111122345689999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=294.28 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=201.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 383 HFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD------ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 568899999876422 2235788999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSI 534 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~ 534 (678)
|+||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999999753 35889999999999999999999999 99999999999998776 5999999998766
Q ss_pred cCCcce---eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 535 AIDQTH---VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 535 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||.... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~------- 224 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK---HSNHLALIFKIA------- 224 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---CcchHHHHHHHh-------
Confidence 533211 1223457889999999988889999999999999999999999985221 111111111110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........+.....++.+++.+||+.+|++||++.|++.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 --SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011112233455678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.41 Aligned_cols=258 Identities=26% Similarity=0.303 Sum_probs=198.4
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChh-----hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDES-----KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
+|++.+.||+|++|.||+|... +++.|+||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 6899999988654322 345677899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+ +|+|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997543 36899999999999999999999999 99999999999999999999999999976654
Q ss_pred CcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---------
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE--------- 606 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 606 (678)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||..... ..........
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD------IDQLGKIFEALGTPTEENW 227 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc------HHHHHHHHHHcCCCchhhh
Confidence 3221 222346778999998854 4578899999999999999999777742211 1111111100
Q ss_pred ---ccchhhcchhhhcC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 ---NCLFDILDDQVRKS-----GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ---~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.............. .....+..+.+++.+||+.+|++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 012335678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=290.54 Aligned_cols=249 Identities=26% Similarity=0.421 Sum_probs=201.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|+..+.||+|++|.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 6789999987543 344567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.+++.... ...+++..++.++.+++.+|+|||+.+ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997542 335899999999999999999999998 9999999999999855 468999999997654322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
......++..|+|||.+....++.++||||||+++|+|++|+.||.. .+............ .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~------~~~~~~~~~~~~~~-~--------- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ANLPALVLKIMSGT-F--------- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc------CchHHHHHHHHhcC-C---------
Confidence 12234578899999999988889999999999999999999999842 22222222221111 0
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+..+.+++.+||+.+|++|||++|++..
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.34 Aligned_cols=266 Identities=28% Similarity=0.444 Sum_probs=219.3
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc----C----CcEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCCceeeEEe
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA----D----GRIIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVKLLG 445 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~----~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~ 445 (678)
.++...++..+.+.||+|.||.|++|... . ...||||.++. ....+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56666677778889999999999999843 1 35799998874 3446678899999999998 5999999999
Q ss_pred EEeeCCcceEEEEeccCCChhhhhcCCC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 041043 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPS-------E----E--LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512 (678)
Q Consensus 446 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 512 (678)
+|...+..++|.||++.|+|.+||+..+ . . ..++..+++.++.|||.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 0 0 23899999999999999999999988 99999999
Q ss_pred CceEECCCCcEEEeeccCcccccCCcceeeeccc--cccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 041043 513 TNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ--GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIW 589 (678)
Q Consensus 513 ~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~ 589 (678)
+|||+.++..+||+|||+++.............. -+..|||||.+....|+.||||||||++||||+| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999977665555433333 3567999999999999999999999999999999 888985311
Q ss_pred cccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 590 ANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
..... .+.+....+...+.....++.++++.||+.+|++||++.|+.+.|+.+..
T Consensus 527 -----~~~~l----------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 -----PTEEL----------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -----cHHHH----------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 01111 12223333444566667899999999999999999999999999999643
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=296.32 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=196.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|+..+.||+|++|.||+|... +++.+|||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999965 68899999876432 23346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+. ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 68999887543 346899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeccccccCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc-----------
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN----------- 607 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 607 (678)
. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||..... ...............
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 22234678899999887644 58899999999999999999999853211 011111110000000
Q ss_pred ----cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 608 ----CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 608 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........... ........++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=295.15 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=201.3
Q ss_pred CCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999996 46889999988766666667789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 999999975 35899999999999999999999999 99999999999999999999999998875543222 12
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||.. .+........... .. .. ....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~------~~~~~~~~~~~~~-~~-----~~--~~~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN------EPPLQAMKRIRDN-LP-----PK--LKNL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC------CCHHHHHHHHHhc-CC-----CC--Cccc
Confidence 234588999999999888899999999999999999999999852 1112222211111 00 00 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...+..+.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 224467999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=309.48 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=205.4
Q ss_pred CCcCCeeeeeCCcEEEEEEEcCCc-EEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 384 FNVNRILGQGGQGTVYKGMLADGR-IIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
|.++..||.|+||.||+++.++.. ..|-|.+...+....++|+-||+||....||+||+|++.+...+.+|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 344567999999999999977543 4567778888888899999999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|.....+-... ..|.+.++..+++|++.||.|||+++ |+|||||+.|||++.+|.++|+|||.+..... .....
T Consensus 114 GAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred chHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 99998887543 46999999999999999999999999 99999999999999999999999999854321 22234
Q ss_pred eccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 543 TKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
....|||.|||||++. ...|+.++||||||++|.||..+.+|... -+....+..+.... ..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaKSe-PP------- 253 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSE-PP------- 253 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhhcC-CC-------
Confidence 4567999999999864 46799999999999999999999999642 22222222222221 11
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+..++..+.+++.+||..||..||+++++++.
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 112256778899999999999999999999999764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.11 Aligned_cols=245 Identities=29% Similarity=0.450 Sum_probs=205.4
Q ss_pred eeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChhh
Q 041043 389 ILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQ 467 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 467 (678)
+||+|.||+||.|+..+ ...+|||-+...+....+-+.+||.+.++|+|.|||+.+|.+.+.+..-+.||..+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999654 56799999988888888899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcEEEeeccCcccccCCcceeeec
Q 041043 468 YLHDPSEELSL--TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTK 544 (678)
Q Consensus 468 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~~~~~~~~~~~~~ 544 (678)
.|+.. -+++ .+...-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+..- ...+..
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 99853 3455 78888899999999999999999 99999999999996 5789999999999876532 233445
Q ss_pred cccccCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 545 VQGTFGYLDPEYFHSS--QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 545 ~~gt~~y~aPE~~~~~--~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
..||..|||||++..+ .|+.++|||||||++.||.||++||..+.... +.+| .+---......+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----AAMF----------kVGmyKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----AAMF----------KVGMYKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----Hhhh----------hhcceecCCCCc
Confidence 6699999999999765 58889999999999999999999996332211 1111 111112234456
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+.+.+...+|.+|+.+||.+||+++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7888899999999999999999999999864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.31 Aligned_cols=246 Identities=27% Similarity=0.385 Sum_probs=199.0
Q ss_pred cCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCC
Q 041043 386 VNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGT 464 (678)
Q Consensus 386 ~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 464 (678)
....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999964 689999999876555556778999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeec
Q 041043 465 LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 544 (678)
Q Consensus 465 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 544 (678)
|.+++.. ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ ....
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 9998853 34899999999999999999999999 99999999999999999999999999875443222 1233
Q ss_pred cccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHH
Q 041043 545 VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTE 624 (678)
Q Consensus 545 ~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (678)
..++..|+|||++.+..++.++||||||+++|||++|+.||.... ............ . .. ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~-~-----~~--~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAMKRLRDSP-P-----PK--LKNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhccC-C-----CC--ccccCC
Confidence 458899999999998889999999999999999999999985221 111111111100 0 00 001122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 625 EIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 625 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+.+++.+||+.+|++||+++|+++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 34568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.63 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=204.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
++|.+.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999854 67899999987655556678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999999642 4789999999999999999999999 99999999999999999999999998875543322
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......+++.|+|||.+....++.++||||||+++|++++|+.||......+. ...... .......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~--------~~~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIAT--------NGTPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhc--------CCCCCCC
Confidence 22234578899999999888899999999999999999999999853211100 000000 0000111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+......+.+++++||..+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345678999999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.37 Aligned_cols=240 Identities=27% Similarity=0.309 Sum_probs=186.9
Q ss_pred eeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC---CCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI---SHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
||+|+||+||+|... +++.||+|++... .......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 5899999987532 222334556677777665 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 9999998743 35899999999999999999999999 99999999999999999999999999875432221 22
Q ss_pred eccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCC
Q 041043 543 TKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (678)
....||+.|+|||.+.+. .++.++||||||+++|||++|+.||.. .+..+......... ... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~------~~~~~~~~~i~~~~---------~~~-~ 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA------EDTQQMYRNIAFGK---------VRF-P 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC------CCHHHHHHHHHcCC---------CCC-C
Confidence 345689999999998764 478999999999999999999999852 22222222211110 000 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 041043 622 KTEEIMEVSDVAKRCLNSNGRSRPT----MKEVAM 652 (678)
Q Consensus 622 ~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 652 (678)
....+.++.+++.+||+.||.+||+ +.|+++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123457889999999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.44 Aligned_cols=244 Identities=27% Similarity=0.364 Sum_probs=200.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999965 5899999987542 2344567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999999754 36899999999999999999999998 999999999999999999999999998765443
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... .......... . .
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~--------~- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------PIQIYEKILE-G--------K- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhc-C--------C-
Confidence 233458899999999988888999999999999999999999985221 1111111111 0 0
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAM 652 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 652 (678)
...+......+.+++.+||..+|.+|| +++|+++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111223356789999999999999998 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.71 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=197.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999965 6899999987532 2344567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 57777775432 35899999999999999999999998 999999999999999999999999998654322
Q ss_pred cceeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 538 QTHVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
....++..|+|||.+. ...++.++||||||+++|||++|+.||... +...........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~------~~~~~~~~~~~~-------- 229 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQN-------- 229 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc------cHHHHHHHHhcC--------
Confidence 2235788999999874 456888999999999999999999998421 111111111100
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
..........+..+.+++.+||+.+|++||++.+++...
T Consensus 230 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 -DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 001111234566899999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=294.27 Aligned_cols=248 Identities=24% Similarity=0.424 Sum_probs=199.6
Q ss_pred CCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCC---CCceeeEEeEEeeCCcceEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQIS---HRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 457 (678)
.|+..+.||+|+||.||+|.. .+++.+++|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 46899999987643 3445677889999999997 999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.++++.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998642 5899999999999999999999999 999999999999999999999999998766543
Q ss_pred cceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
... .....++..|+|||.+.++ .++.++||||||+++|+|++|..||..... ...... .... ..+.
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~~-~~~~-----~~~~ 221 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMML-IPKS-----KPPR 221 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhhc-cccC-----CCCC
Confidence 322 2334588899999988654 468899999999999999999999853211 111100 0000 0000
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+. ....+.++.+++.+||+.||++||++.|+++.
T Consensus 222 ~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11 11245679999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=297.14 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=208.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
+..-|.+.+.||+|.|..|-++++- .|..||||++... +.-....+++|+..|+.++|||||+|+.+......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 3456888899999999999999853 6999999988653 334456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~~~~ 535 (678)
+|.-.+|+|.+||.++.. .+.+....+++.||+.|+.|.|... +|||||||+||.+- +-|-+||.|||++..+.
T Consensus 96 LELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999987654 4899999999999999999999988 99999999999875 66899999999998776
Q ss_pred CCcceeeeccccccCccCccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTD-KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
+... .+...|...|-|||++.+..|.. +.||||||||||.|++|+.||..... .+.+--++|
T Consensus 171 PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------------SETLTmImD 233 (864)
T KOG4717|consen 171 PGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------------SETLTMIMD 233 (864)
T ss_pred Ccch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---------------hhhhhhhhc
Confidence 5433 34567999999999999988764 78999999999999999999962211 111233344
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
-.. ..+...+.+.++||..||..||++|.+.+|++.
T Consensus 234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 332 335677889999999999999999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=287.85 Aligned_cols=249 Identities=31% Similarity=0.475 Sum_probs=204.8
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
.|+..+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999975 688999999877655567889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+++|.+++.... ..+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999997643 46899999999999999999999988 99999999999999999999999999876654332
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (678)
.....++..|++||.+....++.++||||||+++++|++|+.||.... .......... ..... ...
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~-------~~~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP------PMKALFKIAT-NGPPG-------LRN 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHHh-cCCCC-------cCc
Confidence 234468889999999988889999999999999999999999985221 1111111100 00000 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 622 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122567999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.22 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=201.8
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEee-
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLE- 449 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~- 449 (678)
+..++....+.|++.+.||+|+||.||+|... +++.+|+|...... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34555566788999999999999999999964 57899999875543 3446788899999998 69999999999863
Q ss_pred -----CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEE
Q 041043 450 -----VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 524 (678)
Q Consensus 450 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 524 (678)
.+..+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 356799999999999999997543 235888999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCcceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHH
Q 041043 525 IADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATY 599 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~ 599 (678)
|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||..... ....
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-----~~~~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-----MRAL 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-----Hhhh
Confidence 999999875432211 122345888999999875 34578899999999999999999999852211 0100
Q ss_pred HHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 600 FVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
. .. .............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~-~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 F-LI---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-hH---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00 0000011112234568999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.34 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=198.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 456 (678)
++|++.+.||+|+||.||+|... +++.+++|.++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 588999998864332 2234577899999999999999999998877 789999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 59999887543 25899999999999999999999999 99999999999999999999999999876654
Q ss_pred CcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---------
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE--------- 606 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 606 (678)
.... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||..... ..........
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~------~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE------IDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCchHHH
Confidence 3221 2233478899999998754 468899999999999999999999853221 1111111000
Q ss_pred -----------ccchhhcchhhhcCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 607 -----------NCLFDILDDQVRKSGKTE-EIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 607 -----------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..........+....+.. ..+.+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000011111111111 3667899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=293.69 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=205.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++.|+..+.||+|++|.||++..+ +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999999876544 56788999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998643 36999999999999999999999988 9999999999999999999999999886544322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
. ......++..|++||.+.+..++.++||||||+++|+|++|+.||... ............. .. .
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~------~~~~~~~~~~~~~-~~-------~ 235 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE------PPLRALFLITTKG-IP-------P 235 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcC-CC-------C
Confidence 1 122334788999999998888999999999999999999999998421 1111111111110 00 0
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..........+.+++.+||+.+|.+|||+.++++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112245679999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=293.75 Aligned_cols=261 Identities=26% Similarity=0.325 Sum_probs=201.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 457 (678)
++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999975 57899999876432 34557799999999999999999999988654 3679999
Q ss_pred EeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 458 EFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876422 2345899999999999999999999998 99999999999999999999999999865432
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+...... ......+.+.
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~- 231 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIV-NMPNPELKDE- 231 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHh-cCCchhhccC-
Confidence 221 2334788899999999889999999999999999999999998633211 011111111111 1111111000
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......++.+.+++.+||+.+|++|||+.|+++.
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 01112345789999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=294.30 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=194.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHH-HhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVI-LSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.+.||+|+||.||++... +|+.||+|+++... .....++..|+.. ++.++||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999975 68999999876532 2333456666665 666789999999999999999999999
Q ss_pred eccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 459 FIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 459 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|++ |+|.+++... .....+++..++.++.|++.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887642 2235689999999999999999999987 6 99999999999999999999999999876532
Q ss_pred CcceeeeccccccCccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHS----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||... .............. .
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~-~--- 225 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW-----KTPFQQLKQVVEEP-S--- 225 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc-----ccCHHHHHHHHhcC-C---
Confidence 21 1223457889999998865 44688999999999999999999998521 11111111111110 0
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+.++.+++.+||..+|++||++.|+++.
T Consensus 226 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 -----PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112345679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.24 Aligned_cols=262 Identities=22% Similarity=0.344 Sum_probs=195.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||+|++|.||+|..+ +++.||||.+.... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 68899999876432 22234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 9999987543 36899999999999999999999998 99999999999999999999999999865432211
Q ss_pred eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---hccchhh---
Q 041043 540 HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---ENCLFDI--- 612 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 612 (678)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............ ...+...
T Consensus 159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 122346788999999865 45789999999999999999999998532210 000000000000 0000000
Q ss_pred ----------c-chhhhcC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 ----------L-DDQVRKS-GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ----------~-~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
. ...+... ........+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000 00111257789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=294.85 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=196.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++++|.+.+.||+|+||.||+|... +++.+++|.+.... ......+.+|+++++.++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3568999999999999999999864 68899999876433 223346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 67877775432 35788889999999999999999998 999999999999999999999999998754322
Q ss_pred cceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh----------
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---------- 606 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 606 (678)
... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..+.+......
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD-----VFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh-----HHHHHHHHHHHcCCCChhhhh
Confidence 211 222346889999999875 3578899999999999999999999863221 11111111100
Q ss_pred ------ccchhhcchhhhc-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 607 ------NCLFDILDDQVRK-----SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 607 ------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
............. .........+.+++.+|+..||++|||++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 000112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.23 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=221.5
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
+.....++++..++-+|.||.||.|.|.+ .+.|.+|.++. .++-+...+..|.-.+..+.|||+..+.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 33445678888889999999999997654 34567776654 456667889999999999999999999998875
Q ss_pred -CCcceEEEEeccCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 450 -VEVPLLVYEFIPNGTLFQYLH-----DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 450 -~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
...++++|.++.-|+|..||. +.+....++..+...++.|++.|++|||+.+ ++|.||.++|.+||+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 457899999999999999998 5555567888999999999999999999999 9999999999999999999
Q ss_pred EEeeccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 041043 524 KIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 601 (678)
||+|-.+++.+.+.+.+- ......+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------- 506 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------- 506 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---------
Confidence 999999999887766553 333346778999999999999999999999999999999 999985332221
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+...+.+..+...+.+.++++..++.-||..+|++||+.+|++.-|.+...+
T Consensus 507 -------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 -------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 3334445555666788899999999999999999999999999999877643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=290.07 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=201.7
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|+||.||++... +|..+|+|.+... .....+.+.+|++++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 5788999987543 223456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999997543 235799999999999999999999998 99999999999999886 46999999987654322
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.......+++.|+|||.+....++.++|+||||+++|||++|+.||.. .+............ .
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~------~~~~~~~~~~~~~~-~--------- 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG------NNLHQLVLKICQGY-F--------- 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC------ccHHHHHHHHhccc-C---------
Confidence 222334588899999999888899999999999999999999999842 22222222222111 1
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......+..+.+++.+||..+|++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122344579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=292.60 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=199.3
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
+|+..+.||+|++|.||+|+.. +++.||||.++... ....+.+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 58899999886543 233467788999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 89998876554457899999999999999999999998 999999999999999999999999998755432211
Q ss_pred eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh------ccc----
Q 041043 541 VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE------NCL---- 609 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~---- 609 (678)
.....++..|++||.+.+ ..++.++||||||+++|+|++|+.||..... .+......+. ..+
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN------EDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCChhhHHHHh
Confidence 122346888999998865 4578899999999999999999999853221 1111111100 000
Q ss_pred --hhhcch------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 610 --FDILDD------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 610 --~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...... ..........+..+.+++.+||+.||.+||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000001223467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=298.47 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=197.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc---CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Ccce
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPL 454 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 454 (678)
+|++.++||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999975 47899999887632 34456788999999999999999999999988 7899
Q ss_pred EEEEeccCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC----CCcEEEeec
Q 041043 455 LVYEFIPNGTLFQYLHDPSE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE----KYRAKIADF 528 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Df 528 (678)
+|+||+++ +|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67777653322 236899999999999999999999998 999999999999999 999999999
Q ss_pred cCcccccCCcc--eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHH---HHH
Q 041043 529 GTSRSIAIDQT--HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATY---FVE 602 (678)
Q Consensus 529 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~---~~~ 602 (678)
|++........ .......++..|+|||.+.+ ..++.++||||||+++++|++|+.||.............. ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543322 11233457889999998766 4578999999999999999999999964332221100000 000
Q ss_pred HHh---------------hccchhhcchhhhcCCC-----------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 603 CVE---------------ENCLFDILDDQVRKSGK-----------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 603 ~~~---------------~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..+ ........+.......+ .....++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00000000000000000 023457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=318.96 Aligned_cols=269 Identities=20% Similarity=0.270 Sum_probs=190.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC--CcEEEEE------------------EcccCChhhHHHHHHHHHHHhcCCCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD--GRIIAVK------------------KSKVVDESKLEEFINEVVILSQISHRN 439 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~h~n 439 (678)
..++|++.+.||+|+||+||++..+. +...++| +.. ........+.+|+++|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35689999999999999999987542 2222222 111 12233466889999999999999
Q ss_pred eeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE
Q 041043 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 517 (678)
Q Consensus 440 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 517 (678)
|+++++++...+..++++|++. ++|.+++..... .......+++.++.||+.||+|||+.+ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 577777754221 122346677889999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCC-CCccccccCCCh
Q 041043 518 DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP-ISYIWANEGRNL 596 (678)
Q Consensus 518 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p-~~~~~~~~~~~~ 596 (678)
+.++.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987654433333445799999999999999999999999999999999998754 321111111111
Q ss_pred HHHHHHHH--hhc------cchhhcchhhhcCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 597 ATYFVECV--EEN------CLFDILDDQVRKSG---------KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 597 ~~~~~~~~--~~~------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........ .+. .+.+.++....... .......+.+++.+||+.||++|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000 000 00001000000000 01122457788999999999999999999864
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.15 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=198.9
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.|...+.||+|+||.||++... ++..+|+|++... .....+++.+|++++++++|+|++++++++.+.+..++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999964 6889999987532 23345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++ |+|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 996 5788877543 235899999999999999999999998 999999999999999999999999988654321
Q ss_pred ceeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 539 THVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
....++..|+|||.+. .+.++.++||||||+++|||++|+.||... ............
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------~~~~~~~~~~~~--------- 239 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQN--------- 239 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHhc---------
Confidence 2335788999999974 456889999999999999999999998421 111111111111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
..........+..+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 1111112345567899999999999999999999998765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.50 Aligned_cols=250 Identities=29% Similarity=0.460 Sum_probs=205.3
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLVY 457 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 457 (678)
+|...+.||+|++|.||+|... +++.+++|...... ....+.+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 68899999876544 35568899999999999999999999999988 8899999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999997543 6899999999999999999999988 999999999999999999999999998776543
Q ss_pred cce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
... ......++..|++||.+.....+.++||||||+++++|++|..||.... ......... ....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~---------~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKI---------GSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhc---------cccC
Confidence 321 1233458889999999988889999999999999999999999985322 111111111 1111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.....+...+..+.+++.+|++.+|++||++.|++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111223344678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.52 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=196.1
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
|++.+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999964 78999999876433 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
+ ++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689999875432 36899999999999999999999998 999999999999999999999999998755432211
Q ss_pred eeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh--c------cchh
Q 041043 541 VSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE--N------CLFD 611 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~------~~~~ 611 (678)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...... ......+...... . .+.+
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1223468889999987654 5788999999999999999999998532110 0001100000000 0 0000
Q ss_pred hcchh------hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ILDDQ------VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..... .........+..+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000011223457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.30 Aligned_cols=257 Identities=25% Similarity=0.329 Sum_probs=198.0
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceEEEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLVYE 458 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 458 (678)
|++.+.||+|++|.||+|... +++.+|+|++... .....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999976 4789999998754 234456788999999999999999999999988 78999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8988887542 36899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh------ccchh
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE------NCLFD 611 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 611 (678)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......... ..+..
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE------LEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCchhhccc
Confidence 222333456788999998764 4578999999999999999999999853221 1111111100 00000
Q ss_pred --------------hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 --------------ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 --------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.....+........+..+.+++.+||+.+|.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000001112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=289.05 Aligned_cols=247 Identities=28% Similarity=0.365 Sum_probs=202.0
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 5889999987642 23456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999753 36899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
......++..|+|||.+....++.++|+||||+++|+|++|+.||...... ....+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc----------cc
Confidence 223345788999999999888999999999999999999999998632211 11111111110 11
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTM--KEVA 651 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 651 (678)
...+...+..+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12233445789999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.47 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=195.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCc-----
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEV----- 452 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~----- 452 (678)
++|++.+.||+|+||.||+|... +++.||+|..+... ......+.+|+++++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 68999999865432 223467889999999995 6999999999887665
Q ss_pred ceEEEEeccCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeecc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFG 529 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfg 529 (678)
.+++|||+++ +|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 89888865332 246899999999999999999999998 999999999999998 8899999999
Q ss_pred CcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh-c
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE-N 607 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 607 (678)
++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... . ......... .
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~-~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-----L-QQLLHIFKLLG 229 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-----H-HHHHHHHHHhC
Confidence 98765332211 122346788999998865 4578999999999999999999999853211 1 111111100 0
Q ss_pred -----cchhhcc-----------hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 608 -----CLFDILD-----------DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 608 -----~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
....... +............++.++|.+||..||.+||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00000001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.82 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=203.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcc--cCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSK--VVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 456 (678)
....|++.++||.||.+.||++...+.+.+|+|++. ..+.....-|.+|+.+|.+|+ |.+||+|++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 356788999999999999999999888999999764 467777899999999999996 99999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
||+= ..+|..+|++... .++...+..+..|++.++.+.|.++ |||-||||.|+|+-+ |.+||+|||++..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9987 4599999986543 2333377788999999999999999 999999999999965 5999999999998887
Q ss_pred Cccee-eeccccccCccCccccccC-----------CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 537 DQTHV-STKVQGTFGYLDPEYFHSS-----------QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 537 ~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
+.+.. .....||+.||+||.+... +.+.+|||||+|||||+|+.|+.||... .+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~------- 579 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQI------- 579 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHH-------
Confidence 76653 3445799999999987432 2567899999999999999999998521 1111
Q ss_pred hhccchhhcchhhhcCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 605 EENCLFDILDDQVRKSGKT-EEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.++..+.++....+++. ....++.++++.||..||++|||+.|+|+.
T Consensus 580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12344444433322221 111238999999999999999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.58 Aligned_cols=264 Identities=21% Similarity=0.315 Sum_probs=198.9
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV----- 450 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----- 450 (678)
...++|+..+.||+|+||.||++... +++.||+|.+.. .+....+++.+|++++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999964 689999998753 2344556788999999999999999999988643
Q ss_pred -CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 451 -EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 451 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
...++|+||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 34689999996 588888853 2889999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccccc---------CCChHHHH
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE---------GRNLATYF 600 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~---------~~~~~~~~ 600 (678)
+++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... +.....+.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 997654322 1223457889999999999899999999999999999999999986322100 00000000
Q ss_pred HH-------HHhhcc------chhhcchhhh----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 601 VE-------CVEENC------LFDILDDQVR----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 601 ~~-------~~~~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. ...... +......... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 0000000000 00011345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.66 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=200.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----c
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE-----V 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~ 452 (678)
.+++|++.++||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999854 6899999988643 2334567889999999999999999999876543 4
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++++||+++ +|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 7899999964 88888753 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCcce--eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---
Q 041043 533 SIAIDQTH--VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE--- 606 (678)
Q Consensus 533 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 606 (678)
........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCH
Confidence 65432221 1123457889999998754 56889999999999999999999998532110 001111110000
Q ss_pred ccchhhcchh-------h--hcCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 607 NCLFDILDDQ-------V--RKSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 607 ~~~~~~~~~~-------~--~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
.....+.+.. . .... ....+.++.+++.+||+.+|++|||+.|+++. ++....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000000 0 0000 01234678999999999999999999999987 655543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.66 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=198.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Ccc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVP 453 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 453 (678)
.+|++.+.||+|+||.||+|... +++.+++|..... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999964 5889999986421 234456789999999999999999999998764 457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++++||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999999743 34889999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcc--eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 534 IAIDQT--HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 534 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||... .... .+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~-~~~~~-------- 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-----EAMA-AIFKI-------- 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-----CHHH-HHHHH--------
Confidence 532111 1122345788999999999888999999999999999999999998521 1111 11111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.........+....+.+.+++.+||+ +|.+||+..+++.
T Consensus 222 -~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 -ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111122344566789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.24 Aligned_cols=251 Identities=29% Similarity=0.428 Sum_probs=206.0
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|.+.+.||+|+||.||++... +++.+++|++.... ....+++.+|+++++.++|+|++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 58899999886543 35667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997642 1356899999999999999999999998 9999999999999999999999999987654433
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.......+++.|+|||.+....++.++||||||+++++|++|+.||... ............ ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~------~~~~~~~~~~~~-~~--------- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE------NLLELALKILKG-QY--------- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC------cHHHHHHHHhcC-CC---------
Confidence 2233346888999999998888999999999999999999999998422 122222221111 11
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+......+.+++.+||..+|++|||+.|+++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=282.46 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=203.2
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|++|.||++... +++.+++|....... ...+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578999998876543 5667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999999754 46899999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
. .....++..|+|||......++.++|||+||+++|+|++|+.||... ........ ... . ...
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~-----~~~~~~~~-~~~-~---------~~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL-----NPMAALFR-IVQ-D---------DHP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHH-Hhc-c---------CCC
Confidence 2 23345788999999998877899999999999999999999998521 11111111 110 0 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..+......+.+++.+||..+|++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112234567899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=287.33 Aligned_cols=257 Identities=21% Similarity=0.274 Sum_probs=191.9
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeC--CcceEEEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQIS-HRNVVKLLGSCLEV--EVPLLVYE 458 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 458 (678)
|++.++||+|+||.||+|... +++.+|+|+.+... ........+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999964 68899999876532 222334567899999885 99999999999987 88999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|++ ++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58888886532 36899999999999999999999998 999999999999999 999999999997654322
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH-----------hh
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV-----------EE 606 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~ 606 (678)
.. ....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+ ......... ..
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 21 22357889999997654 557889999999999999999999995322111 111111100 00
Q ss_pred ccchhhcchhhh----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 607 NCLFDILDDQVR----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 607 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........+... .......+..+.+++.+||+.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 0001234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.76 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=203.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|++.+.||+|++|.||++... +++.+++|.+... ......++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 6789999987643 344566788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986522 1246899999999999999999999999 999999999999999999999999999776543
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
......+++.|++||.+.+..++.++|+||||+++|||++|+.||... ....... ...... .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~------~~~~~~~-~~~~~~---------~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR------SMQDLRY-KVQRGK---------Y 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHH-HHhcCC---------C
Confidence 222345788999999999888999999999999999999999998522 1111111 111111 1
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+.....++.+++.+||+.+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223556789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.02 Aligned_cols=242 Identities=26% Similarity=0.324 Sum_probs=194.9
Q ss_pred eeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
||.|++|.||++... +++.+++|.+... .....+.+.+|++++++++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 4889999987542 234457799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeecc
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 545 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 545 (678)
.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 9999753 34899999999999999999999998 9999999999999999999999999998665432 22234
Q ss_pred ccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHH
Q 041043 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625 (678)
Q Consensus 546 ~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (678)
.++..|++||.+....++.++|+||||+++|+|++|+.||..... +.......... .......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILK---------GNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhc---------cCCCCCCCccc
Confidence 578899999999888899999999999999999999999853221 11222211111 01111222233
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041043 626 IMEVSDVAKRCLNSNGRSRPT-----MKEVAM 652 (678)
Q Consensus 626 ~~~l~~li~~cl~~dP~~RPt-----~~evl~ 652 (678)
..++.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 668999999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=290.21 Aligned_cols=245 Identities=28% Similarity=0.393 Sum_probs=196.2
Q ss_pred eeeeCCcEEEEEEEcC-CcEEEEEEcccCCh---hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 390 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDE---SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
||+|+||.||+++..+ ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6889999999999764 89999998765333 4567889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc------
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT------ 539 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~------ 539 (678)
.+++.+.. .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997543 6899999999999999999999998 99999999999999999999999999875443321
Q ss_pred -eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 540 -HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.......++..|++||.+.....+.++||||||+++|+|++|+.||... .....+..... + ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~------~~~~~~~~~~~-~--------~~~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE------TPEEIFQNILN-G--------KIE 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHhc-C--------CcC
Confidence 1223345788999999998888999999999999999999999998522 12222222111 0 000
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.......+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0001112568899999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.30 Aligned_cols=264 Identities=26% Similarity=0.368 Sum_probs=197.6
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC----
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVE---- 451 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 451 (678)
...++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 58899999886532 233456788999999999999999999987654
Q ss_pred ------cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 452 ------VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 452 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
..++++||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||+|+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68999999976 777777653 236899999999999999999999998 999999999999999999999
Q ss_pred eeccCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 526 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHh
Confidence 9999997665433222222345778999998865 4578899999999999999999999852111 00111111110
Q ss_pred hhcc---chhh--------cch------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 605 EENC---LFDI--------LDD------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 605 ~~~~---~~~~--------~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.... ...+ .+. ..+.. ....+..+.+++.+||+.+|.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 000 00000 1123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.87 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=196.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 455 (678)
.++|++.+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457899999999999999999975 58999999876432 22234567899999999999999999998765 46799
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|+||++ ++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 48888887532 46899999999999999999999999 9999999999999999999999999997665
Q ss_pred CCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc------c
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN------C 608 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~ 608 (678)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... ....+......- .
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~------~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS------EIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCChhh
Confidence 33211 222335778999999865 457899999999999999999999985321 111111111100 0
Q ss_pred c-----------hhhcchhhhc--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 L-----------FDILDDQVRK--SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~-----------~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+ .......... ......++.+.++|.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000000000 0001135678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=289.62 Aligned_cols=260 Identities=18% Similarity=0.255 Sum_probs=185.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCC----cEEEEEEcccCChhhH-----------HHHHHHHHHHhcCCCCceeeEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADG----RIIAVKKSKVVDESKL-----------EEFINEVVILSQISHRNVVKLL 444 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~l~ 444 (678)
..++|.+.++||+|+||.||+|...++ ..+|+|.......... .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999997543 4566665432221111 1122344456677899999999
Q ss_pred eEEeeCC----cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC
Q 041043 445 GSCLEVE----VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK 520 (678)
Q Consensus 445 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 520 (678)
++..... ..++++|+.. .++.+.+... ...++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9766543 2356777664 3566666532 23578889999999999999999998 9999999999999999
Q ss_pred CcEEEeeccCcccccCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCC
Q 041043 521 YRAKIADFGTSRSIAIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGR 594 (678)
Q Consensus 521 ~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~ 594 (678)
+.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999766432211 1122358999999999999999999999999999999999999996432111
Q ss_pred ChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.... ....+.+..+...... ....++.+.+++..|+..+|++||++.++++.|+
T Consensus 241 ~~~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIH----AAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHH----HhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1100 0000001111111111 1123467999999999999999999999998763
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=288.71 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=197.7
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChh
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF 466 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 466 (678)
.+||+|+||.||++..+ +++.||||++........+.+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 68999999987655556678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccc
Q 041043 467 QYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546 (678)
Q Consensus 467 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 546 (678)
+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ ......
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 98853 24789999999999999999999998 99999999999999999999999998875543221 123345
Q ss_pred cccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHH
Q 041043 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEI 626 (678)
Q Consensus 547 gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (678)
+++.|++||.+....++.++|+||||+++|+|++|+.||... ......... ... ...... ......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~------~~~~~~~~~-~~~-----~~~~~~--~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMI-RDN-----LPPKLK--NLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH-Hhh-----CCcccC--CcccCC
Confidence 788999999998888899999999999999999999998521 111111111 110 000000 112234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 627 MEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 627 ~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+.+++.+||+.+|.+||++.++++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 568899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.67 Aligned_cols=257 Identities=20% Similarity=0.259 Sum_probs=192.0
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCC
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGT 464 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 464 (678)
.+.+|.|+++.|+++.. +++.+|||+++.. +....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34444555555555544 6899999987653 45566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc-----
Q 041043 465 LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT----- 539 (678)
Q Consensus 465 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~----- 539 (678)
|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999986432 35889999999999999999999998 99999999999999999999999998865432211
Q ss_pred -eeeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh-------c--
Q 041043 540 -HVSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE-------N-- 607 (678)
Q Consensus 540 -~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~-- 607 (678)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ........... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA-----TQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccCccccccCch
Confidence 11123346778999999876 3578899999999999999999999963211 11111110000 0
Q ss_pred -----cch--------hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 608 -----CLF--------DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 608 -----~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
... .................++.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000001111223455688999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=289.31 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=195.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 68899999875432 2334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeeccCcccccCC
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAID 537 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~~~~~~ 537 (678)
|++ ++|.+++.... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 58888876432 234688899999999999999999998 999999999999985 567999999999765432
Q ss_pred cceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc---cc----
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN---CL---- 609 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---- 609 (678)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ .....+ ...... .+
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIF-RILGTPNEETWPGVT 232 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCChhhccccc
Confidence 21 1223356889999998866 457889999999999999999999985321110 000000 000000 00
Q ss_pred --hhhcchhh--h----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 --FDILDDQV--R----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 --~~~~~~~~--~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........ . .......++++.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0 00012334578999999999999999999999874
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=291.31 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=194.5
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|...+.||+|+||.||++... +++.+|+|++... .......+.+|+.++.++. |+||+++++++...+..++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999964 5799999987643 2345567899999999996 99999999999998899999999
Q ss_pred ccCCChhhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 460 IPNGTLFQYL---HDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 460 ~~~g~L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
+.. +|.++. ... ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 554433 221 224689999999999999999999975 6 9999999999999999999999999987654
Q ss_pred CCcceeeeccccccCccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSS---QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
..... ....++..|+|||.+... .++.++||||||+++|||++|+.||.... .............
T Consensus 160 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~----- 227 (288)
T cd06616 160 DSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD----- 227 (288)
T ss_pred cCCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC-----
Confidence 32221 223578899999998776 68899999999999999999999985221 1111111111100
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+.+........+.++.+|+.+||+.+|++|||++||++.
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111112223456689999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=293.22 Aligned_cols=262 Identities=18% Similarity=0.318 Sum_probs=196.5
Q ss_pred Ceeeee--CCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQG--GQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
..||+| +||+||++... +++.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999964 7899999987642 334457889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee-
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV- 541 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~- 541 (678)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999976432 35899999999999999999999998 9999999999999999999999998653322111110
Q ss_pred -----eeccccccCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc-------
Q 041043 542 -----STKVQGTFGYLDPEYFHSS--QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN------- 607 (678)
Q Consensus 542 -----~~~~~gt~~y~aPE~~~~~--~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 607 (678)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCccc
Confidence 0112245679999998763 47889999999999999999999985332110 000000000
Q ss_pred -----------------------------cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHH
Q 041043 608 -----------------------------CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LER 656 (678)
Q Consensus 608 -----------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~ 656 (678)
....+.+..............+.+|+++||+.||++|||+.|+++. ++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0001111111222234566789999999999999999999999865 555
Q ss_pred HHh
Q 041043 657 IRA 659 (678)
Q Consensus 657 l~~ 659 (678)
+++
T Consensus 314 ~~~ 316 (328)
T cd08226 314 VKE 316 (328)
T ss_pred HHH
Confidence 554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.75 Aligned_cols=256 Identities=23% Similarity=0.289 Sum_probs=201.3
Q ss_pred CCCcCCeeeeeCCcEEEEEEE----cCCcEEEEEEcccCC----hhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcc
Q 041043 383 HFNVNRILGQGGQGTVYKGML----ADGRIIAVKKSKVVD----ESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 453 (678)
+|++.+.||+|++|.||++.. .+++.+|||.++... ....+.+.+|+++++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999984 356889999876422 23345688999999999 599999999999988999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.+++... ..+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998743 35899999999999999999999988 99999999999999999999999999876
Q ss_pred ccCCcceeeeccccccCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
.............++..|+|||.+.+.. .+.++||||||+++|||++|..||..... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~------ 226 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE--QNSQSEISRRILK------ 226 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc--cchHHHHHHHHHc------
Confidence 6544333233345788999999987654 78899999999999999999999852111 1111111111110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
. ....+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 227 ---~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 ---S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0111233446789999999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=286.79 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=198.7
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
|+..+.||+|++|.||++... +++.+++|.+..... .....+.+|++++++++|+||+++++++...+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999964 688999998764332 34567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 8888887532 46899999999999999999999999 9999999999999999999999999987665433 1
Q ss_pred eeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh------ccchhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE------NCLFDIL 613 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 613 (678)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+......+. ..+....
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE------IDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHcCCCchHhcccch
Confidence 22234577889999998776 789999999999999999999999853211 1111111000 0000000
Q ss_pred c-----------hhh--hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 614 D-----------DQV--RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 614 ~-----------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
+ ... ........+.++.++|.+||+.||.+||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 000 00011235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=287.24 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=192.0
Q ss_pred eeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
||+|+||+||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 6889999987542 223345677899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeecc
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 545 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 545 (678)
.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... ......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence 999975432 36899999999999999999999999 999999999999999999999999998765431 112234
Q ss_pred ccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHH
Q 041043 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625 (678)
Q Consensus 546 ~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (678)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+. .. ... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~----~~~--~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK---VEKEELK----RR----TLE--MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc---ccHHHHH----hc----ccc--ccccCCccC
Confidence 5778999999998888999999999999999999999998532110 0000000 00 000 011122334
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041043 626 IMEVSDVAKRCLNSNGRSRP-----TMKEVAM 652 (678)
Q Consensus 626 ~~~l~~li~~cl~~dP~~RP-----t~~evl~ 652 (678)
++.+.+++.+||+.+|++|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 66889999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.44 Aligned_cols=273 Identities=26% Similarity=0.391 Sum_probs=209.0
Q ss_pred CCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC------cceE
Q 041043 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE------VPLL 455 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~l 455 (678)
+...+.||+|+||.||+|++ ..|+.||||.++. ......+.+.+|+++|++++|+|||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45568899999999999994 5799999998765 34455688999999999999999999999766543 5789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC--CCC--cEEEeeccCc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKY--RAKIADFGTS 531 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~Dfgl~ 531 (678)
|||||.+|+|...|.+..+...|++.+.+.++.+++.||.|||.++ |+||||||.||++- .+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998777778999999999999999999999999 99999999999994 333 4799999999
Q ss_pred ccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
+.+..+. ......||..|++||.+.. ..|+...|.|||||++|+..||..||...+......-..|.....+...+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9776443 5667789999999999995 788999999999999999999999996544332111111111111111010
Q ss_pred hhcchhh------------hcCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHHHhcc
Q 041043 611 DILDDQV------------RKSGKTEEIMEVSDVAKRCLNSNGRSRP--TMKEVAMELERIRACN 661 (678)
Q Consensus 611 ~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~l~~~~ 661 (678)
-...... ...........+-..+..+|..+|++|- ...+....+..|....
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 0011000 1112234445667788889999999997 7777777777766544
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=287.08 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=202.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+.|..-++||+|+||.||-.+.+ .|+.+|.|++... .+......++|-++|++++.+.||.+--.+...+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45777899999999999999854 6899999876431 2233345678999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
..|.||+|.-+|..... ..+++..++.++.+|+.||++||+.. ||.|||||+|||||+.|+++|+|+||+..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999988764 46999999999999999999999999 999999999999999999999999999876644
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||...... ...+-+|..+
T Consensus 341 ~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------------vk~eEvdrr~ 402 (591)
T KOG0986|consen 341 KP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------------VKREEVDRRT 402 (591)
T ss_pred Cc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------------hhHHHHHHHH
Confidence 33 34447999999999999999999999999999999999999999522111 1111122222
Q ss_pred ---hcCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 041043 618 ---RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648 (678)
Q Consensus 618 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 648 (678)
...++...+++..+|.+..|+.||++|..-+
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1234566778899999999999999996433
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=294.28 Aligned_cols=270 Identities=25% Similarity=0.344 Sum_probs=200.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeC--Ccc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEV--EVP 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~--~~~ 453 (678)
..++|++.+.||+|+||.||+|... +++.+|+|++.. .+......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567899999999999999999975 578999998743 2334456788899999999 999999999988654 357
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++|+||++ ++|..++... .+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5999988643 5889999999999999999999998 99999999999999999999999999976
Q ss_pred ccCCcc----eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccC---------CChHHH
Q 041043 534 IAIDQT----HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---------RNLATY 599 (678)
Q Consensus 534 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---------~~~~~~ 599 (678)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12233457889999998755 4578899999999999999999999853211110 000000
Q ss_pred HHHHHhhccchhhcchhhh------cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 600 FVECVEENCLFDILDDQVR------KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
.. .........+++.... .......+.++.+++.+||+.+|++|||+.++++. ++.+.
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 237 IE-SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HH-HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00 0000000001110000 00011235678999999999999999999999976 55554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.34 Aligned_cols=269 Identities=21% Similarity=0.281 Sum_probs=201.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----C
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV-----E 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~ 451 (678)
+.++|.+.+.||+|+||+||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467999999999999999999964 6899999987642 333456778899999999999999999987644 2
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++++||+. ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999996 6899888643 36999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-----
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE----- 605 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 605 (678)
....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ...........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEE 231 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChH
Confidence 7654332 22233457889999998765 46889999999999999999999998532110 00000000000
Q ss_pred ------hccchhhcch---hhh---cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 606 ------ENCLFDILDD---QVR---KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 606 ------~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
.......+.. ... .......+.++.+++.+||+.+|++|||++|+++. ++.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000000000 000 00012345678999999999999999999999988 766553
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=287.15 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=186.7
Q ss_pred eeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHh---cCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 389 ILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILS---QISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++ ..+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58899999775321 122233444544443 3479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999998753 35999999999999999999999999 9999999999999999999999999986543222
Q ss_pred eeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....++..|+|||.+.. ..++.++||||||+++|||++|..||....... .. ....... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~-~~~~~~~----------~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KH-EIDRMTL----------TVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---HH-HHHHHhh----------cCCcC
Confidence 122358999999999864 558899999999999999999999996332111 11 1111100 01112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
.+...+.++.+++.+||+.||++|| |++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2334566899999999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.63 Aligned_cols=256 Identities=29% Similarity=0.365 Sum_probs=194.3
Q ss_pred CCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccC--ChhhHHHHHHHHHHHhcC---CCCceeeEEeEEeeCCc-----
Q 041043 384 FNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVV--DESKLEEFINEVVILSQI---SHRNVVKLLGSCLEVEV----- 452 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~----- 452 (678)
|++.+.||+|+||.||+|+.+. ++.+|+|+++.. .......+.+|+++++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999864 899999988642 222335567788877666 59999999999988776
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++++||+. ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 489998875432 35899999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc---
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL--- 609 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 609 (678)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+...........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS------EADQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC------hHHHHHHHHHHcCCCCh
Confidence 6543322 122346888999999998889999999999999999999999885321 11111111110000
Q ss_pred ----------hhhcchhhh---cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 610 ----------FDILDDQVR---KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 610 ----------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......... ..........+.+++.+||+.||++||+++|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.87 Aligned_cols=270 Identities=20% Similarity=0.301 Sum_probs=200.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----CCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLE----VEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 453 (678)
.++|++.+.||+|++|.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468899999999999999999964 5899999987643 22345678889999999999999999998763 3457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++|+||+. ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 6899998643 34899999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCcce---eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccC---------CChHHHH
Q 041043 534 IAIDQTH---VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---------RNLATYF 600 (678)
Q Consensus 534 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---------~~~~~~~ 600 (678)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ ......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432221 1223467889999999865 4688999999999999999999999953211100 0000000
Q ss_pred HHHHhhccchhhcchhh-hcCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 601 VECVEENCLFDILDDQV-RKSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
. ...........+... .... ....+.++.+++.+||+.+|++|||+++++.. +++..
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 237 N-RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred h-hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0 000000111111000 0000 12235689999999999999999999999885 44444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=281.68 Aligned_cols=243 Identities=26% Similarity=0.283 Sum_probs=189.2
Q ss_pred CeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHH-hcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVIL-SQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..++ ...+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999964 58899999876432 22223445555444 455899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..... .
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 9999999753 35899999999999999999999998 99999999999999999999999999875432 2
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
....++..|+|||.+.+..++.++||||||+++|||++|..||... +....+....... .. ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~-~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE------TPDAVFDNILSRR-IN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhcc-cC------CCCccc
Confidence 2345788999999998888899999999999999999999998521 2222222211110 00 001111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 623 TEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 623 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
...+..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23456799999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.97 Aligned_cols=266 Identities=23% Similarity=0.290 Sum_probs=201.0
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE- 451 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~- 451 (678)
.+....++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 4555688999999999999999999985 46899999987532 2333467889999999999999999999887554
Q ss_pred -----cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEe
Q 041043 452 -----VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526 (678)
Q Consensus 452 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 526 (678)
..++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 348999998 7799888863 35899999999999999999999999 9999999999999999999999
Q ss_pred eccCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 527 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .........
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~------~~~~~~~~~ 230 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH------LDQLMEIMK 230 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHH
Confidence 99998754322 122356889999999876 4588899999999999999999999853211 111111100
Q ss_pred --------------hccchhhcchhhh------cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 606 --------------ENCLFDILDDQVR------KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 606 --------------~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
............. ..........+.+++.+||+.||++|||+.+++.. ++.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0000000000000 00011234568899999999999999999999944 666543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=286.24 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=196.6
Q ss_pred CCCcCCeeeeeCCcEEEEEEE----cCCcEEEEEEcccCC----hhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcc
Q 041043 383 HFNVNRILGQGGQGTVYKGML----ADGRIIAVKKSKVVD----ESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 453 (678)
+|++.+.||+|+||.||++.. .+|+.||+|.+.... ....+++.+|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368899999876422 23346788899999999 599999999999998899
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999999753 35889999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCcceeeeccccccCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSS--QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
.............++..|+|||.+... .++.++||||||+++|+|++|+.||.... ................
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG--EKNSQAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC--ccccHHHHHHHhhccC----
Confidence 543322222334578899999998753 46789999999999999999999985211 1111111111111100
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
...+......+.+++.+||+.+|++|| ++.+++..
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111233456789999999999999997 56666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=291.81 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=192.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc------
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV------ 452 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 452 (678)
++|++.+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46889999999999999999965 58899999875432 2223456789999999999999999999876543
Q ss_pred --ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 453 --PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 453 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
.++|+||+. ++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 499999996 48888886532 35899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcce---eeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-
Q 041043 531 SRSIAIDQTH---VSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE- 605 (678)
Q Consensus 531 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 605 (678)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|..||....... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~ 242 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGS 242 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC
Confidence 9765432221 11233467889999988664 47889999999999999999999985322111 1111111000
Q ss_pred --hccch-----hhcch---------hhhc-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 606 --ENCLF-----DILDD---------QVRK-SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 606 --~~~~~-----~~~~~---------~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..... ...+. .... .........+.+|+.+||..||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 00000 0000 000012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.49 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=196.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+.|...+.||+|+||.||+|... +++.+++|.+.. ......+++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667789999999999999964 578899998753 23344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+. |+|.+++.... ..+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 68888775432 35899999999999999999999998 999999999999999999999999998754322
Q ss_pred cceeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 538 QTHVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
....++..|+|||.+. ...++.++||||||+++|+|++|+.||..... ......... .
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~------- 229 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-N------- 229 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhh-c-------
Confidence 2235788999999974 35678899999999999999999999742110 111111111 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.............+.+|+.+||+.+|++||++.++++.-.
T Consensus 230 -~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 230 -ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0011112345567899999999999999999999997743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.30 Aligned_cols=265 Identities=25% Similarity=0.319 Sum_probs=205.4
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----cce
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVE-----VPL 454 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 454 (678)
+|.+.+.||+|++|.||++... +++.++||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999975 48999999876533 445578999999999999999999999988765 789
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+++||++ ++|.+++... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 5899988753 26999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc--eeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh-----
Q 041043 535 AIDQT--HVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE----- 606 (678)
Q Consensus 535 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 606 (678)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~~~ 227 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI------DQLNLIVEVLGTPS 227 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH------HHHHHHHHhcCCCC
Confidence 54321 112334578899999999887 7899999999999999999999998533211 111111110
Q ss_pred ---------ccchhhcchh-hh-----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhc
Q 041043 607 ---------NCLFDILDDQ-VR-----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRAC 660 (678)
Q Consensus 607 ---------~~~~~~~~~~-~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~~ 660 (678)
......+... .. .......+..+.+++.+||+.+|++|||+++++.. +++++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000000 00 00011235678999999999999999999999986 7777654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=286.93 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=195.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCC-hhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD-ESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 456 (678)
..++|++.+.||+|++|.||+|..++ ++.+|||.++... .....++..|++++.+.. |+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999865 8999999986533 334556777887776665 99999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+. + |+||||+|+||++++++.+||+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 47777765432 3689999999999999999999974 6 9999999999999999999999999987654
Q ss_pred CCcceeeeccccccCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQ----FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
.... .....++..|+|||.+.... ++.++||||||+++|+|++|+.||... ....+......... ..
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~~-~~- 237 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC-----KTEFEVLTKILQEE-PP- 237 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc-----hhHHHHHHHHhcCC-CC-
Confidence 3222 12234778999999987553 788999999999999999999998521 11111111111111 00
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..........++.+|+.+||+.||.+||++.++++.
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 ------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111245678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.29 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=206.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
...|.+.+.||+|.|++|.+|... .+..||||.+... +....+.+.+|+++|+.++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457889999999999999999954 6899999987643 4445567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||..+|.+.+||.++. .+.+..+..++.|+.+|++|+|+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--
Confidence 9999999999998654 4667899999999999999999999 9999999999999999999999999998765
Q ss_pred cceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.........|++.|.|||++.+.+| +++.|+||+|++||-|+.|..||++ .++...- ...+...
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG------~~lk~Lr---------~rvl~gk 271 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG------QNLKELR---------PRVLRGK 271 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC------ccccccc---------chheeee
Confidence 3344566789999999999998765 5699999999999999999999952 2222111 1111111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+. +.-...+..+|++++|..+|.+|++++++.+.
T Consensus 272 ~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 121 22233467899999999999999999999765
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=285.81 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=202.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 456 (678)
++|.+.+.||+|++|.||++... +++.+++|..... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 6899999987542 3344567889999999998 99999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999754 36999999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccc-------------------eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChH
Q 041043 537 DQT-------------------HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLA 597 (678)
Q Consensus 537 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~ 597 (678)
... .......++..|+|||.+....++.++||||||++++++++|+.||.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN------EY 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc------HH
Confidence 321 11223457889999999988889999999999999999999999985221 11
Q ss_pred HHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 041043 598 TYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM----KEVAM 652 (678)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 652 (678)
..+..... .....+...++.+.+++.+||+.+|.+||++ +|++.
T Consensus 229 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111111 1112233446678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=274.86 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=201.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
-++|...++||+|.||+|.+++-+ .++.+|+|+++. ...++...-+.|-++|+..+||.+..|.-.+...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888999999999999999854 689999998875 3455566778899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||..+|.|..+|.+ ...+++...+.+-.+|+.||.|||+.+ ||.||||.+|.|||++|++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 999999999999975 446899999999999999999999998 9999999999999999999999999997533
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
..........|||.|+|||++....|..+.|.|.+||++|||++|+.||..... ...+..+ +-..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh------~kLFeLI---------l~ed 384 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH------EKLFELI---------LMED 384 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch------hHHHHHH---------Hhhh
Confidence 233345677899999999999999999999999999999999999999962211 1111111 1111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCC
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP 645 (678)
...+...+++...|+...|.+||++|.
T Consensus 385 --~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 --LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 122455566788999999999999994
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.73 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=198.6
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee-CCc
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLE-VEV 452 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~ 452 (678)
+..++++|++.+.||+|+||.||++... +++.+|+|++.. ......+.+.+|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3457889999999999999999999855 789999998643 223345678899999999999999999998875 557
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++++||+ +++|.++++. ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 5689888863 24788889999999999999999999 9999999999999999999999999987
Q ss_pred cccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHHH
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---------RNLATYFVE 602 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---------~~~~~~~~~ 602 (678)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ....++...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 122346788999998766 5689999999999999999999999853221100 000111111
Q ss_pred HHhhccchhhcchhhhcCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 603 CVEENCLFDILDDQVRKSGK-----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........-..........+ ....+.+.++|.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 10010000000000000001 1234689999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.13 Aligned_cols=244 Identities=28% Similarity=0.397 Sum_probs=193.6
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
|...+.||+|+||+||+|+.. +++.+++|++... .....+.+.+|+++++.++|||++++++++.+.+..++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999964 5889999987542 234456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+. |+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 57888776432 35899999999999999999999998 99999999999999999999999998864321
Q ss_pred eeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 540 HVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.....++..|+|||.+. ...++.++||||||+++|||++|..||... +............ .
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~------~~~~~~~~~~~~~-~------- 237 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQND-S------- 237 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcC-C-------
Confidence 22345788999999974 456888999999999999999999998522 1111111111110 0
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+..+.+|+.+||+.+|.+||++.+++..
T Consensus 238 -~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122334568999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.88 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=205.1
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
+...+-++.-..+||.|.||.||.+. ..+|...|+|-++. ........+.+|+.++..++|||+|+.+|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34456678888999999999999999 45689999996654 3344567789999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++.||||++|+|.+.+.... ..++.....+..|++.|++|||+++ ||||||||.||||+.+|.+|++|||.+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999997532 4667777778899999999999999 99999999999999999999999999988
Q ss_pred ccCCcce---eeeccccccCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc
Q 041043 534 IAIDQTH---VSTKVQGTFGYLDPEYFHSSQ---FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 534 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
+...... ......||+.|||||++.+.. ...+.||||+||++.||+||++||...+.+ .
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------------~ 1448 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------------W 1448 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------------h
Confidence 7654322 233457999999999997643 456899999999999999999998532211 1
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.++.-+.-.-....+...+.+=.+++.+||+.||++|-++.|+++.
T Consensus 1449 aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111111111233455577788899999999999999877766653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=290.02 Aligned_cols=263 Identities=21% Similarity=0.263 Sum_probs=199.1
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEee
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
...++..++++|.+.+.||+|+||.||++.. .+++.||+|++... +....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 46889999988643 23345678899999999999999999998864
Q ss_pred C------CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 450 V------EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 450 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
. ...+++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 2357777776 7899888864 24899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 041043 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 602 (678)
||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~------~~~~~~ 229 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKL 229 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 99999998754321 223457889999999866 5678899999999999999999999853211 111111
Q ss_pred HHh--------------hccchhhc---chhhhc---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 603 CVE--------------ENCLFDIL---DDQVRK---SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 603 ~~~--------------~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
... .......+ ...... ........++.+++.+||+.||.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100 00000000 000000 0001134578899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=289.37 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=197.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE----- 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 451 (678)
..++|...+.||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999964 6899999987542 2333456889999999999999999999987543
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 35899999964 7776652 24889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE--- 606 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 606 (678)
++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||... +....+......
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~------~~~~~~~~~~~~~~~ 233 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK------DYLDQLTQILKVTGV 233 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHHhcCC
Confidence 8754321 123356888999999876 46888999999999999999999999632 111111111110
Q ss_pred -----------ccchhhcchh---hhcCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhc
Q 041043 607 -----------NCLFDILDDQ---VRKSG---KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRAC 660 (678)
Q Consensus 607 -----------~~~~~~~~~~---~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~~ 660 (678)
.......... .+... .......+.+|+.+||+.||++||+++|++.. ++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000000 00000 01234568899999999999999999999965 7777643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=278.69 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=188.4
Q ss_pred hccCCCcCCee--eeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRIL--GQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~L--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 455 (678)
..++|++.+.+ |+|+||.||++..+ ++..+|+|.......... |+.....+ +||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666666 99999999999964 678899998754322111 22222222 69999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSI 534 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~ 534 (678)
||||+++++|.+++... ..+++.+++.++.|+++||.|||+.+ ++||||+|+||+++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999754 26899999999999999999999999 99999999999999998 9999999998755
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
... ....++..|+|||++.+..++.++||||||+++|||++|+.||..... +......+.... .
T Consensus 161 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~----------~ 224 (267)
T PHA03390 161 GTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ----------Q 224 (267)
T ss_pred CCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh----------c
Confidence 322 123578899999999988899999999999999999999999862211 111111111111 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-MKEVAM 652 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 652 (678)
. ........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 225 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 01112245668999999999999999996 688874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.33 Aligned_cols=255 Identities=27% Similarity=0.363 Sum_probs=197.5
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
|+..+.||+|++|.||+|+.. +++.+++|...... ....+.+..|++++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999976 48999999877542 334567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
+ ++|.+++.+.. ..+++..++.++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999998643 35899999999999999999999998 999999999999999999999999998765443221
Q ss_pred eeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh------hc------
Q 041043 541 VSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE------EN------ 607 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~------ 607 (678)
.....++..|+|||.+... .++.++||||||+++|||++|+.||..... ......... +.
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE------IDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHHHhCCCcHHHHHhhc
Confidence 2223457789999998766 789999999999999999999999853211 111111100 00
Q ss_pred -------cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 608 -------CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 608 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........... .........+.+++.+||+.+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 001122567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.98 Aligned_cols=263 Identities=24% Similarity=0.304 Sum_probs=195.2
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh-hhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEec
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
|++.+.||+|++|+||+|... +++.|+||++..... .......+|+..+++++ |+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 478899998764322 22334567999999999 999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
+|+|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889999987643 246899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccC---------C-ChHHHHHHHHhhccc
Q 041043 541 VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---------R-NLATYFVECVEENCL 609 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---------~-~~~~~~~~~~~~~~~ 609 (678)
.....++..|+|||.+.. ..++.++|+||||++++||++|+.||......+. . ....|..........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 223457889999998754 4578999999999999999999999853221100 0 000000000000000
Q ss_pred hhhcchhhhc---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 FDILDDQVRK---SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...... .........+.+++++||+.+|++|||++|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 0001124679999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=270.97 Aligned_cols=269 Identities=23% Similarity=0.287 Sum_probs=199.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-----CcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEee-CCcc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLE-VEVP 453 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~ 453 (678)
..|+....||+|.||.||+|+-.+ .+.+|||+++.... .-.....+|+.+++.++|||++.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468889999999999999997432 23789998875422 223567899999999999999999999987 7788
Q ss_pred eEEEEeccCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC----CcEEEee
Q 041043 454 LLVYEFIPNGTLFQYLHDPS--EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK----YRAKIAD 527 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~D 527 (678)
++++||.+. +|.+.|+.++ ....++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 8888886433 3357899999999999999999999998 9999999999999877 8999999
Q ss_pred ccCcccccCCccee--eeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccccc-CCCh--HHHHH
Q 041043 528 FGTSRSIAIDQTHV--STKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANE-GRNL--ATYFV 601 (678)
Q Consensus 528 fgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~-~~~~--~~~~~ 601 (678)
||+++.+...-... ...++.|..|.|||.+.+. .|+.+.|||+.|||+.||+|-++-|......- .++. ...+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999887654332 3456679999999998874 68999999999999999999988875432211 1111 11111
Q ss_pred HHHh------hccchh---------hcchhhhcCC-C----------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 602 ECVE------ENCLFD---------ILDDQVRKSG-K----------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 602 ~~~~------~~~~~~---------~~~~~~~~~~-~----------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
++.+ +..+.. .+....+... + ...++...+|+.++|++||.+|.|++|.++..
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1110 011110 0000000000 0 00112367999999999999999999998763
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=286.44 Aligned_cols=260 Identities=25% Similarity=0.300 Sum_probs=192.5
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC------
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVE------ 451 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 451 (678)
.++|++.++||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 58899999875432 222346788999999999999999999876543
Q ss_pred --cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 452 --VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 452 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
..++|+||+.. +|...+... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 677777643 236999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcce----------eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 041043 530 TSRSIAIDQTH----------VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLAT 598 (678)
Q Consensus 530 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~ 598 (678)
++......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~------~~ 234 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD------ID 234 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH------HH
Confidence 98765432211 1122356788999998765 4578899999999999999999999853211 11
Q ss_pred HHHHHHhh------------ccchhhcchhhhcCC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 599 YFVECVEE------------NCLFDILDDQVRKSG-------KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 599 ~~~~~~~~------------~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........ ..+....+....... .....+.+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111100 000000000000000 0122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=278.31 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=194.7
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEccc-----CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKV-----VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
+|.+.+.||+|+||.||++.... +..+++|..+. .......++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998643 34444444332 1223345677899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 22346899999999999999999999998 999999999999976 569999999987654
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.... ......+++.|+|||.+....++.++|+||||+++|+|++|..||.. ............ .
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~------~~~~~~~~~~~~-~-------- 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG------QNFLSVVLRIVE-G-------- 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC------ccHHHHHHHHHc-C--------
Confidence 3222 22334578899999999888889999999999999999999999841 122221111111 0
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.....+...+.++.+++.+||+.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111123455668999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.80 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=194.6
Q ss_pred ccCCC-cCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhh--------------HHHHHHHHHHHhcCCCCceeeEE
Q 041043 381 TDHFN-VNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK--------------LEEFINEVVILSQISHRNVVKLL 444 (678)
Q Consensus 381 ~~~~~-~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~ 444 (678)
.++|. +.+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4578999999999999965 68999999875432211 12577899999999999999999
Q ss_pred eEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEE
Q 041043 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 524 (678)
Q Consensus 445 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 524 (678)
+++...+..+++|||++ |+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999996 6899998643 35899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccccCCc-------------ceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 041043 525 IADFGTSRSIAIDQ-------------THVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWA 590 (678)
Q Consensus 525 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~ 590 (678)
|+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987654111 1111223467889999998764 468899999999999999999999853221
Q ss_pred ccCCChHHHHHHHHhhcc---chhhc------------chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 591 NEGRNLATYFVECVEENC---LFDIL------------DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~---~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. .....+........ +.... ..... ......+..+.+++.+||+.+|++|||++|++..
T Consensus 240 ~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 I---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 11111111111000 00000 00000 0011234678899999999999999999999874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=279.77 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=186.2
Q ss_pred eeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHH---HHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 389 ILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVV---ILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
.||+|+||.||++... +++.||+|.+.... ......+..|.. .++...||||+++++++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999875421 111222344433 4445679999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|+|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999998643 36999999999999999999999998 9999999999999999999999999987553222
Q ss_pred eeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....++..|+|||.+.++ .++.++||||||+++|||++|+.||....... ... ...... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~---~~~-~~~~~~----------~~~~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHE-IDRMTL----------TMAVE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc---hHH-HHHHhh----------ccCCC
Confidence 1234588999999998754 68899999999999999999999986321111 110 000000 00111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
.+...+..+.+++.+||..+|++|| ++.++++.
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1223456899999999999999999 99999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.52 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=196.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC---------
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEV--------- 450 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------- 450 (678)
..+|.+.+.||+|+||.||+|... +++.||+|++...+....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999964 5889999998776666678899999999999999999999876543
Q ss_pred -----CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcEE
Q 041043 451 -----EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAK 524 (678)
Q Consensus 451 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~k 524 (678)
...++|+||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999997 589888853 25889999999999999999999999 99999999999997 456789
Q ss_pred EeeccCcccccCCcce--eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 041043 525 IADFGTSRSIAIDQTH--VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~ 601 (678)
|+|||++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... .....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~------~~~~~ 229 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE------LEQMQ 229 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 9999998765332111 1122357889999998654 5678899999999999999999999953211 11111
Q ss_pred HHHhhc---------c----chhhcc-hhhhcCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 041043 602 ECVEEN---------C----LFDILD-DQVRKSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERI 657 (678)
Q Consensus 602 ~~~~~~---------~----~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l 657 (678)
...... . ...... ....... ......++.+++.+||+.||++|||+.|++.. ++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 000000 0 000000 0000000 11234578899999999999999999999854 5543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=266.97 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=199.5
Q ss_pred hccCCCcC-CeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeC----Cc
Q 041043 380 ATDHFNVN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEV----EV 452 (678)
Q Consensus 380 ~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~ 452 (678)
++++|++. ++||-|-.|.|-....+ .++.+|+|.+... ...++|+++.=.. .|||||.+++++... ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667664 68999999999998864 6889999988653 4556888876555 599999999988753 45
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC---CCCcEEEeecc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFG 529 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfg 529 (678)
+.+|||.|+||.|.+.++++. ...++++++..|.+||..|+.|||+.+ |.||||||+|+|.. .|..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 689999999999999998764 346999999999999999999999999 99999999999996 45579999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
+++.... ........-|+.|.|||++...+|+...|+||+||++|-|++|.+||..... ..+..-....+..+.
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq- 283 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ- 283 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC-
Confidence 9986543 2233445679999999999999999999999999999999999999963322 211111111111110
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
-..........++...++|+.+|..+|.+|.|+.|++..
T Consensus 284 -----y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 -----YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -----ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 011222235667889999999999999999999999876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=269.72 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=199.3
Q ss_pred CeeeeeCCcEEEEEE-EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 388 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
++||+|+++.|-.++ +.+|..+|||++.........++.+|++++.+.+ |+||+.|++++.++...|||||.|.+|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999988 6789999999998877777889999999999996 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC---cEEEeeccCcccccC--C---
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRSIAI--D--- 537 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgl~~~~~~--~--- 537 (678)
..+|+++ ..+++.++.++.++|+.||.+||.++ |.||||||+|||-.+.. -+||+||.+..-... +
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999854 46999999999999999999999999 99999999999997654 489999988754321 1
Q ss_pred -cceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccc-----cCCChHHHHHHHHhh
Q 041043 538 -QTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWAN-----EGRNLATYFVECVEE 606 (678)
Q Consensus 538 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 606 (678)
.+.......|+..|||||+.. ...|+.+.|.||||||||-|++|.+||.+.-.. .+..-..--.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~----- 312 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN----- 312 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH-----
Confidence 111223456888999999863 234777999999999999999999999765432 2222111111
Q ss_pred ccchhhcchhhhc---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 607 NCLFDILDDQVRK---SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 607 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+++-+...... ......+.+..+++...|..++.+|.++.+++.
T Consensus 313 -~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 -KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111111 112334567889999999999999999999987
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.59 Aligned_cols=257 Identities=22% Similarity=0.288 Sum_probs=197.3
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc---
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV--- 452 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 452 (678)
...++|++.+.||+|++|.||+|... +++.+|+|++... +....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999975 5789999987642 23345678889999999999999999998776554
Q ss_pred ---ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 453 ---PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 453 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 79999998 6699999864 35899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh--
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE-- 606 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 606 (678)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~------~~~~~~i~~~~~ 233 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH------IDQLKRIMNLVG 233 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcC
Confidence 98765332 223357888999999865 3678899999999999999999999853211 1111111110
Q ss_pred ------------ccchhhcchhhhcC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 ------------NCLFDILDDQVRKS------GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ------------~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......+....... .....++++.+++.+||+.+|++|||+.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 001235689999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=308.38 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=187.9
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC------
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEV------ 450 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 450 (678)
+-..+|+..+.||+||||.||+++.+ ||+.+|||++... +......+.+|++.|.+|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999976 8999999998654 444567789999999999999999987422110
Q ss_pred --------------------------------------------------------------------------------
Q 041043 451 -------------------------------------------------------------------------------- 450 (678)
Q Consensus 451 -------------------------------------------------------------------------------- 450 (678)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 041043 451 ---------------------------------EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497 (678)
Q Consensus 451 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL 497 (678)
..+|+-||||+..+|.++++++.-. -.....++++++|+.||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 1135678888888888777653211 14678899999999999999
Q ss_pred HhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc----C-------------CcceeeeccccccCccCccccccC
Q 041043 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA----I-------------DQTHVSTKVQGTFGYLDPEYFHSS 560 (678)
Q Consensus 498 H~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~ 560 (678)
|+.+ ||||||||.||+||++..+||+|||++.... . ......+...||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999997721 0 011123445699999999999764
Q ss_pred ---CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhc
Q 041043 561 ---QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCL 637 (678)
Q Consensus 561 ---~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 637 (678)
.|+.|+|+||||+||+||+.- |.. ..+ -...+. ..+.+.+..- .....+..+.-+.+|++|+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~yP---F~T--sME---Ra~iL~-~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLYP---FGT--SME---RASILT-NLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhcc---CCc--hHH---HHHHHH-hcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 499999999999999999974 531 111 111111 1111111110 1112334445678999999
Q ss_pred ccCCCCCCCHHHHHH
Q 041043 638 NSNGRSRPTMKEVAM 652 (678)
Q Consensus 638 ~~dP~~RPt~~evl~ 652 (678)
+.||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999975
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=259.85 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=196.5
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcc-cCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEec
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSK-VVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.+....||.|.-|.||+...+ .|..+|||.+. ..+.++.++++..+.++..-+ .|+||+-+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344567999999999999965 58999999875 455666778888888776654 899999999999999999999998
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
. ..++..|++.. .++++..+-++...+++||.||..++. |+|||+||+|||+|+.|++|++|||++-.+..+.
T Consensus 174 s-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 174 S-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred H-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 4 35666665533 358999999999999999999988763 9999999999999999999999999997665433
Q ss_pred eeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 541 VSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
..+...|-+.|||||.+.. ..|+.++||||||+.|+||.||..||..- +.-.+.+..+..+.. +
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c-----~tdFe~ltkvln~eP------P-- 313 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC-----KTDFEVLTKVLNEEP------P-- 313 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC-----CccHHHHHHHHhcCC------C--
Confidence 3355578999999999865 36888999999999999999999999521 111122222222111 1
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........++.+++++..||++|+.+||...++++.
T Consensus 314 ~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111123367889999999999999999999998875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=281.74 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=191.2
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-C--CcEEEEEEcccC--ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeC----Cc
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-D--GRIIAVKKSKVV--DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEV----EV 452 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~ 452 (678)
+|++.+.||+|+||.||++... . +..+|+|++... .....+.+.+|+++++++ +||||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999965 3 678999987642 223356788999999999 599999999875432 34
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 6899988643 35899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCcce---eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccccc---------CCChHHH
Q 041043 533 SIAIDQTH---VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANE---------GRNLATY 599 (678)
Q Consensus 533 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~---------~~~~~~~ 599 (678)
........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ +......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 1223458899999998765 468899999999999999999999985321100 0000000
Q ss_pred HHHHHhhccchhhcc---hhhh---cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 600 FVECVEENCLFDILD---DQVR---KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........ ...... .... ..........+.+++.+||+.||++|||+.|++..
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPK-AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhh-HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 000000 0000 00011124578999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=270.34 Aligned_cols=236 Identities=30% Similarity=0.366 Sum_probs=192.6
Q ss_pred eeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 390 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
||+|+||.||++... +++.+++|.+.... ....+.+..|++++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 48899999875432 23566889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeecc
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 545 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 545 (678)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 9999754 25899999999999999999999988 9999999999999999999999999987654332 122334
Q ss_pred ccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHH
Q 041043 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625 (678)
Q Consensus 546 ~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (678)
.++..|++||...+...+.++|+||||+++|++++|+.||.... .......... . ....+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~---------~--~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED------RKEIYEKILK---------D--PLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc---------C--CCCCCCCC
Confidence 57889999999988888999999999999999999999985221 1111111111 0 11112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 041043 626 IMEVSDVAKRCLNSNGRSRPTMKE 649 (678)
Q Consensus 626 ~~~l~~li~~cl~~dP~~RPt~~e 649 (678)
+..+.+++.+||..||++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567899999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=277.12 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=202.1
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC--hh-----hHHHHHHHHHHHhcCCCCceeeEEeEEe-e
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ES-----KLEEFINEVVILSQISHRNVVKLLGSCL-E 449 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~ 449 (678)
...++|-+.++||+|+|+.||++.. ...+.||+|+-.... .+ -.+...+|..|.+.|.||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456788899999999999999994 457889999754321 11 1244678999999999999999999986 5
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC---CCCcEEEe
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIA 526 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~ 526 (678)
.+..+-|+||+++.+|.-||+.++ .++++++..|+.||+.||.||.... +||+|-||||.||||. .-|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 567889999999999999998654 5899999999999999999999887 6799999999999995 45789999
Q ss_pred eccCcccccCCcce------eeeccccccCccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh
Q 041043 527 DFGTSRSIAIDQTH------VSTKVQGTFGYLDPEYFHS----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596 (678)
Q Consensus 527 Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~ 596 (678)
|||+++.+..+... ......||.+|++||.+.- .+.+.|.||||+|||+|+.+.|++||...-.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs------ 689 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS------ 689 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh------
Confidence 99999987654322 3455679999999998743 3578899999999999999999999962211
Q ss_pred HHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 597 ATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
-.++..++.+...-+. .....+..+.+..++|++||++--++|....+++.
T Consensus 690 ---QQdILqeNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 690 ---QQDILQENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---HHHHHhhhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0122222222222111 22223556678899999999999999988888764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=301.82 Aligned_cols=145 Identities=30% Similarity=0.413 Sum_probs=131.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|.+.++||+|+||.||+|... +++.||||+++.. +....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999976 6889999987643 3344577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
||+++++|.+++... ..+++..++.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999753 35889999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=298.85 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=216.5
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
..++....++|.+.++||+|+||.|..++.+ .++.+|+|++.. .......-|.+|=.+|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3556666788999999999999999999975 578999998865 334444568889999999999999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
..++|+||||++||+|...+.+.. .+++..+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999997543 6999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
.+-.+..+..-.....+|||.|++||++.. +.|+...|.||+||++|||+.|.-||. ..++...+..++
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHHh
Confidence 998887777777778889999999999852 568999999999999999999999995 345555555555
Q ss_pred hhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 041043 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT---MKEVAME 653 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 653 (678)
.......+- ...+.+++..+||.+.+. +|+.|.. +.++-..
T Consensus 295 ~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 442222111 124567788999998775 6777877 7776544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=285.25 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=210.1
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEee----
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLE---- 449 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~---- 449 (678)
.+...++-|++.+.||.|.+|.||+++. ++++..|+|+..... +..+++..|.++|+.+ .|||++.++|++..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3344567788999999999999999994 568889999876543 3346777899999888 59999999999874
Q ss_pred -CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 450 -VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 450 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
.+.+|||||||.+|+.-|.++... ...+.|..+..|++.++.||++||.+. ++|||||-.||||+.++.+||.||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence 467899999999999999998766 668999999999999999999999998 999999999999999999999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
|.+..+.... .......||+.|||||++... .|+.++|+||||++..||.-|.+|+..+.+..
T Consensus 168 GvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----------- 235 (953)
T KOG0587|consen 168 GVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----------- 235 (953)
T ss_pred eeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----------
Confidence 9998765322 234456799999999998653 36779999999999999999999985332211
Q ss_pred Hhhccchhhcc-hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 604 VEENCLFDILD-DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 604 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
-++.+.. +......+..+.+++.++|..||..|-++||++.++++.
T Consensus 236 ----aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ----ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111 222333467888999999999999999999999998864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=238.97 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=197.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+|.-.++||+|.+|+|++|+.. .++.||+|+.+.. ++.......+|+-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3445678999999999999954 5789999987653 344456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+.. +|..|.... ++.++.+.+..++.|+++||.+.|+++ +.||||||+|.||..+|..|++|||+++.+..+-.
T Consensus 83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 788887653 346899999999999999999999999 99999999999999999999999999998876554
Q ss_pred eeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCC-CCccccccCCChHHHHHHH--Hhhccchhh---
Q 041043 540 HVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKP-ISYIWANEGRNLATYFVEC--VEENCLFDI--- 612 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--- 612 (678)
... ....|..|.+|.++.+. -|+...|+||-|||+.|+.....| |++. +...++...+... ..++.+..+
T Consensus 157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~--dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC--cHHHHHHHHHHHhCCCccccCCccccC
Confidence 433 33478999999998875 488899999999999999985555 4321 1112222222211 112222221
Q ss_pred cchhhhcCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 LDDQVRKSGK---------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
-|-.....++ +.....=++|+.+.|.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111111 111123378999999999999999998775
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=291.47 Aligned_cols=260 Identities=21% Similarity=0.286 Sum_probs=171.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-C----CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeE------Ee
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-D----GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGS------CL 448 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~------~~ 448 (678)
..++|++.++||+|+||.||+|++. + +..||||++...... +.+..| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999975 4 689999987643221 122221 1222222222222211 23
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSEE-----------------LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 511 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 511 (678)
.....++|+||+++++|.++++..... ....+..+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456789999999999999998753211 01123446679999999999999998 9999999
Q ss_pred CCceEECC-CCcEEEeeccCcccccCCcceeeeccccccCccCccccccC----------------------CCCcccch
Q 041043 512 STNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS----------------------QFTDKSDV 568 (678)
Q Consensus 512 ~~NILl~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV 568 (678)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999986654444444456789999999965322 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc----chhhcchhhhcC------CCHHHHHHHHHHHHHhcc
Q 041043 569 YSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC----LFDILDDQVRKS------GKTEEIMEVSDVAKRCLN 638 (678)
Q Consensus 569 wslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~ 638 (678)
|||||+||||+++..++. ..+..........+. +........... ..........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD-------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCc-------hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999776642 111111111111000 000011100000 000012245589999999
Q ss_pred cCCCCCCCHHHHHHH
Q 041043 639 SNGRSRPTMKEVAME 653 (678)
Q Consensus 639 ~dP~~RPt~~evl~~ 653 (678)
.||++|||++|+++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=267.51 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=200.6
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCC--C----ceeeEEeEEeeCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISH--R----NVVKLLGSCLEVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~----niv~l~~~~~~~~~ 452 (678)
.+++|.+...+|+|.||.|-..... .+..||||+++..+.- .+..+-|+++|+++.+ | -++.+.+++...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999999854 4689999999876443 3667789999999942 2 37788889999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-------------
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE------------- 519 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~------------- 519 (678)
.++|+|.+ +-++.++|..++ ..+++...++.|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 559999998754 457899999999999999999999999 999999999999831
Q ss_pred -------CCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 041043 520 -------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592 (678)
Q Consensus 520 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~ 592 (678)
+..+||+|||.+..-.... ..++.|.+|.|||++.+-.++.++||||+||||+|+.||..-|+.....+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3468999999997543322 45668999999999999999999999999999999999999887554222
Q ss_pred CCChHHHHH---------HH-----Hhhccch-----------hhcch----hhhcCCCHHHHHHHHHHHHHhcccCCCC
Q 041043 593 GRNLATYFV---------EC-----VEENCLF-----------DILDD----QVRKSGKTEEIMEVSDVAKRCLNSNGRS 643 (678)
Q Consensus 593 ~~~~~~~~~---------~~-----~~~~~~~-----------~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~ 643 (678)
.-.+.+.+. .. ...+.+. .+.+. .........+..+|.+|+++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 110111111 00 0000000 00000 0001112344457999999999999999
Q ss_pred CCCHHHHHHH
Q 041043 644 RPTMKEVAME 653 (678)
Q Consensus 644 RPt~~evl~~ 653 (678)
|+|++|++..
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=263.92 Aligned_cols=222 Identities=22% Similarity=0.207 Sum_probs=176.8
Q ss_pred eCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChhhhhcC
Q 041043 393 GGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD 471 (678)
Q Consensus 393 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 471 (678)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68899999886532 233455555566799999999999999999999999999999999975
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCc
Q 041043 472 PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551 (678)
Q Consensus 472 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 551 (678)
. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 3 24899999999999999999999998 999999999999999999999999987654322 1223356779
Q ss_pred cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHH
Q 041043 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSD 631 (678)
Q Consensus 552 ~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 631 (678)
+|||.+....++.++||||+|+++|||++|+.|+...... .. .......+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~----~~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN----THTTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc----cccccCCcccCCHHHHH
Confidence 9999998888899999999999999999999886421100 00 00001112234567899
Q ss_pred HHHHhcccCCCCCCCHHHH
Q 041043 632 VAKRCLNSNGRSRPTMKEV 650 (678)
Q Consensus 632 li~~cl~~dP~~RPt~~ev 650 (678)
++.+||+.||++||++.+.
T Consensus 208 li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHccCCHHHhcCCCcc
Confidence 9999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=284.38 Aligned_cols=267 Identities=21% Similarity=0.257 Sum_probs=183.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-----------------cCCcEEEEEEcccCChhhHHHH--------------HHH
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-----------------ADGRIIAVKKSKVVDESKLEEF--------------INE 428 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 428 (678)
..++|++.++||+|+||.||+|.. .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356899999876544333333 346
Q ss_pred HHHHhcCCCCce-----eeEEeEEee--------CCcceEEEEeccCCChhhhhcCCCC---------------------
Q 041043 429 VVILSQISHRNV-----VKLLGSCLE--------VEVPLLVYEFIPNGTLFQYLHDPSE--------------------- 474 (678)
Q Consensus 429 i~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 474 (678)
+.++.+++|.++ +++++++.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 667777653 3567999999999999999974211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCc
Q 041043 475 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554 (678)
Q Consensus 475 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP 554 (678)
...+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123567888999999999999999998 99999999999999999999999999976543322222223357899999
Q ss_pred cccccCC----------------------CCcccchhhHHHHHHHHHhCCC-CCCccccccCCChHHHHHHHHhhccchh
Q 041043 555 EYFHSSQ----------------------FTDKSDVYSFGVVLVELLTGQK-PISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 555 E~~~~~~----------------------~s~ksDVwslGvll~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
|.+.... ...+.||||+||++++|++|.. |+........ .... ...... .+..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~-~~~~~~--~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ-YDNDLN--RWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh-ccchHH--HHHh
Confidence 9875432 1234799999999999999875 6532111000 0000 000000 0000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNG---RSRPTMKEVAME 653 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~ 653 (678)
...............+...+|+.++|..+| .+|+|++|++++
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000011111122345678899999999866 689999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=281.60 Aligned_cols=241 Identities=23% Similarity=0.280 Sum_probs=194.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.++.|.+...+|.|+|+.|-.+.. .+++..++|++.... .+-.+|+.++... +||||+++.+.+.+....++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 366788888899999999999885 457888999886541 2233567666555 6999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE-CCCCcEEEeeccCcccccC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL-DEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~Dfgl~~~~~~ 536 (678)
|.+.++-|.+.+.... ....++..|+.+|+.|+.|||.++ +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999999988886532 223788889999999999999999 9999999999999 5899999999999987765
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
+ .....-|..|.|||++....|++++|+||||++||+|++|+.||.....+ .++...-
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~i 526 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTRI 526 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHhh
Confidence 4 22334678899999999999999999999999999999999998533221 0111111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....+...+++.++|+.+||+.||.+||+|.++...
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1222335677789999999999999999999999765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=262.74 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=198.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 454 (678)
...+|....+||+|+||+|-++..+. .+.+|||+++.. ..++.+--+.|-++|... +-|.+++++.++..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34578999999999999999999653 578999987642 233334445566677665 5788999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+.+|+|--++++.. .+.+..+..++.+||-||-+||+++ |+.||||..|||||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999998643 5888899999999999999999999 999999999999999999999999999753
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
..+ ........|||.|+|||++....|+...|.|||||+||||+.|++||+ +.+-.+.+..+.+.+
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd------GeDE~elF~aI~ehn------- 566 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD------GEDEDELFQAIMEHN------- 566 (683)
T ss_pred ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC------CCCHHHHHHHHHHcc-------
Confidence 322 223456789999999999999999999999999999999999999995 333344444444332
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCC
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 645 (678)
..++...+.+...+....|...|.+|.
T Consensus 567 ----vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ----VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 233566677888999999999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=260.00 Aligned_cols=238 Identities=31% Similarity=0.430 Sum_probs=193.0
Q ss_pred CCcEEEEEEEcC-CcEEEEEEcccCChhh-HHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChhhhhcC
Q 041043 394 GQGTVYKGMLAD-GRIIAVKKSKVVDESK-LEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD 471 (678)
Q Consensus 394 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 471 (678)
+||.||+|...+ ++.+++|+........ .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999987655444 68999999999999999999999999999999999999999999999975
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCc
Q 041043 472 PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551 (678)
Q Consensus 472 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 551 (678)
.. .+++..++.++.+++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 33 2899999999999999999999998 9999999999999999999999999998765432 23344578899
Q ss_pred cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHH
Q 041043 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSD 631 (678)
Q Consensus 552 ~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 631 (678)
++||.+....++.++|||+||+++++|++|..||... ........ ......... .........++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-----~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-----DQLLELFK-KIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHH-HHhccCCCC-------ccccccCCHHHHH
Confidence 9999998888899999999999999999999998521 11111111 111110000 0000014567999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 041043 632 VAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 632 li~~cl~~dP~~RPt~~evl~ 652 (678)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=261.05 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=194.8
Q ss_pred cCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhc-CCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 386 VNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQ-ISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 386 ~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
....||.|+||+|+|-.++ .|+.+|||+++... ..+.++++.|.+...+ -+.||||+++|.+..++..|+.||.|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3457999999999998865 68999999987644 4566788888887544 468999999999999999999999995
Q ss_pred CChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 463 GTLFQYLHD--PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 463 g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
.+|..+.+. ..++..+++.-+-.|...++.||.||...- .|+|||+||+||||+..|.+||+|||++-.+..+ .
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--i 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--I 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--H
Confidence 456554332 112346899999999999999999998764 3999999999999999999999999998765432 2
Q ss_pred eeeccccccCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 541 VSTKVQGTFGYLDPEYFHSS--QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
..+.-.|-..|||||.+... .|..+|||||||++|||+.||+.|+... .+..+.+...+..+... +. .
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~gdpp~-l~----~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIGDPPI-LL----F 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcCCCCe-ec----C
Confidence 23444688889999999653 4888999999999999999999998632 22333333333222111 00 1
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....+.+..|..+|.-||.+|-+.||...++.++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11124567789999999999999999999998765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=272.88 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=197.4
Q ss_pred CCeeeeeCCcEEEEEEE-cCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 387 NRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
.+.||.|.||+||-|+. ++|+.||||.+.. ....+..++++|+.||++++||.||.+.-.++..+..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 57899999999999996 4799999998653 334445789999999999999999999999999999999999995 4
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEeeccCcccccCCcce
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
+..+.|-.. +++.|++.....++.||+.||.|||.++ |+|.||||+||||.. -.++||+|||+++.+.. ..
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ks 721 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KS 721 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch--hh
Confidence 555555432 4567999999999999999999999999 999999999999964 35799999999998763 33
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
....++|||.|+|||++.+..|...-|+||.|||+|--++|..||. ++.++.+.+... .++ ....
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN-----EdEdIndQIQNA-------aFM---yPp~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN-----EDEDINDQIQNA-------AFM---YPPN 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC-----CccchhHHhhcc-------ccc---cCCC
Confidence 4456789999999999999999999999999999999999999995 333222211100 000 1122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...+.+....+||...|+..-++|-|..+-+.
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 23456678899999999999999999887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=254.33 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=192.6
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--------Cc
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--------EV 452 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------~~ 452 (678)
|.-..+||+|.||.||+|..+ .|+.||+|+.-.. ...-.....+|+++|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444578999999999999954 5778899875432 222345678999999999999999999987643 34
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++|+++++. +|...|.... ..++..++.++..++..||.|+|+.. |+|||+|+.|+||+.++.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 6899999976 7888886532 45888999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcce---eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 533 SIAIDQTH---VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 533 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
.+...... ..+..+.|..|++||.+.+ .+|+.+.|||.-|||+.||+|+.+-+++......-.+...+......+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76544332 2344556999999998876 5799999999999999999999988753222111111111111111111
Q ss_pred chhhcchhh---------h-cCC--CHHH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 LFDILDDQV---------R-KSG--KTEE------IMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~~~~~~~~~---------~-~~~--~~~~------~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+.....-.+ . ... -.+. .++..+|+.++|..||.+|+++.+++..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111110000 0 000 0111 2367899999999999999999999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=277.37 Aligned_cols=245 Identities=28% Similarity=0.402 Sum_probs=187.2
Q ss_pred CCcCCeeeeeCCcE-EEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEecc
Q 041043 384 FNVNRILGQGGQGT-VYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
|.-.+++|.|+.|+ ||+|... |+.||||++-. +...-..+|+..|+.- +|||||+.++.-.+.+..|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456799999876 7999985 88999998753 2234456899999888 49999999999999999999999995
Q ss_pred CCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-----CCcEEEeeccCccccc
Q 041043 462 NGTLFQYLHDPSEE-LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-----KYRAKIADFGTSRSIA 535 (678)
Q Consensus 462 ~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgl~~~~~ 535 (678)
.+|.+++...... ........+.+..|+++||++||+.+ ||||||||+||||+. ..+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999874111 11222455778899999999999988 999999999999975 2579999999999887
Q ss_pred CCccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 536 IDQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTG-QKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 536 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.+.... .....||.+|+|||.+....-+.+.|||||||++|+.++| +.||... +.....-......+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-------~~R~~NIl~~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-------LERQANILTGNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch-------HHhhhhhhcCccceee-
Confidence 665543 3456799999999999998888899999999999999995 8999522 1110100001111110
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.....+. +..+||.+|+.++|..||++.+|+.
T Consensus 735 ------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0111112 7889999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=234.46 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=196.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeC--CcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEV--EVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv 456 (678)
.++|++.+++|+|.+++|+.|. ..+.++++||.++.. ..+.+.+|+++|+.|+ ||||+++++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678999999999999999999 456889999998754 4467899999999998 99999999999764 467899
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl~~~~~ 535 (678)
+||+.+.+...... +|+..++...+.++++||.|+|+.| |.|||+||.|++||.. -..+|+|+|++.+..
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999887766553 5788899999999999999999999 9999999999999965 569999999998766
Q ss_pred CCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChH------------HHHHH
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLA------------TYFVE 602 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~------------~~~~~ 602 (678)
+.... +..+.+..|.-||.+-. ..|+..-|+|||||+|..|+..+.||.....+. .++. .++..
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHHH
Confidence 54433 23346778899999876 457889999999999999999999996432221 1111 11111
Q ss_pred HH--hhccchhhcchhhhc--------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 603 CV--EENCLFDILDDQVRK--------SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 603 ~~--~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. -......++....+. +..--..++..+|+.+.|.+|..+|||++|.+..
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 10 001111111111111 1011123678899999999999999999998764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=244.40 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=199.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 455 (678)
.++|.+.++||+|+|.+|..+.++ ..+.+|+|+++. .+.++++=...|-.+..+- +||.+|.++.++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467899999999999999999965 568899997653 2333334445566666554 79999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|.||.++|+|--++++. ..|+++.+..+..+|..||.|||+.+ |+.||||..|||||..|++||+|+|+.+.-.
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999888754 35999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccccc-CCChHHHHHHHHhhccchhhcc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE-GRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.+ ........|||.|+|||.+++..|....|.|+|||+++||+.|+.||+....++ ..+..+++.+.+ ++
T Consensus 403 ~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------le 473 (593)
T KOG0695|consen 403 GP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LE 473 (593)
T ss_pred CC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------hh
Confidence 22 234566789999999999999999999999999999999999999998654322 334444443333 33
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCC
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 645 (678)
.+++. +...+-....+++..|.+||++|.
T Consensus 474 kqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 KQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 34433 233344567889999999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=263.21 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=203.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCc-EEEEEEc---ccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGR-IIAVKKS---KVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~-~vavK~~---~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.+++.+..||-|+||.|=+...+... .+|+|.+ +..+..+.+.+..|-.+|...+.|.||+++-.+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555678999999999998865433 3666654 4567778889999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
|-|-+|.|...|++. +.++......++..+++|++|||+++ ||+|||||+|.+||.+|-+||.|||+++.+...
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999854 46899999999999999999999999 999999999999999999999999999987654
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. +-...|||.|.|||++.+...+.+.|.||||+++|||++|.+||+...+.. ....+.+.- -
T Consensus 574 ~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------tYn~ILkGi---------d 636 (732)
T KOG0614|consen 574 RK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK------TYNLILKGI---------D 636 (732)
T ss_pred Cc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------HHHHHHhhh---------h
Confidence 43 455689999999999999999999999999999999999999997443322 222221111 1
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
....+........+||++....+|.+|.. +.|+-+.
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 12234455567789999999999999965 4555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=244.58 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=198.4
Q ss_pred CCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----CcceE
Q 041043 384 FNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEV-----EVPLL 455 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~l 455 (678)
.+-.+.||.|+||.||..+. ++|+.||.|++.+.- -...+.+.+|+++|..++|.|++..++...-. ++.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34467899999999999985 579999999986532 33457899999999999999999998876543 34678
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
++|.|. .+|...|- +...++...+.-++.||++||+|||+.+ |.||||||.|.|++.|...||+|||+++...
T Consensus 135 ~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 889884 47777775 3457888899999999999999999999 9999999999999999999999999999887
Q ss_pred CCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---------
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE--------- 605 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 605 (678)
.++...++..+-|-.|.|||.+.+ ..|+.+.||||.|||+.||+..+.-|....+.+. .+.+.+...
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ---L~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ---LQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH---HHHHHHHhCCCcHHHHHH
Confidence 777777777778999999999877 5699999999999999999999888753222111 111111111
Q ss_pred --hccchhhcchhhhc---------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 606 --ENCLFDILDDQVRK---------SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 606 --~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
++-...++....+. ..+.....+...+..+++..||++|.+..+.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111122211111 11112233566888899999999999999887654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-29 Score=225.89 Aligned_cols=205 Identities=25% Similarity=0.398 Sum_probs=167.4
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc-CChhhHHHHHHHHHHHhc-CCCCceeeEEeEEeeCCcc
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV-VDESKLEEFINEVVILSQ-ISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~ 453 (678)
++...+...-...||+|++|.|-+-++ ++|+..|+|++.. .+.+...+.++|+.+..+ ...|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444455566677899999999988774 5799999998865 344455677888887655 4699999999999999999
Q ss_pred eEEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 454 LLVYEFIPNGTLFQYLHD-PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
|+.||.|. .+|..|.++ ......+++..+-+|+..+..||.|||++- .++|||+||+||||+.+|++|++|||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 477776543 223467999999999999999999999985 39999999999999999999999999987
Q ss_pred cccCCcceeeeccccccCccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHS----SQFTDKSDVYSFGVVLVELLTGQKPIS 586 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwslGvll~elltg~~p~~ 586 (678)
.+.++-. .+...|-..|||||.+.. ..|+-||||||||+.+.||.+++.||+
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 6654322 122347778999999854 368899999999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=231.34 Aligned_cols=210 Identities=38% Similarity=0.611 Sum_probs=183.9
Q ss_pred eeeeCCcEEEEEEEcC-CcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChhh
Q 041043 390 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQ 467 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 467 (678)
||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999998765443 45789999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeeccCcccccCCcceeeeccc
Q 041043 468 YLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQ 546 (678)
Q Consensus 468 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 546 (678)
++.... ..+++..++.++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 997542 35899999999999999999999998 999999999999999 89999999999876544321 123345
Q ss_pred cccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHH
Q 041043 547 GTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEE 625 (678)
Q Consensus 547 gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (678)
+...|++||.+... ..+.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78889999999887 788999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 626 IMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 626 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 468899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=241.78 Aligned_cols=132 Identities=27% Similarity=0.407 Sum_probs=111.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-----C---CceeeEEeEEeeC-
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-----H---RNVVKLLGSCLEV- 450 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~~~~- 450 (678)
..+|.+.++||.|.|++||++.. +..+.||+|+.+.... -.+....||++|++++ | ..||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36899999999999999999995 5678999999876432 2366788999999984 2 4799999999754
Q ss_pred ---CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE
Q 041043 451 ---EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 517 (678)
Q Consensus 451 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 517 (678)
.+.++|+|++ +-+|..+|.... -.-++...+.+|++||+.||.|||.+. .|+|-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4789999999 668988887643 235899999999999999999999987 39999999999999
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=251.54 Aligned_cols=205 Identities=27% Similarity=0.385 Sum_probs=172.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.-|..++.||-|+||+|.++... ....+|.|.++..+ +.+...++.|-.||..-..+-||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 44667789999999999999854 45678999776543 455667888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC-
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI- 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~- 536 (678)
||++||++-.+|.+. +.+.+..++.++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-+.-
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999999754 46888899999999999999999999 99999999999999999999999999744310
Q ss_pred -C------cce---------------------------------eeeccccccCccCccccccCCCCcccchhhHHHHHH
Q 041043 537 -D------QTH---------------------------------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLV 576 (678)
Q Consensus 537 -~------~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ 576 (678)
+ ..+ .....+||+.|+|||++....++...|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 000 011245899999999999999999999999999999
Q ss_pred HHHhCCCCCCcccccc
Q 041043 577 ELLTGQKPISYIWANE 592 (678)
Q Consensus 577 elltg~~p~~~~~~~~ 592 (678)
||+.|+.||-...+.+
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999996444433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=254.99 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=207.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
..++|++.+.+|.|.+|.|||++. ..++..|+|.++........-..+|+-+++..+||||+.++|.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 356789999999999999999995 4689999999988777777888899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+.+|+|.+..+.. .++++.++....++.++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+...-
T Consensus 93 ycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999988743 46999999999999999999999999 7899999999999999999999999987655322
Q ss_pred ceeeeccccccCccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 539 THVSTKVQGTFGYLDPEYF---HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
. ......||+.|||||+. ..+.|..++|||++|+...|+---++|.....+. ...+. ..+.+ . +
T Consensus 167 ~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-----r~l~L-mTkS~-----~-q 233 (829)
T KOG0576|consen 167 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-----RALFL-MTKSG-----F-Q 233 (829)
T ss_pred h-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-----HHHHH-hhccC-----C-C
Confidence 2 23445799999999986 3467899999999999999998888885322111 11111 11111 1 1
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......+..+.+.+-+|++.+|..+|++|||++.++.
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1222334667788999999999999999999988754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=226.87 Aligned_cols=198 Identities=38% Similarity=0.574 Sum_probs=172.7
Q ss_pred CCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 384 FNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
|.+.+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999865 889999998765544 67889999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+++|.+++..... .+++..++.++.+++.+|.+||..+ ++|+||+|.||+++.++.++|+|||.+..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999975432 1789999999999999999999998 9999999999999999999999999988765443112
Q ss_pred eeccccccCccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 041043 542 STKVQGTFGYLDPEYF-HSSQFTDKSDVYSFGVVLVELLTGQKPIS 586 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~-~~~~~s~ksDVwslGvll~elltg~~p~~ 586 (678)
.....++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2334577889999998 66678889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=245.36 Aligned_cols=196 Identities=23% Similarity=0.360 Sum_probs=166.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCC---CCceeeEEeEEee
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD--------ESKLEEFINEVVILSQIS---HRNVVKLLGSCLE 449 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 449 (678)
..|...+.||+|+||.|+++.++. ...|+||.+.... ....-.+..||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357888999999999999999764 5678888654311 111123556999999997 9999999999999
Q ss_pred CCcceEEEEec-cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 450 VEVPLLVYEFI-PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 450 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
.+.+||++|.. ++-+|.++|..+. .+++.++..|++||+.|+++||+.+ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 5669999998643 5999999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCC
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPIS 586 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwslGvll~elltg~~p~~ 586 (678)
|.+...... ......||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765432 33456799999999999998874 46799999999999999998874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=228.11 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=192.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC------
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV------ 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 450 (678)
...+|.-.+.+|.|.- .|-.+.. -.++.||+|+... .+....++..+|...+..++|+||++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456666777888877 4554443 2478999997542 3455567788999999999999999999998744
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
...++|||+|. .+|...++ ..++-+.+..|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 35689999995 58888886 24788899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH--------
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE-------- 602 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~-------- 602 (678)
++....+ ...+....+..|.|||++.+-.+.+..||||+||++.||++|+.-|.+.. .+.+|..-
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 9865433 45667788999999999998889999999999999999999998875221 12222211
Q ss_pred -------------HHhhcc------chhhc-chhhh--cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 603 -------------CVEENC------LFDIL-DDQVR--KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 603 -------------~~~~~~------~~~~~-~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+... ..+.+ |...+ .+.+.-....+++++.+||..||++|.+++++|+.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111000 00000 00000 01111233467899999999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=235.14 Aligned_cols=265 Identities=20% Similarity=0.247 Sum_probs=203.0
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC------CCceeeEEeEEeeC
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS------HRNVVKLLGSCLEV 450 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~~~~~~~ 450 (678)
+..-.+|.+....|+|-|++|.+|... -|..||||++.+.. .-.+.=+.|+++|++|+ .-|.++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 445678888889999999999999954 47899999998643 23345568999999995 35899999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeecc
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFG 529 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfg 529 (678)
++++||+|-+ ..+|.+.|+....+..|....+..++.|+..||..|...+ |+|.||||.|||+.+. ..+||+|||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999988 5699999998877778999999999999999999999999 9999999999999865 568999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh----
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---- 605 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 605 (678)
.|....... .+.+..+.-|.|||++.+-.|+...|+||.||.||||.||+.-|++...+. +..++.++..
T Consensus 583 SA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~---MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 583 SASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ---MLRLFMELKGKFPN 656 (752)
T ss_pred ccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH---HHHHHHHhcCCCcH
Confidence 987654322 222334556999999999999999999999999999999999987543321 1111111100
Q ss_pred ----hc---------------------------cchhhcch------hh-----hcCCCHHHHHHHHHHHHHhcccCCCC
Q 041043 606 ----EN---------------------------CLFDILDD------QV-----RKSGKTEEIMEVSDVAKRCLNSNGRS 643 (678)
Q Consensus 606 ----~~---------------------------~~~~~~~~------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~ 643 (678)
.+ .+...+.+ .+ ...........|.+|+..||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 00 00000000 00 11112344568899999999999999
Q ss_pred CCCHHHHHHH
Q 041043 644 RPTMKEVAME 653 (678)
Q Consensus 644 RPt~~evl~~ 653 (678)
|.|..|+|..
T Consensus 737 Rit~nqAL~H 746 (752)
T KOG0670|consen 737 RITVNQALKH 746 (752)
T ss_pred cCCHHHHhcC
Confidence 9999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=213.37 Aligned_cols=253 Identities=19% Similarity=0.301 Sum_probs=186.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeE-EeeCCcceEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGS-CLEVEVPLLVY 457 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~~~~~~lv~ 457 (678)
.+.|.+.+.||+|.||.+-++.++. .+.+++|-+.. ......+|.+|...--.|. |.||+..+++ +...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4678999999999999999999764 57788887653 3445678999988776664 8999998875 45667788999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC--CCCcEEEeeccCccccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKYRAKIADFGTSRSIA 535 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgl~~~~~ 535 (678)
||++.|+|.+-+... .+-+....+++.|+++||.|||+++ +||||||.+||||- +..++||+|||+.+...
T Consensus 102 E~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999888643 4778888899999999999999999 99999999999994 44589999999987543
Q ss_pred CCcceeeeccccccCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSS-----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
.. ......+..|.+||..... .....+|||.||++++..+||+.|++..+..+ +....|.. +.. +...
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~-w~~-rk~~ 247 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQ-WLK-RKNP 247 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHH-Hhc-ccCc
Confidence 21 1223346679999986542 24567899999999999999999997333222 22222221 111 1111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
. +... -...++.+.++.++-|..+|++|=-..++.++-
T Consensus 248 ~-~P~~-----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 A-LPKK-----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred c-Cchh-----hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1 1011 123345678899999999999996666665553
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=263.24 Aligned_cols=196 Identities=22% Similarity=0.236 Sum_probs=139.5
Q ss_pred cCCC-CceeeEEeEE-------eeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 041043 434 QISH-RNVVKLLGSC-------LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505 (678)
Q Consensus 434 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 505 (678)
.++| +||+++++++ ......++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 5788888876 2334567888987 56999999753 345999999999999999999999999 9
Q ss_pred EeecCCCCceEECCC-------------------CcEEEeeccCcccccCCc---------------ceeeeccccccCc
Q 041043 506 YHRDIKSTNILLDEK-------------------YRAKIADFGTSRSIAIDQ---------------THVSTKVQGTFGY 551 (678)
Q Consensus 506 vH~Dlk~~NILl~~~-------------------~~~kl~Dfgl~~~~~~~~---------------~~~~~~~~gt~~y 551 (678)
+||||||+||||+.. +.+|++|||+++...... ........+|+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 455666666665321100 0001123578889
Q ss_pred cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHH
Q 041043 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSD 631 (678)
Q Consensus 552 ~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 631 (678)
||||++.+..++.++|||||||+||||++|..|+... ...+..... ....+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~--------~~~~~~~~~-----~~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK--------SRTMSSLRH-----RVLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH--------HHHHHHHHH-----hhcChh-----hhhcCHHHHH
Confidence 9999999999999999999999999999998876311 001111100 001111 1112334668
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 041043 632 VAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 632 li~~cl~~dP~~RPt~~evl~~ 653 (678)
++.+||+.+|.+||++.|+++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=223.17 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=195.6
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCc
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEV 452 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~ 452 (678)
....+.|..+++||+|.|++||++... ..+.||+|.+...+. ...+.+|+++|..+. +.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344567889999999999999999953 367899998865443 356889999999996 9999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeeccCc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTS 531 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~ 531 (678)
..+|+||++.....+++.. ++..++..+++.++.||+++|..| ||||||||+|+|.+. .+.-.|.|||++
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999998863 678899999999999999999999 999999999999984 467889999998
Q ss_pred ccccCC-------------------------------------------cceeeeccccccCccCcccccc-CCCCcccc
Q 041043 532 RSIAID-------------------------------------------QTHVSTKVQGTFGYLDPEYFHS-SQFTDKSD 567 (678)
Q Consensus 532 ~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksD 567 (678)
...... .........||++|.|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 621000 0001123469999999999865 56788999
Q ss_pred hhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH---------Hhhcc--------chhh---------cc-hhhhc-
Q 041043 568 VYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC---------VEENC--------LFDI---------LD-DQVRK- 619 (678)
Q Consensus 568 VwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~~~--------~~~~---------~~-~~~~~- 619 (678)
|||-|||++-+++++.||..... +...+.+...-. .-.+. +..+ ++ .....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999853221 111111111100 00000 0000 00 00000
Q ss_pred --------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 --------SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 --------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......+..+.+|+.+|++.||.+|.|++|.|+.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0111122378899999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=207.28 Aligned_cols=170 Identities=22% Similarity=0.212 Sum_probs=127.8
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
|+|.++++.. ...+++.+++.++.|++.||+|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999753 335999999999999999999999865 999999999999999 99987654322
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (678)
..+++.|+|||++.+..++.++||||||+++|||++|+.||... .................. .. .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~-----~~~~~~~~~~~~~~~~~~---~~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE-----RELSAILEILLNGMPADD---PR-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc-----chhcHHHHHHHHHhccCC---cc-ccccH
Confidence 25889999999999999999999999999999999999998521 111111111111100000 00 00011
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 623 TEEIM--EVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 623 ~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..... ++.+++.+||..+|++||++.|+++.+..+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 22223 699999999999999999999999999877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=211.18 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=197.1
Q ss_pred CcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 385 NVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
.+.-+|.+...|+.|+|+++.+ .++.|++.. ......++|.+|.-.|+.+.||||+.++|.|.....+.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 4455788999999999999844 455565543 2333446789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEe--eccCcccccCCcce
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA--DFGTSRSIAIDQTH 540 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~--Dfgl~~~~~~~~~~ 540 (678)
|+|+..|++.. ....+..++.+++.++|+|++|||+.... |..--|.++.|++|++.+++|+ |--++.
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee--------
Confidence 99999999764 34578889999999999999999998842 4455799999999999998875 322221
Q ss_pred eeeccccccCccCccccccCCC---CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQF---TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
......-.|.||+||.+...+. -.++|+|||+++||||.|...||....+.+ .-+.+.-..+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------------cgmkialegl 406 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------------CGMKIALEGL 406 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------------hhhhhhhccc
Confidence 1111234688999999977543 347899999999999999999996443322 1233444566
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
+...++..+..+..|+.-|+..||.+||.+..++-.||+++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 67778888899999999999999999999999999999875
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=187.68 Aligned_cols=99 Identities=43% Similarity=0.849 Sum_probs=83.5
Q ss_pred CCCCCCCCCCCcccccCCCCCCCCCCCCCCeeecCCC----CccccccCceEEEEecccccceeeccceecccCCCccce
Q 041043 33 KPNCPYSCGNNVTIPFPFGIGENCYFDKLYAIDCKSS----KPILRSINLEVLEFLLEKSTMRVNQSVISSCQDKTTEAS 108 (678)
Q Consensus 33 ~~~C~~~CG~~v~I~yPFgi~~~C~~~~~f~l~C~~~----~~~l~~~~~~v~~i~~~~~~~~v~~~~~~~c~~~~~~~~ 108 (678)
+++||++||| |+||||||||++|++.++|+|+|+++ ++++.+++|+|++|++++++++|.+++.+.|........
T Consensus 1 ~~~C~~~CGn-v~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~~~~~ 79 (106)
T PF13947_consen 1 KPGCPSSCGN-VSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSSSSNS 79 (106)
T ss_pred CCCCCCccCC-EeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCCCCcc
Confidence 5789999996 99999999999999955999999876 455667899999999999999999999988876554332
Q ss_pred ---eecccCcceEEeecCcEEEEEcccc
Q 041043 109 ---FVNLEKLPFYFSYYDNIFSGIGCNN 133 (678)
Q Consensus 109 ---~~~~~~~pf~~s~~~n~~~~~gC~~ 133 (678)
.+++.. ||.+|+++|.|+++||++
T Consensus 80 ~~~~~~~~~-~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 80 SNSNLSLNG-PFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred cccEEeecC-CceEccCCcEEEEECCCC
Confidence 233444 899999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=212.34 Aligned_cols=167 Identities=19% Similarity=0.138 Sum_probs=130.5
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc--CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA--DGRIIAVKKSKVV-----DESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
....++|.+.+.||+|+||+||+|..+ +++.+|||+.... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 445678999999999999999999864 5778899986432 22345679999999999999999853322 2
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCceEECCCCcEEEeecc
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDI-KSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfg 529 (678)
+..++||||+++++|.. +.. .. ...++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 46799999999999963 211 11 1467889999999999999 999999 9999999999999999999
Q ss_pred CcccccCCccee-------eeccccccCccCccccccC
Q 041043 530 TSRSIAIDQTHV-------STKVQGTFGYLDPEYFHSS 560 (678)
Q Consensus 530 l~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 560 (678)
+++.+....... .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998765432111 1345678889999998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-21 Score=200.31 Aligned_cols=262 Identities=21% Similarity=0.223 Sum_probs=195.9
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcCC--cEEEEEEcccCChhhHHHHHHHHHHHhcCCC----CceeeEEeEE-eeCCcceE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLADG--RIIAVKKSKVVDESKLEEFINEVVILSQISH----RNVVKLLGSC-LEVEVPLL 455 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~~~~l 455 (678)
+|.+.++||+|+||.||++...+. ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997553 4788887655433332377888899888873 6888888888 46778899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-----CcEEEeeccC
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-----YRAKIADFGT 530 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~Dfgl 530 (678)
||+.. +.+|.++..... ...++...++.|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 779999876554 567999999999999999999999999 9999999999999865 4699999999
Q ss_pred cc--cccCCcce------e-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 041043 531 SR--SIAIDQTH------V-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 531 ~~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~ 601 (678)
++ ........ . .....||..|.+++...+.+.+.+.|+||++.++.|++.|..|+........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 33222211 1 2234599999999999999999999999999999999999999853321111 11111
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.......... .....+.++.++...+-..+...+|....+...|+......
T Consensus 251 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111110100 11122334556666666689999999999999998887554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-20 Score=192.40 Aligned_cols=261 Identities=29% Similarity=0.396 Sum_probs=197.3
Q ss_pred CCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChh---hHHHHHHHHHHHhcCCCC-ceeeEEeEEeeCCcceEEEEe
Q 041043 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES---KLEEFINEVVILSQISHR-NVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 459 (678)
|.+.+.||.|+|+.||++... ..+++|.+...... ..+.+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567789999999999999976 78888887653322 467899999999999988 799999999777778999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~~~~~ 538 (678)
+.++++.+++........+.......+..|++.++.|+|+.+ ++|||+||+||+++... .+++.|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977764321125889999999999999999999999 99999999999999998 79999999997554433
Q ss_pred ce-----eeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 539 TH-----VSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 539 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
.. ......++..|++||.+.. ...+...|+|++|++++++++|..||...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 22 2355679999999999987 57888999999999999999999996432211 0011111111111100
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.................+.+++..++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223578899999999999999999987765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=176.29 Aligned_cols=262 Identities=18% Similarity=0.230 Sum_probs=198.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCC-CceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 457 (678)
...+|.++++||.|+||.+|.|. ..+|+.||||.-+.... .-++.-|.++.+.|++ ..|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45689999999999999999999 56899999997654322 2356778899999975 67777788888888899999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC---CcEEEeeccCcccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTSRSI 534 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgl~~~~ 534 (678)
|.. +-+|++.+.--. ..++.++++.++-|++.-++|+|.++ .+||||||+|+|..-+ ..+.++|||+++..
T Consensus 91 dLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 668888876432 35888999999999999999999999 9999999999999744 46899999999876
Q ss_pred cCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 535 AIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 535 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
....+. ......||.+|.+-....+.+.+.+-|+=|+|.+|..+.-|..||++..+....+..+...+..-.-.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 543322 23456799999998888887888999999999999999999999987765554433333222211111
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
+ ..+- ...+.++.-.+.-|-..--++-|...-+-+.+.-|.
T Consensus 245 i-----e~LC----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 245 I-----EVLC----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred H-----HHHh----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1 1111 223346677777787777777787776666555444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-20 Score=179.97 Aligned_cols=262 Identities=16% Similarity=0.210 Sum_probs=199.6
Q ss_pred hccCCCcCCeeeeeCCcEEEEEE-EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 457 (678)
..-.|.+.++||+|.||.++.|+ +-+++.||||.-...+ +.-++..|....+.|. .++|...+-+-.+..+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 35579999999999999999999 4579999999754322 2346778888888885 689998888888888889999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-----CcEEEeeccCcc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-----YRAKIADFGTSR 532 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~Dfgl~~ 532 (678)
|.+ +-+|+|+..-- ...++.+.+..+|.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+++
T Consensus 104 dLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 998 66888877532 236899999999999999999999999 9999999999999643 358999999999
Q ss_pred cccCCccee------eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 533 SIAIDQTHV------STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 533 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
......+.. .....||.+||+-....+.+.+.+-|+=|||-++++++-|..||.++.....+.-.+.+.+....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 877655432 34456999999999999999999999999999999999999999877554433333222211111
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
..+..+ ....++++..-++-.-..+-.+-|..+-+...+..+.
T Consensus 258 T~i~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 258 TPIEVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred CCHHHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 111111 1223446666666666667777788877777766665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=214.86 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=183.4
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc-CChhhHHHHHHHHHH--HhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV-VDESKLEEFINEVVI--LSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++...+.||.+.|=+|.+++.+.|. |+||.+-. .+.-..+.|.++++- ...++|||.+++.-+.......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999998887 88887543 334445555554443 4556899999999888788888999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC--C
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI--D 537 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~--~ 537 (678)
..+ +|+|.|.. +.-+...+...|+.|++.||...|..+ |+|||||.+||||+.-.-+.|+||..-+...- +
T Consensus 103 vkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 965 89998863 334677788889999999999999999 99999999999999999999999987655432 2
Q ss_pred c----ceeeeccccccCccCccccccC-----------CCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 041043 538 Q----THVSTKVQGTFGYLDPEYFHSS-----------QFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 538 ~----~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 601 (678)
+ ............|+|||.+... ..+.+.||||+||+++||++ |+++|. +.+.+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHh
Confidence 2 1223333456689999987441 15678999999999999999 677773 222221
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
-..... ...+..+..- +...++.++..|++.||++|.++++.|+.-..+
T Consensus 247 Yr~~~~---~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 YRSGNA---DDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HhccCc---cCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111100 0000111100 112578999999999999999999999884433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=216.46 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=190.2
Q ss_pred CcCCeeeeeCCcEEEEEEEc-CCcEEEEEEc-----ccCChhhH-HHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 385 NVNRILGQGGQGTVYKGMLA-DGRIIAVKKS-----KVVDESKL-EEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~-----~~~~~~~~-~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
...+++|.|++|.|+..... ..+..+.|.. ........ ..+..|+.+-..++|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45689999999987777643 3333344332 11122222 22667888888899999988888777766666669
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++ +|..++.+. ..+...++-.++.|+..|++|||+.+ |.|||+|++|++++.++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999999753 35888899999999999999999999 999999999999999999999999999877654
Q ss_pred cc---eeeeccccccCccCccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 538 QT---HVSTKVQGTFGYLDPEYFHSSQFTD-KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 538 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
.. .......|...|+|||++...+|.. ..||||.|+++..|.+|+.||......+... ....... ...+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~-~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSD-QRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccc-ccccc
Confidence 43 3456677999999999999998877 5799999999999999999986332222211 0000000 00000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
.. ........+.+.+.++.+||+.+|.+|.|+++|++. ++.+..
T Consensus 548 ~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 548 EG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred cC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00 011123445577899999999999999999999875 444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=193.55 Aligned_cols=234 Identities=23% Similarity=0.425 Sum_probs=172.1
Q ss_pred HhcCCCCceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeecC
Q 041043 432 LSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI-YHRDI 510 (678)
Q Consensus 432 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~Dl 510 (678)
|+.+.|.|+.+++|.+.+....+.|.+|+..|+|.+.+.. ....+++.-...++++|+.||+|||... | +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578999999999999999999999999999999999986 3456899999999999999999999876 4 99999
Q ss_pred CCCceEECCCCcEEEeeccCcccccC-CcceeeeccccccCccCccccccCC-------CCcccchhhHHHHHHHHHhCC
Q 041043 511 KSTNILLDEKYRAKIADFGTSRSIAI-DQTHVSTKVQGTFGYLDPEYFHSSQ-------FTDKSDVYSFGVVLVELLTGQ 582 (678)
Q Consensus 511 k~~NILl~~~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~ksDVwslGvll~elltg~ 582 (678)
+++|.++|..+.+||+|||+...... ..........-...|.|||.+.... .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876542 1111112222455799999987641 466899999999999999999
Q ss_pred CCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 583 KPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 583 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
.||......... .+.+..... ......-+.+... .+..+++..++.+||..+|.+||++++|-..++.+.....
T Consensus 156 ~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred CccccccccCCh--HHHHHHHHh--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 999643222221 222222211 0111111111111 1344479999999999999999999999999999887643
Q ss_pred C--CCCchHHHHHhhh
Q 041043 663 Q--DDDDNIQKCYEEL 676 (678)
Q Consensus 663 ~--~~~~~~~~~~~~~ 676 (678)
. .--|+...-+++|
T Consensus 230 ~~~nl~D~m~~~le~Y 245 (484)
T KOG1023|consen 230 SKGNLMDSLFRMLESY 245 (484)
T ss_pred ccchhHHHHHHHHHHH
Confidence 1 2224444444444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-20 Score=179.00 Aligned_cols=173 Identities=13% Similarity=0.132 Sum_probs=133.4
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhh---HHH------HHHHHHHHhcCCCCceeeEEeEEee
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK---LEE------FINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
...++|...++||.|+||.||+... ++..+|||.+....... .+. +.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3578999999999999999999665 57789999886432222 222 5789999999999999999988664
Q ss_pred C--------CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC
Q 041043 450 V--------EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521 (678)
Q Consensus 450 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 521 (678)
. ...+++|||++|.+|.++.. +++ ....+++.+|..+|..+ ++|||++|+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999988742 232 24569999999999999 99999999999999988
Q ss_pred cEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh
Q 041043 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt 580 (678)
++|+|||.......+... ..+.....+..++|+|+||+.+..+..
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999987644211111 013334456679999999998876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=174.73 Aligned_cols=139 Identities=19% Similarity=0.159 Sum_probs=108.1
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChh--h-------H-----------------HHHHHHHHHHhcCCCCce
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES--K-------L-----------------EEFINEVVILSQISHRNV 440 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~h~ni 440 (678)
...||+|+||.||+|...+|+.||||+++..... . . .....|++.++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999987643211 0 0 122349999999988776
Q ss_pred eeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecCCCCceEECC
Q 041043 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL-HSSAYLPIYHRDIKSTNILLDE 519 (678)
Q Consensus 441 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlk~~NILl~~ 519 (678)
....... ....++||||++++++...+.. ...+++.+++.++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 2234899999998877654322 23588999999999999999999 6888 99999999999998
Q ss_pred CCcEEEeeccCcccc
Q 041043 520 KYRAKIADFGTSRSI 534 (678)
Q Consensus 520 ~~~~kl~Dfgl~~~~ 534 (678)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=167.12 Aligned_cols=139 Identities=24% Similarity=0.238 Sum_probs=110.6
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChh--------------------------hHHHHHHHHHHHhcCCCCce
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES--------------------------KLEEFINEVVILSQISHRNV 440 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~h~ni 440 (678)
...||+|++|.||+|...+|+.||||..+..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999987643210 01223578999999999987
Q ss_pred eeEEeEEeeCCcceEEEEeccCCChhhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEEC
Q 041043 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQY-LHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLD 518 (678)
Q Consensus 441 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~ 518 (678)
.....+... ..++||||++++++... +. ...++..+...++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 555444333 34899999998855433 32 2357888999999999999999999 88 99999999999999
Q ss_pred CCCcEEEeeccCccccc
Q 041043 519 EKYRAKIADFGTSRSIA 535 (678)
Q Consensus 519 ~~~~~kl~Dfgl~~~~~ 535 (678)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=172.51 Aligned_cols=232 Identities=20% Similarity=0.267 Sum_probs=149.3
Q ss_pred CCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEccc---CChhhHHHHHHHHHHHhcCCC----------CceeeEEeEEe-
Q 041043 384 FNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKV---VDESKLEEFINEVVILSQISH----------RNVVKLLGSCL- 448 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h----------~niv~l~~~~~- 448 (678)
+...+.||.|+++.||.++... ++.+|+|.... ......+++++|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4556899999999999999764 89999997543 223456778887766655432 22333233222
Q ss_pred --------eC---C-----cceEEEEeccCCChhhhhcC---CCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 041043 449 --------EV---E-----VPLLVYEFIPNGTLFQYLHD---PSE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508 (678)
Q Consensus 449 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 508 (678)
.. . ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 235677777 5688887642 111 123445566778899999999999999 9999
Q ss_pred cCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCcccccc--------CCCCcccchhhHHHHHHHHHh
Q 041043 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS--------SQFTDKSDVYSFGVVLVELLT 580 (678)
Q Consensus 509 Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwslGvll~ellt 580 (678)
||+|+|+|++.+|.++|+||+....... . ......+..|.+||.... -.++.+.|.|+||+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987654322 1 111345678999997643 247889999999999999999
Q ss_pred CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCC
Q 041043 581 GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR 644 (678)
Q Consensus 581 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 644 (678)
+..||........... .-..-. +.++.+++||..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999964432221111 111223 777889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=192.16 Aligned_cols=225 Identities=27% Similarity=0.311 Sum_probs=178.8
Q ss_pred eeeeeCCcEEEEEE----EcCCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEecc
Q 041043 389 ILGQGGQGTVYKGM----LADGRIIAVKKSKVVDE--SKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
.+|+|.||.|++.. .+.|..+|.|.++.... ........|-.++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998765 23466777776543211 11125566788888887 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|.|...+... ...++.........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-..+..
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99999888643 35777888888999999999999999 999999999999999999999999999865443322
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (678)
.||..|||||++. ....++|.||||++++||+||..||.. +....+.. .....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~-----------~~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK-----------AELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh-----------hccCC
Confidence 7899999999998 467899999999999999999999852 11111111 11233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 622 KTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 622 ~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
+.+.+....+++.+++..+|.+|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 56777788999999999999999655
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.9e-19 Score=198.41 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=188.8
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC---CCceeeEEeEEeeCC
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS---HRNVVKLLGSCLEVE 451 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~ 451 (678)
.+.+.-.+.|.+.+.||+|+||+||+|...+|+.||+|.-+..... +|.--.+++.+|+ -+.|..+..++.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 4455567789999999999999999999888999999987654332 3333344455555 345555566666677
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-------CCCcEE
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-------EKYRAK 524 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-------~~~~~k 524 (678)
..+||+||.+.|+|.+++. ....++|..+..++.|++..+++||..+ |||+||||+|.||. +...++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 8899999999999999998 3456999999999999999999999999 99999999999994 344689
Q ss_pred EeeccCcccccCC-cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 041043 525 IADFGTSRSIAID-QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 525 l~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
|+|||.+..+..- +.......++|..+--+|...+..++++.|.|.|+.+++-|+.|+.-= .
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~ 904 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------V 904 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------h
Confidence 9999999776432 223456677899999999999999999999999999999999998531 0
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
.....+. ++..++. .-..+..-+++..+|..|-..=|...++...|+.+..++.
T Consensus 905 ~~g~~~~--~~~~~~R---y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 905 KNGSSWM--VKTNFPR---YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred cCCccee--ccccchh---hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 0110000 0111110 0111233466777777444444777777777777766543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-18 Score=161.23 Aligned_cols=184 Identities=16% Similarity=0.070 Sum_probs=138.3
Q ss_pred CcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChh----hHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEe
Q 041043 385 NVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES----KLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.+...|++|+||+||.+.. ++.+++.+.+.....- ....+.+|+++|++|. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997765 6778887777654331 1235789999999995 5889999886 446999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCceEECCCCcEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDI-KSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
+++.+|...+.. ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654321 12357889999999999999 999999 7999999999999999999998544322
Q ss_pred ce----e--------eeccccccCccCccccccC-CCC-cccchhhHHHHHHHHHhCCCCCC
Q 041043 539 TH----V--------STKVQGTFGYLDPEYFHSS-QFT-DKSDVYSFGVVLVELLTGQKPIS 586 (678)
Q Consensus 539 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwslGvll~elltg~~p~~ 586 (678)
.. . ......++.+++|+...-- ..+ ...+.++-|.-+|.++|+..+.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 1112257778888764332 233 46688899999999999998863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=159.76 Aligned_cols=136 Identities=16% Similarity=0.191 Sum_probs=106.4
Q ss_pred CcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-----CCCceeeEEeEEeeCC---c-ceE
Q 041043 385 NVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-----SHRNVVKLLGSCLEVE---V-PLL 455 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 455 (678)
.-.+.||+|+||.||. ...++.. +||+.........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457999999999996 3233444 68887665455567899999999999 5799999999998864 2 337
Q ss_pred EEEe--ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeecCCCCceEECC----CCcEEEeec
Q 041043 456 VYEF--IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL-AYLHSSAYLPIYHRDIKSTNILLDE----KYRAKIADF 528 (678)
Q Consensus 456 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Df 528 (678)
|+|| ..+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999652 25555 35677888777 9999999 999999999999974 347999995
Q ss_pred cCc
Q 041043 529 GTS 531 (678)
Q Consensus 529 gl~ 531 (678)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.7e-17 Score=161.35 Aligned_cols=217 Identities=20% Similarity=0.231 Sum_probs=148.9
Q ss_pred CCCceeeEEeEEeeC---------------------------CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 041043 436 SHRNVVKLLGSCLEV---------------------------EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488 (678)
Q Consensus 436 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 488 (678)
+|||||++.++|.++ ...|+||...+. +|..|+... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 599999998877541 235788887744 898988643 467778888999
Q ss_pred HHHHHHHHHHhCCCCCeEeecCCCCceEE--CCCC--cEEEeeccCcccccC-----CcceeeeccccccCccCcccccc
Q 041043 489 EVAEALAYLHSSAYLPIYHRDIKSTNILL--DEKY--RAKIADFGTSRSIAI-----DQTHVSTKVQGTFGYLDPEYFHS 559 (678)
Q Consensus 489 ~ia~~L~yLH~~~~~~ivH~Dlk~~NILl--~~~~--~~kl~Dfgl~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~ 559 (678)
|+++|+.|||.++ |.|||+|++|||| |+|. ...|+|||.+-.-.. +.........|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 3443 578999998643211 11122233457888999998754
Q ss_pred CC------CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHH
Q 041043 560 SQ------FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVA 633 (678)
Q Consensus 560 ~~------~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 633 (678)
.. ...|+|.|+.|.+.||+++...||.... +...+. . ...+.++ ...+...+..+++|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG----em~L~~-------r---~Yqe~qL-Palp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG----EMLLDT-------R---TYQESQL-PALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc----hheech-------h---hhhhhhC-CCCcccCChHHHHHH
Confidence 22 2459999999999999999999996421 111100 0 0001111 122445667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHH--------HHHHhccCCCCCchHHHHHhhh
Q 041043 634 KRCLNSNGRSRPTMKEVAMEL--------ERIRACNLQDDDDNIQKCYEEL 676 (678)
Q Consensus 634 ~~cl~~dP~~RPt~~evl~~L--------~~l~~~~~~~~~~~~~~~~~~~ 676 (678)
...|+.||++|++..-....| +.+++. +..-.+.+.+|+-+.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~-~~~~~~~~~~wLL~~ 540 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAM-MEKCGISQMTWLLAG 540 (598)
T ss_pred HHHhcCCccccCCccHHHhHHHHHHhcCchHHHHh-cccccHHHHHHHHHh
Confidence 999999999999987666665 233333 233345555665443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-17 Score=174.84 Aligned_cols=174 Identities=25% Similarity=0.408 Sum_probs=132.6
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
.+++.|++++..+|.+||.+.......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876666678899999999999999999 66 899999999999999999999999998
Q ss_pred ccccCCc-----ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHh
Q 041043 532 RSIAIDQ-----THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 532 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
....... ....+...||..||+||.+.+..|+.|+||||||+||+|++. -.-++... .....+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence 7665444 234556679999999999999999999999999999999998 22222100 0001111
Q ss_pred hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 041043 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 650 (678)
.+ .+.+.....++ .=..|+.+++.+.|.+||++.++
T Consensus 474 ~g----~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DG----IIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cC----CCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 11 11111111112 23489999999999999954443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-16 Score=154.24 Aligned_cols=134 Identities=21% Similarity=0.299 Sum_probs=113.3
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh--------hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDE--------SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
+.||+|++|.||+|.. +|..+++|+...... .....+.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577888887543211 1224578899999999999998888887778888999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998642 12 78899999999999999999 99999999999999 78999999998853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=155.39 Aligned_cols=148 Identities=20% Similarity=0.169 Sum_probs=113.3
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEE--EcCCcEEEEEEcccCChh------------------------hHHHHHHHHH
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGM--LADGRIIAVKKSKVVDES------------------------KLEEFINEVV 430 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~ 430 (678)
+.+-...|.+.+.||+|++|.||+|. ..+|+.||+|..+..... ....+..|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33334458889999999999999998 568999999987643210 1123568999
Q ss_pred HHhcCCCC--ceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 041043 431 ILSQISHR--NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508 (678)
Q Consensus 431 ~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 508 (678)
.++++.+. .+.++++. ...++||||+++++|...... ...+...+...++.|++.+|++||+.+ .++|+
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 99999753 33444432 235899999999888766532 223566677899999999999999987 39999
Q ss_pred cCCCCceEECCCCcEEEeeccCcccc
Q 041043 509 DIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 509 Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
||||+||+++ ++.++|+|||.+...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999988643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.5e-16 Score=149.63 Aligned_cols=139 Identities=21% Similarity=0.223 Sum_probs=109.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh----------------------hhHHHHHHHHHHHhcCCCC
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE----------------------SKLEEFINEVVILSQISHR 438 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~h~ 438 (678)
...|.+.+.||+|+||.||++..++|+.||||+...... .....+..|+.++..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 334777899999999999999988899999997543210 0112356788999998877
Q ss_pred c--eeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceE
Q 041043 439 N--VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 516 (678)
Q Consensus 439 n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 516 (678)
+ +...++ ....+++|||+++++|...... .....++.+++.++.++|..+ ++|+||+|+||+
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil 157 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL 157 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence 4 444443 3456899999999998765431 235678899999999999988 999999999999
Q ss_pred ECCCCcEEEeeccCccccc
Q 041043 517 LDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 517 l~~~~~~kl~Dfgl~~~~~ 535 (678)
+++++.++|+|||++....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.6e-16 Score=173.14 Aligned_cols=138 Identities=20% Similarity=0.290 Sum_probs=112.5
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc-C------ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV-V------DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~-~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
...|...++||+|+||+||+|.+.+...++.++... . .....+.+.+|+++++.++|++++....+.......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445567899999999999999976544333222221 1 112245688999999999999999888888777788
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 35678999999999999999 9999999999999 677999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.4e-16 Score=175.59 Aligned_cols=208 Identities=27% Similarity=0.392 Sum_probs=144.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+|+.++.|..|++|.||...++. .+.+|+|.-+.. - ++ +||..+- +..++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------l------il-----Rnilt~a------~npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------L------IL-----RNILTFA------GNPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------h------hh-----hcccccc------CCccee---
Confidence 4678899999999999999998763 567777433211 0 11 1122111 122222
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
|+=...++. .++++... +.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 ---gDc~tllk~---~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 333333432 12344333 78999999998 99999999999999999999999999865322111
Q ss_pred ------------e--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 540 ------------H--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 540 ------------~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
+ ....+.||+.|+|||++....|....|.|++|+|+||++.|..||.+. ...+.|...+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd------tpeelfg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD------TPEELFGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC------CHHHHHhhhhh
Confidence 1 123457999999999999999999999999999999999999999633 33334444433
Q ss_pred hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC
Q 041043 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 645 (678)
+... ..+.......+.++++.++|+.+|..|-
T Consensus 273 d~i~--------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIE--------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhcc--------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 2211 1122344556899999999999999994
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=149.02 Aligned_cols=130 Identities=20% Similarity=0.324 Sum_probs=106.6
Q ss_pred eeeeeCCcEEEEEEEcCCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 389 ILGQGGQGTVYKGMLADGRIIAVKKSKVVD--------ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.||+|+||.||+|.+ ++..+++|...... ....+++.+|++++..++|+++.....+....+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999995 57788998754321 112356788999999999887766666666677789999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875321 0 78999999999999999 99999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.8e-16 Score=130.05 Aligned_cols=75 Identities=39% Similarity=0.858 Sum_probs=63.1
Q ss_pred CCCCCCCceeeeccCCC-CcceeEEEEeeccCCCCCCCCccCCCcceEEEeecceeecccchhhhhccCCCccEEEEeee
Q 041043 161 DDSCNGIECCKAGVPWA-LKSFNISIISINNATSSSSSSQEEGKCKYAFMVEKEWFESNFKSARRVQNWNQVPVILDWRI 239 (678)
Q Consensus 161 ~~~C~G~gCC~~~i~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~c~~a~~~~~~~~~~~~~~~~~~~~~~~~p~vLdW~i 239 (678)
+++|+|.||||+.||.+ ++.|.+++...+... ...++|+||||+|+.||.+|..++......+.+||+|+|+|
T Consensus 1 n~~CsG~~CCQt~iP~~~~qv~~~~i~~~~~~~------~~~~~Ck~AFL~d~~~~~~n~t~p~~~~~~~y~pv~L~W~i 74 (103)
T PF08488_consen 1 NSSCSGIGCCQTSIPSGLLQVFNVTIESTDGNN------QTSNGCKVAFLVDEDWFSSNITDPEDFHAMGYVPVVLDWFI 74 (103)
T ss_pred CCccCCcceeccCCCCCCceEEEEEeEecCCCc------ccCCCceEEEEeccccccccCCChHHhccCCeeEEEEEEEE
Confidence 46899999999999997 467898888654322 23478999999999999999999988888899999999999
Q ss_pred cC
Q 041043 240 PN 241 (678)
Q Consensus 240 ~~ 241 (678)
+.
T Consensus 75 ~t 76 (103)
T PF08488_consen 75 DT 76 (103)
T ss_pred ec
Confidence 53
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-14 Score=130.38 Aligned_cols=135 Identities=27% Similarity=0.254 Sum_probs=113.8
Q ss_pred cCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCC--CceeeEEeEEeeCCcceEEEEeccCC
Q 041043 386 VNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISH--RNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 386 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++.+++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899998765433 5678899999999976 58899998888878899999999887
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 5567778899999999999986434499999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.2e-14 Score=137.20 Aligned_cols=136 Identities=26% Similarity=0.309 Sum_probs=98.0
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChh--hHHHH----------------------HHHHHHHhcCCCCc--e
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES--KLEEF----------------------INEVVILSQISHRN--V 440 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~Ei~~l~~l~h~n--i 440 (678)
.+.||+|+||+||+|...+++.||||........ ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999986542211 11111 34566666664432 3
Q ss_pred eeEEeEEeeCCcceEEEEeccCCChhhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEEC
Q 041043 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQY-LHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLD 518 (678)
Q Consensus 441 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~ 518 (678)
.+.++. ...++||||++++.+... +.... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444432 346899999998554321 21110 11 5678899999999999999 87 99999999999999
Q ss_pred CCCcEEEeeccCccccc
Q 041043 519 EKYRAKIADFGTSRSIA 535 (678)
Q Consensus 519 ~~~~~kl~Dfgl~~~~~ 535 (678)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-13 Score=137.46 Aligned_cols=135 Identities=20% Similarity=0.296 Sum_probs=105.1
Q ss_pred CCeee-eeCCcEEEEEEEcCCcEEEEEEcccC-------------ChhhHHHHHHHHHHHhcCCCCce--eeEEeEEeeC
Q 041043 387 NRILG-QGGQGTVYKGMLADGRIIAVKKSKVV-------------DESKLEEFINEVVILSQISHRNV--VKLLGSCLEV 450 (678)
Q Consensus 387 ~~~Lg-~G~~g~Vy~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~ 450 (678)
...|| .|+.|+||+.... +..++||+.... +......+.+|++++.+++|++| ++++++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35787 8999999999875 677888866421 11233567889999999998875 6777765433
Q ss_pred C----cceEEEEeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 451 E----VPLLVYEFIPN-GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 451 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
. ..++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+.+ |+|+||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6898888642 34543 3568999999999999 999999999999999999999
Q ss_pred eeccCccc
Q 041043 526 ADFGTSRS 533 (678)
Q Consensus 526 ~Dfgl~~~ 533 (678)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.7e-15 Score=167.56 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=189.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC--CcEEEEEEcccCC--hhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD--GRIIAVKKSKVVD--ESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 456 (678)
..|.+.+.||+|+|+.|-...... ...+|+|...... ....+....|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999998877533 4456666654432 344455666888888887 99999999999999999999
Q ss_pred EEeccCCChhhhh-cCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeecCCCCceEECCCC-cEEEeeccCccc
Q 041043 457 YEFIPNGTLFQYL-HDPSEELSLTWEMRLRIATEVAEALAYLH-SSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRS 533 (678)
Q Consensus 457 ~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~ 533 (678)
.+|..++++.+.+ +... ...+....-..+.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..|++|||++..
T Consensus 100 ~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999988 4321 13566677789999999999999 777 99999999999999999 999999999987
Q ss_pred ccC-Cc-ceeeecccc-ccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 534 IAI-DQ-THVSTKVQG-TFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 534 ~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
+.. .. ........| ++.|+|||...+. ......|+||.|+++.-+++|..|+........ ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------~~ 240 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------RY 240 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--------------cc
Confidence 766 22 233445567 9999999998874 446688999999999999999999753322221 11
Q ss_pred hhhcchhhh--cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 610 FDILDDQVR--KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 610 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
....+.... ............+++.+++..+|..|.+.+++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 241 SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 111111100 1112233446778899999999999999888754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.6e-14 Score=138.00 Aligned_cols=204 Identities=21% Similarity=0.304 Sum_probs=142.2
Q ss_pred HHHhcCCCCceeeEEeEEeeCC-----cceEEEEeccCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 041043 430 VILSQISHRNVVKLLGSCLEVE-----VPLLVYEFIPNGTLFQYLHDPSE-ELSLTWEMRLRIATEVAEALAYLHSSAYL 503 (678)
Q Consensus 430 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 503 (678)
.-|-++-|.||++++.++.+.. ...++.|||+.|+|..+|++... ...+......+|+.||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455567999999999887643 45789999999999999987432 246788888999999999999999988 7
Q ss_pred CeEeecCCCCceEECCCCcEEEeeccCcccc---cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh
Q 041043 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSI---AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580 (678)
Q Consensus 504 ~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt 580 (678)
||+|+++.-+.|++..++-+|++--.-.... ............+.++|.+||+-...+.+.++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 7999999999999999999998532211100 0001111222346789999998877778889999999999999988
Q ss_pred CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 581 GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 581 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+...-. +..... ..+......+...-+ ..=+.++.+|++.+|..||+|++++..
T Consensus 278 lEiq~t-----nseS~~--~~ee~ia~~i~~len------------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQST-----NSESKV--EVEENIANVIIGLEN------------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccC-----CCccee--ehhhhhhhheeeccC------------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 764311 111000 000000000110000 012468899999999999999998765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-12 Score=139.26 Aligned_cols=145 Identities=20% Similarity=0.235 Sum_probs=102.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhH---------------------------------------
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL--------------------------------------- 422 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 422 (678)
..|+ .+.||.|++|.||+|++++|+.||||+.+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 368999999999999999999999998754321110
Q ss_pred -HHHHHHHHHHhcCC----CCceeeEEeEEe-eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHH
Q 041043 423 -EEFINEVVILSQIS----HRNVVKLLGSCL-EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE-ALA 495 (678)
Q Consensus 423 -~~~~~Ei~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~ 495 (678)
-+|.+|+..+.+++ |.+-+.+-.++. ..+..+|||||+++++|.++...... .. .+..++..++. .+.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLN 271 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHH
Confidence 02445666665552 333333333332 34567999999999999887643211 12 23456666666 478
Q ss_pred HHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 496 yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
.+|..+ ++|+|++|.||+++++++++++|||++..+.
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 889988 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-12 Score=138.70 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=181.7
Q ss_pred cCCCcCCeeee--eCCcEEEEEEE---cCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcc
Q 041043 382 DHFNVNRILGQ--GGQGTVYKGML---ADGRIIAVKKSKV--VDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 382 ~~~~~~~~Lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~ 453 (678)
..+...+.+|. |.+|.+|.+.. .++..+|+|+.+. ........=.+|+.....++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999986 4678999998543 22233333456676666664 99999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeec
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE----ALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADF 528 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Df 528 (678)
++-+|.+. .+|..+.+... ..++...++..+.+..+ ||.++|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999995 68888887532 24677788888888888 999999998 9999999999999999 88999999
Q ss_pred cCcccccCCcce----eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 529 GTSRSIAIDQTH----VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 529 gl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
|+...+...... ......+...|++||...+ .++.++|+|++|.++.+..++...........
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------------ 334 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------------ 334 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------------
Confidence 999877654422 2223367888999999875 57889999999999999999876653110000
Q ss_pred hhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
+.++-...+..++......++..++..|++.+|..|++.+.+..
T Consensus 335 ----W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ----WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11100000111112222335666999999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=126.08 Aligned_cols=167 Identities=20% Similarity=0.207 Sum_probs=129.5
Q ss_pred EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHH
Q 041043 403 LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEM 482 (678)
Q Consensus 403 ~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 482 (678)
..++.+|.|...+..+....+...+-++.|+.+|||||++++.....++..|+|+|.+. .|..++++ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44688888888776666556678889999999999999999999999999999999884 57777764 33566
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCC
Q 041043 483 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF 562 (678)
Q Consensus 483 ~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 562 (678)
+-..+.||+.||.|||+.+. ++|++|....|+|+..|..||++|.++.....-.. ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 67788999999999987663 99999999999999999999999998754432221 111112223466777654332
Q ss_pred CcccchhhHHHHHHHHHhCC
Q 041043 563 TDKSDVYSFGVVLVELLTGQ 582 (678)
Q Consensus 563 s~ksDVwslGvll~elltg~ 582 (678)
-..|.|.||++++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.7e-11 Score=112.42 Aligned_cols=130 Identities=25% Similarity=0.190 Sum_probs=96.2
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCcee-eEEeEEeeCCcceEEEEeccCCCh
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV-KLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
.+.|+.|.++.||++... +..+++|....... ....+..|+++++.+.+.+++ +++.+ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 357888999999999875 77899998754322 223467899999988765554 34433 23446899999999877
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA--YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.+.. . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 1 11245679999999999987 12359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-10 Score=128.00 Aligned_cols=148 Identities=18% Similarity=0.197 Sum_probs=98.1
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChh------------------------------hH----
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES------------------------------KL---- 422 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------------------------------~~---- 422 (678)
+.....|+. +.||.|++|.||+|++++ |+.||||+.+..-.. ..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 334456776 789999999999999987 999999987632110 00
Q ss_pred H------HHHHHHHHHhcCC----CCceeeEEeEEee-CCcceEEEEeccCCChhhhh--cCCC-CCCCCCHHHHHHHHH
Q 041043 423 E------EFINEVVILSQIS----HRNVVKLLGSCLE-VEVPLLVYEFIPNGTLFQYL--HDPS-EELSLTWEMRLRIAT 488 (678)
Q Consensus 423 ~------~~~~Ei~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~ 488 (678)
+ ++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++- .... ....+....+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 1 1344555555442 4444444444443 55778999999999998742 2211 001233333333344
Q ss_pred HHHHHHHHHHhCCCCCeEeecCCCCceEECCCC----cEEEeeccCcccccC
Q 041043 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFGTSRSIAI 536 (678)
Q Consensus 489 ~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgl~~~~~~ 536 (678)
|+ ...+ ++|+|++|.||+++.++ ++++.|||+...+..
T Consensus 275 Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 43 4566 99999999999999888 999999999876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-09 Score=103.56 Aligned_cols=135 Identities=18% Similarity=0.149 Sum_probs=97.9
Q ss_pred CeeeeeCCcEEEEEEEcC-------CcEEEEEEcccC-------------C---------hhhHHHHH----HHHHHHhc
Q 041043 388 RILGQGGQGTVYKGMLAD-------GRIIAVKKSKVV-------------D---------ESKLEEFI----NEVVILSQ 434 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~Ei~~l~~ 434 (678)
..||.|.-+.||.|...+ +..+|||..+.. + ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999954321 0 11122333 79999999
Q ss_pred CCC--CceeeEEeEEeeCCcceEEEEeccCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecC
Q 041043 435 ISH--RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQ-YLHDPSEELSLTWEMRLRIATEVAEALAYL-HSSAYLPIYHRDI 510 (678)
Q Consensus 435 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dl 510 (678)
+.. -++.+++++ ..-++||||+.+..+.. .+++ ..++..+...+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 863 456666654 56689999997653322 2221 2345566778889999999999 8888 999999
Q ss_pred CCCceEECCCCcEEEeeccCcccc
Q 041043 511 KSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 511 k~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
++.|||+++ +.+.|+|||.+...
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeC
Confidence 999999974 68999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.1e-11 Score=126.45 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=185.1
Q ss_pred cccccChHH-HHhhccCCCcCCeeeeeCCcEEEEEEEc--CCcEEEEEEcccCChhhHHH--HHHHHHHHhcC-CCCcee
Q 041043 368 RCKIFNSKE-LDKATDHFNVNRILGQGGQGTVYKGMLA--DGRIIAVKKSKVVDESKLEE--FINEVVILSQI-SHRNVV 441 (678)
Q Consensus 368 ~~~~~~~~~-~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l-~h~niv 441 (678)
..++|..++ ......+|.++..||.|.|+.|++...+ ++..+++|.+...-.....+ -..|+.+...+ .|.+++
T Consensus 250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence 334455555 3345667899999999999999988744 57788988765433222222 24566666666 488888
Q ss_pred eEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-
Q 041043 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK- 520 (678)
Q Consensus 442 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~- 520 (678)
+....+......++--||++++++...+. -...+++..++++..|++.++.++|+.. ++|+|++|+||++..+
T Consensus 330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCCccccccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 88877777777789999999998887772 2346788899999999999999999988 9999999999999886
Q ss_pred CcEEEeeccCcccccCCcceeeeccccccCcc--CccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 041043 521 YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL--DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLAT 598 (678)
Q Consensus 521 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~ 598 (678)
+..+++|||.+..+... ........++. +++......+-.+.|++|||.-+.|.+++..--. .+.+
T Consensus 404 ~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-----~~~~--- 471 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-----SGVQ--- 471 (524)
T ss_pred hhhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCc-----cccc---
Confidence 78899999988642211 11112233333 5666677788899999999999999999875311 1111
Q ss_pred HHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 599 YFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
+..+....+.. .......+..+...++..++..||.+.++....+-.+.
T Consensus 472 ----------~~~i~~~~~p~--~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 472 ----------SLTIRSGDTPN--LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ----------ceeeecccccC--CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 11111111111 12222678889999999999999999988776655543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.5e-09 Score=110.95 Aligned_cols=216 Identities=21% Similarity=0.278 Sum_probs=151.9
Q ss_pred CcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----CCcceEEEEeccC-CChhhh
Q 041043 395 QGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE----VEVPLLVYEFIPN-GTLFQY 468 (678)
Q Consensus 395 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~ 468 (678)
..+.||+.. .||..+++|++..........-..-++.++++.|.|+|++.+++.. +...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899884 5899999999844333333344566889999999999999998873 3467899999875 577765
Q ss_pred hcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 469 LHDPS------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 469 l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
--... ++...++..+|.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43221 2245788999999999999999999999 88899999999999999999999998776554
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
+.. |.+.. -.+-|.=.||.+++.|.||...-- ..........
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~-----~~d~~~~s~~--------------- 487 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSN-----RTDSTQSSHL--------------- 487 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccc-----cccchHHHHH---------------
Confidence 331 11111 236789999999999999965310 0000000000
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
.......+.++++++.-....++++ -++.+++.++
T Consensus 488 --~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 --TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred --HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 1112345556777777777777776 5677776654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=106.74 Aligned_cols=141 Identities=23% Similarity=0.279 Sum_probs=110.1
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh-hhHHHHHHHHHHHhcCCC--CceeeEEeEEeeCC---cceEEEEecc
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDE-SKLEEFINEVVILSQISH--RNVVKLLGSCLEVE---VPLLVYEFIP 461 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 461 (678)
+.|+.|..+.+|++...+|+.+++|....... ....++..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998754332 234578899999999976 34566777766542 5689999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA---------------------------------------- 501 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 501 (678)
+.++.+.+.. ..++..++..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888776532 24677888888899999999998531
Q ss_pred -------------CCCeEeecCCCCceEECC--CCcEEEeeccCcc
Q 041043 502 -------------YLPIYHRDIKSTNILLDE--KYRAKIADFGTSR 532 (678)
Q Consensus 502 -------------~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgl~~ 532 (678)
...++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134799999999999998 6678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-09 Score=99.39 Aligned_cols=131 Identities=24% Similarity=0.316 Sum_probs=102.5
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEE-ccc-C------ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKK-SKV-V------DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~-~~~-~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..+++|+-+.+|.+.+. |..+++|. .+. . ..-..+.-.+|+.++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35788999999999875 43466663 221 1 112234567899999999876776666677788888999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
+++-.|.+++... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999643 2567788888899999999 99999999999998775 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-09 Score=97.96 Aligned_cols=143 Identities=20% Similarity=0.257 Sum_probs=109.0
Q ss_pred cCCeeeeeCCcEEEEEEEcCCcEEEEEEc-cc-------CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 386 VNRILGQGGQGTVYKGMLADGRIIAVKKS-KV-------VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 386 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~-~~-------~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
....|.+|+-+.|+++.++ |+...||.- .. ...-...+.++|+++|.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568999999999999985 777677742 21 11223456788999999988667766666777778889999
Q ss_pred EeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC---cEEEeeccCccc
Q 041043 458 EFIPN-GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRS 533 (678)
Q Consensus 458 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgl~~~ 533 (678)
||+++ .++.+++....... ........++..|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48888887654332 222333788999999999999999 99999999999996544 458999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.9e-10 Score=125.98 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=170.6
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
.....+.+.+.+-+-.|.++.+..+.-. .|...++|.....+ ..+.+....+-.++-..++|-++...--+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3445677888888889999999887633 23333333322211 1122222222222223344555554444445677
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
..|+++|..+++|...|+... ..+..-....+..+.++++|||... +.|+|++|.|+|...+++.+++||+...
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 899999999999999998643 4566666677788899999999986 8999999999999999999999998332
Q ss_pred cccCC------------------------------cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 041043 533 SIAID------------------------------QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582 (678)
Q Consensus 533 ~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~ 582 (678)
....- +........+|+.|.+||...+......+|.|++|+.++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 21100 001122345899999999999999999999999999999999999
Q ss_pred CCCCccccccCCChHHHHHHHHhhccchhhcchhh-hcCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 041043 583 KPISYIWANEGRNLATYFVECVEENCLFDILDDQV-RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648 (678)
Q Consensus 583 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 648 (678)
.||....+ .+.+. .++.... ....+.+...+..+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tp------q~~f~---------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETP------QQIFE---------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcch------hhhhh---------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99852211 11111 1111111 1223455667889999999999999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.8e-08 Score=96.85 Aligned_cols=140 Identities=14% Similarity=0.122 Sum_probs=100.3
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhh-H----------HHHHHHHHHHhcCCCCce--eeEEeEEee-----
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK-L----------EEFINEVVILSQISHRNV--VKLLGSCLE----- 449 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~Ei~~l~~l~h~ni--v~l~~~~~~----- 449 (678)
+.+-+-....|.+..+ +|+.+.||+........ . ..+.+|...+.++...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667666 57789999764332111 1 247789999988854333 344555543
Q ss_pred CCcceEEEEeccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-------CC
Q 041043 450 VEVPLLVYEFIPNG-TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-------KY 521 (678)
Q Consensus 450 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-------~~ 521 (678)
....++|+|++++. +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999876 8999885322 123566778899999999999999999 999999999999975 46
Q ss_pred cEEEeeccCcc
Q 041043 522 RAKIADFGTSR 532 (678)
Q Consensus 522 ~~kl~Dfgl~~ 532 (678)
.+.|+||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.7e-08 Score=90.98 Aligned_cols=125 Identities=26% Similarity=0.292 Sum_probs=82.3
Q ss_pred EEEEEEEcCCcEEEEEEcccCC--------------h------------hhHHHHHHHHHHHhcCCCC--ceeeEEeEEe
Q 041043 397 TVYKGMLADGRIIAVKKSKVVD--------------E------------SKLEEFINEVVILSQISHR--NVVKLLGSCL 448 (678)
Q Consensus 397 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~ 448 (678)
.||.|...+|..+|||..+... . .......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998889999999643210 0 0123457899999999865 45566644
Q ss_pred eCCcceEEEEecc--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 449 EVEVPLLVYEFIP--NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY-LHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 449 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
..-.+||||++ +..+...... .++......++.+++..+.. +|..+ |+|+||++.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 5555443321 12234456677788886665 57888 9999999999999988 9999
Q ss_pred eeccCcccc
Q 041043 526 ADFGTSRSI 534 (678)
Q Consensus 526 ~Dfgl~~~~ 534 (678)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-07 Score=96.17 Aligned_cols=263 Identities=17% Similarity=0.183 Sum_probs=157.4
Q ss_pred CCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeE----Ee--eC-CcceE
Q 041043 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGS----CL--EV-EVPLL 455 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~----~~--~~-~~~~l 455 (678)
....+.||+|+.+.+|..--- +..| -|+...-......+ .++.|... .||-+-.-+.+ .. +. ...-+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchh-hchh-heeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 345788999999999864321 1122 23332222111111 12223222 45433221111 00 11 12346
Q ss_pred EEEeccCCCh-hhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 456 VYEFIPNGTL-FQYLHD---PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 456 v~e~~~~g~L-~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
+|+.+++..- ..++.. ...-....|.-.++.++.+|.+.+.||..| .+-+|+.++|+|+++++.+.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 6777655422 222221 122245789999999999999999999999 788999999999999999999885433
Q ss_pred ccccCCcceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCcccccc--CCChHHHHHHH
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTG-QKPISYIWANE--GRNLATYFVEC 603 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg-~~p~~~~~~~~--~~~~~~~~~~~ 603 (678)
..- .........+|...|.+||... +..-+..+|.|.||+++++++.| +.||++..... ...+...
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~---- 238 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD---- 238 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh----
Confidence 221 2233344556889999999754 33456789999999999999996 89997654321 1111100
Q ss_pred Hhhccchhhcchhh-----hcCCC-HHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHHHhc
Q 041043 604 VEENCLFDILDDQV-----RKSGK-TEEIMEVSDVAKRCLNSN--GRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 604 ~~~~~~~~~~~~~~-----~~~~~-~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~l~~~ 660 (678)
+..+.....-+.+. ....+ .-....+..|..+|+... +.-|||++.++..|..++++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111111111111 11111 233457888888888654 56899999999999888764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.7e-07 Score=90.31 Aligned_cols=134 Identities=22% Similarity=0.234 Sum_probs=97.1
Q ss_pred CCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--------------------C--hhhHHHHHHHHHHHhcCCCC--c
Q 041043 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--------------------D--ESKLEEFINEVVILSQISHR--N 439 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~Ei~~l~~l~h~--n 439 (678)
..+...||.|.-+.||.|..++|.++|||.-+.. + ........+|.++|++|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999942211 0 11123456899999999755 6
Q ss_pred eeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC
Q 041043 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE 519 (678)
Q Consensus 440 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 519 (678)
+.+.+++ +.-.+|||++++-.|...- ++.+..-.++..|+.-+.-+-..| +||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666653 4557999999886554321 223334445555555555555677 999999999999999
Q ss_pred CCcEEEeeccCcc
Q 041043 520 KYRAKIADFGTSR 532 (678)
Q Consensus 520 ~~~~kl~Dfgl~~ 532 (678)
||.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.6e-08 Score=108.45 Aligned_cols=153 Identities=26% Similarity=0.330 Sum_probs=107.4
Q ss_pred HHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee--------eeccccccCccCccccc
Q 041043 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV--------STKVQGTFGYLDPEYFH 558 (678)
Q Consensus 487 ~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 558 (678)
+.+++.||.|+|..- .+||++|.|++|.++.++..||..|+.+.......... ..-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999875 49999999999999999999999999876544321111 11123456799999999
Q ss_pred cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcc
Q 041043 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLN 638 (678)
Q Consensus 559 ~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 638 (678)
....+.++|+||+|+++|.+..|..+... ..+..+...+ ....+..-....+.+.+.++++=+.+++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~---a~~~~~~~~~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA---ANGGLLSYSF---------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhh---ccCCcchhhh---------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 98889999999999999999965554321 1111111111 11111222223345667789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 041043 639 SNGRSRPTMKEVAME 653 (678)
Q Consensus 639 ~dP~~RPt~~evl~~ 653 (678)
.++.-||++.++...
T Consensus 251 ~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSI 265 (700)
T ss_pred CCcccCcchhhhhcc
Confidence 999999988887654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-06 Score=85.69 Aligned_cols=106 Identities=23% Similarity=0.260 Sum_probs=84.4
Q ss_pred HHHHHHHHHHHhcCCC--CceeeEEeEEeeCC----cceEEEEeccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 041043 422 LEEFINEVVILSQISH--RNVVKLLGSCLEVE----VPLLVYEFIPNG-TLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494 (678)
Q Consensus 422 ~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 494 (678)
.....+|...+.++.. -...+++++..... ..++|+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3467788888888753 34556667666533 347999999874 79999875322 56677889999999999
Q ss_pred HHHHhCCCCCeEeecCCCCceEECCCC---cEEEeeccCccc
Q 041043 495 AYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRS 533 (678)
Q Consensus 495 ~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgl~~~ 533 (678)
+-||..+ |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.2e-06 Score=81.12 Aligned_cols=139 Identities=19% Similarity=0.129 Sum_probs=102.5
Q ss_pred eeeeCCcEEEEEEEcCCcEEEEEEcccCC------hhhHHHHHHHHHHHhcCCCC--ceeeEEeEEeeC----CcceEEE
Q 041043 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVD------ESKLEEFINEVVILSQISHR--NVVKLLGSCLEV----EVPLLVY 457 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~----~~~~lv~ 457 (678)
-|+||-+.|++-..+ |+.+-+|+....- +.....|.+|+..|.++... .+.+++..-... ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356888889997765 4578888765211 23457899999999998633 344554222222 2357999
Q ss_pred EeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc--EEEeeccCccc
Q 041043 458 EFIPN-GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--AKIADFGTSRS 533 (678)
Q Consensus 458 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgl~~~ 533 (678)
|-+++ -+|.+++.+.. ..+.+...+..++.++++.++-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 58888886532 224677888899999999999999999 999999999999986666 99999986653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.1e-06 Score=91.78 Aligned_cols=149 Identities=16% Similarity=0.188 Sum_probs=96.4
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhh------------------------------HH-----
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK------------------------------LE----- 423 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----- 423 (678)
.....|+. +-|+.++-|.||+|++++|+.||||+.+..-... .+
T Consensus 123 e~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~ 201 (517)
T COG0661 123 ELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR 201 (517)
T ss_pred HHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence 33344442 6799999999999999999999999765321100 11
Q ss_pred -----HHHHHHHHHhcCC-----CCceeeEEeEE-eeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 041043 424 -----EFINEVVILSQIS-----HRNVVKLLGSC-LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492 (678)
Q Consensus 424 -----~~~~Ei~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~ 492 (678)
++.+|...+.+++ .+++ .+=.++ .-.+...|+|||++|-.+.+...-.. ..++.+.+.....++.
T Consensus 202 l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f- 277 (517)
T COG0661 202 LREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF- 277 (517)
T ss_pred HHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH-
Confidence 1344555555542 2333 333333 34677899999999998888843211 2244333333222222
Q ss_pred HHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 493 ~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+..+-..+ ++|.|..|.||+++.++++.+.|||+...+..
T Consensus 278 -~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 -LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22333345 89999999999999999999999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=78.15 Aligned_cols=138 Identities=17% Similarity=0.170 Sum_probs=83.5
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc--eeeEEeEEeeCCcceEEEEeccCCC-
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN--VVKLLGSCLEVEVPLLVYEFIPNGT- 464 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~- 464 (678)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 24567788766422 3345688999999886443 4667777777777789999998863
Q ss_pred hhhhh---------------------cCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEeecC
Q 041043 465 LFQYL---------------------HDPSEELSLTWEMRL-RIAT----------EVAE-ALAYLHSS-AYLPIYHRDI 510 (678)
Q Consensus 465 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~~-~~~~ivH~Dl 510 (678)
+...+ |..... ........ .+.. .+.. ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 111000 01110000 0000 0001 12222211 1234789999
Q ss_pred CCCceEECCCCcEEEeeccCcc
Q 041043 511 KSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 511 k~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.2e-05 Score=75.72 Aligned_cols=137 Identities=17% Similarity=0.232 Sum_probs=91.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHH---------HHHHHHHhcCCCC---ceeeEEeEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF---------INEVVILSQISHR---NVVKLLGSC 447 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~h~---niv~l~~~~ 447 (678)
...+|...+++.......|.+-.. +|..+++|..+.......+.| .+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456777778888777777776666 478899997765443333222 2344444444332 222222222
Q ss_pred e-----eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc
Q 041043 448 L-----EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522 (678)
Q Consensus 448 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 522 (678)
. -....+++|||++|..|.++.. +++ .++..+++++.-||..| ++|+|..|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 2 2234568999999988766542 222 24567788899999999 9999999999999966 4
Q ss_pred EEEeeccCcc
Q 041043 523 AKIADFGTSR 532 (678)
Q Consensus 523 ~kl~Dfgl~~ 532 (678)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=8.7e-05 Score=71.04 Aligned_cols=105 Identities=28% Similarity=0.382 Sum_probs=82.5
Q ss_pred HHHHHHHhcCCC-CceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 041043 426 INEVVILSQISH-RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504 (678)
Q Consensus 426 ~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 504 (678)
..|..+++.+++ +++.+++|.|- .+++.||...+++...-.....-...+|..+.+|+.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 69999999994 4789999987765432111011124689999999999999999999865444
Q ss_pred eEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 505 ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+.-.|++++|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=5e-05 Score=73.99 Aligned_cols=150 Identities=23% Similarity=0.256 Sum_probs=99.3
Q ss_pred ChHHHHhhccCCCcCCeee---eeCCcEEEEEEEcCCcEEEEEEcccCChhh-------------------HHH-----H
Q 041043 373 NSKELDKATDHFNVNRILG---QGGQGTVYKGMLADGRIIAVKKSKVVDESK-------------------LEE-----F 425 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~-----~ 425 (678)
+.+.+....++..+....| .|.-..||+|...++..+|||+.+...... ..+ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3445556666666665555 556668999998889999999765422111 011 1
Q ss_pred HHHHHHHhcCC--CCceeeEEeEEeeCCcceEEEEeccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 041043 426 INEVVILSQIS--HRNVVKLLGSCLEVEVPLLVYEFIPNG-TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SA 501 (678)
Q Consensus 426 ~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~ 501 (678)
..|+.-|+++. +-.+.+.+++. .-.|||||+... .-.-.|+. ..+...+...+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 34777777764 34444455443 236999999543 11112221 223344677788888888888877 66
Q ss_pred CCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 502 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||+||+.-|||+. ++.+.|+|||-+...
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 889999999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.9e-05 Score=75.54 Aligned_cols=143 Identities=24% Similarity=0.241 Sum_probs=83.6
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC--ceeeEEeEEeeC---CcceEEEEecc
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR--NVVKLLGSCLEV---EVPLLVYEFIP 461 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 461 (678)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999877 68999986543 4556778888888888533 345666644332 34689999999
Q ss_pred CCChhh----------------hh---cCCC-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 041043 462 NGTLFQ----------------YL---HDPS-EELSLTWEM---------RLRI------------ATEVAE-ALAYLHS 499 (678)
Q Consensus 462 ~g~L~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~ 499 (678)
+..+.. .+ +... ......... .... ...+.+ .++.++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 1110 111111100 0000 111222 2333332
Q ss_pred ----CCCCCeEeecCCCCceEEC-CCCcEEEeeccCcc
Q 041043 500 ----SAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSR 532 (678)
Q Consensus 500 ----~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~ 532 (678)
.....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1224499999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.2e-05 Score=75.21 Aligned_cols=139 Identities=19% Similarity=0.139 Sum_probs=84.3
Q ss_pred eeeeCC-cEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEeccCCChhh
Q 041043 390 LGQGGQ-GTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQ 467 (678)
Q Consensus 390 Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 467 (678)
|..|.+ ..||+.... +..+.+|...... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788998764 4678888876543 345677888888874 3445567777766667899999999877764
Q ss_pred hh-------------------cCCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 041043 468 YL-------------------HDPSE-ELSLTW--EMRLRIAT--------------------EVAEALAYLHS----SA 501 (678)
Q Consensus 468 ~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~----~~ 501 (678)
.. |.... ...... ...+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11110 001110 00000000 01111222211 11
Q ss_pred CCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 502 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2448999999999999998788999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1e-06 Score=95.00 Aligned_cols=189 Identities=20% Similarity=0.164 Sum_probs=133.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN-VVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 458 (678)
.+.-+...+.+++++.++++|.+.--.+....+.+... ....-++++|.+++||| .+..++-+..+...++.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34444555678889999999887432333334433321 45567899999999999 6666666666778889999
Q ss_pred eccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 459 FIPNG-TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 459 ~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
++..+ +-..-. ...+..+...+...+.+.-++++++||+.- -+|+| ||+..+ ...|..||+....+...
T Consensus 315 i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99776 111111 111223444555667777888999999964 47998 777766 58899999988766543
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~ 585 (678)
. ..+...+++.|+|||+...+.+..+.|+|++|+--.++.-|-+|-
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 3 234456899999999999999999999999998777777777664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00033 Score=82.97 Aligned_cols=79 Identities=14% Similarity=0.283 Sum_probs=56.8
Q ss_pred CCeeeeeCCcEEEEEEEcCC---cEEEEEEcccCC-hhhHHHHHHHHHHHhcCC-CCce--eeEEeEEeeC---CcceEE
Q 041043 387 NRILGQGGQGTVYKGMLADG---RIIAVKKSKVVD-ESKLEEFINEVVILSQIS-HRNV--VKLLGSCLEV---EVPLLV 456 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 456 (678)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788899999999886654 367777754322 123356889999999995 6665 6777777654 467899
Q ss_pred EEeccCCCh
Q 041043 457 YEFIPNGTL 465 (678)
Q Consensus 457 ~e~~~~g~L 465 (678)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00054 Score=65.92 Aligned_cols=131 Identities=24% Similarity=0.312 Sum_probs=90.2
Q ss_pred cCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCC----------------hhhHHHHHHHHHHHhcCC------CCceeeE
Q 041043 386 VNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD----------------ESKLEEFINEVVILSQIS------HRNVVKL 443 (678)
Q Consensus 386 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~l 443 (678)
....||+|+.-.||. +++.....||+..... .....+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999996 3445556677655433 223456667776666665 8899999
Q ss_pred EeEEeeCCcceEEEEeccC------CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE
Q 041043 444 LGSCLEVEVPLLVYEFIPN------GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 517 (678)
Q Consensus 444 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 517 (678)
+|+..++...-+|+|.+.+ -+|.+++++. .++. ...+.+.++ ..||-+.+ |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998743 3688888532 3554 444444444 45666666 9999999999999
Q ss_pred CCCC----cEEEee-cc
Q 041043 518 DEKY----RAKIAD-FG 529 (678)
Q Consensus 518 ~~~~----~~kl~D-fg 529 (678)
..+. .+.|+| ||
T Consensus 152 ~~~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLG 168 (199)
T ss_pred EecCCCceEEEEEeCCC
Confidence 6332 455655 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00032 Score=76.87 Aligned_cols=141 Identities=16% Similarity=0.107 Sum_probs=88.7
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhh-------------------------------------HHHHHHHHH
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK-------------------------------------LEEFINEVV 430 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~Ei~ 430 (678)
+.|+.-+.|.||+|++++|+.||||+.+..-+.. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999765421110 012344554
Q ss_pred HHhcC----CCCce---eeEEeEEe-eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 041043 431 ILSQI----SHRNV---VKLLGSCL-EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502 (678)
Q Consensus 431 ~l~~l----~h~ni---v~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 502 (678)
-..+. +|-++ |.+=.++. -.....|+|||++|..+.+.-.-. +..++...+..-+.+...-+- =..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~qI--f~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQI--FKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHHH--HhcC-
Confidence 44333 45551 22323333 345779999999998766543211 122555544333333322222 2334
Q ss_pred CCeEeecCCCCceEECC----CCcEEEeeccCccccc
Q 041043 503 LPIYHRDIKSTNILLDE----KYRAKIADFGTSRSIA 535 (678)
Q Consensus 503 ~~ivH~Dlk~~NILl~~----~~~~kl~Dfgl~~~~~ 535 (678)
++|.|=.|.||++.. ++.+.+-|||+...+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 899999999999984 6789999999986554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0005 Score=63.50 Aligned_cols=131 Identities=19% Similarity=0.181 Sum_probs=87.9
Q ss_pred CCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
....+.|++|.+|.||+|.+. |..+|+|..+..+ ....+..|+++|..+.-.++.+=+-.+ +.-++.|||+.+-
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~ 97 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCc
Confidence 345678999999999999997 5588888766433 346788899999999876665433222 2224559999887
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC-CCceEECCCCcEEEeeccCccc
Q 041043 464 TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK-STNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 464 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
.|.+.-... +.+. +..+++.---|...+ |-|+.|+ |...+|..+..+.|+||..+..
T Consensus 98 ~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 776655321 2223 334444434455556 8898887 4555555555999999998863
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0011 Score=68.68 Aligned_cols=78 Identities=10% Similarity=0.042 Sum_probs=56.6
Q ss_pred CcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCC---CceeeEEeEEee---CCcceEEEE
Q 041043 385 NVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISH---RNVVKLLGSCLE---VEVPLLVYE 458 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e 458 (678)
...+.||.|..+.||+....+++ +++|..+.. .....+..|.+.|+.|.. ..+.++++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34567999999999998766554 566664331 123578899999998853 367788887754 356899999
Q ss_pred eccCCCh
Q 041043 459 FIPNGTL 465 (678)
Q Consensus 459 ~~~~g~L 465 (678)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00032 Score=81.31 Aligned_cols=198 Identities=20% Similarity=0.215 Sum_probs=139.4
Q ss_pred HHHHHHHHHHhcCCCCceeeEEeEEeeCCcc----eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 041043 423 EEFINEVVILSQISHRNVVKLLGSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498 (678)
Q Consensus 423 ~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 498 (678)
.....|++.+....|+|++.++.+..+.... .+..+++..-++...++.. ..++....+.+..++..||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHH
Confidence 3445577788889999999999988765432 3455778777888777643 35888999999999999999999
Q ss_pred hCCCCCeEeecCCCC---ceEECCCCcEEEe--eccCcccccCCcceeeeccccccCccCccccccCCCCc--ccchhhH
Q 041043 499 SSAYLPIYHRDIKST---NILLDEKYRAKIA--DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD--KSDVYSF 571 (678)
Q Consensus 499 ~~~~~~ivH~Dlk~~---NILl~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVwsl 571 (678)
+.. +.|.-|..+ +-..+.++.+.++ ||+.+......... ....-+..+.+||......+.. ..|+|.+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHH
Confidence 986 666666665 6666777788877 99888765433322 1223455678888876655444 4799999
Q ss_pred HHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041043 572 GVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVA 651 (678)
Q Consensus 572 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 651 (678)
|.++..+..|..+-.. . .....+++.. ....+.+...+|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~-----~-------------~~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEK-----S-------------AVPVSLLDVL--------STSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccc-----c-------------cchhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999998765210 0 0011111111 111577889999999999999999998
Q ss_pred HHH
Q 041043 652 MEL 654 (678)
Q Consensus 652 ~~L 654 (678)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00074 Score=67.44 Aligned_cols=73 Identities=18% Similarity=0.238 Sum_probs=44.6
Q ss_pred CeeeeeCCc-EEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC---ceeeEEeEEeeC---CcceEEEEec
Q 041043 388 RILGQGGQG-TVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR---NVVKLLGSCLEV---EVPLLVYEFI 460 (678)
Q Consensus 388 ~~Lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 460 (678)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.++++.+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58875 234667765432 2345788999999888532 233444433222 2358899999
Q ss_pred cCCChh
Q 041043 461 PNGTLF 466 (678)
Q Consensus 461 ~~g~L~ 466 (678)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.001 Score=66.34 Aligned_cols=74 Identities=23% Similarity=0.244 Sum_probs=47.4
Q ss_pred CeeeeeCCcEEEEEEEcC--CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCcee-eEEeEEeeCCcceEEEEeccCCC
Q 041043 388 RILGQGGQGTVYKGMLAD--GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV-KLLGSCLEVEVPLLVYEFIPNGT 464 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~ 464 (678)
+.|..|-...+|+....+ ++.+++|........ .....+|+.+++.+...+++ ++++.. + ..+++||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence 467778888999988764 678888876543221 12334788888888544443 343332 1 248999998876
Q ss_pred hh
Q 041043 465 LF 466 (678)
Q Consensus 465 L~ 466 (678)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 53
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00063 Score=68.90 Aligned_cols=137 Identities=16% Similarity=0.135 Sum_probs=76.8
Q ss_pred eeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCcee-eEEeEEeeCCcceEEEEeccCCChhhh
Q 041043 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV-KLLGSCLEVEVPLLVYEFIPNGTLFQY 468 (678)
Q Consensus 390 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~~~ 468 (678)
+..|-...+|+... +++.+++|........-.-...+|.++++.+....+. +++... ..++|+||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 45577788998874 5677888875433222111346788888888644332 333332 24799999988665421
Q ss_pred -----------------hcCCCC-CCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEeecCCCCce
Q 041043 469 -----------------LHDPSE-ELSLTWEMR-LRIATE---------VAEALAYLHSS-----AYLPIYHRDIKSTNI 515 (678)
Q Consensus 469 -----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~ivH~Dlk~~NI 515 (678)
||.... ...++.... .....+ +...+..+... ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 122111 111222111 111111 11112222211 113489999999999
Q ss_pred EECCCCcEEEeeccCcc
Q 041043 516 LLDEKYRAKIADFGTSR 532 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~ 532 (678)
++++++ +.|+||+.+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.003 Score=67.50 Aligned_cols=75 Identities=20% Similarity=0.229 Sum_probs=54.0
Q ss_pred CeeeeeCCcEEEEEEEcCC-cEEEEEEcccC-----C--hhhHHHHHHHHHHHhcCC---CCceeeEEeEEeeCCcceEE
Q 041043 388 RILGQGGQGTVYKGMLADG-RIIAVKKSKVV-----D--ESKLEEFINEVVILSQIS---HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv 456 (678)
+.||.|.+..||+....+| +.++||.-... + .-..+.+..|.+.|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998877 58999974311 1 224567778888888863 2456666666 44567899
Q ss_pred EEeccCCC
Q 041043 457 YEFIPNGT 464 (678)
Q Consensus 457 ~e~~~~g~ 464 (678)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0039 Score=59.60 Aligned_cols=125 Identities=29% Similarity=0.443 Sum_probs=89.3
Q ss_pred cCCCcCCeeeeeCC-cEEEEEEEcCCcEEEEEEcccC---C---------h---------hhHHHHHHHHHHHhcCC---
Q 041043 382 DHFNVNRILGQGGQ-GTVYKGMLADGRIIAVKKSKVV---D---------E---------SKLEEFINEVVILSQIS--- 436 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~---~---------~---------~~~~~~~~Ei~~l~~l~--- 436 (678)
..++..+.||.|.. |.||++... |+.+|+|..+.. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999985 789999983220 0 0 11235778888888775
Q ss_pred CCce--eeEEeEEeeCC------------------cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 041043 437 HRNV--VKLLGSCLEVE------------------VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496 (678)
Q Consensus 437 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 496 (678)
+.++ ++.+||..-.. ...+|.||.+... .+.. .-+.++.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 88899874321 1246777665432 1222 335667778889
Q ss_pred HHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 497 LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
+|..+ |+-+|++++|.. .-||.|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999986 4488999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0047 Score=63.95 Aligned_cols=142 Identities=20% Similarity=0.198 Sum_probs=83.3
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc--eeeEEeE------EeeCCcceEEEE
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN--VVKLLGS------CLEVEVPLLVYE 458 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 458 (678)
.+.|..|....+|+....+ ..+++|..... ..+....|+++++.+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999987654 46788877642 2345667888887775332 3444331 223455689999
Q ss_pred eccCCChhh----h----------hcCCCCC--------CCCCHHHHH----------HHHHHHHHHHHHHHhC----CC
Q 041043 459 FIPNGTLFQ----Y----------LHDPSEE--------LSLTWEMRL----------RIATEVAEALAYLHSS----AY 502 (678)
Q Consensus 459 ~~~~g~L~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~~ia~~L~yLH~~----~~ 502 (678)
|++|..+.. . +|..... ....|.... .....+..++.++... ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876532 0 1110000 111221111 0112233445555431 11
Q ss_pred CCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 503 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 248999999999999998778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0043 Score=64.46 Aligned_cols=140 Identities=26% Similarity=0.331 Sum_probs=81.7
Q ss_pred CeeeeeCCcEEEEEEEcC-------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCcee-eEEeEEeeCCcceEEEEe
Q 041043 388 RILGQGGQGTVYKGMLAD-------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV-KLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 459 (678)
+.|..|-...+|+....+ ++.+++|...... .......+|.++++.+....+. ++++... -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 345556667899888655 4788899865432 2234556788888888643333 3444442 2468999
Q ss_pred ccCCChhhh-----------------hcCCCCCC------CCC--HHHHHH--------------------------HHH
Q 041043 460 IPNGTLFQY-----------------LHDPSEEL------SLT--WEMRLR--------------------------IAT 488 (678)
Q Consensus 460 ~~~g~L~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 488 (678)
++|..+... +|+..... ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 888766431 11111110 010 111100 112
Q ss_pred HHHHHHHHHHh------CCCCCeEeecCCCCceEECCC----CcEEEeeccCcc
Q 041043 489 EVAEALAYLHS------SAYLPIYHRDIKSTNILLDEK----YRAKIADFGTSR 532 (678)
Q Consensus 489 ~ia~~L~yLH~------~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgl~~ 532 (678)
.+...+.+|.. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233444432 123458999999999999985 889999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.015 Score=60.88 Aligned_cols=156 Identities=15% Similarity=0.188 Sum_probs=81.6
Q ss_pred ChHHHHhhccCCCc-----CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC--ceeeEEe
Q 041043 373 NSKELDKATDHFNV-----NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR--NVVKLLG 445 (678)
Q Consensus 373 ~~~~~~~~~~~~~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~ 445 (678)
+.+++...-+.|.+ .+.|+.|....+|+....+| .+++|+....+. +....|+.+++.|... .+.+++.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCccee
Confidence 34444444344543 34566777788999887655 578887652222 3333455555554311 1233332
Q ss_pred ------EEeeCCcceEEEEeccCCChhh--------------hhcCCCCC--------CCCCH-HHHHH-----------
Q 041043 446 ------SCLEVEVPLLVYEFIPNGTLFQ--------------YLHDPSEE--------LSLTW-EMRLR----------- 485 (678)
Q Consensus 446 ------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~--------~~l~~-~~~~~----------- 485 (678)
+....+..++++||++|..+.. .+|..... ..+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1223456789999998864321 11111110 11112 11111
Q ss_pred -HH-HHHHHHHHHHHhC----CCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 486 -IA-TEVAEALAYLHSS----AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 486 -i~-~~ia~~L~yLH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.+ ..+...++.+... -...++|+|+.+.|||++++...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 1111222333211 12349999999999999977666899999774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0069 Score=62.03 Aligned_cols=73 Identities=23% Similarity=0.220 Sum_probs=47.9
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC---CCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS---HRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
.+.|+.|....+|+.. .+++.+.||... ......|..|.+-|+.|. --.+.+++++....+..+|++||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678888999999987 568889999766 223356778888888773 456778899888888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.018 Score=59.45 Aligned_cols=132 Identities=20% Similarity=0.255 Sum_probs=80.8
Q ss_pred eCCcEEEEEEEcCCcEEEEEEcc-cCChhhHHHHHHHHHHHhcCCC--CceeeEEeEEeeCC--cceEEEEeccCCChhh
Q 041043 393 GGQGTVYKGMLADGRIIAVKKSK-VVDESKLEEFINEVVILSQISH--RNVVKLLGSCLEVE--VPLLVYEFIPNGTLFQ 467 (678)
Q Consensus 393 G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~g~L~~ 467 (678)
|..-.+|..... ++++++++-. ...........+|.++++.+.- .-+...++.|.+.. .++.||+|.++..+.+
T Consensus 36 G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 333344444433 7777777331 2334455667788888888753 33445566676655 7799999998854433
Q ss_pred hhcCCCCCCCCCHHHHHHHH-HHHHHHHHHHHh-----------------------------------------------
Q 041043 468 YLHDPSEELSLTWEMRLRIA-TEVAEALAYLHS----------------------------------------------- 499 (678)
Q Consensus 468 ~l~~~~~~~~l~~~~~~~i~-~~ia~~L~yLH~----------------------------------------------- 499 (678)
.+.... .. .+++ ..++..|+-||+
T Consensus 115 ~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 115 ALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred cCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 332110 00 1111 234444444443
Q ss_pred ---CC-----CCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 500 ---SA-----YLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 500 ---~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
+. .+.++|+|+.+.|++++++..+-|.||+++..
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22 14689999999999999998899999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.022 Score=59.39 Aligned_cols=155 Identities=18% Similarity=0.236 Sum_probs=85.1
Q ss_pred HHHHhhccCCCc-----CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc--eeeEEeE-
Q 041043 375 KELDKATDHFNV-----NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN--VVKLLGS- 446 (678)
Q Consensus 375 ~~~~~~~~~~~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~- 446 (678)
+++...-++|.+ .+.++.|....+|+....++ .+++|+..... ..++...|++++..|.... +.+++..
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 444444444443 35567777789999876555 56678654321 1234456667776664222 3343331
Q ss_pred -----EeeCCcceEEEEeccCCChhh--------------hhcCCCCC------C---CCCHHHHH------------HH
Q 041043 447 -----CLEVEVPLLVYEFIPNGTLFQ--------------YLHDPSEE------L---SLTWEMRL------------RI 486 (678)
Q Consensus 447 -----~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~------~---~l~~~~~~------------~i 486 (678)
....+..++++||++|..+.. .+|..... . .-.|.... ..
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 122355689999998754321 11211110 0 01111100 01
Q ss_pred HHHHHHHHHHHHh----CCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 487 ATEVAEALAYLHS----SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 487 ~~~ia~~L~yLH~----~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
...+.+.++++.. .....++|+|+.+.||++++++...|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 1223345555543 112459999999999999998877899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.021 Score=58.43 Aligned_cols=30 Identities=27% Similarity=0.520 Sum_probs=25.0
Q ss_pred CCeEeecCCCCceEECCCCc-EEEeeccCcc
Q 041043 503 LPIYHRDIKSTNILLDEKYR-AKIADFGTSR 532 (678)
Q Consensus 503 ~~ivH~Dlk~~NILl~~~~~-~kl~Dfgl~~ 532 (678)
+.++|+|+++.|||+++++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 34899999999999997555 5699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0053 Score=62.13 Aligned_cols=134 Identities=16% Similarity=0.185 Sum_probs=91.7
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC-----------------Chhh-----HHHHHHHHHHHhcCCC--C
Q 041043 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV-----------------DESK-----LEEFINEVVILSQISH--R 438 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~~~-----~~~~~~Ei~~l~~l~h--~ 438 (678)
-+.+++.||-|.-+.||.+...+|++.++|.-+.. .... .-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 36778999999999999999999999988832210 0001 1234568888888753 2
Q ss_pred ceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC
Q 041043 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 518 (678)
Q Consensus 439 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~ 518 (678)
-+.+.+++ +..++|||++.+-.|...-+- .+.. .+...+..-+.-|..+| +||+|..-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 33344433 445789999987766543321 1222 33444444566677888 99999999999999
Q ss_pred CCCcEEEeeccCcc
Q 041043 519 EKYRAKIADFGTSR 532 (678)
Q Consensus 519 ~~~~~kl~Dfgl~~ 532 (678)
+++.++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999996543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.025 Score=59.85 Aligned_cols=139 Identities=22% Similarity=0.243 Sum_probs=78.3
Q ss_pred eeeeeCCcEEEEEEEcC-----CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCcee-eEEeEEeeCCcceEEEEeccC
Q 041043 389 ILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV-KLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 462 (678)
.|..|-.-.+|+....+ ++.+++|..........+ -.+|.++++.+...++. ++++.+.. + .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 44456677889887532 367888877654332222 36788888888644444 34454422 2 58999977
Q ss_pred CChhhh-----------------hcCCCCC--C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 041043 463 GTLFQY-----------------LHDPSEE--L-SLTWEMRLRIATEV-----------------AEALAYL----HS-S 500 (678)
Q Consensus 463 g~L~~~-----------------l~~~~~~--~-~l~~~~~~~i~~~i-----------------a~~L~yL----H~-~ 500 (678)
.+|... +|+..-. . ...+.++.++..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 1221100 0 11123332332111 1112222 21 1
Q ss_pred CCCCeEeecCCCCceEECC-CCcEEEeeccCcc
Q 041043 501 AYLPIYHRDIKSTNILLDE-KYRAKIADFGTSR 532 (678)
Q Consensus 501 ~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~ 532 (678)
....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1234899999999999986 4689999998774
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.00056 Score=81.06 Aligned_cols=160 Identities=14% Similarity=-0.002 Sum_probs=113.3
Q ss_pred HHHHHHHHhcCCCCceeeEEeEEee--CCcceEEEEeccCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 041043 425 FINEVVILSQISHRNVVKLLGSCLE--VEVPLLVYEFIPNGTLFQYLHDPSEE-LSLTWEMRLRIATEVAEALAYLHSSA 501 (678)
Q Consensus 425 ~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~ 501 (678)
...|...++...|+++.....-... ....+.+++|+..|.+.+.|-+..++ ..++..-+...-.+...+..-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3344444555678888766554433 34568999999999999998765443 23333333333333355555544432
Q ss_pred C--CCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHH
Q 041043 502 Y--LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELL 579 (678)
Q Consensus 502 ~--~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ell 579 (678)
. -.-+|++||+-|.+|..+..+|++++|+.+..... ........+++.|+.|+....-.++.++|+|..|+.+|+.-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 1 23689999999999999999999999999843332 22334445788899999998888899999999999999998
Q ss_pred hCCCCC
Q 041043 580 TGQKPI 585 (678)
Q Consensus 580 tg~~p~ 585 (678)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.08 Score=54.81 Aligned_cols=141 Identities=19% Similarity=0.243 Sum_probs=93.4
Q ss_pred CcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC-----Ch--------------------hhHHH-HHHHHHHHhcCCCC
Q 041043 385 NVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV-----DE--------------------SKLEE-FINEVVILSQISHR 438 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~--------------------~~~~~-~~~Ei~~l~~l~h~ 438 (678)
.+.-.|..|.-..||.+...+|..+|||+.+.. ++ .-++- .-.|+.-|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445678889999999999999999999965421 11 01111 12477778887654
Q ss_pred ceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC
Q 041043 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 518 (678)
Q Consensus 439 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~ 518 (678)
.|.-.--.... .-.|||+|+... .|-.-.-....++...+..+-.+++.-+.-|-.... +||.||+--|+|+.
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrd---gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRD---GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCC---CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence 43322222221 236899998521 111111123457777888888888888888876653 99999999999986
Q ss_pred CCCcEEEeeccCccc
Q 041043 519 EKYRAKIADFGTSRS 533 (678)
Q Consensus 519 ~~~~~kl~Dfgl~~~ 533 (678)
+ |.+.|+|.+-+..
T Consensus 300 d-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVE 313 (520)
T ss_pred C-CEEEEEEcccccc
Confidence 5 5899999887643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.28 Score=52.54 Aligned_cols=80 Identities=16% Similarity=0.136 Sum_probs=52.3
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEccc----CCh---hhHHHHHHHHHHHhcCC---CCceeeEEeEEeeCCcceEE
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKV----VDE---SKLEEFINEVVILSQIS---HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv 456 (678)
.+.||.|....||+.... +..++||+-.. ... -..++-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467898999999998864 55688986441 111 13344455677776664 346777887776 456889
Q ss_pred EEeccC--CChhhhh
Q 041043 457 YEFIPN--GTLFQYL 469 (678)
Q Consensus 457 ~e~~~~--g~L~~~l 469 (678)
||++++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3455444
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.15 Score=53.03 Aligned_cols=29 Identities=28% Similarity=0.389 Sum_probs=24.8
Q ss_pred CCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 503 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999988 578899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.019 Score=70.07 Aligned_cols=40 Identities=28% Similarity=0.633 Sum_probs=25.1
Q ss_pred CCceEeecCCCCCCCccccCC---ccc------CcccCCCCCccccCCC
Q 041043 266 GGLFRCSCKEKYHGNPYFLHG---CQD------LRCENYEGGYRCVNPK 305 (678)
Q Consensus 266 ~~~~~C~C~~gy~gnpy~~~g---C~~------~~c~~~~~~~~c~~~~ 305 (678)
.++|.|+|+.||.|---..+| |.. ..|.|..|.+.|-|+.
T Consensus 3921 ~n~f~CnC~~gyTG~~Ce~~Gi~eCs~n~C~~gg~C~n~~gsf~CncT~ 3969 (4289)
T KOG1219|consen 3921 YNGFLCNCPNGYTGKRCEARGISECSKNVCGTGGQCINIPGSFHCNCTP 3969 (4289)
T ss_pred CCCeeEeCCCCccCceeecccccccccccccCCceeeccCCceEeccCh
Confidence 345667777777776655555 542 2366678888886653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.14 Score=53.97 Aligned_cols=140 Identities=18% Similarity=0.197 Sum_probs=76.0
Q ss_pred CeeeeeCCcEEEEEEEcC----CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCcee-eEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLAD----GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV-KLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.|..|=.-.+|+....+ +..+++|....... ..-.-.+|..+++.+..-++- ++++++ ..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence 344446667788887543 23788887654332 222335788888888655553 445444 222 58888876
Q ss_pred CChhh-----------------hhcCCCC--CC-CCCHHHHHHHHHHH----------------------HHHHHH----
Q 041043 463 GTLFQ-----------------YLHDPSE--EL-SLTWEMRLRIATEV----------------------AEALAY---- 496 (678)
Q Consensus 463 g~L~~-----------------~l~~~~~--~~-~l~~~~~~~i~~~i----------------------a~~L~y---- 496 (678)
..|.. .+|...- .. .-.+..+.++..++ ..-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 55421 1122110 00 11122222222111 111111
Q ss_pred HHhCC-CCCeEeecCCCCceEECC-CCcEEEeeccCcc
Q 041043 497 LHSSA-YLPIYHRDIKSTNILLDE-KYRAKIADFGTSR 532 (678)
Q Consensus 497 LH~~~-~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~ 532 (678)
+...+ .+-++|.|+.+.|||+++ ++.++++||..+-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21111 123789999999999975 5789999999874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.031 Score=54.64 Aligned_cols=29 Identities=28% Similarity=0.483 Sum_probs=20.7
Q ss_pred CeEeecCCCCceEE-CCCCcEEEeeccCcc
Q 041043 504 PIYHRDIKSTNILL-DEKYRAKIADFGTSR 532 (678)
Q Consensus 504 ~ivH~Dlk~~NILl-~~~~~~kl~Dfgl~~ 532 (678)
-+.|+|+.+.|||+ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 37899999999999 889999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.3 Score=50.84 Aligned_cols=29 Identities=17% Similarity=0.318 Sum_probs=26.7
Q ss_pred CeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 504 PIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 504 ~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++|+|+.+.|||+++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 49999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.5 Score=46.01 Aligned_cols=74 Identities=20% Similarity=0.230 Sum_probs=50.3
Q ss_pred eeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC---CCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 389 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS---HRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
.+.-|.--..|.... +..++.||.-. ......|..|+.-|..|. --.+.+++.+-.+.+..++|+||++-|.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 344444444455443 35678888643 344567788887777764 45677888888888999999999998666
Q ss_pred h
Q 041043 466 F 466 (678)
Q Consensus 466 ~ 466 (678)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.048 Score=32.63 Aligned_cols=23 Identities=30% Similarity=0.769 Sum_probs=17.4
Q ss_pred ceEeecCCCCCCCccccCCcccCc
Q 041043 268 LFRCSCKEKYHGNPYFLHGCQDLR 291 (678)
Q Consensus 268 ~~~C~C~~gy~gnpy~~~gC~~~~ 291 (678)
+|+|.|+.||.-+|- ...|+||+
T Consensus 1 sy~C~C~~Gy~l~~d-~~~C~DId 23 (24)
T PF12662_consen 1 SYTCSCPPGYQLSPD-GRSCEDID 23 (24)
T ss_pred CEEeeCCCCCcCCCC-CCccccCC
Confidence 478999999987762 24688875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.42 Score=50.22 Aligned_cols=79 Identities=20% Similarity=0.201 Sum_probs=49.9
Q ss_pred eeeeeCCcEEEEEEEcCC-cEEEEEEcc----c---CChhhHHHHHHHHHHHhcCC--CCc-eeeEEeEEeeCCcceEEE
Q 041043 389 ILGQGGQGTVYKGMLADG-RIIAVKKSK----V---VDESKLEEFINEVVILSQIS--HRN-VVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~~~-~~vavK~~~----~---~~~~~~~~~~~Ei~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~ 457 (678)
.||.|...-||++..++| +.|+||.-. . .-+-..++..-|.+.|+... -|. +.+++ +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 578888899999997654 589999632 1 11334556667888887764 343 33343 33455667999
Q ss_pred EeccCC-Chhhhh
Q 041043 458 EFIPNG-TLFQYL 469 (678)
Q Consensus 458 e~~~~g-~L~~~l 469 (678)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998543 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.23 Score=52.88 Aligned_cols=74 Identities=15% Similarity=0.119 Sum_probs=48.3
Q ss_pred CCeeeeeCCcEEEEEEEcC-CcEEEEEEc----cc--CChhhHHHHHHHHHHHhcCC--CC-ceeeEEeEEeeCCcceEE
Q 041043 387 NRILGQGGQGTVYKGMLAD-GRIIAVKKS----KV--VDESKLEEFINEVVILSQIS--HR-NVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~----~~--~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lv 456 (678)
.+.||.|.-.-||++...+ ++.|+||.- +. .-.-..++..-|.+.|+... -| .+.+++. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4578999999999999743 567999953 21 11334567777888888764 34 3444443 344555678
Q ss_pred EEeccC
Q 041043 457 YEFIPN 462 (678)
Q Consensus 457 ~e~~~~ 462 (678)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 887743
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.17 Score=52.49 Aligned_cols=53 Identities=28% Similarity=0.318 Sum_probs=46.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 478 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 478 l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
..+++.+.++.+-+.-+.-+...- +.-|||+.-.||||+ +|++.|+||.+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 468899999999888888887654 589999999999999 99999999999984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.75 E-value=2 Score=44.99 Aligned_cols=93 Identities=14% Similarity=0.115 Sum_probs=52.4
Q ss_pred ccChHHHHhhccCCCcC---C-eeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC--ceeeEE
Q 041043 371 IFNSKELDKATDHFNVN---R-ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR--NVVKLL 444 (678)
Q Consensus 371 ~~~~~~~~~~~~~~~~~---~-~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~ 444 (678)
.++.+.+..+...+-+. + ..=.+.-..||+....++..+++|..+.. .....++..|++.+..|... .++...
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 34555555544444331 1 11224456799998878888999987532 22345666777777766321 122211
Q ss_pred ---e--EEeeCCcceEEEEeccCCC
Q 041043 445 ---G--SCLEVEVPLLVYEFIPNGT 464 (678)
Q Consensus 445 ---~--~~~~~~~~~lv~e~~~~g~ 464 (678)
| ....++..+.++++++|..
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCC
Confidence 1 1223456778999987754
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.66 E-value=1.1 Score=46.81 Aligned_cols=140 Identities=22% Similarity=0.317 Sum_probs=81.6
Q ss_pred eeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc------eeeEEeEE--eeCC--cceEEEE
Q 041043 389 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN------VVKLLGSC--LEVE--VPLLVYE 458 (678)
Q Consensus 389 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~--~~~~--~~~lv~e 458 (678)
.|.+ .-..+|+....+|+. ++|..... ....++..|+..++.|.-.. +..+-|-. .-.. ..+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456789988887777 77876654 34456777888887774211 22222211 1123 6678999
Q ss_pred eccCCChhh-h--------------hcC----CC-----CCCCCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 041043 459 FIPNGTLFQ-Y--------------LHD----PS-----EELSLTWEM-------------RLRIATEVAEALAYLHSSA 501 (678)
Q Consensus 459 ~~~~g~L~~-~--------------l~~----~~-----~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~~ 501 (678)
|++|..+.. . ||. .. ......|.. -.....++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887773 1 111 00 011223320 0112334444444444322
Q ss_pred C-----CC--eEeecCCCCceEECCCCc-EEEeeccCcc
Q 041043 502 Y-----LP--IYHRDIKSTNILLDEKYR-AKIADFGTSR 532 (678)
Q Consensus 502 ~-----~~--ivH~Dlk~~NILl~~~~~-~kl~Dfgl~~ 532 (678)
. .+ ++|+|+.|.|||++++.. +.+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 12 899999999999999885 8999999764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.27 Score=47.44 Aligned_cols=152 Identities=17% Similarity=0.132 Sum_probs=87.8
Q ss_pred CCcEEEEEEEcCCcEEEEEEcccCChh-hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCChhhhhcCC
Q 041043 394 GQGTVYKGMLADGRIIAVKKSKVVDES-KLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP 472 (678)
Q Consensus 394 ~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 472 (678)
+.++.-++.-+-| ...+|++....-. ...-|..+..++.+++ .|+++..= ....+-++.|++-.-
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~--------- 139 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI--------- 139 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc---------
Confidence 3344444443223 3455555543333 3456778888888875 56666521 233455888887321
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCcc
Q 041043 473 SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552 (678)
Q Consensus 473 ~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~ 552 (678)
..... .++.-=+.+|.-.|+.. ...+|+|-.|+||+-|++|.+||.|=+..- .. +.-|.
T Consensus 140 ---~i~~~----N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~-----------~V~~v 198 (308)
T PF07387_consen 140 ---KINFS----NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN-----------QVNMV 198 (308)
T ss_pred ---ccchh----HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--hh-----------eeeEE
Confidence 01111 11112245677788654 348999999999999999999999976432 11 11122
Q ss_pred CccccccCCCCcccchhhHHHHHHHHHhCCC
Q 041043 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQK 583 (678)
Q Consensus 553 aPE~~~~~~~s~ksDVwslGvll~elltg~~ 583 (678)
--| ....+.++.+-+|=.-++++.....
T Consensus 199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 199 NIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 211 1235677888888777777776443
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 678 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-28 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-25 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-25 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-24 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-24 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-24 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-19 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-18 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-18 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-18 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-18 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-18 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-18 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-12 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-118
Identities = 117/298 (39%), Positives = 168/298 (56%), Gaps = 7/298 (2%)
Query: 369 CKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINE 428
+L++AT++F+ ++G G G VYKG+L DG +A+K+ +EEF E
Sbjct: 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 429 VVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEE-LSLTWEMRLRIA 487
+ LS H ++V L+G C E +L+Y+++ NG L ++L+ +S++WE RL I
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI-DQTHVSTKVQ 546
A L YLH+ I HRD+KS NILLDE + KI DFG S+ DQTH+ST V+
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
GT GY+DPEYF + T+KSDVYSFGVVL E+L + I E NLA + VE
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQD 664
L I+D + + E + + D A +CL + RP+M +V +LE A LQ+
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE--YALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-110
Identities = 111/290 (38%), Positives = 170/290 (58%), Gaps = 4/290 (1%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINE 428
K F+ +EL A+D+F+ ILG+GG G VYKG LADG ++AVK+ K E +F E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 429 VVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD-PSEELSLTWEMRLRIA 487
V ++S HRN+++L G C+ LLVY ++ NG++ L + P + L W R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
A LAYLH I HRD+K+ NILLDE++ A + DFG ++ + THV+T V+G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWA--NEGRNLATYFVECVE 605
T G++ PEY + + ++K+DV+ +GV+L+EL+TGQ+ ++ L + ++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
E L ++D ++ + K EE+ ++ VA C S+ RP M EV LE
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-106
Identities = 101/308 (32%), Positives = 162/308 (52%), Gaps = 18/308 (5%)
Query: 361 SLDGSIDRCKIFNSKELDKATDHFN------VNRILGQGGQGTVYKGMLADGRIIAVKK- 413
SL+ S R F+ EL T++F+ +G+GG G VYKG + + +AVKK
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 414 -SKVVDESK--LEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH 470
+ V ++ ++F E+ ++++ H N+V+LLG + + LVY ++PNG+L L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 471 DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530
L+W MR +IA A + +LH + HRDIKS NILLDE + AKI+DFG
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 531 SRSIAI-DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIW 589
+R+ QT +++++ GT Y+ PE + T KSD+YSFGVVL+E++TG +
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE-- 236
Query: 590 ANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649
E + L E +E + D+ + + + VA +CL+ RP +K+
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 650 VAMELERI 657
V L+ +
Sbjct: 297 VQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 2e-75
Identities = 67/313 (21%), Positives = 118/313 (37%), Gaps = 37/313 (11%)
Query: 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI 431
++ L + + + +G G V+K L +AVK + D+ + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 432 LSQISHRNVVKLLGSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
L + H N+++ +G+ L+ F G+L +L ++W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIA 127
Query: 488 TEVAEALAYLHSSAY-------LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540
+A LAYLH I HRDIKS N+LL A IADFG + ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 541 VSTKVQ-GTFGYLDPEYFHSS-----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGR 594
T Q GT Y+ PE + + D+Y+ G+VL EL +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA----ADGPVD 243
Query: 595 NLATYFVECVEENCLFDILDDQVRKSG----------KTEEIMEVSDVAKRCLNSNGRSR 644
F E + ++ + + + V K + + + + C + + +R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 645 PTMKEVAMELERI 657
+ V + ++
Sbjct: 304 LSAGCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-72
Identities = 79/299 (26%), Positives = 138/299 (46%), Gaps = 26/299 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
V ++G+G G V K + +A+K+ + ES+ + FI E+ LS+++H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 442 KLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
KL G+CL P+ LV E+ G+L+ LH T + + ++ +AYLHS
Sbjct: 65 KLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 501 AYLPIYHRDIKSTNILLDEKYR-AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+ HRD+K N+LL KI DFGT+ D T +G+ ++ PE F
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619
S +++K DV+S+G++L E++T +KP + G A + V ++ +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP----FDEIG-GPAFRIMWAVHNGTRPPLIKN---- 228
Query: 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQKCYEELSM 678
+ + + RC + + RP+M+E+ + + D+ C L
Sbjct: 229 ---LPK--PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPP 282
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-71
Identities = 86/331 (25%), Positives = 139/331 (41%), Gaps = 49/331 (14%)
Query: 337 RRRIKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQG 396
+ + L + ++ D I C + + +G G G
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-------------IKEKIGAGSFG 51
Query: 397 TVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454
TV++ G +AVK D ++ EF+ EV I+ ++ H N+V +G+ +
Sbjct: 52 TVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514
+V E++ G+L++ LH L RL +A +VA+ + YLH+ PI HR++KS N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPN 169
Query: 515 ILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVV 574
+L+D+KY K+ DFG SR A S GT ++ PE +KSDVYSFGV+
Sbjct: 170 LLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 575 LVELLTGQKP--------ISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEI 626
L EL T Q+P + + + L + N + QV I
Sbjct: 229 LWELATLQQPWGNLNPAQVVAAVGFKCKRLE------IPRNL-----NPQVA------AI 271
Query: 627 MEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+E C + RP+ + L +
Sbjct: 272 IE------GCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-69
Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDES-------KLEEFINEVVILS 433
+ + +G+GG G V+KG + D ++A+K + D K +EF EV I+S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
++H N+VKL G P +V EF+P G L+ L D + + W ++LR+ ++A
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIALG 134
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEK-----YRAKIADFGTSRSIAIDQTHVSTKVQGT 548
+ Y+ + PI HRD++S NI L AK+ADFG S+ H + + G
Sbjct: 135 IEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGN 189
Query: 549 FGYLDPEYF--HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
F ++ PE +T+K+D YSF ++L +LTG+ P + + EE
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREE 245
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
I +D + +V + C + + + RP + EL +
Sbjct: 246 GLRPTIPED-------CPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-67
Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 51/290 (17%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDES----KLEEFINEVVILSQISHRNVVKL 443
I+G GG G VY+ G +AVK ++ + +E E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
G CL+ LV EF G L + L + ++ + A ++A + YLH A +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 504 PIYHRDIKSTNILLDEKYR--------AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
PI HRD+KS+NIL+ +K KI DFG +R +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAA-GAYAWMAPE 184
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKP--------ISYIWANEGRNLATYFVECVEEN 607
+S F+ SDV+S+GV+L ELLTG+ P ++Y A L +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP------IPST 238
Query: 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
C + ++ME C N + SRP+ + +L I
Sbjct: 239 C-----PEPFA------KLME------DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 9e-65
Identities = 65/292 (22%), Positives = 110/292 (37%), Gaps = 47/292 (16%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRN 439
N L + G ++KG G I VK KV K +F E L SH N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 440 VVKLLGSCLEVEVPLL--VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
V+ +LG+C P + ++P G+L+ LH+ + ++ A ++A +A+L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
H+ I + S ++++DE A+I+ S S ++ PE
Sbjct: 128 HTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEAL 180
Query: 558 ---HSSQFTDKSDVYSFGVVLVELLTGQKP--------ISYIWANEGRNLATYFVECVEE 606
+D++SF V+L EL+T + P I A EG +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------IPP 234
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
V K +M+ C+N + RP + LE+++
Sbjct: 235 GI-----SPHVSK------LMK------ICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-62
Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 386 VNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKL 443
+ ++G+G G VY G G + A++ + +E +L+ F EV+ Q H NVV
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
+G+C+ ++ TL+ + D L +IA E+ + + YLH+
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAK--- 149
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI----DQTHVSTKVQGTFGYLDPEYFHS 559
I H+D+KS N+ D + I DFG + + G +L PE
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 560 SQ---------FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
F+ SDV++ G + EL + P + + A + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKTQ-PAEAIIWQ--MGTGMKP 261
Query: 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
++ + K E+SD+ C RPT ++ LE++
Sbjct: 262 NLSQIGMGK--------EISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-61
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 388 RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGS 446
+LG+G G K G ++ +K+ DE F+ EV ++ + H NV+K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
+ + + E+I GTL + + W R+ A ++A +AYLHS I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLHSM---NII 130
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-------------VSTKVQGTFGYLD 553
HRD+ S N L+ E +ADFG +R + ++T V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
PE + + +K DV+SFG+VL E++ R + F V
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP---RTMD--FGLNVRGF------ 239
Query: 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
+ + + RC + + RP+ ++ LE +R
Sbjct: 240 ---LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-61
Identities = 80/282 (28%), Positives = 124/282 (43%), Gaps = 25/282 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRN 439
V + +G G GTVYKG +AVK V +L+ F NEV +L + H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
++ +G +V ++ +L+ +LH E + + IA + A + YLH+
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA 138
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLDPE--- 555
I HRD+KS NI L E KI DFG + + +H ++ G+ ++ PE
Sbjct: 139 K---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615
S+ ++ +SDVY+FG+VL EL+TGQ P Y N +E V L L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP--Y----SNINNRDQIIEMVGRGSLSPDLSK 249
Query: 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
K + + CL RP+ + E+E +
Sbjct: 250 VRSNCPK-----RMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-60
Identities = 72/324 (22%), Positives = 125/324 (38%), Gaps = 48/324 (14%)
Query: 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI 431
+ E D+ + ++G+G G VYKG L D R +AVK + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 432 --LSQISHRNVVKLLGSCLEVEVP-----LLVYEFIPNGTLFQYLHDPSEELSLTWEMRL 484
+ + H N+ + + V LLV E+ PNG+L +YL + W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 485 RIATEVAEALAYLHSSAY------LPIYHRDIKSTNILLDEKYRAKIADFGTSR------ 532
R+A V LAYLH+ I HRD+ S N+L+ I+DFG S
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 533 -SIAIDQTHVSTKVQGTFGYLDPEYF-------HSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ + + GT Y+ PE + D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 585 ISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIME-----------VSDVA 633
+ + +A F V + F+ + V + + + E + +
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 634 KRCLNSNGRSRPTMKEVAMELERI 657
+ C + + +R T + + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAEL 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-55
Identities = 62/300 (20%), Positives = 114/300 (38%), Gaps = 43/300 (14%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI--LSQISHRNVVKLLG 445
+G+G G V++G G +AVK + + + E + + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 446 SCLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
S + L+ + G+L+ YL + L LRI +A LA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 502 YL-----PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV---STKVQGTFGYLD 553
+ I HRD+KS NIL+ + + IAD G + + + + GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 554 PE------YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607
PE + D+++FG+VL E+ + + F + V +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV-----EDYKPPFYDVVPND 240
Query: 608 CLFDILDDQV---------RKSGKTEEIM-EVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
F+ + V ++ + ++ + K C N +R T + L +I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-53
Identities = 71/337 (21%), Positives = 129/337 (38%), Gaps = 54/337 (16%)
Query: 354 LLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKK 413
L+EQ +S GS + + + +G+G G V+ G G +AVK
Sbjct: 14 LIEQSQSSGSGS---GLPLLVQRTI--AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKV 67
Query: 414 SKVVDESKLEEFINE--VVILSQISHRNVVKLLGSCLEVEVP----LLVYEFIPNGTLFQ 467
+E + E + + H N++ + + ++ L+ ++ NG+L+
Sbjct: 68 FFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124
Query: 468 YLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL-----PIYHRDIKSTNILLDEKYR 522
YL + L + L++A L +LH+ + I HRD+KS NIL+ +
Sbjct: 125 YLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180
Query: 523 AKIADFGTSRSIAIDQTHV---STKVQGTFGYLDPE------YFHSSQFTDKSDVYSFGV 573
IAD G + D V GT Y+ PE + Q +D+YSFG+
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240
Query: 574 VLVELLTGQKPISYIWANEGRNLATY---FVECVEENCLFDILDDQV---------RKSG 621
+L E+ G + Y + + V + ++ + + V
Sbjct: 241 ILWEVARRCVS--------GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW 292
Query: 622 KTEEIM-EVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
++E + ++ + C N SR T V L ++
Sbjct: 293 SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 62/302 (20%), Positives = 116/302 (38%), Gaps = 49/302 (16%)
Query: 389 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINE--VVILSQISHRNVVKLLGS 446
+G+G G V++G G +AVK + + + E + + H N++ + +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 447 CLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
+ LV ++ +G+LF YL+ + +T E +++A A LA+LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 503 L-----PIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGYLDP 554
I HRD+KS NIL+ + IAD G + S GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 555 E------YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATY---FVECVE 605
E + ++D+Y+ G+V E+ G Y + + V
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--------GGIHEDYQLPYYDLVP 272
Query: 606 ENCLFDILDDQVRKSGK----------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
+ + + V + E + ++ + + C +NG +R T + L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 656 RI 657
++
Sbjct: 333 QL 334
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 68/280 (24%), Positives = 119/280 (42%), Gaps = 34/280 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQISH 437
+F + + +G+G VY+ L DG +A+KK ++D + I E+ +L Q++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMR-LRIATEVAEALAY 496
NV+K S +E +V E G L + + ++ L E + ++ AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
+HS + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616
H + + KSD++S G +L E+ Q P + + NL + L +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYS----------LCKKI--- 250
Query: 617 VRKSGKTEEI------MEVSDVAKRCLNSNGRSRPTMKEV 650
+ + E+ + C+N + RP + V
Sbjct: 251 --EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 45/296 (15%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRI-IAVKKSKV-VDESKLEEFINEVVILS 433
L+ + + +G+G G V+ G L +AVK + + +F+ E IL
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
Q SH N+V+L+G C + + +V E + G +L L + + L++ + A
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAG 225
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY-- 551
+ YL S + HRD+ + N L+ EK KI+DFG SR A D + ++
Sbjct: 226 MEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKW 281
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE----- 605
PE + +++ +SDV+SFG++L E + G P Y + E VE
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASP--Y----PNLSNQQ-TREFVEKGGRL 334
Query: 606 ---ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
E C +M ++C RP+ + EL+ IR
Sbjct: 335 PCPELC-----------PDAVFRLM------EQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 71/282 (25%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHR 438
+ + V +G G G K +DG+I+ K+ + E++ + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 439 NVVKLLGSCLEVEVPLL--VYEFIPNGTLFQYLHDPSEELSLTWEMR-LRIATEVAEALA 495
N+V+ ++ L V E+ G L + ++E E LR+ T++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 496 YLHS--SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
H + HRD+K N+ LD K K+ DFG +R + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
PE + + +KSD++S G +L EL P + L
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKE--------------L 224
Query: 614 DDQVRKSGKTEEIM-----EVSDVAKRCLNSNGRSRPTMKEV 650
++R+ GK I E++++ R LN RP+++E+
Sbjct: 225 AGKIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 66/294 (22%), Positives = 125/294 (42%), Gaps = 50/294 (17%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR-----IIAVKKSKV-VDESKLEEFINEVVILSQI 435
F ++LG G GTVYKG+ +A+K+ + +E ++E +++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+ +V +LLG CL L+ + +P G L Y+ + + + + L ++A+ +
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMN 131
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT---FGYL 552
YL + HRD+ + N+L+ KI DFG ++ + ++ +G ++
Sbjct: 132 YLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWM 186
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE------ 605
E +T +SDV+S+GV + EL+T G KP Y + +E
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--Y-DGIPASEI----SSILEKGERLP 239
Query: 606 --ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
C D+ IM ++C + SRP +E+ +E ++
Sbjct: 240 QPPICTIDVY-----------MIM------RKCWMIDADSRPKFRELIIEFSKM 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-41
Identities = 76/296 (25%), Positives = 141/296 (47%), Gaps = 26/296 (8%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRI-IAVKKSKVVDESKLEEFINEVVILSQ 434
E+++ + LG G G VY+G+ + +AVK K D ++EEF+ E ++ +
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 272
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
I H N+V+LLG C ++ EF+ G L YL + ++ + L +AT+++ A+
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 331
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
YL ++ HR++ + N L+ E + K+ADFG SR + D + + P
Sbjct: 332 EYLEKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
E ++F+ KSDV++FGV+L E+ T G P I ++ E +E++ +
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERP 441
Query: 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI-RACNLQDDDDN 668
+ +V ++ + C N RP+ E+ E + + ++ D+ +
Sbjct: 442 EGCPE---------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 488
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 59/273 (21%), Positives = 114/273 (41%), Gaps = 34/273 (12%)
Query: 387 NRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK--LEEFINEVVILSQISHRNVVKL 443
+ +G+G TVYKG+ +A + + +K + F E +L + H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 444 LGSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
S +LV E + +GTL YL + ++ ++ + L +LH+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 147
Query: 500 SAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
PI HRD+K NI + KI D G + + + + V GT ++ PE +
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMY- 202
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV--ECVEENCLFDILDDQ 616
++ + DVY+FG+ ++E+ T + P ++ Y V+ + +
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649
V+ ++ + C+ N R ++K+
Sbjct: 259 VK------------EIIEGCIRQNKDERYSIKD 279
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 71/294 (24%), Positives = 129/294 (43%), Gaps = 33/294 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQIS 436
H LG+G G+V G ++AVK+ + + +F E+ IL +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 437 HRNVVKLLGSCLE-VEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+VK G L LV E++P+G L +L L + L ++++ + +
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGM 140
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYL 552
YL S + HRD+ + NIL++ + KIADFG ++ + +D+ + + G +
Sbjct: 141 EYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611
PE + F+ +SDV+SFGVVL EL T K + E + + + L +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLE 255
Query: 612 ILDDQVRKSGKTEEIM--------EVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+L++ R + EV ++ K C + + RP+ + +L+ +
Sbjct: 256 LLEEGQR--------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 61/295 (20%), Positives = 115/295 (38%), Gaps = 34/295 (11%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
H+ + LG+GG V L DG A+K+ ++ EE E + +H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 442 KLLGSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMR-LRIATEVAEALAY 496
+L+ CL L+ F GTL+ + ++ + E + L + + L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQ------GT 548
+H+ HRD+K TNILL ++ + + D G+ I ++ + + +Q T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 549 FGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605
Y PE F +++DV+S G VL ++ G+ P + V
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DMVFQKGDSVALAV 260
Query: 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660
+N L + + + + + RP + + +LE ++
Sbjct: 261 QNQLSIPQSPRHSS--------ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 36/302 (11%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVV 430
+ ++ H + LG+G G+V G ++AVKK + E L +F E+
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 431 ILSQISHRNVVKLLGSCLE-VEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488
IL + H N+VK G C L L+ E++P G+L YL E + L+ +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTS 121
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
++ + + YL + Y+ HRD+ + NIL++ + R KI DFG ++ + D+ K G
Sbjct: 122 QICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 549 F--GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLAT--YFVECV 604
+ PE S+F+ SDV+SFGVVL EL T + A R + V
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 605 EENCLFDILDDQVRKSGKTEEIM--------EVSDVAKRCLNSNGRSRPTMKEVAMELER 656
L ++L + R + E+ + C N+N RP+ +++A+ +++
Sbjct: 239 FH--LIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 657 IR 658
IR
Sbjct: 289 IR 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 82/302 (27%), Positives = 139/302 (46%), Gaps = 36/302 (11%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVV 430
+ ++ H + LG+G G+V G ++AVKK + E L +F E+
Sbjct: 37 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 431 ILSQISHRNVVKLLGSCLE-VEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488
IL + H N+VK G C L L+ E++P G+L YL E + L+ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTS 152
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
++ + + YL + Y+ HRD+ + NIL++ + R KI DFG ++ + D+ + K G
Sbjct: 153 QICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 549 F--GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLAT--YFVECV 604
+ PE S+F+ SDV+SFGVVL EL T + A R + V
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 605 EENCLFDILDDQVRKSGKTEEIM--------EVSDVAKRCLNSNGRSRPTMKEVAMELER 656
L ++L + R + E+ + C N+N RP+ +++A+ +++
Sbjct: 270 FH--LIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
Query: 657 IR 658
IR
Sbjct: 320 IR 321
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-41
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 53/310 (17%)
Query: 388 RILGQGGQGTVYKGMLADGR----IIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442
++G+G G VY G L D AVK + D ++ +F+ E +I+ SH NV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 443 LLGSCLEVEVPLL-VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
LLG CL E L V ++ +G L ++ + + ++ + + +VA+ + +L S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASKK 212
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL-----DPEY 556
++ HRD+ + N +LDEK+ K+ADFG +R + + T L E
Sbjct: 213 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALES 267
Query: 557 FHSSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWANEGRNLATYFVECVEE 606
+ +FT KSDV+SFGV+L EL+T G P Y+ +GR L E
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGRRLLQ------PE 319
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDD 666
C + E+M +C + RP+ E+ + I + + +
Sbjct: 320 YCPDPLY-----------EVM------LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362
Query: 667 DNIQKCYEEL 676
++ Y +
Sbjct: 363 VHVNATYVNV 372
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 76/296 (25%), Positives = 118/296 (39%), Gaps = 36/296 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKV-VDESKLEEFINEVVILSQI 435
+ R LG+G G V G ++AVK K + E+ IL +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 436 SHRNVVKLLGSCLEVEVP--LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
H +++K G C + LV E++P G+L YL S + L A ++ E
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEG 146
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GY 551
+AYLH+ Y+ HRD+ + N+LLD KI DFG ++++ + + G +
Sbjct: 147 MAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLF 610
PE +F SDV+SFGV L ELLT S V L
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR--LT 261
Query: 611 DILDDQVRKSGKTEEIM--------EVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
++L+ R + EV + K C + RPT + + L+ +
Sbjct: 262 ELLERGER--------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-41
Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 34/295 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKV-VDESKLEEFINEVVILSQI 435
R LG+G G V G +AVK K + + + E+ IL +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 436 SHRNVVKLLGSCLEVEVP--LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
H N+VK G C E L+ EF+P+G+L +YL +++L +L+ A ++ +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK--QQLKYAVQICKG 138
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GY 551
+ YL S Y+ HRD+ + N+L++ +++ KI DFG +++I D+ + + K +
Sbjct: 139 MDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLF 610
PE S+F SDV+SFGV L ELLT S + T+ V L
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR--LV 253
Query: 611 DILDDQVRKSGKTEEIM--------EVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+ L + R + EV + ++C +R + + + E +
Sbjct: 254 NTLKEGKR--------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 47/302 (15%)
Query: 382 DHFNVNRILGQGGQGTVYKGML--ADGRIIAV-----KKSKVVDESKLEEFINEVVILSQ 434
+ LG G G V +G G+ ++V K + +++FI EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+ HRN+++L G L +V E P G+L L L R A +VAE +
Sbjct: 78 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGM 134
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY--L 552
YL S ++ HRD+ + N+LL + KI DFG R++ + H + +
Sbjct: 135 GYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611
PE + F+ SD + FGV L E+ T GQ+P + G N +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--W----IGLNGS-------------Q 232
Query: 612 ILDDQVRKSGKTEEIM--------EVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663
IL ++ K G E + ++ +V +C RPT + L + +++
Sbjct: 233 IL-HKIDKEG---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
Query: 664 DD 665
+
Sbjct: 289 AE 290
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEV 429
+E++ ++ +I+G G G V G L R + A+K K E + +F++E
Sbjct: 44 REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 430 VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE 489
I+ Q H N+++L G + ++V E++ NG+L +L + ++ + +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRG 159
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
V + YL Y+ HRD+ + N+L+D K++DFG SR + D T G
Sbjct: 160 VGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 550 GYL--DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE F+ SDV+SFGVV+ E+L G++P
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
EL + + + + LG G G V G +AVK K +EF E + ++
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKL 60
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
SH +VK G C + +V E+I NG L YL S L L + +V E +A
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMA 118
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGY 551
+L S ++ HRD+ + N L+D K++DFG +R + DQ + V TK V+ +
Sbjct: 119 FLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS--- 172
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE FH +++ KSDV++FG+++ E+ + G+ P
Sbjct: 173 -APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 386 VNRILGQGGQGTVYKGMLADGRI---IAVK--KSKVVDESKLEEFINEVVILSQISHRNV 440
++ LG G GTV KG ++ +AVK K++ D + +E + E ++ Q+ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
V+++G C E +LV E G L +YL + + + + +V+ + YL S
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 136
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFH 558
++ HRD+ + N+LL ++ AKI+DFG S+++ D+ + + G + + PE +
Sbjct: 137 NFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 559 SSQFTDKSDVYSFGVVLVELLT-GQKP 584
+F+ KSDV+SFGV++ E + GQKP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
E+D + LG G G V G +A+K K +EFI E ++ +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNL 76
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
SH +V+L G C + ++ E++ NG L YL + L + +V EA+
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAME 134
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGY 551
YL S +L HRD+ + N L++++ K++DFG SR + D+ + V +K V+ +
Sbjct: 135 YLESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--- 188
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE S+F+ KSD+++FGV++ E+ + G+ P
Sbjct: 189 -PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
+D + +G G G V+ G + +A+K + E+FI E ++ ++
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKL 60
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
SH +V+L G CLE LV EF+ +G L YL + E L + +V E +A
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMA 118
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGY 551
YL + + HRD+ + N L+ E K++DFG +R + DQ + TK V+
Sbjct: 119 YLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--- 172
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE F S+++ KSDV+SFGV++ E+ + G+ P
Sbjct: 173 -SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 17/215 (7%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRI-IAVKKSKVVDESKLEEFINEVVILSQ 434
E+++ + LG G G VY+G+ + +AVK K D ++EEF+ E ++ +
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
I H N+V+LLG C ++ EF+ G L YL + ++ + L +AT+++ A+
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAM 124
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK----VQGTFG 550
YL ++ HRD+ + N L+ E + K+ADFG SR + D ++ T
Sbjct: 125 EYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-- 179
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE ++F+ KSDV++FGV+L E+ T G P
Sbjct: 180 --APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 79/326 (24%), Positives = 139/326 (42%), Gaps = 63/326 (19%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADG----RIIAVK--KSKVVDESKLEEFINEVVILSQI 435
F + R+LG+G G+V + L +AVK K+ ++ S +EEF+ E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 436 SHRNVVKLLGSCLEVE------VPLLVYEFIPNGTLFQYL--HDPSEE-LSLTWEMRLRI 486
H +V KL+G L +P+++ F+ +G L +L E +L + +R
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546
++A + YL S ++ HRD+ + N +L E +ADFG SR I + Q
Sbjct: 143 MVDIACGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQ 195
Query: 547 GTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWAN 591
G L E + +T SDV++FGV + E++T GQ P +Y+
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL--I 253
Query: 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVA 651
G L + C+ ++ ++M +C +++ + RP+ +
Sbjct: 254 GGNRL-----KQ-PPECMEEV-----------YDLM------YQCWSADPKQRPSFTCLR 290
Query: 652 MELERIRACNLQDDDDNIQKCYEELS 677
MELE I +L + Y +
Sbjct: 291 MELENILG-HLSVLSTSQDPLYINIE 315
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 55/300 (18%)
Query: 388 RILGQGGQGTVYKGMLADGR----IIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442
++G+G G VY G L D AVK + D ++ +F+ E +I+ SH NV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 443 LLGSCLEVEVPLL-VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
LLG CL E L V ++ +G L ++ + + ++ + + +VA+ + YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASKK 148
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL------DPE 555
++ HRD+ + N +LDEK+ K+ADFG +R + V G E
Sbjct: 149 FV---HRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALE 202
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWANEGRNLATYFVECVE 605
+ +FT KSDV+SFGV+L EL+T G P Y+ +GR L
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGRRL-----LQ-P 254
Query: 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDD 665
E C + E+M +C + RP+ E+ + I + + +
Sbjct: 255 EYCPDPLY-----------EVM------LKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 7e-40
Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 16/216 (7%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGML--ADGRII--AVK--KSKVVDESKLEEFINEV 429
+ + + +NRILG+G G VY+G+ G I AVK K ++K E+F++E
Sbjct: 8 GIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEA 64
Query: 430 VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE 489
VI+ + H ++VKL+G E E ++ E P G L YL L + + + +
Sbjct: 65 VIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 121
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ +A+AYL S + HRDI NIL+ K+ DFG SR I + + ++ +
Sbjct: 122 ICKAMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 178
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
++ PE + +FT SDV+ F V + E+L+ G++P
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRI-----IAVKKSKV-VDESKLEEFINE 428
E+ +++G G G VYKGML +A+K K E + +F+ E
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 429 VVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488
I+ Q SH N+++L G + + +++ E++ NG L ++L + E S+ + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLR 154
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
+A + YL + Y+ HRD+ + NIL++ K++DFG SR + D T G
Sbjct: 155 GIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 549 FGY--LDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE +FT SDV+SFG+V+ E++T G++P
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 76/277 (27%), Positives = 117/277 (42%), Gaps = 38/277 (13%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGS 446
+LG+G G VY G L++ IA+K+ D + E+ + + H+N+V+ LGS
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT-EVAEALAYLHSSAYLPI 505
E + E +P G+L L L E + T ++ E L YLH + I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 506 YHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ--F 562
HRDIK N+L++ KI+DFGTS+ +A T GT Y+ PE +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 563 TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK 622
+D++S G ++E+ TG+ P + G A F +V
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP----FYELGEPQAAMF---------------KVGMFKV 243
Query: 623 TEEIME-VSDVAK----RCLNSNGRSRPTMKEVAMEL 654
EI E +S AK +C + R A +L
Sbjct: 244 HPEIPESMSAEAKAFILKCFEPDPDKRAC----ANDL 276
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 15/218 (6%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEV 429
KELD + ++++++G G G V G L + I A+K KV E + +F+ E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 430 VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE 489
I+ Q H N+++L G + + ++V E++ NG+L +L + ++ + +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRG 155
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+A + YL Y+ HRD+ + NIL++ K++DFG R + D T G
Sbjct: 156 IASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 550 GYL--DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE +FT SDV+S+G+VL E+++ G++P
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
E+ + + + LG G G V+ G +AVK K + F+ E ++ Q+
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQL 65
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
H+ +V+L + E ++ E++ NG+L +L P + LT L +A ++AE +A
Sbjct: 66 QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMA 123
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
++ Y+ HRD+++ NIL+ + KIADFG +R I ++ + + PE
Sbjct: 124 FIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+ FT KSDV+SFG++L E++T G+ P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 14/215 (6%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEVV 430
E+ + + + R +G+G G V++G+ + + A+K K +S E+F+ E +
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 431 ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
+ Q H ++VKL+G E ++ E G L +L L L + A ++
Sbjct: 69 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQL 125
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
+ ALAYL S ++ HRDI + N+L+ K+ DFG SR + + ++K +
Sbjct: 126 STALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
++ PE + +FT SDV+ FGV + E+L G KP
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 61/272 (22%), Positives = 114/272 (41%), Gaps = 24/272 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHR 438
+ + + +G+G G DGR +K+ + + + EE EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
N+V+ S E +V ++ G LF+ ++ L + L ++ AL ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVH 142
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
I HRDIKS NI L + ++ DFG +R + + GT YL PE
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
+ + +KSD+++ G VL EL T + E ++ ++ + + F +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAF------EAGSMKNLVLKII--SGSFPPVSLHYS 250
Query: 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
++ + + N R RP++ +
Sbjct: 251 Y--------DLRSLVSQLFKRNPRDRPSVNSI 274
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 63/301 (20%), Positives = 124/301 (41%), Gaps = 52/301 (17%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGR-----IIAVKKSKV-VDESKLEEFINE 428
+ + ++LG G GTV+KG+ + +K + + +
Sbjct: 8 RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 429 VVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488
++ + + H ++V+LLG C LV +++P G+L ++ L ++ L
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGV 122
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
++A+ + YL + HR++ + N+LL + ++ADFG + + D +
Sbjct: 123 QIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEA 177
Query: 549 ---FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECV 604
++ E H ++T +SDV+S+GV + EL+T G +P Y + + +
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--Y-AGLRLAEV----PDLL 230
Query: 605 E--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656
E + C D+ +M +C + RPT KE+A E R
Sbjct: 231 EKGERLAQPQICTIDVY-----------MVM------VKCWMIDENIRPTFKELANEFTR 273
Query: 657 I 657
+
Sbjct: 274 M 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 66/294 (22%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR-----IIAVKKSKV-VDESKLEEFINEVVILSQI 435
F ++LG G GTVYKG+ +A+K+ + +E ++E +++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+ +V +LLG CL L+ + +P G L Y+ + + + + L ++A+ +
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMN 131
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT---FGYL 552
YL + HRD+ + N+L+ KI DFG ++ + ++ +G ++
Sbjct: 132 YLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWM 186
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE------ 605
E +T +SDV+S+GV + EL+T G KP Y + +E
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--Y-DGIPASEI----SSILEKGERLP 239
Query: 606 --ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
C D+ IM +C + SRP +E+ +E ++
Sbjct: 240 QPPICTIDVY-----------MIM------VKCWMIDADSRPKFRELIIEFSKM 276
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 79/312 (25%), Positives = 135/312 (43%), Gaps = 62/312 (19%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR----IIAVK--KSKVVDESKLEEFINEVVILSQI 435
+ + +ILG+G G+V +G L +AVK K + ++EEF++E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 436 SHRNVVKLLGSCLEVE-----VPLLVYEFIPNGTLFQYL---HDPSEELSLTWEMRLRIA 487
SH NV++LLG C+E+ P+++ F+ G L YL + + + L+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
++A + YL + +L HRD+ + N +L + +ADFG S+ I + QG
Sbjct: 154 VDIALGMEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQG 206
Query: 548 TFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWANE 592
+ E +T KSDV++FGV + E+ T G P Y+
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL--LH 264
Query: 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652
G L + E+CL ++ EIM C ++ RPT + +
Sbjct: 265 GHRL-----KQ-PEDCLDEL-----------YEIM------YSCWRTDPLDRPTFSVLRL 301
Query: 653 ELERIRACNLQD 664
+LE++ +L D
Sbjct: 302 QLEKLLE-SLPD 312
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 64/213 (30%), Positives = 114/213 (53%), Gaps = 19/213 (8%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
L+ + + +G+G G V G G +AVK K +++ + F+ E +++Q+
Sbjct: 17 ALNM--KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQL 71
Query: 436 SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
H N+V+LLG +E + L +V E++ G+L YL L + L+ + +V EA+
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAM 130
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYL 552
YL + ++ HRD+ + N+L+ E AK++DFG ++ + T + K V+ T
Sbjct: 131 EYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWT---- 181
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 77/297 (25%), Positives = 135/297 (45%), Gaps = 49/297 (16%)
Query: 388 RILGQGGQGTVYKGMLADGR----IIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442
R++G+G G VY G D A+K + + ++E F+ E +++ ++H NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 443 LLGSCLEVE-VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
L+G L E +P ++ ++ +G L Q++ P ++ + +VA + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK--DLISFGLQVARGMEYLAEQK 144
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTF--GYLDPEYFH 558
++ HRD+ + N +LDE + K+ADFG +R I + V + E
Sbjct: 145 FV---HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 559 SSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWANEGRNLATYFVECVEENC 608
+ +FT KSDV+SFGV+L ELLT G P ++ +GR L E C
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL--AQGRRL-----PQ-PEYC 253
Query: 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDD 665
+ ++M ++C ++ RPT + + E+E+I + L D
Sbjct: 254 PDSLY-----------QVM------QQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 3e-39
Identities = 46/214 (21%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKG--MLADGRIIAVKKSKVV----DESKLEEFINEVVILSQI 435
+ V + GG G +Y +GR + +K + D + E L+++
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK---GLVHSGDAEAQAMAMAERQFLAEV 136
Query: 436 SHRNVVKLL-----GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
H ++V++ V +V E++ +L + L + E+
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEI 191
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
AL+YLHS + + + D+K NI+L E+ + K+ D G I+ + GT G
Sbjct: 192 LPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPG 242
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ PE + T +D+Y+ G L L
Sbjct: 243 FQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVV 441
+ LG GG TVY +A+K E L+ F EV SQ+SH+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
++ E + LV E+I TL +Y+ L+ + + ++ + + + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST-KVQGTFGYLDPEYFHSS 560
I HRDIK NIL+D KI DFG +++++ + + T V GT Y PE
Sbjct: 132 ---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 561 QFTDKSDVYSFGVVLVELLTGQKP 584
+ +D+YS G+VL E+L G+ P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-39
Identities = 64/213 (30%), Positives = 113/213 (53%), Gaps = 19/213 (8%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
L+ + + +G+G G V G G +AVK K +++ + F+ E +++Q+
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQL 243
Query: 436 SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
H N+V+LLG +E + L +V E++ G+L YL L + L+ + +V EA+
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAM 302
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYL 552
YL + ++ HRD+ + N+L+ E AK++DFG ++ T + K V+ T
Sbjct: 303 EYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWT---- 353
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
PE +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-39
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
E+ + + + LGQG G V+ G +A+K K E F+ E ++ ++
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 236
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
H +V+L E E +V E++ G+L +L L + +A ++A +A
Sbjct: 237 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMA 294
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
Y+ Y+ HRD+++ NIL+ E K+ADFG +R I ++ + + PE
Sbjct: 295 YVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+FT KSDV+SFG++L EL T G+ P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 61/206 (29%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 386 VNRILGQGGQGTVYKGML--ADGRI-IAVKKSKV-VDESKLEEFINEVVILSQISHRNVV 441
+ LG G G+V +G+ +I +A+K K +++ EE + E I+ Q+ + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+L+G C E +LV E G L ++L EE+ + +V+ + YL
Sbjct: 74 RLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKN 130
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFHS 559
++ HRD+ + N+LL ++ AKI+DFG S+++ D ++ + + G + + PE +
Sbjct: 131 FV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 560 SQFTDKSDVYSFGVVLVELLT-GQKP 584
+F+ +SDV+S+GV + E L+ GQKP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-38
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
E+ + + + LGQG G V+ G +A+K K E F+ E ++ ++
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 319
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
H +V+L E E +V E++ G+L +L L + +A ++A +A
Sbjct: 320 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMA 377
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
Y+ Y+ HRD+++ NIL+ E K+ADFG +R I ++ + + PE
Sbjct: 378 YVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+FT KSDV+SFG++L EL T G+ P
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 68/284 (23%), Positives = 115/284 (40%), Gaps = 48/284 (16%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVK 442
F ++G GG G V+K DG+ +K+ V + E+ EV L+++ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLDHVNIVH 68
Query: 443 LLGSCLEVEVPL----------------LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI 486
G + + EF GTL Q++ E L + L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALEL 127
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546
++ + + Y+HS + +RD+K +NI L + + KI DFG S+ D T+ +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182
Query: 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
GT Y+ PE S + + D+Y+ G++L ELL A E T
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFT-------- 229
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ I+ D K + + ++ L+ RP E+
Sbjct: 230 DLRDGIISDIFDK--------KEKTLLQKLLSKKPEDRPNTSEI 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 67/304 (22%)
Query: 388 RILGQGGQGTVYKGMLADGR------IIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
LG+G G V+ + ++AVK K ES ++F E +L+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEEL----------SLTWEMRLRIATE 489
+ G C E L+V+E++ +G L ++L H P +L L L +A++
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 548
VA + YL ++ HRD+ + N L+ + KI DFG SR I + D V +
Sbjct: 167 VAAGMVYLAGLHFV---HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR---- 219
Query: 549 FGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWANEG 593
L PE +FT +SDV+SFGVVL E+ T G++P I I +G
Sbjct: 220 -TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI--TQG 276
Query: 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653
R L E C + IM + C + R ++K+V
Sbjct: 277 REL-----ER-PRAC-----------PPEVYAIM------RGCWQREPQQRHSIKDVHAR 313
Query: 654 LERI 657
L+ +
Sbjct: 314 LQAL 317
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 62/285 (21%), Positives = 118/285 (41%), Gaps = 40/285 (14%)
Query: 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHRN 439
+++ + +G GG V++ + +I A+K + D L+ + NE+ L+++ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87
Query: 440 --VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+++L + + +V E N L +L ++ S+ R + EA+ +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTI 143
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-GTFGYLDPE- 555
H I H D+K N L+ + K+ DFG + + D T V Q GT Y+ PE
Sbjct: 144 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 556 ----------YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605
S+ + KSDV+S G +L + G+ P + ++ ++
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAI-ID 254
Query: 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
N + D K + DV K CL + + R ++ E+
Sbjct: 255 PNHEIEF-PDIPEKDLQ--------DVLKCCLKRDPKQRISIPEL 290
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 74/305 (24%), Positives = 124/305 (40%), Gaps = 66/305 (21%)
Query: 388 RILGQGGQGTVYKGMLADGR------IIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
R LG+G G V+ + ++AVK K + ++F E +L+ + H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYL-------------HDPSEELSLTWEMRLRIAT 488
K G C + + ++V+E++ +G L ++L + L L IA+
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
++A + YL S ++ HRD+ + N L+ KI DFG SR + + G
Sbjct: 141 QIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV----GG 193
Query: 549 FGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP---------ISYIWANEG 593
L PE +FT +SDV+SFGV+L E+ T G++P I I +G
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI--TQG 251
Query: 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653
R L E C + ++M C + R +KE+
Sbjct: 252 RVL-----ER-PRVC-----------PKEVYDVM------LGCWQREPQQRLNIKEIYKI 288
Query: 654 LERIR 658
L +
Sbjct: 289 LHALG 293
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 75/322 (23%), Positives = 135/322 (41%), Gaps = 63/322 (19%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR------IIAVKKSKV-VDESKLEEFINEVVILSQ 434
+ ++R LGQG G VY+G+ +A+K + EF+NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL-------HDPSEELSLTWEMRLRIA 487
+ +VV+LLG + + L++ E + G L YL + + +++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
E+A+ +AYL+++ ++ HRD+ + N ++ E + KI DFG +R I + +G
Sbjct: 145 GEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKG 197
Query: 548 TFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFV 601
G L PE FT SDV+SFGVVL E+ T ++P + + +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VL 250
Query: 602 ECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653
V +NC + E+M + C N + RP+ E+
Sbjct: 251 RFVMEGGLLDKPDNCPDML-----------FELM------RMCWQYNPKMRPSFLEIISS 293
Query: 654 LERIRACNLQDDDDNIQKCYEE 675
++ ++ + Y E
Sbjct: 294 IKEE----MEPGFREVSFYYSE 311
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-38
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 435
E+ + + + + LG G G V+ +AVK K +E F+ E ++ +
Sbjct: 184 EIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 240
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
H +VKL + E ++ EF+ G+L +L E + + ++AE +A
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMA 298
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
++ Y+ HRD+++ NIL+ KIADFG +R I ++ + + PE
Sbjct: 299 FIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
+ FT KSDV+SFG++L+E++T G+ P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 62/284 (21%), Positives = 117/284 (41%), Gaps = 38/284 (13%)
Query: 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQISH--R 438
+++ + +G GG V++ + +I A+K + D L+ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
+++L + + +V E N L +L ++ S+ R + EA+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-GTFGYLDPE-- 555
I H D+K N L+ + K+ DFG + + D T V Q GT Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 556 ---------YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
S+ + KSDV+S G +L + G+ P + ++ ++
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLH-AIIDP 236
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
N + D K + DV K CL + + R ++ E+
Sbjct: 237 NHEIEF-PDIPEKDLQ--------DVLKCCLKRDPKQRISIPEL 271
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 18/207 (8%)
Query: 386 VNRILGQGGQGTVYKGMLAD---GRIIAVK---KSKVVDESKLEEFINEVVILSQISHRN 439
+ R++G+GG G VY+ D RI+A+K ++ D E ++ +
Sbjct: 38 LRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
VV + + I L L + L + I ++ AL H+
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST--KVQGTFGYLDPEYF 557
+ HRD+K NIL+ A + DFG + A ++ GT Y+ PE F
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKP 584
S T ++D+Y+ VL E LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 60/294 (20%), Positives = 114/294 (38%), Gaps = 46/294 (15%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRN 439
F + LG+GG G V++ D A+K+ ++ + E E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 440 VVKLLGSCLE---------VEVPLLVY---EFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
+V+ + LE + +Y + L +++ + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ- 546
++AEA+ +LHS + HRD+K +NI K+ DFG ++ D+ +
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 547 ----------GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596
GT Y+ PE H + ++ K D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------- 225
Query: 597 ATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
F +E + + T++ + + L+ + RP +
Sbjct: 226 --PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 51/234 (21%), Positives = 97/234 (41%), Gaps = 44/234 (18%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRI--------IAVKKSKVVDESKLEEFIN 427
++ + N LGQG ++KG+ + + +K + E F
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
++S++SH+++V G C+ + +LV EF+ G+L YL +++ W+ L +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--------AKIADFGTSRSIAIDQT 539
++A A+ +L + + H ++ + NILL + K++D G S ++
Sbjct: 120 KQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175
Query: 540 HVSTKVQGTFGYLD-------PE-YFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
L PE + +D +SFG L E+ + G KP
Sbjct: 176 -----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-37
Identities = 60/202 (29%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 390 LGQGGQGTVYKGML--ADGRI-IAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLG 445
LG G G+V +G+ +I +A+K K +++ EE + E I+ Q+ + +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 505
C E +LV E G L ++L EE+ + +V+ + YL ++
Sbjct: 404 VCQA-EALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 506 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY--LDPEYFHSSQFT 563
HR++ + N+LL ++ AKI+DFG S+++ D ++ + + G + PE + +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 564 DKSDVYSFGVVLVELLT-GQKP 584
+SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 38/284 (13%)
Query: 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQISH--R 438
+++ + +G GG V++ + +I A+K + D L+ + NE+ L+++
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
+++L + + +V E N L +L ++ S+ R + EA+ +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-GTFGYLDPE-- 555
I H D+K N L+ + K+ DFG + + D T V Q G Y+ PE
Sbjct: 173 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 556 ---------YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
S+ + KSDV+S G +L + G+ P + ++ ++
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLH-AIIDP 283
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
N + D K + DV K CL + + R ++ E+
Sbjct: 284 NHEIEF-PDIPEKDLQ--------DVLKCCLKRDPKQRISIPEL 318
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 386 VNRILGQGGQGTVYKGMLAD---GRIIAVK--KSKVV-DESKLEEFINEVVILSQISHRN 439
+ ILG GG V+ D R +AVK ++ + D S F E + ++H
Sbjct: 16 LGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 440 VVKLL--GS--CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+V + G +P +V E++ TL +H E +T + + + + +AL
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALN 130
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV--STKVQGTFGYLD 553
+ H + I HRD+K NI++ K+ DFG +R+IA V + V GT YL
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE +SDVYS G VL E+LTG+ P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 85/320 (26%), Positives = 128/320 (40%), Gaps = 66/320 (20%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSK-VVDESKLEEFINEVVILSQ 434
D + + LG+G G V + R +AVK K S+ ++E+ IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 435 I-SHRNVVKLLGSCLEVEVPLLV-YEFIPNGTLFQYL-------------HDPSEELSLT 479
I H NVV LLG+C + PL+V EF G L YL + + LT
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
E + + +VA+ + +L S + HRD+ + NILL EK KI DFG +R I D
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 540 HVSTKVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEG 593
+ V+ L PE +T +SDV+SFGV+L E+ + G P + +E
Sbjct: 204 Y----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 594 RNLATYFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645
F ++ + ++ + M C + RP
Sbjct: 260 ------FCRRLKEGTRMRAPDYTTPEM-----------YQTM------LDCWHGEPSQRP 296
Query: 646 TMKEVAMELERIRACNLQDD 665
T E+ L + N Q D
Sbjct: 297 TFSELVEHLGNLLQANAQQD 316
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-36
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEV 429
E+ + + + R +G+G G V++G+ + + A+K K +S E+F+ E
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 430 VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE 489
+ + Q H ++VKL+G E ++ E G L +L L L + A +
Sbjct: 443 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQ 499
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
++ ALAYL S ++ HRDI + N+L+ K+ DFG SR + + ++K +
Sbjct: 500 LSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
++ PE + +FT SDV+ FGV + E+L G KP
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 69/325 (21%), Positives = 114/325 (35%), Gaps = 48/325 (14%)
Query: 337 RRRIKQKEENFKKNGGLLLEQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQG 396
++++ + N G+LL ++L +D E + +G+G G
Sbjct: 24 SAKLQRLGPETEDNEGVLLTEKLKPVDY-----------EYREEVHWMTHQPRVGRGSFG 72
Query: 397 TVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455
V++ G AVKK V E+V + +S +V L G+ E +
Sbjct: 73 EVHRMKDKQTGFQCAVKK---VRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT-EVAEALAYLHSSAYLPIYHRDIKSTN 514
E + G+L Q + + L E R + E L YLH+ I H D+K+ N
Sbjct: 128 FMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQALEGLEYLHTRR---ILHGDVKADN 180
Query: 515 ILLDEK-YRAKIADFGTSRSIAIDQTHVSTK----VQGTFGYLDPEYFHSSQFTDKSDVY 569
+LL RA + DFG + + D S + GT ++ PE K D++
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 570 SFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEV 629
S +++ +L G P W R + E +
Sbjct: 241 SSCCMMLHMLNGCHP----WTQYFRGPLCLKI--ASEPPPIREIPPSCAPLTA------- 287
Query: 630 SDVAKRCLNSNGRSRPTMKEVAMEL 654
+ L R + AMEL
Sbjct: 288 -QAIQEGLRKEPVHRAS----AMEL 307
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 15/208 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK--LEEFINEVVILSQI-SH 437
F LG G G V+K DGR+ AVK+S + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLR-IATEVAEALAY 496
V+L + E + L E +L Q+ L E ++ + ALA+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
LHS + H D+K NI L + R K+ DFG + + G Y+ PE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPEL 227
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ +DV+S G+ ++E+ +
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMEL 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 42/233 (18%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
F +LGQG G V K D R A+KK + E KL ++EV++L+ ++H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 440 VVKLLGSCLEVEVPL-------------LVYEFIPNGTLFQYLHD---PSEELSLTWEMR 483
VV+ + LE + + E+ NGTL+ +H + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-----DEY 118
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI--------- 534
R+ ++ EAL+Y+HS I HRD+K NI +DE KI DFG ++++
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 535 -----AIDQTHVSTKVQGTFGYLDPEYFHSSQFTD-KSDVYSFGVVLVELLTG 581
++++ + GT Y+ E + + K D+YS G++ E++
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 81/311 (26%), Positives = 124/311 (39%), Gaps = 61/311 (19%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGR------IIAVKKSKVV-DESKLEEFIN 427
KE+ + + + R LG G G VY+G ++ +AVK V E +F+
Sbjct: 25 KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL----HDPSEELSLTWEMR 483
E +I+S+ +H+N+V+ +G L+ ++ E + G L +L PS+ SL
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTH 540
L +A ++A YL + ++ HRDI + N LL AKI DFG +R I +
Sbjct: 143 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 541 VSTKVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGR 594
G L PE F FT K+D +SFGV+L E+ + G P E
Sbjct: 200 RK----GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-- 253
Query: 595 NLATYFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT 646
+E V +NC G IM +C RP
Sbjct: 254 -----VLEFVTSGGRMDPPKNC-----------PGPVYRIM------TQCWQHQPEDRPN 291
Query: 647 MKEVAMELERI 657
+ +E
Sbjct: 292 FAIILERIEYC 302
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 73/318 (22%), Positives = 134/318 (42%), Gaps = 73/318 (22%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR------IIAVKKSKV-VDESKLEEFINEVVILSQ 434
+ + + LG+G G V K + +AVK K S+L + ++E +L Q
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL---------------------HDPS 473
++H +V+KL G+C + LL+ E+ G+L +L D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 474 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533
+E +LT + A ++++ + YL + HRD+ + NIL+ E + KI+DFG SR
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 534 IAIDQTHVSTKVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISY 587
+ + ++ V+ + G + E +T +SDV+SFGV+L E++T G P
Sbjct: 200 VYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 588 IWANEGRNLATYFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNS 639
I ++ +NC ++ +M +C
Sbjct: 256 IPPER-------LFNLLKTGHRMERPDNCSEEM-----------YRLM------LQCWKQ 291
Query: 640 NGRSRPTMKEVAMELERI 657
RP +++ +LE++
Sbjct: 292 EPDKRPVFADISKDLEKM 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 75/321 (23%), Positives = 131/321 (40%), Gaps = 68/321 (21%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR--------IIAVKKSK-VVDESKLEEFINEVVIL 432
D + + LG+G G V +AVK K E L + ++E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 433 SQI-SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL-------------HDPSEELSL 478
I H+N++ LLG+C + ++ E+ G L +YL + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538
T++ + ++A + YL S + HRD+ + N+L+ E KIADFG +R I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 539 THVSTKVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592
+ + T G L PE +T +SDV+SFGV++ E+ T G P I E
Sbjct: 212 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 593 GRNLATYFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR 644
+ ++ NC ++ +M + C ++ R
Sbjct: 268 -------LFKLLKEGHRMDKPANCTNEL-----------YMMM------RDCWHAVPSQR 303
Query: 645 PTMKEVAMELERIRACNLQDD 665
PT K++ +L+RI ++
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 79/298 (26%), Positives = 118/298 (39%), Gaps = 59/298 (19%)
Query: 388 RILGQGGQGTVYKGMLADGR------IIAVKKSKVV-DESKLEEFINEVVILSQISHRNV 440
R LG G G VY+G ++ +AVK V E +F+ E +I+S+ +H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYL----HDPSEELSLTWEMRLRIATEVAEALAY 496
V+ +G L+ ++ E + G L +L PS+ SL L +A ++A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 497 LHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL- 552
L + ++ HRDI + N LL AKI DFG +R I + G L
Sbjct: 197 LEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----GGCAMLP 249
Query: 553 ----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE-- 605
PE F FT K+D +SFGV+L E+ + G P E +E V
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTSG 302
Query: 606 ------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+NC G IM +C RP + +E
Sbjct: 303 GRMDPPKNC-----------PGPVYRIM------TQCWQHQPEDRPNFAIILERIEYC 343
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 36/315 (11%), Positives = 71/315 (22%), Gaps = 60/315 (19%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVI 431
L + + L G + V+ + A+K S+LE
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 432 LSQISHRNVVKLLGSCLEVEVP--------------------------LLVYEFIPNGTL 465
+++ + + + LL+ + L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDL 174
Query: 466 FQYLHD----PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521
+ ++ A L S + H N+ +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDG 231
Query: 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS--QFTDKSDVYSFGVVLVELL 579
R + D + Y E+ ++S FT + + G+ + +
Sbjct: 232 RLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 580 TGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAK----R 635
P ++ L S + D K R
Sbjct: 288 CLFLP---FGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
Query: 636 CLNSNGRSRPTMKEV 650
LN + R R E
Sbjct: 336 FLNFDRRRRLLPLEA 350
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 74/315 (23%), Positives = 129/315 (40%), Gaps = 68/315 (21%)
Query: 388 RILGQGGQGTVYKGMLADGR--------IIAVKKSK-VVDESKLEEFINEVVILSQI-SH 437
+ LG+G G V +AVK K E L + ++E+ ++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL-------------HDPSEELSLTWEMRL 484
+N++ LLG+C + ++ E+ G L +YL + E +T++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 544
++A + YL S + HRD+ + N+L+ E KIADFG +R I +
Sbjct: 207 SCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259
Query: 545 VQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLAT 598
+ T G L PE +T +SDV+SFGV++ E+ T G P I E
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------ 313
Query: 599 YFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ ++ NC ++ +M + C ++ RPT K++
Sbjct: 314 -LFKLLKEGHRMDKPANCTNEL-----------YMMM------RDCWHAVPSQRPTFKQL 355
Query: 651 AMELERIRACNLQDD 665
+L+RI ++
Sbjct: 356 VEDLDRILTLTTNEE 370
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 75/326 (23%), Positives = 131/326 (40%), Gaps = 79/326 (24%)
Query: 388 RILGQGGQGTVYKGMLADGR------IIAVKKSKV-VDESKLEEFINEVVILSQISHRNV 440
R +G+G G V++ ++AVK K +F E ++++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEEL-------------------SLT 479
VKLLG C + L++E++ G L ++L P L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
+L IA +VA +AYL ++ HRD+ + N L+ E KIADFG SR+I
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 540 HVSTKVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP--------- 584
+ + PE +++T +SDV+++GVVL E+ + G +P
Sbjct: 230 Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
Query: 585 ISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR 644
I Y+ +G L C ENC ++ +M + C + R
Sbjct: 286 IYYV--RDGNIL-----AC-PENCPLEL-----------YNLM------RLCWSKLPADR 320
Query: 645 PTMKEVAMELERIRACNLQDDDDNIQ 670
P+ + L+R+ + + +
Sbjct: 321 PSFCSIHRILQRM----CERAEGTVG 342
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 6e-35
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 23/269 (8%)
Query: 379 KATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQIS 436
+ + + LG GG G V + + G +A+K+ + + E + E+ I+ +++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 437 HRNVVKLL------GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
H NVV ++PLL E+ G L +YL+ L + +++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTHVSTKVQG 547
+ AL YLH + I HRD+K NI+L ++ KI D G ++ + DQ + T+ G
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVG 185
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607
T YL PE ++T D +SFG + E +TG +P + V E
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF------LPNWQPVQWHGKVREK 239
Query: 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRC 636
I+ +G + +
Sbjct: 240 SNEHIV-VYDDLTGAVKFSSVLPTPNHLS 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 21/219 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQISHRN 439
+ ++ ILGQG V++G G + A+K + + ++ + E +L +++H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 440 VVKLLG--SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+VKL +L+ EF P G+L+ L +PS L L + +V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 498 HSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
+ I HR+IK NI+ D + K+ DFG +R + D + GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183
Query: 554 PEYF--------HSSQFTDKSDVYSFGVVLVELLTGQKP 584
P+ + H ++ D++S GV TG P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 67/316 (21%), Positives = 122/316 (38%), Gaps = 43/316 (13%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNV 440
V R+L +GG VY+ + GR A+K+ +E K I EV + ++S H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 441 VKLLGSCLEVEVP-------LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
V+ + + L+ + G L ++L L+ + L+I + A
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ------- 546
+ ++H PI HRD+K N+LL + K+ DFG++ +I+ + + +
Sbjct: 149 VQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 547 ----GTFGYLDPEYFHSSQ---FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATY 599
T Y PE +K D+++ G +L L Q P
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--------------- 252
Query: 600 FVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
F E+ I++ + + + + L N R ++ EV +L+ I A
Sbjct: 253 F----EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 660 CNLQDDDDNIQKCYEE 675
+ I + E+
Sbjct: 309 ARNVNPKSPITELLEQ 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 78/321 (24%), Positives = 129/321 (40%), Gaps = 68/321 (21%)
Query: 387 NRILGQGGQGTVYKGMLAD--------GRIIAVKKSK-VVDESKLEEFINEVVILSQI-S 436
+ LG+G G V +AVK K E L + I+E+ ++ I
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL-------------HDPSEELSLTWEMR 483
H+N++ LLG+C + ++ E+ G L +YL + E L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543
+ A +VA + YL S + HRD+ + N+L+ E KIADFG +R I +
Sbjct: 194 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 544 KVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLA 597
+ T G L PE +T +SDV+SFGV+L E+ T G P + E
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 301
Query: 598 TYFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649
+ ++ NC ++ +M + C ++ RPT K+
Sbjct: 302 --LFKLLKEGHRMDKPSNCTNEL-----------YMMM------RDCWHAVPSQRPTFKQ 342
Query: 650 VAMELERIRACNLQDDDDNIQ 670
+ +L+RI A +
Sbjct: 343 LVEDLDRIVALTSNQEMGYYH 363
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 79/325 (24%), Positives = 136/325 (41%), Gaps = 71/325 (21%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGR------IIAVKKSK-VVDESKLEEFINEVVILSQ 434
+ + + LG G G V + +AVK K ++ E ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 435 I-SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL---------------HDPSEELSL 478
+ +H N+V LLG+C L++ E+ G L +L +EL+L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538
E L + +VA+ +A+L S + HRD+ + NILL KI DFG +R I D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 539 THVSTKVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592
+V L PE + +T +SDV+S+G+ L EL + G P Y
Sbjct: 200 NYVVK----GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--Y----P 249
Query: 593 GRNLATYFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR 644
G + + F + ++ E+ + +IM K C +++ R
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHA-----------PAEMYDIM------KTCWDADPLKR 292
Query: 645 PTMKEVAMELERIRACNLQDDDDNI 669
PT K++ +E+ + + ++I
Sbjct: 293 PTFKQIVQLIEKQ----ISESTNHI 313
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 66/302 (21%)
Query: 388 RILGQGGQGTVYKGMLADG---RIIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVK 442
++G+G G V K + A+K+ K + +F E+ +L ++ H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYL-------------HDPSEELSLTWEMRLRIATE 489
LLG+C L E+ P+G L +L S +L+ + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
VA + YL ++ HRD+ + NIL+ E Y AKIADFG SR V+ T
Sbjct: 151 VARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTM 200
Query: 550 GYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVEC 603
G L E + S +T SDV+S+GV+L E+++ G P Y L E
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--Y-CGMTCAEL----YEK 253
Query: 604 VE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655
+ NC ++ ++M ++C RP+ ++ + L
Sbjct: 254 LPQGYRLEKPLNCDDEVY-----------DLM------RQCWREKPYERPSFAQILVSLN 296
Query: 656 RI 657
R+
Sbjct: 297 RM 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 388 RILGQGGQGTVYKGMLADGR------IIAVK--KSKVVDESKLEEFINEVVILSQISHRN 439
LG+ G VYKG L +A+K K K + EEF +E ++ +++ H N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHPN 73
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH-------------DPSEELSLTWEMRLRI 486
VV LLG + + +++ + +G L ++L D + + +L + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546
++A + YL S + H+D+ + N+L+ +K KI+D G R + +
Sbjct: 134 VAQIAAGMEYLSSHHVV---HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL---- 186
Query: 547 GTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKP 584
L PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 63/312 (20%)
Query: 388 RILGQGGQGTVYKGMLADGR------IIAVKKSK-VVDESKLEEFINEVVILSQI-SHRN 439
+ LG G G V + +AVK K + E ++E+ I+S + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD-----------PSEELSLTWEMRLRIAT 488
+V LLG+C L++ E+ G L +L + + L ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
+VA+ +A+L S + HRD+ + N+LL + AKI DFG +R I D ++
Sbjct: 172 QVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK----G 224
Query: 549 FGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVE 602
L PE +T +SDV+S+G++L E+ + G P Y G + + F +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--Y----PGILVNSKFYK 278
Query: 603 CVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654
V+ IM + C RPT +++ L
Sbjct: 279 LVKDGYQMAQPAFA-----------PKNIYSIM------QACWALEPTHRPTFQQICSFL 321
Query: 655 ERIRACNLQDDD 666
+ + ++ D
Sbjct: 322 QEQAQEDRRERD 333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 6e-34
Identities = 65/306 (21%), Positives = 118/306 (38%), Gaps = 37/306 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQISHRN 439
+ ++ ILGQG V++G G + A+K + + ++ + E +L +++H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 440 VVKLLG--SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+VKL +L+ EF P G+L+ L +PS L L + +V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 498 HSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
+ I HR+IK NI+ D + K+ DFG +R + D + GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183
Query: 554 PEYF--------HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605
P+ + H ++ D++S GV TG P + R + +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGPRRNKEVMYKIIT 241
Query: 606 ENCLFDILDDQVRKSGKTEEIME--------------VSDVAKRCLNSNGRSRPTMKEVA 651
I Q ++G + + ++ V L ++ +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 652 MELERI 657
E I
Sbjct: 302 AETSDI 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 41/282 (14%)
Query: 384 FNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVK 442
F +LG G +GT+ + D R +AV K + EV +L + H NV++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAV---KRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
+ + + + E TL +Y+ + + + + + LA+LHS
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS--- 136
Query: 503 LPIYHRDIKSTNILLDEK-----YRAKIADFGTSRSIAIDQ--THVSTKVQGTFGYLDPE 555
L I HRD+K NIL+ +A I+DFG + +A+ + + V GT G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 556 YFHSSQF---TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612
T D++S G V +++ + R + C D
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSLQRQA-----NILLGACSLDC 249
Query: 613 LDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
L + +A+ + + + + RP+ K V
Sbjct: 250 LHPEK----------HEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 76/324 (23%), Positives = 126/324 (38%), Gaps = 76/324 (23%)
Query: 388 RILGQGGQGTVYKGMLADGR------IIAVKKSK-VVDESKLEEFINEVVILSQI-SHRN 439
++LG G G V +AVK K D S+ E ++E+ +++Q+ SH N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--------------------HDPSEELSLT 479
+V LLG+C L++E+ G L YL + + LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
+E L A +VA+ + +L + + HRD+ + N+L+ KI DFG +R I D
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 540 HVSTKVQGTFGYL-----DPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEG 593
+V L PE +T KSDV+S+G++L E+ + G P I +
Sbjct: 228 YVVR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283
Query: 594 RNLATYFVECVE--------ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645
F + ++ +I IM + C + R RP
Sbjct: 284 ------FYKLIQNGFKMDQPFYATEEI-----------YIIM------QSCWAFDSRKRP 320
Query: 646 TMKEVAMELERIRACNLQDDDDNI 669
+ + L L D ++ +
Sbjct: 321 SFPNLTSFLGCQ----LADAEEAM 340
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 60/302 (19%), Positives = 109/302 (36%), Gaps = 66/302 (21%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQIS- 436
T F+ +G G G+V+K + DG I A+K+SK + + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLR-IATEVAEALA 495
H +VV+ + E + L+ E+ G+L + + +S E L+ + +V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 496 YLHSSAYLPIYHRDIKSTNILLDE-------------------KYRAKIADFGTSRSIAI 536
Y+HS + + H DIK +NI + K KI D G I+
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 537 DQTHVSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRN 595
Q G +L E + K+D+++ + +V + N
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRN---- 233
Query: 596 LATYFVECVEENCLFDILDDQVRK--SGKTEEI-----MEVSDVAKRCLNSNGRSRPTMK 648
DQ + G+ I E +++ K ++ + RP+
Sbjct: 234 ------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
Query: 649 EV 650
+
Sbjct: 276 AL 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ F + R LG+G G VY I+A+K K+++ + EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
N+++L G + L+ E+ P GT+++ L + + TE+A AL+Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 125
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ----GTFGYLD 553
HS + HRDIK N+LL KIADFG S H + + GT YL
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLP 175
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE +K D++S GV+ E L G+ P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 73/292 (25%), Positives = 117/292 (40%), Gaps = 37/292 (12%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEF 425
+F +D + R+LG+G G V G+ AVK K +V ++ E
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 426 INEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLR 485
+ EV +L Q+ H N++KL + LV E G LF + + R
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAAR 130
Query: 486 IATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVS 542
I +V + Y+H I HRD+K N+LL + +I DFG S + +
Sbjct: 131 IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKM 185
Query: 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE 602
GT Y+ PE H + + +K DV+S GV+L LL+G P + G N +
Sbjct: 186 KDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN------GANEYDILKK 238
Query: 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ F+ + +VS+ AK + L R + ++
Sbjct: 239 VEKGKYTFE-----------LPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 38/302 (12%), Positives = 75/302 (24%), Gaps = 63/302 (20%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH------ 437
+LGQ + G V ++ + +++ EV+ L +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 438 ----------RNVVKLLGSCLEVEV-----------PLLVYEFI--PNGTLFQYLHD-PS 473
++VK + V +Y + T + L S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 474 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533
SL RL++ +V LA LH + H ++ +I+LD++ + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQ-----FTDKSDVYSFGVVLVELLTGQKPISYI 588
+ Q T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 589 WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648
+ I V + + L R
Sbjct: 317 -----------NTDDAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPL 359
Query: 649 EV 650
+
Sbjct: 360 QA 361
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 4e-32
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ F V +LG+G VY+ + G +A+K K + ++ NEV I Q+ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 438 RNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
++++L E + LV E NG + +YL + + S E R ++ + Y
Sbjct: 71 PSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEAR-HFMHQIITGMLY 127
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ------GTFG 550
LHS I HRD+ +N+LL KIADFG + T + + GT
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPN 177
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
Y+ PE S +SDV+S G + LL G+ P
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-32
Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 38/291 (13%)
Query: 371 IFNSKELDKATDHFNVNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFI 426
+F + + ++ + + LG G G V A+K K+ V S + +
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLL 84
Query: 427 NEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI 486
EV +L + H N++KL + LV E G LF + + I
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVI 141
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVST 543
+V + YLH I HRD+K N+LL ++ KI DFG S +
Sbjct: 142 IKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMK 196
Query: 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603
+ GT Y+ PE + +K DV+S GV+L LL G P G+ +
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG------GQTDQEILRKV 249
Query: 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ FD + E VS+ AK + L + + R + ++
Sbjct: 250 EKGKYTFD-----------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ +G+G G V GR +AVK + + + E NEVVI+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
VV++ S L E ++ EF+ G L D ++ L E + V +ALAYLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+ HRDIKS +ILL R K++DFG I+ D + V GT ++ PE
Sbjct: 160 QG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
S + + D++S G++++E++ G+ P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ +GQG GTVY M +A G+ +A+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+V L S L + +V E++ G+L D E + + E +AL +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+ + HRDIKS NILL K+ DFG I +Q+ ST V GT ++ PE
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP 584
+ K D++S G++ +E++ G+ P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
D F++ R LG+G G VY LA + I+A+K KS++ E + E+ I S
Sbjct: 14 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP---SEELSLTWEMRLRIATEVA 491
+ H N++++ + + L+ EF P G L++ L E+ S E+A
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA------TFMEELA 124
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
+AL Y H + HRDIK N+L+ K KIADFG S + GT Y
Sbjct: 125 DALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDY 178
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
L PE +K D++ GV+ E L G P
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 77/329 (23%), Positives = 127/329 (38%), Gaps = 53/329 (16%)
Query: 356 EQQLNSLDGSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKS 414
EQQ L+ + K + D F LG G G V+K G ++A K
Sbjct: 11 EQQRKRLEAFLT----QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI 66
Query: 415 KV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPS 473
+ + + + I E+ +L + + +V G+ + E + G+L Q L
Sbjct: 67 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 126
Query: 474 --EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531
E L +++ V + L YL I HRD+K +NIL++ + K+ DFG S
Sbjct: 127 RIPEQILG-----KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 532 ----RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISY 587
S+A + V GT Y+ PE + ++ +SD++S G+ LVE+ G+ PI
Sbjct: 180 GQLIDSMA--NSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 588 IWANEGRNLATYFVECVEENC-----------------------LFDILDDQVRKSGKTE 624
A E + VE +F++LD V +
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292
Query: 625 EIMEVSDVAK----RCLNSNGRSRPTMKE 649
S + +CL N R +K+
Sbjct: 293 PSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 41/320 (12%), Positives = 85/320 (26%), Gaps = 74/320 (23%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVI 431
EL + +LGQ + G V ++ + +++ EV+
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 432 LSQI-------------------------SHRNVVKLLGSCLEVEVP--LLVYEFI--PN 462
L + + ++++ ++ V +Y +
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 463 GTLFQYLHD-PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521
T + L S SL RL++ +V LA LH + H ++ +I+LD++
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 243
Query: 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF-----------HSSQFTDKSDVYS 570
+ F + G+ PE + T D ++
Sbjct: 244 GVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 571 FGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVS 630
G+V+ + P + I V
Sbjct: 299 LGLVIYWIWCADLP---------------ITKDAALGGSEWIFRSCKNIPQ------PVR 337
Query: 631 DVAKRCLNSNGRSRPTMKEV 650
+ + L R +
Sbjct: 338 ALLEGFLRYPKEDRLLPLQA 357
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 71/305 (23%), Positives = 110/305 (36%), Gaps = 62/305 (20%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNV 440
+ +ILG G GTV GR +AV K + + + E+ +L++ H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAV---KRMLIDFCDIALMEIKLLTESDDHPNV 71
Query: 441 VKLLGSCLEVEVPLLVY---EFIPNGTLFQYLHDP---SEELSLTWEMRLR-IATEVAEA 493
++ S +Y E N L + E L L E + ++A
Sbjct: 72 IRYYCSE---TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEK-------------YRAKIADFGTSRSIAIDQTH 540
+A+LHS L I HRD+K NIL+ R I+DFG + + Q+
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 541 VSTKVQ---GTFGYLDPEYFHSSQF-------TDKSDVYSFGVVLVELLT-GQKPISYIW 589
T + GT G+ PE S T D++S G V +L+ G+ P
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FG 241
Query: 590 ANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRP 645
R E N + I K + A + ++ + RP
Sbjct: 242 DKYSR----------ESNIIRGIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 646 TMKEV 650
T +V
Sbjct: 289 TAMKV 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 15/208 (7%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ F+V LG+G G+VYK + G+I+A+K+ V ES L+E I E+ I+ Q +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT---EVAEALAY 496
VVK GS + +V E+ G++ + ++ L+ IAT + L Y
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLEY 140
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
LH HRDIK+ NILL+ + AK+ADFG + + +T + GT ++ PE
Sbjct: 141 LHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ +D++S G+ +E+ G+ P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ + + LG G G VYK G + A K + E +LE++I E+ IL+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT---EVAEALAY 496
+VKLLG+ ++ EF P G + + + L+ I ++ EAL +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE- 555
LHS I HRD+K+ N+L+ + ++ADFG S + + GT ++ PE
Sbjct: 133 LHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 556 ----YFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ + K+D++S G+ L+E+ + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 76/301 (25%), Positives = 111/301 (36%), Gaps = 47/301 (15%)
Query: 371 IFNSKELDKATDHFNVNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVD-------- 418
++ K+ K + + R LG G G V A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 419 --ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEEL 476
E EE NE+ +L + H N++KL + + LV EF G LF+ +
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRH 141
Query: 477 SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRS 533
I ++ + YLH I HRDIK NILL + KI DFG S
Sbjct: 142 KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG 593
+ + GT Y+ PE + +K DV+S GV++ LL G P G
Sbjct: 199 --FSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFG------G 249
Query: 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKE 649
+N + + FD + +SD AK L + R T +E
Sbjct: 250 QNDQDIIKKVEKGKYYFD-----------FNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 650 V 650
Sbjct: 299 A 299
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVILSQISHR 438
+ F +G+G G V+KG+ +++A+K + E ++E+ E+ +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQ-YLHDPSEELSLTWEMRLRIAT---EVAEAL 494
V K GS L+ ++ E++ G+ P +E IAT E+ + L
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ--------IATILREILKGL 132
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
YLHS HRDIK+ N+LL E K+ADFG + + Q +T V GT ++ P
Sbjct: 133 DYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKPIS 586
E S + K+D++S G+ +EL G+ P S
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ R LG+GG ++ + A K KS ++ + E+ E+ I ++H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 438 RNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAEAL 494
++VV G E + +V E +L + E E R ++
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIVLGC 154
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
YLH + + HRD+K N+ L+E KI DFG + + D + GT Y+ P
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
E + + DV+S G ++ LL G+ P
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 55/239 (23%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLA--DGRIIAVK-----------------K 413
KE DK + + + R L QG + L D + A+K
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 414 SKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLH-- 470
K+ +SK ++F NE+ I++ I + + G + + ++YE++ N ++ ++
Sbjct: 79 DKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 471 ---DPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527
D + + ++ I V + +Y+H+ I HRD+K +NIL+D+ R K++D
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSD 195
Query: 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTD--KSDVYSFGVVLVELLTGQKP 584
FG S +GT+ ++ PE+F + + K D++S G+ L + P
Sbjct: 196 FGES---EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ R LG+GG ++ + A K KS ++ + E+ E+ I ++H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 438 RNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAEAL 494
++VV G E + +V E +L + E E R ++
Sbjct: 75 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIVLGC 128
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
YLH + + HRD+K N+ L+E KI DFG + + D + GT Y+ P
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
E + + DV+S G ++ LL G+ P
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 43/235 (18%), Positives = 76/235 (32%), Gaps = 23/235 (9%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKS---KVVDESKLEEF- 425
I E + V+ +LG+G VY+ D K+ KV + EF
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112
Query: 426 --INEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD--PSEELSLTWE 481
+ L +K + L +LV E GTL ++ + E +
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 482 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA-----------KIADFGT 530
+ + A + + +H I H DIK N +L + + D G
Sbjct: 173 LVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 531 SRSI-AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
S + + + T T G+ E + + + D + + +L G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 71/281 (25%), Positives = 110/281 (39%), Gaps = 38/281 (13%)
Query: 381 TDHFNVNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
+ +N+ +LG+G G V K + AVK K+ ++ + EV +L ++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLD 79
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H N++KL + +V E G LF + + + RI +V + Y
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITY 136
Query: 497 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
+H I HRD+K NILL ++ KI DFG S Q GT Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIA 191
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
PE + + +K DV+S GV+L LL+G P G+N FD
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY------GKNEYDILKRVETGKYAFD-- 242
Query: 614 DDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ +SD AK + L + R T +
Sbjct: 243 ---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 42/277 (15%), Positives = 85/277 (30%), Gaps = 57/277 (20%)
Query: 390 LGQGGQGTVYKGMLAD---GRIIAVK---KSKVVDESKLEEFINEVVILSQISHRNVVKL 443
G ++ + D R +A+ V+ + L+E ++ + LS+I V ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503
L L+V E+I G+L + + +R +A A H +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT 563
+ + + + +A T +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPD------------------ANPQ-------- 182
Query: 564 DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623
D+ G L LL + P+ G A D + +
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----------ERDTAGQPIEPADID 229
Query: 624 EEI-MEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
+I ++S VA R + +G R + +++ A
Sbjct: 230 RDIPFQISAVAARSVQGDGGIRSAS-TLLNLMQQATA 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVD----ESKLEEFINEVVILSQIS 436
D + + ++G G V +A+K ++ ++ ++E + E+ +SQ
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCH 71
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNG---TLFQYLHDPSEELSLTWEMRLRIAT---EV 490
H N+V S + + LV + + G + +++ E S + IAT EV
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREV 130
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF- 549
E L YLH + + HRD+K+ NILL E +IADFG S +A KV+ TF
Sbjct: 131 LEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 550 G---YLDPEYFHSSQFTD-KSDVYSFGVVLVELLTGQKPIS 586
G ++ PE + D K+D++SFG+ +EL TG P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 43/224 (19%), Positives = 84/224 (37%), Gaps = 31/224 (13%)
Query: 381 TDHFNVNRILGQGGQ--GTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQI 435
+ + ++G+G + TV G + V++ + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLF----QYLHDPSEELSLTWEMRLRIAT--- 488
+H N+V + + +V F+ G+ + D EL+ IA
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA--------IAYILQ 135
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-- 546
V +AL Y+H Y+ HR +K+++IL+ + ++ ++ S+
Sbjct: 136 GVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 547 ----GTFGYLDPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKP 584
+L PE + + KSD+YS G+ EL G P
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
+ F +ILG+G TV +LA R A+K K ++ E+K+ E ++S+
Sbjct: 30 EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEA 493
+ H VKL + + E + NG L +Y+ + S E R E+ A
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD-ETCTRFYTAEIVSA 142
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-VQGTFGYL 552
L YLH I HRD+K NILL+E +I DFGT++ ++ + GT Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE SD+++ G ++ +L+ G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK---LEEFINEVVILSQIS 436
F+ R +G G G VY + + ++A+KK + ++ I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNG--TLFQYLHDPSEELSLTWEMRLRIAT---EVA 491
H N ++ G L LV E+ L + P +E+ IA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE--------IAAVTHGAL 164
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
+ LAYLHS + HRD+K+ NILL E K+ DFG++ +A + V GT +
Sbjct: 165 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYW 216
Query: 552 LDPE---YFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ PE Q+ K DV+S G+ +EL + P
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-28
Identities = 76/320 (23%), Positives = 124/320 (38%), Gaps = 59/320 (18%)
Query: 361 SLDGSIDRCKIFNSKELDKAT-------DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK 412
+L S ++ +F +D + D + +++ LG G G V + +A++
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 413 ---KSKVV-----DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGT 464
K K + E+ IL +++H ++K+ + +V E + G
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGE 225
Query: 465 LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKY 521
LF + L ++ A+ YLH I HRD+K N+LL +E
Sbjct: 226 LFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDC 279
Query: 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF---TDKSDVYSFGVVLVEL 578
KI DFG S+ + + + + T GT YL PE S D +S GV+L
Sbjct: 280 LIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337
Query: 579 LTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGK----TEEIMEVSDVAK 634
L+G P F E + L DQ+ SGK E EVS+ A
Sbjct: 338 LSGYPP---------------FSEHRTQVSLK----DQI-TSGKYNFIPEVWAEVSEKAL 377
Query: 635 ----RCLNSNGRSRPTMKEV 650
+ L + ++R T +E
Sbjct: 378 DLVKKLLVVDPKARFTTEEA 397
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
D++++ LG G G V++ + A GR+ K +D+ NE+ I++Q+
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 106
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H ++ L + + +L+ EF+ G LF + E+ ++ + + E L +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKH 164
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
+H I H DIK NI+ + K + KI DFG + ++ + T + P
Sbjct: 165 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAP 219
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
E +D+++ GV+ LL+G P
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 60/280 (21%), Positives = 107/280 (38%), Gaps = 37/280 (13%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
DH++++ LG G G V++ A G A K D+ E E+ +S +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 212
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H +V L + + +++YEF+ G LF+ + D E ++ + + +V + L +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCH 270
Query: 497 LHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
+H H D+K NI+ K K+ DFG + +D GT + P
Sbjct: 271 MHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAP 325
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614
E +D++S GV+ LL+G P G N + D
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPF------GGENDDETLRNVKSCDWNMD--- 376
Query: 615 DQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+S+ K + L ++ +R T+ +
Sbjct: 377 --------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
F +LG G V+ G++ A+K KS +S LE NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H N+V L LV + + G LF + E T + + +V A+ Y
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVKY 121
Query: 497 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
LH I HRD+K N+L +E + I DFG S+ ++Q + + GT GY+
Sbjct: 122 LHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVA 175
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE ++ D +S GV+ LL G P
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 67/282 (23%), Positives = 107/282 (37%), Gaps = 38/282 (13%)
Query: 381 TDHFNVNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
D F R LG G G V+ + G +K K + + +E+ E+ +L +
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD 78
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEEL-SLTWEMRLRIATEVAEALA 495
H N++K+ + +V E G L + + +L+ + ++ ALA
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 496 YLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
Y HS + H+D+K NIL KI DFG + ST GT Y+
Sbjct: 139 YFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTALYM 193
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612
PE F T K D++S GVV+ LLTG P G +L + + +
Sbjct: 194 APEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF------TGTSLEEVQQKATYKEPNYA- 245
Query: 613 LDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
E ++ A + L + RP+ +V
Sbjct: 246 -----------VECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 73/285 (25%), Positives = 114/285 (40%), Gaps = 46/285 (16%)
Query: 381 TDHFNVNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
+ +N+ +LG+G G V K + AVK K+ ++ + EV +L ++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLD 79
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H N++KL + +V E G LF + + + RI +V + Y
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITY 136
Query: 497 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
+H I HRD+K NILL ++ KI DFG S Q GT Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIA 191
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
PE + + +K DV+S GV+L LL+G P G+N E +
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY------GKN----------EYDIL--- 231
Query: 614 DDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+V GK + +SD AK + L + R T +
Sbjct: 232 -KRVET-GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 60/281 (21%), Positives = 102/281 (36%), Gaps = 40/281 (14%)
Query: 381 TDHFNVNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
++ + +G+G G V A K K V D + + E+ I+ +
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLD 64
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H N+++L + + LV E G LF+ + + RI +V A+AY
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAY 121
Query: 497 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
H L + HRD+K N L K+ DFG + + GT Y+
Sbjct: 122 CHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVS 176
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
P+ + + D +S GV++ LL G P S + ++ E F
Sbjct: 177 PQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFS------APTDSEVMLKIREGTFTFP-- 227
Query: 614 DDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
++ + VS A+ R L + + R T +
Sbjct: 228 ---------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 50/295 (16%), Positives = 98/295 (33%), Gaps = 35/295 (11%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEE---FI 426
K+ + +H + R + K I +S S
Sbjct: 50 KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPS 109
Query: 427 NEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI 486
++ + S +N V L + + L +++ + L I
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169
Query: 487 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546
++AEA+ +LHS + HRD+K +NI K+ DFG ++ D+ +
Sbjct: 170 FIQIAEAVEFLHSKGLM---HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 547 -----------GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRN 595
GT Y+ PE H + ++ K D++S G++L ELL
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------- 277
Query: 596 LATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
E + + + T++ + + + L+ + RP ++
Sbjct: 278 ---------ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRN 439
F + +G+GG G V++ D A+K+ ++ + E E+ + EV L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEM 482
+V+ + LE E + P S
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 44/288 (15%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL--EEFINEVVILSQ 434
D + + ++G+G V + + G+ AVK +K L E+ E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD-PSEELSLTWEMRLRIATEVAEA 493
+ H ++V+LL + + +V+EF+ L + + + ++ EA
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 494 LAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
L Y H I HRD+K +LL + K+ FG + + +V GT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
++ PE + DV+ GV+L LL+G P + + R LF
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP---FYGTKER--------------LF 241
Query: 611 DILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ + GK + +S+ AK R L + R T+ E
Sbjct: 242 ----EGI-IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 20/229 (8%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFIN 427
KI + D + +G+G G+V K + G+I+AVK+ + VDE + ++ +
Sbjct: 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 428 EV-VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-R 485
++ V++ +V+ G+ + E + Y + S + E L +
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 486 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHV 541
I +AL +L + L I HRDIK +NILLD K+ DFG S SIA
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA------ 181
Query: 542 STKVQGTFGYLDPEYFHSSQFTD----KSDVYSFGVVLVELLTGQKPIS 586
T+ G Y+ PE S +SDV+S G+ L EL TG+ P
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HR 438
F + ++G G G VYKG + G++ A+K V + EE E+ +L + S HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 439 NVVKLLGSCLEVEVPL------LVYEFIPNGTLFQYLHDPSEELSLTWEMRLR---IAT- 488
N+ G+ ++ P LV EF G++ ++ + T L+ IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEEWIAYI 134
Query: 489 --EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 546
E+ L++LH + HRDIK N+LL E K+ DFG S + +T +
Sbjct: 135 CREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI- 190
Query: 547 GTFGYLDPEYFHSSQFTD-----KSDVYSFGVVLVELLTGQKP 584
GT ++ PE + D KSD++S G+ +E+ G P
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 433
D +++ LG G V K + G A K K + + EE EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
Q+ H NV+ L +L+ E + G LF +L +++ SL+ E ++ +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDG 127
Query: 494 LAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ YLH+ I H D+K NI+L K+ DFG + I+ + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIFGTP 182
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ PE + ++D++S GV+ LL+G P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
DHF + R +G+G G V D ++ A+K K K V+ +++ E+ I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEALAY 496
+V L S + E +V + + G L +L + + E +++ E+ AL Y
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK-EETVKLFICELVMALDY 130
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
L + I HRD+K NILLDE I DF + + + + + GT Y+ PE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 557 FHSSQFT--DKS-DVYSFGVVLVELLTGQKP 584
F S + + D +S GV ELL G++P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
+D+++V LG+G V + + G A K K+ ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQ 63
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H N+V+L S E LV++ + G LF+ + + ++ E++AY
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAY 120
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRA---KIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
HS I HR++K N+LL K + K+ADFG + + + + GT GYL
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLS 175
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE ++ D+++ GV+L LL G P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 64/285 (22%), Positives = 122/285 (42%), Gaps = 35/285 (12%)
Query: 377 LDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEV-VILS 433
++ D LG+G G V K + G+I+AVK+ + V+ + + + ++ + +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL-RIATEVAE 492
+ V G+ + E + + +L ++ ++ E L +IA + +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGT 548
AL +LHS L + HRD+K +N+L++ + K+ DFG S +A D G
Sbjct: 121 ALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-----IDA-GC 172
Query: 549 FGYLDPE----YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604
Y+ PE + ++ KSD++S G+ ++EL + P + T F
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--------SWGTPF---- 220
Query: 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649
L ++++ + + E D +CL N + RPT E
Sbjct: 221 --QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 44/289 (15%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVIL 432
D +D F V LG+G VY+ + A+K K VD+ + E+ +L
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVL 102
Query: 433 SQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
++SH N++KL LV E + G LF + E+ + ++ E
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERDAADAVKQILE 159
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
A+AYLH I HRD+K N+L KIADFG S+ + + + V GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTP 214
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609
GY PE + + D++S G++ LL G +P F + + +
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FYDERGDQFM 259
Query: 610 FDILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
F ++ + + EVS AK + + + + R T +
Sbjct: 260 F----RRILN-CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 63/277 (22%), Positives = 112/277 (40%), Gaps = 37/277 (13%)
Query: 387 NRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLL 444
++ LG+G K + + AVK ++ + E+ L H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLP 504
+ LV E + G LF+ + ++ + I ++ A++++H +
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHD---VG 126
Query: 505 IYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
+ HRD+K N+L ++ KI DFG +R D + T T Y PE + +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
+ + D++S GV+L +L+GQ P +++ T VE + +++K G
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVP---FQSHDRSLTCTSAVE------IM----KKIKK-G 231
Query: 622 K----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
E VS AK L + R M +
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 433
D +++ LG G V K + G A K K + + EE EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
Q+ H N++ L +L+ E + G LF +L +++ SL+ E ++ +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDG 127
Query: 494 LAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ YLH+ I H D+K NI+L K+ DFG + I+ + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIFGTP 182
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ PE + ++D++S GV+ LL+G P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 12/225 (5%)
Query: 367 DRCKIFNSKELDKAT-DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESK 421
R + E D F R+LG+GG G V+ + G++ A K K ++
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 422 LEEFINEVVILSQISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTW 480
+ + E IL+++ R +V L E + L LV + G + ++++ E+
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 481 EMRLRI-ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
E R ++ L +LH I +RD+K N+LLD+ +I+D G + + QT
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
GT G++ PE ++ D ++ GV L E++ + P
Sbjct: 345 KTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 16/228 (7%)
Query: 364 GSIDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDE 419
+ R F K +D+++V LG+G V + + G A K K+
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70
Query: 420 SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLT 479
++ E I ++ H N+V+L S E LV++ + G LF+ + +
Sbjct: 71 DF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYS 126
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA---KIADFGTSRSIAI 536
++ E++AY HS I HR++K N+LL K + K+ADFG + +
Sbjct: 127 EADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-- 181
Query: 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ + GT GYL PE ++ D+++ GV+L LL G P
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 36/281 (12%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
T+ + + LG+G V + + + G+ A K+ ++ E I +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLK 68
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H N+V+L S E L+++ + G LF+ + + ++ EA+ +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLH 125
Query: 497 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
H + + HR++K N+LL + K+ADFG + + +Q GT GYL
Sbjct: 126 CHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLS 181
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
PE + D+++ GV+L LL G P W + + + F
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPP---FW---DEDQHRLYQQIKAGAYDFP-- 233
Query: 614 DDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ E V+ AK + L N R T E
Sbjct: 234 ---------SPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 27/228 (11%)
Query: 373 NSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEV- 429
+ + +G G G V+K G +IAVK+ + ++ + + + ++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 430 VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIA 487
V+L +V+ G+ + + E + P E L ++
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMT 130
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVST 543
+ +AL YL + HRD+K +NILLDE+ + K+ DFG S A
Sbjct: 131 VAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA------KD 182
Query: 544 KVQGTFGYLDPEYFHSSQFTD-----KSDVYSFGVVLVELLTGQKPIS 586
+ G Y+ PE T ++DV+S G+ LVEL TGQ P
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 381 TDHFNVNR--ILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
+ V++ ILG G G V+K A G +A K + D+ EE NE+ +++Q
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQ 142
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+ H N+++L + +LV E++ G LF + D E +LT + ++ E +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGI 200
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
++H + I H D+K NIL + KI DFG +R GT +L
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNFGTPEFL 255
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE + + +D++S GV+ LL+G P
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 75/293 (25%), Positives = 116/293 (39%), Gaps = 52/293 (17%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEE-----FINEVVI 431
D + +++ LG G G V + +A+K K K S E E+ I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 432 LSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
L +++H ++K+ + +V E + G LF + L ++
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQML 124
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
A+ YLH I HRD+K N+LL +E KI DFG S+ + +T + + GT
Sbjct: 125 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGT 179
Query: 549 FGYLDPEYFHSSQ---FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605
YL PE S + D +S GV+L L+G P F E
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSEHRT 224
Query: 606 ENCLFDILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ L DQ+ SGK E EVS+ A + L + ++R T +E
Sbjct: 225 QVSLK----DQI-TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 433
D+++ LG G V K + G A K K + + E+ EV IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
+I H NV+ L +L+ E + G LF +L +E+ SLT E ++
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNG 126
Query: 494 LAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ YLHS L I H D+K NI+L K R KI DFG + ID + + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGTP 181
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ PE + ++D++S GV+ LL+G P
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQISH 437
+ + + LG+G G V++ + + + K K K D+ ++ E+ IL+ H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARH 60
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
RN++ L S +E ++++EFI +F+ ++ L + +V EAL +L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFL 118
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
HS I H DI+ NI+ + + KI +FG +R + + Y PE
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPE 173
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ +D++S G ++ LL+G P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 66/300 (22%)
Query: 374 SKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFIN-- 427
KE + + V +LG GG G+VY G+ ++D +A+K K ++ D +L
Sbjct: 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 428 -EVVILSQISHR--NVVKLLGSCLEV-EVP---LLVYEFI-PNGTLFQYL--HDP-SEEL 476
EVV+L ++S V++LL + E P +L+ E P LF ++ EEL
Sbjct: 95 MEVVLLKKVSSGFSGVIRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 477 SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIA 535
+ R +V EA+ + H+ + HRDIK NIL+D + K+ DFG+ A
Sbjct: 151 A-----R-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 198
Query: 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPISYIWANEGR 594
+ + V T GT Y PE+ ++ + V+S G++L +++ G P
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------- 248
Query: 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
F+ D+ G+ VS + CL RPT +E+
Sbjct: 249 ---------------FE--HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 433
DH+ + LG G V K G+ A K K ++ + EE EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
+I H N++ L +L+ E + G LF +L +E+ SLT + + ++ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDG 120
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRA----KIADFGTSRSIAIDQTHVSTKVQGTF 549
+ YLHS I H D+K NI+L +K K+ DFG + I+ + + GT
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIFGTP 175
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ PE + ++D++S GV+ LL+G P
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 68/333 (20%), Positives = 117/333 (35%), Gaps = 74/333 (22%)
Query: 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK-----KSKVVDESKLEEF 425
F L + +++ +GQG G V + I A+K K + ++ +E
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 426 INEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRL- 484
EV ++ ++ H N+ +L + + LV E G L L+ ++ + M +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 485 ------------------------------------RIATEVAEALAYLHSSAYLPIYHR 508
I ++ AL YLH+ I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHR 192
Query: 509 DIKSTNILL--DEKYRAKIADFGTSRSIAI---DQTHVSTKVQGTFGYLDPEYFHSSQ-- 561
DIK N L ++ + K+ DFG S+ + + T GT ++ PE +++
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
+ K D +S GV+L LL G P G N A + + + F+
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVPF------PGVNDADTISQVLNKKLCFE---------- 296
Query: 622 KTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+S +A+ LN N R
Sbjct: 297 -NPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 26/219 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
D F + +++G+G V + G++ A+K K ++ ++ F E +L
Sbjct: 61 DDFEILKVIGRGAFSEV---AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 435 ISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAE 492
R + +L + E L LV E+ G L L E + R E+
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIVM 173
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
A+ +H L HRDIK NILLD ++ADFG+ + D T S GT YL
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 553 DPEYFHSSQFTDKSDVY-------SFGVVLVELLTGQKP 584
PE + + Y + GV E+ GQ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
+ F + +++G+G G V + ++ A+K K +++ ++ F E +L
Sbjct: 74 EDFEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEA 493
+ + L + + LV ++ G L L + L E R E+ A
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVIA 187
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
+ +H L HRDIK NIL+D ++ADFG+ + D T S+ GT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 554 PEYFHSSQFTDKS-----DVYSFGVVLVELLTGQKP 584
PE + + D +S GV + E+L G+ P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHR 438
++ + + +G+G V + GR +A+K K+++ + + L++ EV I+ ++H
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHP 74
Query: 439 NVVKLLGSCLEV-EVP---LLVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAE 492
N+VKL EV E L+ E+ G +F YL H +E E R ++
Sbjct: 75 NIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EAR-SKFRQIVS 125
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
A+ Y H I HRD+K+ N+LLD KIADFG S + + G Y
Sbjct: 126 AVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYA 180
Query: 553 DPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKP 584
PE F ++ + DV+S GV+L L++G P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVD------ESKLEEFINEVV 430
+++ ILG+G V + + + AVK + + E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 431 ILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE 489
IL ++S H N+++L + LV++ + G LF YL +E+++L+ + +I
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRA 132
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ E + LH L I HRD+K NILLD+ K+ DFG S +D +V GT
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTP 187
Query: 550 GYLDPEYFHSSQFTDKS------DVYSFGVVLVELLTGQKP 584
YL PE S + D++S GV++ LL G P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 13/227 (5%)
Query: 364 GSIDRCKIFNSKELDKAT-DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVD 418
+R + E T + F R+LG+GG G V + G++ A K K ++
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 419 ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELS 477
+NE IL +++ R VV L E + L LV + G L +++ +
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283
Query: 478 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537
A E+ L LH I +RD+K NILLD+ +I+D G + +
Sbjct: 284 PEARAVFYAA-EICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
Query: 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
QT + +V GT GY+ PE + ++T D ++ G +L E++ GQ P
Sbjct: 340 QT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 79/303 (26%), Positives = 128/303 (42%), Gaps = 68/303 (22%)
Query: 373 NSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFIN- 427
K+ + + + +LG+GG GTV+ G L D +A+K +++V+ S L + +
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 428 --EVVILSQIS----HRNVVKLLGSCLEV-EVP---LLVYEF-IPNGTLFQYL--HDP-S 473
EV +L ++ H V++LL + E +LV E +P LF Y+ P
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLL----DWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137
Query: 474 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSR 532
E S R +V A+ + HS + HRDIK NIL+D + AK+ DFG+
Sbjct: 138 EGPS-----R-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG- 187
Query: 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPISYIWAN 591
A+ T GT Y PE+ Q+ + V+S G++L +++ G P
Sbjct: 188 --ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP------- 238
Query: 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVA----KRCLNSNGRSRPTM 647
F+ DQ + VS +RCL SRP++
Sbjct: 239 ------------------FE--RDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSL 278
Query: 648 KEV 650
+E+
Sbjct: 279 EEI 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 38/279 (13%)
Query: 336 IRRRIKQKEENFKKNGGLL-LEQQLNSLDGSIDRCK---IFNSKELDKAT---------- 381
R ++ + + + + L+ LD + + +K +D
Sbjct: 2 FETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKI 61
Query: 382 -------DHFNVNRILGQGGQGTVYK-GMLADGRIIAVK---KSKVVDESKLEEFINEVV 430
+ + V +++G+G G V + ++ A+K K +++ S F E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 431 ILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATE 489
I++ + VV+L + + +V E++P G L + + ++ E R E
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVP---EKWARFYTAE 176
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
V AL +HS + HRD+K N+LLD+ K+ADFGT + + GT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 550 GYLDPEYFHSSQFT---DKS-DVYSFGVVLVELLTGQKP 584
Y+ PE S + D +S GV L E+L G P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 23/231 (9%)
Query: 363 DGSIDRCKIFNSKELDKAT-DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KS 414
D K + + + A D F+ + LG G G V ML G A+K K
Sbjct: 21 KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQ 77
Query: 415 KVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE 474
KVV ++E +NE IL ++ +VKL S + +V E++ G +F +L
Sbjct: 78 KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IG 136
Query: 475 ELSLTWEMRLRI-ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533
S E R A ++ YLHS L + +RD+K N+L+D++ ++ DFG ++
Sbjct: 137 RFS---EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ +T + GT L PE S + D ++ GV++ E+ G P
Sbjct: 191 V-KGRTWT---LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 49/287 (17%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HR 438
TD + V +G G + + A AVK ++D+SK + E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHP 76
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP---SEELSLTWEMRLRIATEVAEALA 495
N++ L + + +V E + G L + SE E + + + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITKTVE 130
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRA----KIADFGTSRSIAIDQTHVSTKVQGTFGY 551
YLH+ + HRD+K +NIL ++ +I DFG ++ + + + T T +
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANF 186
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611
+ PE + D++S GV+L +LTG P +
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP---FANGPDDT----------PEEIL- 232
Query: 612 ILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
++ GK VSD AK + L+ + R T V
Sbjct: 233 ---ARIGS-GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 53/294 (18%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKV-----VDESKLEEFINEVVI 431
++ ++G+G V + + A G AVK + E E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 432 LSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
L Q++ H +++ L+ S LV++ + G LF YL +E+++L+ + I +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSL 209
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
EA+++LH+ I HRD+K NILLD+ + +++DFG S ++ ++ GT G
Sbjct: 210 LEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELCGTPG 264
Query: 551 YLDPEYFHSSQFTD------KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604
YL PE S + D+++ GV+L LL G P R
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW------HRR--------- 309
Query: 605 EENCLFDILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ + + + G+ + E + S K R L + +R T ++
Sbjct: 310 -QILML----RMIME-GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 53/303 (17%)
Query: 381 TDHFNVNR-ILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQI 435
D + + +LG+G V + L + AVK K S++ EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQC 67
Query: 436 S-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDP---SEELSLTWEMRLRIATEVA 491
HRNV++L+ E + LV+E + G++ ++H +E E + +VA
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVA 121
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQ-- 546
AL +LH+ I HRD+K NIL ++ KI DF I ++
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 547 ----GTFGYLDPEYFHSSQFTDKS-----DVYSFGVVLVELLTGQKPISYIWANEGRNLA 597
G+ Y+ PE + D++S GV+L LL+G P G +
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---FVGRCGSDCG 235
Query: 598 TYFVECVE--ENCLFDILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTM 647
E +N LF + +++ GK ++ +S AK + L + + R +
Sbjct: 236 WDRGEACPACQNMLF----ESIQE-GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 648 KEV 650
+V
Sbjct: 291 AQV 293
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 16/224 (7%)
Query: 370 KIFNSKELDKATDHFNVN-RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEE 424
+ + ++ + + + + LG+G V + + + G+ A K K + + + E
Sbjct: 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AE 74
Query: 425 FINEVVILSQISHR-NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMR 483
++E+ +L V+ L +L+ E+ G +F E ++
Sbjct: 75 ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE-MVSENDV 133
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTH 540
+R+ ++ E + YLH I H D+K NILL KI DFG SR I
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHAC 188
Query: 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
++ GT YL PE + T +D+++ G++ LLT P
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHR 438
H+ + LG G G V G G +AVK + K+ + + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 439 NVVKLLGSCLEV-EVP---LLVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAE 492
+++KL +V P +V E++ G LF Y+ H EE+ E R R+ ++
Sbjct: 72 HIIKLY----QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILS 122
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
A+ Y H + HRD+K N+LLD AKIADFG S ++ D + T G+ Y
Sbjct: 123 AVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYA 177
Query: 553 DPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKP 584
PE + + D++S GV+L LL G P
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 62/220 (28%), Positives = 111/220 (50%), Gaps = 21/220 (9%)
Query: 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFIN-EVVI 431
+ K ++ + +++G G G V++ L + +A+K KV+ + + F N E+ I
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQD---KRFKNRELQI 85
Query: 432 LSQISHRNVVKLL-----GSCLEVEVPL-LVYEFIPNGTLFQYL-HDPSEELSLTWEMRL 484
+ + H NVV L + EV L LV E++P T+++ H + ++ +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK 144
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVST 543
++ +LAY+HS + I HRDIK N+LLD K+ DFG+++ + + +VS
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 544 KVQGTFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQ 582
+ Y PE F ++ +T D++S G V+ EL+ GQ
Sbjct: 202 IC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFIN-EVVILSQISH 437
+ + +LG+G G V + + AVK K K+ E + E+ +L ++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 438 RNVVKLLGSCLEV---EVPL---LVYEFIPNGT--LFQYLHDPSEELSLTWEMRLRIATE 489
+NV++L+ +V E +V E+ G + + P + + +
Sbjct: 66 KNVIQLV----DVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFP-VCQAH-GYFCQ 117
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 548
+ + L YLHS I H+DIK N+LL KI+ G + ++ QG+
Sbjct: 118 LIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 549 FGYLDPEYFHSSQFTD--KSDVYSFGVVLVELLTGQKP 584
+ PE + K D++S GV L + TG P
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQIS- 436
+ F+V+RI+G+GG G VY AD G++ A+K K ++ + +NE ++LS +S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 437 --HRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAE 492
+V + L + + + G L +L S E +R A E+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFS---EADMRFYAAEIIL 303
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
L ++H+ + +RD+K NILLDE +I+D G + + + H V GT GY+
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYM 357
Query: 553 DPEYFHSSQFTDKS-DVYSFGVVLVELLTGQKP 584
PE D S D +S G +L +LL G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 52/235 (22%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVV-----------------------DES 420
+G+G G V D A+K K K++
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 421 KLEEFINEVVILSQISHRNVVKLLGSCLEV-EVPL-----LVYEFIPNGTLFQYLHDP-- 472
+E+ E+ IL ++ H NVVKL+ EV + P +V+E + G + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 473 SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532
SE+ + ++ + + YLH Y I HRDIK +N+L+ E KIADFG S
Sbjct: 135 SEDQAR------FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT---DKSDVYSFGVVLVELLTGQKP 584
+S V GT ++ PE ++ DV++ GV L + GQ P
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKV-----VDESKLEEFINEVVILS 433
++ LG G G V+ + + + VK K KV +++ KL + E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 434 QISHRNVVKLLGSCLEVEVPL-LVYEFIPNGT-LFQYL--HDPSEELSLTWEMRLRIATE 489
++ H N++K+L E + LV E +G LF ++ H +E I +
Sbjct: 85 RVEHANIIKVL-DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQ 138
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 549
+ A+ YL I HRDIK NI++ E + K+ DFG++ + + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTI 193
Query: 550 GYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKP 584
Y PE + + + +++S GV L L+ + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 32/232 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN----EVVILSQIS 436
+ +++ + LG+G G V + +AVK +VD + + E+ I ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 437 HRNVVKLLGSCLEV-EVPL---LVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEV 490
H NVVK L E+ G LF + E + + R ++
Sbjct: 64 HENVVKFY----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQL 114
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTF 549
+ YLH + I HRDIK N+LLDE+ KI+DFG + ++ + K+ GT
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 550 GYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600
Y+ PE +F + DV+S G+VL +L G+ P W + Y
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYS 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-22
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
+ F ++LG+G G V +L GR A+K K +V + ++ + E +L
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 435 ISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAE 492
H + L + L V E+ G LF +L E + E R R E+
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS---RERVFS-EDRARFYGAEIVS 259
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
AL YLHS + +RD+K N++LD+ KI DFG + D + T GT YL
Sbjct: 260 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 316
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE + + D + GVV+ E++ G+ P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 39/224 (17%)
Query: 381 TDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFIN-EVVILSQISHR 438
+ +++G G G VY+ L D G ++A+KK V+ + + F N E+ I+ ++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKR---FKNRELQIMRKLDHC 107
Query: 439 NVVKLL-----GSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEEL---------SLTWEMR 483
N+V+L + EV L LV +++P T+++ S +++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL- 165
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVS 542
R +LAY+HS I HRDIK N+LLD + K+ DFG+++ + + +VS
Sbjct: 166 FR-------SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 543 TKVQGTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ Y PE F ++ +T DV+S G VL ELL GQ PI
Sbjct: 216 YIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 32/232 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN----EVVILSQIS 436
+ +++ + LG+G G V + +AVK +VD + + E+ I ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 437 HRNVVKLLGSCLEV-EVP---LLVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEV 490
H NVVK L E+ G LF + E + + R ++
Sbjct: 64 HENVVKFY----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQL 114
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTF 549
+ YLH + I HRDIK N+LLDE+ KI+DFG + ++ + K+ GT
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 550 GYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600
Y+ PE +F + DV+S G+VL +L G+ P W + Y
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYS 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
F + R LG G G V L +GR A+K K VV ++E +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEA 493
++H ++++ G+ + + ++ ++I G LF L + + A EV A
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP-NPVAKFYAAEVCLA 118
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF-G-- 550
L YLHS I +RD+K NILLD+ KI DFG ++ + D T+ T G
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY-------TLCGTP 167
Query: 551 -YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
Y+ PE + + D +SFG+++ E+L G P
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN-----EVVILSQISHRNVVKL 443
LG+G TVYK +I+A+KK K+ S+ ++ IN E+ +L ++SH N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 444 LGSCLEVEVPL----LVYEFIPNGTLFQYLHDPSEEL------SLTWEMRLRIATEVAEA 493
L + LV++F+ L + D S L + M L+
Sbjct: 78 L----DAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYML-MTLQ-------G 124
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
L YLH L HRD+K N+LLDE K+ADFG ++S + +V T Y
Sbjct: 125 LEYLHQHWIL---HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRA 180
Query: 554 PEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE F + + D+++ G +L ELL P
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHR 438
H+ + LG G G V G G +AVK + K+ + + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 439 NVVKLLGSCLEV-EVP---LLVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAE 492
+++KL +V P +V E++ G LF Y+ + +E E R R+ ++
Sbjct: 77 HIIKLY----QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQILS 127
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
+ Y H + HRD+K N+LLD AKIADFG S ++ D + T G+ Y
Sbjct: 128 GVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYA 182
Query: 553 DPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKP 584
PE + + D++S GV+L LL G P
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 65/288 (22%), Positives = 118/288 (40%), Gaps = 47/288 (16%)
Query: 381 TDHFNVNR-ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-H 437
TD + +++ +LG G G V + G+ A+K ++ +S EV Q S
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKAR--QEVDHHWQASGG 81
Query: 438 RNVVKLLG----SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
++V +L L++ E + G LF + + ++ + T I ++ A
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTA 140
Query: 494 LAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
+ +LHS I HRD+K N+L ++ K+ DFG ++ Q + T T
Sbjct: 141 IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPY 194
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
Y+ PE ++ D++S GV++ LL G P ++N +
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---FYSN-------------TGQAIS 238
Query: 611 DILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ ++R G+ E EVS+ AK L ++ R T+ +
Sbjct: 239 PGMKRRIRL-GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVKLL 444
+G+G GTV+K I+A+K+ ++ D+ E + E+ +L ++ H+N+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLH 67
Query: 445 GSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEEL------SLTWEMRLRIATEVAEAL 494
+V LV+EF L +Y + +L S +++ L+ L
Sbjct: 68 ----DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL-LK-------GL 114
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
+ HS + HRD+K N+L++ K+A+FG +R+ I S +V T Y P
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPP 170
Query: 555 EY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ F + ++ D++S G + EL +P+
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 21/220 (9%)
Query: 379 KATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES--KLEEFINEVVILSQI 435
K D F V R+ GQG GTV G G +A+KK V+ + + E + + L+ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFRNRE-LQIMQDLAVL 76
Query: 436 SHRNVVKLL------GSCLEVEVPL-LVYEFIPNGTLFQYL-HDPSEELSLTWEMRLRIA 487
H N+V+L G ++ L +V E++P+ TL + + +++ +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQ 546
++ ++ LH + + + HRDIK N+L++E K+ DFG+++ ++ + +V+
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC- 193
Query: 547 GTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ Y PE F + +T D++S G + E++ G+ PI
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 382 DHFNVNRILGQGGQGTVY----KGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQI 435
F + ++LGQG G V+ ++ A+K K + E IL ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 436 SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAEA 493
+H +VKL + E L L+ +F+ G LF L S+E+ T E ++ E+A A
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFT-EEDVKFYLAELALA 138
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
L +LHS L I +RD+K NILLDE+ K+ DFG S+ +ID + GT Y+
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE + T +D +SFGV++ E+LTG P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF----INEVVILSQISH 437
+ + +G+G G VYK + GRI+A+K+ ++ E E I E+ +L ++ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHH 78
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
N+V L+ LV+EF+ L + L + L + ++++ ++ +A+
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLRGVAHC 135
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY- 556
H I HRD+K N+L++ K+ADFG +R+ I + +V T Y P+
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
S +++ D++S G + E++TG KP+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG-KPL 219
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 22/243 (9%)
Query: 356 EQQLNSLDGSIDRCKIFNSKELDKAT-DHFNVNRILGQGGQGTVY---KGMLAD-GRIIA 410
+ L + + +K ++F + ++LG G G V+ K D G++ A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 411 VK---KSKVVDESKLEEFI-NEVVILSQISHRN-VVKLLGSCLEVEVPL-LVYEFIPNGT 464
+K K+ +V ++K E E +L I +V L + E L L+ ++I G
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGE 145
Query: 465 LFQYLHDPSEELSLTWEMRLRI-ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523
LF +L S+ T E ++I E+ AL +LH L I +RDIK NILLD
Sbjct: 146 LFTHL---SQRERFT-EHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHV 198
Query: 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHSSQFTDKS-DVYSFGVVLVELLTG 581
+ DFG S+ D+T + GT Y+ P+ DK+ D +S GV++ ELLTG
Sbjct: 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 582 QKP 584
P
Sbjct: 259 ASP 261
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 3e-20
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 390 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVKLLG 445
+G+G G VYK G A+KK ++ E E I E+ IL ++ H N+VKL
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLY- 66
Query: 446 SCLEVEVPL----LVYEFIPNGTLFQYLHDPSEEL------SLTWEMRLRIATEVAEALA 495
+V LV+E + L + L L S ++ L +A
Sbjct: 67 ---DVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQL-LN-------GIA 114
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
Y H + HRD+K N+L++ + KIADFG +R+ I + ++ T Y P+
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
Query: 556 Y-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
S +++ D++S G + E++ G P+
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISHR 438
+ + LG+G G V + +A+K + + E+ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 439 NVVKLLGSCLEV-EVP---LLVYEFIPNGTLFQYL--HDPSEELSLTWEMRLRIATEVAE 492
+++KL +V P ++V E+ G LF Y+ E E R R ++
Sbjct: 70 HIIKLY----DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE----DEGR-RFFQQIIC 119
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
A+ Y H I HRD+K N+LLD+ KIADFG S +I D + T G+ Y
Sbjct: 120 AIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYA 174
Query: 553 DPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKP 584
PE + + + DV+S G+VL +L G+ P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQISHRNVVKLLGS 446
+G+G G V+K G+I+A+KK ++ + + I E+ +L Q+ H N+V LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68
Query: 447 CLEVEVPL----LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY 502
EV LV+E+ + T+ L + ++ I + +A+ + H
Sbjct: 69 --EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEH-LVK-SITWQTLQAVNFCHKHNC 123
Query: 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY-FHSSQ 561
+ HRD+K NIL+ + K+ DFG +R + + +V T Y PE +Q
Sbjct: 124 I---HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQ 179
Query: 562 FTDKSDVYSFGVVLVELLTGQ 582
+ DV++ G V ELL+G
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV 200
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA-------DGRIIAVK---KSKVVDESK-LEEFINEVV 430
+ F + R+LG+GG G V G+I A+K K+ +V +K E
Sbjct: 17 ECFELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 431 ILSQISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-AT 488
IL ++ H +V L+ + L L+ E++ G LF L E E
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---REGIFM-EDTACFYLA 128
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
E++ AL +LH I +RD+K NI+L+ + K+ DFG + +I V+ GT
Sbjct: 129 EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGT 184
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
Y+ PE S D +S G ++ ++LTG P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 21/212 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
+ F+ ++LG+G G V +L GR A+K K ++ + ++ + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 435 ISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVAE 492
H + L + L V E+ G LF +L S E T E R R E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL---SRERVFT-EERARFYGAEIVS 116
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
AL YLHS + +RDIK N++LD+ KI DFG + D + T GT YL
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
PE + + D + GVV+ E++ G+ P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVKLL 444
LG+G TVYKG ++A+K+ ++ E E I EV +L + H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 445 GSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEEL------SLTWEMRLRIATEVAEAL 494
++ LV+E++ L QYL D + + LR L
Sbjct: 67 ----DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF-QLLR-------GL 113
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
AY H + HRD+K N+L++E+ K+ADFG +R+ +I +V T Y P
Sbjct: 114 AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPP 169
Query: 555 EY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ S+ ++ + D++ G + E+ TG +P+
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQISHRNVVKLLGS 446
+G+G G V K GRI+A+KK D+ K+ + I E+ +L Q+ H N+V LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 506
C + + LV+EF+ + T+ L L ++ + ++ + + HS +
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQ-VVQ-KYLFQIINGIGFCHSHNII--- 146
Query: 507 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY-FHSSQFTDK 565
HRDIK NIL+ + K+ DFG +R++A +V T Y PE ++
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKA 205
Query: 566 SDVYSFGVVLVELLTGQ 582
DV++ G ++ E+ G+
Sbjct: 206 VDVWAIGCLVTEMFMGE 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQIS 436
+ +GQG G V+K G+ +A+KK + +E E F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 437 HRNVVKLLGSCLEVEVPL--------LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIAT 488
H NVV L+ C P LV++F + L L + + +L+ E++ R+
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQ 131
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK---- 544
+ L Y+H + L HRD+K+ N+L+ K+ADFG +R+ ++ + +
Sbjct: 132 MLLNGLYYIHRNKIL---HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 545 -VQGTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
V T Y PE + D++ G ++ E+ T PI
Sbjct: 189 VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPI 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HR 438
D + + R LG+G V++ + + + + VK K V + K E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGP 91
Query: 439 NVVKLLGSCLEVEV---PLLVYEFIPNGTLFQYLHDPSEEL--SLTWEMRLRIATEVAEA 493
N++ L ++ V P LV+E + N Q ++ +E+ L+ A
Sbjct: 92 NIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI-LK-------A 142
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRA-KIADFGTSRSIAIDQT---HVSTKVQGTF 549
L Y HS I HRD+K N+++D ++R ++ D+G + Q V+++
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195
Query: 550 GYLDPEYFHSSQFTDKS-DVYSFGVVLVELLTGQKPI 585
+ PE Q D S D++S G +L ++ ++P
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 28/232 (12%)
Query: 374 SKELDKATDHFNVNRI-LGQGGQGTVYKGM---LADGRIIAVKKSKVVDESKLEEFINEV 429
S E ++ D F +G+G G VYK D + A+K+ + E+
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREI 69
Query: 430 VILSQISHRNVVKLLGSCLE-VEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
+L ++ H NV+ L L + + L++++ + L+ + + ++L
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRG 128
Query: 488 T------EVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAI- 536
++ + + YLH++ L HRD+K NIL+ E+ R KIAD G +R
Sbjct: 129 MVKSLLYQILDGIHYLHANWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 537 --DQTHVSTKVQGTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ V TF Y PE + +T D+++ G + ELLT +PI
Sbjct: 186 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 36/251 (14%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
F++ R++G+G V +L RI A+K K V D+ ++ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 435 I-SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
+H +V L SC + E L V E++ G L ++ + L E R + E++
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEIS 120
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
AL YLH I +RD+K N+LLD + K+ D+G + ST GT Y
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 176
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP---ISYIWANEGRNLATYFVECVEENC 608
+ PE + D ++ GV++ E++ G+ P + + E+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT----------EDY 226
Query: 609 LFD-ILDDQVR 618
LF IL+ Q+R
Sbjct: 227 LFQVILEKQIR 237
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 45/286 (15%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRN 439
D+ +++LG G G V + A+K ++ + EV + + S +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPH 116
Query: 440 VVKLLGSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
+V+++ + L+V E + G LF + D ++ + T I + EA+
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQ 175
Query: 496 YLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
YLHS + I HRD+K N+L K+ DFG ++ + ++T T Y+
Sbjct: 176 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYV 230
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612
PE ++ D++S GV++ LL G P ++N G +
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPP---FYSNHGLA---------ISPGMK-- 276
Query: 613 LDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
++R G+ E EVS+ K L + R T+ E
Sbjct: 277 --TRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 26/209 (12%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVKLL 444
LG G TVYKG+ G +A+K+ K+ E E I E+ ++ ++ H N+V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLY 69
Query: 445 GSCLEVEVPL----LVYEFIPNGTLFQYLHDPSEELS---LTWEMRLRIATEVAEALAYL 497
+V LV+EF+ N L +Y+ + + L + ++ + LA+
Sbjct: 70 ----DVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY- 556
H + I HRD+K N+L++++ + K+ DFG +R+ I S++V T Y P+
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVL 180
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
S ++ D++S G +L E++TG KP+
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITG-KPL 208
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 65/251 (25%), Positives = 109/251 (43%), Gaps = 36/251 (14%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
F++ R++G+G V +L RI A++ K V D+ ++ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 435 I-SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
+H +V L SC + E L V E++ G L ++ + L E R + E++
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEIS 163
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
AL YLH I +RD+K N+LLD + K+ D+G + ST GT Y
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 219
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP---ISYIWANEGRNLATYFVECVEENC 608
+ PE + D ++ GV++ E++ G+ P + + E+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT----------EDY 269
Query: 609 LFD-ILDDQVR 618
LF IL+ Q+R
Sbjct: 270 LFQVILEKQIR 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 49/225 (21%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
D ++ + +G G G ++AVK + +DE ++ E++ + H
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ---REIINHRSLRH 75
Query: 438 RNVVKLLGSCLEVEVPL------LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
N+V+ EV L ++ E+ G L++ + + R + + A
Sbjct: 76 PNIVRFK------EVILTPTHLAIIMEYASGGELYERICN-----------AGRFSEDEA 118
Query: 492 --------EALAYLHSSAYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQTHV 541
++Y HS + I HRD+K N LLD R KI DFG S+S +
Sbjct: 119 RFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 174
Query: 542 STKVQGTFGYLDPEYFHSSQFTD--KSDVYSFGVVLVELLTGQKP 584
+ V GT Y+ PE Q D +DV+S GV L +L G P
Sbjct: 175 KSTV-GTPAYIAPEVL-LRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
F+ +++G+G G V +LA + AVK K ++ + + + ++E +L +
Sbjct: 38 SDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 435 -ISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
+ H +V L + L V ++I G LF +L E E R R A E+A
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ---RERCFL-EPRARFYAAEIA 149
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
AL YLHS L I +RD+K NILLD + + DFG + I+ ++ GT Y
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEY 205
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
L PE H + D + G VL E+L G P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN-----EVVIL---SQIS 436
V I G G GTVYK G +A+K +V + + EV +L
Sbjct: 14 VAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 437 HRNVVKLL----GSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
H NVV+L+ S + E+ + LV+E + L YL D + L E + +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQFL 130
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
L +LH++ + HRD+K NIL+ K+ADFG +R + V T Y
Sbjct: 131 RGLDFLHANCIV---HRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE S + D++S G + E+ KP+
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 52/235 (22%)
Query: 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKK--SKVVDESKLEEFIN---------EV 429
+ V R + G G V G+ ++G +A+K+ + V D + + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 430 VILSQISHRNVVKLLGSCLEVEVPL---------LVYEFIPNGTLFQYLHDPSEELS--- 477
+L+ H N++ L ++ V LV E + L Q +HD +S
Sbjct: 81 RLLNHFHHPNILGLR----DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 478 ---LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534
+ + L L LH + + HRD+ NILL + I DF +R
Sbjct: 136 IQYFMYHI-LL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 535 AIDQT---HVSTKVQGTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
D +V+ + Y PE FT D++S G V+ E+ K +
Sbjct: 185 TADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
D+F R+LG+G G V MLA G + AVK K ++ + +E + E ILS
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 435 I-SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
+H + +L C + L V EF+ G L ++ + E R R A E+
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD-EARARFYAAEII 134
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
AL +LH I +RD+K N+LLD + K+ADFG + + +T GT Y
Sbjct: 135 SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDY 190
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ PE + D ++ GV+L E+L G P
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQISHRNVVKLL 444
LG+G G VYK + +A+K+ ++ E + E I EV +L ++ HRN+++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 445 GSCLEVEVPLLVYEFIPNGTLFQYLH-----DPSEELSLTWEMRLRIATEVAEALAYLHS 499
L++E+ N L +Y+ S +++ + + HS
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL--------INGVNFCHS 150
Query: 500 SAYLPIYHRDIKSTNILLDEKYRA-----KIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
L HRD+K N+LL + KI DFG +R+ I + ++ T Y P
Sbjct: 151 RRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPP 206
Query: 555 EY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
E S ++ D++S + E+L P+
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 23/226 (10%)
Query: 370 KIFNSKELDKAT-DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESK 421
K N+ D+ FN +LG+G G V ML+ + AVK K V+ +
Sbjct: 7 KFDNNGNRDRMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDD 63
Query: 422 LEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLT 479
+E + E +L+ + +L SC + L V E++ G L ++ +
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK 119
Query: 480 WEMRLRI-ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538
E A E+A L +L S I +RD+K N++LD + KIADFG + D
Sbjct: 120 -EPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
T GT Y+ PE + D ++FGV+L E+L GQ P
Sbjct: 176 VTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 53/249 (21%), Positives = 107/249 (42%), Gaps = 54/249 (21%)
Query: 377 LDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFIN-EVVILSQ 434
L+ ++ +++ + LG G G V + + G+ A+KK V+ + + + N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--VLQDPR---YKNRELDIMKV 56
Query: 435 ISHRNVVKLL-------------------------------------GSCLEVEVPL-LV 456
+ H N++KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 457 YEFIPNGTLFQYL-HDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515
E++P+ TL + L S+ + ++ A+ ++HS L I HRDIK N+
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNL 172
Query: 516 LLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFHSSQFTDKSDVYSFGV 573
L++ + K+ DFG+++ + + V+ + Y PE ++++T D++S G
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 574 VLVELLTGQ 582
V EL+ G+
Sbjct: 231 VFGELILGK 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 386 VNRILGQGGQGTVYKG--MLADGRIIAVKKSKVVDESKLEEF----INEVVIL---SQIS 436
V I G+G G V+K + GR +A+K+ +V E I EV +L
Sbjct: 16 VAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFE 72
Query: 437 HRNVVKLL----GSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
H NVV+L S + E L LV+E + L YL D E + E + ++
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLL 130
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
L +LHS + HRD+K NIL+ + K+ADFG +R + S V T Y
Sbjct: 131 RGLDFLHSHRVV---HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWY 185
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE S + D++S G + E+ KP+
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
+ F ++++LG+G G V LA + A+K K V+ + +E + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 435 -ISHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
H + + + + L V E++ G L ++ R A E+
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD-LSRATFYAAEII 128
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
L +LHS I +RD+K NILLD+ KIADFG + + + GT Y
Sbjct: 129 LGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ PE ++ D +SFGV+L E+L GQ P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.1 bits (210), Expect = 3e-17
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
FN +LG+G G V ML+ + AVK K V+ + +E + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 435 I-SHRNVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRI-ATEVA 491
+ +L SC + L V E++ G L ++ E A E+A
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK-EPHAVFYAAEIA 452
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
L +L S I +RD+K N++LD + KIADFG + D T GT Y
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 508
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ PE + D ++FGV+L E+L GQ P
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 44/231 (19%)
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
+ + S V E + + + + LT E + + +VA+ + +L S
Sbjct: 153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 212
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD-----PE 555
+ HRD+ + NILL EK KI DFG +R I D +V L PE
Sbjct: 213 KCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD----ARLPLKWMAPE 265
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVE--------E 606
+T +SDV+SFGV+L E+ + G P + +E F ++ +
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRAPD 319
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
++ + M C + RPT E+ L +
Sbjct: 320 YTTPEMY-----------QTM------LDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 35/104 (33%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSK-VVDESKLEEFINEVVILSQ 434
D + + LG+G G V + A R +AVK K S+ ++E+ IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 435 I-SHRNVVKLLGSCLEVEVPLLV-YEFIPNGTLFQYLHDPSEEL 476
I H NVV LLG+C + PL+V EF G L YL E
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 125
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQISH 437
+ + +G G QG V R +A+KK +++ E+V++ ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 438 RNVVKLLGSCLEVEVPL----------LVYEFIPNGTLFQYLHDPSEEL---SLTWEMRL 484
+N++ LL V P +V E + L Q + + L ++M L
Sbjct: 84 KNIIGLL----NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM-L 137
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 544
+ +LHS+ I HRD+K +NI++ KI DFG +R+ + + T
Sbjct: 138 C-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 185
Query: 545 VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
T Y PE + + D++S G ++ E++ G +
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFI-NEVVILSQISH 437
+ +G G G+V + G +A+KK S+ + E+++L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 438 RNVVKLLGSCLEVEVPL----------LVYEFIPNGTLFQYLHDP-SEE--LSLTWEMRL 484
NV+ LL +V P LV F+ L + + SEE L ++M L
Sbjct: 83 ENVIGLL----DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQM-L 136
Query: 485 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VST 543
+ L Y+HS+ + HRD+K N+ ++E KI DFG +R + T V T
Sbjct: 137 K-------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
Query: 544 KVQGTFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+ Y PE + D++S G ++ E+LTG K +
Sbjct: 187 RW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQISH 437
+ + +G G G V + G +A+KK +S+L E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 438 RNVVKLLGSCLEVEVPL----------LVYEFIPNGTLFQYLHDPSEELS------LTWE 481
NV+ LL +V P LV F+ L + + E+L L ++
Sbjct: 84 ENVIGLL----DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK--HEKLGEDRIQFLVYQ 136
Query: 482 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-H 540
M L+ L Y+H++ I HRD+K N+ ++E KI DFG +R + T +
Sbjct: 137 M-LK-------GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 541 VSTKVQGTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
V T+ Y PE + ++T D++S G ++ E++TG K +
Sbjct: 186 VVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQISH 437
+ + +G G QG V R +A+KK +++ E+V++ ++H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 438 RNVVKLL------GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
+N++ LL + E + LV E + L Q + L E + ++
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQML 174
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
+ +LHS+ I HRD+K +NI++ KI DFG +R+ + + T T Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 229
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
PE + + D++S G ++ E++ K +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 57/234 (24%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN---------EVV 430
+ +G+G G V + +A+KK + F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77
Query: 431 ILSQISHRNVVKLLGSCLEVEVPL---------LVYEFIPNGT-LFQYLHDPSEELS--- 477
IL + H N++ + ++ +V + + T L++ L ++ LS
Sbjct: 78 ILLRFRHENIIGIN----DIIRAPTIEQMKDVYIVQDLM--ETDLYKLLK--TQHLSNDH 129
Query: 478 ---LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534
+++ LR L Y+HS+ + HRD+K +N+LL+ KI DFG +R
Sbjct: 130 ICYFLYQI-LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 535 AIDQTHVS--TKVQGTFGYLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
D H T+ T Y PE +S +T D++S G +L E+L+ +PI
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 63/298 (21%), Positives = 108/298 (36%), Gaps = 66/298 (22%)
Query: 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINE 428
K+ D+ +++LG G G V + A+K ++ + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARRE 60
Query: 429 VVILSQIS-HRNVVKLLGSCLEVEVP----LLVYEFIPNGTLFQYLHDPSEELSLTWEMR 483
V + + S ++V+++ + L+V E + G LF + D ++ + T
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREA 119
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTH 540
I + EA+ YLHS + I HRD+K N+L K+ DFG
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG----------- 165
Query: 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600
+ + G Y D D++S GV++ LL G P ++N G
Sbjct: 166 FAKETTGE-KY-DKS----------CDMWSLGVIMYILLCGYPP---FYSNHGLA----- 205
Query: 601 VECVEENCLFDILDDQVRKSGK----TEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ ++R G+ E EVS+ K L + R T+ E
Sbjct: 206 ----ISPGMK----TRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 45/226 (19%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQISH 437
+ + +G G G+V G +AVKK +S + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 438 RNVVKLLGSCLEVEVPL----------LVYEFIPNGTLFQYLHDPSEELS------LTWE 481
NV+ LL +V P LV + L + ++L+ L ++
Sbjct: 88 ENVIGLL----DVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK--CQKLTDDHVQFLIYQ 140
Query: 482 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-H 540
+ LR L Y+HS+ I HRD+K +N+ ++E KI DFG +R A + T +
Sbjct: 141 I-LR-------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 541 VSTKVQGTFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
V+T+ Y PE + + D++S G ++ ELLTG + +
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 64/241 (26%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN---------EVV 430
+ F + +LG+G G V G I+A+KK +E F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 431 ILSQISHRNVVKLLGSCLEVEVPL---------LVYEFIPNGT-LFQYLHDPSEELS--- 477
IL H N++ + ++ P ++ E + T L + + ++ LS
Sbjct: 62 ILKHFKHENIITIF----NIQRPDSFENFNEVYIIQELM--QTDLHRVIS--TQMLSDDH 113
Query: 478 ---LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534
++ LR A+ LH S + HRD+K +N+L++ K+ DFG +R I
Sbjct: 114 IQYFIYQT-LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 535 AIDQTHVSTKVQGTFG---------YLDPEY-FHSSQFTDKSDVYSFGVVLVELLTGQKP 584
S G Y PE S++++ DV+S G +L EL +P
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP 221
Query: 585 I 585
I
Sbjct: 222 I 222
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 382 DHFN----VNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQ 434
DH V +++G+G G V K + +A+K +++ + + E+ IL
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEH 149
Query: 435 ISHR------NVVKLLGS-------CLEVEVPLL---VYEFIPNGTLFQYLHDPSEELSL 478
+ + NV+ +L + C+ E LL +YE I FQ L L
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNK-FQGFS-----LPL 201
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAI 536
+ A + + L LH I H D+K NILL ++ R+ K+ DFG+S
Sbjct: 202 VR----KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CY 251
Query: 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
+ V T +Q F Y PE +++ D++S G +L ELLTG
Sbjct: 252 EHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 45/228 (19%)
Query: 378 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK----KSKVVDESKLEEFINEVVIL 432
+K D + ++ ++G+G G V K + +A+K K ++++++E V +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-----VRLL 104
Query: 433 SQISHR------NVVKLLGS-------CLEVEVPLL---VYEFIPNGTLFQYLHDPSEEL 476
++ +V L CL E +L +Y+ + N T F+ + L
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRN-TNFRGVS-----L 156
Query: 477 SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSI 534
+LT + A ++ AL +L + L I H D+K NILL R+ KI DFG+S
Sbjct: 157 NLTR----KFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS--- 208
Query: 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
+ +Q F Y PE + D++S G +LVE+ TG+
Sbjct: 209 CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ + LG GG G V+ + + +A+KK + D ++ + E+ I+ ++ H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQY-------------LHD--PSEELS------L 478
+VK+ E+ P G+L + L + L
Sbjct: 70 IVKVF----EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAID 537
+++ LR L Y+HS+ + HRD+K N+ ++ E KI DFG +R +
Sbjct: 126 MYQL-LR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 538 QTH-------VSTKVQGTFGYLDPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
+H + TK Y P + +T D+++ G + E+LTG K +
Sbjct: 175 YSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 45/248 (18%), Positives = 92/248 (37%), Gaps = 65/248 (26%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-----SKVVDESKLEEFINEVVILSQ 434
D++ + ++G+G G VY + +A+KK ++D ++ + E+ IL++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNR 81
Query: 435 ISHRNVVKLLGSCLEVEVPL---------LVYEFIPNGT-LFQYLHDPSEELS------L 478
+ +++L ++ +P +V E + L + P L+ +
Sbjct: 82 LKSDYIIRLY----DLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP-IFLTEEHIKTI 134
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538
+ + L ++H S I HRD+K N LL++ K+ DFG +R+I ++
Sbjct: 135 LYNL-LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 539 THVSTKVQGTFGYLDP----------EY------------FHSSQFTDKSDVYSFGVVLV 576
P + +T D++S G +
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 577 ELLTGQKP 584
ELL +
Sbjct: 244 ELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 41/202 (20%), Positives = 84/202 (41%), Gaps = 41/202 (20%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-----SKVVDESKLEEFINEVVILSQ 434
D + + ++G G G V + + R++A+KK ++D ++ + E+ IL++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNR 108
Query: 435 ISHRNVVKLLGSCLEVEVPL---------LVYEFIPNGT-LFQYLHDP---SEEL--SLT 479
++H +VVK+L ++ +P +V E + + P +E +L
Sbjct: 109 LNHDHVVKVL----DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLL 162
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
+ + L + Y+HS+ I HRD+K N L+++ K+ DFG +R++ +
Sbjct: 163 YNL-LV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 540 HVSTKVQGTFGYLDPEYFHSSQ 561
S
Sbjct: 212 GNSQLPISPREDDMNLVTFPHT 233
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 47/228 (20%), Positives = 86/228 (37%), Gaps = 49/228 (21%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVK--KSK------VVDESKLEEFINEVVILSQ-- 434
+ R LG G TV+ + + +A+K + DE KL + +N+ +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 435 ISHRNVVKLLGS-----------CLEVEVPLL---VYEFIPNGTLFQYLHDPSEELSLTW 480
+ +++KLL + E +L + I + + L
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKK-YEHRGIP-----LIYVK 134
Query: 481 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA------KIADFGTSRSI 534
+I+ ++ L Y+H I H DIK N+L++ KIAD G +
Sbjct: 135 ----QISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW- 187
Query: 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ 582
H + +Q Y PE + + +D++S ++ EL+TG
Sbjct: 188 --YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 64/246 (26%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-----SKVVDESKLEEFINEVVILSQ 434
+ + + LG+G G V+K + G ++AVKK D + E++IL++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTE 64
Query: 435 IS-HRNVVKLLGSCLEVEVPL------LVYEFIPNGT-LFQYLHDPSEELS------LTW 480
+S H N+V LL V LV++++ T L + + L + +
Sbjct: 65 LSGHENIVNLL----NVLRADNDRDVYLVFDYM--ETDLHAVIR--ANILEPVHKQYVVY 116
Query: 481 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540
++ ++ + YLHS + HRD+K +NILL+ + K+ADFG SRS +
Sbjct: 117 QL-IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 541 VSTKVQGTFGYLDPEYFHSSQFTD---------------------KSDVYSFGVVLVELL 579
+ + TD D++S G +L E+L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 580 TGQKPI 585
G KPI
Sbjct: 226 CG-KPI 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 73/374 (19%), Positives = 117/374 (31%), Gaps = 114/374 (30%)
Query: 378 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQ 434
D ++V R LG G TV+ + + +A+K KS E E ++E+ +L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKS 89
Query: 435 IS--------HRNVVKLLGSCLEVEVPL-----LVYEFIPNG-TLFQYLHDPSEELSLTW 480
+ VV+LL ++ +V+E G L +++ S L
Sbjct: 90 VRNSDPNDPNREMVVQLLDD-FKISGVNGTHICMVFE--VLGHHLLKWIIK-SNYQGLPL 145
Query: 481 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----------------------- 517
+I +V + L YLH+ I H DIK NILL
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 518 --------------------------DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
EK + KIAD G + H + +Q T Y
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQ-TRQY 259
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQK-------------------------PIS 586
E S + +D++S + EL TG +
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319
Query: 587 YIWANEGRNLATYF--------VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLN 638
G+ +F + ++ LF++L ++ S EE +D L
Sbjct: 320 RKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQ--EEAAGFTDFLLPMLE 377
Query: 639 SNGRSRPTMKEVAM 652
R T E
Sbjct: 378 LIPEKRATAAECLR 391
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 1e-09
Identities = 62/428 (14%), Positives = 134/428 (31%), Gaps = 115/428 (26%)
Query: 288 QDLRCENYEGGYRCVNPKRPKVYTIILGIGTGLGGLLLSIGALWLCIIIRRRIKQK--EE 345
+ C++ + + + K + I+ + G L W + + + QK EE
Sbjct: 31 DNFDCKDVQDMPKSILSK--EEIDHIIMSKDAVSGTLR---LFWTLLSKQEEMVQKFVEE 85
Query: 346 NFKKNGGLLLEQ-QLNSLDGSID-------RCKIFNSKE-LDKATDHFNVNRI-----LG 391
+ N L+ + S+ R +++N + K +NV+R+ L
Sbjct: 86 VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK----YNVSRLQPYLKLR 141
Query: 392 QG------GQGTVYKGMLADGRIIAVKKSKVV-----DESKLEEFINEVVILSQISHRNV 440
Q + + G+L G K+ V + ++ L+
Sbjct: 142 QALLELRPAKNVLIDGVLGSG------KTWVALDVCLSYKVQCKMDFKIFWLN------- 188
Query: 441 VKLLGSCLEVEVPL-----LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA 495
L +C E L L+Y+ PN + D S + L + L
Sbjct: 189 ---LKNCNSPETVLEMLQKLLYQIDPN---WTSRSDHSSNIKLRIH-------SIQAELR 235
Query: 496 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID---QTHVSTKVQGTFGYL 552
L + + ++ ++L AK + A + + ++T+ + +L
Sbjct: 236 RL-------LKSKPYENCLLVLLNVQNAKAWN-------AFNLSCKILLTTRFKQVTDFL 281
Query: 553 DPE-YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611
H + L P +E ++L ++ + +C
Sbjct: 282 SAATTTH--------------ISLDHHSMTLTP------DEVKSL---LLKYL--DCRPQ 316
Query: 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQD-DDDNIQ 670
L +V + +S +A+ + +L I +L + +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 671 KCYEELSM 678
K ++ LS+
Sbjct: 373 KMFDRLSV 380
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 35/184 (19%), Positives = 63/184 (34%), Gaps = 36/184 (19%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--------VDESKLEEFINEVVILS 433
+ + + +G GG G +Y A KV E K + + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 434 QISHRNVVKLLGSCLEVEVPLLVY--EFIPNGTLF------------QYLHDPSEELSLT 479
+ R + LG +PL G + Q + +
Sbjct: 98 KWIERKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK- 150
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI--ADFGTSRSIAID 537
L++ + + L Y+H + Y+ H DIK+ N+LL K ++ AD+G S +
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 538 QTHV 541
H
Sbjct: 207 GNHK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 61/251 (24%), Positives = 89/251 (35%), Gaps = 71/251 (28%)
Query: 378 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK----KSKVVDESKLEEFINEVVIL 432
+ F V R +G G G V + + + AVK K +K+E IL
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADIL 85
Query: 433 SQISHR-----NVVKLLGS-------CLEVEVPLL---VYEFI-PNGTLFQYLHDPSEEL 476
+I + N+VK G CL E L +YE I N + H +
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNN--YNGFH-----I 136
Query: 477 SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA------------- 523
E+ +AL YL + + H D+K NILLD+ Y
Sbjct: 137 EDIK----LYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189
Query: 524 ------------KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSF 571
K+ DFG + + + + Y PE + + SD++SF
Sbjct: 190 KIQIYRTKSTGIKLIDFGCA---TFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSF 245
Query: 572 GVVLVELLTGQ 582
G VL EL TG
Sbjct: 246 GCVLAELYTGS 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 5e-09
Identities = 32/204 (15%), Positives = 61/204 (29%), Gaps = 54/204 (26%)
Query: 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE--------SKLEEFINEVVI 431
T+ +G+G G V++ + AD +A+K + EE + E++I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 432 LSQI---------SHRNVVKLLGSCL----------------------EVEVPL------ 454
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 455 --LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512
+V EF G + + + I ++ +LA + L HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 513 TNILLDEKYRAKIADFGTSRSIAI 536
N+LL + K+ +S I
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTI 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 51/243 (20%), Positives = 84/243 (34%), Gaps = 65/243 (26%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM--LADGRIIAVK----KSKVVDESKLEEFINEVVILSQ 434
+ + + LG+G G V + + +A+K K + ++LE + +L +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKK 72
Query: 435 ISHR------NVVKLLGS-------CLEVEVPLL---VYEFIPNGTLFQYLHDPSEELSL 478
I + V + C+ E LL +EF+ FQ L
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENN-FQPYP-----LPH 124
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA--------------- 523
+A ++ AL +LH + H D+K NIL
Sbjct: 125 VR----HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 524 ----KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELL 579
++ADFG++ D H +T V Y PE + DV+S G +L E
Sbjct: 178 NTSIRVADFGSA---TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 580 TGQ 582
G
Sbjct: 234 RGF 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 33/185 (17%), Positives = 66/185 (35%), Gaps = 35/185 (18%)
Query: 383 HFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV-----------DESKLEEFINEVVI 431
+ V +GQGG G +Y + + VV E K + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 432 LSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQY------LHDPS-EEL------SL 478
+ + +K LG VP + + Y +++
Sbjct: 96 IQKWIRTRKLKYLG------VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 479 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI--ADFGTSRSIAI 536
+ + L+++ + + L Y+H Y+ H DIK++N+LL+ K ++ D+G +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 537 DQTHV 541
+ H
Sbjct: 207 EGVHK 211
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 57/247 (23%), Positives = 94/247 (38%), Gaps = 67/247 (27%)
Query: 378 DKATDHFNVNRILGQGGQGTVYKG--MLADGRIIAVK----KSKVVDESKLEEFINEVVI 431
D + + + LG+G G V + A GR +AVK + + ++ E + +
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQV 64
Query: 432 LSQISHR------NVVKLLGS-------CLEVEVPLL---VYEFI-PNGTLFQYLHDPSE 474
L ++ V++L C+ E LL Y+FI NG F
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENG--FLPFR---- 116
Query: 475 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL-DEKYRA---------- 523
L ++A ++ +++ +LHS + H D+K NIL Y
Sbjct: 117 -LDHIR----KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168
Query: 524 --------KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVL 575
K+ DFG++ D H ST V Y PE + ++ DV+S G +L
Sbjct: 169 RTLINPDIKVVDFGSA---TYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCIL 224
Query: 576 VELLTGQ 582
+E G
Sbjct: 225 IEYYLGF 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RN 439
+ + + R +G G G +Y G +A G +A+K V ++K + E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 440 VVKLLGSCLEVEVPLLVYEFI-PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
+ + E + ++V E + P+ L + S + SL + L +A ++ + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAK---IADFGTSRSI--AIDQTHVSTK----VQGTF 549
S ++ HRD+K N L+ + I DFG ++ A H+ + + GT
Sbjct: 123 SKNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 550 GYLDPEYFHSSQFTDKS---DVYSFGVVLVELLTGQKP 584
Y ++ ++S D+ S G VL+ G P
Sbjct: 180 RYASI---NTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRN 439
+ F + R +G G G +Y G + +A+K V ++K + + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 440 VVKLLGSCLEVEVPLLVYEFI-PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
+ + +E + +LV + + P+ L + S +LSL + L +A ++ + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAK---IADFGTSRSIAIDQTHV------STKVQGTF 549
S ++L HRDIK N L+ RA I DFG ++ TH + + GT
Sbjct: 121 SKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 550 GYLDPEYFHSSQFTDKS---DVYSFGVVLVELLTGQKP 584
Y ++ ++S D+ S G VL+ L G P
Sbjct: 178 RYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 29/190 (15%), Positives = 70/190 (36%), Gaps = 35/190 (18%)
Query: 378 DKATDHFNVNRILGQGGQGTVYKGM---------LADGRIIAVK----KSKVVDESKLEE 424
DK+ + + + QG +Y+ + ++K ++ +E +
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 425 FINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNG-------TLF----QYLHDPS 473
+ + +++ LL +P + + Q D S
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLA------IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVS 151
Query: 474 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI--ADFGTS 531
+ L+ L++A + +AL +LH + Y+ H ++ + NI +D + ++++ A +G +
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 532 RSIAIDQTHV 541
HV
Sbjct: 209 FRYCPSGKHV 218
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 30/159 (18%), Positives = 63/159 (39%), Gaps = 17/159 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RN 439
H+ V R +G+G G +++G L + + +A+K S + +E ++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 440 VVKLLGSCLEVEVPLLVYEFI-PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
+ + E +LV + + P+ L L + S+ + A ++ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAK-----IADFGTSR 532
+ + +RDIK N L+ + DFG +
Sbjct: 124 EKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 17/158 (10%)
Query: 383 HFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RNV 440
+F V + +G G G + G L +A+K + +S+ + E Q+ +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 441 VKLLGSCLEVEVPLLVYEFI-PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
++ + +V E + P+ L SL + L IA ++ + Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPS--LEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAK-----IADFGTSR 532
+ +RD+K N L+ I DF ++
Sbjct: 124 KNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 1e-04
Identities = 15/48 (31%), Positives = 17/48 (35%), Gaps = 13/48 (27%)
Query: 267 GLFRCSCKEKYHGNPYFLHGCQDL-------------RCENYEGGYRC 301
G F C C E Y + C D+ C N EG YRC
Sbjct: 23 GDFECKCDEGYESGFMMMKNCMDIDECQRDPLLCRGGVCHNTEGSYRC 70
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.63 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.26 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.26 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.7 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 93.61 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.51 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.1 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 90.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.62 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.12 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.28 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 85.52 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 83.16 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 83.12 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 83.04 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 82.55 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 81.99 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 81.75 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 81.53 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=442.36 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=219.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|.+.+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|++.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999864 478899999988777788899999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 456 VYEFIPNGTLFQYLHDPS----------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
||||+++|+|.++|+... ....++|.+++.|+.|||+||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2356999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHH
Q 041043 526 ADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||... +..+.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~------~~~~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL------SNNEVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHH
Confidence 999999876544333 2334568999999999999999999999999999999999 89999532 222222222
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
.. +. +...+...++++.+|+.+||+.||++|||++||++.|+++.+..+
T Consensus 244 ~~-~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 244 TQ-GR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HH-TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred Hc-CC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 22 11 122234556789999999999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=443.71 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=213.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|.+.++||+|+||+||+|+++ +++.||||+++..+....++|.+|+++|++++|||||+++|++.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778899999999999999864 478999999988888888899999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 456 VYEFIPNGTLFQYLHDPSE------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
||||+++|+|.++|+.... ...++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999986432 246999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 041043 524 KIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 601 (678)
||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||... +..+.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~------~~~~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------SNTEAID 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS------CHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC------CHHHHHH
Confidence 99999999876543322 3345679999999999999999999999999999999999 89999532 2222222
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.+.. + .+...+...++++.+|+.+||+.||++|||++||++.|+.|.+.
T Consensus 272 ~i~~-g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CITQ-G---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHH-T---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHc-C---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2221 1 11223345567899999999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=436.98 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=213.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
..+++.++||+|+||+||+|.+. +++.||||+++.. +....++|.+|+.++++++|||||+++|++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667789999999999999963 4678999998653 3345678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC
Q 041043 455 LVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 521 (678)
+||||+++|+|.++|+.... ...++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975321 246899999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 041043 522 RAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATY 599 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~ 599 (678)
.+||+|||+++........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||... +..+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~------~~~~~ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY------SNQDV 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC------CHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC------CHHHH
Confidence 9999999999876543322 3445679999999999999999999999999999999999 89999532 22222
Q ss_pred HHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 600 FVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
...+. .+ .+...+...++.+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 257 ~~~i~-~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 257 VEMIR-NR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHH-TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHH-cC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22221 11 112234456678999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=425.98 Aligned_cols=265 Identities=27% Similarity=0.415 Sum_probs=209.5
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
|+...+++.+.++||+|+||+||+|++++ .||||.++. .+....++|.+|+++|++++|||||+++|++.+ +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 34456788899999999999999998753 589998764 345567889999999999999999999998864 5689
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++|+... ..++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 108 iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999997543 46999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCc-ceeeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 535 AIDQ-THVSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 535 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
.... ........||+.|||||++.. ..|+.++|||||||+||||+||+.||... +....+......+...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~------~~~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI------NNRDQIIFMVGRGYAS 256 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC------CCHHHHHHHHHTTCCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC------ChHHHHHHHHhcCCCC
Confidence 5322 223445679999999999864 45899999999999999999999999522 1122222222221111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+.+ ...+...++++.+|+.+||+.||++|||++||++.|+.|+..
T Consensus 257 ----p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 257 ----PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ----CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ----CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 100 112334567899999999999999999999999999988753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=435.34 Aligned_cols=274 Identities=29% Similarity=0.435 Sum_probs=225.6
Q ss_pred cChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCC-CceeeE
Q 041043 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVV-DESKLEEFINEVVILSQISH-RNVVKL 443 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h-~niv~l 443 (678)
++.++|+...++|++.+.||+|+||+||+|.+.. ++.||||+++.. .....++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 5567788888999999999999999999999643 368999998654 34556789999999999975 899999
Q ss_pred EeEEeeC-CcceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 041043 444 LGSCLEV-EVPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509 (678)
Q Consensus 444 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 509 (678)
+|+|.+. +..++||||+++|+|.++|+.... ...+++.+++.++.|||+||+|||+++ |+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999975321 345899999999999999999999999 99999
Q ss_pred CCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCc
Q 041043 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISY 587 (678)
Q Consensus 510 lk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~ 587 (678)
|||+||||++++.+||+|||+++.+..+... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999877554433 3445678999999999999999999999999999999998 8999963
Q ss_pred cccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCC
Q 041043 588 IWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663 (678)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~ 663 (678)
.. ..+.+...+..+ .+...+...++++.+|+.+||+.||++|||++||++.|+++.+.+.+
T Consensus 291 ~~------~~~~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 291 VK------IDEEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp CC------CSHHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred CC------HHHHHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 21 112222222222 22223344567899999999999999999999999999999876544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=420.74 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=211.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999975 68999999987655555677899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999974 35999999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......||+.|||||++.+..|+.++|||||||+||||++|+.||.. .+..+.+..+.... .. ...
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------~~~~~~~~~i~~~~-~~-------~~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN------EPPLKAMKMIRDNL-PP-------RLK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHSS-CC-------CCS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHHcCC-CC-------CCC
Confidence 23456799999999999999999999999999999999999999952 22233232222211 00 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.....++++.+||.+||+.||++|||++|+++.
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123455689999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=422.30 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=206.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.+.||+|+||+||+|+.. +|+.||||++.. .+....+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 689999998754 345567889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|+|.++|.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999997532 345799999999999999999999999 9999999999999999999999999998764321
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.......||+.|||||++.+..|+.++|||||||+||||++|+.||. +.+..+.+........
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~------~~~~~~~~~~i~~~~~---------- 242 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE------AGSMKNLVLKIISGSF---------- 242 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC------CSSHHHHHHHHHHTCC----------
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC------CcCHHHHHHHHHcCCC----------
Confidence 22344579999999999999999999999999999999999999995 2334444443333221
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...++++.+||.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223455689999999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=414.04 Aligned_cols=269 Identities=23% Similarity=0.323 Sum_probs=202.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHH--HHHHHHhcCCCCceeeEEeEEeeCC----cceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFI--NEVVILSQISHRNVVKLLGSCLEVE----VPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~Ei~~l~~l~h~niv~l~~~~~~~~----~~~l 455 (678)
++|.+.++||+|+||+||+|++ +|+.||||+++... .+++. .|+..+.+++|||||++++++.+.+ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4678889999999999999998 58999999986532 23333 4555567889999999999998764 4689
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA-----YLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
||||+++|+|.++|+.. .++|..+++++.|+++||+|||++. .++|+||||||+||||++++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999999753 5899999999999999999999871 23499999999999999999999999999
Q ss_pred cccccCCccee---eeccccccCccCccccccC------CCCcccchhhHHHHHHHHHhCCCCCCcccccc--------C
Q 041043 531 SRSIAIDQTHV---STKVQGTFGYLDPEYFHSS------QFTDKSDVYSFGVVLVELLTGQKPISYIWANE--------G 593 (678)
Q Consensus 531 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwslGvll~elltg~~p~~~~~~~~--------~ 593 (678)
++......... .....||+.|||||++.+. .++.++|||||||+||||+||..|+....... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98765443322 2345699999999998764 36789999999999999999988774322111 0
Q ss_pred CChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
...................+... ....+..+.+.+|+.+||+.||++||||+||++.|++|.+++
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchHHHHHHHHhcccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 11111122222111111111111 112456678999999999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=412.67 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=211.5
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.+.||+|+||+||+|+.. +++.||||.+... +....+.+.+|+++|++++|||||++++++.+.+..++|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357999999999999999999964 6899999988532 334567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.++|++. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 111 mEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999999753 46999999999999999999999999 99999999999999999999999999987754
Q ss_pred Ccc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 537 DQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 537 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
... .......||+.|||||++.+..|+.++|||||||+||||++|+.||. +.+....+..+....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~------~~~~~~~~~~i~~~~-------- 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEGLIFAKIIKLE-------- 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC------CSSHHHHHHHHHHTC--------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC------CCCHHHHHHHHHcCC--------
Confidence 332 23455679999999999999999999999999999999999999995 233333333333221
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...+...++++.+||.+||+.||++|||++|++.
T Consensus 251 ---~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1122334567899999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=401.75 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=199.8
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----CCcceEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLE----VEVPLLV 456 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv 456 (678)
|.+.++||+|+||+||+|.+. ++..||+|++.. ......+.|.+|+++|++++|||||++++++.+ .+..++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366778999999999999975 588999998753 345567789999999999999999999999875 3457999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~~~~ 535 (678)
|||+++|+|.++|++. ..+++..++.++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999753 46999999999999999999999987 4599999999999998 48999999999997543
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......||+.|||||++.+ .|+.++|||||||+||||+||+.||.. ..+.......... +....
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~-----~~~~~~~~~~i~~-~~~~~---- 249 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE-----CQNAAQIYRRVTS-GVKPA---- 249 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT-----CSSHHHHHHHHTT-TCCCG----
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC-----CCcHHHHHHHHHc-CCCCC----
Confidence 32 2345679999999998865 699999999999999999999999952 2223332222222 11111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.. +...++++.+||.+||+.||++|||++|+++
T Consensus 250 ~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1122346899999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=414.49 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=206.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.+.|.+.++||+|+||+||+|+.+ +|+.||||+++.... ..+|++++++++|||||++++++.+.+..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456788889999999999999975 689999999865322 24799999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccccCCc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~~~~~ 538 (678)
+++|+|.++|++. ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+++.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999753 36999999999999999999999999 99999999999999987 69999999998765432
Q ss_pred ce----eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 539 TH----VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 539 ~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.. ......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ..+. ..+......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~---~~i~~~~~~----- 274 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR---GPLC---LKIASEPPP----- 274 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC---SCCH---HHHHHSCCG-----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHH---HHHHcCCCC-----
Confidence 21 12335699999999999999999999999999999999999999963221 1111 111111110
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
....+...++.+.+||.+||+.||++|||+.|+++.|.....
T Consensus 275 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 275 ---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp ---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 011234456789999999999999999999999999877664
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=421.96 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=212.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.+.|++.++||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356899999999999999999975 6899999998766666667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.++++. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999964 24999999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.. .+....+..+.... .. ..
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------~~~~~~~~~i~~~~-~~-------~~ 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN------EPPLKAMKMIRDNL-PP-------RL 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHSC-CC-------CC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHHcCC-CC-------CC
Confidence 23456799999999999999999999999999999999999999952 22232222222111 00 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......++++.+||.+||+.||++|||++|+++.
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123445689999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=397.22 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=193.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||+|... +|+.||||++... +....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 6899999987542 3344567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+ +|+|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+||||++++++||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68999999753 36999999999999999999999999 999999999999999999999999999865432
Q ss_pred cceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
. ......||+.|||||++.+..+ +.++|||||||++|||++|+.||. +.+....+.......
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~------~~~~~~~~~~i~~~~--------- 228 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD------DESIPVLFKNISNGV--------- 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC------CSSHHHHHHHHHHTC---------
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC------CCCHHHHHHHHHcCC---------
Confidence 2 2344679999999999998876 579999999999999999999995 233333333332211
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...++++.+|+.+||+.||++|||++|+++.
T Consensus 229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11123345678999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=403.00 Aligned_cols=242 Identities=27% Similarity=0.327 Sum_probs=195.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|++.+.||+|+||+||+|+.. .++.||||.++.. ......++.+|+++|++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 4689999987542 22234568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.++|++. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999753 36999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.... ......||+.|||||++.+..|+.++|||||||+||||+||+.||.. .+..+.+.......
T Consensus 178 ~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~~~-------- 242 (304)
T 3ubd_A 178 DHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG------KDRKETMTMILKAK-------- 242 (304)
T ss_dssp ---C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC--------
T ss_pred CCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC------cCHHHHHHHHHcCC--------
Confidence 3322 23446799999999999999999999999999999999999999952 33333333332221
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
...+...++++.+|+.+||+.||++|||+
T Consensus 243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 11233455689999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=392.06 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=190.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc-------
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV------- 452 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------- 452 (678)
++|++.+.||+|+||+||+|+.. +|+.||||+++..+ ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999965 68999999986543 4455789999999999999999999999876543
Q ss_pred -----ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEee
Q 041043 453 -----PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527 (678)
Q Consensus 453 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 527 (678)
.++||||+++|+|.++++........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999987654445677889999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCcce-----------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh
Q 041043 528 FGTSRSIAIDQTH-----------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596 (678)
Q Consensus 528 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~ 596 (678)
||+++.+...... ..+...||+.|||||++.+..|+.++|||||||+||||++ ||... .+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999876543221 1233569999999999999999999999999999999997 66411 001
Q ss_pred HHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 597 ATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........ ...... ......+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~-~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVR-NLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-TTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHh-cCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 111100 01233456788999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=383.21 Aligned_cols=286 Identities=40% Similarity=0.623 Sum_probs=248.6
Q ss_pred cChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC
Q 041043 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE 451 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 451 (678)
+...+++..+++|++.+.||+|+||.||+|.+++++.||||+.........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44556677889999999999999999999998889999999988777777889999999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976432 235899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCc-ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 531 SRSIAIDQ-THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 531 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
+....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......+.........+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 97654322 22233445899999999999889999999999999999999999999766555556666666666666666
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
...+++........+.+..+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 677777666667788999999999999999999999999999999998864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=387.30 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=204.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC------C
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV------E 451 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 451 (678)
.++|++.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999974 6899999998643 344567889999999999999999999987643 5
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..|+||||++ |+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999996 7899999753 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc---ceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc
Q 041043 532 RSIAIDQ---THVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 532 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
+.+.... ........||+.|||||++.+. .++.++||||+||++|||++|+.||.+ .+....+..+....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g------~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG------KNYVHQLQLIMMVL 279 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC------SSHHHHHHHHHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC------CCHHHHHHHHHHhc
Confidence 8764322 2233456799999999998775 468999999999999999999999953 22222222221110
Q ss_pred -cc-hhhcc-----------hhhh--cCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 041043 608 -CL-FDILD-----------DQVR--KSGK-----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERI 657 (678)
Q Consensus 608 -~~-~~~~~-----------~~~~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l 657 (678)
.. ..... .... ...+ ...++++.+||.+||+.||++|||++|+++. |.+.
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00 00000 0000 0001 1224578899999999999999999999875 4443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=379.07 Aligned_cols=291 Identities=38% Similarity=0.615 Sum_probs=248.5
Q ss_pred cccccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCCceeeEEeE
Q 041043 368 RCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE-SKLEEFINEVVILSQISHRNVVKLLGS 446 (678)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~ 446 (678)
..+.|+..++....++|++.+.||+|+||.||+|..++++.||||++..... .....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567889999999999999999999999999999988899999999865432 223368999999999999999999999
Q ss_pred EeeCCcceEEEEeccCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 447 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
+.+.+..++||||+++|+|.++++.... ...+++..++.++.|++.||+|||+.....|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999987542 345999999999999999999999991112999999999999999999999
Q ss_pred eeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc--cccCCChHHHHHHH
Q 041043 526 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIW--ANEGRNLATYFVEC 603 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~--~~~~~~~~~~~~~~ 603 (678)
+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998776555555556679999999999988889999999999999999999999996332 22334455566555
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
........+.+.........+.++.+.+++.+||+.||++|||++||+++|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 6666677777777777778889999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=381.44 Aligned_cols=197 Identities=21% Similarity=0.353 Sum_probs=170.0
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcc
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 453 (678)
...++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999853 46789999876433 345788999999998 699999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeeccCcc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSR 532 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl~~ 532 (678)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999994 3899999999999999999999999 9999999999999876 799999999997
Q ss_pred cccCCcc---------------------------eeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCC
Q 041043 533 SIAIDQT---------------------------HVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKP 584 (678)
Q Consensus 533 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p 584 (678)
....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 112334699999999999775 589999999999999999999999
Q ss_pred CC
Q 041043 585 IS 586 (678)
Q Consensus 585 ~~ 586 (678)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 95
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=396.89 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=212.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.++|++.+.||+|+||.||+|..+ +|+.||+|.+........+.+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999975 6899999998877777778899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC--CcEEEeeccCcccccCC
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAID 537 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgl~~~~~~~ 537 (678)
+++|+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999753 246999999999999999999999999 9999999999999854 89999999999876543
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
. ......||+.|||||++.+..|+.++|||||||+||||++|+.||.. .+..+.+..+....... ..
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~------~~~~~~~~~i~~~~~~~---~~-- 377 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG------ENDDETLRNVKSCDWNM---DD-- 377 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC------SSHHHHHHHHHTTCCCC---CS--
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHHhCCCCC---Cc--
Confidence 3 23445799999999999999999999999999999999999999952 23333333332211100 00
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......++++.+||.+||+.||++|||+.|+++.
T Consensus 378 --~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112335678899999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=356.14 Aligned_cols=284 Identities=34% Similarity=0.577 Sum_probs=231.6
Q ss_pred cccccChHHHHhhccCCCcC------CeeeeeCCcEEEEEEEcCCcEEEEEEcccC----ChhhHHHHHHHHHHHhcCCC
Q 041043 368 RCKIFNSKELDKATDHFNVN------RILGQGGQGTVYKGMLADGRIIAVKKSKVV----DESKLEEFINEVVILSQISH 437 (678)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~------~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h 437 (678)
....|+..+++.++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 44678999999999998877 8999999999999987 5889999987542 34456789999999999999
Q ss_pred CceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE
Q 041043 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 517 (678)
Q Consensus 438 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 517 (678)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999986554557999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh
Q 041043 518 DEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596 (678)
Q Consensus 518 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~ 596 (678)
++++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS--SSBT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc--hHHH
Confidence 99999999999999765543222 2334568999999998865 588999999999999999999999964322 1222
Q ss_pred HHHHHHHHhh-ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 597 ATYFVECVEE-NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 597 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
..+....... ..+...++... ...+...++.+.+++.+||+.||.+|||++||++.|++|.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222222221 12233333322 23456778899999999999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=368.07 Aligned_cols=275 Identities=29% Similarity=0.449 Sum_probs=211.1
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
...+++...++|++.+.||+|+||+||+|.. +++.||||++... .....+++.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3444555677899999999999999999987 5889999987653 345567899999999999999999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
+..++||||+++|+|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 999999999999999999986543345899999999999999999999987 4599999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||... .............
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~------~~~~~~~~~~~~~--- 255 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL------NPAQVVAAVGFKC--- 255 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS------CHHHHHHHHHHSC---
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcC---
Confidence 97543322 2233456899999999999999999999999999999999999999532 1122111111111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCC
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDD 665 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~ 665 (678)
.....+...++++.+|+.+||+.||++|||++|+++.|+.+.+...+..
T Consensus 256 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 256 ------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred ------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 1112233455679999999999999999999999999999997655443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=389.03 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=201.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC------ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV------DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
++|++.++||+|+||+||+++.+ +|+.||||++... ......+...++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999975 6899999987531 1222233345577788889999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++|.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+++.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999753 36999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
.... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||.... ..+............
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~---~~~~~~i~~~i~~~~------ 410 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK---TKDKHEIDRMTLTMA------ 410 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG---CCCHHHHHHHHHHCC------
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhcCCC------
Confidence 5432 234579999999999965 579999999999999999999999996322 122222222211111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
...+...++++.+||.+||+.||++|++ ++||++.
T Consensus 411 -----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1223345678999999999999999998 6777654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.99 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=216.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.++|.+.++||+|+||+||++... +++.||+|++...+....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 457888999999999999999975 5899999998877788889999999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999863 235999999999999999999999999 99999999999999999999999999987643322
Q ss_pred ee-------------eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 540 HV-------------STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 540 ~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------- 234 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------- 234 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence 21 11456899999999999999999999999999999999999998643322211000
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..........+...++.+.+|+.+||+.||++|||++|+++.|+.++..
T Consensus 235 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 235 -----NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -----CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000111111233345788999999999999999999999999999854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.39 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=215.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEee
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCLE 449 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 449 (678)
..++|.+.+.||+|+||.||+|... ++..||||.++.. .....+++.+|+++++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3568899999999999999999852 3467999998754 344567899999999999 89999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceE
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 516 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 516 (678)
.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999975431 235899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCC
Q 041043 517 LDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGR 594 (678)
Q Consensus 517 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~ 594 (678)
|+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----- 310 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 310 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence 999999999999999865433221 2233456789999999999999999999999999999999 999985321
Q ss_pred ChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
....+.... . ..+...+...+.++.+|+.+||+.||++|||+.|+++.|++|....
T Consensus 311 -~~~~~~~~~-~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 311 -VEELFKLLK-E---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -GGGHHHHHH-T---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHh-c---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111111 1 1112223445568999999999999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=355.97 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=217.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3567899999999999999999998899999999875433 346799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999997543 35899999999999999999999999 99999999999999999999999999986654333
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.......+++.|+|||.+....++.++||||||+++|||++ |+.||.. ............. ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~------~~~~~~~~~~~~~----------~~ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN------RSNSEVVEDISTG----------FR 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------CCHHHHHHHHHTT----------CC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC------CCHHHHHHHHhcC----------cc
Confidence 33344456788999999998999999999999999999999 9999852 2222222222211 11
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
...+...+..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 1122334567999999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=361.06 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=213.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
..++|.+.+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3567899999999999999999974 3557999998754 4555678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999997542 35999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 535 AIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 535 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||... ............
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~------~~~~~~~~~~~~----- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM------TNRDVISSVEEG----- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS------CHHHHHHHHHTT-----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC------CHHHHHHHHHcC-----
Confidence 543222 2223346778999999998899999999999999999999 99998532 112222211111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+...+..+.+|+.+||+.||++|||++||++.|+.+...
T Consensus 271 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 -----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11222344556899999999999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.84 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=210.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999995 56899999998766556677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999753 4899999999999999999999999 99999999999999999999999999876654333
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||... +.............. ..
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~~~~~~~~--------~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------NPLRALYLIATNGTP--------EL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHHCSC--------CC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC--------CC
Confidence 233456999999999999999999999999999999999999999522 112112111111110 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1123445678999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=353.57 Aligned_cols=279 Identities=25% Similarity=0.385 Sum_probs=215.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|++.+.||+|+||.||++... +++.||+|.+.. ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3568999999999999999999964 688999998743 334556789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999999753 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||... ............. ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~------~~~~~~~~~~~~~-~~~---- 231 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE------TAVSIAIKHIQDS-VPN---- 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS------CHHHHHHHHHSSC-CCC----
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHhhcc-CCC----
Confidence 44434444566999999999999999999999999999999999999999522 2222222222111 100
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhccCCCCCchHHHHHhhh
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-TMKEVAMELERIRACNLQDDDDNIQKCYEEL 676 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~l~~~~~~~~~~~~~~~~~~~ 676 (678)
.........++.+.+++.+||+.||++|| +++++.+.|+++....-..++....+.++++
T Consensus 232 -~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 292 (294)
T 4eqm_A 232 -VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKTI 292 (294)
T ss_dssp -HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC-------
T ss_pred -cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhhhhcchhh
Confidence 00111223456799999999999999998 9999999999998766655554444444443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=361.49 Aligned_cols=267 Identities=29% Similarity=0.488 Sum_probs=212.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-----cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Ccc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 453 (678)
.++|++.+.||+|+||+||++.+ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 35889999999887777788999999999999999999999998654 458
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999997542 35899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc----
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN---- 607 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 607 (678)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... +.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~ 235 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 235 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccc
Confidence 6543322 223345777899999999999999999999999999999999997532111 00000000
Q ss_pred ----cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 608 ----CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 608 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+....+...+...++++.+|+.+||+.||++|||++|+++.|++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 01111111112223445567899999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=352.42 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=216.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
..++|++.+.||+|+||.||++..+++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4568999999999999999999998888999999875433 346799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999753 235899999999999999999999999 99999999999999999999999999987665544
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||... ............. .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~~~----------~ 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY------TNSEVVLKVSQGH----------R 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHHTTC----------C
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc------ChHHHHHHHHcCC----------C
Confidence 44444556778999999998889999999999999999999 99998522 1122222211111 1
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
...+...++.+.+++.+||+.||++|||++|+++.|+.++..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111223345799999999999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=373.05 Aligned_cols=264 Identities=28% Similarity=0.427 Sum_probs=216.0
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++...++|.+.+.||+|+||.||+|.+. +++.||||.++.. .....++|.+|++++++++||||+++++++...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 34455678999999999999999999986 6899999998653 344456789999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 188 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 9999999999999999743 235899999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcceee-eccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 534 IAIDQTHVS-TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 534 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
......... ....+++.|+|||.+....++.++||||||+++|||++ |..||..... .. .......
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~-~~~~~~~----- 330 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQ-TREFVEK----- 330 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HH-HHHHHHT-----
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHc-----
Confidence 443222111 12235778999999998899999999999999999998 9999853211 11 1111111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..+...+...++++.+|+.+||+.||++|||++++++.|++|++.
T Consensus 331 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 ----GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111222334456899999999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=366.38 Aligned_cols=260 Identities=23% Similarity=0.432 Sum_probs=203.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
..++|++.+.||+|+||.||+|... ++..||||+++.. .....++|.+|++++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999865 5678999998754 4555678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999864 336899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 535 AIDQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 535 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||... .........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~------~~~~~~~~i-------- 263 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM------SNQDVIKAV-------- 263 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC------CHHHHHHHH--------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHH--------
Confidence 5432221 122235778999999999999999999999999999998 99998532 111111111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....+...+...+..+.+|+.+||+.||++||+++||++.|+++...
T Consensus 264 --~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 264 --DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11112222334556899999999999999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=367.44 Aligned_cols=273 Identities=29% Similarity=0.425 Sum_probs=221.3
Q ss_pred ccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceee
Q 041043 371 IFNSKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVK 442 (678)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~ 442 (678)
.+...+++...++|.+.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3567788888999999999999999999999842 4579999998753 344567899999999999 7999999
Q ss_pred EEeEEeeCCc-ceEEEEeccCCChhhhhcCCCC-----------------------------------------------
Q 041043 443 LLGSCLEVEV-PLLVYEFIPNGTLFQYLHDPSE----------------------------------------------- 474 (678)
Q Consensus 443 l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 474 (678)
+++++.+.+. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999986532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 475 ----------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 475 ----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999999 9999999999999999999999999998664433
Q ss_pred c-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 539 T-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 539 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ...+.......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~--------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEEFCRRLKEG--------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------SHHHHHHHHHT---------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch------hHHHHHHHHcC---------
Confidence 2 23344568899999999999999999999999999999998 9999853211 11111111111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.....+...++++.+++.+||+.||++|||++|++++|+++.+.+
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 111222334567999999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=357.76 Aligned_cols=272 Identities=27% Similarity=0.433 Sum_probs=220.0
Q ss_pred cccChHHHHhhccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceee
Q 041043 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442 (678)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~ 442 (678)
+.+...+++...++|.+.+.||+|+||.||++.. .+++.||||.+... .....+.+.+|++++++++||||++
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp ---CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred eccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceee
Confidence 3344445556678899999999999999999986 23578999998653 4556678999999999999999999
Q ss_pred EEeEEeeCCcceEEEEeccCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 041043 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSE---------------------ELSLTWEMRLRIATEVAEALAYLHSSA 501 (678)
Q Consensus 443 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~ 501 (678)
+++++.+.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999976432 234899999999999999999999999
Q ss_pred CCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh
Q 041043 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT 580 (678)
Q Consensus 502 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt 580 (678)
|+||||||+|||+++++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++
T Consensus 171 ---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 171 ---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp ---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred ---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999876543332 2233456788999999998889999999999999999999
Q ss_pred -CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 581 -GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 581 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
|+.||...... .... .... ......+...++.+.+|+.+||+.||++|||+.|+++.|+++..
T Consensus 248 ~g~~p~~~~~~~------~~~~-~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 248 LGGNPYPGIPPE------RLFN-LLKT---------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TSCCSSTTCCGG------GHHH-HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH------HHHH-Hhhc---------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99998532211 1111 1111 11122233455689999999999999999999999999999876
Q ss_pred c
Q 041043 660 C 660 (678)
Q Consensus 660 ~ 660 (678)
.
T Consensus 312 ~ 312 (314)
T 2ivs_A 312 K 312 (314)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=361.16 Aligned_cols=269 Identities=25% Similarity=0.329 Sum_probs=210.9
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc----ce
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV----PL 454 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----~~ 454 (678)
...++|++.++||+|+||+||+|+.. ++.||||++..... ....+.+|+.++++++||||+++++++..... .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34578999999999999999999876 79999999865433 33456679999999999999999999987553 59
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeecCCCCceEECCCCcEE
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS----------AYLPIYHRDIKSTNILLDEKYRAK 524 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------~~~~ivH~Dlk~~NILl~~~~~~k 524 (678)
+||||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 999999999999999753 489999999999999999999998 7 99999999999999999999
Q ss_pred EeeccCcccccCCcce-eeeccccccCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCccccccCCC---
Q 041043 525 IADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSS-----QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRN--- 595 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~--- 595 (678)
|+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999776543322 23335689999999998763 45678999999999999999999996433222111
Q ss_pred -------hHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 596 -------LATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 596 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
...+.. ..........+.... .....++++.+|+.+||+.||++|||++||++.|++|+..
T Consensus 252 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQE-VVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHH-HHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhh-hhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111 111111111111111 1234567799999999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=380.77 Aligned_cols=267 Identities=24% Similarity=0.404 Sum_probs=220.0
Q ss_pred cChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC
Q 041043 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE 451 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 451 (678)
+..++++...++|.+.+.||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++||||+++++++. .+
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34455667788999999999999999999999888999999987543 35688999999999999999999999986 66
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++||||+++|+|.++++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred ccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 7899999999999999997532 235889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
+..............++..|+|||.+....++.++||||||++||||++ |+.||... ...+.......
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~------~~~~~~~~i~~----- 400 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRALER----- 400 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHH-----
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHc-----
Confidence 8764332222233346788999999998899999999999999999999 99998532 22222221111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..+...+...++++.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 401 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 401 -----GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 112222344567899999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=351.25 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=214.8
Q ss_pred ccChHHHHhhccC----------CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc
Q 041043 371 IFNSKELDKATDH----------FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439 (678)
Q Consensus 371 ~~~~~~~~~~~~~----------~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n 439 (678)
.++.++++.+++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4666777666553 666789999999999999976 69999999987766667788999999999999999
Q ss_pred eeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC
Q 041043 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE 519 (678)
Q Consensus 440 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 519 (678)
|+++++++...+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999999964 35899999999999999999999998 999999999999999
Q ss_pred CCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHH
Q 041043 520 KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATY 599 (678)
Q Consensus 520 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~ 599 (678)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||... .....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~------~~~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD------SPVQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHH
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHH
Confidence 99999999999976654322 233456999999999999999999999999999999999999998522 22222
Q ss_pred HHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 600 FVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........ ... .......++.+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~-~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRDSP-PPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHSS-CCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCC-CCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22211111 000 01112344678999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.69 Aligned_cols=270 Identities=29% Similarity=0.431 Sum_probs=220.5
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEE
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLL 444 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~ 444 (678)
..++...++|.+.+.||+|+||.||+|... .+..||||+++.. .....+++.+|+++++++ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 334556688999999999999999999952 2367999998653 445567899999999999 899999999
Q ss_pred eEEeeCCcceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 041043 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 511 (678)
Q Consensus 445 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 511 (678)
+++.+.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+|||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 218 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 999999999999999999999999975431 245999999999999999999999999 9999999
Q ss_pred CCceEECCCCcEEEeeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 041043 512 STNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIW 589 (678)
Q Consensus 512 ~~NILl~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~ 589 (678)
|+||||++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~- 297 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV- 297 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 9999999999999999999986654322 22334457889999999999999999999999999999999 99998522
Q ss_pred cccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCC
Q 041043 590 ANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663 (678)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~ 663 (678)
........... . .....+...+.++.+|+.+||+.||++|||++||++.|+++......
T Consensus 298 -----~~~~~~~~~~~-~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 298 -----PVEELFKLLKE-G---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp -----CHHHHHHHHHT-T---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred -----CHHHHHHHHHc-C---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 22222222211 1 11122334456799999999999999999999999999999865543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=353.64 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=214.3
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
++...++|++.+.||+|+||.||++.+.++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++|
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3445678999999999999999999999888999999875433 346799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp ECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999997632 35999999999999999999999999 99999999999999999999999999986654
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...........
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~--------- 237 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIAQG--------- 237 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTT---------
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC------hhHHHHHHhcc---------
Confidence 33333333456788999999998899999999999999999998 999985321 11112111111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+...++.+.+|+.+||+.||++|||++|+++.|+++...
T Consensus 238 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 238 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11112233346799999999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.46 Aligned_cols=280 Identities=26% Similarity=0.428 Sum_probs=218.7
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc--------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEe
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLG 445 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~ 445 (678)
.++...++|.+.+.||+|+||.||+|... ++..||||+++.. .....+++.+|+++++++ +||||+++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34445678999999999999999999863 4678999998754 345567899999999999 8999999999
Q ss_pred EEeeCCcceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 041043 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512 (678)
Q Consensus 446 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 512 (678)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 185 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCcc
Confidence 99999999999999999999999986532 234899999999999999999999999 99999999
Q ss_pred CceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 041043 513 TNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWA 590 (678)
Q Consensus 513 ~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~ 590 (678)
+|||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-- 263 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-- 263 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC--
Confidence 9999999999999999999876543322 2233456789999999988889999999999999999999 99998532
Q ss_pred ccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCchHH
Q 041043 591 NEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQ 670 (678)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~ 670 (678)
............ .....+...+..+.+++.+||+.||.+|||++|+++.|+++.......+...+.
T Consensus 264 ----~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~~~ 329 (334)
T 2pvf_A 264 ----PVEELFKLLKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLS 329 (334)
T ss_dssp ----CHHHHHHHHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--------
T ss_pred ----CHHHHHHHHhcC----------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcccCCC
Confidence 222222211111 111223344567999999999999999999999999999999876665555554
Q ss_pred HHHh
Q 041043 671 KCYE 674 (678)
Q Consensus 671 ~~~~ 674 (678)
+.++
T Consensus 330 ~~l~ 333 (334)
T 2pvf_A 330 QPLE 333 (334)
T ss_dssp ----
T ss_pred Cccc
Confidence 4443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=354.55 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=209.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.. .+....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456899999999999999999997 5789999998754 3455677899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999976543
Q ss_pred CcceeeeccccccCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......||+.|+|||.+.+..+. .++||||||+++|||++|+.||.. .+............
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~------~~~~~~~~~i~~~~-------- 230 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGK-------- 230 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC--------
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCC--------
Confidence 32 23445699999999999887765 799999999999999999999952 23333222222211
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+.++.+|+.+||+.||.+|||++|+++.
T Consensus 231 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ---YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11122345678899999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=350.30 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=201.9
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
+...++|++.+.||+|+||.||+|.... +..||+|..+.. .....+.+.+|+.++++++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4456789999999999999999999643 457999987653 3445678999999999999999999999974 567
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 89999999999999999753 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
..............+++.|+|||.+....++.++||||||+++|||++ |..||...... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------~~~~~i~~~~---- 234 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGE---- 234 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTC----
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------HHHHHHHcCC----
Confidence 765443333344457789999999998899999999999999999997 99998632211 1111111111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....+...++.+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1112334556899999999999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=381.78 Aligned_cols=263 Identities=28% Similarity=0.461 Sum_probs=218.9
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
+++...++|.+.++||+|+||.||+|.+.. +..||||.++... ...++|.+|+++|++++||||+++++++.+.+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 344456778999999999999999999865 8899999987543 34678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999997542 345899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
............++..|+|||.+....++.++||||||++||||++ |..||..... ..... .+
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------~~~~~----------~~ 432 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYE----------LL 432 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHH----------HH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------HHHHH----------HH
Confidence 5443333334456788999999998899999999999999999999 9999863221 11111 11
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
....+...+...++.+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1222223344556789999999999999999999999999998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.11 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=215.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|++.+.||+|+||.||++...+++.||+|.+..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467889999999999999999998889999999876433 3468999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999999997542 35899999999999999999999999 999999999999999999999999999865433222
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.. ............. ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~------~~~~~~~~~i~~~----------~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN------RSNSEVVEDISTG----------FRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------CCHHHHHHHHHTT----------CCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC------CCHHHHHHHHhcC----------CcC
Confidence 2333456788999999998889999999999999999999 8999852 2222222222111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
..+...+..+.+++.+||+.||++|||++|+++.|+++.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 112334567899999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=371.20 Aligned_cols=259 Identities=28% Similarity=0.467 Sum_probs=213.3
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-cceE
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE-VPLL 455 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~l 455 (678)
++...++|++.+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+++|++++||||+++++++.+.+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3445678899999999999999999985 7899999987543 4578999999999999999999999987765 7899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.++++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999998542 234799999999999999999999999 9999999999999999999999999997543
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.. .....++..|+|||.+.+..++.++||||||++||||++ |+.||...... .. .... ..
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~---~~~i-~~-------- 401 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV---VPRV-EK-------- 401 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---TH---HHHH-HT--------
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHH-Hc--------
Confidence 22 122357889999999999999999999999999999998 99998633211 11 1111 11
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
..+...+...++.+.+|+.+||+.||++|||++|+++.|+.|...++
T Consensus 402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 11222334456789999999999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=352.67 Aligned_cols=270 Identities=28% Similarity=0.450 Sum_probs=219.9
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCCceeeEEe
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-SHRNVVKLLG 445 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~ 445 (678)
..+++...++|.+.+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|+++++++ +||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 344555667899999999999999999985 246799999986543 34567899999999999 8999999999
Q ss_pred EEeeCCcceEEEEeccCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 041043 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPSE---------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDI 510 (678)
Q Consensus 446 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 510 (678)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 171 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 171 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 99999999999999999999999976432 125899999999999999999999999 999999
Q ss_pred CCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 041043 511 KSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYI 588 (678)
Q Consensus 511 k~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~ 588 (678)
||+|||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999999876544332 2334457889999999999899999999999999999999 99998532
Q ss_pred ccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 589 WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.. .......... ......+...+..+.+|+.+||+.||.+|||++|+++.|+++....
T Consensus 252 ~~------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 252 PV------DSKFYKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CS------SHHHHHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cc------hhHHHHHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11 1111111111 1111223344568999999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.70 Aligned_cols=266 Identities=26% Similarity=0.388 Sum_probs=212.8
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
...++...++|.+.++||+|+||.||+|.++++..||||.++... ...++|.+|+++|++++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 344556678899999999999999999999888899999987543 335789999999999999999999999876 678
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.++++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 99999999999999997421 235899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.............++..|+|||.+....++.++||||||+++|||++ |+.||... ...+.......
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~------~~~~~~~~i~~------- 396 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVER------- 396 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHT-------
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHc-------
Confidence 65433333333456789999999998899999999999999999999 99998532 11222211111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
..+...+...++.+.+|+.+||+.||++|||++++++.|+.+....
T Consensus 397 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 397 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1112223445678999999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.92 Aligned_cols=268 Identities=27% Similarity=0.434 Sum_probs=214.8
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSC 447 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 447 (678)
+++...++|.+.+.||+|+||.||+|.. .++..||||.+... .....+.+.+|+++++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4555678899999999999999999996 24568999998643 334457899999999999 899999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEE--------------------LSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 507 (678)
...+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999999865321 34899999999999999999999999 999
Q ss_pred ecCCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 041043 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPI 585 (678)
Q Consensus 508 ~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~ 585 (678)
|||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876543332 2334557889999999998899999999999999999998 99998
Q ss_pred CccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 586 SYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
..... ...+....... .....+...++.+.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus 276 ~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 276 PGIPV------DANFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TTCCC------SHHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ccCCc------HHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 53211 11122222211 112223344568999999999999999999999999999988653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.01 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=204.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhc--CCCCceeeEEeEEeeC----Ccc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ--ISHRNVVKLLGSCLEV----EVP 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~----~~~ 453 (678)
..++|++.+.||+|+||+||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999998 6899999998643 34566677777766 7999999999987653 457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH--------SSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 899999999999999964 35999999999999999999999 777 999999999999999999999
Q ss_pred eeccCcccccCCccee---eeccccccCccCccccccC------CCCcccchhhHHHHHHHHHhC----------CCCCC
Q 041043 526 ADFGTSRSIAIDQTHV---STKVQGTFGYLDPEYFHSS------QFTDKSDVYSFGVVLVELLTG----------QKPIS 586 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwslGvll~elltg----------~~p~~ 586 (678)
+|||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997655443332 2234689999999999876 455799999999999999999 77775
Q ss_pred ccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 587 YIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
....... . ................... .......+..+.+|+.+||+.||++|||++||++.|++|
T Consensus 235 ~~~~~~~-~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDP-S-FEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSC-C-HHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCc-c-hhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3322211 1 1112221111111100000 111235678899999999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=346.73 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=217.2
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++++...++|++.+.||+|+||.||+|...++..||||.+.... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 345556678899999999999999999999888899999886543 34578999999999999999999999886 4568
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 99999999999999997531 125899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~~~~~~~------ 226 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERG------ 226 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHTT------
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc------CHHHHHHHHhcc------
Confidence 65444333344456789999999998889999999999999999999 89998532 112222111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+...++.+.+|+.+||+.||++|||++++++.|+.+...
T Consensus 227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 ----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11112234456899999999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.65 Aligned_cols=264 Identities=28% Similarity=0.452 Sum_probs=221.2
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
+++...++|++.+.||+|+||.||+|.... +..||+|.+... ....+++.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 444567789999999999999999999764 789999998753 345678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999997643 346899999999999999999999999 999999999999999999999999999877
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ...... +
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------~~~~~~----------~ 225 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYEL----------L 225 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHH----------H
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH----------H
Confidence 6555444455567889999999998899999999999999999999 9999853211 111111 1
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
........+...++.+.+|+.+||+.||++|||++|+++.|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11112222344556899999999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.29 Aligned_cols=266 Identities=26% Similarity=0.411 Sum_probs=216.2
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEe
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCL 448 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 448 (678)
.++...++|.+.+.||+|+||.||+|... +++.||||.++.. .....+.+.+|++++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34456788999999999999999999975 3488999998754 3445678999999999999999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSE---------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 507 (678)
+.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999999976421 146899999999999999999999999 999
Q ss_pred ecCCCCceEECCCCcEEEeeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 041043 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPI 585 (678)
Q Consensus 508 ~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~ 585 (678)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976543322 22334457889999999998899999999999999999999 99998
Q ss_pred CccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 586 SYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
... ......... ..+.. ...+...+..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 278 ~~~------~~~~~~~~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGM------AHEEVIYYV-RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTS------CHHHHHHHH-HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCC------ChHHHHHHH-hCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 532 112222211 11111 112234456799999999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.92 Aligned_cols=254 Identities=29% Similarity=0.480 Sum_probs=199.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh----hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE----SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.+.||+|+||.||+|.+. ++.||||..+.... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999975 88999998765332 3357789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC--------CCcEEEeec
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE--------KYRAKIADF 528 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~Df 528 (678)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999963 35899999999999999999999998666899999999999986 778999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
|++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ...........
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~-- 229 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAMN-- 229 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHTS--
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHhhhcC--
Confidence 9997654322 223468999999999999899999999999999999999999995321 11111111111
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
......+...++.+.+++.+||+.||++|||++|+++.|++|
T Consensus 230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122334456799999999999999999999999999865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.77 Aligned_cols=257 Identities=26% Similarity=0.492 Sum_probs=203.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
.++|++.++||+|+||+||+|.+. +++ +||+|.+... .....+++.+|++++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356889999999999999999964 343 4688887543 3445678999999999999999999999998754 78
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999998643 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 535 AIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 535 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ + ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~-------------~~~ 231 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I-------------SSI 231 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H-------------HHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H-------------HHH
Confidence 543332 2233456889999999999999999999999999999999 999986322111 1 111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
+........+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111222234455689999999999999999999999999998864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=354.19 Aligned_cols=265 Identities=29% Similarity=0.450 Sum_probs=199.8
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcCC----cEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLADG----RIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE 451 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 451 (678)
....++|++.+.||+|+||.||+|..... ..||||.++.. .....+++.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34467899999999999999999996543 27999988653 4556788999999999999999999999998776
Q ss_pred cc------eEEEEeccCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc
Q 041043 452 VP------LLVYEFIPNGTLFQYLHDPS---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522 (678)
Q Consensus 452 ~~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 522 (678)
.. ++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 99999999999999996422 2235899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 041043 523 AKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 523 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 600 (678)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~ 249 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------AEIY 249 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh------HHHH
Confidence 999999999765443322 2233456788999999999999999999999999999999 8999853221 1111
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
....... ....+...++++.+|+.+||+.||++|||+.|+++.|+++....
T Consensus 250 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 250 NYLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 11223345568999999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.14 Aligned_cols=271 Identities=24% Similarity=0.362 Sum_probs=215.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC--cceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVE--VPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv 456 (678)
.++|.+.++||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999976 48999999986533 344677889999999999999999999998765 67899
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE----CCCCcEEEeeccCcc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSR 532 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgl~~ 532 (678)
|||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655555999999999999999999999999 9999999999999 888889999999998
Q ss_pred cccCCcceeeeccccccCccCccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFH--------SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
....... .....+|+.|+|||++. +..++.++||||||+++|||++|+.||...... ...........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKII 240 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG--GGCHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--chhHHHHHHHh
Confidence 7654332 23356899999999986 467899999999999999999999999533221 11222222222
Q ss_pred hhccc---hhhc-----------chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 605 EENCL---FDIL-----------DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 605 ~~~~~---~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
..... ..+. +..............+.+|+.+||+.||++|||++|+++....-.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 21110 0000 001112335678889999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.60 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=212.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999953 4678999998653 455566899999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC---cEEEe
Q 041043 454 LLVYEFIPNGTLFQYLHDPS----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIA 526 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 526 (678)
++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 2245899999999999999999999999 99999999999999554 59999
Q ss_pred eccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHH
Q 041043 527 DFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 527 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||... ..........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~------~~~~~~~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK------SNQEVLEFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHH
Confidence 9999975432221 22334457899999999999999999999999999999998 99998522 2222222222
Q ss_pred hhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
... ....+...+..+.+|+.+||+.||++|||++||++.|+.+...
T Consensus 301 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111 1122334456799999999999999999999999999988753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.33 Aligned_cols=249 Identities=25% Similarity=0.323 Sum_probs=207.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.+.||+|+||+||++..+ +++.||+|.++.. .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999975 6899999988642 234457789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999999743 35899999999999999999999999 99999999999999999999999999975432
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+............
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~~~~--------- 221 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------QDHERLFELILMEE--------- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC---------
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC------CCHHHHHHHHHcCC---------
Confidence 22 223445699999999999999999999999999999999999999952 22222222222211
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
...+...+.++.+|+.+||+.||++|| +++|+++.
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112234456789999999999999999 89999765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=340.86 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=209.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--CcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 456 (678)
.++|.+.+.||+|+||.||+|+.+ ++.||||.++.. +....+++.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457899999999999999999985 889999987653 455567899999999999999999999999877 778999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ .+++||||||+|||++.++.++|.|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999998643 235899999999999999999999977 4599999999999999999999999988754332
Q ss_pred CcceeeeccccccCccCccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTD---KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||... .............
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~------ 227 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL------SNMEIGMKVALEG------ 227 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS------CHHHHHHHHHHSC------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc------ChHHHHHHHHhcC------
Confidence 2235789999999998765544 799999999999999999999522 1222222221111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
.....+...+..+.+++.+||+.||++|||++|+++.|+++++
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 ---LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1122233455679999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.02 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=204.2
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
...++|++.++||+|+||+||+|...+++.||+|++... +....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345789999999999999999999988999999988643 233457789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||++ |+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99997 58888887543 35899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc---chhh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC---LFDI 612 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 612 (678)
... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ............... +...
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD---DDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST---TTHHHHHHHHHCCCCTTTSGGG
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHHCCCChHHhhhh
Confidence 322 2333468999999999876 5689999999999999999999999964322 112222222111110 0000
Q ss_pred cc-------------hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 LD-------------DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ~~-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+ ...........++++.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00000001123457899999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=349.10 Aligned_cols=274 Identities=30% Similarity=0.435 Sum_probs=220.9
Q ss_pred cChHHHHhhccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeE
Q 041043 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKL 443 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l 443 (678)
+...+++...++|.+.+.||+|+||.||+|.. .+++.||||.++.. .....+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45667777889999999999999999999984 24689999998653 344567899999999999 69999999
Q ss_pred EeEEeeCC-cceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 041043 444 LGSCLEVE-VPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509 (678)
Q Consensus 444 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 509 (678)
++++...+ ..++|+||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988755 58999999999999999986543 123889999999999999999999999 99999
Q ss_pred CCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCc
Q 041043 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISY 587 (678)
Q Consensus 510 lk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~ 587 (678)
|||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999866543322 2334557889999999999999999999999999999998 9999853
Q ss_pred cccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCC
Q 041043 588 IWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663 (678)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~ 663 (678)
... ...+........ ....+...++.+.+++.+||+.||.+|||+.|+++.|+.+.+.+..
T Consensus 254 ~~~------~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 254 VKI------DEEFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp CCC------SHHHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cch------hHHHHHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 211 111111111111 1112233456799999999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=366.46 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=213.5
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEee
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
..+++...++|++.++||+|+||+||+|+.++ ++.||+|+++... ....+.+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 45566677899999999999999999999764 7899999886421 1223348899999999999999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999863 246999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||.. .+..+.+..+.
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~------~~~~~~~~~i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIM 294 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC------CChhHHHHhhh
Confidence 99876655554455567999999999987 56789999999999999999999999952 22333333322
Q ss_pred hhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041043 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS--RPTMKEVAME 653 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 653 (678)
....... ........++++.+||++||..+|++ ||+++|+++.
T Consensus 295 ~~~~~~~------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKERFQ------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHHHCC------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hcccccc------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2110000 00111234567899999999988888 9999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.48 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=201.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc------
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV------ 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 452 (678)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999976 7899999998643 34456789999999999999999999999866432
Q ss_pred ---------------------------------------------------ceEEEEeccCCChhhhhcCCCCCCCCCHH
Q 041043 453 ---------------------------------------------------PLLVYEFIPNGTLFQYLHDPSEELSLTWE 481 (678)
Q Consensus 453 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~ 481 (678)
.++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999987665667888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc-----------eeeeccccccC
Q 041043 482 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-----------HVSTKVQGTFG 550 (678)
Q Consensus 482 ~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~~ 550 (678)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987654321 11233468999
Q ss_pred ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHH
Q 041043 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVS 630 (678)
Q Consensus 551 y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (678)
|+|||.+.+..++.++||||||+++|||++|..|+.. ....... ....... .......+.+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~-~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITD-VRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHH-HHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHH-hhccCCC---------cccccCChhHH
Confidence 9999999999999999999999999999999877420 0000000 0010000 00123445788
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 041043 631 DVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 631 ~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+|+.+||+.||++|||++|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.91 Aligned_cols=259 Identities=29% Similarity=0.424 Sum_probs=207.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
..++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45689999999999999999998643 246999988654 44566789999999999999999999999764 4578
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999753 235899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..... .
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~---~~~~~-~------ 230 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVI---GVLEK-G------ 230 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHH---HHHHH-T------
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHH---HHHhc-C------
Confidence 5444333344557889999999998899999999999999999998 99998532211 111 11111 1
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.....+...++.+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 ---DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11111233456799999999999999999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.58 Aligned_cols=281 Identities=24% Similarity=0.339 Sum_probs=209.1
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEee---
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLE--- 449 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--- 449 (678)
..++....+|++.++||+|+||.||++... +++.||||++........+.+.+|+.+++++. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 344455678999999999999999999964 68999999987777777788999999999996 9999999999853
Q ss_pred -----CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEE
Q 041043 450 -----VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 524 (678)
Q Consensus 450 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 524 (678)
....++|+||+. |+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEE
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEE
Confidence 334789999995 799999875434456999999999999999999999987 3599999999999999999999
Q ss_pred EeeccCcccccCCccee-----------eeccccccCccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 041043 525 IADFGTSRSIAIDQTHV-----------STKVQGTFGYLDPEYF---HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWA 590 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwslGvll~elltg~~p~~~~~~ 590 (678)
|+|||++.......... .....+|+.|+|||.+ .+..++.++||||||+++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 1134589999999998 566788999999999999999999999852111
Q ss_pred ccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCchHH
Q 041043 591 NEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDNIQ 670 (678)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~~~~ 670 (678)
. .+................+.+|+.+||+.||++|||++|+++.|+.+...........+.
T Consensus 259 ------~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~ 319 (337)
T 3ll6_A 259 ------L-------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319 (337)
T ss_dssp --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCH
T ss_pred ------H-------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHH
Confidence 0 011111111111222345889999999999999999999999999999877666666676
Q ss_pred HHHhhh
Q 041043 671 KCYEEL 676 (678)
Q Consensus 671 ~~~~~~ 676 (678)
++.++.
T Consensus 320 ~~~~~~ 325 (337)
T 3ll6_A 320 ELLEQN 325 (337)
T ss_dssp HHHTCC
T ss_pred HHHHHc
Confidence 666653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=344.70 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=208.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
..++|.+.+.||+|+||.||++... +++.+|+|.+... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578999999999999999999975 5789999988754 3445678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC--CCcEEEeeccCcccccC
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE--KYRAKIADFGTSRSIAI 536 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgl~~~~~~ 536 (678)
|+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999999753 235899999999999999999999999 999999999999987 78999999999987654
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.. ................. ...
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~------~~~~~~~~~i~~~~~~~---~~~ 225 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA------ETNQQIIENIMNAEYTF---DEE 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHTCCCC---CHH
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC------CCHHHHHHHHHcCCCCC---Chh
Confidence 33 23345689999999999988899999999999999999999999952 22222222222211100 000
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. ...+.++.+|+.+||..||++|||+.|+++.
T Consensus 226 ~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 1234578999999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.96 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=206.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
..++|.+.+.||+|+||.||++... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567999999999999999999975 589999998764322 135789999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC----cEEEeec
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADF 528 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Df 528 (678)
.++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999753 46999999999999999999999999 99999999999998877 7999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.. .+....+........
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~------~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG------DTKQETLANITAVSY 235 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC------SSHHHHHHHHHTTCC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhcCC
Confidence 9998765432 23345699999999999998999999999999999999999999952 222222222222110
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
. .+.... ...++.+.+||.+||..||++|||+.|+++
T Consensus 236 ~---~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 D---FDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C---CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C---CCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001111 123457899999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=338.89 Aligned_cols=265 Identities=15% Similarity=0.160 Sum_probs=212.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 457 (678)
..++|++.+.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+++++++ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 456799999999999999999996 578999999876432 234678899999999 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc-----EEEeeccCcc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-----AKIADFGTSR 532 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgl~~ 532 (678)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 86 e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 999999998542 35999999999999999999999999 999999999999987776 9999999998
Q ss_pred cccCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 533 SIAIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 533 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~ 236 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEK 236 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc---cHHHHHHHHhh
Confidence 76543321 2344568999999999999999999999999999999999999996432211 12211111111
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.... ..... ....++++.+|+.+||+.||++|||+++|++.|+++....
T Consensus 237 ~~~~--~~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 237 KQST--PLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHS--CHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCc--cHHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 0000 00000 1123467999999999999999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.70 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=203.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999976 68999999876433 2334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999753 35999999999999999999999999 9999999999999999999999999997654332
Q ss_pred ce-eeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 539 TH-VSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 539 ~~-~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ....+........
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~-------- 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-----SCQEYSDWKEKKT-------- 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT-----TSHHHHHHHTTCT--------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhcccc--------
Confidence 22 2344578999999999987765 7799999999999999999999953211 1111111111110
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+..+.+|+.+||+.||++|||++|+++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011112344578899999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.94 Aligned_cols=271 Identities=26% Similarity=0.419 Sum_probs=220.4
Q ss_pred cccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceee
Q 041043 370 KIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVK 442 (678)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~ 442 (678)
..+..++++...++|.+.+.||+|+||.||+|... +++.||||.+... ......++.+|++++++++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34566777888899999999999999999999864 3678999998653 3445567999999999999999999
Q ss_pred EEeEEeeCCcceEEEEeccCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 443 LLGSCLEVEVPLLVYEFIPNGTLFQYLHDPS-------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 443 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
+++++.+.+..++||||+++|+|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 9999999999999999999999999997421 1235799999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccC
Q 041043 516 LLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEG 593 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~ 593 (678)
|++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----- 244 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----- 244 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-----
Confidence 9999999999999999765433222 1223346889999999998899999999999999999999 88888532
Q ss_pred CChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
............. . ...+...+..+.+|+.+||+.||++|||+.|+++.|+++..
T Consensus 245 -~~~~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 245 -SNEQVLRFVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -CHHHHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -CHHHHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2222222221111 1 11223445679999999999999999999999999988754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.84 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=202.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|++.+.||+|+||.||++... ++.||||++.. ....+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357888999999999999999985 78899999864 345578999999999999999999999876 4589999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeEeecCCCCceEECCCCc-EEEeeccCcccccC
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS---SAYLPIYHRDIKSTNILLDEKYR-AKIADFGTSRSIAI 536 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~---~~~~~ivH~Dlk~~NILl~~~~~-~kl~Dfgl~~~~~~ 536 (678)
++|+|.++++.......+++..++.++.|+++||+|||+ .+ |+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999875544457899999999999999999999 56 999999999999998886 79999999975432
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ........... ...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~-~~~-------- 221 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG----GPAFRIMWAVH-NGT-------- 221 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC----SSHHHHHHHHH-TTC--------
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC----ccHHHHHHHHh-cCC--------
Confidence 2 223458999999999999999999999999999999999999985321 11111111111 111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
........+..+.+|+.+||+.||++|||++|+++.|+.+...-
T Consensus 222 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp -CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred -CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11112234457899999999999999999999999999998543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=352.13 Aligned_cols=269 Identities=25% Similarity=0.418 Sum_probs=217.3
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEe
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLG 445 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~ 445 (678)
.++++...++|.+.+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+++++++ +||||+++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34566677899999999999999999999642 247999988654 345567899999999999 8999999999
Q ss_pred EEeeCCcceEEEEeccCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCc
Q 041043 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPS-----------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 446 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 514 (678)
++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 9999999999999999999999997421 1235899999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccccc
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~ 592 (678)
||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 272 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV-- 272 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS--
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch--
Confidence 99999999999999999866543322 2333457889999999998899999999999999999999 8899853211
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
...+....... .....+...++.+.+|+.+||+.||.+|||++|+++.|+++...
T Consensus 273 ----~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 273 ----NSKFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----SHHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----hHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11111111111 11112233356789999999999999999999999999988753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=376.71 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=217.2
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.+.++...++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344566678899999999999999999999888899999987543 335789999999999999999999999876 678
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.++|+... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 99999999999999997421 235899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.............++..|+|||.+....++.++||||||++||||++ |+.||... ...+...... .+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~------~~~~~~~~i~-~~----- 480 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVE-RG----- 480 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC------CHHHHHHHHH-TT-----
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHH-cC-----
Confidence 65332222233446788999999998899999999999999999999 89998532 1122222111 11
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.+...+...++.+.+||.+||+.||++|||+++|++.|+.+...
T Consensus 481 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 481 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11222334556899999999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.82 Aligned_cols=264 Identities=28% Similarity=0.412 Sum_probs=209.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-----cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Cc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EV 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~ 452 (678)
.++|++.+.||+|+||.||++.+ .+++.||||++... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688899999999999999984 36889999998643 334567899999999999999999999999876 56
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 799999999999999996432 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccc--------cCCChHHHHHH
Q 041043 533 SIAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWAN--------EGRNLATYFVE 602 (678)
Q Consensus 533 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~--------~~~~~~~~~~~ 602 (678)
........ ......+|..|+|||.+.+..++.++||||||+++|||++|..|+...... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 252 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-- 252 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH--
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH--
Confidence 76554332 233456788899999999989999999999999999999999986421100 000011111
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
...+........+...++.+.+|+.+||+.||++|||++|+++.|+++.
T Consensus 253 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 -------VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp -------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111122233455678999999999999999999999999999885
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.02 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=211.8
Q ss_pred ccCCCcCC-eeeeeCCcEEEEEEEc---CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNR-ILGQGGQGTVYKGMLA---DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.++|.+.+ .||+|+||.||+|... ++..||||.++.. .....+++.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45566665 9999999999999853 5788999998764 445677899999999999999999999999 5567899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999999753 345999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 536 IDQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 536 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~-~i~~~----- 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------GPEVMA-FIEQG----- 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------THHHHH-HHHTT-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HHHHHH-HHhcC-----
Confidence 433322 223346889999999988889999999999999999998 999985321 111111 11111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.....+...++.+.+++.+||+.||++||++.|+++.|+++....
T Consensus 230 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 230 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 112223445668999999999999999999999999999998554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=344.91 Aligned_cols=263 Identities=15% Similarity=0.183 Sum_probs=211.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|.+.+.||+|+||+||+|.. .+++.||||.+..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 5789999998765332 24688999999999 89999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc-----EEEeeccCccc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-----AKIADFGTSRS 533 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgl~~~ 533 (678)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999854 246999999999999999999999999 999999999999999887 99999999987
Q ss_pred ccCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc
Q 041043 534 IAIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 534 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~---~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK---ADTLKERYQKIGDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC---CSSHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc---cccHHHHHHHHHhhh
Confidence 6443322 1234569999999999999999999999999999999999999996432 222332222221111
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
... ...... ...+ ++.+++.+||+.||.+||++++|++.|+++....
T Consensus 237 ~~~--~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 237 RAT--PIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHS--CHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccC--CHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 000000 0122 7999999999999999999999999999888543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.77 Aligned_cols=270 Identities=22% Similarity=0.345 Sum_probs=212.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----CCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE----VEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~ 454 (678)
..++|++.+.||+|+||.||++.. .+++.||||++...+....+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456899999999999999999997 5789999999877777778899999999999999999999999873 34678
Q ss_pred EEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 455 LVYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
+|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999997521 2346899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCcce--------eeeccccccCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 041043 534 IAIDQTH--------VSTKVQGTFGYLDPEYFHSSQ---FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 534 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 602 (678)
....... ......+|+.|+|||.+.... ++.++||||||+++|||++|+.||....... .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~---- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL---- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhH----
Confidence 4321110 012234689999999987654 6889999999999999999999985321111 11111
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCC
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDD 666 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~ 666 (678)
..............+..+.+|+.+||+.||.+|||++|+++.|+.+.........
T Consensus 259 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 313 (317)
T 2buj_A 259 ---------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313 (317)
T ss_dssp ---------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC---
T ss_pred ---------HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCCC
Confidence 0111111112234456899999999999999999999999999999876555443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.79 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=207.7
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
...++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999975 5899999987543 44556789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC---CcEEEeeccCcc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTSR 532 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgl~~ 532 (678)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999999753 35899999999999999999999999 9999999999999865 459999999998
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.. .+...............
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~------~~~~~~~~~i~~~~~~~-- 249 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD------EDQHRLYAQIKAGAYDY-- 249 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTCCCC--
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC------CCHHHHHHHHHhCCCCC--
Confidence 665322 22345699999999999998999999999999999999999999852 12222222222111000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........++++.+|+.+||+.||++|||+.|+++.
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000012345678999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.73 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=209.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999975 6889999998776666677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC--CCcEEEeeccCcccccCC
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE--KYRAKIADFGTSRSIAID 537 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgl~~~~~~~ 537 (678)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999753 235899999999999999999999999 999999999999974 578999999999876543
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+............ .. .
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~------~~~~~~~~~i~~~~-~~------~ 269 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG------EDDLETLQNVKRCD-WE------F 269 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC------SSHHHHHHHHHHCC-CC------C
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC------CCHHHHHHHHHhCC-CC------C
Confidence 32 2334689999999999999999999999999999999999999952 22222222222111 00 0
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........+.++.+||.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111122345678999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=346.96 Aligned_cols=271 Identities=27% Similarity=0.379 Sum_probs=212.2
Q ss_pred cCC-CcCCeeeeeCCcEEEEEEEc-----CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC--Cc
Q 041043 382 DHF-NVNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEV--EV 452 (678)
Q Consensus 382 ~~~-~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~ 452 (678)
++| ++.+.||+|+||+||++.+. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 88999999999999998743 5789999998754 345567899999999999999999999999874 56
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 78999999999999999753 3899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 533 SIAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 533 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ...+.........+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHH
Confidence 76543322 233445788899999999988999999999999999999999998532111000 000000000001112
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..+........+...+.++.+|+.+||+.||++|||++|+++.|+++.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 22222223333445667899999999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.35 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=211.7
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
.+++...++|++.++||+|+||+||+++.+ +++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 455666789999999999999999999976 5889999987542 122234588999999999999999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
+..++||||+++|+|.++++.. .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999743 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ----FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
++..............||+.|+|||++.... ++.++||||||+++|||++|+.||.. .+....+..+...
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNH 288 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHTH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC------CChhhHHHHHHhc
Confidence 9876654444445667999999999997655 78899999999999999999999952 2333333333221
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRS--RPTMKEVAME 653 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 653 (678)
.. .+........+.++.+||.+||+.+|++ ||+++|+++.
T Consensus 289 ~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 10 0111111234567899999999999988 9999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.38 Aligned_cols=255 Identities=30% Similarity=0.547 Sum_probs=204.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhh-------HHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK-------LEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
.++|++.+.||+|+||+||+|... +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467999999999999999999974 68999999875433211 167899999999999999999999986544
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc-----EEEee
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-----AKIAD 527 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~D 527 (678)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999997643 46999999999999999999999987 45999999999999988776 99999
Q ss_pred ccCcccccCCcceeeeccccccCccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH--SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
||+++.... ......+|+.|+|||.+. ...++.++||||||+++|||++|+.||..... ...........
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~ 244 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY----GKIKFINMIRE 244 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC----CHHHHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc----cHHHHHHHHhc
Confidence 999975432 233456899999999984 45678899999999999999999999953211 11111111111
Q ss_pred hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
. ......+...++.+.+|+.+||+.||++|||++|+++.|++|
T Consensus 245 ~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 E---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp S---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred c---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 111222334556899999999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.14 Aligned_cols=271 Identities=25% Similarity=0.365 Sum_probs=207.7
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcC--CCCceeeEEeEEeeC--
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI--SHRNVVKLLGSCLEV-- 450 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~~~~~~~-- 450 (678)
.......++|++.+.||+|+||.||+|... ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334556678999999999999999999986 899999988543 234556666666665 899999999999887
Q ss_pred --CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEeecCCCCceEECCC
Q 041043 451 --EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS--------AYLPIYHRDIKSTNILLDEK 520 (678)
Q Consensus 451 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------~~~~ivH~Dlk~~NILl~~~ 520 (678)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+|||++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 6789999999999999999643 589999999999999999999998 6 9999999999999999
Q ss_pred CcEEEeeccCcccccCCccee---eeccccccCccCccccccCCCCcc------cchhhHHHHHHHHHhC----------
Q 041043 521 YRAKIADFGTSRSIAIDQTHV---STKVQGTFGYLDPEYFHSSQFTDK------SDVYSFGVVLVELLTG---------- 581 (678)
Q Consensus 521 ~~~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------sDVwslGvll~elltg---------- 581 (678)
+.+||+|||++.......... .....||+.|+|||.+.+...+.+ +||||||+++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999997654433221 124468999999999987766654 9999999999999999
Q ss_pred CCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 582 QKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 582 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
+.||....... ...................... ....+.++++.+|+.+||+.||++|||+.||++.|+++....
T Consensus 259 ~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 259 QLPYHDLVPSD--PSYEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCTTTTTSCSS--CCHHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccHhhhcCCC--CchhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 55554322211 1111122222111111111111 012367788999999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=351.58 Aligned_cols=270 Identities=16% Similarity=0.224 Sum_probs=208.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC------CcEEEEEEcccCChhhH-----------HHHHHHHHHHhcCCCCceee
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDESKL-----------EEFINEVVILSQISHRNVVK 442 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~ 442 (678)
..++|.+.+.||+|+||.||+|.+.+ ++.||||.+........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999764 47899998765442211 22445667788889999999
Q ss_pred EEeEEeeC----CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC
Q 041043 443 LLGSCLEV----EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 518 (678)
Q Consensus 443 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~ 518 (678)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998875 4579999999 99999999753 246999999999999999999999998 99999999999999
Q ss_pred --CCCcEEEeeccCcccccCCccee------eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 041043 519 --EKYRAKIADFGTSRSIAIDQTHV------STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWA 590 (678)
Q Consensus 519 --~~~~~kl~Dfgl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~ 590 (678)
.++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999997765332211 1234599999999999999999999999999999999999999963211
Q ss_pred ccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 591 NEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
. ...... ........+..+++..+. ....+.++.+++.+||+.||++||+++++++.|+++....
T Consensus 267 ~--~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 267 D--PKYVRD-SKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp C--HHHHHH-HHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C--HHHHHH-HHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1 111111 111111223333333221 1233467899999999999999999999999999988543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.12 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=202.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 455 (678)
.++|++.+.||+|+||+||+++.+ +++.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999975 5899999988642 334556788999999988 69999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999753 35999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+....+..+....
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~------~~~~~~~~~i~~~~-------- 240 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA------ENEDDLFEAILNDE-------- 240 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC--------
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC------CCHHHHHHHHHcCC--------
Confidence 22 2223445699999999999988899999999999999999999999952 22233333332221
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM------KEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 652 (678)
...+...+..+.+|+.+||+.||++||++ +|+++
T Consensus 241 ---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11123345678999999999999999998 66665
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.57 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=199.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE--SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||+|+||+||+|...+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47889999999999999999998899999998865332 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++ +|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 9999987542 45899999999999999999999999 99999999999999999999999999976543222
Q ss_pred eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---hc---cchhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---EN---CLFDI 612 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~ 612 (678)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......... .. .+...
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS------EADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHHCCCChhhchhh
Confidence 2233458999999999876 458999999999999999999999995321 1111111111 00 00000
Q ss_pred -----cchhhh-------cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 -----LDDQVR-------KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 -----~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+.... .......++++.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0011234567899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.85 Aligned_cols=276 Identities=26% Similarity=0.376 Sum_probs=214.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-----cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE--VEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 453 (678)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788999999999999999984 3678999999988777778889999999999999999999999874 4568
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 89999999999999997532 35899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ...........+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHH
Confidence 6543332 22334578889999999998899999999999999999999999853211100000 00000000000111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
.+........+...++.+.+|+.+||+.||++|||++|+++.|+.+.....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 112222223344566789999999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=344.76 Aligned_cols=260 Identities=24% Similarity=0.427 Sum_probs=205.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC-----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
..++|.+.+.||+|+||.||+|.... +..||||.++.. .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34577888999999999999998653 246999998653 344567899999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999753 246899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
....... ......+++.|+|||.+....++.++||||||+++|||++ |+.||... ............
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~~~~~~~~~~~---- 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMKAINDG---- 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTT----
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC------CHHHHHHHHHCC----
Confidence 6543221 1222346788999999998899999999999999999999 99998532 111111111111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.+...+...+..+.+|+.+||+.||++||+++|+++.|+++...
T Consensus 267 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11112334456799999999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=343.88 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=206.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
..++|.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457899999999999999999975 589999998764322 236789999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC----cEEEeec
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADF 528 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Df 528 (678)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999753 46999999999999999999999999 99999999999999887 8999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
|++....... ......||+.|+|||++....++.++||||||+++|+|++|+.||... ..............
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANVSAVNY 234 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHTCC
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC------CHHHHHHHHHhcCC
Confidence 9998764332 223456999999999999889999999999999999999999999522 22222222211110
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. ...... ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 235 --~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 --E-FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --C-CCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --C-cCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000000 1224578899999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.79 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=203.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|++.+.||+|+||+||+|.+. +++ +||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999964 344 37888765332 333456788999999999999999999886 566889
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999864 246899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~------ 233 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL------AEVPD-LLEKG------ 233 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT------THHHH-HHHTT------
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH------HHHHH-HHHcC------
Confidence 44332 2344567889999999999999999999999999999999 9999863211 11111 11111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
.....+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 234 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ---ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111122234468899999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.33 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=207.0
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
...++|++.+.||+|+||.||++... +|+.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34568999999999999999999964 6899999987543 33456778999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC---CCCcEEEeeccCcc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSR 532 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgl~~ 532 (678)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999999753 35999999999999999999999999 99999999999998 56789999999997
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.. .+....+..........
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~~~~~-- 232 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD------EDQHRLYQQIKAGAYDF-- 232 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHTCCCC--
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC------ccHHHHHHHHHhCCCCC--
Confidence 6654332 23345699999999999998999999999999999999999999952 22222222222211000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........++++.+|+.+||+.||++|||+.|+++.
T Consensus 233 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 011112345678999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.58 Aligned_cols=264 Identities=28% Similarity=0.467 Sum_probs=201.1
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc--CC--cEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee-CCcceEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA--DG--RIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLE-VEVPLLV 456 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~--~~--~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv 456 (678)
.|.+.+.||+|+||+||+|.+. ++ ..||||.++. .+....+++.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999964 22 4689998764 344567889999999999999999999998764 4578999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999997543 35889999999999999999999999 99999999999999999999999999986543
Q ss_pred Ccce---eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 537 DQTH---VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 537 ~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... ...... ......
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~---~~~~~~---~~~~~~----- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITV---YLLQGR----- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---SSCHHH---HHHTTC-----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC---HHHHHH---HHHcCC-----
Confidence 3221 1233456788999999999999999999999999999999 667764321 111111 111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCCCCc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDD 667 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~~~~ 667 (678)
+...+...+..+.+++.+||+.||++|||++|+++.|+++...-..+...
T Consensus 314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~ 363 (373)
T 3c1x_A 314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363 (373)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccccee
Confidence 11112334567999999999999999999999999999998765544433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.75 Aligned_cols=266 Identities=29% Similarity=0.478 Sum_probs=214.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-----cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC--cc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE--VP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~ 453 (678)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46788999999999999999984 368899999998777777889999999999999999999999987654 78
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++|+||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999997643 35899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc----
Q 041043 534 IAIDQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN---- 607 (678)
Q Consensus 534 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 607 (678)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--------~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--------HHHHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--------HHHHhhccccchh
Confidence 65443321 2234467789999999988899999999999999999999998742210 000000000
Q ss_pred ----cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 608 ----CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 608 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
.+.+.+....+...+...+.++.+|+.+||+.||++|||++|+++.|++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111111111122234456789999999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.98 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=197.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh--------------------------hhHHHHHHHHHHHh
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--------------------------SKLEEFINEVVILS 433 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~ 433 (678)
.++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999964 688999998754321 12357899999999
Q ss_pred cCCCCceeeEEeEEee--CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 041043 434 QISHRNVVKLLGSCLE--VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 511 (678)
Q Consensus 434 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 511 (678)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.+++.++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 5678999999999999887643 36999999999999999999999999 9999999
Q ss_pred CCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcc
Q 041043 512 STNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ---FTDKSDVYSFGVVLVELLTGQKPISYI 588 (678)
Q Consensus 512 ~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwslGvll~elltg~~p~~~~ 588 (678)
|+|||++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~- 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD- 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-
Confidence 9999999999999999999987654332 233456999999999998755 37789999999999999999999852
Q ss_pred ccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 589 WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.............. . ........++.+.+|+.+||+.||++|||++|+++
T Consensus 243 -----~~~~~~~~~~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 -----ERIMCLHSKIKSQA-L--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----SSHHHHHHHHHHCC-C--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----ccHHHHHHHHhccc-C--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 22222222211111 0 11111234467899999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=343.68 Aligned_cols=266 Identities=25% Similarity=0.460 Sum_probs=203.3
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEee
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
++....++|.+.+.||+|+||.||+|... .+..||+|.++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34445678999999999999999999864 2458999988643 45556789999999999999999999999987
Q ss_pred CCc-----ceEEEEeccCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC
Q 041043 450 VEV-----PLLVYEFIPNGTLFQYLHDP---SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521 (678)
Q Consensus 450 ~~~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 521 (678)
.+. .++|+||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 553 49999999999999998432 22356999999999999999999999999 99999999999999999
Q ss_pred cEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 041043 522 RAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATY 599 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~ 599 (678)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~ 258 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------HEM 258 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH------HHH
Confidence 9999999999766433222 2233457889999999999999999999999999999999 8888853211 111
Q ss_pred HHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 600 FVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
........ ....+...+..+.+++.+||+.||++|||++++++.|+++...
T Consensus 259 ~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 YDYLLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 1112234456799999999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.10 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=206.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.+.||+|+||+||++... +|+.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999975 6899999987642 223456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+....+.......
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~------~~~~~~~~~i~~~~--------- 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD------SNTMKTYEKILNAE--------- 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHCC---------
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCC---------
Confidence 2 2345689999999999999999999999999999999999999952 22222232222211
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
...+...+.++.+|+.+||+.||++|| +++|+++.
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111233456789999999999999999 88888854
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=337.98 Aligned_cols=263 Identities=30% Similarity=0.490 Sum_probs=200.1
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
+...++|++.++||+|+||+||+|... ..+|||.++.. .....+.+.+|++++++++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 344678999999999999999999864 35999987643 455667899999999999999999999965 5567899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999999754 346899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCc-ceeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 536 IDQ-THVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 536 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||.... . ...............
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~-~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-----N-RDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-----C-HHHHHHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-----h-HHHHHHHhcccccCc
Confidence 322 22233456899999999986 5678889999999999999999999995321 1 112222222221111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
.. .......++.+.+|+.+||+.||++|||++|+++.|+++.+
T Consensus 246 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 01123445689999999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.62 Aligned_cols=257 Identities=26% Similarity=0.503 Sum_probs=202.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
.++|++.++||+|+||.||+|.+. +++ +|++|.+.. ......+++.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 344 467777643 34455688999999999999999999999998754 78
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999997643 35899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 535 AIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 535 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~-------------~~ 231 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS-------------SI 231 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-------------HH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH-------------HH
Confidence 433322 2233446788999999999999999999999999999999 999986322111 11 11
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
+........+...+..+.+|+.+||+.||++|||++|+++.|+++..
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111222234455679999999999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.64 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=204.1
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-CcceEEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEV-EVPLLVY 457 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 457 (678)
...++|++.+.||+|+||.||++... ++.||||.++... ..+.+.+|++++++++||||+++++++.+. +..++|+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999875 8899999987533 457899999999999999999999997654 4789999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999999997432 123789999999999999999999999 999999999999999999999999998754322
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... .. .
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~-~~---------~ 230 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRV-EK---------G 230 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------GGHHHHH-TT---------T
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hc---------C
Confidence 122357889999999998899999999999999999998 9999853211 1111111 11 1
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
.....+...++.+.+++.+||+.||++|||+.|+++.|++++..+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~ 276 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence 1122233455689999999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=340.01 Aligned_cols=262 Identities=27% Similarity=0.397 Sum_probs=209.6
Q ss_pred HHHhhccCCCcCC-eeeeeCCcEEEEEEEc---CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEee
Q 041043 376 ELDKATDHFNVNR-ILGQGGQGTVYKGMLA---DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 376 ~~~~~~~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
++....++|.+.+ .||+|+||.||+|.+. +++.||||.++... ....+++.+|++++++++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3334456788887 9999999999999643 46889999886532 33467899999999999999999999998 6
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence 67789999999999999999753 35899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhh
Q 041043 530 TSRSIAIDQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 530 l~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~-~~~~~ 235 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVT-AMLEK 235 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHH-HHHHT
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC------HHHHH-HHHHc
Confidence 998765443332 222346788999999998889999999999999999999 999985321 11111 11111
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
. .....+...++.+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 236 ~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 236 G---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 11122334556899999999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=337.83 Aligned_cols=254 Identities=21% Similarity=0.372 Sum_probs=205.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC-C-------cEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD-G-------RIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
.++|.+.+.||+|+||+||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678899999999999999999643 3 5799999877777777899999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc--------EE
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--------AK 524 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~k 524 (678)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999997532 34899999999999999999999999 999999999999998887 99
Q ss_pred EeeccCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 041043 525 IADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
|+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+.. ...........
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~-----~~~~~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-----ALDSQRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT-----TSCHHHHHHHH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc-----ccchHHHHHHh
Confidence 9999998654322 23457889999999987 6789999999999999999996554421 11111111111
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.... ..+...+.++.+|+.+||+.||++|||++|+++.|+++....
T Consensus 232 ~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 EDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111 111122346889999999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.56 Aligned_cols=259 Identities=21% Similarity=0.332 Sum_probs=201.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47899999999999999999975 5899999987643 34445788999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 566655432 245999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ceeeeccccccCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh------ccchh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE------NCLFD 611 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 611 (678)
. ......+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+.. +............. ..+..
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~-----~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-----GNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-----CSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC-----CCCHHHHHHHHHHHhCCCChhhhhh
Confidence 2 233456899999999998765 79999999999999999999888642 22222222222111 00000
Q ss_pred hcc------------hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ILD------------DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
... ...........+.++.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00000111234567899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.85 Aligned_cols=261 Identities=29% Similarity=0.463 Sum_probs=206.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEe-eCCcce
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCL-EVEVPL 454 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~ 454 (678)
..+|++.+.||+|+||.||+|...+ ...+|+|.+.. .+....+.+.+|++++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568889999999999999999643 23689998765 34456678999999999999999999999865 456789
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999753 345899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCcce---eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 535 AIDQTH---VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 535 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.... .... ........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~---~~~~~~~~--- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDI---TVYLLQGR--- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC---TTTH---HHHHHTTC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC---HHHH---HHHHhcCC---
Confidence 443221 2233457789999999999999999999999999999999 455553211 1111 11111111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
....+...+..+.+++.+||+.||++|||++|+++.|+++...-.
T Consensus 250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111122344579999999999999999999999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.14 Aligned_cols=262 Identities=22% Similarity=0.259 Sum_probs=201.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||++... +++.||+|.+... +....+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 6889999998643 333457899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999976654
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
..........+++.|+|||.+.+..++.++||||||+++|||++|+.||.... .. ........... .
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~-~~~~~~~~~~~----~-- 253 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ------LS-VMGAHINQAIP----R-- 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH------HH-HHHHHHHSCCC----C--
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch------HH-HHHHHhccCCC----C--
Confidence 43333445568999999999999899999999999999999999999985321 11 11111111100 0
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhccC
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRP-TMKEVAMELERIRACNL 662 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~l~~~~~ 662 (678)
........+..+.+++.+||+.||++|| +++++++.|+.+.....
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0011223445789999999999999999 99999999998876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=371.57 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=206.0
Q ss_pred ccCCCcCC-eeeeeCCcEEEEEEEc---CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNR-ILGQGGQGTVYKGMLA---DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .....+++.+|+++|++++||||+++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34444444 7999999999999864 4568999998764 34467889999999999999999999999876 56899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999999754 346999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 536 IDQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 536 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... .....+++.|+|||++....++.++||||||++||||++ |+.||..... .+... .+..
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~-~i~~------ 554 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMA-FIEQ------ 554 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------HHHHH-HHHT------
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHH-HHHc------
Confidence 433222 122335689999999999999999999999999999998 9999963221 11111 1111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..+...+...+.++.+|+.+||+.||++||++++|++.|+.+...
T Consensus 555 ---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 555 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 112223345567899999999999999999999999999998743
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.53 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=208.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcE--EEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRI--IAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 456 (678)
++|++.+.||+|+||.||+|... ++.. +|+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999964 4554 488987642 344556799999999999 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 457 YEFIPNGTLFQYLHDPS-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
|||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999998643 2346899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 041043 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 602 (678)
||+|||+++..... .......+++.|+|||.+....++.++||||||+++|||++ |+.||... ........
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~~~~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEK 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC------cHHHHHHH
Confidence 99999998743221 11233346889999999998889999999999999999998 99998532 22221111
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCC
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~ 663 (678)
. .. ......+...++.+.+|+.+||+.||++|||++|+++.|+++......
T Consensus 254 ~-~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 254 L-PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp G-GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred h-hc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 1 11 111222334456899999999999999999999999999999876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=332.49 Aligned_cols=266 Identities=20% Similarity=0.241 Sum_probs=207.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEE-eeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC-LEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 457 (678)
..++|++.+.||+|+||.||+|.. .+++.||||....... .+++.+|+++++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 467899999999999999999996 5689999997654322 24578899999999988877777666 5667789999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE---CCCCcEEEeeccCcccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSI 534 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgl~~~~ 534 (678)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999997432 35999999999999999999999999 9999999999999 78899999999999876
Q ss_pred cCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 535 AIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 535 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 22345689999999999999999999999999999999999999975443333333222221111110
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
.. .. ....++.+.+|+.+||+.||++|||++|+++.|+++.....
T Consensus 239 ~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 IE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hh-----hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00 00 01224579999999999999999999999999999986543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.07 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=208.4
Q ss_pred CCCcCCeeeeeCCcEEEEEEEcC-C---cEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc-eEE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLAD-G---RIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP-LLV 456 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-~lv 456 (678)
.|...++||+|+||+||+|.+.+ + ..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998542 2 37999988653 345567899999999999999999999999876655 999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999863 346899999999999999999999999 99999999999999999999999999976543
Q ss_pred Ccc---eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 537 DQT---HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 537 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~~~-------- 243 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH-----IDPFDLTHFLAQ-------- 243 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCGGGHHHHHHT--------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc-----CCHHHHHHHhhc--------
Confidence 321 1223345788999999999999999999999999999999966654311 111111111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCC
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQD 664 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 664 (678)
......+...++.+.+++.+||+.||.+|||++|+++.|+++...-...
T Consensus 244 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 244 --GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred --CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 1111123334567999999999999999999999999999998764433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.65 Aligned_cols=272 Identities=24% Similarity=0.359 Sum_probs=213.4
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhc--CCCCceeeEEeEEeeCC
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ--ISHRNVVKLLGSCLEVE 451 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~ 451 (678)
...-....++|.+.+.||+|+||.||+|+. +++.||||.+.. ...+.+.+|+++++. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333455678899999999999999999998 489999999864 334677889999887 78999999999998776
Q ss_pred ----cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCceEECC
Q 041043 452 ----VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH--------SSAYLPIYHRDIKSTNILLDE 519 (678)
Q Consensus 452 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlk~~NILl~~ 519 (678)
..++||||+++|+|.+++.+. .+++..++.++.|++.||+||| +.+ |+||||||+|||++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 789999999999999999743 5899999999999999999999 777 999999999999999
Q ss_pred CCcEEEeeccCcccccCCcce---eeeccccccCccCccccccC------CCCcccchhhHHHHHHHHHhC---------
Q 041043 520 KYRAKIADFGTSRSIAIDQTH---VSTKVQGTFGYLDPEYFHSS------QFTDKSDVYSFGVVLVELLTG--------- 581 (678)
Q Consensus 520 ~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwslGvll~elltg--------- 581 (678)
++.+||+|||++......... ......+|+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999776544332 22345689999999998765 234689999999999999999
Q ss_pred -CCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 582 -QKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 582 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..||......+ .....+. ...........+.... ...+....+.+|+.+||+.||++|||++||++.|++|.++
T Consensus 263 ~~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 263 YQLPYYDLVPSD-PSVEEMR-KVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCCTTTTTSCSS-CCHHHHH-HHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCccccCcCc-ccHHHHH-HHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 66775322211 1222222 2221111111111111 1246677899999999999999999999999999999875
Q ss_pred c
Q 041043 661 N 661 (678)
Q Consensus 661 ~ 661 (678)
.
T Consensus 338 ~ 338 (342)
T 1b6c_B 338 E 338 (342)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.29 Aligned_cols=264 Identities=27% Similarity=0.376 Sum_probs=202.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc--
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP-- 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-- 453 (678)
..++|++.+.||+|+||.||++.. .+++.||||+++.. +....+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356899999999999999999996 56899999998653 334456889999999999999999999998876554
Q ss_pred --eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 454 --LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 454 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
++||||+++++|.++++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999999999743 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 532 RSIAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 532 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.. ................
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~------~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG------DSPVSVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC------CChHHHHHHHhcCCCC
Confidence 866543222 22335689999999999999999999999999999999999999952 2222222222222111
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHHHHHhccC
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE-VAMELERIRACNL 662 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-vl~~L~~l~~~~~ 662 (678)
. .... ....+.++.+|+.+||+.||++||++.+ +.+.|.++.....
T Consensus 238 ~----~~~~---~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 284 (311)
T 3ork_A 238 P----PSAR---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284 (311)
T ss_dssp C----HHHH---STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred C----cccc---cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence 1 0000 1123457899999999999999996555 5556777765443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=331.07 Aligned_cols=267 Identities=19% Similarity=0.245 Sum_probs=211.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEE-eeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC-LEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 457 (678)
..++|++.+.||+|+||.||+|.. .+++.||||.+..... .+++.+|+++++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999996 5789999998765332 24688999999999998877766665 5566779999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE---CCCCcEEEeeccCcccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSI 534 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgl~~~~ 534 (678)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 999999997432 35999999999999999999999999 9999999999999 48889999999999876
Q ss_pred cCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 535 AIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 535 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 544321 12345689999999999999999999999999999999999999975443333333222221111110
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCC
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~ 663 (678)
. ... ....++++.+++.+||+.||++|||++|+++.|+++......
T Consensus 239 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 I-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp H-----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred h-----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 000 122345799999999999999999999999999999865543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.19 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=200.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 455 (678)
.++|++.++||+|+||+||+++.+ +++.||+|+++.. .....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999976 5789999987643 233345688899999887 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999753 35999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC--CChHHHHHHHHhhccchhhc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG--RNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 613 (678)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..........+....
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 222 223456799999999999999999999999999999999999999964322111 111111211111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
...+...+.++.+||.+||+.||++||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11233455678999999999999999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.36 Aligned_cols=274 Identities=24% Similarity=0.347 Sum_probs=217.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC--cceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVE--VPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv 456 (678)
.++|.+.++||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999976 48999999986533 334577889999999999999999999998765 67999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE----CCCCcEEEeeccCcc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSR 532 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgl~~ 532 (678)
|||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987554455999999999999999999999999 9999999999999 788889999999998
Q ss_pred cccCCcceeeeccccccCccCcccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHS--------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
....... .....||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... ...........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~--~~~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKII 240 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT--TTCHHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc--cchHHHHHHHh
Confidence 6644322 233568999999999865 46788999999999999999999999533221 12222233332
Q ss_pred hhccchhh------c--------chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 605 EENCLFDI------L--------DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 605 ~~~~~~~~------~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.......+ . +..............+.+++.+||+.||++|||++|+++.++++....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 22111000 0 001112234677889999999999999999999999999999988653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.23 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=196.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE----cCCcEEEEEEcccC----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML----ADGRIIAVKKSKVV----DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
.++|++.+.||+|+||.||++.. .+++.||+|+++.. .......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 47899999988653 23345668899999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999743 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.. .+............
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~------~~~~~~~~~i~~~~----- 237 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG------ENRKKTIDKILKCK----- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHTC-----
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC------CCHHHHHHHHHhCC-----
Confidence 543222 223345689999999999988899999999999999999999999952 22222222222111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
...+...+.++.+|+.+||+.||++|| ++.|+++.
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 112233456789999999999999999 77787764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.30 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=205.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
..++|++.+.||+|+||.||++... +++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999975 6899999987532 122457899999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc---EEEeecc
Q 041043 454 LLVYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFG 529 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfg 529 (678)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999998886432 2335899999999999999999999999 999999999999986654 9999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||... ....+....... .
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~i~~~~-~ 249 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-------KERLFEGIIKGK-Y 249 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-------HHHHHHHHHHTC-C
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-------HHHHHHHHHcCC-C
Confidence 9987654322 233456999999999999989999999999999999999999999531 111122221111 0
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. ...... ...++++.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000 1234578999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=345.88 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=205.3
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcc
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 453 (678)
...++|.+.+.||+|+||.||+|+.+ +++.||||.++.. .....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 5899999988642 133456788899999876 899999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999753 35899999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+....+.......
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~~~~------ 234 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG------QDEEELFHSIRMDN------ 234 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC------
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC------CCHHHHHHHHHhCC------
Confidence 43222 223445799999999999999999999999999999999999999952 22222222222211
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK-EVAM 652 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 652 (678)
...+...+.++.+|+.+||+.||++||++. |+++
T Consensus 235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111223456789999999999999999998 6653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.88 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=205.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999975 6899999987542 2234578899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999865432
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+....+..+....
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~~~~---------- 254 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA------DQPIQIYEKIVSGK---------- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC----------
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC------CCHHHHHHHHHcCC----------
Confidence 2334689999999999999999999999999999999999999952 22233332222211
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
...+...+..+.+|+.+||+.||++||+ ++|+++.
T Consensus 255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1112334567999999999999999998 7888654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=341.29 Aligned_cols=245 Identities=24% Similarity=0.273 Sum_probs=193.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.++||+|+||+||+|... +++.||||++... ......++..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999976 7899999987542 333444556666666555 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 679999887542 35999999999999999999999999 99999999999999999999999999876543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.... ..... ... .....
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~-~~~----~~~~~ 272 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQL-RQG----YLPPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHH-TTT----CCCHH
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHH-hcc----CCCcc
Confidence 22 2334568999999999876 78999999999999999999977653110 01111 111 01111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.. ...++++.+|+.+||+.||++|||++|+++
T Consensus 273 ~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 123467999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.93 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=190.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999964 58999999886533 3344678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 459 FIPNGTLFQYLHDPS---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|++ |+|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886421 2245899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---ccchh
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---NCLFD 611 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 611 (678)
.... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........... ..+..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhh
Confidence 3222 2233468999999999876 468999999999999999999999996322111 11111111100 00000
Q ss_pred h-----------------cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 612 I-----------------LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 612 ~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. +...+........+.++.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 00000011111234579999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.07 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=204.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|.+.+.||+|+||.||+|.. .+++.||||+++. .+....+++.+|++++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999996 4789999998764 345566789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 456 VYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986421 2345899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||... ............ .....
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~-~~~~~---- 256 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCKKIE-QCDYP---- 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHHH-TTCSC----
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc----chhHHHHHHHhh-cccCC----
Confidence 43222 223346899999999999999999999999999999999999998521 112222222111 11111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.......+.++.+|+.+||+.||++|||++||++.|++|++..
T Consensus 257 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 ----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp ----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1111234567999999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.85 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=205.1
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEe
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQISHRNVVKLLGSCL 448 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 448 (678)
.++....++|.+.+.||+|+||.||+|... +++.||+|.+... +....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 345667788999999999999999999974 6789999987532 3456678999999999999999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHH
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPS-------------------------------------EELSLTWEMRLRIATEVA 491 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia 491 (678)
+.+..++||||+++|+|.+++.... ....+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999999995210 012346788899999999
Q ss_pred HHHHHHHhCCCCCeEeecCCCCceEECCCC--cEEEeeccCcccccCCcc---eeeeccccccCccCcccccc--CCCCc
Q 041043 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQT---HVSTKVQGTFGYLDPEYFHS--SQFTD 564 (678)
Q Consensus 492 ~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~ 564 (678)
.||+|||+.+ |+||||||+|||++.++ .+||+|||++........ .......||+.|+|||.+.. ..++.
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999999 99999999999998776 899999999986543221 12344568999999999875 67889
Q ss_pred ccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCC
Q 041043 565 KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR 644 (678)
Q Consensus 565 ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 644 (678)
++||||||+++|||++|+.||... ................. .+ .....++.+.+|+.+||+.||++|
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGV------NDADTISQVLNKKLCFE--NP-----NYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCCTT--SG-----GGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCC------ChHHHHHHHHhcccccC--Cc-----ccccCCHHHHHHHHHHcCCChhHC
Confidence 999999999999999999999532 22222222222211110 00 011235678999999999999999
Q ss_pred CCHHHHHHH
Q 041043 645 PTMKEVAME 653 (678)
Q Consensus 645 Pt~~evl~~ 653 (678)
||+.|+++.
T Consensus 323 ps~~~~l~h 331 (345)
T 3hko_A 323 FDAMRALQH 331 (345)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhcC
Confidence 999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=341.31 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=201.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 456 (678)
++|++.+.||+|+||.||+++.+ +++.||+|+++.. .....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57889999999999999999975 5889999987642 445567788999999988 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999743 35999999999999999999999999 99999999999999999999999999975432
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC--CChHHHHHHHHhhccchhhcc
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG--RNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...............
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 22 223445799999999999999999999999999999999999999964322111 011111111111111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 647 (678)
...+...+.++.+|+.+||+.||++||++
T Consensus 236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11233455678999999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.62 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=192.6
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
+...++|++.+.||+|+||.||+|... +++.||||.++... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 445678999999999999999999976 57899999987532 346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEeeccCccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRS 533 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl~~~ 533 (678)
|||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999999753 35899999999999999999999999 999999999999975 88999999999976
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ......+........ .
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~i~~~~~-~--- 269 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE-----RGDQFMFRRILNCEY-Y--- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT-----TCHHHHHHHHHTTCC-C---
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC-----cccHHHHHHHHhCCC-c---
Confidence 5432 2233456899999999999989999999999999999999999998522 111112222222110 0
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 270 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 ---FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112345678999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.89 Aligned_cols=265 Identities=17% Similarity=0.223 Sum_probs=200.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccCChh-----------hHHHHHHHHHHHhcCCCCceeeEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVDES-----------KLEEFINEVVILSQISHRNVVKLLG 445 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~~ 445 (678)
.++|.+.+.||+|+||.||+|... ++..+|||+....... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5688999987654321 1134678889999999999999999
Q ss_pred EEee----CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC
Q 041043 446 SCLE----VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 521 (678)
Q Consensus 446 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 521 (678)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999997543 6999999999999999999999998 99999999999999887
Q ss_pred --cEEEeeccCcccccCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC
Q 041043 522 --RAKIADFGTSRSIAIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG 593 (678)
Q Consensus 522 --~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~ 593 (678)
.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---- 264 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL---- 264 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT----
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc----
Confidence 9999999999876433211 1134468999999999999899999999999999999999999995211
Q ss_pred CChHHHHHHHHh-hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 594 RNLATYFVECVE-ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 594 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
............ ...+...+.. .......++++.+++.+||+.||++|||+++|++.|+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVAVQTAKTNLLDELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHHHHHHHHHHHHTTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHHHHHHHHhhcccccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111100000 0001111100 00011344589999999999999999999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=344.10 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=202.5
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999996 56899999987532 122235788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+ +|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78999998743 35999999999999999999999999 99999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||......+. ...+...
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~ 223 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC 223 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC
Confidence 32 2234569999999999988776 6899999999999999999999953211110 0001000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+...++.+.+|+.+||+.||.+|||++|+++.
T Consensus 224 --~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 --VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011223345678999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=347.99 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=200.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCC--CceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISH--RNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~l 455 (678)
..++|++.+.||+|+||.||++...+++.||||++.. .+....+.+.+|++++++++| +||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4567999999999999999999988899999998754 345556789999999999986 999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||| +.+++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 5688999999853 35899999999999999999999999 99999999999997 5789999999998765
Q ss_pred CCcce-eeeccccccCccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 041043 536 IDQTH-VSTKVQGTFGYLDPEYFHS-----------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 536 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||... .........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~- 232 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHA- 232 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHH-
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-----hhHHHHHHH-
Confidence 43322 2334569999999999864 67889999999999999999999999521 111111111
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+++.......+......+.+|+.+||+.||++|||+.|+++.
T Consensus 233 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 122222222233334578999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.61 Aligned_cols=268 Identities=18% Similarity=0.268 Sum_probs=204.8
Q ss_pred hccCCCcCCeeeee--CCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQG--GQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
..++|++.++||+| +||.||++... +++.||||++.. ......+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999976 689999998764 33555678889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999997642 235899999999999999999999999 999999999999999999999999988654
Q ss_pred cCCcce------eeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-
Q 041043 535 AIDQTH------VSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE- 605 (678)
Q Consensus 535 ~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 605 (678)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCc
Confidence 322111 1122368889999999987 578999999999999999999999996322111 00000000000
Q ss_pred ---------------------hccchhhcch---------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 ---------------------ENCLFDILDD---------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 ---------------------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......... ..........++.+.+|+.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000000 00001122345679999999999999999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=352.90 Aligned_cols=263 Identities=24% Similarity=0.297 Sum_probs=210.9
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEe
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCL 448 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 448 (678)
..++++...++|++.+.||+|+||+||++..+ +++.||||+++.. .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34556667789999999999999999999975 6899999998642 2223345889999999999999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
+.+..++||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999997532 35899999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFH-------SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~ 601 (678)
|+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||.. .+....+.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~------~~~~~~~~ 280 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA------DSTAETYG 280 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC------CCHHHHHH
Confidence 999876654444444567999999999987 35689999999999999999999999952 22223232
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR---PTMKEVAME 653 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~ 653 (678)
.+........ ........+.++.+||.+||. +|++| |+++|+++.
T Consensus 281 ~i~~~~~~~~------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYKEHLS------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHHHHCC------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhcccCcC------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2222110000 000112345689999999999 99998 589988764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=342.11 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=205.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcC-CcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 454 (678)
..++|++.+.||+|+||+||++..+. ++.||||.++.. .....+.+..|..+++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35689999999999999999999764 789999987642 233457788999999988 7999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999743 35899999999999999999999999 999999999999999999999999999754
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+....+..+....
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~------~~~~~~~~~i~~~~------- 237 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG------EDEDELFQSIMEHN------- 237 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC-------
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC------CCHHHHHHHHHhCC-------
Confidence 3222 223445699999999999999999999999999999999999999952 22233333322211
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
...+...+.++.+|+.+||+.||++||+ ++|+++.
T Consensus 238 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122344568999999999999999995 4666654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.90 Aligned_cols=272 Identities=17% Similarity=0.214 Sum_probs=218.0
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEE------EcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC---CCceeeEEe
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGM------LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS---HRNVVKLLG 445 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~ 445 (678)
.+++...++|.+.++||+|+||+||+|. ..+++.||||+++... .+++..|++++++++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4455567889999999999999999994 4568899999987543 356777888888886 999999999
Q ss_pred EEeeCCcceEEEEeccCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC----
Q 041043 446 SCLEVEVPLLVYEFIPNGTLFQYLHDPS--EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---- 519 (678)
Q Consensus 446 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---- 519 (678)
++...+..++||||+++|+|.++++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 9999999999999999999999997421 2346999999999999999999999999 999999999999998
Q ss_pred -------CCcEEEeeccCcccccC-CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccc
Q 041043 520 -------KYRAKIADFGTSRSIAI-DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWAN 591 (678)
Q Consensus 520 -------~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~ 591 (678)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999976542 2233445567999999999999999999999999999999999999998532111
Q ss_pred cCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHhccCCCCCchHH
Q 041043 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSR-PTMKEVAMELERIRACNLQDDDDNIQ 670 (678)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~l~~~~~~~~~~~~~ 670 (678)
. ... ...... ....+.+.+++..||+.+|.+| |+++++.+.|+++........-+.+.
T Consensus 292 ~--------------~~~----~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~~~~~l~ 350 (365)
T 3e7e_A 292 E--------------CKP----EGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALR 350 (365)
T ss_dssp E--------------EEE----CSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTTTHHHHH
T ss_pred c--------------eee----chhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhhchHHHH
Confidence 0 000 011111 1124567899999999999999 78999999999999876665544444
Q ss_pred HHH
Q 041043 671 KCY 673 (678)
Q Consensus 671 ~~~ 673 (678)
+.+
T Consensus 351 ~~l 353 (365)
T 3e7e_A 351 NRL 353 (365)
T ss_dssp HHH
T ss_pred HHH
Confidence 433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.12 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=196.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.++|.+.+.||+|+||+||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 568999999999999999999976 689999999865332 236788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc--EEEeeccCcccccCC
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--AKIADFGTSRSIAID 537 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgl~~~~~~~ 537 (678)
+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999643 35999999999999999999999999 999999999999987765 999999998743322
Q ss_pred cceeeeccccccCccCccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDK-SDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.... ............... .
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~~~~~~~~~---------~ 238 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPRDYRKTIQRILSV---------K 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC------CCCHHHHHHHHHTT---------C
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhcC---------C
Confidence 12234469999999999988777665 899999999999999999996322 112222222222111 1
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111112334678999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.53 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=208.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE------cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
..++|.+.+.||+|+||.||+|.+ .+++.||||.+... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 34678999998643 45556789999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEE
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSE----ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKI 525 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl 525 (678)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 245899999999999999999999999 999999999999984 456999
Q ss_pred eeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHH
Q 041043 526 ADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||... .........
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------~~~~~~~~~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK------SNQEVLEFV 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc------CHHHHHHHH
Confidence 99999875543222 22334557889999999998899999999999999999998 98998522 112222111
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.... ....+...+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 259 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1111 1112234456789999999999999999999999999988743
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.07 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=204.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467899999999999999999975 5789999987542 234457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999853 35999999999999999999999999 99999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
. .......||+.|+|||++.. ..++.++||||||+++|||++|+.||..... .............
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~------- 235 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS---TSSKEIVHTFETT------- 235 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT---SCHHHHHHHHHHC-------
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC---ccHHHHHHHHhhc-------
Confidence 2 22344579999999999874 4589999999999999999999999953221 1222222111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-MKEVAM 652 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 652 (678)
....+...+..+.+|+.+||+.||++||+ ++++++
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11223345568999999999999999998 666654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=342.89 Aligned_cols=210 Identities=27% Similarity=0.310 Sum_probs=183.2
Q ss_pred cccccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-----CCcee
Q 041043 368 RCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS-----HRNVV 441 (678)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv 441 (678)
....++..+.....++|.+.++||+|+||+||+|... +++.||||+++. .....+.+..|+++++.++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3445666667777899999999999999999999974 688999999864 3445567888999999996 99999
Q ss_pred eEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC--
Q 041043 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-- 519 (678)
Q Consensus 442 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-- 519 (678)
++++++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 9999999999999999999 899999997643 235899999999999999999999999 999999999999975
Q ss_pred -----------------------CCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHH
Q 041043 520 -----------------------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLV 576 (678)
Q Consensus 520 -----------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ 576 (678)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999764332 23456899999999999999999999999999999
Q ss_pred HHHhCCCCCCc
Q 041043 577 ELLTGQKPISY 587 (678)
Q Consensus 577 elltg~~p~~~ 587 (678)
||++|+.||..
T Consensus 251 ell~g~~pf~~ 261 (360)
T 3llt_A 251 ELYTGSLLFRT 261 (360)
T ss_dssp HHHHSSCSCCC
T ss_pred HHHHCCCCCCC
Confidence 99999999963
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.70 Aligned_cols=247 Identities=26% Similarity=0.305 Sum_probs=199.3
Q ss_pred CCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 387 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
.+.||+|+||.||+|... +|+.||+|+++.......+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999964 6899999999877767778999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE--CCCCcEEEeeccCcccccCCcceeee
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL--DEKYRAKIADFGTSRSIAIDQTHVST 543 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~Dfgl~~~~~~~~~~~~~ 543 (678)
.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 9998643 235899999999999999999999999 9999999999999 6778999999999987654322 23
Q ss_pred ccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCH
Q 041043 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKT 623 (678)
Q Consensus 544 ~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (678)
...||+.|+|||++....++.++||||||+++|||++|+.||... +....+......... .... ...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~i~~~~~~--~~~~-----~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD------NDAETLNNILACRWD--LEDE-----EFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCC--SCSG-----GGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhccCC--CChh-----hhc
Confidence 346899999999999889999999999999999999999999532 222222222221100 0000 012
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 624 EEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 624 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
..++++.+|+.+||+.||++|||++|+++.
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 234678999999999999999999999873
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=340.35 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=181.1
Q ss_pred CCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEeccCCC
Q 041043 387 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGT 464 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 464 (678)
.+.||+|+||.||++... +++.||||++.. .....+.+|++++++++ ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 589999999864 24467789999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC---cEEEeeccCcccccCCccee
Q 041043 465 LFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 465 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgl~~~~~~~~~~~ 541 (678)
|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 99999753 46999999999999999999999999 99999999999997665 899999999986543322 2
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC-CChHHHHHHHHhhccchhhcchhhhcC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG-RNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
.....+|+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ....+... .....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~~~-~~~~~---- 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDFS-FEGEA---- 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-HHTTTCCC-CCSHH----
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-HHHcCCCC-CCccc----
Confidence 3345689999999999999999999999999999999999999964332211 11222222 11111110 00000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....++++.+|+.+||+.||++|||++|+++.
T Consensus 240 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 -WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred -ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01235679999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.53 Aligned_cols=273 Identities=24% Similarity=0.377 Sum_probs=201.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHH--hcCCCCceeeEEeEEee-----CCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVIL--SQISHRNVVKLLGSCLE-----VEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l--~~l~h~niv~l~~~~~~-----~~~ 452 (678)
..++|++.+.||+|+||.||+|.. +++.||||++.... .+.+..|.+++ ..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 346899999999999999999987 58999999986432 34445555554 45899999999986543 225
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeecCCCCceEECCCCcE
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS---------AYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
.++||||+++|+|.+++... ..++..++.++.||+.||+|||+. + |+||||||+||||+.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 68999999999999999653 358999999999999999999998 7 9999999999999999999
Q ss_pred EEeeccCcccccCCcc-------eeeeccccccCccCcccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 041043 524 KIADFGTSRSIAIDQT-------HVSTKVQGTFGYLDPEYFHS-------SQFTDKSDVYSFGVVLVELLTGQKPISYIW 589 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwslGvll~elltg~~p~~~~~ 589 (678)
||+|||++........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987643221 12233468999999999876 356678999999999999999987764322
Q ss_pred cccC-CC----------hHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 590 ANEG-RN----------LATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 590 ~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
.... .. .................+.. ........++.+.+|+.+||+.||++|||++|+++.|++|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 2111 00 00111111111100000000 01112346778999999999999999999999999999999
Q ss_pred hccCCCC
Q 041043 659 ACNLQDD 665 (678)
Q Consensus 659 ~~~~~~~ 665 (678)
..-..+.
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 6544443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=327.78 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=205.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
..++|.+.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999975 467899999876555667889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE---CCCCcEEEeeccCccccc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgl~~~~~ 535 (678)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999998753 35899999999999999999999999 9999999999999 788999999999997655
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
... ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||... ............. .. .. .
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~-~~-~~-~ 228 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP------TDSEVMLKIREGT-FT-FP-E 228 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCC-CC-CC-H
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCC-CC-CC-c
Confidence 332 22344689999999998754 899999999999999999999999532 1222222221111 00 00 0
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
... ...++.+.+|+.+||+.||++|||+.|+++.
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1234678999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=352.51 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=206.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357899999999999999999975 68999999886422 23456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999753 46999999999999999999999999 99999999999999999999999999987543
Q ss_pred CcceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.. ......+.......
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~------~~~~~~~~~i~~~~-------- 232 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD------DHVPTLFKKICDGI-------- 232 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC------SSSHHHHHHHHTTC--------
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC------CCHHHHHHHHhcCC--------
Confidence 22 2334569999999999988765 6899999999999999999999952 22222222222211
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+.++.+|+.+||+.||++|||++|+++.
T Consensus 233 ---~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 ---FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 01122334578999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=336.35 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=198.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999975 58999999875433 3345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999988753 35899999999999999999999999 9999999999999999999999999997655332
Q ss_pred ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-----------h
Q 041043 539 THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE-----------E 606 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 606 (678)
. ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ .......... .
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHHT
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhccccccccccccc
Confidence 2 2234468999999999876 568999999999999999999999996332211 0000111000 0
Q ss_pred ccchhhcc-hhhhcCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 NCLFDILD-DQVRKSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........ +...... ....+..+.+|+.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000 0000000 02344578999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.86 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=206.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee---------
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE--------- 449 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 449 (678)
..++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467899999999999999999976 78999999987543 356789999999999999999998864
Q ss_pred -------CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc
Q 041043 450 -------VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522 (678)
Q Consensus 450 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 522 (678)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345799999999999999997532 246899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 041043 523 AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 523 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 602 (678)
+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+... ......
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH
Confidence 99999999976654322 23346899999999999988999999999999999999999886310 011111
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
.... ..+...+..+.+++.+||+.||++|||+.|+++.|+.+++.
T Consensus 231 -~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 -LRDG------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHTT------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -hhcc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111 11222345688999999999999999999999999999854
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.70 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=207.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999975 588999998754 3455667899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc---EEEeeccCccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFGTSRS 533 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgl~~~ 533 (678)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999988753 35899999999999999999999999 999999999999986655 99999999976
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.. .............. ..
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~------~~~~~~~~~~~~~~-~~--- 225 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD------EDQHRLYAQIKAGA-YD--- 225 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTC-CC---
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC------CchhHHHHHHHhcc-cc---
Confidence 543322 2345689999999999999999999999999999999999999852 12222222221111 10
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.........++++.+|+.+||+.||++|||++|+++.
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0001112345678999999999999999999999885
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.13 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=199.5
Q ss_pred ccCCCcC-CeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEE
Q 041043 381 TDHFNVN-RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 381 ~~~~~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.++|.+. +.||+|+||+||++.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568774 7899999999999995 46899999998766666678899999999985 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc---EEEeeccCcccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFGTSRSI 534 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgl~~~~ 534 (678)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999753 35899999999999999999999999 999999999999998776 999999998765
Q ss_pred cCCcc------eeeeccccccCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh-------
Q 041043 535 AIDQT------HVSTKVQGTFGYLDPEYFHS-----SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL------- 596 (678)
Q Consensus 535 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~------- 596 (678)
..... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223458999999999875 4578899999999999999999999964322211000
Q ss_pred -HHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 597 -ATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 597 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.............. .... .. ...+..+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~i~~~~~~-~~~~-~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-FPDK-DW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCC-CCHH-HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcc-cCch-hc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111111100 0000 00 1234578999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.78 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=202.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.+.|+..+.||+|+||+||+|.. .+++.||||++... .....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588899999999999999996 57899999988643 233456799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||++ |+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 6888888643 236899999999999999999999999 99999999999999999999999999976543
Q ss_pred CcceeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||... +.............
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~------~~~~~~~~~~~~~~----- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES----- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCC-----
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCC-----
Confidence 2 2346899999999984 567899999999999999999999998522 12222222221110
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMEL 654 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 654 (678)
........++.+.+|+.+||+.||++|||++|+++..
T Consensus 271 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 271 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111223456789999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=327.67 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=204.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457899999999999999999975 6899999987543 33456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999743 35899999999999999999999999 9999999999999999999999999997654332
Q ss_pred ce-eeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 539 TH-VSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 539 ~~-~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ...+.........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~------- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEYSDWKEKKTY------- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-----SHHHHHHHTTCTT-------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHhhhcccc-------
Confidence 21 2334568999999999987665 77999999999999999999999532111 1111111111100
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.......+..+.+|+.+||+.||++|||++|+++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0111234457889999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.39 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=208.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.+.|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456889999999999999999964 68899999876433 4456889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999964 35899999999999999999999999 9999999999999999999999999997654332
Q ss_pred ceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ......... ... .
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~---------~ 236 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFLIP-KNN---------P 236 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHH-HSC---------C
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC------HHHHHHHhh-cCC---------C
Confidence 2 2234568999999999999999999999999999999999999985321 111111111 111 1
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
.......+..+.+|+.+||+.||++|||+.|+++..--
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 11122345678999999999999999999999986433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.85 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=200.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCC--CCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQIS--HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||++...+++.||||++.. .+....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 456999999999999999999988899999998754 34556788999999999996 59999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|| +.+++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999999854 36899999999999999999999999 99999999999996 57999999999987654
Q ss_pred Ccce-eeeccccccCccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 537 DQTH-VSTKVQGTFGYLDPEYFHS-----------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 537 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
.... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||... ......+...
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-----~~~~~~~~~~- 280 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHAI- 280 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCHHHHHHHH-
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh-----hHHHHHHHHH-
Confidence 3322 2344569999999999865 36888999999999999999999999522 1111112211
Q ss_pred hhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
++.......+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 281 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 --------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 22222222222234578999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=355.66 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=197.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|++.++||+|+||.||++... +++.||||+++. ........+.+|++++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999964 689999998764 234455678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999999753 358999999999999999999998 88 999999999999999999999999999754
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.. ..............
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~~~~------- 365 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------QDHEKLFELILMEE------- 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC-------
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC------CCHHHHHHHHHhCC-------
Confidence 3322 223446799999999999999999999999999999999999999952 22222222222211
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
...+...++++.+|+.+||+.||++|| |++|+++.
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111233456789999999999999999 99999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=329.15 Aligned_cols=248 Identities=29% Similarity=0.413 Sum_probs=202.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567999999999999999999965 56799999875422 2234678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999999753 35899999999999999999999998 9999999999999999999999999886543
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.. .............
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~------~~~~~~~~~~~~~--------- 222 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRV--------- 222 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHT---------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC------CcHHHHHHHHHhC---------
Confidence 22 22345689999999999998999999999999999999999999852 2222222221111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+...++.+.+|+.+||+.||++|||++|+++.
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111223345678999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=368.22 Aligned_cols=249 Identities=29% Similarity=0.426 Sum_probs=200.9
Q ss_pred CeeeeeCCcEEEEEEEc---CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLA---DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
+.||+|+||.||+|.+. .++.||||+++.. +....+++.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 4578999998753 3445688999999999999999999999986 4567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce--
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-- 540 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-- 540 (678)
|+|.++++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999743 35899999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+|+.|+|||++....++.++||||||++||||++ |+.||..... ..... .+.. ..+.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~-~i~~---------~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTA-MLEK---------GERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH-HHHT---------TCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH-HHHc---------CCCC
Confidence 2233446788999999999999999999999999999998 9999953221 11111 1111 1122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
..+...++++.+|+.+||+.||++|||+++|++.|+++..
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2234456789999999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=336.79 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=201.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc--CCc--EEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA--DGR--IIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++|++.+.||+|+||+||+|.+. +++ .||||.++.. .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457899999999999999999863 233 6899987643 3455678999999999999999999999998755 8
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++|+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999753 235899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||... .............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~~~--- 241 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEG--- 241 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC------CHHHHHHHHHccC---
Confidence 6543332 2233457788999999998889999999999999999999 99998532 2222222222111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCC
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQ 663 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~ 663 (678)
.....+...+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 242 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 242 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred ------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 11112234556899999999999999999999999999999875543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.86 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=197.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE----- 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 451 (678)
..++|++.+.||+|+||+||+|... +++.||||++... .....+++.+|+++++.++||||+++++++...+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999965 5899999998643 4556678999999999999999999999997654
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 45999999976 57677643 3899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh----
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---- 606 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 606 (678)
++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... +....+..+.+.
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~------~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR------DYIDQWNKVIEQLGTP 282 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHHHCSC
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHHhcCCC
Confidence 9865432 2234457899999999999999999999999999999999999999632 212222211110
Q ss_pred ------------------cc------chhhcchhhhcCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 ------------------NC------LFDILDDQVRKSG---KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ------------------~~------~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. +............ ......++.+|+.+||+.||++|||++|+++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000000000000 01225679999999999999999999999885
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=335.54 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=206.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
..++|++.+.||+|+||.||++... +++.||+|.+..... ...+++.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999975 589999998764322 136789999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC----cEEEeec
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADF 528 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Df 528 (678)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999753 35899999999999999999999999 99999999999999888 7999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
|++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||... ..............
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANITSVSY 235 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTCC
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhccc
Confidence 9998665432 223456899999999999989999999999999999999999999522 22222222211110
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....... ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ---~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 ---DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011111 1233578999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.92 Aligned_cols=266 Identities=15% Similarity=0.200 Sum_probs=207.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcC---------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceee---------
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLAD---------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVK--------- 442 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~--------- 442 (678)
.++|.+.+.||+|+||.||+|.... ++.||||.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999763 789999998643 46789999999999999988
Q ss_pred ------EEeEEee-CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 443 ------LLGSCLE-VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 443 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
+++++.. .+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5677766 67889999999 999999998542 246999999999999999999999999 99999999999
Q ss_pred EECCCC--cEEEeeccCcccccCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 041043 516 LLDEKY--RAKIADFGTSRSIAIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISY 587 (678)
Q Consensus 516 Ll~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~ 587 (678)
|++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876543221 11334689999999999998999999999999999999999999963
Q ss_pred cccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccC
Q 041043 588 IWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNL 662 (678)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~ 662 (678)
..... ............ ....+.+... .....+.++.+|+.+||+.||++|||++|+++.|+++.+...
T Consensus 271 ~~~~~-~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNT-EDIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCH-HHHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCH-HHHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 32111 011111111110 0111111000 001234679999999999999999999999999999986543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=332.42 Aligned_cols=261 Identities=24% Similarity=0.298 Sum_probs=198.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC-----hhhHHHHHHHHHHHhcCC---CCceeeEEeEEeeC
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-----ESKLEEFINEVVILSQIS---HRNVVKLLGSCLEV 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~ 450 (678)
..++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 468999999876322 112345667777777664 99999999999876
Q ss_pred C-----cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 451 E-----VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 451 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
. ..++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 699999986532 34999999999999999999999999 999999999999999999999
Q ss_pred eeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 526 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
+|||+++..... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||... ...........
T Consensus 162 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~------~~~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN------SEADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS------SHHHHHHHHHH
T ss_pred eeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHH
Confidence 999999765432 2234456899999999999999999999999999999999999999532 22222222211
Q ss_pred hc------cchhh---cchhhhcC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 EN------CLFDI---LDDQVRKS-------GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 ~~------~~~~~---~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. .+... ........ ...+.++.+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 10 00000 00000000 012334678999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=344.32 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=195.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHH-HhcCCCCceeeEEeEEeeCCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVI-LSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
.++|++.+.||+|+||+||+++.+ +++.||||+++.. .....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999976 5789999987543 23344566777776 577899999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999753 35899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.. .+....+..+....
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~------~~~~~~~~~i~~~~-------- 255 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS------RNTAEMYDNILNKP-------- 255 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC------SBHHHHHHHHHHSC--------
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC------CCHHHHHHHHHhcc--------
Confidence 222 223455799999999999999999999999999999999999999952 22233333222211
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+..+.+|+.+||+.||++||++.+.++.
T Consensus 256 ---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 256 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp ---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred ---cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 11123345678999999999999999998644433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=343.75 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=196.4
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCC--c
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVE--V 452 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~ 452 (678)
...++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999964 689999998753 34556678899999999997 999999999997554 6
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 689999974 25899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCC--------------------cceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccc
Q 041043 533 SIAID--------------------QTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWAN 591 (678)
Q Consensus 533 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~ 591 (678)
..... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-- 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS-- 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 65321 1112334579999999999876 678999999999999999999999996322
Q ss_pred cCCChHHHHHHHHhh---ccch-----------hhcc---------------------h-hhhcCCCHHHHHHHHHHHHH
Q 041043 592 EGRNLATYFVECVEE---NCLF-----------DILD---------------------D-QVRKSGKTEEIMEVSDVAKR 635 (678)
Q Consensus 592 ~~~~~~~~~~~~~~~---~~~~-----------~~~~---------------------~-~~~~~~~~~~~~~l~~li~~ 635 (678)
....+...... .... ..+. . ..........++++.+|+.+
T Consensus 236 ----~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 236 ----TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp ----HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred ----HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 11111111110 0000 0000 0 00000011234578999999
Q ss_pred hcccCCCCCCCHHHHHHH--HHHHH
Q 041043 636 CLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 636 cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
||+.||++|||++|+++. |..+.
T Consensus 312 ~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred hhccCcccCCCHHHHhCCHHHHHhc
Confidence 999999999999999887 54443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=330.16 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=202.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
++|....+||+|+||.||+|.. .+++.||||.+...+....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556999999999999996 468899999987766666788999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeeccCcccccCCcc
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgl~~~~~~~~~ 539 (678)
++++|.+++........+++..++.++.|++.||+|||+.+ |+|+||||+|||++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999986554556789999999999999999999999 999999999999987 89999999999976543221
Q ss_pred eeeeccccccCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
......+++.|+|||.+.... ++.++||||||+++|||++|+.||..... .......... ...
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~---------~~~ 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQAAMFKVGM---------FKV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHHHHHHHHH---------HCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhHHHHhhcc---------ccc
Confidence 223456899999999987643 78999999999999999999999852211 1111110000 011
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112233455688999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.60 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=184.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45789999999999999999997 478999999875422 22347789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999998642 46899999999999999999999999 99999999999999999999999999976543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ... .+....
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~---------~~~~~~ 228 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN------TLN---------KVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH------HHH---------HHhhcc
Confidence 2221 223468999999999998889999999999999999999999985322111 000 000000
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112234567899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.24 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=207.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999976 4789999987542 345567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999998743 35899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.. ..............
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~------~~~~~~~~~~~~~~--------- 231 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET------SCLKETYLRIKKNE--------- 231 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHTTC---------
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHhhcc---------
Confidence 322 23345689999999999988899999999999999999999999852 22222222221111
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+......+.+++.+||+.||++|||++|+++.
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122344578999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=329.36 Aligned_cols=252 Identities=26% Similarity=0.353 Sum_probs=198.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|.+.+.||+|+||.||++... ++..+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457899999999999999999975 5889999987543 33456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE---CCCCcEEEeeccCcccc
Q 041043 459 FIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSI 534 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgl~~~~ 534 (678)
|+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986421 1246899999999999999999999999 9999999999999 45678999999999765
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.... ......+++.|+|||.+. ..++.++||||||+++|||++|+.||... .................
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~------~~~~~~~~~~~~~~~~~--- 245 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT------SLEEVQQKATYKEPNYA--- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCCCC---
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC------CHHHHHhhhccCCcccc---
Confidence 4322 233456899999999986 46899999999999999999999999532 22221111111110000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......++.+.+|+.+||+.||++|||++|+++
T Consensus 246 -----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 -----VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001113457889999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=323.66 Aligned_cols=263 Identities=27% Similarity=0.359 Sum_probs=208.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++|++.+.||+|+||.||++... +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999976 689999998754321 2367899999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC----cEEEeecc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFG 529 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfg 529 (678)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999742 35899999999999999999999999 99999999999998877 89999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
++....... ......+++.|+|||.+....++.++||||||+++|+|++|+.||... ..............
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~- 228 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE------TKQETLTNISAVNY- 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTTCC-
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc------chHHHHHHhHhccc-
Confidence 997654322 223446899999999999889999999999999999999999998532 11222221111110
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHhccCCC
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM--ELERIRACNLQD 664 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~l~~~~~~~ 664 (678)
....... ...++.+.+|+.+||+.||++|||+.|+++ .++.++..+...
T Consensus 229 --~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 279 (283)
T 3bhy_A 229 --DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279 (283)
T ss_dssp --CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC--
T ss_pred --CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhhc
Confidence 0001111 122457899999999999999999999998 477777665433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.25 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=203.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--------ESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
..++|++.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999996 468899999876532 11334678899999999999999999999999
Q ss_pred CcceEEEEeccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 451 EVPLLVYEFIPNG-TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 451 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
+..++||||+..| +|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 999999754 35999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
++........ .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------ 235 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------ 235 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence 9987654332 233568999999999988776 7899999999999999999999853211
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...... ..+...++++.+|+.+||+.||++|||++|+++.
T Consensus 236 ---~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000100 1122245578999999999999999999999885
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.86 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=204.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
..++|.+.+.||+|+||.||++... +++.||+|.++.......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4567899999999999999999975 689999999876555556778999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE---CCCCcEEEeeccCccccc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgl~~~~~ 535 (678)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999643 35899999999999999999999999 9999999999999 788999999999987543
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||... ............. ..
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~-~~----- 225 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE------TESKLFEKIKEGY-YE----- 225 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHCC-CC-----
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCC-CC-----
Confidence 22 122345899999999999999999999999999999999999998522 1222222222111 00
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.........+..+.+|+.+||+.||++|||++|+++.
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011122345679999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=365.74 Aligned_cols=265 Identities=25% Similarity=0.401 Sum_probs=211.9
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEe
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCL 448 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 448 (678)
..+++...++|++.+.||+|+||.||+|.+.. +..||||+.+.. .....+.+.+|+.++++++||||+++++++.
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34455566789999999999999999999742 467999988653 4445578999999999999999999999984
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
.+..++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 46689999999999999999753 235899999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhc
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
|+++..............+++.|+|||.+....++.++||||||+++|||++ |..||... .............
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~------~~~~~~~~i~~~~ 609 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------KNNDVIGRIENGE 609 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHHTC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHcCC
Confidence 9998765444333344557789999999998899999999999999999997 99998532 1122222221111
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+...+...+..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 610 ----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 ----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1112334456899999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=330.63 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=199.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 455 (678)
..++|++.+.||+|+||+||+|... +++.||||.+.. .......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467899999999999999999976 789999998764 3344567889999999999 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC--------------
Q 041043 456 VYEFIPNGTLFQYLHDPSE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-------------- 520 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-------------- 520 (678)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975321 145899999999999999999999999 9999999999999844
Q ss_pred -----CcEEEeeccCcccccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCC
Q 041043 521 -----YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGR 594 (678)
Q Consensus 521 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~ 594 (678)
..+||+|||++....... ...+|+.|+|||.+.+. .++.++||||||+++|||++|..++... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h
Confidence 479999999997655332 23489999999999775 5678999999999999999998875311 0
Q ss_pred ChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. ..... .... ...+...++.+.+|+.+||+.||++|||++|+++.
T Consensus 236 -~---~~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -Q---WHEIR-QGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -H---HHHHH-TTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -H---HHHHH-cCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 11111 1111 11223345679999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.33 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=193.1
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
...++|++.++||+|+||+||++... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999964 68999999986543 2335678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE-----CCCCcEEEeeccC
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL-----DEKYRAKIADFGT 530 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl-----~~~~~~kl~Dfgl 530 (678)
||||++ |+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 5999999754 35899999999999999999999999 9999999999999 4556699999999
Q ss_pred cccccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc--
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN-- 607 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 607 (678)
+........ ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||... .............
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD------SEIDQLFKIFEVLGL 256 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHHHCC
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC------CHHHHHHHHHHHhCC
Confidence 976543322 23334579999999999874 4899999999999999999999999532 1112222221110
Q ss_pred ----cchhh-------------cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 608 ----CLFDI-------------LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 608 ----~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+... ....+.........+++.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 0000000000113467899999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.99 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=207.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3467999999999999999999975 4789999987542 34566789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999998743 35899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.. ..............
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~------~~~~~~~~~~~~~~-------- 257 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET------SCLKETYLRIKKNE-------- 257 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHTC--------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC------CCHHHHHHHHhcCC--------
Confidence 3322 23345689999999999988899999999999999999999999852 22222222221111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+......+.+|+.+||+.||++|||++|+++.
T Consensus 258 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01122334578899999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.88 Aligned_cols=267 Identities=24% Similarity=0.353 Sum_probs=197.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhh-HHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK-LEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|.+.+.||+|+||+||+|... +++.||+|++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999975 68999999886533222 22456799999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
++ |+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 59999987543 35899999999999999999999999 99999999999999999999999999976543222
Q ss_pred eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---ccchhhcch
Q 041043 540 HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---NCLFDILDD 615 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 615 (678)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........... ..+......
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcc
Confidence 2233468999999999876 568999999999999999999999996322111 11111111110 011111110
Q ss_pred hh---------hc----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 616 QV---------RK----SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 616 ~~---------~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
.. .. ......+.++.+|+.+||+.||++|||++|+++. +..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00 00 0011234578999999999999999999999884 44443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=352.88 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=208.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|.+.+.||+|+||.||++... +|+.||+|++... .....+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467899999999999999999975 6899999987542 22345678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999998643 235899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~--~~~~~i~~~i~~-~-------- 404 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--IKREEVERLVKE-V-------- 404 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC--CCHHHHHHHHHH-C--------
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc--hhHHHHHHHhhc-c--------
Confidence 3322 23457999999999999989999999999999999999999999632211 111111111111 1
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
....+...+.++.+||.+||+.||++|| +++|+++.
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112334556899999999999999999 78888764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=341.71 Aligned_cols=255 Identities=26% Similarity=0.332 Sum_probs=205.5
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE----cCCcEEEEEEcccCC----hhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCC
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML----ADGRIIAVKKSKVVD----ESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVE 451 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 451 (678)
.++|++.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999997 368999999876421 23345677899999999 6999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999753 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcceeeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
+..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ..............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKS--- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS--CCCHHHHHHHHHHC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc--cchHHHHHHHHhcc---
Confidence 8765444444445679999999999985 3478899999999999999999999963221 11222222211111
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAMEL 654 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 654 (678)
....+...+..+.+|+.+||+.||++|| |++|+++..
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1112334456789999999999999999 999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=330.79 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=204.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLE--VEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l 455 (678)
.++|++.+.||+|+||.||++... +++.||+|.+... +....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999975 6899999987643 45566789999999999999999999998864 567899
Q ss_pred EEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 456 VYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSA--YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997532 2235899999999999999999999976 1239999999999999999999999999987
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||... ........ ...+..
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~-i~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGK-IREGKF--- 233 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH-HHHTCC---
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc------CHHHHHHH-Hhhccc---
Confidence 6543221 122345899999999999888999999999999999999999998532 11111111 111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELER 656 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 656 (678)
...+...+.++.+++.+||+.||++|||++|+++.+..
T Consensus 234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11223445689999999999999999999999986643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.90 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=200.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3567999999999999999999975 4899999987543 334456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999999887643 35899999999999999999999999 99999999999999999999999999976543
Q ss_pred CcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH----------HHHh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV----------ECVE 605 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~ 605 (678)
... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+ .+..... ....
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHH
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhh
Confidence 222 23344689999999999875 78999999999999999999999996322111 0000000 0000
Q ss_pred hc-cchhhcchhhhcCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 EN-CLFDILDDQVRKSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 ~~-~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. .......+...... ....++.+.+|+.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000000000001 11335689999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=336.72 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=192.6
Q ss_pred ccCCCcC-CeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHH-hcCCCCceeeEEeEEee----CCcc
Q 041043 381 TDHFNVN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVIL-SQISHRNVVKLLGSCLE----VEVP 453 (678)
Q Consensus 381 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~~ 453 (678)
.++|.+. ++||+|+||+||++... +++.||||+++.. ..+.+|++++ +..+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 78999999999999975 5889999998632 4567888887 45589999999999875 5678
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEeeccC
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 530 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl 530 (678)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999998643 246999999999999999999999999 999999999999997 78999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCC-ChHHHHHHHHhhccc
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGR-NLATYFVECVEENCL 609 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 609 (678)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .... ... .+..
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~i~-~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIR-MGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---HHH-HTCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---HHH-cCcc
Confidence 98654322 233456899999999999999999999999999999999999999643221111 1111 111 1100
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. .........+.++.+||.+||+.||++|||+.|+++.
T Consensus 285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0001112345679999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.28 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=207.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357899999999999999999975 57889999875421 22346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999865443
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||... .............
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~--------- 228 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP------SHTETHRRIVNVD--------- 228 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTTC---------
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC------CHhHHHHHHhccc---------
Confidence 22 23446899999999999989999999999999999999999998522 1122121111110
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
...+...+..+.+++.+||+.||.+|||++|+++. ++....
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 11223345678999999999999999999999874 444333
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=343.86 Aligned_cols=265 Identities=19% Similarity=0.281 Sum_probs=208.6
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCC-CceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 457 (678)
..++|.+.++||+|+||.||+|.. .+++.||||+....... +++.+|+++++.++| +++..+..+..+.+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999996 56899999987643322 357899999999987 55556666667778889999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE---CCCCcEEEeeccCcccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSI 534 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgl~~~~ 534 (678)
||+ +++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++..
T Consensus 83 e~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 999999997432 35999999999999999999999999 9999999999999 68899999999999876
Q ss_pred cCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 535 AIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 535 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
...... ......||+.|+|||.+.+..++.++||||||++||||++|+.||....... ....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~i~~~~- 232 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKK- 232 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS---HHHHHHHHHHHH-
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh---HHHHHHHHhhcc-
Confidence 543322 1224569999999999999999999999999999999999999996433222 222222211111
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
....+. .+. ...+.++.+|+.+||+.+|++||++++|++.|+.+....
T Consensus 233 ~~~~~~-~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 233 VATSIE-ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHSCHH-HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccccHH-HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 111111 111 122457999999999999999999999999999998544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.54 Aligned_cols=262 Identities=25% Similarity=0.275 Sum_probs=198.0
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChh-----hHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDES-----KLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
...++|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 5899999988643221 12468899999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999985 8999887543 45889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc----
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN---- 607 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 607 (678)
....... ......+|+.|+|||.+.+. .++.++||||||+++|||++|..||... .....+.......
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~------~~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD------SDLDQLTRIFETLGTPT 233 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHHHCCCC
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHHHcCCCC
Confidence 6643322 23345689999999998764 5889999999999999999999998532 2222222222110
Q ss_pred --cchhh------cchhhhcCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 608 --CLFDI------LDDQVRKSGK-----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 608 --~~~~~------~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+... .........+ ...+.++.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0000000001 2234689999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=342.21 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=168.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----C
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV-----E 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~ 451 (678)
..++|.+.+.||+|+||.||+|... +++.||||++.. .+....+.+.+|+++|++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999965 578999999864 3445567899999999999999999999999776 5
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++||||++ |+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999986 6999999753 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcce---------------------eeeccccccCccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 041043 532 RSIAIDQTH---------------------VSTKVQGTFGYLDPEYF-HSSQFTDKSDVYSFGVVLVELLTGQKPIS 586 (678)
Q Consensus 532 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwslGvll~elltg~~p~~ 586 (678)
+........ ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876533211 23456789999999986 55679999999999999999998655553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.26 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=201.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
..++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3567999999999999999999976 588999999877666777899999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999998753 235899999999999999999999999 9999999999999999999999999875432111
Q ss_pred ceeeeccccccCccCcccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 539 THVSTKVQGTFGYLDPEYF-----HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
.......+++.|+|||.+ ....++.++||||||+++|+|++|+.||... +...............
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~--- 241 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSDPPT--- 241 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCCCC---
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC------CHHHHHHHHhccCCcc---
Confidence 112334689999999998 4567899999999999999999999998532 2222222222111100
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01123345678999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.41 Aligned_cols=271 Identities=25% Similarity=0.398 Sum_probs=208.5
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467899999999999999999975 6899999988654 45556789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
|+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999753 3589999999999999999999996 7 999999999999999999999999998654321
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh---------------------
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL--------------------- 596 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~--------------------- 596 (678)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 22334689999999999999999999999999999999999999964322110000
Q ss_pred --HHHHHHHHhhccchhhcchhh----hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhc
Q 041043 597 --ATYFVECVEENCLFDILDDQV----RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRAC 660 (678)
Q Consensus 597 --~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~~ 660 (678)
..+...........+.++... ........+.++.+|+.+||+.||++|||++|+++. ++.....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 000000000000011111111 111112345679999999999999999999999986 4444443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.57 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=200.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----CCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLE----VEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 453 (678)
.+.|.+.+.||+|+||.||+|... ++..||+|.+.. .+....+.+.+|++++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788889999999999999974 578999998754 345667889999999999999999999999875 3457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcEEEeeccCcc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSR 532 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~ 532 (678)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++ +++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999753 35899999999999999999999987 3599999999999998 78999999999997
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. ............... ...
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~-----~~~~~~~~~~~~~~~-~~~- 249 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE-----CQNAAQIYRRVTSGV-KPA- 249 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT-----CSSHHHHHHHHTTTC-CCG-
T ss_pred cccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC-----cCcHHHHHHHHhccC-Ccc-
Confidence 544322 233468999999998874 589999999999999999999999952 222222222222111 110
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.. +...++++.+|+.+||+.||++|||++|+++
T Consensus 250 ---~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 ---SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1122346899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=349.39 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=207.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|.+.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999975 68999999885422 23456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976432 346999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... +...............
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~--~~~~~~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG--EKVENKELKQRVLEQA-------- 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT--CCCCHHHHHHHHHHCC--------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc--cchhHHHHHHHHhhcc--------
Confidence 4322 2234579999999999999999999999999999999999999996321 1112222222222111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM-----KEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 652 (678)
...+...+..+.+|+.+||+.||++||++ +|+++
T Consensus 410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11233455688999999999999999975 55654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.08 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=202.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 457 (678)
..++|++.+.||+|+||.||++..+ +++.||||.+..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999975 588999999865432 234688888887 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC----CcEEEeeccCccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK----YRAKIADFGTSRS 533 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgl~~~ 533 (678)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999754 35999999999999999999999999 9999999999998543 3599999999986
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
...... ......+|+.|+|||++.+..++.++||||||+++|||++|..||... ........+..... +...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~~~~i~~-~~~~--- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG---PDDTPEEILARIGS-GKFS--- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS---TTSCHHHHHHHHHH-CCCC---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC---CcCCHHHHHHHHcc-CCcc---
Confidence 654332 233456899999999998888899999999999999999999999632 11222222222221 1111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.........++++.+|+.+||+.||++|||+.|+++.
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111123445688999999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.74 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=197.6
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999976 68999999875432 2345688999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999753 35899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCcceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.. ............ ..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~------~~~~~~~~~~~~-~~------ 227 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD------EHVPTLFKKIRG-GV------ 227 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHH-CC------
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC------CcHHHHHHHhhc-Cc------
Confidence 322 2233468999999999987765 6899999999999999999999852 222222222111 10
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+......+.+++.+||+.||++|||++|+++.
T Consensus 228 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122334578999999999999999999999884
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=346.96 Aligned_cols=195 Identities=26% Similarity=0.441 Sum_probs=156.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----C
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV-----E 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~ 451 (678)
..++|++.+.||+|+||+||+|... +++.||||++.. .+....+++.+|+++|++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3578999999999999999999965 689999998754 3445567899999999999999999999998543 4
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 679999998 57999999753 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc--------------------------eeeeccccccCccCcccc-ccCCCCcccchhhHHHHHHHHHhC
Q 041043 532 RSIAIDQT--------------------------HVSTKVQGTFGYLDPEYF-HSSQFTDKSDVYSFGVVLVELLTG 581 (678)
Q Consensus 532 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwslGvll~elltg 581 (678)
+....... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643221 122345689999999986 556799999999999999999994
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.46 Aligned_cols=261 Identities=22% Similarity=0.273 Sum_probs=198.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE----- 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 451 (678)
..++|.+.+.||+|+||.||+|... +|+.||||++.. .+....+++.+|++++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999974 689999999854 33445678999999999999999999999998653
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++||||+ +++|.++++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 359999999 8899999974 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh-cc
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE-NC 608 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 608 (678)
++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ....+...... +.
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD------HLDQLKEIMKVTGT 244 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCC
Confidence 9865432 234568999999999877 679999999999999999999999996321 11112111110 00
Q ss_pred -chh------------hcch------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 609 -LFD------------ILDD------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 609 -~~~------------~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
..+ .+.. ..........++.+.+|+.+||+.||++|||++|+++. ++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000 0000 00000112335678999999999999999999999985 55443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=345.82 Aligned_cols=249 Identities=17% Similarity=0.174 Sum_probs=194.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc---CChhhHHHHHHHHH---HHhcCCCCceeeEE-------e
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVV---ILSQISHRNVVKLL-------G 445 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei~---~l~~l~h~niv~l~-------~ 445 (678)
..++|.+.+.||+|+||+||+|.. .+|+.||||++.. ......+.+.+|++ ++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356789999999999999999995 5689999999863 34456688999994 55556899999998 5
Q ss_pred EEeeCC-----------------cceEEEEeccCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 041043 446 SCLEVE-----------------VPLLVYEFIPNGTLFQYLHDPSE----ELSLTWEMRLRIATEVAEALAYLHSSAYLP 504 (678)
Q Consensus 446 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 504 (678)
++.+.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 555443 278999999 6899999975311 123446888999999999999999999
Q ss_pred eEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccC-----------CCCcccchhhHHH
Q 041043 505 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-----------QFTDKSDVYSFGV 573 (678)
Q Consensus 505 ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwslGv 573 (678)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985322 2334457 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-
Q 041043 574 VLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM- 652 (678)
Q Consensus 574 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~- 652 (678)
++|||++|+.||....... ....+.. .....++++.+|+.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~---------------~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------C---------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCccccccc---------------chhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999985321111 0111111 01223457899999999999999999999987
Q ss_pred -HHHHHH
Q 041043 653 -ELERIR 658 (678)
Q Consensus 653 -~L~~l~ 658 (678)
.++.++
T Consensus 361 p~f~~~~ 367 (377)
T 3byv_A 361 PEYEQLR 367 (377)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 355544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.12 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=191.7
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCCCCceeeEEeEEee
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--------ESKLEEFINEVVILSQISHRNVVKLLGSCLE 449 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 449 (678)
...++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999965 57899999875421 122335889999999999999999999975
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC---CcEEEe
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIA 526 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~ 526 (678)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 45579999999999999999753 35999999999999999999999999 9999999999999754 459999
Q ss_pred eccCcccccCCcceeeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 041043 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 527 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
|||+++..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ...+.. .
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~----~ 356 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKD----Q 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS--SCCHHH----H
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc--hHHHHH----H
Confidence 99999865432 22344569999999999853 5688899999999999999999999963211 111111 1
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....... .. +... ...++.+.+|+.+||+.||++|||++|+++.
T Consensus 357 i~~~~~~-~~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYN-FI-PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCC-CC-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCC-CC-chhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111110 00 0000 1234578999999999999999999998863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.06 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=200.3
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC-----------ChhhHHHHHHHHHHHhcCCCCceee
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV-----------DESKLEEFINEVVILSQISHRNVVK 442 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~Ei~~l~~l~h~niv~ 442 (678)
..++....++|.+.+.||+|+||.||+|...+++.||||++... +....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677888999999999999999999999888999999987532 2223478999999999999999999
Q ss_pred EEeEEeeCC-----cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE
Q 041043 443 LLGSCLEVE-----VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 517 (678)
Q Consensus 443 l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl 517 (678)
+++++...+ ..++||||++ |+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999986533 4699999997 6888888753 346999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccCcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh
Q 041043 518 DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL 596 (678)
Q Consensus 518 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~ 596 (678)
+.++.+||+|||++....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~------~~ 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS------TF 239 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS------SH
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC------CH
Confidence 999999999999997543322 2334568999999999876 67899999999999999999999999532 21
Q ss_pred HHHHHHHHhh---ccch-----------hhcchhhhc-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 597 ATYFVECVEE---NCLF-----------DILDDQVRK-------SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 597 ~~~~~~~~~~---~~~~-----------~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......... .... ..+...... .......+.+.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 2222211110 0000 000000000 0011234578999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=331.70 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=187.8
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
....++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+++.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34467899999999999999999995 468999999876433 3445778899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 456 VYEFIPNGTLFQYLHD-----PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
||||+++++|.+++.. ......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999863 112346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcc----eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 531 SRSIAIDQT----HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 531 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
+........ .......+|+.|+|||.+.. ..++.++||||||+++|||++|+.||...... ........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------KVLMLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh------hHHHHHhc
Confidence 876543221 11233468999999999876 56899999999999999999999999632211 11111111
Q ss_pred hccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. .................+..+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 ND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11 111100000111112334578999999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=328.77 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=200.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEee--CCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLE--VEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~lv 456 (678)
.++|++.+.||+|+||+||+|.. .+++.||||.++... .+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999986 468999999987433 467889999999997 9999999999987 5678999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~~ 535 (678)
|||+++++|.+++. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999985 3889999999999999999999999 99999999999999776 89999999998654
Q ss_pred CCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH---hhccchh
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV---EENCLFD 611 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 611 (678)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......... .......
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-----~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-----DNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS-----SHHHHHHHHHHHHCHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC-----chHHHHHHHHHhcCCchhhh
Confidence 3322 234468999999999877 678999999999999999999999985221 1111111111 0000100
Q ss_pred hcch-----------------------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 612 ILDD-----------------------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 612 ~~~~-----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.++. ..........++++.+|+.+||+.||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 00011112245789999999999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.77 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=206.0
Q ss_pred HHHHhhccCCCcC-CeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCC-CCceeeEEeEEee
Q 041043 375 KELDKATDHFNVN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQIS-HRNVVKLLGSCLE 449 (678)
Q Consensus 375 ~~~~~~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~ 449 (678)
...+...++|.+. +.||+|+||.||++... +++.||+|+++.. ......++.+|+.++++++ ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3445556678877 89999999999999975 5899999987642 3344678999999999995 6999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEe
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIA 526 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~ 526 (678)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999996532 346999999999999999999999999 999999999999998 7899999
Q ss_pred eccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 527 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
|||++....... ......+|+.|+|||.+....++.++||||||+++|||++|+.||... ............
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE------DNQETYLNISQV 248 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHT
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CchHHHHHHHhc
Confidence 999998654322 223456899999999999999999999999999999999999999532 222222221111
Q ss_pred ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. ...........++.+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 N-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1 001111123345678999999999999999999999865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.26 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=204.5
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcC-CCCceeeEEeE
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--------ESKLEEFINEVVILSQI-SHRNVVKLLGS 446 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~ 446 (678)
.....++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999985 69999999875432 12245688999999999 79999999999
Q ss_pred EeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEe
Q 041043 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526 (678)
Q Consensus 447 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 526 (678)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999743 35899999999999999999999999 9999999999999999999999
Q ss_pred eccCcccccCCcceeeeccccccCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 041043 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 527 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~ 600 (678)
|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||... ......
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~------~~~~~~ 314 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR------RQILML 314 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC------CHHHHH
Confidence 999997665332 2234568999999999863 35788999999999999999999998521 112222
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
....... .. ...+. . ...+..+.+|+.+||+.||++|||++|+++
T Consensus 315 ~~i~~~~-~~-~~~~~-~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMIMEGQ-YQ-FSSPE-W----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHTC-CC-CCHHH-H----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhCC-CC-CCCcc-c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2111111 00 00000 0 122356899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.60 Aligned_cols=264 Identities=21% Similarity=0.298 Sum_probs=199.4
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-------
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEV------- 450 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------- 450 (678)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999997 468999999875432 33346788999999999999999999999874
Q ss_pred -CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 451 -EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 451 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
+..++||||+++ +|.+.+.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 7888776543 35999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCc---ceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh
Q 041043 530 TSRSIAIDQ---THVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605 (678)
Q Consensus 530 l~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 605 (678)
+++...... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ..........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence 997654322 122334568999999999876 458999999999999999999999986321111 1111111110
Q ss_pred h---ccchhhcchhh--------hcCCC-H------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 E---NCLFDILDDQV--------RKSGK-T------EEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 ~---~~~~~~~~~~~--------~~~~~-~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. ..+........ ..... . ...+.+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00000000000 00000 0 013468899999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=349.22 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=208.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
..++|.+.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567999999999999999999975 6899999987532 23456789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE---CCCCcEEEeeccCcc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSR 532 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgl~~ 532 (678)
|+||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999754 35999999999999999999999999 9999999999999 567899999999997
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+................
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~------~~~~~~~~~i~~~~~~~~- 247 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG------ANEYDILKKVEKGKYTFE- 247 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCCCCCC-
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC------CCHHHHHHHHHcCCCCCC-
Confidence 654332 2234569999999999876 689999999999999999999999953 222222222222111100
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
.......++.+.+|+.+||+.||++|||++|+++. ++...
T Consensus 248 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 248 ------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 00012345678999999999999999999999975 44443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.41 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=199.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC----hhhHHHHHHHHHHHhcCCCCceeeEEeEEe--eCCc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD----ESKLEEFINEVVILSQISHRNVVKLLGSCL--EVEV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~ 452 (678)
..++|.+.+.||+|+||.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3568999999999999999999964 68899999876432 234578999999999999999999999984 4457
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||++++ |.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 777776532 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCc-ceeeeccccccCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 533 SIAIDQ-THVSTKVQGTFGYLDPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 533 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
...... ........+++.|+|||.+.+.. ++.++||||||+++|||++|+.||.. .+............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~------~~~~~~~~~i~~~~-- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG------DNIYKLFENIGKGS-- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHCC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC------chHHHHHHHHhcCC--
Confidence 664322 22234456899999999987644 47799999999999999999999852 22222222221111
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 230 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ---------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122345678999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=325.49 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=200.6
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
...++|++.+.||+|+||.||+|... +|+.||+|.+.... ..+++.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999975 58999999886532 3467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999632 235899999999999999999999999 999999999999999999999999999765433
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ............ ..
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~------- 243 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH------PMRAIFMIPTNP-PP------- 243 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC-CC-------
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCC-Cc-------
Confidence 22 2234468999999999999899999999999999999999999985221 111111111110 00
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001122345678999999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.43 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=200.9
Q ss_pred cChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEee
Q 041043 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLE 449 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 449 (678)
++..++....++|++.+.||+|+||.||+|... +++.||||.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344455567789999999999999999999974 68999999886533 3346889999999998 79999999999987
Q ss_pred ------CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 450 ------VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 450 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 457899999999999999997542 246899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCcccccCCcceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 041043 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLAT 598 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~ 598 (678)
||+|||++........ ......+++.|+|||.+. ...++.++||||||+++|+|++|+.||.... ...
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~ 241 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------PMR 241 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHH
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHH
Confidence 9999999876543221 223346899999999987 5668899999999999999999999985221 111
Q ss_pred HHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 599 YFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
....... .... .......+..+.+|+.+||..||++|||++|+++.
T Consensus 242 ~~~~~~~-~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 ALFLIPR-NPAP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHH-SCCC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhc-Cccc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111 1110 11122334678999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.12 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=191.6
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC-h-hhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-E-SKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..++|++.+.||+|+||+||++.. .+++.||+|+++... . ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999997 468999999886532 2 2333455566668889999999999999999999999
Q ss_pred EEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 457 YEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
|||++ |+|.+++... .....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5888877531 1234699999999999999999999998 8 999999999999999999999999999765
Q ss_pred cCCcceeeeccccccCccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYF----HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
..... .....+|+.|+|||.+ ....++.++||||||+++|||++|+.||... ...............
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~-- 231 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW-----GTPFQQLKQVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC-----SCHHHHHHHHHHSCC--
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc-----CchHHHHHHHhccCC--
Confidence 43322 2334689999999996 4567899999999999999999999998521 112222222222111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
........+.++.+|+.+||+.||++|||++|+++. ++...
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 232 -------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred -------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 111122345679999999999999999999999883 44433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=326.16 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=196.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEe----------
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCL---------- 448 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~---------- 448 (678)
..++|.+.+.||+|+||.||+|... +++.||+|++...+....+++.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3568999999999999999999976 48999999988777777889999999999999999999999874
Q ss_pred ----eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcE
Q 041043 449 ----EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRA 523 (678)
Q Consensus 449 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ 523 (678)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3456789999997 699999964 35899999999999999999999999 99999999999997 67799
Q ss_pred EEeeccCcccccCCcce--eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 041043 524 KIADFGTSRSIAIDQTH--VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~ 600 (678)
||+|||++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.... .....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~ 234 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH------ELEQM 234 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC------HHHHH
Confidence 99999999865432221 2233457899999998865 678999999999999999999999996322 11112
Q ss_pred HHHHhhccc-------------hhhcchhhh-cCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 601 VECVEENCL-------------FDILDDQVR-KSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 601 ~~~~~~~~~-------------~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
......... ...+..... ... ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 211111100 000000000 000 11235679999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=359.91 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=207.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcce
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 454 (678)
..++|++.++||+|+||+||+|... +++.||||+++.. .....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999975 5789999987642 233456788999999988 6999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999853 35999999999999999999999999 999999999999999999999999999864
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||.. .+....+..+....
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~------~~~~~~~~~i~~~~------- 558 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG------EDEDELFQSIMEHN------- 558 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHSSC-------
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC------CCHHHHHHHHHhCC-------
Confidence 3322 223456799999999999999999999999999999999999999953 23333333333221
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM-----KEVAM 652 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 652 (678)
...+...+.++.+||.+||+.||++||++ +||++
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11233456689999999999999999998 66654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.26 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=203.7
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..++|++.++||+|+||+||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999975 6899999987532 233457899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC---CCCcEEEeeccCccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRS 533 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgl~~~ 533 (678)
+||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999998753 35899999999999999999999999 99999999999995 566899999999976
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. ..................
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~------~~~~~~~~~i~~~~~~~~-- 242 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG------KNEYDILKRVETGKYAFD-- 242 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTCCCSC--
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCCCCCC--
Confidence 54332 2334569999999999876 589999999999999999999999952 222222222222111100
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......++++.+|+.+||+.||++|||+.|+++.
T Consensus 243 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00012345678999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.79 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=194.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE----- 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 451 (678)
..++|.+.+.||+|+||.||+|... +++.||||++.. .+....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3568999999999999999999965 688999998764 34455678899999999999999999999997655
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++||||++ |+|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 6799999997 578888863 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh----
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---- 606 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 606 (678)
++..... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||.... ....+......
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD------HIDQWNKVIEQLGTP 245 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHC-CCCC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCC
Confidence 9765432 22334568999999999999899999999999999999999999996322 11111111110
Q ss_pred ------------------cc------chhhcchhhhcCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 ------------------NC------LFDILDDQVRKSG---KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ------------------~~------~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. +............ ....+..+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 0000000000000 12336689999999999999999999999885
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=337.60 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=198.0
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC----
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE---- 451 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 451 (678)
++...++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+++++.++||||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345677899999999999999999996 4689999998764322 2347999999999999999999985432
Q ss_pred ----------------------------------cceEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHH
Q 041043 452 ----------------------------------VPLLVYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAY 496 (678)
Q Consensus 452 ----------------------------------~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~y 496 (678)
..++||||++ |+|.+.+... .....+++..++.++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3789999998 5777776531 123469999999999999999999
Q ss_pred HHhCCCCCeEeecCCCCceEEC-CCCcEEEeeccCcccccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHH
Q 041043 497 LHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVV 574 (678)
Q Consensus 497 LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvl 574 (678)
||+.+ |+||||||+|||++ +++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999997 688999999999986643332 2344689999999998764 48999999999999
Q ss_pred HHHHHhCCCCCCccccccCCChHHHHHHHHh---hccch---------------hhcchhhhcCCCHHHHHHHHHHHHHh
Q 041043 575 LVELLTGQKPISYIWANEGRNLATYFVECVE---ENCLF---------------DILDDQVRKSGKTEEIMEVSDVAKRC 636 (678)
Q Consensus 575 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~c 636 (678)
+|||++|+.||... ...+.+..... ..... ...........+...+.++.+|+.+|
T Consensus 232 l~ell~g~~pf~~~------~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 232 FGELILGKPLFSGE------TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHSSCSSCCS------SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCC------ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 99999999999632 11122222111 00000 00000111111223456789999999
Q ss_pred cccCCCCCCCHHHHHHH--HHHHHh
Q 041043 637 LNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 637 l~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
|+.||++|||+.|+++. ++.++.
T Consensus 306 L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred ccCChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999864 555543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=346.64 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=200.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
..++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999975 68899999876432 33457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEeeccCccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRS 533 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl~~~ 533 (678)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999998743 35899999999999999999999999 999999999999976 45599999999987
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. ......+.......... .
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~------~~~~~~~~~i~~~~~~~--~ 257 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG------QTDQEILRKVEKGKYTF--D 257 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTCCCC--C
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCCCCC--C
Confidence 65332 233456999999999986 4689999999999999999999999953 22222222222211100 0
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+. ....++.+.+|+.+||+.||++|||+.|+++.
T Consensus 258 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 11234678999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.03 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=197.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc------c
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV------P 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------~ 453 (678)
...+|.+.++||+|+||.||+|....+..+|+|++..... ...+|+++++.++||||+++++++...+. .
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3457999999999999999999988777799998754322 12369999999999999999999965443 7
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcEEEeeccCcc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSR 532 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~ 532 (678)
++||||++++.+............+++..++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 899999987544433322222346999999999999999999999999 99999999999999 79999999999998
Q ss_pred cccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---cc
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---NC 608 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 608 (678)
....... .....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||.... ....+...... ..
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES------GIDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCC
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCC
Confidence 7643322 2345689999999998764 58999999999999999999999996321 11111111110 00
Q ss_pred ---------------chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 609 ---------------LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 609 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
.................++++.+|+.+||+.||++|||+.|+++. ++.++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 000000000001112245689999999999999999999999975 555543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=331.49 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=204.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChh-----------------hHHHHHHHHHHHhcCCCCceeeE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES-----------------KLEEFINEVVILSQISHRNVVKL 443 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~h~niv~l 443 (678)
.++|.+.+.||+|+||.||+|.. +++.||||.+...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999999999 8999999987642211 12789999999999999999999
Q ss_pred EeEEeeCCcceEEEEeccCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceE
Q 041043 444 LGSCLEVEVPLLVYEFIPNGTLFQY------LHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNIL 516 (678)
Q Consensus 444 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NIL 516 (678)
++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999999 5432 14579999999999999999999999 88 999999999999
Q ss_pred ECCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCccccccCC
Q 041043 517 LDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTD-KSDVYSFGVVLVELLTGQKPISYIWANEGR 594 (678)
Q Consensus 517 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwslGvll~elltg~~p~~~~~~~~~~ 594 (678)
++.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----- 256 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI----- 256 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 999999999999999865433 33445689999999999887 6666 9999999999999999999996321
Q ss_pred ChHHHHHHHHhhccchhhcc---------hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 595 NLATYFVECVEENCLFDILD---------DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
............ ......+ ...........+..+.+|+.+||+.||.+|||++|+++
T Consensus 257 ~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112222222211 1100000 00000001334568899999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.58 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=204.3
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---------hhhHHHHHHHHHHHhcCC-CCceeeEEeEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---------ESKLEEFINEVVILSQIS-HRNVVKLLGSC 447 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~ 447 (678)
...++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999975 58999999876432 223467889999999996 99999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEee
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 527 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 527 (678)
...+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999753 35899999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCcceeeeccccccCccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH------SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~ 601 (678)
||++....... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||... .......
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~ 239 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLR 239 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc------cHHHHHH
Confidence 99997654332 223456899999999985 456888999999999999999999998522 2222222
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...... .. .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 221111 00 000111234567999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.55 Aligned_cols=253 Identities=28% Similarity=0.353 Sum_probs=202.7
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh-------------hhHHHHHHHHHHHhcCCCCceeeEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-------------SKLEEFINEVVILSQISHRNVVKLL 444 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l~ 444 (678)
...++|.+.++||+|+||+||+|... +++.||||.+..... ...+++.+|++++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45678999999999999999999975 578999998764321 3357789999999999999999999
Q ss_pred eEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC---
Q 041043 445 GSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY--- 521 (678)
Q Consensus 445 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~--- 521 (678)
+++.+....++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999999743 35999999999999999999999999 99999999999998776
Q ss_pred cEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 041043 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFV 601 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~ 601 (678)
.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. ......+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~------~~~~~~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG------QNDQDIIK 257 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC------CCHHHHHH
Confidence 69999999998665432 233456999999999987 4689999999999999999999999953 22222222
Q ss_pred HHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 602 ECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.......... .... ...++++.+|+.+||+.||.+|||++|+++.
T Consensus 258 ~i~~~~~~~~---~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYYFD---FNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCCCC---HHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCCC---cccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222111000 0000 1234578999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.87 Aligned_cols=255 Identities=13% Similarity=0.094 Sum_probs=183.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcC--CCCceeeEE-------eE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQI--SHRNVVKLL-------GS 446 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~ 446 (678)
....|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3456889999999999999999965 78999999987643 24456677885544444 699988755 44
Q ss_pred EeeC-----------------CcceEEEEeccCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 041043 447 CLEV-----------------EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMR------LRIATEVAEALAYLHSSAYL 503 (678)
Q Consensus 447 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~ 503 (678)
+... ...++||||++ |+|.+++.... ..+++..+ +.++.||+.||+|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 4433 23799999998 89999997532 13455555 788899999999999999
Q ss_pred CeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhC
Q 041043 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTG 581 (678)
Q Consensus 504 ~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg 581 (678)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++||||||++||||++|
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986532 1224457799999999987 6799999999999999999999
Q ss_pred CCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 582 QKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 582 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
+.||............ ....................++.+.+|+.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999644322111000 00000001111111112244568999999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.48 Aligned_cols=264 Identities=20% Similarity=0.303 Sum_probs=202.5
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----C
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEV-----E 451 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~ 451 (678)
...++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34578999999999999999999965 6889999998643 344557899999999999999999999999765 3
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++|+||++ |+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 5789999997 5999999642 4899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccee--eeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 532 RSIAIDQTHV--STKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 532 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
.......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .............
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPS 252 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCC
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence 8665432221 234568999999998654 558999999999999999999999996322111 1111111110000
Q ss_pred ---chhhcc---h----hh--hcCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 ---LFDILD---D----QV--RKSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ---~~~~~~---~----~~--~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+....+ . .. .... ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0 00 0000 01234578999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.41 Aligned_cols=263 Identities=24% Similarity=0.260 Sum_probs=202.5
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC--------CCceeeEEeEEe--
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS--------HRNVVKLLGSCL-- 448 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~-- 448 (678)
..++|.+.++||+|+||+||+|... +++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3578999999999999999999964 6889999998743 445678899999999985 788999999987
Q ss_pred --eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCC----
Q 041043 449 --EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKY---- 521 (678)
Q Consensus 449 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~---- 521 (678)
.....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 455789999999 556666665432 24599999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------cEEEeeccCcccccCCcceeeeccccccCccCccc
Q 041043 522 ---------------------------------------------RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556 (678)
Q Consensus 522 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~ 556 (678)
.+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999765432 233468999999999
Q ss_pred cccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-hccc-h----------hhcch---------
Q 041043 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE-ENCL-F----------DILDD--------- 615 (678)
Q Consensus 557 ~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-~----------~~~~~--------- 615 (678)
+.+..++.++||||||++||||++|+.||......+............. .+.. . .....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9998999999999999999999999999964332221111111111110 0000 0 00000
Q ss_pred ----------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 ----------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
......+...+..+.+|+.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0011235677788999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.77 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=201.9
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCC--CCceeeEEeEEee
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQIS--HRNVVKLLGSCLE 449 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~ 449 (678)
...+....++|++.+.||+|+||.||++...+++.||||++.. .+....+.+.+|++++++++ |+||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3444556678999999999999999999988899999998754 34556788999999999997 5999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
.+..++||| +.+++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 5688999999753 36899999999999999999999999 999999999999965 899999999
Q ss_pred CcccccCCcce-eeeccccccCccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChH
Q 041043 530 TSRSIAIDQTH-VSTKVQGTFGYLDPEYFHS-----------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLA 597 (678)
Q Consensus 530 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~ 597 (678)
++......... ......+++.|+|||.+.. ..++.++||||||+++|||++|+.||.... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~ 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQI 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----HHH
Confidence 99876543322 2234468999999999875 468889999999999999999999985221 111
Q ss_pred HHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 598 TYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...... .+.......+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SKLHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 11111112222234578999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=332.85 Aligned_cols=257 Identities=23% Similarity=0.283 Sum_probs=185.1
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV----- 450 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----- 450 (678)
...++|++.+.||+|+||.||+|.. .+|+.||||++.. .+....+.+.+|+++++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3467899999999999999999996 4689999999864 3445567889999999999999999999998754
Q ss_pred -CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 451 -EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 451 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
...++|+|++ +++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 4579999999 7899998864 35999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE--- 605 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 605 (678)
+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ....+.....
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g 247 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------HIDQLKLILRLVG 247 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHC
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhC
Confidence 99764322 234568999999999877 678999999999999999999999996322 1111111111
Q ss_pred hc---cchhhcch-------hhh--cCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 606 EN---CLFDILDD-------QVR--KSGK-----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 606 ~~---~~~~~~~~-------~~~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. .+..+... .+. .... ....+.+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 00000000 000 0000 1224578999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.52 Aligned_cols=199 Identities=23% Similarity=0.334 Sum_probs=172.5
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcC------CCCceeeEEeEEeeCC
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI------SHRNVVKLLGSCLEVE 451 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~ 451 (678)
....+|++.++||+|+||+||+|... +++.||||+++.. ....+++.+|+++++.+ +|+||+++++++...+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 34567999999999999999999865 5889999998753 34456778888888877 5779999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc--EEEeecc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--AKIADFG 529 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfg 529 (678)
..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999996 69999987643 235899999999999999999999999 999999999999999887 9999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISY 587 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~ 587 (678)
++...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99754322 2334689999999999998999999999999999999999999963
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=320.98 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=194.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee---------
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE--------- 449 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 449 (678)
..++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567899999999999999999974 789999998864 34456789999999999999999999998865
Q ss_pred ----CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEE
Q 041043 450 ----VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 525 (678)
Q Consensus 450 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 525 (678)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 34678999999999999999753 245788999999999999999999999 999999999999999999999
Q ss_pred eeccCcccccCCc-------------ceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccc
Q 041043 526 ADFGTSRSIAIDQ-------------THVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWAN 591 (678)
Q Consensus 526 ~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~ 591 (678)
+|||++....... ........+++.|+|||.+.+. .++.++||||||+++|||++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 9999997654321 1122344689999999999764 68999999999999999998 44311
Q ss_pred cCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
............. ........+...+..+.+|+.+||+.||.+|||++|+++
T Consensus 232 --~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 --MERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --hhHHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111111110 011112223444567899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.39 Aligned_cols=262 Identities=25% Similarity=0.330 Sum_probs=200.3
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEE--cCCcEEEEEEcccCC--hhhHHHHHHHHHHHhcC---CCCceeeEEeEEe---
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGML--ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQI---SHRNVVKLLGSCL--- 448 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~--- 448 (678)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3567899999999999999999997 367899999875422 22233566777777666 8999999999987
Q ss_pred --eCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEe
Q 041043 449 --EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526 (678)
Q Consensus 449 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 526 (678)
.....++|+||++ |+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999997643 235899999999999999999999999 9999999999999999999999
Q ss_pred eccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 527 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~ 234 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------DVDQLGKILDV 234 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHHH
Confidence 999997654322 2234568999999999999899999999999999999999999985321 11112222110
Q ss_pred c------cchhhc----------chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 N------CLFDIL----------DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 ~------~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. .+.... ............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000 0000001122345678999999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.32 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=195.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--------ESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3567999999999999999999975 57899999875422 22334688999999999999999999998765
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc---EEEee
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIAD 527 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~D 527 (678)
+ .++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 89999999999999999753 36899999999999999999999999 999999999999987654 99999
Q ss_pred ccCcccccCCcceeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 041043 528 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604 (678)
Q Consensus 528 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 604 (678)
||++....... ......+|+.|+|||.+. ...++.++||||||+++|+|++|+.||...... ..+....
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~---- 232 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQI---- 232 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHH----
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHH----
Confidence 99997654321 223346899999999974 467889999999999999999999999632211 1111111
Q ss_pred hhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 605 EENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...... . .+... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~-~-~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYN-F-IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCC-C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccc-c-Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111110 0 00000 123457899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=337.87 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=183.7
Q ss_pred ccCCCc-CCeeeeeCCcEEEEEEEc---CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcce
Q 041043 381 TDHFNV-NRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE--VEVPL 454 (678)
Q Consensus 381 ~~~~~~-~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~ 454 (678)
.+.|++ .++||+|+||+||+|... +++.||||++..... .+.+.+|+++|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344665 568999999999999975 478999999875332 3468899999999999999999999965 56789
Q ss_pred EEEEeccCCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE----CCCCcEE
Q 041043 455 LVYEFIPNGTLFQYLHDP------SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAK 524 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~k 524 (678)
+||||++ |+|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 5888887521 12235899999999999999999999999 9999999999999 7788999
Q ss_pred EeeccCcccccCCcc--eeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccC---CChHH
Q 041043 525 IADFGTSRSIAIDQT--HVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG---RNLAT 598 (678)
Q Consensus 525 l~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~---~~~~~ 598 (678)
|+|||+++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987653222 22334568999999999887 4589999999999999999999999964322100 00011
Q ss_pred HHHHHHh---h---ccchhh------------cchhhhcC---------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041043 599 YFVECVE---E---NCLFDI------------LDDQVRKS---------GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVA 651 (678)
Q Consensus 599 ~~~~~~~---~---~~~~~~------------~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 651 (678)
.+..... . ..+..+ ........ ........+.+|+.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1111110 0 000000 00000000 0001135688999999999999999999998
Q ss_pred HH
Q 041043 652 ME 653 (678)
Q Consensus 652 ~~ 653 (678)
+.
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 85
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.49 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=195.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC------cc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE------VP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~ 453 (678)
..+|++.+.||+|+||.||+|... +++.||||++..... .+.+|++++++++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346889999999999999999975 589999998764322 2347999999999999999999986432 35
Q ss_pred eEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-CcEEEeeccCc
Q 041043 454 LLVYEFIPNGTLFQYLHDP-SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTS 531 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl~ 531 (678)
++||||+++ +|.+.+... .....+++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999975 666655421 12346999999999999999999999999 9999999999999955 57899999999
Q ss_pred ccccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh---c
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE---N 607 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 607 (678)
+....... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||... +....+..+... .
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~------~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD------SGVDQLVEIIKVLGTP 276 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHHHCSC
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHHHhCCC
Confidence 86543322 2345689999999998764 7899999999999999999999999632 111112211110 0
Q ss_pred c---c-------hhhcchhhh-----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 608 C---L-------FDILDDQVR-----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 608 ~---~-------~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
. + .+...+.+. .......+.++.+|+.+||+.||++|||+.|+++. ++.+..
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 0 0 000000000 00112334689999999999999999999999874 555553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=334.66 Aligned_cols=266 Identities=24% Similarity=0.391 Sum_probs=204.7
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV 450 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 450 (678)
...+++...++|++.+.||+|+||.||+|...+ .+|+|.++.. +....+.+.+|++++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345556667889999999999999999999754 4899987643 233446688899999999999999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
+..++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999997642 35899999999999999999999999 99999999999998 67999999999
Q ss_pred cccccCCc----ceeeeccccccCccCcccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChH
Q 041043 531 SRSIAIDQ----THVSTKVQGTFGYLDPEYFHS---------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLA 597 (678)
Q Consensus 531 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~ 597 (678)
+....... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~~~ 249 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ------PAE 249 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC------CHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHH
Confidence 87543211 112233458999999999864 35788999999999999999999998522 122
Q ss_pred HHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 598 TYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
........ ..... ......+.++.+++.+||..||++|||++|++++|+++.+..
T Consensus 250 ~~~~~~~~-~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 250 AIIWQMGT-GMKPN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHHT-TCCCC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHHhcc-CCCCC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 22221111 11110 011123346889999999999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=328.77 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=194.2
Q ss_pred hHHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc
Q 041043 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV 452 (678)
Q Consensus 374 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 452 (678)
..+.....++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++.++.++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3455667789999999999999999999975 68999999875432 233466788888999999999999999976443
Q ss_pred -------ceEEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeecCCCCceEECC-CC
Q 041043 453 -------PLLVYEFIPNGTLFQYLHD-PSEELSLTWEMRLRIATEVAEALAYLH--SSAYLPIYHRDIKSTNILLDE-KY 521 (678)
Q Consensus 453 -------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlk~~NILl~~-~~ 521 (678)
.++||||++++ |.+.+.. ......+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 78999999864 4443321 123446899999999999999999999 888 999999999999996 89
Q ss_pred cEEEeeccCcccccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 041043 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~ 600 (678)
.+||+|||++........ .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||.... .....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~~ 241 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN------SAGQL 241 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC------hHHHH
Confidence 999999999986654332 2345689999999998665 48999999999999999999999995321 11112
Q ss_pred HHHHhh---------------ccchhhc------chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 041043 601 VECVEE---------------NCLFDIL------DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERI 657 (678)
Q Consensus 601 ~~~~~~---------------~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l 657 (678)
...... ....... -...........+.++.+|+.+||+.||++|||+.|+++. ++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 111110 0000000 0001111122356789999999999999999999999986 5555
Q ss_pred H
Q 041043 658 R 658 (678)
Q Consensus 658 ~ 658 (678)
.
T Consensus 322 ~ 322 (360)
T 3e3p_A 322 H 322 (360)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.87 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=198.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc---
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP--- 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~--- 453 (678)
..++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4678999999999999999999965 6899999988653 344567899999999999999999999999877655
Q ss_pred ---eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 454 ---LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 454 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
++||||++ ++|.+++.. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 689888842 3899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
++..... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||... +..+...........
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~~ 260 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK------DYLDQLTQILKVTGV 260 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHHHCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHHhCC
Confidence 9754322 234568999999999887 67899999999999999999999999532 222222222110000
Q ss_pred --hhhc-----------chhhhcC--C-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 610 --FDIL-----------DDQVRKS--G-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 610 --~~~~-----------~~~~~~~--~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+.. ....... . ....++.+.+|+.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 0000000 0 11235689999999999999999999999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.23 Aligned_cols=261 Identities=20% Similarity=0.292 Sum_probs=204.0
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE--cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC------ceeeEEeEEeeCC
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML--ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR------NVVKLLGSCLEVE 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~l~~~~~~~~ 451 (678)
..++|++.+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 356899999999999999999986 36889999998753 34457788999999998765 4999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC------------
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE------------ 519 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~------------ 519 (678)
..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 889999997643 236899999999999999999999999 999999999999987
Q ss_pred -------CCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 041043 520 -------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592 (678)
Q Consensus 520 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~ 592 (678)
++.+||+|||++...... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999764322 233468999999999999899999999999999999999999996332211
Q ss_pred CCChHHHHHHHHhhcc--------chhh---------------------cch-hhhcCCCHHHHHHHHHHHHHhcccCCC
Q 041043 593 GRNLATYFVECVEENC--------LFDI---------------------LDD-QVRKSGKTEEIMEVSDVAKRCLNSNGR 642 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~--------~~~~---------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~ 642 (678)
............. .... ... ...........+++.+|+.+||+.||+
T Consensus 242 ---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 242 ---HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp ---HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred ---HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 1111111110000 0000 000 000112345678899999999999999
Q ss_pred CCCCHHHHHHH
Q 041043 643 SRPTMKEVAME 653 (678)
Q Consensus 643 ~RPt~~evl~~ 653 (678)
+|||++|+++.
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=325.77 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=202.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----Cc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEV-----EV 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 452 (678)
..++|.+.+.||+|+||.||+|... +|+.||||++... ......++.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999975 6899999998643 344566788999999999999999999988754 56
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++|+||++ ++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 799999997 699999874 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcce---------eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 041043 533 SIAIDQTH---------VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVE 602 (678)
Q Consensus 533 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 602 (678)
........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~ 234 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD------YRHQLLL 234 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHH
Confidence 76432211 1123468999999998764 678999999999999999999999996321 1111111
Q ss_pred HHh---hcc----ch--------hhcchhhh-cCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 603 CVE---ENC----LF--------DILDDQVR-KSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 603 ~~~---~~~----~~--------~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
... ... .. +....... ... ....+.++.+|+.+||+.||++|||++|+++. ++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 110 000 00 00000000 000 11334678999999999999999999999874 44443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=314.81 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=203.3
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
...++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999975 6899999987542 33456789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC---CcEEEeeccCcc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTSR 532 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgl~~ 532 (678)
|+||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999998643 35899999999999999999999999 9999999999999754 479999999997
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||... ........... +.....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~-~~~~~~ 242 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK------NEYDILKRVET-GKYAFD 242 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHH-CCCCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHc-CCCCCC
Confidence 6543222 223458899999999876 4899999999999999999999998532 22222222211 111000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. + .....+.++.+++.+||+.||++|||+.|+++.
T Consensus 243 ~-~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 L-P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp S-G-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c-h-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 0 012234578999999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.72 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=197.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc----
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV---- 452 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 452 (678)
..++|.+.+.||+|+||.||+|... +|+.||||++.. .+....+.+.+|+.++++++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3568999999999999999999975 689999999754 234456788999999999999999999999987654
Q ss_pred --ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 453 --PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 453 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
.++||||++ ++|.+++.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 689888742 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc-
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC- 608 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 608 (678)
+...... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||... +....+........
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK------DYLDQLTQILKVTGV 242 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS------CHHHHHHHHHHHHCB
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHHHhCC
Confidence 9764322 233468999999999877 67899999999999999999999999532 11122221111000
Q ss_pred -----chh--------hcc---hhhh---cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 -----LFD--------ILD---DQVR---KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 -----~~~--------~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
... .+. .... .......+..+.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000 0000 01122446789999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.79 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=202.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-----------CCceeeEEeEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-----------HRNVVKLLGSCL 448 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~ 448 (678)
.++|.+.+.||+|+||+||+|.. .+++.||||.+.. +....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 45799999999999999999996 4689999999864 3445577889999999886 899999999998
Q ss_pred eCC----cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEEC-----
Q 041043 449 EVE----VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLD----- 518 (678)
Q Consensus 449 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~----- 518 (678)
..+ ..++|||++ +++|.+++.... ...+++..++.++.||+.||+|||+. + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 679999999 899999997643 23589999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChH
Q 041043 519 -EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLA 597 (678)
Q Consensus 519 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~ 597 (678)
..+.+||+|||++...... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999765432 23346899999999999999999999999999999999999999643322111111
Q ss_pred HHHHHHHhh-ccchh-----------h-----------------cch--hhhcCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 041043 598 TYFVECVEE-NCLFD-----------I-----------------LDD--QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT 646 (678)
Q Consensus 598 ~~~~~~~~~-~~~~~-----------~-----------------~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 646 (678)
......... +.... . +.. ......+...+.++.+||.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110 00000 0 000 0012345677889999999999999999999
Q ss_pred HHHHHHH
Q 041043 647 MKEVAME 653 (678)
Q Consensus 647 ~~evl~~ 653 (678)
++|+++.
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=324.95 Aligned_cols=201 Identities=26% Similarity=0.373 Sum_probs=171.7
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CC-----ceeeEEeEEee
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HR-----NVVKLLGSCLE 449 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~~ 449 (678)
.+...++|++.+.||+|+||+||+|... +++.||||+++.. ....+++..|+++++.++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3455689999999999999999999965 5789999998743 344567888999988885 44 49999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeecCCCCceEEC--CCCcEEE
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS--SAYLPIYHRDIKSTNILLD--EKYRAKI 525 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~--~~~~~ivH~Dlk~~NILl~--~~~~~kl 525 (678)
.+..++||||++ |+|.+++.... ...+++..++.++.|++.||.|||. .+ |+||||||+||||+ .++.+||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 999999999996 59999997643 2358999999999999999999995 45 99999999999995 5788999
Q ss_pred eeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 041043 526 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISY 587 (678)
Q Consensus 526 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~ 587 (678)
+|||+++..... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999865432 2345689999999999999999999999999999999999999963
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.86 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=182.1
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHH-HHhcCCCCceeeEEeEEeeCCcce
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVV-ILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
+...++|.+.+.||+|+||.||+|... +++.||||++... ......++..|+. +++.++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 344578999999999999999999975 6899999988654 3344456666666 778889999999999999999999
Q ss_pred EEEEeccCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 455 LVYEFIPNGTLFQYLHDP--SEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
+||||+++ +|.+++... .....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999975 888777521 1134689999999999999999999998 8 999999999999999999999999999
Q ss_pred ccccCCcceeeeccccccCccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYF----HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
........ .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||...... ...
T Consensus 174 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~-------- 238 (327)
T 3aln_A 174 GQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQ-------- 238 (327)
T ss_dssp CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------
T ss_pred eecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHH--------
Confidence 76543222 2233689999999998 4566899999999999999999999999632110 000
Q ss_pred cchhhcch---hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 608 CLFDILDD---QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 608 ~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
+..+... .+........+..+.+|+.+||+.||++|||++|+++.
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 239 -LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0111111 11111112345689999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.27 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=191.7
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCCh------hhHHHHHHHHHHHhcC----CCCceeeE
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE------SKLEEFINEVVILSQI----SHRNVVKL 443 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l----~h~niv~l 443 (678)
.+.+...++|++.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.+++++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34556678899999999999999999986 4688999999865432 1233466799999988 89999999
Q ss_pred EeEEeeCCcceEEEEe-ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCC
Q 041043 444 LGSCLEVEVPLLVYEF-IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKY 521 (678)
Q Consensus 444 ~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~ 521 (678)
++++...+..++|+|+ +.+++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ .++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 9999999999999999 7899999999753 35899999999999999999999999 99999999999999 889
Q ss_pred cEEEeeccCcccccCCcceeeeccccccCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 041043 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFT-DKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~ 600 (678)
.+||+|||++....... .....++..|+|||.+.+..+. .++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence 99999999998665332 2344589999999998876664 58999999999999999999985210
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.... . ....+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 244 -~~~~---------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 -EILE---------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HHHH---------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHhh---------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 011123345678999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.97 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=175.2
Q ss_pred hccCCCcC-CeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----CCcc
Q 041043 380 ATDHFNVN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLE----VEVP 453 (678)
Q Consensus 380 ~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 453 (678)
..++|.+. ++||+|+||+||+|... +++.||||++... . ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45678885 46999999999999976 6899999998642 1 122223344667799999999999876 4457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEeeccC
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 530 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl 530 (678)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999998653 246999999999999999999999999 999999999999986 45599999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
+...... ......+|+.|+|||.+....++.++||||||+++|+|++|+.||........ ...........
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~--- 248 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLG--- 248 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcc---
Confidence 9765422 22334679999999999888899999999999999999999999953221110 00000000000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
............+.++.+|+.+||+.||++|||++|+++.
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111112345679999999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=333.65 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=188.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345557889999999998777778999999987642 345678999999876 8999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC-------------CcE
Q 041043 461 PNGTLFQYLHDPSEEL----SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-------------YRA 523 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-------------~~~ 523 (678)
+ |+|.+++....... ..++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999998643211 1133456789999999999999999 9999999999999654 489
Q ss_pred EEeeccCcccccCCcce---eeeccccccCccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcccccc
Q 041043 524 KIADFGTSRSIAIDQTH---VSTKVQGTFGYLDPEYFHS-------SQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~ 592 (678)
||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-- 245 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-- 245 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--
Confidence 99999999876543322 1234569999999999865 568999999999999999999 9999852211
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.. .......... ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 246 ---~~---~~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 ---RE---SNIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HH---HHHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hH---HHHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 1111110000 01111224567788999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=317.02 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=200.8
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CC-cEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc------eeeEEeEEeeCC
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DG-RIIAVKKSKVVDESKLEEFINEVVILSQISHRN------VVKLLGSCLEVE 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~ 451 (678)
..++|++.+.||+|+||+||++... ++ +.||+|.++.. ....+.+.+|++++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999974 34 68999998643 345577889999999997665 899999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEE--------------
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL-------------- 517 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl-------------- 517 (678)
..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 667777776532 235899999999999999999999998 9999999999999
Q ss_pred -----CCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccccc
Q 041043 518 -----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592 (678)
Q Consensus 518 -----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~ 592 (678)
+.++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999764322 234568999999999999999999999999999999999999996322111
Q ss_pred CCChHHHHHHHHhhc--------cchhhc-----------------c-----hhhhcCCCHHHHHHHHHHHHHhcccCCC
Q 041043 593 GRNLATYFVECVEEN--------CLFDIL-----------------D-----DQVRKSGKTEEIMEVSDVAKRCLNSNGR 642 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~--------~~~~~~-----------------~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~ 642 (678)
............ ...... . .............++.+|+.+||+.||+
T Consensus 247 ---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 247 ---HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp ---HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred ---HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 111111111000 000000 0 0000112344567899999999999999
Q ss_pred CCCCHHHHHHH
Q 041043 643 SRPTMKEVAME 653 (678)
Q Consensus 643 ~RPt~~evl~~ 653 (678)
+|||++|+++.
T Consensus 324 ~Rpt~~e~l~h 334 (355)
T 2eu9_A 324 QRITLAEALLH 334 (355)
T ss_dssp TSCCHHHHTTS
T ss_pred hCcCHHHHhcC
Confidence 99999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.86 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=199.7
Q ss_pred ChHHHHhhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCCh------hhHHHHHHHHHHHhcCC--CCceeeE
Q 041043 373 NSKELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE------SKLEEFINEVVILSQIS--HRNVVKL 443 (678)
Q Consensus 373 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--h~niv~l 443 (678)
...+.+...++|++.+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|++++++++ |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3445566678899999999999999999996 4689999998754321 12245778999999996 5999999
Q ss_pred EeEEeeCCcceEEEEeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCC
Q 041043 444 LGSCLEVEVPLLVYEFIPN-GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKY 521 (678)
Q Consensus 444 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~ 521 (678)
++++...+..++|+|++.+ ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 9999999999999999976 8999999753 35899999999999999999999999 99999999999999 789
Q ss_pred cEEEeeccCcccccCCcceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 041043 522 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 522 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~ 600 (678)
.+||+|||++....... .....+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------- 253 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 253 (320)
T ss_dssp EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------
Confidence 99999999998664322 233458999999999887665 678999999999999999999985211
Q ss_pred HHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 601 VECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...... ...+...++++.+|+.+||+.||++|||++|+++.
T Consensus 254 -~~~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 -EIIRGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHHHCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhhccc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000100 01122334578999999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=344.11 Aligned_cols=271 Identities=25% Similarity=0.377 Sum_probs=208.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee------CCc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLE------VEV 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~ 452 (678)
.++|.+.+.||+|+||.||+|... +|+.||||+++. ......+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999964 689999998765 345566789999999999999999999998765 667
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCc---EEEeecc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFG 529 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfg 529 (678)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999987655556899999999999999999999999 999999999999997665 9999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh----
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---- 605 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 605 (678)
++....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...|......
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence 998664332 23345689999999999999999999999999999999999999953211 0100000000
Q ss_pred hccchhhcch--------hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHHHHhcc
Q 041043 606 ENCLFDILDD--------QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE-----VAMELERIRACN 661 (678)
Q Consensus 606 ~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-----vl~~L~~l~~~~ 661 (678)
.......... ..........++.+.+|+.+||..||++|||++| +.+.++.+....
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000000 0011234457789999999999999999999998 567777777654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.66 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=185.6
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhh-HHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESK-LEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
....++|++.+.||+|+||.||+|... +++.||||++.... ... .+.+.++..+++.++||||+++++++.+.+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 344567899999999999999999975 68999999886533 222 334455556788889999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
+||||+ ++.+..+.... ...+++..++.++.|++.||+|||+. + |+|+||||+|||++.++.+||+|||++..
T Consensus 101 lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999 45555555422 23589999999999999999999995 8 99999999999999999999999999976
Q ss_pred ccCCcceeeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
..... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||... ...............
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 175 LVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-----KTDFEVLTKVLQEEP 247 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHHHHHSCC
T ss_pred ccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC-----CccHHHHHHHhccCC
Confidence 54322 223346899999999984 456888999999999999999999998521 122222222222111
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
. ........+.++.+|+.+||+.||.+|||++|+++. +++...
T Consensus 248 ~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 248 P--------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp C--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred C--------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 0 000112244678999999999999999999999874 444443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=326.30 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=188.2
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 458 (678)
...+|...++||+|+||+||.....+++.||||++..... +.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3456888999999999997665566799999998864322 2356899999999 79999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-----CCcEEEeeccCccc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-----KYRAKIADFGTSRS 533 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgl~~~ 533 (678)
|++ |+|.+++..... .+.+..++.++.||+.||+|||+.+ |+||||||+||||+. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 699999986432 3455567789999999999999999 999999999999953 34688999999987
Q ss_pred ccCCcc--eeeeccccccCccCccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhc
Q 041043 534 IAIDQT--HVSTKVQGTFGYLDPEYFH---SSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 534 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
...... .......||+.|+|||++. ...++.++||||||+++|||++ |..||.... ...........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-------~~~~~~~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-------QRQANILLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-------THHHHHHTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-------HHHHHHHhccC
Confidence 654322 2234456999999999997 4567889999999999999999 888984211 11111111111
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
... ...........+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 01112345567889999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=342.31 Aligned_cols=240 Identities=21% Similarity=0.327 Sum_probs=195.3
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc--CCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc-----
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA--DGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV----- 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 452 (678)
.++|++.+.||+|+||.||++.+. +++.||||++.. .+....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 589999998764 344556788999999999999999999999987765
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||+++++|.+++.. .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999988753 5899999999999999999999999 9999999999999986 99999999998
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
..... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||....... +
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~ 284 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------L 284 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------C
T ss_pred hcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-------------------c
Confidence 65432 345689999999998765 4889999999999999999998875321110 0
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-TMKEVAMELERIR 658 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~l~ 658 (678)
.. ........+.+.+|+.+||+.||++|| +++++.+.|..+.
T Consensus 285 ~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 000112345789999999999999999 5666777776654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.53 Aligned_cols=234 Identities=16% Similarity=0.143 Sum_probs=185.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
.++|++.+.||+|+||.||+|... +++.||||.+... +....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999975 4899999998653 244567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++++|.++++.. ....++..++.|++.||+|||+.+ |+||||||+|||+++++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999532 356678899999999999999999 9999999999999999999998543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
|++ .++.++||||||+++|||++|+.||......+..... ..........
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~- 224 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQPIE- 224 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCBCC-
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCCCC-
Confidence 333 2688999999999999999999999643221100000 0000000000
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
........++++.+|+.+||+.||++| |+.|+++.|+++....
T Consensus 225 -~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 -PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000012344579999999999999999 9999999999988654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.19 Aligned_cols=228 Identities=24% Similarity=0.324 Sum_probs=179.3
Q ss_pred ccCCCcC-CeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHH-hcCCCCceeeEEeEEee----CCcc
Q 041043 381 TDHFNVN-RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVIL-SQISHRNVVKLLGSCLE----VEVP 453 (678)
Q Consensus 381 ~~~~~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~~ 453 (678)
.++|.+. +.||+|+||.||++.. .+++.||+|.++.. ..+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3556666 7899999999999997 46899999998642 4567888888 66689999999999887 6678
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEeeccC
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 530 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl 530 (678)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999998643 246999999999999999999999999 999999999999998 78999999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
+.... +..++.++||||||+++|||++|+.||........ ......
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 86432 23467899999999999999999999953221110 000000
Q ss_pred hhcchhhhcCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 611 DILDDQVRKSGK----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 611 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+.... ...+ ...+.++.+|+.+||+.||++|||++|+++.
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0011 1235689999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.15 Aligned_cols=245 Identities=18% Similarity=0.190 Sum_probs=181.9
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCCh---hhHHHHHHHHHHHhcCCC-Cce---------eeEE
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE---SKLEEFINEVVILSQISH-RNV---------VKLL 444 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h-~ni---------v~l~ 444 (678)
.....|...++||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++| +|. +...
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3445678889999999999999995 4689999998874332 235789999999999987 221 1111
Q ss_pred eE------------Eee-----CCcceEEEEeccCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 041043 445 GS------------CLE-----VEVPLLVYEFIPNGTLFQYLHD----PSEELSLTWEMRLRIATEVAEALAYLHSSAYL 503 (678)
Q Consensus 445 ~~------------~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 503 (678)
.. ... ....+++|+++ +++|.+++.. ......+++..++.++.|++.||+|||+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 11 111 12345666655 6899999841 112346888999999999999999999999
Q ss_pred CeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeeccccccCccCcccc----------ccCCCCcccchhhHHH
Q 041043 504 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF----------HSSQFTDKSDVYSFGV 573 (678)
Q Consensus 504 ~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwslGv 573 (678)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||+
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998764322 334457 999999999 5556888999999999
Q ss_pred HHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 574 VLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 574 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
++|||++|+.||......+. ...++.. ....++.+.+|+.+||+.||++|||+.|+++.
T Consensus 306 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999963221111 1111110 11234679999999999999999998887543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=308.34 Aligned_cols=242 Identities=17% Similarity=0.200 Sum_probs=184.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCC---------CCceeeE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--------ESKLEEFINEVVILSQIS---------HRNVVKL 443 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------h~niv~l 443 (678)
.++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999998 68999999876532 334578889999998886 7777777
Q ss_pred EeEEe-----------------e-------------CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 041043 444 LGSCL-----------------E-------------VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493 (678)
Q Consensus 444 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 493 (678)
.+++. + .+..++||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 76543 2 6788999999999987777743 358999999999999999
Q ss_pred HHHHH-hCCCCCeEeecCCCCceEECCCC--------------------cEEEeeccCcccccCCcceeeeccccccCcc
Q 041043 494 LAYLH-SSAYLPIYHRDIKSTNILLDEKY--------------------RAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552 (678)
Q Consensus 494 L~yLH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~ 552 (678)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 888 99999999999999887 8999999999865432 236899999
Q ss_pred CccccccCCCCcccchhhHHHH-HHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHH
Q 041043 553 DPEYFHSSQFTDKSDVYSFGVV-LVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSD 631 (678)
Q Consensus 553 aPE~~~~~~~s~ksDVwslGvl-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 631 (678)
|||++.+.. +.++|||||+.+ .+++++|..||... ................. ...........++++.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccC----cccchhhhhhcCHHHHH
Confidence 999998766 889999998776 77889999997310 00000000111000000 00000112457789999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 041043 632 VAKRCLNSNGRSRPTMKEVA 651 (678)
Q Consensus 632 li~~cl~~dP~~RPt~~evl 651 (678)
|+.+||+.| |++|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-28 Score=272.86 Aligned_cols=184 Identities=20% Similarity=0.157 Sum_probs=129.4
Q ss_pred eeeeCCcEEEEEE-EcCCcEEEEEEcccC----------ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEEE
Q 041043 390 LGQGGQGTVYKGM-LADGRIIAVKKSKVV----------DESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 390 Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 457 (678)
.+.|++|.+..+. .-.|+.+++|.+... .+...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4445555554433 234788999987532 123456799999999999 6999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||++|++|.++|.+. ..++.. +|+.||+.||+|||+++ |+||||||+||||++++++||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999864 346654 48899999999999999 999999999999999999999999999876543
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p 584 (678)
.. ......||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 2344569999999999875 467789999999999888776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=248.60 Aligned_cols=184 Identities=15% Similarity=0.219 Sum_probs=145.7
Q ss_pred CcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCC--------hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 385 NVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--------ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
...++||+|+||+||++.. .++.+++|+..... ....+++.+|++++++++||||+++..+....+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999954 47788888743211 11245689999999999999999777777788888999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++++|.++++. ++.++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999974 5589999999999999999 999999999999999 999999999987654
Q ss_pred Cccee------eeccccccCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 041043 537 DQTHV------STKVQGTFGYLDPEYFHS--SQFTDKSDVYSFGVVLVELLTGQKPI 585 (678)
Q Consensus 537 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwslGvll~elltg~~p~ 585 (678)
..... .....||+.|+|||++.. ..|+.++|+|+..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32221 234579999999999987 56888999999999888888877765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=206.29 Aligned_cols=151 Identities=19% Similarity=0.167 Sum_probs=122.2
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCCh------------------hhHHHHHHHHHHHhcCCCC
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE------------------SKLEEFINEVVILSQISHR 438 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~ 438 (678)
+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444566777899999999999999997799999998864221 23567899999999999
Q ss_pred ceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC
Q 041043 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 518 (678)
Q Consensus 439 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~ 518 (678)
| +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 66666543 366799999999999998 531 124479999999999999999 99999999999999
Q ss_pred CCCcEEEeeccCcccccCCcceeeeccccccCccCcccccc
Q 041043 519 EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559 (678)
Q Consensus 519 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 559 (678)
++.+||+|||+++ .+..++|||++..
T Consensus 228 -~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 9999999999986 3445789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=172.36 Aligned_cols=137 Identities=20% Similarity=0.215 Sum_probs=107.2
Q ss_pred CCCcCCeeeeeCCcEEEEEEE-cCCcE--EEEEEcccCCh------------------------hhHHHHHHHHHHHhcC
Q 041043 383 HFNVNRILGQGGQGTVYKGML-ADGRI--IAVKKSKVVDE------------------------SKLEEFINEVVILSQI 435 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~Ei~~l~~l 435 (678)
-|.+.+.||+|+||.||+|.. .+|+. ||||..+.... .....+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999997 68888 99998643211 1123678899999999
Q ss_pred CCCce--eeEEeEEeeCCcceEEEEeccC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEe
Q 041043 436 SHRNV--VKLLGSCLEVEVPLLVYEFIPN-G----TLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH-SSAYLPIYH 507 (678)
Q Consensus 436 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH 507 (678)
+|+++ ..+++. +..++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 334432 467899999942 4 66666532 234567889999999999999 888 999
Q ss_pred ecCCCCceEECCCCcEEEeeccCcccc
Q 041043 508 RDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 508 ~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
|||||+|||+++ .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8.5e-16 Score=161.15 Aligned_cols=138 Identities=14% Similarity=0.160 Sum_probs=99.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCC--------------hhhHHHH--------HHHHHHHhcCCCCc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--------------ESKLEEF--------INEVVILSQISHRN 439 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~--------~~Ei~~l~~l~h~n 439 (678)
.-|++.+.||+|++|.||+|...+|+.||||..+... ....... .+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3488999999999999999999899999999754210 0011111 34566666665444
Q ss_pred eeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC
Q 041043 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE 519 (678)
Q Consensus 440 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 519 (678)
+.-..-+. ....+|||||+++++|..+... .....++.|++.+|.+||+.+ ||||||||.||||++
T Consensus 175 v~vp~p~~--~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIA--QSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEE--EETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeee--ccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 32211111 1234799999999888765431 123567899999999999999 999999999999987
Q ss_pred CC----------cEEEeeccCccc
Q 041043 520 KY----------RAKIADFGTSRS 533 (678)
Q Consensus 520 ~~----------~~kl~Dfgl~~~ 533 (678)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.4e-11 Score=122.35 Aligned_cols=146 Identities=16% Similarity=0.096 Sum_probs=113.2
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 456 (678)
......|.+...++.|+.+.||+.... +..+++|............+.+|+++++.+. +..+.+++++..+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344456888888888889999999754 6889999876422222346888999999885 67788899999888899999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA----------------------------------- 501 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 501 (678)
|||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999876421 1223468899999999999821
Q ss_pred ---------------------CCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 502 ---------------------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 502 ---------------------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=3.3e-10 Score=113.51 Aligned_cols=137 Identities=18% Similarity=0.186 Sum_probs=100.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc--eeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN--VVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 459 (678)
..+.+..+.+.|..+.||+....+|+.+++|..... ....+.+|+++++.+++.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333455569999998777888999986543 2245778999999886544 45688888777788999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA-------------------------------------- 501 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 501 (678)
+++.+|. ... .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 221 11 2357788888888888753
Q ss_pred -----------------CCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 502 -----------------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 502 -----------------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=3.7e-09 Score=111.51 Aligned_cols=141 Identities=14% Similarity=0.218 Sum_probs=105.6
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcc--cCC-hhhHHHHHHHHHHHhcCC--CCceeeEEeEEeeC---CcceEEEE
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSK--VVD-ESKLEEFINEVVILSQIS--HRNVVKLLGSCLEV---EVPLLVYE 458 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 458 (678)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999988754 577888765 322 122356788999999987 45678888888766 44899999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA------------------------------------- 501 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 501 (678)
|+++..+.+... ..++..++..++.++++.|+.||...
T Consensus 122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999987754221 23678888999999999999999831
Q ss_pred ------------------CCCeEeecCCCCceEECCCCc--EEEeeccCccc
Q 041043 502 ------------------YLPIYHRDIKSTNILLDEKYR--AKIADFGTSRS 533 (678)
Q Consensus 502 ------------------~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgl~~~ 533 (678)
...++|+|+++.|||+++++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134899999999999997753 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=3.2e-09 Score=109.16 Aligned_cols=185 Identities=22% Similarity=0.256 Sum_probs=121.8
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCc--eeeEEeEEeeCC---cceEEEEec
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRN--VVKLLGSCLEVE---VPLLVYEFI 460 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 460 (678)
.+.++.|....||+.. ..+++|.... ......+.+|+++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 4578887543 234567889999998884 332 334444433333 358999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA--------------------------------------- 501 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------- 501 (678)
++.+|.+... ..++..++..++.+++..|+.||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988875432 13677888889999999999999621
Q ss_pred ----------------CCCeEeecCCCCceEECC--CCcEEEeeccCcccccCCcceeeec--------------ccccc
Q 041043 502 ----------------YLPIYHRDIKSTNILLDE--KYRAKIADFGTSRSIAIDQTHVSTK--------------VQGTF 549 (678)
Q Consensus 502 ----------------~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgl~~~~~~~~~~~~~~--------------~~gt~ 549 (678)
.+.++|+|+++.||++++ +..+.|+||+.+..... ....... .....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHc
Confidence 134799999999999998 55688999998754211 1000000 00000
Q ss_pred CccC-ccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 041043 550 GYLD-PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585 (678)
Q Consensus 550 ~y~a-PE~~~~~~~s~ksDVwslGvll~elltg~~p~ 585 (678)
+... |+.... .....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 222111 112358999999999999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=7.6e-06 Score=83.88 Aligned_cols=135 Identities=18% Similarity=0.167 Sum_probs=96.4
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC---ceeeEEeEEe-eCCcceEEEEeccC
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR---NVVKLLGSCL-EVEVPLLVYEFIPN 462 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 462 (678)
.+.++.|....||+. +..+++|+.. .......+.+|+++|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 5667788743 234456789999999999753 3556666664 34567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA----------------------------------------- 501 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------- 501 (678)
..|.+.... .++..+...++.++++.|+.||+..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888764321 2455666667777777777776532
Q ss_pred ----------------CCCeEeecCCCCceEECC---CCc-EEEeeccCcc
Q 041043 502 ----------------YLPIYHRDIKSTNILLDE---KYR-AKIADFGTSR 532 (678)
Q Consensus 502 ----------------~~~ivH~Dlk~~NILl~~---~~~-~kl~Dfgl~~ 532 (678)
.+.++|+|+++.|||+++ ++. +.|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 123699999999999997 455 5899999774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=5.9e-06 Score=82.89 Aligned_cols=134 Identities=22% Similarity=0.207 Sum_probs=97.5
Q ss_pred eeeeeCCc-EEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 389 ILGQGGQG-TVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 389 ~Lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
.+..|..+ .||+.... ++..+++|+... .....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 68987754 456788887653 23456788999998885 34467788888888999999999999888
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-------------------------------------------
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY------------------------------------------- 502 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~------------------------------------------- 502 (678)
.+..... ......+..+++..|+.||....
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7765321 12234566677777777775321
Q ss_pred ------------CCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 503 ------------LPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 503 ------------~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127999999999999988777899999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=8.9e-06 Score=85.24 Aligned_cols=80 Identities=4% Similarity=-0.022 Sum_probs=54.3
Q ss_pred Cee-eeeCCcEEEEEEEc-------CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCC---CceeeEEeEEeeC---
Q 041043 388 RIL-GQGGQGTVYKGMLA-------DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISH---RNVVKLLGSCLEV--- 450 (678)
Q Consensus 388 ~~L-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~--- 450 (678)
+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+.. ..+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 77888899988754 26678888764322 0012456778888888742 3566777776654
Q ss_pred CcceEEEEeccCCChhh
Q 041043 451 EVPLLVYEFIPNGTLFQ 467 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~ 467 (678)
+..++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=9.6e-05 Score=74.81 Aligned_cols=80 Identities=19% Similarity=0.138 Sum_probs=57.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC---ceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR---NVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~~~~~lv~e 458 (678)
..+.-.+.+|.|..+.||+.+..||+.+++|+...........|..|++.|+.|... -+.+++++ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 344556789999999999999999999999987654443345678899998888422 23444443 34589999
Q ss_pred eccCCCh
Q 041043 459 FIPNGTL 465 (678)
Q Consensus 459 ~~~~g~L 465 (678)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9887643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=75.52 Aligned_cols=140 Identities=15% Similarity=0.171 Sum_probs=78.1
Q ss_pred CeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-----CCceeeEE-e--EEeeCCcceEEEEe
Q 041043 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-----HRNVVKLL-G--SCLEVEVPLLVYEF 459 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 459 (678)
+.|+.|..+.||+....+| .+++|+... .. .++..|+.+++.+. .|.++... | +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455577889999987655 488888764 22 23334555555443 24433311 1 12345667899999
Q ss_pred ccCCChh--------------hhhcCCCC----C-------CCCCHHHH-------------------------------
Q 041043 460 IPNGTLF--------------QYLHDPSE----E-------LSLTWEMR------------------------------- 483 (678)
Q Consensus 460 ~~~g~L~--------------~~l~~~~~----~-------~~l~~~~~------------------------------- 483 (678)
+++..+. ..+|.... . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221100 0 01123211
Q ss_pred HHHHHHHHHHHHHHHh--------C--CCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 484 LRIATEVAEALAYLHS--------S--AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 484 ~~i~~~ia~~L~yLH~--------~--~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
..+..++..++++|+. . ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224446667763 0 12349999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=77.66 Aligned_cols=75 Identities=16% Similarity=0.181 Sum_probs=49.0
Q ss_pred CCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCCh-------hhHHHHHHHHHHHhcCCC--Cc-eeeEEeEEeeCCcceE
Q 041043 387 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-------SKLEEFINEVVILSQISH--RN-VVKLLGSCLEVEVPLL 455 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--~n-iv~l~~~~~~~~~~~l 455 (678)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 467899997542211 123456788888887742 33 3345543 4556789
Q ss_pred EEEeccCC
Q 041043 456 VYEFIPNG 463 (678)
Q Consensus 456 v~e~~~~g 463 (678)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0014 Score=66.99 Aligned_cols=138 Identities=16% Similarity=0.133 Sum_probs=91.1
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC---CCceeeEEeEEeeCCcceEEEEeccCC
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS---HRNVVKLLGSCLEVEVPLLVYEFIPNG 463 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 463 (678)
.+.|+.|....+|+... ++..+++|..... ....+..|.+.|+.|. ...+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45789999999999886 4677888876532 3567888999988884 356788888888778899999999987
Q ss_pred Chhh-----------hhcCCCC--C-----------------CCCCHHHHH---HHH----------------HHHHHHH
Q 041043 464 TLFQ-----------YLHDPSE--E-----------------LSLTWEMRL---RIA----------------TEVAEAL 494 (678)
Q Consensus 464 ~L~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~----------------~~ia~~L 494 (678)
.+.. .||.... . -.-+|.... ++. ..++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 2332211 0 012454321 111 1122222
Q ss_pred -HHHHh-CCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 495 -AYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 495 -~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23432 2235699999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0022 Score=68.54 Aligned_cols=78 Identities=8% Similarity=0.077 Sum_probs=46.2
Q ss_pred CCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceeeecc-ccccCccCccccccC---CCCcccchhhHHHHHHHH
Q 041043 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFGYLDPEYFHSS---QFTDKSDVYSFGVVLVEL 578 (678)
Q Consensus 503 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~ksDVwslGvll~el 578 (678)
..++|+|+++.|||+++++ ++|+||+.+..-... ....... .-...|++|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3499999999999999876 999999987642211 0000000 011345666554321 112234556777788877
Q ss_pred HhCC
Q 041043 579 LTGQ 582 (678)
Q Consensus 579 ltg~ 582 (678)
+++.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0022 Score=60.76 Aligned_cols=103 Identities=14% Similarity=0.036 Sum_probs=67.1
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcceee
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 542 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~~ 542 (678)
-+|.+.|+.. +.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 4788888754 3579999999999999999887732110 11333457899999999998764 1110
Q ss_pred eccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 041043 543 TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP 584 (678)
Q Consensus 543 ~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p 584 (678)
.....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223466888763 3456788999999999998874443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0027 Score=64.47 Aligned_cols=71 Identities=15% Similarity=0.131 Sum_probs=43.1
Q ss_pred CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCce-eeEEeEEeeCCcceEEEEec-cCCC
Q 041043 387 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV-VKLLGSCLEVEVPLLVYEFI-PNGT 464 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~ 464 (678)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578888999999998 45778876542111 1122457777777643233 345443 344468999999 5544
Q ss_pred h
Q 041043 465 L 465 (678)
Q Consensus 465 L 465 (678)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0026 Score=68.06 Aligned_cols=73 Identities=19% Similarity=0.244 Sum_probs=48.6
Q ss_pred CCeeeeeCCcEEEEEEEcC--------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCce-eeEEeEEeeCCcceEEE
Q 041043 387 NRILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV-VKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 457 (678)
.+.|+.|....+|+....+ +..+++|+..... ..+.+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567778889999998753 4788899874321 12455679988888853334 456665432 3899
Q ss_pred EeccCCCh
Q 041043 458 EFIPNGTL 465 (678)
Q Consensus 458 e~~~~g~L 465 (678)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99976443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0081 Score=61.77 Aligned_cols=31 Identities=26% Similarity=0.450 Sum_probs=26.5
Q ss_pred CCeEeecCCCCceEECCC----CcEEEeeccCccc
Q 041043 503 LPIYHRDIKSTNILLDEK----YRAKIADFGTSRS 533 (678)
Q Consensus 503 ~~ivH~Dlk~~NILl~~~----~~~kl~Dfgl~~~ 533 (678)
..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999875 6899999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.023 Score=58.12 Aligned_cols=157 Identities=15% Similarity=0.120 Sum_probs=85.6
Q ss_pred cChHHHHhhccCCCc-----CCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCC--ceeeEE
Q 041043 372 FNSKELDKATDHFNV-----NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHR--NVVKLL 444 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~ 444 (678)
.+.+++...-+.|.+ ...|+ |....||+....+|+.+++|...... ...+.+..|..+++.+... .+.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 444555444344432 23466 78889999887777789999875321 1234566788877777422 234444
Q ss_pred eE-----EeeCCcceEEEEeccCCChhh-----h---------hcC----CC--CCCCCCHHHH----------------
Q 041043 445 GS-----CLEVEVPLLVYEFIPNGTLFQ-----Y---------LHD----PS--EELSLTWEMR---------------- 483 (678)
Q Consensus 445 ~~-----~~~~~~~~lv~e~~~~g~L~~-----~---------l~~----~~--~~~~l~~~~~---------------- 483 (678)
.. ....+..+++++++++..+.. + +|. .. .....++...
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 122445578999998754321 0 111 00 0111222111
Q ss_pred ------HHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 484 ------LRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 484 ------~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
...+..++..+.-+-.. ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 11111222222222111 123378999999999999 4 89999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.04 Score=56.07 Aligned_cols=158 Identities=12% Similarity=0.155 Sum_probs=85.3
Q ss_pred cChHHHHhhccCCCcC-----CeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc--eeeEE
Q 041043 372 FNSKELDKATDHFNVN-----RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN--VVKLL 444 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~-----~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~ 444 (678)
++.+++.....+|.+. +.|+.|....+|+....+| .+++|..... ...+++..|+.+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 4455565555556552 3466677889999987666 5778876542 11234556777776664222 23333
Q ss_pred eE------EeeCCcceEEEEeccCCChhh--------------hhcCC----CCC--CCC---CHHHHHH----------
Q 041043 445 GS------CLEVEVPLLVYEFIPNGTLFQ--------------YLHDP----SEE--LSL---TWEMRLR---------- 485 (678)
Q Consensus 445 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~--~~l---~~~~~~~---------- 485 (678)
.. ....+..+++++|+++..+.. .+|.. ... ... .|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122355689999998765321 11211 000 001 1222110
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 486 --IATEVAEALAYLHSS----AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 486 --i~~~ia~~L~yLH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
+...+...++.++.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 12348999999999999987666899998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0093 Score=62.49 Aligned_cols=140 Identities=19% Similarity=0.255 Sum_probs=81.3
Q ss_pred CeeeeeCCcEEEEEEEc--------CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeEEeeCCcceEEEE
Q 041043 388 RILGQGGQGTVYKGMLA--------DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN-VVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 458 (678)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+...+ ..++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46767888889998864 2478899986432 223456678999998885322 2456655543 29999
Q ss_pred eccCCChhhh-----------------hcCCCC--CCCC--CHHHHHHHHHHHHH-------------------HHHH--
Q 041043 459 FIPNGTLFQY-----------------LHDPSE--ELSL--TWEMRLRIATEVAE-------------------ALAY-- 496 (678)
Q Consensus 459 ~~~~g~L~~~-----------------l~~~~~--~~~l--~~~~~~~i~~~ia~-------------------~L~y-- 496 (678)
|+++.+|..- ||.... .... -+.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987655321 122111 1112 23455555444321 2233
Q ss_pred --HHhCC-CCCeEeecCCCCceEECCC----CcEEEeeccCcc
Q 041043 497 --LHSSA-YLPIYHRDIKSTNILLDEK----YRAKIADFGTSR 532 (678)
Q Consensus 497 --LH~~~-~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgl~~ 532 (678)
|.... ...++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32222 2348999999999999876 789999999774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.014 Score=62.78 Aligned_cols=73 Identities=14% Similarity=0.031 Sum_probs=46.2
Q ss_pred CeeeeeCCcEEEEEEEcC-CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCce-eeEEeEEeeCCcceEEEEeccCCCh
Q 041043 388 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV-VKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
+.|+.|-...+|+....+ +..+++|+........ -...+|..+++.|...++ .++++.+. + .+|+||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 567778889999998765 4778888764322111 112478888888875555 45666552 2 359999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0081 Score=62.79 Aligned_cols=73 Identities=14% Similarity=0.128 Sum_probs=43.1
Q ss_pred CeeeeeCCcEEEEEEEcC---------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc-eeeEEeEEeeCCcceEEE
Q 041043 388 RILGQGGQGTVYKGMLAD---------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRN-VVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 457 (678)
+.|+.|....+|+....+ +..+++|+...... .......|.++++.+...+ ..++++.. .-++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 456778888999988654 26788887654221 1112356788887775333 33555443 247899
Q ss_pred EeccCCCh
Q 041043 458 EFIPNGTL 465 (678)
Q Consensus 458 e~~~~g~L 465 (678)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.26 E-value=0.097 Score=53.84 Aligned_cols=30 Identities=23% Similarity=0.389 Sum_probs=26.6
Q ss_pred CCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 503 LPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 503 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
..++|+|+.+.||++++++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 458999999999999988889999998764
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=93.61 E-value=0.018 Score=46.14 Aligned_cols=47 Identities=36% Similarity=0.885 Sum_probs=32.3
Q ss_pred CccccCCCCceEeecCCCCCCCccccCCcccC-------------cccCCCCCccccCCCC
Q 041043 259 SHCESDEGGLFRCSCKEKYHGNPYFLHGCQDL-------------RCENYEGGYRCVNPKR 306 (678)
Q Consensus 259 s~C~~~~~~~~~C~C~~gy~gnpy~~~gC~~~-------------~c~~~~~~~~c~~~~~ 306 (678)
+.|.+.. ++|+|.|+.||.++++....|+++ .|.|+.|+|.|.++..
T Consensus 16 g~C~n~~-g~y~C~C~~Gy~~~~~~g~~C~dideC~~~~~~C~~~~C~n~~g~y~C~C~~G 75 (86)
T 1lmj_A 16 GQCVNTP-GDFECKCDEGYESGFMMMKNCMDIDECQRDPLLCRGGVCHNTEGSYRCECPPG 75 (86)
T ss_dssp SCEEEET-TEEEECCCSSEEECTTTSSSEEECCHHHHCSSTTTTSEEEEETTEEEEESCTT
T ss_pred CEEECCC-CCEEeeCCCCcCccCCCCCccCCcccccCCCCcCCCCEeEcCCCCEEEECcCC
Confidence 4687654 578899999999776543344443 4556678888887753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.51 E-value=0.056 Score=57.35 Aligned_cols=74 Identities=12% Similarity=0.085 Sum_probs=46.9
Q ss_pred CCeeeeeCCcEEEEEEEcC--------CcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCce-eeEEeEEeeCCcceEEE
Q 041043 387 NRILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV-VKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 457 (678)
.+.|..|-...+|+....+ +..+++|+....... .-...+|..+++.+...++ .++++.+ .-++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3567778888999998753 578888886543211 1123467888877753233 4455432 237899
Q ss_pred EeccCCCh
Q 041043 458 EFIPNGTL 465 (678)
Q Consensus 458 e~~~~g~L 465 (678)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.10 E-value=0.004 Score=42.08 Aligned_cols=7 Identities=29% Similarity=0.463 Sum_probs=2.7
Q ss_pred EEeeecc
Q 041043 313 ILGIGTG 319 (678)
Q Consensus 313 ii~i~~~ 319 (678)
+++.++|
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 3333334
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.72 E-value=0.079 Score=42.44 Aligned_cols=45 Identities=40% Similarity=0.858 Sum_probs=32.0
Q ss_pred CCccccCCCCceEeecCCCCCCCccccCCcccC----------cccCCCCCccccCC
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNPYFLHGCQDL----------RCENYEGGYRCVNP 304 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnpy~~~gC~~~----------~c~~~~~~~~c~~~ 304 (678)
++.|.+.. ++|+|.|+.||.+++.- ..|+++ .|.|+.|+|.|.+|
T Consensus 15 ~~~C~n~~-g~y~C~C~~G~~~~~~g-~~C~dideC~~~~C~~~C~n~~g~y~C~C~ 69 (87)
T 1z6c_A 15 TAVCKNIP-GDFECECPEGYRYNLKS-KSCEDIDECSENMCAQLCVNYPGGYTCYCD 69 (87)
T ss_dssp TSSCCCBT-TBCCCSSSTTCEEETTT-TEEECCCHHHHSCCSSEECCCSSSCCEECC
T ss_pred CCEeECCC-CCEEEECCCCceECCCC-CcCCCcCeeCCCCCCCEEEccCCCEEEECC
Confidence 46786654 56889999999977642 124433 47778899999886
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.62 E-value=0.74 Score=48.33 Aligned_cols=28 Identities=39% Similarity=0.542 Sum_probs=24.2
Q ss_pred eEeecCCCCceEE------CCCCcEEEeeccCcc
Q 041043 505 IYHRDIKSTNILL------DEKYRAKIADFGTSR 532 (678)
Q Consensus 505 ivH~Dlk~~NILl------~~~~~~kl~Dfgl~~ 532 (678)
++|+|+.+.|||+ +++..++++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999999874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.12 E-value=1 Score=42.60 Aligned_cols=115 Identities=12% Similarity=0.107 Sum_probs=78.3
Q ss_pred CCCceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeecCCCCc
Q 041043 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALA-YLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 436 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~ivH~Dlk~~N 514 (678)
.||++ -..+-.+.+...+.++.-+++.-...++ .++...+++++.+|+.... ++++ -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57887 4445566777777777665554444443 3788999999999988777 5655 5688999999
Q ss_pred eEECCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPIS 586 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~ 586 (678)
|++|.++.++|.-.|+-..+.+.. +.+|-+ .-.+=+++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPPDE-------------WDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSSCS-------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcccCCCCC-------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999999999888654322110 112211 1235577888888888774
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.28 E-value=1 Score=42.44 Aligned_cols=116 Identities=9% Similarity=0.103 Sum_probs=78.5
Q ss_pred CCCceeeEEeEEeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCce
Q 041043 436 SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 515 (678)
Q Consensus 436 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 515 (678)
.||++++. .+-.+.+...+.|+.-+.+.=...++ .++...+++++.+|+....++++ -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57888866 45556666666665544332222233 47889999999999998866665 46889999999
Q ss_pred EECCCCcEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 041043 516 LLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPIS 586 (678)
Q Consensus 516 Ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~ 586 (678)
+++.++.+++.-.|+...+. |.. .+...=.-.+=+++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l~------------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVD------------------PLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBS------------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999887653322 110 0111112245678888999998874
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=85.52 E-value=0.2 Score=41.85 Aligned_cols=43 Identities=28% Similarity=0.733 Sum_probs=17.8
Q ss_pred ccccCCCCceEeecCCCCCCCccccCCcccCc-----------ccCCCCCccccCCC
Q 041043 260 HCESDEGGLFRCSCKEKYHGNPYFLHGCQDLR-----------CENYEGGYRCVNPK 305 (678)
Q Consensus 260 ~C~~~~~~~~~C~C~~gy~gnpy~~~gC~~~~-----------c~~~~~~~~c~~~~ 305 (678)
.|.+.. ++|+|.|+.||.|++ ...|++++ |.|+.|+|.|.++.
T Consensus 42 ~C~n~~-g~y~C~C~~Gy~g~~--g~~C~dideC~~~~~C~~~C~n~~gsy~C~C~~ 95 (107)
T 2w2n_E 42 VCNDLK-IGYECLCPDGFQLVA--QRRCEDIDECQDPDTCSQLCVNLEGGYKCQCEE 95 (107)
T ss_dssp EEECCS-BSCEEECCTTCEEET--TTEEEC---------------------------
T ss_pred EeEeCC-CCeEEECCCCccccC--CCccccccccCCCCCcCCeeecCCCCEEEECCC
Confidence 566543 568899999999842 12344443 55566777777664
|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
Probab=83.16 E-value=0.49 Score=49.72 Aligned_cols=44 Identities=27% Similarity=0.701 Sum_probs=29.6
Q ss_pred CccccCCCCceEeecCCCCCCCccccCCcccC-----------cccCCCCCccccCCC
Q 041043 259 SHCESDEGGLFRCSCKEKYHGNPYFLHGCQDL-----------RCENYEGGYRCVNPK 305 (678)
Q Consensus 259 s~C~~~~~~~~~C~C~~gy~gnpy~~~gC~~~-----------~c~~~~~~~~c~~~~ 305 (678)
..|.+.. ++|+|.|+.||.++. ...|+++ .|.|+.|+|.|.|+.
T Consensus 12 ~~C~~~~-~~y~C~C~~G~~~~~--~~~C~dideC~~~~~C~~~C~n~~g~~~C~C~~ 66 (400)
T 3p5b_L 12 HVCNDLK-IGYECLCPDGFQLVA--QRRCEDIDECQDPDTCSQLCVNLEGGYKCQCEE 66 (400)
T ss_dssp SEEEECS-SSEEEECCTTEEECS--SSCEEECCCCSTTSSCSSCCBCCSSSCBCCCCT
T ss_pred CEeECCC-CCeEEECCCCCCcCC--CCcccCchhhhccCCCCCccCCCccceeeeccc
Confidence 4677664 568899999998521 1224333 366778899998875
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=83.12 E-value=0.97 Score=39.95 Aligned_cols=46 Identities=17% Similarity=0.470 Sum_probs=32.2
Q ss_pred CCccccCCCCceEeecCCCCCCCccc--------cCCcccCcc-cCCCCCccccCCC
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNPYF--------LHGCQDLRC-ENYEGGYRCVNPK 305 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnpy~--------~~gC~~~~c-~~~~~~~~c~~~~ 305 (678)
++.|.+.. ++|.|.|+.||.|.--. ..+|+. .| .|+.|+|.|.++.
T Consensus 59 ~g~C~~~~-~~y~C~C~~G~~G~~C~~~deC~~~~~~C~~-~C~~n~~g~y~C~C~~ 113 (146)
T 1x7a_L 59 GGLCKDDI-NSYECWCQVGFEGKNCELDATCNIKNGRCKQ-FCKTGADSKVLCSCTT 113 (146)
T ss_dssp TCEEEECS-SCEEEECCSSEESTTTCEECCTTSGGGSCSS-BCCCCSSSCCCCBCCT
T ss_pred CCEeECCC-CCEEEecCCCCcCCcCCCCccccCCCCCCcC-CCCCCCCCCEEeEcCC
Confidence 46787664 56889999999875321 123444 57 7888999998875
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=83.04 E-value=0.77 Score=36.04 Aligned_cols=47 Identities=26% Similarity=0.601 Sum_probs=30.8
Q ss_pred CCccccCCCCceEeecCCCCCCCccc---------cCCcccCcccCCCCCccccCCC
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNPYF---------LHGCQDLRCENYEGGYRCVNPK 305 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnpy~---------~~gC~~~~c~~~~~~~~c~~~~ 305 (678)
++.|.+.. ++|+|.|+.||.++... ...|++..|.|..|+|.|.++.
T Consensus 16 ~g~C~n~~-g~y~C~C~~Gy~~~g~~C~dideC~~~~~C~~~~C~n~~g~y~C~C~~ 71 (82)
T 1emn_A 16 HGQCINTD-GSYRCECPFGYILAGNECVDTDECSVGNPCGNGTCKNVIGGFECTCEE 71 (82)
T ss_dssp SSEECCCS-SCCCEECCTTEEEETTEEEECCGGGTCCTTSSSCEEECSSSEEECCSS
T ss_pred CCEEEecC-CCEEEECCCCeECCCCccCCcccccCCCCCCCCEeECCCCCEEeECCC
Confidence 36787654 57889999999732211 1234444567778888888775
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=82.55 E-value=0.53 Score=39.69 Aligned_cols=47 Identities=26% Similarity=0.568 Sum_probs=31.7
Q ss_pred CCCccccCCCCceEeecCCCCCCCcccc-----------CCcccCcccCCCCCccccCCC
Q 041043 257 STSHCESDEGGLFRCSCKEKYHGNPYFL-----------HGCQDLRCENYEGGYRCVNPK 305 (678)
Q Consensus 257 ~~s~C~~~~~~~~~C~C~~gy~gnpy~~-----------~gC~~~~c~~~~~~~~c~~~~ 305 (678)
.++.|.+.. ++|+|.|+.||.|+.-.. .+|+. .|.|+.|+|.|.++.
T Consensus 24 ~~g~C~~~~-~~y~C~C~~G~~G~~C~~~~~~~~C~~~~~~C~~-~C~n~~g~y~C~C~~ 81 (114)
T 1aut_L 24 GHGTCIDGI-GSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCTH-YCLEEVGWRRCSCAP 81 (114)
T ss_dssp TSEEECCCS-SCCCEEECTTEESTTSCEECCSSSSSSGGGGCSS-EEEECSSSEEEECCT
T ss_pred CcCCCCCCC-CCcEeeCCCCCcCCCcCcCCcCCcCcCCCCCCCC-EeECCCCCEEeECCC
Confidence 346786654 568899999999875221 12222 566778889888875
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=81.99 E-value=0.43 Score=41.99 Aligned_cols=47 Identities=32% Similarity=0.614 Sum_probs=31.8
Q ss_pred CCccccCCCCceEeecCCCCCCCccc-------cCCcccCc--------------ccCCCCCccccCCC
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNPYF-------LHGCQDLR--------------CENYEGGYRCVNPK 305 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnpy~-------~~gC~~~~--------------c~~~~~~~~c~~~~ 305 (678)
++.|.+.. ++|.|.|+.||.|++.. ...|++++ |.|+.|+|.|.++.
T Consensus 58 ~~~C~n~~-g~y~C~C~~Gy~g~~~~~~~~~~~~~~C~dideC~~~~~~C~~~~~C~n~~g~y~C~C~~ 125 (143)
T 2bou_A 58 FSDCWNTE-GSYDCVCSPGYEPVSGAKTFKNESENTCQDVDECSSGQHQCDSSTVCFNTVGSYSCRCRP 125 (143)
T ss_dssp TEEEEECS-SCEEEEECTTEEETTCCSCBSSGGGCCEEECCHHHHTCCCCCTTSEEEECSSCEEEECCS
T ss_pred CCEEEcCC-CCeEeECCCCcccCcCccccccCCCCCcCCccCccCcCCCCCCCCEEECCCCCEEeeCCC
Confidence 46787654 57889999999998642 12344432 55567888887764
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.75 E-value=0.87 Score=46.03 Aligned_cols=46 Identities=22% Similarity=0.544 Sum_probs=28.3
Q ss_pred CCccccCCCCceEeecCCCCCCCccc--cCC--------cccCcccCCCCCccccCCC
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNPYF--LHG--------CQDLRCENYEGGYRCVNPK 305 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnpy~--~~g--------C~~~~c~~~~~~~~c~~~~ 305 (678)
++.|.+.. ++|.|.|+.||.|+--. .+. |+. .|.|..|+|.|.|+.
T Consensus 16 ~g~C~~~~-~~~~C~C~~g~~g~~C~~~~~eC~~~~~~~C~~-~C~~~~g~~~C~C~~ 71 (317)
T 3h5c_B 16 NGSCQDSI-WGYTCTCSPGYEGSNCELAKNECHPERTDGCQH-FCLPGQESYTCSCAQ 71 (317)
T ss_dssp TCCCCCCS-SSCCCCCSSSCCSSSSCCCSSSCCTTCTTSCSS-EEECCSSSCEEECCT
T ss_pred CCEeECCC-CCeEEECCCCCcCCccccCcccCCCCCCCCCcC-ccccCCCeeEEeccc
Confidence 46676554 55778888888876432 122 333 466667777776654
|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=81.53 E-value=0.34 Score=50.66 Aligned_cols=44 Identities=30% Similarity=0.704 Sum_probs=6.8
Q ss_pred ccccCCCCceEeecCCCCCCCccccCCcccCc-----------ccCCCCCccccCCC
Q 041043 260 HCESDEGGLFRCSCKEKYHGNPYFLHGCQDLR-----------CENYEGGYRCVNPK 305 (678)
Q Consensus 260 ~C~~~~~~~~~C~C~~gy~gnpy~~~gC~~~~-----------c~~~~~~~~c~~~~ 305 (678)
.|.+ ..++|+|.|+.||+.++.- ..|++++ |.|+.|+|.|.|+.
T Consensus 16 ~C~~-~~g~~~C~C~~G~~l~~~~-~~C~d~~eC~~~~~C~~~C~~~~g~~~C~C~~ 70 (386)
T 3v65_B 16 KCQM-IRGAVQCTCHTGYRLTEDG-RTCQDVNECAEEGYCSQGCTNSEGAFQCWCEA 70 (386)
T ss_dssp --------------------------------------CCTTEEC-----CCEECCT
T ss_pred CCcC-CCCCcEeECCCCceECCCC-CccCccceeCCcCcccCcCCCCCCCCeEEECC
Confidence 4633 3456889999999865532 2344433 56678888888875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 678 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 1e-71
Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 21/282 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
V + +G G GTVYKG + + +L+ F NEV +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+G +V ++ +L+ +LH E + IA + A+ + YLH
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH--- 121
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFHSS 560
I HRD+KS NI L E KI DFG + + +H ++ G+ ++ PE
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 561 Q---FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617
++ +SDVY+FG+VL EL+TGQ P N + V L L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659
K + + CL RP ++ +E +
Sbjct: 236 SNCPK-----AMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-65
Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 21/276 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
+ + LG G G V+ G +AVK K + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+L + E ++ E++ NG+L +L P + LT L +A ++AE +A++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
HRD+++ NIL+ + KIADFG +R I ++ + + PE +
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
FT KSDV+SFG++L E++T + N + L+ R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------------VIQNLERGYRMVR 231
Query: 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
E+ + + C RPT + LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-65
Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 21/277 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
+ +G G G V+ G + +A+K + E+FI E ++ ++SH +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+L G CLE LV+EF+ +G L YL ++ E L + +V E +AYL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
+ HRD+ + N L+ E K++DFG +R + DQ ST + + PE F S+
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
++ KSDV+SFGV++ E+ + K E + + + + R
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223
Query: 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
V + C RP + +L I
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 8e-65
Identities = 70/303 (23%), Positives = 125/303 (41%), Gaps = 37/303 (12%)
Query: 377 LDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQ 434
++ D F LG G G V+K G ++A K + + + I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+ +V G+ + E + G+L Q L + ++ +++ V + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
YL I HRD+K +NIL++ + K+ DFG S + ++ GT Y+ P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE---------------------- 592
E + ++ +SD++S G+ LVE+ G+ PI A E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 593 -GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVS----DVAKRCLNSNGRSRPTM 647
GR L++Y ++ +F++LD V + S D +CL N R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 648 KEV 650
K++
Sbjct: 293 KQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-64
Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
+ + +G+G G V G G +AVK K +++ + F+ E +++Q+ H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 442 KLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
+LLG +E + L +V E++ G+L YL + L + L+ + +V EA+ YL +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 122
Query: 501 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSS 560
HRD+ + N+L+ E AK++DFG ++ + Q + + PE
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREK 175
Query: 561 QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620
+F+ KSDV+SFG++L E+ + + + V VE+ D D
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPP-- 227
Query: 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
V +V K C + + RP+ ++ +LE I+
Sbjct: 228 -------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (537), Expect = 1e-63
Identities = 76/299 (25%), Positives = 136/299 (45%), Gaps = 29/299 (9%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQ 434
E+++ + LG G G VY+G+ +AVK K D ++EEF+ E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
I H N+V+LLG C ++ EF+ G L YL + ++ + L +AT+++ A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAM 128
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
YL HRD+ + N L+ E + K+ADFG SR + D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 555 EYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614
E ++F+ KSDV++FGV+L E+ T ++ + ++++L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDD--DNIQK 671
R +V ++ + C N RP+ E+ E + Q+ D ++K
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM----FQESSISDEVEK 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-62
Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 21/276 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
+ LG G G V G +A+K K +EFI E ++ +SH +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+L G C + ++ E++ NG L YL + + L + +V EA+ YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLE--- 117
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
HRD+ + N L++++ K++DFG SR + D+ S + + PE S+
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
F+ KSD+++FGV++ E+ + K + N + + +R
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------------TAEHIAQGLRLYR 222
Query: 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+V + C + RPT K + + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (522), Expect = 2e-61
Identities = 68/312 (21%), Positives = 127/312 (40%), Gaps = 47/312 (15%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFIN 427
L+ ++ R +G+G G V++ ++AVK + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS---------- 477
E ++++ + N+VKLLG C + L++E++ G L ++L S
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 478 -----------LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526
L+ +L IA +VA +AYL HRD+ + N L+ E KIA
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIA 182
Query: 527 DFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPI 585
DFG SR+I D ++ PE +++T +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241
Query: 586 SYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP 645
+ E ++ + D + + +E+ ++ + C + RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRP 287
Query: 646 TMKEVAMELERI 657
+ + L+R+
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-61
Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 21/276 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVV 441
+ + LGQG G V+ G +A+K K S E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+L E +V E++ G+L +L + + L + +A ++A +AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE--- 130
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
+ HRD+++ NIL+ E K+ADFG +R I ++ + + PE +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 562 FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621
FT KSDV+SFG++L EL T + + + D ++ R
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235
Query: 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
E + D+ +C RPT + + LE
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 5e-61
Identities = 68/277 (24%), Positives = 122/277 (44%), Gaps = 25/277 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQISHR 438
+ + V +G G G K +DG+I+ K + E++ + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 439 NVVKLLGSCLEVE--VPLLVYEFIPNGTLFQYLHDPSEEL-SLTWEMRLRIATEVAEALA 495
N+V+ ++ +V E+ G L + ++E L E LR+ T++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 496 YLH--SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
H S + HRD+K N+ LD K K+ DFG +R + T + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
PE + + +KSD++S G +L EL P F ++ I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP---------------FTAFSQKELAGKIR 227
Query: 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ + R+ E++++ R LN RP+++E+
Sbjct: 228 EGKFRRIPYRYS-DELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-61
Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 29/294 (9%)
Query: 388 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSC 447
+G+G G V++G G +AVK E + E+ + H N++ + +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 448 LE----VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY- 502
+ LV ++ +G+LF YL+ ++T E +++A A LA+LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 503 ----LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS---TKVQGTFGYLDPE 555
I HRD+KS NIL+ + IAD G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 556 YFHSS------QFTDKSDVYSFGVVLVELLTGQKPIS----YIWANEGRNLATYFVECVE 605
S + ++D+Y+ G+V E+ Y + VE +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 606 ENCLFDILDDQVRKSGKTEEIM-EVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
+ L + ++ E + ++ + + C +NG +R T + L ++
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-60
Identities = 76/273 (27%), Positives = 112/273 (41%), Gaps = 30/273 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ F + R LG+G G VY I+A+K K+++ + EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
N+++L G + L+ E+ P GT+++ L S + TE+A AL+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS + HRDIK N+LL KIADFG S + + GT YL PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617
+K D++S GV+ E L G+ P F + I +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP---------------FEANTYQETYKRISRVEF 221
Query: 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
E D+ R L N RP ++EV
Sbjct: 222 TFPDFVTE--GARDLISRLLKHNPSQRPMLREV 252
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-60
Identities = 66/292 (22%), Positives = 129/292 (44%), Gaps = 30/292 (10%)
Query: 374 SKELDKATDHFNVNRILGQGGQGTVYKGMLADG-----RIIAVKK-SKVVDESKLEEFIN 427
+ E+ +++G G G VYKGML +A+K E + +F+
Sbjct: 1 TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 428 EVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIA 487
E I+ Q SH N+++L G + + +++ E++ NG L ++L + E S + +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGML 116
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTKV 545
+A + YL + + HRD+ + NIL++ K++DFG SR + D T+ ++
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 546 QGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE 605
+ + PE +FT SDV+SFG+V+ E++T + + +N
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221
Query: 606 ENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+ ++D R + + + +C RP ++ L+++
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-60
Identities = 80/305 (26%), Positives = 139/305 (45%), Gaps = 31/305 (10%)
Query: 378 DKATDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKK-SKVVDESKLEEFINEVVIL 432
HFN ++G+G G VY G L D AVK +++ D ++ +F+ E +I+
Sbjct: 25 SSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 433 SQISHRNVVKLLGSCLEVE-VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
SH NV+ LLG CL E PL+V ++ +G L ++ + E + T + + +VA
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVA 140
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA---IDQTHVSTKVQGT 548
+ + +L HRD+ + N +LDEK+ K+ADFG +R + D H T +
Sbjct: 141 KGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608
++ E + +FT KSDV+SFGV+L EL+T P + + +
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--------------PYPDVNTFDI 243
Query: 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQDDDDN 668
+L + R + +V +C + RP+ E+ + I + + + +
Sbjct: 244 TVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302
Query: 669 IQKCY 673
+ Y
Sbjct: 303 VNATY 307
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 7e-60
Identities = 73/316 (23%), Positives = 132/316 (41%), Gaps = 41/316 (12%)
Query: 366 IDRCKIFNSKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKK-SKVVD 418
ID ++ + + + + + LG G G V + +AVK
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 419 ESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD------ 471
++ E ++E+ +LS + H N+V LLG+C L++ E+ G L +L
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 472 ---------PSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 522
+EL+L E L + +VA+ +A+L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRI 183
Query: 523 AKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTG 581
KI DFG +R I D + V + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 582 QKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNG 641
+ ++ + ++ + R E+ D+ K C +++
Sbjct: 244 GSS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 642 RSRPTMKEVAMELERI 657
RPT K++ +E+
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 5e-59
Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 31/279 (11%)
Query: 387 NRILGQGGQGTVYKGMLAD---GRIIAVK--KSKVVDESKLEEFINEVVILSQISHRNVV 441
++ LG G GTV KG + +AVK K++ D + +E + E ++ Q+ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
+++G C E E +LV E G L +YL + + + + +V+ + YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYLDPEYFHS 559
HRD+ + N+LL ++ AKI+DFG S+++ D+ + + + + PE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 560 SQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
+F+ KSDV+SFGV++ E + GQKP + +E + +L+ R
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER 228
Query: 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
E+ D+ C + +RP V + L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 6e-59
Identities = 68/291 (23%), Positives = 129/291 (44%), Gaps = 30/291 (10%)
Query: 375 KELDKATDHFNV-NRILGQGGQGTVYKGMLA---DGRIIAVKK-SKVVDESKLEEFINEV 429
K+L D+ + + LG G G+V +G+ +A+K + +++ EE + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 430 VILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATE 489
I+ Q+ + +V+L+G C + E +LV E G L ++L EE+ + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQG 547
V+ + YL HRD+ + N+LL ++ AKI+DFG S+++ D ++ + + +
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 548 TFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEE 606
+ PE + +F+ +SDV+S+GV + E L+ GQKP + E + +E+
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
+ + E+ + C RP V +
Sbjct: 228 GKRMECPPECPP---------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 8e-59
Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 25/272 (9%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN 439
+ +GQG GTVY M +A G+ +A+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+V L S L + +V E++ G+L + + + E +AL +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+ HRDIKS NILL K+ DFG I +Q+ ST V GT ++ PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619
+ K D++S G++ +E++ G+ P ++ L+ I + +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPLRALYLIATNGTPE 235
Query: 620 SGKTEEI-MEVSDVAKRCLNSNGRSRPTMKEV 650
E++ D RCL+ + R + KE+
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-59
Identities = 61/276 (22%), Positives = 123/276 (44%), Gaps = 32/276 (11%)
Query: 384 FNVNRILGQGGQGTVYKGMLAD-GRIIAVKK--SKVVDESKLEEFINEVVILSQISHRNV 440
+ +G+G TVYKG+ + +A + + + +S+ + F E +L + H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 441 VKLLGSCLEV----EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
V+ S + +LV E + +GTL YL + ++ ++ + L +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 497 LHSSAYLPIYHRDIKSTNILL-DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
LH+ PI HRD+K NI + KI D G + + + + V GT ++ PE
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPE 183
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615
+ ++ + DVY+FG+ ++E+ T + P + EC ++ +
Sbjct: 184 MY-EEKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTS 227
Query: 616 QVRKSGKTEEIM-EVSDVAKRCLNSNGRSRPTMKEV 650
V+ + + + EV ++ + C+ N R ++K++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 1e-58
Identities = 61/304 (20%), Positives = 125/304 (41%), Gaps = 38/304 (12%)
Query: 372 FNSKELDKATDHFN---------VNRILGQGGQGTVYKGMLA----DGRIIAVKK-SKVV 417
F ++ ++A F + +++G G G V G L +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 418 DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS 477
E + +F++E I+ Q H NV+ L G + +++ EF+ NG+L +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 478 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537
T + + +A + YL + HRD+ + NIL++ K++DFG SR + D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 538 QTHVSTK----VQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG 593
+ + + + PE +FT SDV+S+G+V+ E+++ + + N+
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 594 RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653
+ + ++ R + + + C + RP ++
Sbjct: 242 ---------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 654 LERI 657
L+++
Sbjct: 287 LDKM 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 3e-58
Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 29/284 (10%)
Query: 374 SKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVIL 432
+++L+ D + + LG G G VYK + A K E +LE+++ E+ IL
Sbjct: 5 TRDLN-PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 433 SQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
+ H N+VKLL + ++ EF G + + + LT + + +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLD 121
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
AL YLH I HRD+K+ NIL K+ADFG S + + GT ++
Sbjct: 122 ALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWM 177
Query: 553 DPEYFHSSQ-----FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607
PE + K+DV+S G+ L+E+ + P E
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP---------------HHELNPMR 222
Query: 608 CLFDILDDQVRKSGKTEEI-MEVSDVAKRCLNSNGRSRPTMKEV 650
L I + + D K+CL N +R T ++
Sbjct: 223 VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 8e-58
Identities = 65/280 (23%), Positives = 106/280 (37%), Gaps = 33/280 (11%)
Query: 378 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILS 433
D F+ R +G G G VY + + ++A+K S K ++ I EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
++ H N ++ G L LV E+ + L + +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQG 127
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 553
LAYLHS + HRD+K+ NILL E K+ DFG++ +A + V GT ++
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMA 179
Query: 554 PEYFHSS---QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
PE + Q+ K DV+S G+ +EL + P + L+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---------------LFNMNAMSALY 224
Query: 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
I ++ + CL + RPT + +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 9e-58
Identities = 68/303 (22%), Positives = 122/303 (40%), Gaps = 46/303 (15%)
Query: 382 DHFNVNRILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFINEVVILSQ 434
++ ++LG G G V +AVK + D S+ E ++E+ +++Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 435 I-SHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS---------------- 477
+ SH N+V LLG+C L++E+ G L YL E+ S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 478 ----LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533
LT+E L A +VA+ + +L HRD+ + N+L+ KI DFG +R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 534 IAIDQTHVS-TKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANE 592
I D +V + ++ PE +T KSDV+S+G++L E+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266
Query: 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652
+ + + ++ + + E+ + + C + R RP+ +
Sbjct: 267 -------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 653 ELE 655
L
Sbjct: 320 FLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 26/281 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKK-SKVVDESKLEEFINEVVILSQIS 436
+ + R +G+G G V++G+ +A+K +S E+F+ E + + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H ++VKL+G E V ++ E G L +L SL + A +++ ALAY
Sbjct: 67 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAY 123
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
L S HRDI + N+L+ K+ DFG SR + + ++K + ++ PE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616
+ +FT SDV+ FGV + E+L + V+ N + +++
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVK---------------PFQGVKNNDVIGRIENG 225
Query: 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
R + + +C + RP E+ +L I
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 24/273 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQISHRN 439
+ +++ + LG+G G V + +AVK E E+ I ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
VVK G E + L E+ G LF + ++ + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID-QTHVSTKVQGTFGYLDPEYFH 558
+ I HRDIK N+LLDE+ KI+DFG + + + + K+ GT Y+ PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 559 SSQFTD-KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617
+F DV+S G+VL +L G+ P + ++ + + E + +D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ + L N +R T+ ++
Sbjct: 237 L------------ALLHKILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-56
Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 38/295 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADG---RIIAVKK-SKVVDESKLEEFINEVVILSQIS- 436
+ ++G+G G V K + A+K+ + + +F E+ +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH-------------DPSEELSLTWEMR 483
H N++ LLG+C L E+ P+G L +L S +L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543
L A +VA + YL HRD+ + NIL+ E Y AKIADFG SR + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603
+ ++ E + S +T SDV+S+GV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
+ L++ L R EV D+ ++C RP+ ++ + L R+
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 7e-56
Identities = 63/286 (22%), Positives = 129/286 (45%), Gaps = 29/286 (10%)
Query: 379 KATDHFNVNRILGQGGQGTVYKGMLAD-----GRIIAVKK-SKVVDESKLEEFINEVVIL 432
K T+ F ++LG G GTVYKG+ +A+K+ + +E ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 433 SQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
+ + + +V +LLG CL L+ + +P G L Y+ + + + + L ++A+
Sbjct: 66 ASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAK 122
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGY 551
+ YL + HRD+ + N+L+ KI DFG ++ + A ++ + + + +
Sbjct: 123 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611
+ E +T +SDV+S+GV + EL+T + + + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
IL+ R ++V + +C + SRP +E+ +E ++
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 29/286 (10%)
Query: 382 DHFNVNRILGQGGQGTVYKGML----ADGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
+ LG G G V +G +AVK + +++FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+ HRN+++L G L + +V E P G+L L + R A +VAE +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH--VSTKVQGTFGYL 552
YL S HRD+ + N+LL + KI DFG R++ + H + + F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612
PE + F+ SD + FGV L E+ T + ++ L I
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------PWIGLNGSQILHKI 227
Query: 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658
+ R + ++ +V +C RPT + L +
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (475), Expect = 4e-54
Identities = 60/274 (21%), Positives = 111/274 (40%), Gaps = 27/274 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
DH++++ LG G G V++ A G A K ES E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
V L + + +++YEF+ G LF+ + D E ++ + + +V + L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 501 AYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
H D+K NI+ K K+ DFG + + Q+ T GT + PE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
+D++S GV+ LL+G P F ++ L ++
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSP---------------FGGENDDETLRNVKSCDWN 243
Query: 619 KSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
+ + D ++ L ++ +R T+ +
Sbjct: 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (467), Expect = 7e-54
Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 30/289 (10%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIS 436
+D + + ILG GG V+ L R +AVK D S F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 437 HRNVVKLLGSCLEVE----VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
H +V + + +P +V E++ TL +H +T + + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV--STKVQGTFG 550
AL + H I HRD+K NI++ K+ DFG +R+IA V + V GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
YL PE +SDVYS G VL E+LTG+ P G + + + V E+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-TMKEVAMELERIR 658
+ + ++ V + L N +R T E+ +L R+
Sbjct: 234 PSARHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 68/277 (24%), Positives = 113/277 (40%), Gaps = 28/277 (10%)
Query: 379 KATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQ 434
K + F +ILG+G TV LA R A+K K ++ E+K+ E ++S+
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+ H VKL + + E + NG L +Y+ S E+ AL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSAL 121
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID-QTHVSTKVQGTFGYLD 553
YLH I HRD+K NILL+E +I DFGT++ ++ + + + GT Y+
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 554 PEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
PE SD+++ G ++ +L+ G P F E I+
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP---------------FRAGNEYLIFQKII 223
Query: 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ K + D+ ++ L + R +E+
Sbjct: 224 KLEYDFPEKFFP--KARDLVEKLLVLDATKRLGCEEM 258
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-52
Identities = 81/309 (26%), Positives = 126/309 (40%), Gaps = 40/309 (12%)
Query: 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGM------LADGRIIAVKK-SKVVDESKLEE 424
+++ + + D + + LG+G G V + A R +AVK + S+
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 425 FINEVVILSQISHR-NVVKLLGSCLEVEVPL-LVYEFIPNGTLFQYLHDPSEELS----- 477
++E+ IL I H NVV LLG+C + PL ++ EF G L YL E
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 478 --------LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529
LT E + + +VA+ + +L S HRD+ + NILL EK KI DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 530 TSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYI 588
+R I D +V + ++ PE +T +SDV+SFGV+L E+ +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--- 236
Query: 589 WANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK 648
G + F ++E D E+ C + RPT
Sbjct: 237 --YPGVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFS 285
Query: 649 EVAMELERI 657
E+ L +
Sbjct: 286 ELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 7e-52
Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 44/308 (14%)
Query: 376 ELDKATDHFNVNRILGQGGQGTVYKGML--------ADGRIIAVKK-SKVVDESKLEEFI 426
EL + D + + LG+G G V +AVK E L + I
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 427 NEVVILSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLH-------------DP 472
+E+ ++ I H+N++ LLG+C + ++ E+ G L +YL
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 473 SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532
+ E L+ + + A +VA + YL S HRD+ + N+L+ E KIADFG +R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 533 SIAIDQTHVSTKVQ-GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWAN 591
I + T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------- 236
Query: 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVA 651
V LF +L + R + E+ + + C ++ RPT K++
Sbjct: 237 --------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 652 MELERIRA 659
+L+RI A
Sbjct: 289 EDLDRIVA 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-52
Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 33/291 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFINEVVILSQ 434
+ ++R LGQG G VY+G+ +A+K ++ + EF+NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 435 ISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELS-------LTWEMRLRIA 487
+ +VV+LLG + + L++ E + G L YL ++ + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 488 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQ 546
E+A+ +AYL+++ HRD+ + N ++ E + KI DFG +R I D K
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 547 GTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606
++ PE FT SDV+SFGVVL E+ T + +NE + V E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVME 250
Query: 607 NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657
L D D+ + ++ + C N + RP+ E+ ++
Sbjct: 251 GGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (457), Expect = 2e-51
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 27/274 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
D++++ LG G G V++ + A GR+ K NE+ I++Q+ H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
+ L + + +L+ EF+ G LF + +E+ ++ + + E L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 501 AYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
I H DIK NI+ + K KI DFG + + D+ T T + PE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVD 201
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618
+D+++ GV+ LL+G P F + L ++
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGEDDLETLQNVKRCDWE 246
Query: 619 KSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
+ E D K L R R T+ +
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 2e-51
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 24/280 (8%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVIL 432
K+ + D ++ +LG G V +++A+K +K E K NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 433 SQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
+I H N+V L L+ + + G LF + + T R+ +V +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
A+ YLH + + LDE + I+DFG S+ D V + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYV 176
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612
PE ++ D +S GV+ LL G P F + + I
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP---------------FYDENDAKLFEQI 221
Query: 613 LDDQVRKSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
L + + + D + + + R T ++
Sbjct: 222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 7e-50
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 42/288 (14%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK---------SKVVDESKLEEFINEVVI 431
+++ ILG+G V + + + AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 432 LSQIS-HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
L ++S H N+++L + LV++ + G LF YL E+++L+ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 550
E + LH L I HRD+K NILLD+ K+ DFG S +D +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPS 174
Query: 551 YLDPEYFHSSQ------FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV 604
YL PE S + + D++S GV++ LL G P F
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---------------FWHRK 219
Query: 605 EENCLFDILDDQVRKSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
+ L I+ + + V D+ R L + R T +E
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 63/281 (22%), Positives = 115/281 (40%), Gaps = 31/281 (11%)
Query: 375 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILS 433
KEL + + + LG+G G V++ + + + K K V + E+ IL+
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILN 56
Query: 434 QISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEA 493
HRN++ L S +E ++++EFI +F+ ++ + L + +V EA
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEA 114
Query: 494 LAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
L +LHS I H DI+ NI+ + KI +FG +R + + Y
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEY 169
Query: 552 LDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFD 611
PE + +D++S G ++ LL+G P F+ + + +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FLAETNQQIIEN 214
Query: 612 ILDDQVRKSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
I++ + + + + E D R L +SR T E
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-46
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 31/278 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILS-QIS 436
+ F ++++LG+G G V+ + A+K K V+ + +E + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 437 HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
H + + + E V E++ G L ++ + A E+ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 497 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
LHS I +RD+K NILLD+ KIADFG + + +T GT Y+ PE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF-DILDD 615
++ D +SFGV+L E+L GQ P G++ F +N + L+
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPF------HGQDEEELFHSIRMDNPFYPRWLEK 228
Query: 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653
+ + D+ + R ++ +
Sbjct: 229 EAK------------DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (402), Expect = 1e-44
Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 20/283 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRN 439
+ ++ +G+G G VYK G A+KK ++ DE I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 440 VVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+VKL + +LV+E + L ++ +AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 500 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHS 559
+ HRD+K N+L++ + KIADFG +R+ I + ++ + S
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 560 SQFTDKSDVYSFGVVLVELLTGQKP------------ISYIWANEGRNLATYFVECVEEN 607
+++ D++S G + E++ G I I E + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
F + + +S D+ + L + R T K+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 2e-44
Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 31/276 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
F + R LG G G V+ +GR A+K K VV ++E +E ++LS ++H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
++++ G+ + + ++ ++I G LF L + A EV AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS I +RD+K NILLD+ KI DFG ++ + V+ + GT Y+ PE
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617
+ + D +SFG+++ E+L G P F + IL+ ++
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP---------------FYDSNTMKTYEKILNAEL 218
Query: 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653
R E +V D+ R + + R + E
Sbjct: 219 RFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-44
Identities = 55/289 (19%), Positives = 110/289 (38%), Gaps = 22/289 (7%)
Query: 381 TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQISHR 438
+ +G+G G V + +A+KK S ++ + + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
N++ + + + ++ + L+ + L+ + ++ L Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS--TKVQGTFGYLDPEY 556
S + HRD+K +N+LL+ KI DFG +R D H T+ T Y PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 557 FHSSQFTDKS-DVYSFGVVLVELLTGQKP---------ISYIWANEGRNLATYFVECVEE 606
+S+ KS D++S G +L E+L+ + +++I G +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 607 NCLFDILDDQVRKSGKTEEIM-----EVSDVAKRCLNSNGRSRPTMKEV 650
+L + + + D+ + L N R +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 160 bits (405), Expect = 4e-44
Identities = 61/274 (22%), Positives = 110/274 (40%), Gaps = 31/274 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQIS- 436
+ F+V+RI+G+GG G VY AD G++ A+K K ++ + +NE ++LS +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 437 --HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEAL 494
+V + + + + + + G L +L + A E+ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 495 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 554
++H+ + +RD+K NILLDE +I+D G + + + H GT GY+ P
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 555 EYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613
E + +D +S G +L +LL G P + + L D
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTM 647
++R + + L + R
Sbjct: 233 SPELR------------SLLEGLLQRDVNRRLGC 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-43
Identities = 60/292 (20%), Positives = 103/292 (35%), Gaps = 25/292 (8%)
Query: 379 KATDHFNVNRILGQGGQGTVYKG--MLADGRIIAVK--KSKVVDESKLEEFINEVVILSQ 434
+A + +G+G G V+K + GR +A+K + + +E I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 435 IS---HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQ---YLHDPSEELSLTWEMRLRIAT 488
+ H NVV+L C + + Q D E + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 489 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 548
++ L +LHS + HRD+K NIL+ + K+ADFG +R + T V T
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178
Query: 549 FGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPIS-----YIWANEGRNLATYFVEC 603
Y PE S + D++S G + E+ + + E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 604 VEENCLFDILDDQVRKSGKTEEIM-----EVSDVAKRCLNSNGRSRPTMKEV 650
+ + + E+ + D+ +CL N R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 39/293 (13%)
Query: 371 IFNSKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESK---LE 423
+F + +D D+++ LG G V K + G A K K + + E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 424 EFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMR 483
+ EV IL +I H NV+ L +L+ E + G LF +L + SLT E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEA 115
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE----KYRAKIADFGTSRSIAIDQT 539
++ + YLHS L I H D+K NI+L + K R KI DFG + I D
Sbjct: 116 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFG 170
Query: 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATY 599
+ + GT ++ PE + ++D++S GV+ LL+G P
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------- 215
Query: 600 FVECVEENCLFDILDDQVRKSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
F+ ++ L ++ + D +R L + + R T+++
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 6e-43
Identities = 52/297 (17%), Positives = 99/297 (33%), Gaps = 29/297 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
+ + + R +G G G +Y G +A G +A+K V ++K + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 441 VKLLGSCL-EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+ + C E + ++V E + + + + + L +A ++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121
Query: 500 SAYLPIYHRDIKSTNIL---LDEKYRAKIADFGTSRSIAIDQTHV------STKVQGTFG 550
HRD+K N L + I DFG ++ +TH + + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 551 YLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
Y + + + D+ S G VL+ G P + A R E +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI-RACNLQDDD 666
+ E + C + +P + + D
Sbjct: 239 VLCKGYPS---------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 6e-43
Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 20/284 (7%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQISHR 438
++F +G+G G VYK G ++A+K + E I E+ +L +++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
N+VKLL LV+EF+ D S + + ++ + LA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
S + HRD+K N+L++ + K+ADFG +R+ + + +V +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKP---------ISYIWANEGRNLATYFVECVEENCL 609
++ D++S G + E++T + + I+ G +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 610 FDILDDQVRKSGKT---EEIMEVSDVAKRCLNSNGRSRPTMKEV 650
R+ + + + L+ + R + K
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 67/287 (23%), Positives = 108/287 (37%), Gaps = 28/287 (9%)
Query: 384 FNVNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVK 442
+ +++G G G VY+ L D G ++A+KK E+ I+ ++ H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 443 LLGSCLEVEVP------LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAY 496
L LV +++P H + +L ++ +LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 497 LHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 555
+HS I HRDIK N+LLD K+ DFG+++ + + +VS + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193
Query: 556 YFHSSQFTDKSDVYSFGVVLVELLTGQKP------------ISYIWANEGRNLATYFVEC 603
F ++ +T DV+S G VL ELL GQ I + R
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
E I K + E + R L +R T E
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-42
Identities = 55/274 (20%), Positives = 108/274 (39%), Gaps = 29/274 (10%)
Query: 386 VNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKL 443
+++LG G G V + A+K + + EV + + S ++V++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 70
Query: 444 LGSCLEV----EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS 499
+ + + L+V E + G LF + D ++ + T I + EA+ YLHS
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS 129
Query: 500 SAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
I HRD+K N+L K+ DFG ++ + + T Y+ PE
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEV 184
Query: 557 FHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616
++ D++S GV++ LL G P + + + ++ ++ + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ + EV + + L + R T+ E
Sbjct: 241 WSEVSE-----EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 7e-42
Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 25/281 (8%)
Query: 388 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEE-----FINEVVILSQISHRNVV 441
LG+G TVYK +I+A+KK K+ S+ ++ + E+ +L ++SH N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 442 KLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA 501
LL + LV++F+ L LT + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 502 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQ 561
I HRD+K N+LLDE K+ADFG ++S + +V T Y PE ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 562 FTD-KSDVYSFGVVLVELLTGQKP---------ISYIWANEGRNLATYFVECVEENCLFD 611
D+++ G +L ELL ++ I+ G + +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 612 ILDDQVRKSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEV 650
++ D+ + N +R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 42/280 (15%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLE---EFINEVVILSQ 434
+ V +LG GG G+VY G+ ++D +A+K K ++ D +L EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 435 IS--HRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
+S V++LL + +L+ E +E +L E+ +V E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 551
A+ + H+ + HRDIK NIL+D + K+ DFG+ + + V T GT Y
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175
Query: 552 LDPEYFHSSQFTDKS-DVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
PE+ ++ +S V+S G++L +++ G P + E +F + V C
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRVSSECQ- 232
Query: 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEV 650
+ + CL RPT +E+
Sbjct: 233 --------------------HLIRWCLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 51/286 (17%), Positives = 109/286 (38%), Gaps = 24/286 (8%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHR 438
+ +G+G GTV+K I+A+K+ ++ DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 439 NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLH 498
N+V+L + LV+EF + + E+ ++ + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118
Query: 499 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFH 558
+ HRD+K N+L++ K+A+FG +R+ I S +V + F
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 559 SSQFTDKSDVYSFGVVLVELLTGQKP----------ISYIWANEGRNLATYFVECVEENC 608
+ ++ D++S G + EL +P + I+ G + + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW-PSMTKLP 234
Query: 609 LFDILDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ + + +++ + L N R + +E
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
+ F+ ++LG+G G V A GR A+K K ++ + ++ + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+ L + + V E+ G LF +L E T E E+ AL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS + +RDIK N++LD+ KI DFG + D + T GT YL PE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKP 584
+ + D + GVV+ E++ G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (352), Expect = 1e-37
Identities = 44/298 (14%), Positives = 96/298 (32%), Gaps = 29/298 (9%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV 440
H+ V R +G+G G +++G L + + +A+K S + +E ++
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 441 VKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS 500
+ + + + ++ + +L L + S + A ++ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS--VKTVAMAAKQMLARVQSIHEK 120
Query: 501 AYLPIYHRDIKSTNILLDEKYR-----AKIADFGTSRSIAIDQTHV------STKVQGTF 549
+ +RDIK N L+ + DFG + T + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 550 GYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609
Y+ + + + D+ + G V + L G P + A + E + L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI-RACNLQDDD 666
++ E N + P + ++ N +D+
Sbjct: 238 RELCAGFPE---------EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 57/299 (19%), Positives = 107/299 (35%), Gaps = 36/299 (12%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHR 438
+ +GQG G V+K G+ +A+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 439 NVVKLLGSCLEVEVP--------LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEV 490
NVV L+ C P LV++F + + + T R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 491 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT---HVSTKVQG 547
L Y+H + I HRD+K+ N+L+ K+ADFG +R+ ++ + + T
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 548 TFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKP---------ISYIWANEGRNLA 597
T Y PE + + D++ G ++ E+ T ++ I G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 598 TYFVECVEENCLFDILDDQVRKSGKTEEIMEVS------DVAKRCLNSNGRSRPTMKEV 650
+ + + +K + + D+ + L + R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 3e-37
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQISH 437
D F+ + LG G G V G A+K K KVV ++E +NE IL ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 438 RNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
+VKL S + +V E++ G +F +L + A ++ YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157
Query: 498 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 557
HS L + +RD+K N+L+D++ ++ DFG ++ + + GT L PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEII 210
Query: 558 HSSQFTDKSDVYSFGVVLVELLTGQKP 584
S + D ++ GV++ E+ G P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-37
Identities = 53/301 (17%), Positives = 105/301 (34%), Gaps = 28/301 (9%)
Query: 372 FNSKELDKAT----DHFNVNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEE 424
F +E+ K + + +G G G V + G +A+K E +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 425 FINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHD-PSEELSLTWEMR 483
E+ +L + H NV+ LL E +F + L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 484 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 543
+ ++ + L Y+H+ I HRD+K N+ ++E KI DFG +R + ++
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP---------ISYIWANEGR 594
V + + ++T D++S G ++ E++TG+ + I G
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIM-----EVSDVAKRCLNSNGRSRPTMKE 649
A + + + + I+ ++ ++ L + R T E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 650 V 650
Sbjct: 298 A 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 1e-35
Identities = 59/298 (19%), Positives = 118/298 (39%), Gaps = 45/298 (15%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRN 439
D + + R LG+G V++ + + + + VK ++ K ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPN 91
Query: 440 VVKLLGSCLEV--EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYL 497
++ L + P LV+E + N Q +LT E+ +AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 498 HSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 556
HS + I HRD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 557 FHSSQFTD-KSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD- 614
Q D D++S G +L ++ ++P + ++ + + + L+D +D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 615 ------------------DQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTMKEV 650
+ + +E VS A + L + +SR T +E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 6e-35
Identities = 70/285 (24%), Positives = 112/285 (39%), Gaps = 34/285 (11%)
Query: 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESK-LEEFINEVVILS 433
++F + ++LG G G V+ G++ A+K K+ +V ++K E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 434 QISHR-NVVKLLGSCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
I +V L + L+ ++I G LF +L T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVL 140
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
AL +LH L I +RDIK NILLD + DFG S+ D+T + GT Y+
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 553 DPEYFHSSQ--FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610
P+ D +S GV++ ELLTG P F E+N
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---------------FTVDGEKNSQA 242
Query: 611 DILDDQVRKSGKTEEIM--EVSDVAKRCLNSNGRSRPTMKEVAME 653
+I ++ + M D+ +R L + + R +
Sbjct: 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 53/303 (17%), Positives = 106/303 (34%), Gaps = 45/303 (14%)
Query: 382 DHFNVNRILGQGGQGTVYKGM-LADGRIIAVKK--SKVVDESKLEEFINEVVILSQISHR 438
+ + +G G QG V R +A+KK +++ + E+V++ ++H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 439 NVVKLLGSCL------EVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAE 492
N++ LL E + LV E + + E + ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 493 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 552
+ +LHS+ HRD+K +NI++ KI DFG +R+ + + T T Y
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 553 DPEYFHSSQFTDKSDVYSFGVVLVELLTGQ--------------------KPISYIWANE 592
PE + + D++S G ++ E++ + P
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 593 GRNLATYFVECVEENCL-FDILDDQVRKSGKTEEIMEVSDVAK----RCLNSNGRSRPTM 647
+ Y + L F L +E + A+ + L + R ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 648 KEV 650
+
Sbjct: 306 DDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-32
Identities = 56/305 (18%), Positives = 103/305 (33%), Gaps = 36/305 (11%)
Query: 372 FNSKELDKA----TDHFNVNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEE 424
F +EL+K + + +G G G+V G +AVK +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 425 FINEVVILSQISHRNVVKLLGSCLEVE-----VPLLVYEFIPNGTLFQYLHDPSEELSLT 479
E+ +L + H NV+ LL + + + L + LT
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LT 119
Query: 480 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539
+ + ++ L Y+HS+ HRD+K +N+ ++E KI DFG +R
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP---------ISYIWA 590
++ V + + + D++S G ++ ELLTG+ + I
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 591 NEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIM-----EVSDVAKRCLNSNGRSRP 645
G A + E+ I + D+ ++ L + R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 646 TMKEV 650
T +
Sbjct: 294 TAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 4e-27
Identities = 67/356 (18%), Positives = 123/356 (34%), Gaps = 72/356 (20%)
Query: 384 FNVNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVK 442
+ + R LG G TV+ + + +A+K + D+ E +E+ +L +++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 443 LLGSCLEVEVPLLVY-------------EFIPNGTLFQYLHDPSEELSLTWEMRLRIATE 489
+ LL + F G L E + +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 490 VAEALAYLHSSAYLPIYHRDIKSTNILLDEK------YRAKIADFGTSRSIAIDQTHVST 543
+ L Y+H I H DIK N+L++ + KIAD G + T+
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-- 189
Query: 544 KVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKP------------------- 584
T Y PE + + +D++S ++ EL+TG
Sbjct: 190 --IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 585 ------ISYIWANEGRNLATYF--------VECVEENCLFDILDDQVRKSGKTEEIMEVS 630
+ G+ T+F + ++ L D+L ++ + S +E E+S
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK--DEAKEIS 305
Query: 631 DVAKRCLNSNGRSRPTMKEV----------AMELERIRACNLQDDDDNIQKCYEEL 676
D L + R R + ME R+ L +I +EE+
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEV 361
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 4e-20
Identities = 29/163 (17%), Positives = 53/163 (32%), Gaps = 28/163 (17%)
Query: 386 VNRILGQGGQGTVYKGMLADGRIIAVK----------KSKVVDESKLEEFINEVVILSQI 435
+ +++G+G + V+ VK K K + F + ++
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 436 SHRNVVKLLG----SCLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVA 491
R + KL G E ++ E I L++ E + +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMIL 113
Query: 492 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534
E +A + I H D+ N+L+ E I DF S +
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.98 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.86 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 93.52 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.03 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.86 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.28 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.12 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.4 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 82.44 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.09 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 80.67 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=414.33 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=205.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEecc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIP 461 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 461 (678)
++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999889999999987543 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee
Q 041043 462 NGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 541 (678)
Q Consensus 462 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~ 541 (678)
+|+|.+++.... ..+++..++.++.|||.||+|||+.+ |+||||||+||||++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999997643 46899999999999999999999999 9999999999999999999999999998766544444
Q ss_pred eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcCC
Q 041043 542 STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKSG 621 (678)
Q Consensus 542 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (678)
.....||+.|+|||++.+..++.++||||||+++|||+|+..|+. ...+..+........ .+...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~-----~~~~~~~~~~~i~~~----------~~~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-----ENRSNSEVVEDISTG----------FRLYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT-----CSCCHHHHHHHHHHT----------CCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC-----CCCCHHHHHHHHHhc----------CCCCC
Confidence 445678999999999999999999999999999999999654442 222223322222221 11222
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 622 KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 622 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+...++++.+|+.+||+.||++|||++||++.|++|++.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 334456899999999999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=411.59 Aligned_cols=265 Identities=28% Similarity=0.443 Sum_probs=209.2
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
|+...++|++.+.||+|+||+||+|+++ ..||||+++. .+....+.|.+|+++|++++||||+++++++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 3445678999999999999999999864 3599998764 345667899999999999999999999998754 5689
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++++... ..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 80 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 9999999999999997543 35999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-eeeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 535 AIDQT-HVSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 535 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
..... .......||+.|||||++.. ..++.++|||||||+||||+||+.||... ............+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~------~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI------NNRDQIIFMVGRGYLS 228 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC------CCHHHHHHHHHHTSCC
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC------ChHHHHHHHHhcCCCC
Confidence 54332 23445679999999999864 35889999999999999999999999532 1111222222222111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
. .. ...+...++++.+|+.+||+.||++|||++||++.|+.|++.
T Consensus 229 p----~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 P----DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp C----CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C----cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0 00 111234456899999999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=413.89 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=217.7
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
++++...++|++.+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34555567899999999999999999999888999999987543 345789999999999999999999998754 5679
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.+++.... ...+++.+++.|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence 9999999999999886532 235899999999999999999999998 999999999999999999999999999987
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
............+|+.|+|||++.+..++.++||||||+++|||+||..|+. ......+.......
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~-----~~~~~~~~~~~i~~--------- 225 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPEVIQNLER--------- 225 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS-----TTCCHHHHHHHHHT---------
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHh---------
Confidence 6555555555678999999999999999999999999999999999766653 12222222222211
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
..+...+...++++.+|+.+||+.||++||||+||++.|+.+-.
T Consensus 226 -~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 -GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11222233455689999999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-51 Score=418.44 Aligned_cols=266 Identities=27% Similarity=0.435 Sum_probs=222.8
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
++|+...++|++.+.||+|+||+||+|.++ +++.||||+++.. ....++|.+|+++|++++|||||++++++.+.+..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 345555678999999999999999999976 5889999998754 33467899999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999997542 346999999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
.............+++.|+|||++.+..++.++||||||+++|||++|+.|+. .+.+...... ..
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~-----~~~~~~~~~~-~i--------- 229 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYE-LL--------- 229 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS-----TTCCHHHHHH-HH---------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC-----CcchHHHHHH-HH---------
Confidence 76655555555668999999999999999999999999999999999877763 2222222221 11
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....+...+...++++.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12222333445567899999999999999999999999999988653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-50 Score=409.92 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=203.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-C---cEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-G---RIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
++|++.++||+|+||+||+|.++. + ..||||++.. ......++|.+|+++|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467788999999999999999752 2 3689998764 4555667899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999998643 36999999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccee----eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 537 DQTHV----STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 537 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
..... .....+|+.|+|||.+.+..++.++|||||||+||||+| |+.||... ...+.......
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~------~~~~~~~~i~~------ 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------TNQDVINAIEQ------ 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHT------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC------CHHHHHHHHHc------
Confidence 33221 122357899999999999999999999999999999998 89998532 22222222211
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
..+...+.+.++++.+|+.+||+.||++|||++||++.|++|.+.
T Consensus 249 ----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 122223445567899999999999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=399.83 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=215.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++|++.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|++.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 357899999999999999999998889999999875433 4478999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.+++.... ..+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999987543 46899999999999999999999998 999999999999999999999999999876655444
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||... +..+....... + .+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~------~~~~~~~~i~~-~---------~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------TNSETAEHIAQ-G---------LRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS------CHHHHHHHHHT-T---------CCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC------CHHHHHHHHHh-C---------CCC
Confidence 4455678999999999999999999999999999999998 89898532 22222222221 1 112
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
..+...++++.+|+.+||+.||++|||++|+++.|.+|
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22334456899999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=400.81 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=210.0
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
++|++.+.||+|+||+||+|.. .+|+.||||+++..+....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999996 468999999987655556688999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.+++.+ ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998864 25999999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhcC
Q 041043 541 VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRKS 620 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+.............. ...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~~~~~~~~--------~~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRALYLIATNGTP--------ELQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHHCSC--------CCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC------CCHHHHHHHHHhCCCC--------CCC
Confidence 23445699999999999999999999999999999999999999952 2222222222222111 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 621 GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 621 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.+...++++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12344568999999999999999999999976
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=399.96 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=203.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+++.+|+++|++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999975 68999999876433 33446789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.++|+.. ..+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9999999999743 46999999999999999999999999 99999999999999999999999999987654332
Q ss_pred e-eeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 540 H-VSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 540 ~-~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
. ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... ..............
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~~~~~~~~~--------- 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEYSDWKEKKT--------- 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS-----TTSHHHHHHHTTCT---------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCC---------
Confidence 2 3445679999999999988776 578999999999999999999995321 11111111111111
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
........++++.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111234567889999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=401.57 Aligned_cols=260 Identities=24% Similarity=0.408 Sum_probs=206.9
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCC-----cEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADG-----RIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
.+.|+..++||+|+||+||+|.+++. ..||||+++. ......++|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999997642 4799998864 34455668999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+.+|+|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999887543 46999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 535 AIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 535 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+.. .....+.+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~-----~~~~~~~~~~i--------- 226 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-----ELSNHEVMKAI--------- 226 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT-----TCCHHHHHHHH---------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc-----cCCHHHHHHHH---------
Confidence 543222 22334589999999999999999999999999999999997666531 12222222221
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....+...+...+.++.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 227 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 12222333445567899999999999999999999999999998763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=401.61 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=210.1
Q ss_pred cCCCcCC-eeeeeCCcEEEEEEEc---CCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNR-ILGQGGQGTVYKGMLA---DGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
++|.+.+ +||+|+||+||+|.++ ++..||||.++. .+....++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999864 355799999865 345567889999999999999999999999864 568999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.+++.... ..+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999986543 46999999999999999999999999 99999999999999999999999999987765
Q ss_pred Cccee--eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 537 DQTHV--STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 537 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... .....||+.|+|||++....++.++|||||||++|||+| |+.||... ...+.... +..+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~------~~~~~~~~-i~~~------ 228 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM------KGPEVMAF-IEQG------ 228 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CTHHHHHH-HHTT------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC------CHHHHHHH-HHcC------
Confidence 43332 233458899999999999999999999999999999998 89999532 11222221 2211
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
.+...+...++++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 229 ---~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1222344556789999999999999999999999999987763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=394.14 Aligned_cols=245 Identities=29% Similarity=0.421 Sum_probs=207.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||+|+.+ +++.||+|++... +....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999975 6889999987532 2334577899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999743 35999999999999999999999999 999999999999999999999999999765433
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
. .....||+.|+|||++.+..++.++|||||||+||||++|+.||.. .+..+.+.......
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~~---------- 220 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVE---------- 220 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHTTC----------
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC------CCHHHHHHHHHcCC----------
Confidence 2 2345799999999999999999999999999999999999999952 23333332222211
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...+...++++.+|+.+||+.||++|||++|+++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1122334568899999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=396.41 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=202.1
Q ss_pred CeeeeeCCcEEEEEEEcC---CcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEeccC
Q 041043 388 RILGQGGQGTVYKGMLAD---GRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFIPN 462 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 462 (678)
++||+|+||+||+|.+++ ++.||||+++. .+....++|.+|+++|++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 46899998864 334456789999999999999999999999854 567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCccee-
Q 041043 463 GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV- 541 (678)
Q Consensus 463 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~~- 541 (678)
|+|.++++.. ..+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999999753 35999999999999999999999998 9999999999999999999999999998765443332
Q ss_pred -eeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhhc
Q 041043 542 -STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVRK 619 (678)
Q Consensus 542 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (678)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||... ...+..... .. ..+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~------~~~~~~~~i-~~---------~~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM------KGSEVTAML-EK---------GERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHH-HT---------TCCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC------CHHHHHHHH-Hc---------CCCC
Confidence 234568999999999999999999999999999999998 89999532 222222211 11 1122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 620 SGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 620 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
..+...++++.+|+.+||+.||++|||++||++.|+..-
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 233445678999999999999999999999999988764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=401.96 Aligned_cols=264 Identities=25% Similarity=0.367 Sum_probs=210.7
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEE
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 456 (678)
++...++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++. .+..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEE
Confidence 334457899999999999999999999988899999987543 34578999999999999999999999985 4567999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|..++.... ...++|.+++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 90 ~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999999987532 235999999999999999999999999 99999999999999999999999999987655
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
..........+|+.|+|||++....++.++||||||+++|||++|+.|+. ......+.+......
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~-----~~~~~~~~~~~i~~~---------- 230 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERG---------- 230 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS-----TTCCHHHHHHHHHTT----------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC-----CCCCHHHHHHHHHhc----------
Confidence 44444455678999999999999999999999999999999999777653 222223222222211
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
.+...+...++++.+||.+||+.||++|||+++|+++|+.+....
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 122233455678999999999999999999999999999877543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=407.90 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=211.0
Q ss_pred HHhhccCCCcCCeeeeeCCcEEEEEEEcC-C-----cEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEe
Q 041043 377 LDKATDHFNVNRILGQGGQGTVYKGMLAD-G-----RIIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVKLLGSCL 448 (678)
Q Consensus 377 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 448 (678)
++...++|++.++||+|+||+||+|++.. + ..||||++.. .+....+.+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34455789999999999999999999653 2 3689998754 3444557899999999998 8999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPSE--------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 508 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 508 (678)
+.+..++||||+++|+|.++|+.... ...+++..++.++.||++||+|||+.+ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999976432 135899999999999999999999998 9999
Q ss_pred cCCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 041043 509 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPIS 586 (678)
Q Consensus 509 Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~ 586 (678)
||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544333 3344568999999999999999999999999999999998 899985
Q ss_pred ccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 041043 587 YIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELE 655 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 655 (678)
.... ...+...... ..+...+...++++.+||.+||+.||++|||++||+++|.
T Consensus 269 ~~~~------~~~~~~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPV------DANFYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCC------SHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCH------HHHHHHHHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3211 1112222222 2222334455678999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=398.34 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=207.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
+.|++.+.||+|+||+||+|... +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999975 68999999987767777788999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.+++.+. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 999999998643 235999999999999999999999999 9999999999999999999999999997543321 1
Q ss_pred eeeccccccCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 541 VSTKVQGTFGYLDPEYFH-----SSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.+........ .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~------~~~~~~~i~~~~~-~----- 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN------PMRVLLKIAKSEP-P----- 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC------GGGHHHHHHHSCC-C-----
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC------HHHHHHHHHcCCC-C-----
Confidence 223456999999999984 4568899999999999999999999995321 1222222222111 0
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
....+...++++.+|+.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112345568999999999999999999999876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=397.97 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=197.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--CCcceE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLE--VEVPLL 455 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l 455 (678)
.++|++.+.||+|+||+||+|+.+ +|+.||||.+... ++...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 357999999999999999999975 6899999987543 45566789999999999999999999999865 356789
Q ss_pred EEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 456 VYEFIPNGTLFQYLHDPS-EELSLTWEMRLRIATEVAEALAYLHSSAY--LPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
||||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.+. .+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986422 23469999999999999999999998651 249999999999999999999999999998
Q ss_pred cccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.. .+..+....... ...
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~------~~~~~~~~~i~~-~~~--- 231 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKELAGKIRE-GKF--- 231 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHH-TCC---
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC------CCHHHHHHHHHc-CCC---
Confidence 7654322 23456799999999999999999999999999999999999999952 222222222221 111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...+...++++.+|+.+||+.||++|||++|+++
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122345568999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=394.38 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=202.2
Q ss_pred hhccCCCcCCeeeeeCCcEEEEEEEcC----CcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 379 KATDHFNVNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 379 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
...++|++.+.||+|+||+||+|.+.. +..||||.++.. .....+.|.+|++++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345689999999999999999998643 357899988653 4445678999999999999999999999985 4678
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
++||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999999988653 346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhh
Q 041043 534 IAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDI 612 (678)
Q Consensus 534 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (678)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |..||..... .+.........
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------~~~~~~i~~~~----- 226 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENGE----- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHHHHTTC-----
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-----
Confidence 66554445555678999999999999999999999999999999998 8888853221 11111111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 613 LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+...+...++++.+||.+||+.||++|||++||++.|++|.+.
T Consensus 227 -----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1122344567899999999999999999999999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=383.31 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=199.0
Q ss_pred CCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEee----CCcceEE
Q 041043 384 FNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLE----VEVPLLV 456 (678)
Q Consensus 384 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv 456 (678)
|++.++||+|+||+||+|... +++.||+|++.. ......+.+.+|+++|++++||||+++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356778999999999999975 578999998754 345567789999999999999999999999875 3457899
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC-CCCcEEEeeccCccccc
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIA 535 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgl~~~~~ 535 (678)
|||+++|+|.+++.+. ..+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999753 36999999999999999999999987 4599999999999996 57899999999997644
Q ss_pred CCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcch
Q 041043 536 IDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDD 615 (678)
Q Consensus 536 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (678)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.. ..+.......... +....
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~-----~~~~~~~~~~i~~-~~~~~---- 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE-----CQNAAQIYRRVTS-GVKPA---- 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT-----CSSHHHHHHHHTT-TCCCG----
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC-----cccHHHHHHHHHc-CCCCc----
Confidence 32 2334579999999999875 599999999999999999999999952 2222222222221 11111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 616 QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 616 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.. +...++++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 1123346899999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-48 Score=398.18 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=215.0
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEe
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCL 448 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 448 (678)
+++...++|++.+.||+|+||+||+|+++ +++.||||+++... ....++|.+|+++|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 45556778999999999999999999964 35789999986543 444678999999999999999999999999
Q ss_pred eCCcceEEEEeccCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 041043 449 EVEVPLLVYEFIPNGTLFQYLHDPS---------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 507 (678)
Q Consensus 449 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 507 (678)
+.+..++++||+++|+|.++|+... ....+++..++.++.|++.||+|||+.+ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999996422 1235899999999999999999999999 999
Q ss_pred ecCCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCC-CCC
Q 041043 508 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ-KPI 585 (678)
Q Consensus 508 ~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~-~p~ 585 (678)
|||||+||||+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999866443322 334456889999999999999999999999999999999986 566
Q ss_pred CccccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 041043 586 SYIWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIR 658 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~ 658 (678)
.. .+..+...... .+.. ...+...++++.+|+.+||+.||++||||.||+++|++|.
T Consensus 244 ~~------~~~~e~~~~v~-~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YG------MAHEEVIYYVR-DGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TT------SCHHHHHHHHH-TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CC------CCHHHHHHHHH-cCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 42 22222222222 2211 1223344568999999999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=393.72 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=206.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||+|... +++.||||++... +....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999974 6899999987532 2344578999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999998743 36999999999999999999999999 999999999999999999999999999876543
Q ss_pred cc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 538 QT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 538 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||.. .+....+.......
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------~~~~~~~~~i~~~~--------- 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA------GNEYLIFQKIIKLE--------- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHTTC---------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC------cCHHHHHHHHHcCC---------
Confidence 32 233456799999999999999999999999999999999999999952 23333333222211
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...++++.+||.+||+.||++|||++|++..
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11223445678999999999999999999997653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=390.50 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=203.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-CcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEV-EVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 459 (678)
.++|++.+.||+|+||.||+|.++ |+.||||+++.. ...++|.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 456888899999999999999985 789999998653 3457899999999999999999999998654 568999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+++|+|.++|.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999997432 235899999999999999999999998 999999999999999999999999999865432
Q ss_pred eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhcchhhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDILDDQVR 618 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (678)
.....++..|+|||++.+..++.++||||||+++|||+| |+.||... ...+..... . ...+
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~------~~~~~~~~i-~---------~~~~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRV-E---------KGYK 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS------CGGGHHHHH-T---------TTCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC------CHHHHHHHH-H---------cCCC
Confidence 223457889999999999999999999999999999998 67776422 111111111 1 1222
Q ss_pred cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 619 KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 619 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
...+...++++.+|+.+||+.||++|||++|++++|++|+..+
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 3334445578999999999999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=403.88 Aligned_cols=271 Identities=26% Similarity=0.408 Sum_probs=209.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
..++|++.++||+|+||+||+|... +|+.||+|+++.. +....+++.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999974 6899999988643 3445678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. + |+||||||+||||++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999753 3599999999999999999999974 7 99999999999999999999999999986543
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCCh-----H--------------
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNL-----A-------------- 597 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~-----~-------------- 597 (678)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 22345799999999999999999999999999999999999999964221110000 0
Q ss_pred ----HHHHHHHhhccchhhcchhhh----cCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 041043 598 ----TYFVECVEENCLFDILDDQVR----KSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRA 659 (678)
Q Consensus 598 ----~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~ 659 (678)
.............+..+.... .......+.++.+|+.+||+.||++|||++|+++. |++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 000000000000001100000 00011234678999999999999999999999984 655443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.5e-47 Score=395.24 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=212.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
-++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999974 6899999999877777778899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC--CCCcEEEeeccCcccccCC
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgl~~~~~~~ 537 (678)
+++|+|.+++.+. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999653 235999999999999999999999999 99999999999996 4678999999999876543
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..........
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~~~~~------- 244 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG------ENDDETLRNVKSCDWNM------- 244 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTCCCS-------
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC------CCHHHHHHHHHhCCCCC-------
Confidence 32 3445799999999999999999999999999999999999999952 23333333332221100
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........++++.+||.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112344678999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-47 Score=391.08 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=193.3
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+.+.|++.+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999975 68999999876432 233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC---CCCcEEEeeccCcccc
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSI 534 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgl~~~~ 534 (678)
||+++|+|.++|... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999753 46999999999999999999999999 99999999999994 5789999999999865
Q ss_pred cCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.. ................
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------~~~~~~~~~i~~~~~~----- 227 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD------ENDAKLFEQILKAEYE----- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHTTCCC-----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC------CCHHHHHHHHhccCCC-----
Confidence 4322 23345699999999999999999999999999999999999999952 2222222222221110
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.........++++.+|+.+||+.||++|||++|+++.
T Consensus 228 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 --FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111123445689999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=392.12 Aligned_cols=271 Identities=28% Similarity=0.427 Sum_probs=209.5
Q ss_pred cChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCCceeeE
Q 041043 372 FNSKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVKL 443 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l 443 (678)
++.++++...++|++.++||+|+||+||+|.+. +++.||||+++. ......+++.+|++.+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 345666666788999999999999999999964 246899999864 3445567788888888777 68999999
Q ss_pred EeEEeeCC-cceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 041043 444 LGSCLEVE-VPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 509 (678)
Q Consensus 444 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 509 (678)
++++.+.+ ..++||||+++|+|.++|+.... ...+++.+++.++.||++||+|||+.+ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 99987654 67999999999999999974321 235899999999999999999999999 99999
Q ss_pred CCCCceEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCc
Q 041043 510 IKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ-KPISY 587 (678)
Q Consensus 510 lk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~-~p~~~ 587 (678)
|||+||||++++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543332 334457999999999999999999999999999999999975 56642
Q ss_pred cccccCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 588 IWANEGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
. .....+......+ .+...+...++++.+|+.+||+.||++|||++|++++|++|.+.
T Consensus 240 ~------~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 V------KIDEEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp C------CCSHHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------CHHHHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 1112222222222 12222334556799999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=393.09 Aligned_cols=256 Identities=26% Similarity=0.487 Sum_probs=205.2
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCc----EEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLL 455 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 455 (678)
++|++.++||+|+||+||+|.+. +|+ +||+|+++. .+....++|.+|++++++++|||||+++|++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999964 343 689998764 3445568899999999999999999999999764 5678
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 535 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~ 535 (678)
++|++.+|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999988764 346999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 536 IDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 536 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
..... ......||+.|+|||.+.++.++.++||||||++||||+| |+.||..... .+.. ..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------~~~~----------~~i 226 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEIS----------SIL 226 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------GGHH----------HHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------HHHH----------HHH
Confidence 54433 2334568999999999999999999999999999999999 7888853221 1111 111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA 659 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~ 659 (678)
....+...+...++++.+|+.+||+.||++|||++|+++.|+++..
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1222223344556789999999999999999999999999988863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-47 Score=391.19 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=202.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
+.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999964 68899999876432 344567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|..++... ..+++.+++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999998776532 46999999999999999999999999 999999999999999999999999999865432
Q ss_pred cceeeeccccccCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcc
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHS---SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILD 614 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (678)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.. ......+.......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~------~~~~~~~~~i~~~~------- 230 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNE------- 230 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHSC-------
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC------CCHHHHHHHHHhCC-------
Confidence 23469999999999864 4589999999999999999999999852 22222222222211
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 615 DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 615 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.....+...++++.+|+.+||+.||++|||++|+++
T Consensus 231 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 --SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111112334568999999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-46 Score=391.96 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=211.8
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
.++|++.+.||+|+||+||+|... +|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999964 6999999998776666677889999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC--CCCcEEEeeccCcccccCC
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgl~~~~~~~ 537 (678)
+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||++..+...
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999988653 335999999999999999999999999 99999999999998 6789999999999876543
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+....+........ ..
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~------~~~~~~~~~i~~~~~-------~~ 247 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG------EDDLETLQNVKRCDW-------EF 247 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC------SSHHHHHHHHHHCCC-------CC
T ss_pred Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCCC-------CC
Confidence 32 3445689999999999999999999999999999999999999952 222222222222110 01
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
........++++.+||.+||+.||.+|||++|+++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111123455688999999999999999999999873
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=385.52 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=208.4
Q ss_pred CCeeeeeCCcEEEEEEEcCC----cEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-CcceEEEEec
Q 041043 387 NRILGQGGQGTVYKGMLADG----RIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV-EVPLLVYEFI 460 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 460 (678)
.++||+|+||+||+|.+.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 3689998864 4566678899999999999999999999998764 5789999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
++|+|.++++... ..+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999998643 35788999999999999999999998 999999999999999999999999999876543322
Q ss_pred ---eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 541 ---VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 541 ---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
......||+.|+|||.+....++.++||||||+++|||+||+.||.... +..+.........
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-----~~~~~~~~i~~g~---------- 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYLLQGR---------- 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTC----------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHcCC----------
Confidence 2233468999999999999999999999999999999999888875221 1111111111111
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhccCCC
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACNLQD 664 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~~~~ 664 (678)
+...+...++++.+||.+||+.||++||||+||++.|++|.+.-..+
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 11122334567999999999999999999999999999999765443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=388.81 Aligned_cols=268 Identities=28% Similarity=0.435 Sum_probs=218.5
Q ss_pred HHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 041043 376 ELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVKLLGSC 447 (678)
Q Consensus 376 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 447 (678)
.++...++|++.++||+|+||.||+|++. +++.||||+++. .......+|.+|+++++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 45555678999999999999999999852 457899999865 3445567899999999999 699999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPS---------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 512 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 512 (678)
.+.+..++||||+++|+|.++++... ....+++..++.++.||++||+|||+++ ++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999997543 1235899999999999999999999999 99999999
Q ss_pred CceEECCCCcEEEeeccCcccccCCcc-eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccc
Q 041043 513 TNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWAN 591 (678)
Q Consensus 513 ~NILl~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~ 591 (678)
+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+|+..|+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~----- 248 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----- 248 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS-----
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC-----
Confidence 999999999999999999987664433 33445678999999999999999999999999999999999544432
Q ss_pred cCCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 592 EGRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
...+....+..... ...+...+...+.++.+||.+||+.||++|||++||+++|+++...
T Consensus 249 ~~~~~~~~~~~~i~---------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 249 PGMPVDSKFYKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TTCCSSHHHHHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHh---------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11122222222222 2223333444567899999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-46 Score=379.80 Aligned_cols=260 Identities=27% Similarity=0.387 Sum_probs=207.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCc----
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEV---- 452 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 452 (678)
.++|++.+.||+|+||+||+|+. .+|+.||||.++.. +....+.+.+|++++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 56899999999999999999996 46899999998642 34456789999999999999999999999986543
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999998753 36999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCcc--eeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 533 SIAIDQT--HVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 533 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~------~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG------DSPVSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC------cCHHHHHHHHHhcCCCC
Confidence 6543322 233445799999999999999999999999999999999999999952 23333333333322111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHh
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRP-TMKEVAMELERIRA 659 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~l~~ 659 (678)
. .......++++.+|+.+||+.||++|| |++++++.|.+++.
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 0 111223456799999999999999999 89999999998863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=386.87 Aligned_cols=259 Identities=28% Similarity=0.474 Sum_probs=208.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC-Cc--EEEEEEccc-CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD-GR--IIAVKKSKV-VDESKLEEFINEVVILSQI-SHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 456 (678)
++|++.++||+|+||+||+|++++ +. .||||+++. ......++|.+|+++|+++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999999754 43 578888754 3444567899999999998 799999999999999999999
Q ss_pred EEeccCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcE
Q 041043 457 YEFIPNGTLFQYLHDP-------------SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 523 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 523 (678)
|||+++|+|.++|+.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999764 22357999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCC-CCCccccccCCChHHHHHH
Q 041043 524 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQK-PISYIWANEGRNLATYFVE 602 (678)
Q Consensus 524 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~-p~~~~~~~~~~~~~~~~~~ 602 (678)
||+|||+++...... ......+|..|+|||.+....++.++||||||+++|||++|.. ||. +.+..+....
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~------~~~~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT------TCCHHHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC------CCCHHHHHHH
Confidence 999999997544222 2233458999999999999999999999999999999999765 553 2233322222
Q ss_pred HHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 603 CVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
+.. ..+...+...++++.+||.+||+.||++||||+||++.|++|....
T Consensus 239 i~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 239 LPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHh----------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111 1122334455678999999999999999999999999999998654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=383.45 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=200.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcC--C--cEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLAD--G--RIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
++|++.+.||+|+||+||+|++.. + ..||||+++.. +....++|.+|+++|++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998642 2 37899987542 34456789999999999999999999999965 5678
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999988753 235999999999999999999999998 999999999999999999999999999887
Q ss_pred cCCcce--eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHhhccchh
Q 041043 535 AIDQTH--VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANEGRNLATYFVECVEENCLFD 611 (678)
Q Consensus 535 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (678)
...... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.. .+..+........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~------~~~~~~~~~i~~~~---- 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG------LNGSQILHKIDKEG---- 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT------CCHHHHHHHHHTSC----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC------cCHHHHHHHHHhCC----
Confidence 554333 2334457889999999999999999999999999999998 8999852 23333333332222
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 041043 612 ILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERI 657 (678)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l 657 (678)
.+...+...+.++.+|+.+||+.||++|||++||++.|++.
T Consensus 232 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11222334456899999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=383.09 Aligned_cols=251 Identities=27% Similarity=0.356 Sum_probs=206.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC------ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcc
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV------DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 453 (678)
.++|++.+.||+|+||+||+|..+ +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999974 6899999987532 122467899999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC----cEEEeecc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFG 529 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfg 529 (678)
++||||+++|+|.++|... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999753 36999999999999999999999999 99999999999998776 59999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
++....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+...........
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG------DTKQETLANVSAVNYE 234 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHTTCCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC------CCHHHHHHHHHhcCCC
Confidence 998764332 23345689999999999999999999999999999999999999952 2222222222221100
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
...... ...+..+.+||.+||+.||++|||++|+++
T Consensus 235 ---~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 ---FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCchhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111 123457889999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=386.50 Aligned_cols=264 Identities=29% Similarity=0.443 Sum_probs=212.2
Q ss_pred HhhccCCCcCCeeeeeCCcEEEEEEEcC--------CcEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 041043 378 DKATDHFNVNRILGQGGQGTVYKGMLAD--------GRIIAVKKSKVV-DESKLEEFINEVVILSQI-SHRNVVKLLGSC 447 (678)
Q Consensus 378 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 447 (678)
+...++|++.+.||+|+||.||+|+... +..||||+++.. ......++.+|+..+.++ +||||+++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3445689999999999999999998532 247999998653 345567899999999888 799999999999
Q ss_pred eeCCcceEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCc
Q 041043 448 LEVEVPLLVYEFIPNGTLFQYLHDPSE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 514 (678)
Q Consensus 448 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 514 (678)
.+.+..++||||+++|+|.++|..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 999999999999999999999975432 246899999999999999999999999 9999999999
Q ss_pred eEECCCCcEEEeeccCcccccCCcce-eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccccc
Q 041043 515 ILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLT-GQKPISYIWANE 592 (678)
Q Consensus 515 ILl~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~ellt-g~~p~~~~~~~~ 592 (678)
||++.++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..||..
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~----- 240 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----- 240 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-----
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-----
Confidence 99999999999999999877544333 2344568999999999999999999999999999999998 6778742
Q ss_pred CCChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 593 GRNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
....+.+. .+..+ .+...+...++++.+|+.+||+.||++|||++||++.|++|.+.
T Consensus 241 -~~~~~~~~-~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 241 -VPVEELFK-LLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -CCHHHHHH-HHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCHHHHHH-HHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 22222222 22211 12223334556899999999999999999999999999999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=383.44 Aligned_cols=248 Identities=26% Similarity=0.330 Sum_probs=208.5
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5789999999999999999997 46899999987632 3345678899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999753 35899999999999999999999999 999999999999999999999999999865433
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+....+.......
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~------~~~~~~~~~i~~~~---------- 221 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------QDHERLFELILMEE---------- 221 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC----------
T ss_pred Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC------cCHHHHHHHHhcCC----------
Confidence 22 23446799999999999999999999999999999999999999953 22233332222211
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 653 (678)
...+...++++.+||.+||+.||++||+ ++|+++.
T Consensus 222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1123345567899999999999999995 7888763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=384.74 Aligned_cols=271 Identities=26% Similarity=0.406 Sum_probs=221.0
Q ss_pred ccChHHHHhhccCCCcCCeeeeeCCcEEEEEEEc------CCcEEEEEEccc-CChhhHHHHHHHHHHHhcCCCCceeeE
Q 041043 371 IFNSKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIIAVKKSKV-VDESKLEEFINEVVILSQISHRNVVKL 443 (678)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l 443 (678)
++-.++|+...++|++.+.||+|+||+||+|.+. +++.||||+++. ........|.+|++++++++||||+++
T Consensus 9 ~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred CcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 3444566667789999999999999999999863 357899999864 344555679999999999999999999
Q ss_pred EeEEeeCCcceEEEEeccCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceE
Q 041043 444 LGSCLEVEVPLLVYEFIPNGTLFQYLHDP-------SEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 516 (678)
Q Consensus 444 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIL 516 (678)
++++...+..++||||+++|+|.+++... .....+++..+..++.|+++||+|||+++ |+||||||+|||
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiL 165 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 165 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCcee
Confidence 99999999999999999999999998642 12235799999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccCcccccCCccee-eeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCccccccCC
Q 041043 517 LDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQ-KPISYIWANEGR 594 (678)
Q Consensus 517 l~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~-~p~~~~~~~~~~ 594 (678)
|++++++||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+||. .||. +.
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~------~~ 239 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ------GL 239 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT------TS
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC------CC
Confidence 9999999999999998765443332 33346899999999999999999999999999999999985 5663 23
Q ss_pred ChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 595 NLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
+..+.+....... +...+...++.+.+|+.+||+.||++|||++||+++|++..+.
T Consensus 240 ~~~~~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 240 SNEQVLRFVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp CHHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CHHHHHHHHHhCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 3333333332211 1122334456899999999999999999999999999877543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=378.94 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=203.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHH--HHhcCCCCceeeEEeEEeeCC----cce
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVV--ILSQISHRNVVKLLGSCLEVE----VPL 454 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~--~l~~l~h~niv~l~~~~~~~~----~~~ 454 (678)
.++|.+.+.||+|+||+||+|++ +|+.||||+++.. ..+++..|.+ .+.+++||||+++++++.+.+ ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 34677889999999999999997 5899999988643 2344444544 456789999999999998754 468
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA-----YLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
+||||+++|+|.++|++. .++|.+++.++.|+|.||+|||+.. ..+|+||||||+||||++++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999999753 4899999999999999999999741 1239999999999999999999999999
Q ss_pred CcccccCCcce---eeeccccccCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCccccccC-------
Q 041043 530 TSRSIAIDQTH---VSTKVQGTFGYLDPEYFHSSQ------FTDKSDVYSFGVVLVELLTGQKPISYIWANEG------- 593 (678)
Q Consensus 530 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwslGvll~elltg~~p~~~~~~~~~------- 593 (678)
+++........ ......||+.|+|||++.+.. ++.++||||||++||||+||..|+........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99876544332 234467999999999987643 57799999999999999999988743221110
Q ss_pred -CChHHHHHHHHhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhcc
Q 041043 594 -RNLATYFVECVEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRACN 661 (678)
Q Consensus 594 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~~ 661 (678)
..................-+.... ...+....+.+|+.+||+.||++|||+.||++.|++|..++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCccc---CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111122222222111111010111 12345677999999999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-45 Score=379.16 Aligned_cols=245 Identities=27% Similarity=0.392 Sum_probs=206.9
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999974 6899999987532 2344678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999999753 35889999999999999999999999 999999999999999999999999999876432
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||.. .+..+.........
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~i~~~~---------- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD------SNTMKTYEKILNAE---------- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHCC----------
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC------cCHHHHHHHHHcCC----------
Confidence 2345799999999999999999999999999999999999999952 23333333222211
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAME 653 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 653 (678)
...+...++++.+++.+||+.||.+|| |++|+++.
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112233456789999999999999996 89999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-45 Score=369.70 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=205.0
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC---------hhhHHHHHHHHHHHhcCC-CCceeeEEeEEee
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---------ESKLEEFINEVVILSQIS-HRNVVKLLGSCLE 449 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~ 449 (678)
.++|++.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999996 468999999875432 122356889999999997 9999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeecc
Q 041043 450 VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 529 (678)
Q Consensus 450 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 529 (678)
.+..++||||+++|+|.++|+.. ..+++.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999743 36999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcceeeeccccccCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHS------SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVEC 603 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 603 (678)
+++.+.... ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||.. .+........
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~------~~~~~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH------RKQMLMLRMI 227 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC------CCHHHHHHHH
Confidence 998765432 2344679999999999853 3468899999999999999999999952 2222222222
Q ss_pred HhhccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 604 VEENCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.... .. .........++++.+|+.+||+.||++|||++||++
T Consensus 228 ~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2211 10 111112345578999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=376.60 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=207.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
..++|++.+.||+|+||+||+|... +++.||||.++.... ..+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999975 688999999876443 34678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCC--CcEEEeeccCcccccC
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAI 536 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgl~~~~~~ 536 (678)
|+++|+|.++|+... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999997542 35999999999999999999999999 9999999999999854 5899999999987654
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
.. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.. .+....+......... .+..
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~------~~~~~~~~~i~~~~~~---~~~~ 225 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA------ETNQQIIENIMNAEYT---FDEE 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHTCCC---CCHH
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCCCC---CChh
Confidence 32 23345689999999999999999999999999999999999999952 2223333333222110 0011
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. ...++++.+|+.+||+.||++|||++|+++.
T Consensus 226 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1234578999999999999999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-44 Score=379.40 Aligned_cols=244 Identities=23% Similarity=0.301 Sum_probs=206.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 457 (678)
++|++.+.||+|+||+||+|+.+ +|+.||||++.. .+....+.+.+|+++|++++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999975 689999998753 22344578899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 537 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~ 537 (678)
||+.+|+|..++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999999753 35999999999999999999999999 999999999999999999999999999876532
Q ss_pred cceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchhh
Q 041043 538 QTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQV 617 (678)
Q Consensus 538 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (678)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.. .+............
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~i~~~~---------- 254 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA------DQPIQIYEKIVSGK---------- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC----------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC------cCHHHHHHHHhcCC----------
Confidence 2345699999999999999999999999999999999999999952 23333333322211
Q ss_pred hcCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041043 618 RKSGKTEEIMEVSDVAKRCLNSNGRSRP-----TMKEVAM 652 (678)
Q Consensus 618 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 652 (678)
...+...++++.+|+.+||+.||.+|+ |++|+++
T Consensus 255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111234456799999999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=375.98 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=204.3
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC---ChhhHHHHHHHHHHHh-cCCCCceeeEEeEEeeCCcceEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILS-QISHRNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~lv 456 (678)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999975 6899999998632 2334566777777765 68999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccC
Q 041043 457 YEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 536 (678)
Q Consensus 457 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~ 536 (678)
|||+++|+|.++++.. ..+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999753 35899999999999999999999999 99999999999999999999999999986554
Q ss_pred CcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhcchh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDILDDQ 616 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (678)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~~~--------- 219 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG------QDEEELFHSIRMDN--------- 219 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC---------
T ss_pred ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC------CCHHHHHHHHHcCC---------
Confidence 332 33445799999999999999999999999999999999999999952 23333332222211
Q ss_pred hhcCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 041043 617 VRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMK-EVAM 652 (678)
Q Consensus 617 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 652 (678)
...+...++++.+|+.+||+.||++|||+. |+++
T Consensus 220 --~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111233456799999999999999999996 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-44 Score=376.78 Aligned_cols=248 Identities=22% Similarity=0.272 Sum_probs=198.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccC------ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcce
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV------DESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPL 454 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 454 (678)
++|++.++||+|+||+||+|+.. +|+.||||++... .........+|+++++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999975 6899999987531 1111223344577888889999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccc
Q 041043 455 LVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 534 (678)
Q Consensus 455 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~ 534 (678)
+||||+++|+|.++|.+. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999753 35899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccchhhc
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLFDIL 613 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (678)
.... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||..... ........ ....
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~-~~~~------- 223 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT---KDKHEIDR-MTLT------- 223 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS---SCHHHHHH-HSSS-------
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-hccc-------
Confidence 5432 234569999999999875 5689999999999999999999999963221 11211111 1000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041043 614 DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAM 652 (678)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 652 (678)
. ....+...++++.+||.+||+.||++||| ++|+++
T Consensus 224 -~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 -M--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -C--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -C--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 11122344567999999999999999999 678875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=373.26 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=198.0
Q ss_pred ccCCCcC-CeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhc-CCCCceeeEEeEEee----CCcc
Q 041043 381 TDHFNVN-RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQ-ISHRNVVKLLGSCLE----VEVP 453 (678)
Q Consensus 381 ~~~~~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~----~~~~ 453 (678)
.++|.+. +.||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.+ .+||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3578776 4699999999999996 46899999998642 457789998755 589999999999875 3568
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC---CCcEEEeeccC
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 530 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgl 530 (678)
++||||+++|+|.++|.+.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999998643 346999999999999999999999999 999999999999985 56799999999
Q ss_pred cccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
++....... .....||+.|+|||++.+..++.++|||||||+||+|+||+.||......+ .......
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---~~~~~~~-------- 227 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKT-------- 227 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH---HHHHHHH--------
Confidence 987654332 344569999999999999999999999999999999999999995321111 1110000
Q ss_pred hhcchhhhcC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 611 DILDDQVRKS--GKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 611 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.+........ .....++++.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000011011 112445789999999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=368.55 Aligned_cols=254 Identities=25% Similarity=0.259 Sum_probs=194.2
Q ss_pred CCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhh-----HHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEec
Q 041043 387 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK-----LEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEFI 460 (678)
Q Consensus 387 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 460 (678)
.++||+|+||+||+|... +|+.||||+++...... .+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999964 68999999886433221 346889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcce
Q 041043 461 PNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 540 (678)
Q Consensus 461 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~~ 540 (678)
+++++..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 98877766653 346899999999999999999999999 999999999999999999999999999866543322
Q ss_pred eeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh------ccchhhc
Q 041043 541 VSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE------NCLFDIL 613 (678)
Q Consensus 541 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 613 (678)
.....||+.|+|||++... .++.++|||||||++|||++|+.||.... ..+......+. ..+....
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~------~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS------DLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC------HHHHHHHHHHhcCCCChhhccchh
Confidence 2345689999999998754 57999999999999999999999985321 11112211110 0000000
Q ss_pred ch------hhhcCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 614 DD------QVRKSGK-----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 614 ~~------~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. ......+ ...++++.+|+.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 0000001 1234678999999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-43 Score=362.94 Aligned_cols=258 Identities=23% Similarity=0.294 Sum_probs=200.1
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEEe
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYEF 459 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 459 (678)
++|++.++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999999999999986533 33357899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCcc
Q 041043 460 IPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 539 (678)
Q Consensus 460 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~~ 539 (678)
+.++.+..+.+. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 988777666653 346999999999999999999999998 99999999999999999999999999987544322
Q ss_pred eeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---hc---cchhh
Q 041043 540 HVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---EN---CLFDI 612 (678)
Q Consensus 540 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~ 612 (678)
......+++.|+|||.+... .++.++||||||+++|||++|+.||.... ..+....... .. .....
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS------EADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC------HHHHHHHHHHhhCCCChhhccch
Confidence 23334589999999998764 56899999999999999999999995321 1111111111 00 00000
Q ss_pred cc-----hhh-------hcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 613 LD-----DQV-------RKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 613 ~~-----~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.. ... ........++.+.+|+++||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000 00111233467899999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=363.70 Aligned_cols=264 Identities=21% Similarity=0.333 Sum_probs=200.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.++||+|+||+||+|+. .+|+.||||+++... +...+++.+|+++|++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999997 568999999986432 2335789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
|+.++ +.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99754 44444332 2346999999999999999999999999 9999999999999999999999999998664333
Q ss_pred ceeeeccccccCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh-hccchhhcchh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE-ENCLFDILDDQ 616 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 616 (678)
. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||... +.......... .+...+.....
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD------SEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHHHCCCCTTTSTT
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC------CHHHHHHHHHHhcCCCchhhccc
Confidence 2 233456999999999877655 578999999999999999999999532 11111111111 00000000000
Q ss_pred h-----------hc-CC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 041043 617 V-----------RK-SG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERI 657 (678)
Q Consensus 617 ~-----------~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l 657 (678)
. .. .. ....++++.+|+.+||+.||++|||++|+++. |+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 00 00 01234678999999999999999999999875 4444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=361.99 Aligned_cols=260 Identities=24% Similarity=0.310 Sum_probs=196.7
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-C-CcEEEEEEcccC--ChhhHHHHHHHHHHHhcC---CCCceeeEEeEEee----
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-D-GRIIAVKKSKVV--DESKLEEFINEVVILSQI---SHRNVVKLLGSCLE---- 449 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~---- 449 (678)
.++|++.++||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999973 4 567999987532 222234566777776665 79999999999863
Q ss_pred -CCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeec
Q 041043 450 -VEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 528 (678)
Q Consensus 450 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 528 (678)
....++++||++++.+....... ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 24678999999988776555432 346899999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh--
Q 041043 529 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE-- 606 (678)
Q Consensus 529 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 606 (678)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.+......
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS------SDVDQLGKILDVIG 232 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHHHC
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC------CHHHHHHHHHHhhC
Confidence 9987654322 334567999999999999999999999999999999999999999532 222222221110
Q ss_pred -c---cchhh----------cchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 -N---CLFDI----------LDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 -~---~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
. .+... .............++.+.+|+.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000 00000001122344678899999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=362.63 Aligned_cols=241 Identities=27% Similarity=0.404 Sum_probs=196.1
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCC---h---hhHHHHHHHHHHHhcCC--CCceeeEEeEEeeCC
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---E---SKLEEFINEVVILSQIS--HRNVVKLLGSCLEVE 451 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~---~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~ 451 (678)
.++|++.++||+|+||+||+|+.. +|+.||||+++... . ....++.+|++++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999964 68999999875321 1 12234678999999987 899999999999999
Q ss_pred cceEEEEeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-CCcEEEeecc
Q 041043 452 VPLLVYEFIPN-GTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFG 529 (678)
Q Consensus 452 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfg 529 (678)
..++||||+.+ +++.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 6788888643 36999999999999999999999999 999999999999985 4799999999
Q ss_pred CcccccCCcceeeeccccccCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc
Q 041043 530 TSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQF-TDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC 608 (678)
Q Consensus 530 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 608 (678)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ......
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~- 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ- 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCC-
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcc-
Confidence 99765432 2334579999999999987765 567899999999999999999995210 011110
Q ss_pred chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 609 LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...+...++++.+|+.+||+.||++|||++|+++.
T Consensus 221 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01122345678999999999999999999999763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=355.41 Aligned_cols=260 Identities=21% Similarity=0.264 Sum_probs=194.7
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEee--------C
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLE--------V 450 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~ 450 (678)
++|++.++||+|+||+||+|+. ++|+.||||++... .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6799999999999999999997 47899999987542 33445778999999999999999999998865 3
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 451 EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 451 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
+..++||||++++.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 457899999988777655543 335899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcce---eeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh
Q 041043 531 SRSIAIDQTH---VSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE 606 (678)
Q Consensus 531 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 606 (678)
++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~------~~~~~~~i~~~ 237 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT------EQHQLALISQL 237 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC------HHHHHHHHHHh
Confidence 9766533322 22334689999999998765 68999999999999999999999995321 11111111110
Q ss_pred -cc-----chhh--------cchhhhcCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 607 -NC-----LFDI--------LDDQVRKSGK-------TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 607 -~~-----~~~~--------~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
.. .... .......... ....+.+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 0000 0000000000 1113467899999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-41 Score=345.51 Aligned_cols=269 Identities=19% Similarity=0.217 Sum_probs=202.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeE-EeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKL-LGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l-~~~~~~~~~~~lv~e 458 (678)
.++|++.+.||+|+||+||+|+. .+|+.||||.+..... .+++..|++++++++|+|++.. .++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46799999999999999999996 4689999998765332 2467899999999987765555 555567778899999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEEC---CCCcEEEeeccCccccc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIA 535 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgl~~~~~ 535 (678)
|+. ++|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 994 5666666532 236999999999999999999999999 99999999999986 45579999999998765
Q ss_pred CCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc
Q 041043 536 IDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL 609 (678)
Q Consensus 536 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (678)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 43322 23445799999999999999999999999999999999999999964332222111111110000000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh-ccCCCCC
Q 041043 610 FDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRA-CNLQDDD 666 (678)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~-~~~~~~~ 666 (678)
.+.. ....++++.+++.+||+.+|++||+++++.+.|+++.. .....+.
T Consensus 237 ----~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~ 286 (299)
T d1ckia_ 237 ----IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286 (299)
T ss_dssp ----HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSC
T ss_pred ----hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCC
Confidence 0011 11234578999999999999999999999999998864 3344443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=359.13 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=196.8
Q ss_pred CCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC------cceE
Q 041043 383 HFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE------VPLL 455 (678)
Q Consensus 383 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~l 455 (678)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|+++|++++||||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999975 689999999865332 2347999999999999999999986432 3689
Q ss_pred EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccc
Q 041043 456 VYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSI 534 (678)
Q Consensus 456 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~ 534 (678)
||||++++.+....+.......+++.+++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987644443332223456999999999999999999999999 99999999999999775 8999999999876
Q ss_pred cCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHh---h----
Q 041043 535 AIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVE---E---- 606 (678)
Q Consensus 535 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~---- 606 (678)
..... .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..... .
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~------~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH------HHHHHHHHHHHCCCCHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH------HHHHHHHHHHhCCChHH
Confidence 54332 234568999999998765 5689999999999999999999999953221 111111110 0
Q ss_pred -----------ccchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhc
Q 041043 607 -----------NCLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIRAC 660 (678)
Q Consensus 607 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~~~ 660 (678)
...................++++.+|+.+||+.||++|||++|+++. |+.++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 00000000001111122345678999999999999999999999974 6666543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=353.73 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=197.4
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC----cc
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQISHRNVVKLLGSCLEVE----VP 453 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~ 453 (678)
++.+|++.++||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456799999999999999999996 47999999998643 3455678999999999999999999999987654 23
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCccc
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 533 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~ 533 (678)
+++++++.+|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||||++++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5566777899999999642 5999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcce--eeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 534 IAIDQTH--VSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 534 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
....... ......||+.|+|||++.. ..++.++||||+|+++|||++|+.||......+ ...............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChh
Confidence 6443322 2344568999999999854 567889999999999999999999995322111 000000000000000
Q ss_pred --------hhcchh--h--hcCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 611 --------DILDDQ--V--RKSGK-----TEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 611 --------~~~~~~--~--~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
...... . ....+ ...+.++.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0 00000 1223478899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=359.22 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=196.9
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCC-----
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVE----- 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 451 (678)
..++|++.++||+|+||+||+|... +|+.||||+++. .+....+.+.+|+++|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999964 699999999864 34455678999999999999999999999998655
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccC
Q 041043 452 -VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 530 (678)
Q Consensus 452 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 530 (678)
..++||||+ +.+|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 468999999 5678777753 35999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcceeeeccccccCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhh-cc
Q 041043 531 SRSIAIDQTHVSTKVQGTFGYLDPEYFHS-SQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEE-NC 608 (678)
Q Consensus 531 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 608 (678)
++..... .+...+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .......... +.
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~------~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH------LDQLKEIMKVTGT 237 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh------HHHHHHHHhccCC
Confidence 9865432 234568999999999876 4568999999999999999999999963211 1111111000 00
Q ss_pred --------------------chhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 609 --------------------LFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 609 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
......... .......++.+.+|+.+||+.||++|||++|+++. |+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000 00112234578899999999999999999999985 65554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=346.45 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=205.4
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeCCcceEEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 458 (678)
++|++.++||+|+||+||+|+.. +++.||||+++. ......+++.+|+.+|+.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 689999998754 334556889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcccccCCc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 538 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~~~~~~~ 538 (678)
++.+++|..+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999998888753 35899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeeccccccCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhcc------chh
Q 041043 539 THVSTKVQGTFGYLDPEYFHSSQ-FTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENC------LFD 611 (678)
Q Consensus 539 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 611 (678)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||. .+.+..+.......... ...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF-----PGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC-----CCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC-----CCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 2 233345788899999987665 6899999999999999999999974 22333332222211100 000
Q ss_pred ---hcc---------hhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 612 ---ILD---------DQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 612 ---~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
..+ ...........++.+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00001112334567899999999999999999999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-41 Score=342.98 Aligned_cols=263 Identities=16% Similarity=0.170 Sum_probs=207.6
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEcccCChhhHHHHHHHHHHHhcCCC-CceeeEEeEEeeCCcceEEEE
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQISH-RNVVKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 458 (678)
.++|++.++||+|+||+||+|+.. +|+.||||.+..... .+++.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 568999999999999999999965 689999998754322 2457789999999975 899999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECC-----CCcEEEeeccCccc
Q 041043 459 FIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-----KYRAKIADFGTSRS 533 (678)
Q Consensus 459 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgl~~~ 533 (678)
|+ +++|.++++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 689999987543 35899999999999999999999999 999999999999974 57899999999987
Q ss_pred ccCCcce------eeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhc
Q 041043 534 IAIDQTH------VSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEEN 607 (678)
Q Consensus 534 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 607 (678)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~---~~~~~~~~i~~~~ 232 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA---TNKQKYERIGEKK 232 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC---CHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch---hHHHHHHHHHhcc
Confidence 6543221 233456999999999999999999999999999999999999999633222 1222221111111
Q ss_pred cchhhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhc
Q 041043 608 CLFDILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAMELERIRAC 660 (678)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~l~~~ 660 (678)
. . ..-..+. ...++++.+++..|+..+|++||+++.+.+.|+++...
T Consensus 233 ~-~-~~~~~l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 233 Q-S-TPLRELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp H-H-SCHHHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred C-C-CChHHhc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 0 0 0001111 12335789999999999999999999999999887643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=351.78 Aligned_cols=252 Identities=26% Similarity=0.332 Sum_probs=203.6
Q ss_pred cCCCcCCeeeeeCCcEEEEEEEc----CCcEEEEEEcccC----ChhhHHHHHHHHHHHhcCCC-CceeeEEeEEeeCCc
Q 041043 382 DHFNVNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV----DESKLEEFINEVVILSQISH-RNVVKLLGSCLEVEV 452 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~ 452 (678)
++|++.+.||+|+||+||+|... +|+.||||.++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 4789999987532 22345678899999999976 899999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 453 PLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 453 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.++++||+.+|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999997543 5788999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcceeeeccccccCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccch
Q 041043 533 SIAIDQTHVSTKVQGTFGYLDPEYFHSS--QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCLF 610 (678)
Q Consensus 533 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (678)
.+............|++.|+|||.+... .++.++|||||||+||||++|+.||..... ..............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~--~~~~~~i~~~~~~~---- 251 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKS---- 251 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS--CCCHHHHHHHHHHC----
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcccC----
Confidence 7655544445556799999999998764 467899999999999999999999963321 11122111111111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041043 611 DILDDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPT-----MKEVAM 652 (678)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 652 (678)
....+...++++.+|+.+||++||++||| ++|+++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11123345678999999999999999994 788876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-40 Score=345.86 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=195.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeC--CcceEEE
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEV--EVPLLVY 457 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 457 (678)
++|++.++||+|+||+||+|+. .+++.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 468999999987543 467889999999996 99999999998754 4688999
Q ss_pred EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCC-cEEEeeccCcccccC
Q 041043 458 EFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAI 536 (678)
Q Consensus 458 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgl~~~~~~ 536 (678)
||+++++|..+.+ .+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999987653 4899999999999999999999999 99999999999998654 699999999987654
Q ss_pred CcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH---------hh
Q 041043 537 DQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECV---------EE 606 (678)
Q Consensus 537 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~ 606 (678)
... .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||........ ......... ..
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHH
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhh
Confidence 322 3445689999999998765 479999999999999999999999863221110 000000000 00
Q ss_pred cc------chhhc--------chhhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041043 607 NC------LFDIL--------DDQVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKEVAM 652 (678)
Q Consensus 607 ~~------~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 652 (678)
.. ..... ............++++.+||++||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 000011111234567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=344.41 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=191.2
Q ss_pred ccCCCcCCeeeeeCCcEEEEEEEc-CCcEEEEEEccc--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC------C
Q 041043 381 TDHFNVNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQISHRNVVKLLGSCLEV------E 451 (678)
Q Consensus 381 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 451 (678)
.++|++.++||+|+||+||+|... +|+.||||++.. .+....+++.+|++++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999975 699999999864 3455567899999999999999999999999643 5
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..++||||+.++ +.+.+.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 679999999765 4455532 4899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccC----------------CC
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEG----------------RN 595 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~----------------~~ 595 (678)
+..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||........ ..
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 765432 233455689999999999999999999999999999999999999953211000 00
Q ss_pred hHHHHHHHHhhcc------chhhcchhhhcCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041043 596 LATYFVECVEENC------LFDILDDQVRKSG---KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME 653 (678)
Q Consensus 596 ~~~~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 653 (678)
............. ............. ....+.++.+|+++||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000001111100 0000101111111 13456789999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-40 Score=344.35 Aligned_cols=262 Identities=20% Similarity=0.245 Sum_probs=198.1
Q ss_pred hccCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEeeC-----C
Q 041043 380 ATDHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQISHRNVVKLLGSCLEV-----E 451 (678)
Q Consensus 380 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~ 451 (678)
+.++|++.++||+|+||+||+|.. .+|+.||||+++.. +....+++.+|+++|++++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 467899999999999999999996 46999999998643 345567889999999999999999999998643 3
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEeeccCc
Q 041043 452 VPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 531 (678)
Q Consensus 452 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~ 531 (678)
..+++++++.+|+|.++++.. .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 457778888999999999642 5999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCcceeeeccccccCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHhhccc-
Q 041043 532 RSIAIDQTHVSTKVQGTFGYLDPEYFHSS-QFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYFVECVEENCL- 609 (678)
Q Consensus 532 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 609 (678)
...... .....|++.|+|||.+.+. .++.++||||||+++|+|++|+.||.... ..............
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~------~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------HIDQLKLILRLVGTP 238 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCC
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCC
Confidence 754322 2335689999999987665 46889999999999999999999995321 11111111110000
Q ss_pred -hh------------hcchhhh-cCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 041043 610 -FD------------ILDDQVR-KSG-----KTEEIMEVSDVAKRCLNSNGRSRPTMKEVAME--LERIR 658 (678)
Q Consensus 610 -~~------------~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~l~ 658 (678)
.+ ....... ... ....++++.+||.+||+.||++|||++|+++. |.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00 0000000 000 01234578899999999999999999999974 55443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-36 Score=314.75 Aligned_cols=264 Identities=21% Similarity=0.224 Sum_probs=191.8
Q ss_pred cCCCcCCeeeeeCCcEEEEEEE-cCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-----------CCceeeEEeEEee
Q 041043 382 DHFNVNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-----------HRNVVKLLGSCLE 449 (678)
Q Consensus 382 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~~ 449 (678)
.+|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999997 47899999998753 334567888999988875 5789999988865
Q ss_pred C--CcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCceEECCCC-----
Q 041043 450 V--EVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKY----- 521 (678)
Q Consensus 450 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~----- 521 (678)
. ...++++++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4456666666554433333333344578999999999999999999998 77 99999999999998655
Q ss_pred -cEEEeeccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 041043 522 -RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVVLVELLTGQKPISYIWANEGRNLATYF 600 (678)
Q Consensus 522 -~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvll~elltg~~p~~~~~~~~~~~~~~~~ 600 (678)
.+|++|||.+...... .....||+.|+|||++....++.++||||+|++++||++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999998754322 23456999999999999999999999999999999999999999643222111111111
Q ss_pred HHHHhh-cc-----------chhh-----------------cch--hhhcCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041043 601 VECVEE-NC-----------LFDI-----------------LDD--QVRKSGKTEEIMEVSDVAKRCLNSNGRSRPTMKE 649 (678)
Q Consensus 601 ~~~~~~-~~-----------~~~~-----------------~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 649 (678)
...... +. .... ... ..........++++.+|+.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111000 00 0000 000 0112234677889999999999999999999999
Q ss_pred HHHH
Q 041043 650 VAME 653 (678)
Q Consensus 650 vl~~ 653 (678)
+++.
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3.5e-22 Score=189.77 Aligned_cols=168 Identities=19% Similarity=0.194 Sum_probs=120.2
Q ss_pred CcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCC------------------hhhHHHHHHHHHHHhcCCCCceeeEEeE
Q 041043 385 NVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD------------------ESKLEEFINEVVILSQISHRNVVKLLGS 446 (678)
Q Consensus 385 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 446 (678)
.+.++||+|+||+||+|...+|+.||||.++... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999999899999999754211 0112345568899999999999988765
Q ss_pred EeeCCcceEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCceEECCCCcEEEe
Q 041043 447 CLEVEVPLLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 526 (678)
Q Consensus 447 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 526 (678)
. ..+++|||+++..+.+ +++.....++.|++.+|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998865543 333445678999999999999999 9999999999999965 58999
Q ss_pred eccCcccccCCcceeeeccccccCccCccccccCCCCcccchhhHHHH
Q 041043 527 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFHSSQFTDKSDVYSFGVV 574 (678)
Q Consensus 527 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwslGvl 574 (678)
|||++.....+..... ...+... -.|. ....|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHH--HHHHHHH-HHHH-HcCCCCCcccHHHHHHH
Confidence 9999876543222100 0000000 0011 13467889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=3.4e-07 Score=89.23 Aligned_cols=149 Identities=17% Similarity=0.129 Sum_probs=103.5
Q ss_pred HHHHhhccCCCcCCeeeeeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEeeCCcc
Q 041043 375 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS-HRNVVKLLGSCLEVEVP 453 (678)
Q Consensus 375 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~ 453 (678)
.++.+..+.|+..+..+.++...||+... ++..+++|+...........+.+|...++.+. +--+.+++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667777666555455678999875 45567788765544444445677888887764 43456778888888889
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-------------------------------
Q 041043 454 LLVYEFIPNGTLFQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSAY------------------------------- 502 (678)
Q Consensus 454 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~------------------------------- 502 (678)
++||+++++.++.+..... .....++.++++.++.||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999998887654321 1123355666667777775321
Q ss_pred -------------------------CCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 503 -------------------------LPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 503 -------------------------~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
..++|+|+.|.|||++++...-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999987667799999774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=4.4e-05 Score=73.21 Aligned_cols=130 Identities=19% Similarity=0.173 Sum_probs=86.0
Q ss_pred eeeeeCC-cEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCC--CCceeeEEeEEeeCCcceEEEEeccCCCh
Q 041043 389 ILGQGGQ-GTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIS--HRNVVKLLGSCLEVEVPLLVYEFIPNGTL 465 (678)
Q Consensus 389 ~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L 465 (678)
.+..|.. ..||+...+++..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 678999988888889997655433 34566777777664 23356778887888888999999988665
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 041043 466 FQYLHDPSEELSLTWEMRLRIATEVAEALAYLHSSA-------------------------------------------- 501 (678)
Q Consensus 466 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------------- 501 (678)
.+.. +.. ...+.++++.|+-||+..
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 111 112233444444444311
Q ss_pred -----------CCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 502 -----------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 502 -----------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
.+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0127999999999999988777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.98 E-value=0.00077 Score=68.81 Aligned_cols=75 Identities=17% Similarity=0.208 Sum_probs=47.0
Q ss_pred CeeeeeCCcEEEEEEEcC-CcEEEEEEccc----CC---hhhHHHHHHHHHHHhcCC-C--CceeeEEeEEeeCCcceEE
Q 041043 388 RILGQGGQGTVYKGMLAD-GRIIAVKKSKV----VD---ESKLEEFINEVVILSQIS-H--RNVVKLLGSCLEVEVPLLV 456 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~~---~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~lv 456 (678)
+.||.|....||+....+ ++.++||.... .. ....++...|.+.|+.+. + ..+.+++. .+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 468889999999998654 67888885321 11 112344566888887663 2 33445554 355677899
Q ss_pred EEeccCCC
Q 041043 457 YEFIPNGT 464 (678)
Q Consensus 457 ~e~~~~g~ 464 (678)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.05 E-value=0.01 Score=58.31 Aligned_cols=68 Identities=15% Similarity=0.082 Sum_probs=44.1
Q ss_pred cEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCce--eeEE-----eEEeeCCcceEEEEeccCCC
Q 041043 396 GTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRNV--VKLL-----GSCLEVEVPLLVYEFIPNGT 464 (678)
Q Consensus 396 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~ 464 (678)
-.||+...++|+.+++|..+.. ....+++..|...+..|....+ +..+ ......+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 5899999999999999987543 2234667788888877742222 1111 12234556788899887643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.94 E-value=0.0062 Score=61.83 Aligned_cols=72 Identities=21% Similarity=0.257 Sum_probs=47.4
Q ss_pred CeeeeeCCcEEEEEEEcCC--------cEEEEEEcccCChhhHHHHHHHHHHHhcCCCCce-eeEEeEEeeCCcceEEEE
Q 041043 388 RILGQGGQGTVYKGMLADG--------RIIAVKKSKVVDESKLEEFINEVVILSQISHRNV-VKLLGSCLEVEVPLLVYE 458 (678)
Q Consensus 388 ~~Lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 458 (678)
+.|+.|-.-.+|+....++ +.|+++..... . ......+|.++++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5677787888999886543 46777765532 2 22345688899888853344 466666532 68899
Q ss_pred eccCCCh
Q 041043 459 FIPNGTL 465 (678)
Q Consensus 459 ~~~~g~L 465 (678)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9986544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.86 E-value=0.059 Score=52.24 Aligned_cols=158 Identities=10% Similarity=0.050 Sum_probs=81.9
Q ss_pred cChHHHHhhccCCCcCCeee-----eeCCcEEEEEEEcCCcEEEEEEcccCChhhHHHHHHHHHHHhcCCCCc-----ee
Q 041043 372 FNSKELDKATDHFNVNRILG-----QGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQISHRN-----VV 441 (678)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~Lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-----iv 441 (678)
.+.++++....+|.+.+... .|---+.|+.+..+|+ +++|+..... ..+++..|++++..|...+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 46778888888898865543 4555678998877665 7888765421 2234445666666664222 11
Q ss_pred eEEe---EEeeCCcceEEEEeccCCChhhh--------------hc----CCC--CCCCCC------------------H
Q 041043 442 KLLG---SCLEVEVPLLVYEFIPNGTLFQY--------------LH----DPS--EELSLT------------------W 480 (678)
Q Consensus 442 ~l~~---~~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~~--~~~~l~------------------~ 480 (678)
...+ +.........++.+..+...... ++ ... ...... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1110 11223444556666554322110 00 000 000000 0
Q ss_pred HHHHHHHHHHHHHHHHHHhCC-CCCeEeecCCCCceEECCCCcEEEeeccCcc
Q 041043 481 EMRLRIATEVAEALAYLHSSA-YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 532 (678)
Q Consensus 481 ~~~~~i~~~ia~~L~yLH~~~-~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl~~ 532 (678)
......+..+...+...+... ...++|+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122233333333333321 1348999999999999998777899999874
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.52 E-value=0.0098 Score=38.14 Aligned_cols=26 Identities=27% Similarity=0.551 Sum_probs=20.9
Q ss_pred CCCccccCCCCceEeecCCCCCCCccc
Q 041043 257 STSHCESDEGGLFRCSCKEKYHGNPYF 283 (678)
Q Consensus 257 ~~s~C~~~~~~~~~C~C~~gy~gnpy~ 283 (678)
.++.|.+.. ++|.|.|+.||.||.+.
T Consensus 11 ~~A~C~Nt~-Gsy~C~C~~Gy~GdG~~ 36 (40)
T d1gl4a2 11 VHAECRDYA-TGFCCRCVANYTGNGRQ 36 (40)
T ss_dssp TTEEEEECS-SCEEEEECTTEEECSSS
T ss_pred CCCEeecCC-CCeEeECCCCCcCCCCE
Confidence 457888765 56889999999998753
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.03 E-value=0.047 Score=35.50 Aligned_cols=23 Identities=26% Similarity=0.651 Sum_probs=18.0
Q ss_pred CCccccCCCCceEeecCCCCCCCc
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNP 281 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnp 281 (678)
++.|.+.. |+|+|.|+.||.+++
T Consensus 16 ~~~C~Nt~-Gsy~C~C~~Gy~~~g 38 (43)
T d1emoa1 16 HGQCINTD-GSYRCECPFGYILAG 38 (43)
T ss_dssp SSCCCCCS-SCCCCCCCTTEEESS
T ss_pred CCEeECCC-CCeEeECCCCcccCC
Confidence 46787765 678899999998754
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.86 E-value=0.062 Score=35.06 Aligned_cols=23 Identities=30% Similarity=0.764 Sum_probs=18.5
Q ss_pred CCccccCCCCceEeecCCCCCCCc
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNP 281 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnp 281 (678)
++.|.+.. |+|+|.|+.||+++.
T Consensus 15 ~~~C~Nt~-Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 15 RGQCVNTP-GDFECKCDEGYESGF 37 (44)
T ss_dssp TSCEEEET-TEEEECCCSSEEECT
T ss_pred CCEeEcCC-CCeEEeCCCCCccCC
Confidence 46787765 779999999998864
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.28 E-value=0.19 Score=32.35 Aligned_cols=23 Identities=30% Similarity=0.755 Sum_probs=18.2
Q ss_pred CCccccCCCCceEeecCCCCCCCc
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNP 281 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnp 281 (678)
++.|.+.. |+|+|.|+.||..++
T Consensus 14 ~~~C~Nt~-Gsy~C~C~~Gy~l~~ 36 (42)
T d1lmja2 14 GGVCHNTE-GSYRCECPPGHQLSP 36 (42)
T ss_dssp TSEEEEET-TEEEEESCTTSCCCS
T ss_pred CCEeECCC-CCeEEeCCCCCeECc
Confidence 45787765 789999999998665
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.12 E-value=0.18 Score=32.36 Aligned_cols=24 Identities=29% Similarity=0.764 Sum_probs=18.7
Q ss_pred cCCCccccCCCCceEeecCCCCCCC
Q 041043 256 TSTSHCESDEGGLFRCSCKEKYHGN 280 (678)
Q Consensus 256 ~~~s~C~~~~~~~~~C~C~~gy~gn 280 (678)
..++.|.+.. ++|.|.|+.||.|.
T Consensus 14 ~n~g~C~n~~-g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 14 EHAGKCINTL-GSFECQCLQGYTGP 37 (42)
T ss_dssp STTCEEEECS-SSEEEECCTTEEST
T ss_pred CCCcEeECCC-CCEEeECCCCCcCC
Confidence 3458888754 56889999999985
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.40 E-value=0.23 Score=32.05 Aligned_cols=23 Identities=30% Similarity=0.641 Sum_probs=18.1
Q ss_pred CCccccCCCCceEeecCCCCCCCc
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNP 281 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnp 281 (678)
++.|.+.. |+|+|.|+.||..++
T Consensus 15 ~~~C~Nt~-Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 15 GGKCINTF-GSFQCRCPTGYYLNE 37 (43)
T ss_dssp TSEEEECS-SCEEEECCTTCCBCT
T ss_pred CCEEECCC-CCeEeECCCCCeECc
Confidence 35787775 779999999998655
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.44 E-value=0.28 Score=31.01 Aligned_cols=22 Identities=23% Similarity=0.463 Sum_probs=17.3
Q ss_pred CccccCCCCceEeecCCCCCCCc
Q 041043 259 SHCESDEGGLFRCSCKEKYHGNP 281 (678)
Q Consensus 259 s~C~~~~~~~~~C~C~~gy~gnp 281 (678)
..|.+.. |+|+|.|+.||..++
T Consensus 13 ~~C~N~~-Gsy~C~C~~Gy~l~g 34 (40)
T d1dx5i3 13 GVCHNLP-GTFECICGPDSALAG 34 (40)
T ss_dssp SEEEECS-SSEEEEECSSSSCEE
T ss_pred CEeeCCC-CCeEeECCCCCeeCC
Confidence 4576654 779999999998865
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.09 E-value=0.2 Score=32.35 Aligned_cols=23 Identities=26% Similarity=0.807 Sum_probs=18.2
Q ss_pred CCccccCCCCceEeecCCCCCCCc
Q 041043 258 TSHCESDEGGLFRCSCKEKYHGNP 281 (678)
Q Consensus 258 ~s~C~~~~~~~~~C~C~~gy~gnp 281 (678)
+..|.+.. |+|.|.|+.||+.++
T Consensus 14 ~~~C~Nt~-G~y~C~C~~Gy~l~~ 36 (43)
T d1uzka1 14 SGNCVNTP-GSYICDCPPDFELNP 36 (43)
T ss_dssp TSEEEEET-TEEEEECCTTCEECT
T ss_pred CCEeECCC-CCEEEecCCCCEECC
Confidence 36787765 678999999998765
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.67 E-value=0.24 Score=33.61 Aligned_cols=21 Identities=29% Similarity=0.649 Sum_probs=16.4
Q ss_pred CccccCCCCceEeecCCCCCCC
Q 041043 259 SHCESDEGGLFRCSCKEKYHGN 280 (678)
Q Consensus 259 s~C~~~~~~~~~C~C~~gy~gn 280 (678)
..|.+.. |+|+|.|+.||..+
T Consensus 24 ~~C~Nt~-GsY~C~C~~Gy~l~ 44 (53)
T d1apqa_ 24 HLCHNYV-GGYFCSCRPGYELQ 44 (53)
T ss_dssp SEEEEET-TEEEEECSTTCEEC
T ss_pred CEeEcCC-CCeEeECCCCCeEC
Confidence 4577765 78999999999744
|